Global: ^ONCO(165.5

FileMan FileNo	FileMan Filename	Package
165.5	ONCOLOGY PRIMARY	Oncology

Package	Total	Routines
Oncology	200	ONC2PS04 ONC2PS13 ONC2PS1A ONC2PS4A ONCACD0 ONCACD1 ONCACDU1 ONCACDU2 ONCASCI ONCATF ONCATF1 ONCBPC1 ONCBPC2 ONCBPC3 ONCBPC4 ONCBPC5 ONCBPC6 ONCBPC8 ONCBRP1 ONCBRP2 ONCBRP3 ONCBRP4 ONCBRP5 ONCBRP5A ONCBRP6 ONCBRP7 ONCBRP9 ONCCPC1 ONCCPC2 ONCCPC3 ONCCPC4 ONCCPC5 ONCCPC6 ONCCPC7 ONCCPC9 ONCCS ONCCS2 ONCCSRS ONCCSRS1 ONCCSSTF ONCEDIT ONCEDIT2 ONCFUNC ONCGENED ONCGPC1 ONCGPC2 ONCGPC3 ONCGPC4 ONCGPC5 ONCGPC7 ONCGPC7A ONCGPC7B ONCHPC1 ONCHPC2 ONCHPC3 ONCHPC4 ONCHPC4A ONCHPC5 ONCHPC8 ONCHPC8A ONCIPC1 ONCIPC2 ONCIPC2A ONCIPC3 ONCIPC3A ONCIPC3B ONCIPC3C ONCIPC4 ONCIPC5 ONCIPC8 ONCIPC8A ONCIPC8B ONCIPC8C ONCLPC1 ONCLPC2 ONCLPC3 ONCLPC4 ONCLPC5 ONCLPC6 ONCLPC7 ONCLPC9 ONCLPC9A ONCLPC9B ONCMPC1 ONCMPC2 ONCMPC3 ONCMPC4 ONCMPC5 ONCMPC7 ONCMPC9 ONCMPH ONCNPC1 ONCNPC2 ONCNPC3 ONCNPC4 ONCNPC5 ONCNPC6 ONCNPC8 ONCNPI ONCNTX ONCNTX1 ONCOAI ONCOAIC ONCOAIF ONCOAIM ONCOAIP ONCOAIP1 ONCOAIP2 ONCOAIQ ONCOAIT ONCOCC ONCOCOF ONCOCOM ONCOCOML ONCODSP ONCODSR ONCOEDC ONCOEDC1 ONCOEDC2 ONCOFDP ONCOGEN ONCOPA1 ONCOPA4 ONCOPAR ONCOPMP ONCOPRT ONCORF ONCOSSA ONCOSUR ONCOSUR3 ONCOTM ONCOTNE ONCOTNO ONCOTNS ONCOU55 ONCOUK ONCOUTC ONCOXA3 ONCOXNC ONCOY52 ONCOY54 ONCOY55 ONCP2P1 ONCP2P2 ONCP2P3 ONCP2P4 ONCP2P4A ONCP2P5 ONCP2P6 ONCP2P8 ONCPCI ONCPCS ONCPHC ONCPM ONCPMB ONCPMC ONCPML ONCPMP ONCPPC1 ONCPPC2 ONCPPC3 ONCPPC4 ONCPPC5 ONCPPC6 ONCPPC7 ONCPPC9 ONCPPC9A ONCPPC9B ONCPSD ONCPST44 ONCPST48 ONCPTX ONCRFNR ONCSAPI1 ONCSG5 ONCSPC1 ONCSPC2 ONCSPC3 ONCSPC4 ONCSPC5 ONCSPC6 ONCSPC8 ONCSPC8A ONCSRVTM ONCSTX ONCSYMP ONCTIME ONCTNMC ONCTPC1 ONCTPC2 ONCTPC3 ONCTPC4 ONCTPC5 ONCTPC6 ONCTPC8 ONCTPC8A ONCTXSM ONCUTX ONCUTX1 ONCWEBCS
Health Summary	1	GMTSONE

Package	Total	FileMan Files
Oncology	1	COMPUTED PRIMARY(#165.59)[.01]

Package	Total	FileMan Files
Oncology	38	ONCOLOGY PATIENT(#160)[.02] TYPE OF RECURRENCE(#160.12)[71, 71.4, #165.572(.02)] FACILITY(#160.19)[.03, 5, 6, 7, 50.1, 51.1, 52.1, 53.1, 54.1, 55.1, 57.1, #165.51(2)] PRIMARY PAYER AT DIAGNOSIS(#160.3)[18] ICDO TOPOGRAPHY(#164)[20, 803, 805, 1102, 1104, 1403, 1573, #165.52(1)] ICDO-SITES(#164.08)[.022] ICD-O-2 MORPHOLOGY(#164.1)[22, 804, 806] TUMOR MARKERS(#164.15)[25.1, 25.2, 25.3] KARNOFSKY'S RATING(#164.17)[1311, 1367, 1371] CHEMOTHERAPEUTIC DRUGS(#164.18)[1423, 1423.1, 1423.2, 1423.3, 1423.4, 1576, 1576.1, 1576.2] SITE-GROUP FOR ONCOLOGY(#164.2)[.01, 148.1, 148.2, 148.3, 148.4] OTHER STAGING FOR ONCOLOGY(#164.3)[39] PRIMARY CANCER STATUS CODE(#164.42)[95, #165.573(.02)] GRADE(#164.43)[24] TYPE OF STAGING SYSTEM (PEDIATRIC)(#164.6)[849] RADIATION TREATMENT VOLUME(#164.7)[125, 129] RADIATION COMPLETION STATUS(#164.8)[128] ONCO RADIATION EXTERNAL BEAM(#164.81)[5502, 5512, 5522] ONCO RADIATION TREATMENT VOLUME(#164.82)[5504, 5514, 5524] ONCO RADIATION TO DRAINING LN(#164.83)[5505, 5515, 5525] ONCO RADIATION TREATMENT MODALITY(#164.84)[5506, 5516, 5526] WHO HISTOLOGICAL CLASSIFICATION(#164.9)[1308] ONCOLOGY CONTACT(#165)[2, 2.1, 2.2, 2.3, 2.4, 66] CLASS OF CASE(#165.3)[.04] ONCOLOGY STAGED BY CODES(#165.7)[19, 89] CASEFINDING SOURCE(#166)[21] BLADDER PHYSICIAN SPECIALTY(#166.12)[347, 348] REGIONAL TREATMENT MODALITY(#166.13)[363, 363.1] ONCOLOGY SUBSITE(#166.3)[519] HEMATOLOGIC TRANSPLANT/ENDOCRINE PROCEDURES(#167)[153, 153.2, #165.51(.02)] ONCO BRAIN MOLECULAR MARKERS(#167.1)[3816] GLEASON PATTERNS(#167.2)[3838, 3839] ONCO LN STATUS(#167.3)[3884] ONCO PERIPHERAL BLOOD INVOLVEMENT(#167.4)[3910] ONCO RESIDUAL TUMOR VOLUME(#167.5)[3921] TYPE OF REPORTING SOURCE(#168)[1.2] TYPE OF MULTIPLE TUMORS(#169)[194] ICD-O-3 MORPHOLOGY(#169.3)[22.3]
Kernel	3	INSTITUTION(#4)[2000] STATE(#5)[16, 7000, 7001, 7023] NEW PERSON(#200)[64.1, 92, 199, 244]
DRG Grouper	1	ICD DIAGNOSIS(#80)[1400, 1400.1, 1400.2, 1400.3, 1400.4, 1400.5, 1426, 1426.1, 1426.2, 1426.3, 1426.4, 1571, 1571.1, 1571.2, 1571.3, 1571.4, 1571.5, 1579, 1579.1, 1579.2, 1579.3, 1579.4]

Fields, Total: 1896

Field #	Name	Loc	Type	Details
.01	SITE/GP	0;1	POINTER TO SITE-GROUP FOR ONCOLOGY FILE (#164.2)	**********************REQUIRED FIELD********************** SITE-GROUP FOR ONCOLOGY(#164.2) LAST EDITED: `AUG 12, 2005` HELP-PROMPT: `Enter the SITE/GP which best categorizes the primary.` DESCRIPTION: `Enter the SITE/GP for this primary.` SCREEN: `S DIC("S")="I '$P(^(0),U,3)"` EXPLANATION: `Histologic site groups may not be selected.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^B` `1)= S ^ONCO(165.5,"B",$E(X,1,30),DA)=""` `2)= K ^ONCO(165.5,"B",$E(X,1,30),DA)` CROSS-REFERENCE: `165.5^ACF^MUMPS` `1)= S ^ONCO(165.59,DA,0)=X` `2)= K ^ONCO(165.59,DA,0)` `This cross reference creates an entry in File 165.59 which consists on;y of computed fields for this file. It is a side-car/side-kick file which does not store any data, but references other data for reports.`
.0101	PRIMARY SITE/GP		COMPUTED	MUMPS CODE: `S X="" I D0>0 S X=$P(^ONCO(164.2,$P(^ONCO(165.5,D0,0),U),0),U)` ALGORITHM: `S X=.01 OF ^ONCO(164.2)` DESCRIPTION: `A COMPUTED FIELD RECORDING THE PRIMARY SITE/GROUP FOR ONCOLOGY.`
.015	SELECTED SITES		COMPUTED	MUMPS CODE: `S X="" D SICD^ONCOCOS` ALGORITHM: `S X="" D SICD^ONCOCOS` LAST EDITED: `JAN 11, 2007` DESCRIPTION: `This COMPUTED field displays selected SITE/GP (165.5,.01) values.`
.017	SYSTEMS		COMPUTED	MUMPS CODE: `S X="" D SYS^ONCOCOS` ALGORITHM: `S X="" D SYS^ONCOCOS` DESCRIPTION: `COMPUTED FIELD RECORDING THE MAJOR BODY SYSTEMS, SUCH AS LYMPHATIC, GASTROINTESTINAL, GENITOURINARY, ETC.`
.02	PATIENT NAME	0;2	POINTER TO ONCOLOGY PATIENT FILE (#160)	**********************REQUIRED FIELD********************** ONCOLOGY PATIENT(#160) INPUT TRANSFORM: `I $D(X) D PSEX^ONCOCKI` LAST EDITED: `JUN 20, 1996` DESCRIPTION: `Enter Oncology Patient Name.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^C` `1)= S ^ONCO(165.5,"C",$E(X,1,30),DA)=""` `2)= K ^ONCO(165.5,"C",$E(X,1,30),DA)` `Indexes file by PATIENT NAME.`
.022	ICDO-SITE	0;22	POINTER TO ICDO-SITES FILE (#164.08)	**********************REQUIRED FIELD********************** ICDO-SITES(#164.08) LAST EDITED: `APR 06, 1990` DESCRIPTION: `Listing of primary sites in accordance with ICDO-2 (1992).`
.023	PRIMARY SITE CODE PREFIX		COMPUTED	MUMPS CODE: `S X=$P($G(^ONCO(165.5,D0,2)),U,1) I X'="" S X="C"_$E(X,3,4)` ALGORITHM: `CUSTOM CODED` LAST EDITED: `NOV 25, 2005` DESCRIPTION: `Identifies the three-digit code prefix for the primary site.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
.025	PATIENT ID		COMPUTED	MUMPS CODE: `S X="" D PID^ONCOCOP` ALGORITHM: `S X="" D PID^ONCOCOP` DESCRIPTION: `COMPUTED FIELD FOR RECORDING THE PATIENT IDENTIFICATION NUMBER.`
.03	REPORTING FACILITY	0;3	POINTER TO FACILITY FILE (#160.19)	**********************REQUIRED FIELD********************** FACILITY(#160.19) OUTPUT TRANSFORM: `I Y'="" S Y=$P($G(^ONCO(160.19,Y,0)),U,2)` LAST EDITED: `OCT 22, 2008` DESCRIPTION: `REPORTING FACILITY identifies the facility reporting the case.` GROUP: `ACOS-REQUIRED`
.04	CLASS OF CASE	0;4	POINTER TO CLASS OF CASE FILE (#165.3)	**********************REQUIRED FIELD********************** CLASS OF CASE(#165.3) INPUT TRANSFORM: `D COCIT^ONCOSUR1` OUTPUT TRANSFORM: `S:Y'="" Y=$P(^ONCO(165.3,Y,0),U,1)_" "_$P(^ONCO(165.3,Y,0),U,2)` LAST EDITED: `JUN 21, 2022` HELP-PROMPT: `Enter a CLASS OF CASE code.` DESCRIPTION: `CLASS OF CASE reflects the facility's role in managing the cancer, whether the cancer is required to be reported by CoC, and whether the case was diagnosed after the program's Reference Date.` `CLASS OF CASE divides cases into two groups.` `Analytic cases (codes 00-22) are those that are required by CoC to be abstracted because of the program's primary responsibility in managing the cancer. Analytic cases are grouped according to the location of diagnosis` `and first course of treatment.` `Nonanalytic cases (codes 30-49 and 99) may be abstracted by the facility to meet central registry requirements or in response to a request by the facility's cancer program. Nonanalytic cases are grouped according to the` `reason a patient who received care at the facility is nonanalytic, or the reason a patient who never received care at the facility may have been abstracted.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `^^TRIGGER^165.5^.042` `1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,0)):^(0),1:"") S X=$P(Y(1),U,20),X=X S DIU=X K Y S X=DIV S X=$S(X>9:0,1:1) S DIH=$G(^ONCO(165.5,DIV(0),0)),DIV=X S $P(^(0),U,20)=DIV,DIH=165.5,DIG=.042 D ^DICR` `2)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,0)):^(0),1:"") S X=$P(Y(1),U,20),X=X S DIU=X K Y S X="" S DIH=$G(^ONCO(165.5,DIV(0),0)),DIV=X S $P(^(0),U,20)=DIV,DIH=165.5,DIG=.042 D ^DICR` `CREATE VALUE)= S X=$S(X>9:0,1:1)` `DELETE VALUE)= @` `FIELD)= CLASS CATEGORY` `CLASS CATEGORY (165.5,.042) will be stuffed with either 1 (ANALYTIC) or 0 (NONANALYTIC) depending on the CLASS OF CASE value.` CROSS-REFERENCE: `165.5^AAY^MUMPS` `1)= I X>-1,X<10 S XX=$P(^ONCO(165.5,DA,0),U,7) S:XX'="" ^ONCO(165.5,"AAY",XX,DA)=""` `2)= I X>-1,X<10 S XX=$P(^ONCO(165.5,DA,0),U,7) K:XX'="" ^ONCO(165.5,"AAY",XX,DA) K XX` `Creates an index of analytic (CLASS OF CASE 00-22) cases cross-referenced by ACCESSION YEAR (165.5,.07).`
.041	CLASS NO.		COMPUTED	MUMPS CODE: `N COC S COC=$E($$GET1^DIQ(165.5,D0,.04,"E"),1,2),X=$S(COC="":"None",1:COC)` ALGORITHM: `N COC S COC=$E($$GET1^DIQ(165.5,D0,.04,"E"),1,2),X=$S(COC="":"None",1:COC)` LAST EDITED: `AUG 18, 2010` DESCRIPTION: `Computed CLASS OF CASE code. It is derived from CLASS OF CASE (165.5,.04).`
.042	CLASS CATEGORY	0;20	SET	**********************REQUIRED FIELD********************** '0' FOR NONANALYTIC; '1' FOR ANALYTIC; LAST EDITED: `OCT 29, 2002` HELP-PROMPT: `DO NOT PROMPT-FIELD IS STUFFED BY #.04 (CLASS OF CASE)` DESCRIPTION: `Record the category of case, either Analytic or Nonanalytic.` NOTES: `TRIGGERED by the CLASS OF CASE field of the ONCOLOGY PRIMARY File` CROSS-REFERENCE: `165.5^AG` `1)= S ^ONCO(165.5,"AG",$E(X,1,30),DA)=""` `2)= K ^ONCO(165.5,"AG",$E(X,1,30),DA)` `Indexes file by CLASS CATEGORY.`
.043	ANALYTIC PRIMARY REQ FOLLOWUP		COMPUTED	MUMPS CODE: `D ARFPRI^ONCOCOM` ALGORITHM: `D ARFPRI^ONCOCOM` LAST EDITED: `OCT 08, 2014`
.05	ACCESSION NUMBER	0;5	FREE TEXT	**********************REQUIRED FIELD********************** INPUT TRANSFORM: `K:X[""""!($A(X)=45) X I $D(X) K:$L(X)>9!($L(X)<9)!'(X?.N)!($E(X,5,9)="00000") X I $D(X) D ACN^ONCOCKI` LAST EDITED: `DEC 07, 1999` HELP-PROMPT: `Enter the 9-digit ACCESSION NUMBER.` DESCRIPTION: `Provides a unique identifier for the patient consisting of the year in which the patient was first seen at the reporting facility and the consecutive order in which the patient was abstracted.` `For further information see FORDS page 33.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^D1^MUMPS` `1)= S XX=$P(^ONCO(165.5,DA,0),U,6) Q:XX="" S ^ONCO(165.5,"D",$E(X,1,4)_"-"_$E(X,5,9)_"/"_XX,DA)=""` `2)= S XX=$P(^ONCO(165.5,DA,0),U,6) Q:XX="" K ^ONCO(165.5,"D",$E(X,1,4)_"-"_$E(X,5,9)_"/"_XX,DA)` `Indexes the file by the display value of ACCESSION NUMBER and SEQUENCE NUMBER.` CROSS-REFERENCE: `165.5^AE^MUMPS` `1)= S ^ONCO(165.5,"AE",X,$P(^ONCO(165.5,DA,0),U,2),DA)=""` `2)= K ^ONCO(165.5,"AE",X,$P(^ONCO(165.5,DA,0),U,2),DA)` `Indexes the file by ACCESSION NUMBER and PATIENT NAME.` CROSS-REFERENCE: `165.5^AF^MUMPS` `1)= S ^ONCO(165.5,"AF",999999999-X,DA)=""` `2)= K ^ONCO(165.5,"AF",999999999-X,DA)` `Indexes the file in inverse order by ACCESSION NUMBER.` CROSS-REFERENCE: `165.5^AA` `1)= S ^ONCO(165.5,"AA",$E(X,1,30),DA)=""` `2)= K ^ONCO(165.5,"AA",$E(X,1,30),DA)` `Indexes file by ACCESSION NUMBER.` CROSS-REFERENCE: `165.5^AC^MUMPS` `1)= S ^ONCO(165.5,"AC",$P(^ONCO(165.5,DA,0),U,2),X,DA)=""` `2)= K ^ONCO(165.5,"AC",$P(^ONCO(165.5,DA,0),U,2),X,DA)` `Indexes the file by PATIENT NAME and ACCESSION NUMBER.`
.06	SEQUENCE NUMBER	0;6	FREE TEXT	INPUT TRANSFORM: `K:X[""""!($A(X)=45) X I $D(X) K:$L(X)>2!($L(X)<2) X I $D(X) D SEQ^ONCOCKI` LAST EDITED: `AUG 16, 2000` HELP-PROMPT: `Enter two numerics, e.g. '00' for one primary only.` DESCRIPTION: `Indicates the sequence of malignant and non-malignant neoplasms over the lifetime of the patient.` `Codes 00-59 and 99 indicate neoplasms of in situ or malignant behavior (Behavior equals 2 or 3).` `Codes 60-88 indicate neoplasms of non-malignant behavior (Behavior equals 0 or 1).` `Code 00 only if the patient has a single malignant primary. If the patient develops a subsequent malignant or in situ primary tumor, change the code for the first tumor from 00 to 01, and number subsequent tumors` `sequentially. Code 59 for the fifty-ninth of fifty-nine independent malignant or in situ primaries. Code 99 for an unspecified malignant or in situ sequence number or unknown.` `Code 60 only if the patient has a single non-malignant primary. If the patient develops a subsequent non-malignant primary, change the code for the first tumor from 60 to 61, and assign codes to subsequent non-malignant` `tumors sequentially. Code 87 for the twenty-seventh of twenty-seven independent non- malignant primaries. Code 88 for an unspecified number of neoplasms in this category.` `For further information see FORDS pages 34-35.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^D^MUMPS` `1)= S XX=$P(^ONCO(165.5,DA,0),U,5) Q:XX="" S ^ONCO(165.5,"D",$E(XX,1,4)_"-"_$E(XX,5,9)_"/"_X,DA)=""` `2)= S XX=$P(^ONCO(165.5,DA,0),U,5) Q:XX="" K ^ONCO(165.5,"D",$E(XX,1,4)_"-"_$E(XX,5,9)_"/"_X,DA)` `Indexes the file by the display value of ACCESSION NO. and SEQUENCE NO.`
.061	ACC/SEQ NUMBER		COMPUTED	MUMPS CODE: `X ^DD(165.5,.061,9.3) S X=$E(Y(165.5,.061,5),Y(165.5,.061,6),X) S Y=X,X=Y(165.5,.061,4),X=X_Y_"/"_$P(Y(165.5,.061,1),U,6)` `9.2 = S Y(165.5,.061,1)=$S($D(^ONCO(165.5,D0,0)):^(0),1:"") S X=$P(Y(165.5,.061,1),U,5),Y(165.5,.061,2)=X S X=1,Y(165.5,.061,3)=X S X=4` `9.3 = X ^DD(165.5,.061,9.2) S X=$E(Y(165.5,.061,2),Y(165.5,.061,3),X)_"-",Y(165.5,.061,4)=X S X=$P(Y(165.5,.061,1),U,5),Y(165.5,.061,5)=X S X=5,Y(165.5,.061,6)=X S X=9` ALGORITHM: `$E(ACCESSION NUMBER,1,4)_"-"_$E(ACCESSION NUMBER,5,9)_"/"_SEQUENCE NO.` LAST EDITED: `DEC 07, 1999` DESCRIPTION: `ACC/SEQ NUMBER concatinates the ACCESSION NUMBER and SEQUENCE NUMBER values.`
.07	ACCESSION YEAR	0;7	FREE TEXT	**********************REQUIRED FIELD********************** INPUT TRANSFORM: `K:X[""""!($A(X)=45) X I $D(X) K:$L(X)>4!($L(X)<4)!'(X?4N) X` LAST EDITED: `DEC 07, 1999` HELP-PROMPT: `Enter the year first seen for this primary.` DESCRIPTION: `ACCESSION YEAR (aka YEAR FIRST SEEN FOR THIS PRIMARY) is the year the patient was first seen at the reporting institution for diagnosis and/ or treatment of this primary. It is NOT the year that the registrar accession` `the case. ACCESSION YEAR relates only to one primary tumor. A patient with multiple primaries can have a different ACCESSION YEAR on each abstract.` `This data item is used to produce an accession register. The accession register identifies all primaries first treated or seen at the reporting institution for a given year.` CROSS-REFERENCE: `165.5^AY` `1)= S ^ONCO(165.5,"AY",$E(X,1,30),DA)=""` `2)= K ^ONCO(165.5,"AY",$E(X,1,30),DA)` `Indexes file by ACCESSION YEAR.` CROSS-REFERENCE: `165.5^AAY1^MUMPS` `1)= S XX=$P($G(^ONCO(165.5,DA,0)),U,20) S:XX ^ONCO(165.5,"AAY",X,DA)="" K XX` `2)= S XX=$P($G(^ONCO(165.5,DA,0)),U,20) K:XX ^ONCO(165.5,"AAY",X,DA) K XX` `Maintains an index by ACCESSION YEAR for primaries with stages.` CROSS-REFERENCE: `165.5^ACAY^MUMPS` `1)= S ^ONCO(165.5,"ACAY")=X` `2)= S ^ONCO(165.5,"ACAY")=$E(DT,1)+17_$E(DT,2,3)` `Maintains a default ACCESSION YEAR for the system.`
.08	MEDICAL RECORD NUMBER		COMPUTED	MUMPS CODE: `X ^DD(165.5,.08,9.2) X $P(^DD(160,2,0),U,5,99) S Y(165.5,.08,101)=X S X=Y(165.5,.08,101) S D0=Y(165.5,.08,80)` `9.2 = S Y(165.5,.08,80)=$S($D(D0):D0,1:""),Y(165.5,.08,1)=$S($D(^ONCO(165.5,D0,0)):^(0),1:""),D0=$P(Y(165.5,.08,1),U,2) S:'$D(^ONCO(160,+D0,0)) D0=-1` ALGORITHM: `PATIENT NAME:SSN` DESCRIPTION: `Records the medical record number usually assigned by the reporting facility's health information management (HIM) department.` `For further information see FORDS page 36.`
.09	SOCIAL SECURITY NUMBER		COMPUTED	MUMPS CODE: `X ^DD(165.5,.09,9.2) X $P(^DD(160,2,0),U,5,99) S Y(165.5,.09,101)=X S X=Y(165.5,.09,101) S D0=Y(165.5,.09,80)` `9.2 = S Y(165.5,.09,80)=$S($D(D0):D0,1:""),Y(165.5,.09,1)=$S($D(^ONCO(165.5,D0,0)):^(0),1:""),D0=$P(Y(165.5,.09,1),U,2) S:'$D(^ONCO(160,+D0,0)) D0=-1` ALGORITHM: `PATIENT NAME:SSN` LAST EDITED: `FEB 12, 2003` DESCRIPTION: `Records the patient's Social Security Number.` `For further information see FORDS page 37.`
.091	STATUS		COMPUTED	MUMPS CODE: `X ^DD(165.5,.091,9.3) S X=$P($P(Y(165.5,.091,102),$C(59)_$P(Y(165.5,.091,101),U,1)_":",2),$C(59),1) S D0=Y(165.5,.091,80)` `9.2 = S Y(165.5,.091,80)=$S($D(D0):D0,1:""),Y(165.5,.091,1)=$S($D(^ONCO(165.5,D0,0)):^(0),1:""),D0=$P(Y(165.5,.091,1),U,2) S:'$D(^ONCO(160,+D0,0)) D0=-1` `9.3 = X ^DD(165.5,.091,9.2) S Y(165.5,.091,102)=$C(59)_$S($D(^DD(160,15,0)):$P(^(0),U,3),1:""),Y(165.5,.091,101)=$S($D(^ONCO(160,D0,1)):^(1),1:"")` ALGORITHM: `PATIENT NAME:STATUS` LAST EDITED: `FEB 06, 1991` DESCRIPTION: `STATUS IS EITHER ALIVE OR DEAD.`
.093	PLACE OF BIRTH (STATE)		COMPUTED	MUMPS CODE: `X ^DD(165.5,.093,9.2) S Y(165.5,.093,101)=$S($D(^ONCO(160,D0,0)):^(0),1:"") S X=$S('$D(^ONCO(165.2,+$P(Y(165.5,.093,101),U,5),0)):"",1:$P(^(0),U,1)) S D0=Y(165.5,.093,80)` `9.2 = S Y(165.5,.093,80)=$S($D(D0):D0,1:""),Y(165.5,.093,1)=$S($D(^ONCO(165.5,D0,0)):^(0),1:""),D0=$P(Y(165.5,.093,1),U,2) S:'$D(^ONCO(160,+D0,0)) D0=-1` ALGORITHM: `PATIENT NAME:PLACE OF BIRTH` DESCRIPTION: `THE STATE WHERE THE PATIENT WAS BORN.`
.1	SEX		COMPUTED	MUMPS CODE: `X ^DD(165.5,.1,9.3) S X=$P($P(Y(165.5,.1,102),$C(59)_$P(Y(165.5,.1,101),U,8)_":",2),$C(59),1) S D0=Y(165.5,.1,80)` `9.2 = S Y(165.5,.1,80)=$S($D(D0):D0,1:""),Y(165.5,.1,1)=$S($D(^ONCO(165.5,D0,0)):^(0),1:""),D0=$P(Y(165.5,.1,1),U,2) S:'$D(^ONCO(160,+D0,0)) D0=-1` `9.3 = X ^DD(165.5,.1,9.2) S Y(165.5,.1,102)=$C(59)_$S($D(^DD(160,10,0)):$P(^(0),U,3),1:""),Y(165.5,.1,101)=$S($D(^ONCO(160,D0,0)):^(0),1:"")` ALGORITHM: `PATIENT NAME:SEX` LAST EDITED: `MAY 26, 1999` DESCRIPTION: `Code the patient's SEX.`
.115	STATE		COMPUTED	MUMPS CODE: `X ^DD(165.5,.115,9.2) X $P(^DD(160,.115,0),U,5,99) S Y(165.5,.115,101)=X S X=Y(165.5,.115,101) S D0=Y(165.5,.115,80)` `9.2 = S Y(165.5,.115,80)=$S($D(D0):D0,1:""),Y(165.5,.115,1)=$S($D(^ONCO(165.5,D0,0)):^(0),1:""),D0=$P(Y(165.5,.115,1),U,2) S:'$D(^ONCO(160,+D0,0)) D0=-1` ALGORITHM: `PATIENT NAME:STATE` DESCRIPTION: `THE PATIENT'S STATE OF RESIDENCY AT THE TIME OF DIAGNOSIS.`
.1157	ST-COUNTY		COMPUTED	MUMPS CODE: `D STCT^ONCOCOP` ALGORITHM: `D STCT^ONCOCOP` LAST EDITED: `MAR 22, 1991` DESCRIPTION: `STATE AND COUNTY COMPUTED FIELD.`
.117	COUNTY		COMPUTED	MUMPS CODE: `X ^DD(165.5,.117,9.2) X $P(^DD(160,.117,0),U,5,99) S Y(165.5,.117,101)=X S X=Y(165.5,.117,101) S D0=Y(165.5,.117,80)` `9.2 = S Y(165.5,.117,80)=$S($D(D0):D0,1:""),Y(165.5,.117,1)=$S($D(^ONCO(165.5,D0,0)):^(0),1:""),D0=$P(Y(165.5,.117,1),U,2) S:'$D(^ONCO(160,+D0,0)) D0=-1` ALGORITHM: `PATIENT NAME:COUNTY` DESCRIPTION: `THE PATIENT'S RESIDENCE COUNTY AT THE TIME OF DIAGNOSIS.`
.12	RACE		COMPUTED	MUMPS CODE: `X ^DD(165.5,.12,9.2) S Y(165.5,.12,101)=$S($D(^ONCO(160,D0,0)):^(0),1:"") S X=$S('$D(^ONCO(164.46,+$P(Y(165.5,.12,101),U,6),0)):"",1:$P(^(0),U,1)) S D0=Y(165.5,.12,80)` `9.2 = S Y(165.5,.12,80)=$S($D(D0):D0,1:""),Y(165.5,.12,1)=$S($D(^ONCO(165.5,D0,0)):^(0),1:""),D0=$P(Y(165.5,.12,1),U,2) S:'$D(^ONCO(160,+D0,0)) D0=-1` `9.3 = X ^DD(165.5,.12,9.2) S Y(165.5,.12,102)=$C(59)_$S($D(^DD(160,8,0)):$P(^(0),U,3),1:""),Y(165.5,.12,101)=$S($D(^ONCO(160,D0,0)):^(0),1:"")` ALGORITHM: `PATIENT NAME:RACE` LAST EDITED: `NOV 12, 1996` DESCRIPTION: `"Race" is analyzed with the data item Spanish/Hispanic origin. Both items must be recorded.`
.13	RACE-SEX		COMPUTED	MUMPS CODE: `S X="" D RSX^ONCOCOS` ALGORITHM: `S X="" D RSX^ONCOCOS` DESCRIPTION: `COMPUTED FIELD COMBINING BOTH RACE AND SEX, USED IN CROSS TABULATIONS.`
.14	SEX-RACE		COMPUTED	MUMPS CODE: `S X="" D SXR^ONCOCOS` ALGORITHM: `S X="" D SXR^ONCOCOS` DESCRIPTION: `This is the combined race and sex code, used for cross tabulations.`
1	DATE OF INPATIENT ADMISSION	0;8	DATE	INPUT TRANSFORM: `D FADIT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `JUN 07, 2000` HELP-PROMPT: `*** DATE OF INPATIENT ADMISSION MUST BE BEFORE/EQUAL DATE OF INPATIENT DISCHARGE` DESCRIPTION: `Record the date of the inpatient admission to the facility for the most definitive surgery. If the patient does not have surgery, use the inpatient admission date for any other cancer-directed therapy. If the patient` `has no cancer-directed therapy, use the date of inpatient admission for diagnostic evaluation.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1.1	DATE OF INPATIENT DISCHARGE	0;9	DATE	INPUT TRANSFORM: `D DSDTIT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `JUN 07, 2000` HELP-PROMPT: `DATE OF INPATIENT DISCHARGE MUST BE AFTER/EQUAL DATE OF INPATIENT ADMISSION` DESCRIPTION: `Record the date of the inpatient discharge from the facility for the most definitive sugery. If the patient did not have surgery, use the inpatient discharge date for any other cancer-directed therapy. If the patient` `has no cancer-directed therapy, use the date of inpatient discharge for diagnostic evaluation.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1.2	TYPE OF REPORTING SOURCE	0;10	POINTER TO TYPE OF REPORTING SOURCE FILE (#168)	TYPE OF REPORTING SOURCE(#168) OUTPUT TRANSFORM: `S:Y'="" Y=$P(^ONCO(168,Y,0),U,2)` LAST EDITED: `MAR 28, 2006` DESCRIPTION: `Code the source documents used to abstract the cancer being reported. This item is used by central registries.`
2	PRIMARY SURGEON	0;11	POINTER TO ONCOLOGY CONTACT FILE (#165)	ONCOLOGY CONTACT(#165) INPUT TRANSFORM: `S DIC("S")="I $P(^(0),U,2)=2" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X` LAST EDITED: `MAY 08, 2023` HELP-PROMPT: `Enter the physician who performed the most definitive surgical procedure. You may not enter a new physician contact; that must be done in "Update Oncology Physician Contacts" under UTL menu.` DESCRIPTION: `Records the physician who performed the most definitive surgical procedure.` `For further information see FORDS page 77.` SCREEN: `S DIC("S")="I $P(^(0),U,2)=2"` EXPLANATION: `Enter a PHYSICIAN CONTACT.` GROUP: `ACOS-RECOMMENDED` CROSS-REFERENCE: `165.5^ACP^MUMPS` `1)= S ^ONCO(165,"ACP",X,$P(^ONCO(165.5,DA,0),U,2))=""` `2)= K ^ONCO(165,"ACP",X,$P(^ONCO(165.5,DA,0),U,2))` `Creates a list under the Contact file of contacts, and associated patients orginating from the Primary file pointers to the Contact File.` CROSS-REFERENCE: `165.5^APC^MUMPS` `1)= S ^ONCO(165,"APC",$P(^ONCO(165.5,DA,0),U,2),X)=""` `2)= K ^ONCO(165,"APC",$P(^ONCO(165.5,DA,0),U,2),X)` `Creates a list under the contact file of patients, and associated contacts originating from the Primary file pointers to the contact file.` CROSS-REFERENCE: `165.5^APS^MUMPS` `1)= S ^ONCO(165.5,"APS",X,$P(^ONCO(165.5,DA,0),U,2),DA)=""` `2)= K ^ONCO(165.5,"APS",X,$P(^ONCO(165.5,DA,0),U,2),DA)` `Creates a list of CONTACTs and the ONCOLOGY PATIENTs who use them.`
2.1	FOLLOWING PHYSICIAN	0;12	POINTER TO ONCOLOGY CONTACT FILE (#165)	ONCOLOGY CONTACT(#165) INPUT TRANSFORM: `S DIC("S")="I ($P(^(0),U,2)=2)!($P(^(0),U,2)=4)" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X` LAST EDITED: `MAY 08, 2023` HELP-PROMPT: `Enter the person currently responsible for the patient's medical care. You may not enter a new physician contact; that must be done in "Update Oncology Physician Contacts" under UTL menu.` DESCRIPTION: `Records the person currently responsible for the patient's medical care.` `For further information see FORDS page 76.` SCREEN: `S DIC("S")="I ($P(^(0),U,2)=2)!($P(^(0),U,2)=4)"` EXPLANATION: `Enter a PHYSICIAN or INSTITUTION CONTACT.` CROSS-REFERENCE: `165.5^ACP^MUMPS` `1)= S ^ONCO(165,"ACP",X,$P(^ONCO(165.5,DA,0),U,2))=""` `2)= K ^ONCO(165,"ACP",X,$P(^ONCO(165.5,DA,0),U,2))` `Creates a list under the Contact file of contacts, and associated patients orginating from the Primary file pointers to the Contact File.` CROSS-REFERENCE: `165.5^APC^MUMPS` `1)= S ^ONCO(165,"APC",$P(^ONCO(165.5,DA,0),U,2),X)=""` `2)= K ^ONCO(165,"APC",$P(^ONCO(165.5,DA,0),U,2),X)` `Creates a list under the contact file of patients, and associated contacts originating from the Primary file pointers to the contact file.` CROSS-REFERENCE: `165.5^AFP^MUMPS` `1)= S ^ONCO(165.5,"AFP",X,$P(^ONCO(165.5,DA,0),U,2),DA)=""` `2)= K ^ONCO(165.5,"AFP",X,$P(^ONCO(165.5,DA,0),U,2),DA)` `Creates a list of CONTACTs and the ONCOLOGY PATIENTs who use them.`
2.2	MANAGING PHYSICIAN	0;13	POINTER TO ONCOLOGY CONTACT FILE (#165)	ONCOLOGY CONTACT(#165) INPUT TRANSFORM: `S DIC("S")="I $P(^(0),U,2)=2" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X` LAST EDITED: `MAY 08, 2023` HELP-PROMPT: `Enter the physician who is responsible for the overall management of the patient. You may not enter a new physician contact; that must be done in "Update Oncology Physician Contacts" under UTL menu.` DESCRIPTION: `Identifies the physician who is responsible for the overall management of the patient during diagnosis and/or treatment of this cancer.` SCREEN: `S DIC("S")="I $P(^(0),U,2)=2"` EXPLANATION: `Enter a PHYSICIAN TYPE ONCOLOGY CONTACT.` GROUP: `ACOS-RECOMMENDED` CROSS-REFERENCE: `165.5^ACP^MUMPS` `1)= S ^ONCO(165,"ACP",X,$P(^ONCO(165.5,DA,0),U,2))=""` `2)= K ^ONCO(165,"ACP",X,$P(^ONCO(165.5,DA,0),U,2))` `Creates a list under the Contact file of contacts, and associated patients orginating from the Primary file pointers to the Contact File.` CROSS-REFERENCE: `165.5^APC^MUMPS` `1)= S ^ONCO(165,"APC",$P(^ONCO(165.5,DA,0),U,2),X)=""` `2)= K ^ONCO(165,"APC",$P(^ONCO(165.5,DA,0),U,2),X)` `Creates a list under the contact file of patients, and associated contacts originating from the Primary file pointers to the contact file.` CROSS-REFERENCE: `165.5^AMP^MUMPS` `1)= S ^ONCO(165.5,"AMP",X,$P(^ONCO(165.5,DA,0),U,2),DA)=""` `2)= K ^ONCO(165.5,"AMP",X,$P(^ONCO(165.5,DA,0),U,2),DA)` `Creates a list of CONTACTs and the ONCOLOGY PATIENTs who use them.`
2.3	PHYSICIAN #3	0;14	POINTER TO ONCOLOGY CONTACT FILE (#165)	ONCOLOGY CONTACT(#165) INPUT TRANSFORM: `S DIC("S")="I $P(^(0),U,2)=2" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X` LAST EDITED: `MAY 08, 2023` HELP-PROMPT: `Enter another physician involved in the care of the patient. You may not enter a new physician contact; that must be done in "Update Oncology Physician Contacts" under UTL menu.` DESCRIPTION: `Records another physician involved in the care of the patient. The Commission on Cancer recommends that this data item identify the physician who performed the most definitive radiation therapy.` `For further information see FORDS page 78.` SCREEN: `S DIC("S")="I $P(^(0),U,2)=2"` EXPLANATION: `Enter a PHYSICIAN CONTACT.` GROUP: `ACOS-RECOMMENDED` CROSS-REFERENCE: `165.5^ACP^MUMPS` `1)= S ^ONCO(165,"ACP",X,$P(^ONCO(165.5,DA,0),U,2))=""` `2)= K ^ONCO(165,"ACP",X,$P(^ONCO(165.5,DA,0),U,2))` `Creates a list under the Contact file of contacts, and associated patients orginating from the Primary file pointers to the Contact File.` CROSS-REFERENCE: `165.5^APC^MUMPS` `1)= S ^ONCO(165,"APC",$P(^ONCO(165.5,DA,0),U,2),X)=""` `2)= K ^ONCO(165,"APC",$P(^ONCO(165.5,DA,0),U,2),X)` `Creates a list under the contact file of patients, and associated contacts originating from the Primary file pointers to the contact file.` CROSS-REFERENCE: `165.5^AOP3^MUMPS` `1)= S ^ONCO(165.5,"AOP3",X,$P(^ONCO(165.5,DA,0),U,2),DA)=""` `2)= K ^ONCO(165.5,"AOP3",X,$P(^ONCO(165.5,DA,0),U,2),DA)` `Creates a list of CONTACTs and the ONCOLOGY PATIENTs who use them.`
2.4	PHYSICIAN #4	0;15	POINTER TO ONCOLOGY CONTACT FILE (#165)	ONCOLOGY CONTACT(#165) INPUT TRANSFORM: `S DIC("S")="I $P(^(0),U,2)=2" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X` LAST EDITED: `MAY 08, 2023` HELP-PROMPT: `Enter another physician involved in the care of the patient. You may not enter a new physician contact; that must be done in "Update Oncology Physician Contacts" under UTL menu.` DESCRIPTION: `Records another physician involved in the care of the patient. The Commission on Cancer recommends that this data item identify the physician who gives the most definitive systemic therapy.` `For further information see FORDS page 79.` SCREEN: `S DIC("S")="I $P(^(0),U,2)=2"` EXPLANATION: `Enter a PHYSICIAN CONTACT.` GROUP: `ACOS-RECOMMENDED` CROSS-REFERENCE: `165.5^ACP^MUMPS` `1)= S ^ONCO(165,"ACP",X,$P(^ONCO(165.5,DA,0),U,2))=""` `2)= K ^ONCO(165,"ACP",X,$P(^ONCO(165.5,DA,0),U,2))` `Creates a list under the Contact file of contacts, and associated patients orginating from the Primary file pointers to the Contact File.` CROSS-REFERENCE: `165.5^APC^MUMPS` `1)= S ^ONCO(165,"APC",$P(^ONCO(165.5,DA,0),U,2),X)=""` `2)= K ^ONCO(165,"APC",$P(^ONCO(165.5,DA,0),U,2),X)` `Creates a list under the contact file of patients, and associated contacts originating from the Primary file pointers to the contact file.` CROSS-REFERENCE: `165.5^AOP4^MUMPS` `1)= S ^ONCO(165.5,"AOP4",X,$P(^ONCO(165.5,DA,0),U,2),DA)=""` `2)= K ^ONCO(165.5,"AOP4",X,$P(^ONCO(165.5,DA,0),U,2),DA)` `Creates a list of CONTACTs and the ONCOLOGY PATIENTs who use them.`
3	DATE DX	0;16	DATE	**********************REQUIRED FIELD********************** INPUT TRANSFORM: `D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT S X=Y K:Y<1 X K %DT(0) I $D(X) D DTDXIT^ONCODXD` `MAXIMUM LENGTH: 12` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `JUN 21, 2022` HELP-PROMPT: `Future dates are not allowed.` DESCRIPTION: `Records the date of initial diagnosis by a physician for the tumor being reported.` `For further information see FORDS pages 89-90.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^ADX` `1)= S ^ONCO(165.5,"ADX",$E(X,1,30),DA)=""` `2)= K ^ONCO(165.5,"ADX",$E(X,1,30),DA)` `3)= DO NOT DELETE` `Cross-reference by DATE DX`
3.1	DIAGNOSIS EPISODE CARE		COMPUTED	MUMPS CODE: `S X="" D ADM^ONCOCON` ALGORITHM: `S X="" D ADM^ONCOCON` DESCRIPTION: `RECORDS THE CARE THE PATIENT RECEIVED DURING THE CURRENT EPISODE OF TREATMENT AT DIAGNOSIS.`
3.5	YEAR DX		COMPUTED DATE	MUMPS CODE: `S Y(165.5,3.5,1)=$S($D(^ONCO(165.5,D0,0)):^(0),1:"") S X=$P(Y(165.5,3.5,1),U,16),X=X S X=X,X=$E(X,1,3)_"0000" S:'X X=""` ALGORITHM: `YEAR(INTERNAL(DATE DX))` LAST EDITED: `MAR 10, 1998` DESCRIPTION: `DATE DX (165.5,3) year`
4	AGE AT DX		COMPUTED	MUMPS CODE: `D AGE^ONCOCOM` ALGORITHM: `D AGE^ONCOCOM` LAST EDITED: `JUN 21, 1990` DESCRIPTION: `Records the age of the patient at his or her last birthday before diagnosis.` `For further information see FORDS page 58.`
4.1	DX AGE-GP		COMPUTED	MUMPS CODE: `D DEC^ONCOCOM` ALGORITHM: `D DEC^ONCOCOM` LAST EDITED: `JUL 19, 1990` DESCRIPTION: `DIAGNOSIS AGE GROUP WILL GROUP PATIENTS BY AGE.`
5	DX FACILITY	0;17	POINTER TO FACILITY FILE (#160.19)	FACILITY(#160.19) OUTPUT TRANSFORM: `S:Y'="" Y=$S($D(^ONCO(160.19,Y,0)):$P(^(0),U,2),1:Y)` LAST EDITED: `MAY 31, 1996` HELP-PROMPT: `Enter Hospital which diagnosed this Primary.` DESCRIPTION: `Record the name of the facility where diagnosis was first made.` EXECUTABLE HELP: `D HELP^ONCOFLF`
6	FACILITY REFERRED FROM	0;18	POINTER TO FACILITY FILE (#160.19)	FACILITY(#160.19) OUTPUT TRANSFORM: `S:Y'="" Y=$S($D(^ONCO(160.19,Y,0)):$P(^(0),U,2),1:Y)` LAST EDITED: `NOV 06, 2002` DESCRIPTION: `Identifies the facility that referred the patient to the reporting facility.` `For further information see FORDS page 85.` EXECUTABLE HELP: `D HELP^ONCOFLF` GROUP: `ACOS-REQUIRED`
7	FACILITY REFERRED TO	0;19	POINTER TO FACILITY FILE (#160.19)	FACILITY(#160.19) OUTPUT TRANSFORM: `S:Y'="" Y=$S($D(^ONCO(160.19,Y,0)):$P(^(0),U,2),1:Y)` LAST EDITED: `NOV 06, 2002` DESCRIPTION: `Identifies the facility to which the patient was referred for further care after discharge from the reporting facility.` `For further information see FORDS page 86.` EXECUTABLE HELP: `D HELP^ONCOFLF` GROUP: `ACOS-RECOMMENDED`
8	PATIENT ADDRESS AT DX	1;1	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>40!($L(X)<1) X I $D(X) D NP^ONCOIT` LAST EDITED: `JUN 21, 2001` HELP-PROMPT: `Enter 1-40 uppercase alphanumeric characters. No punctuation.` DESCRIPTION: `Identifies the patient's address (number and street) at the time of diagnosis.` `For further information see FORDS page 42.` GROUP: `ACOS-RECOMMENDED` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
8.1	CITY/TOWN AT DX	1;12	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>20!($L(X)<1) X I $D(X) D NP^ONCOIT` LAST EDITED: `JUN 21, 2001` HELP-PROMPT: `Enter 1-20 uppercase alphanumeric characters. No punctuation.` DESCRIPTION: `Identifies the name of the city or town in which the patient resides at the time the tumor is diagnosed and treated.` `For further information see FORDS page 44.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` `TRIGGERED by the POSTAL CODE AT DX field of the ONCOLOGY PRIMARY File`
8.2	PATIENT ADDRESS AT DX - SUPP	1;13	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>40!($L(X)<1) X I $D(X) D NP^ONCOIT` LAST EDITED: `NOV 04, 2002` HELP-PROMPT: `Enter 1-40 uppercase alphanumeric characters. No punctuation.` DESCRIPTION: `Provides the ability to store additional adress information such as the name of a place or facility (ie, a nursing home or name of an apartment complex) at the time of diagnosis.` `For further information see FORDS page 43.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
9	POSTAL CODE AT DX	1;2	FREE TEXT	INPUT TRANSFORM: `D PCDX^ONCPCDX` OUTPUT TRANSFORM: `NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!` LAST EDITED: `AUG 25, 2010` HELP-PROMPT: `Enter the 5-digit US postal code or 6-character Canadian postal code.` DESCRIPTION: `Identifies the postal code of the patient's address at diagnosis.` `For U.S. residents, record the patient's five-digit postal code at the time of diagnosis and treatment.` `For Canadian residents, record the six-character postal code.` GROUP: `SEER` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `^^TRIGGER^165.5^10` `1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(0)=X I (X?5N)&(X'=88888)&(X'=99999) I X S X=DIV S Y(1)=$S($D(^ONCO(165.5,D0,1)):^(1),1:"") S X=$P(Y(1),U,3),X=X S DIU=X K Y S X=DIV S X=ONCCOUNTY K ONCCOUNTY X ^DD(165.5,9,1,1,1.4)` `1.4)= S DIH=$G(^ONCO(165.5,DIV(0),1)),DIV=X S $P(^(1),U,3)=DIV,DIH=165.5,DIG=10 D ^DICR` `2)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(0)=X I (X?5N)&(X'=88888)&(X'=99999) I X S X=DIV S Y(1)=$S($D(^ONCO(165.5,D0,1)):^(1),1:"") S X=$P(Y(1),U,3),X=X S DIU=X K Y S X="" X ^DD(165.5,9,1,1,2.4)` `2.4)= S DIH=$G(^ONCO(165.5,DIV(0),1)),DIV=X S $P(^(1),U,3)=DIV,DIH=165.5,DIG=10 D ^DICR` `CREATE CONDITION)= I (X?5N)&(X'=88888)&(X'=99999)` `CREATE VALUE)= S X=ONCCOUNTY K ONCCOUNTY` `DELETE CONDITION)= I (X?5N)&(X'=88888)&(X'=99999)` `DELETE VALUE)= @` `FIELD)= COUNTY AT DX` `COUNTY AT DX (165.5,10) will be stuffed with the COUNTY (5.12,2) value associated with the selected POSTAL CODE. If the POSTAL CODE AT DX value is a Canadian postal code or 88888 or 99999, this trigger cross-reference` `will not be executed.` CROSS-REFERENCE: `^^TRIGGER^165.5^16` `1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(0)=X I (X?5N)&(X'=88888)&(X'=99999) I X S X=DIV S Y(1)=$S($D(^ONCO(165.5,D0,1)):^(1),1:"") S X=$P(Y(1),U,4),X=X S DIU=X K Y S X=DIV S X=ONCSTATE K ONCSTATE X ^DD(165.5,9,1,2,1.4)` `1.4)= S DIH=$G(^ONCO(165.5,DIV(0),1)),DIV=X S $P(^(1),U,4)=DIV,DIH=165.5,DIG=16 D ^DICR` `2)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(0)=X I (X?5N)&(X'=88888)&(X'=99999) I X S X=DIV S Y(1)=$S($D(^ONCO(165.5,D0,1)):^(1),1:"") S X=$P(Y(1),U,4),X=X S DIU=X K Y S X="" X ^DD(165.5,9,1,2,2.4)` `2.4)= S DIH=$G(^ONCO(165.5,DIV(0),1)),DIV=X S $P(^(1),U,4)=DIV,DIH=165.5,DIG=16 D ^DICR` `CREATE CONDITION)= I (X?5N)&(X'=88888)&(X'=99999)` `CREATE VALUE)= S X=ONCSTATE K ONCSTATE` `DELETE CONDITION)= I (X?5N)&(X'=88888)&(X'=99999)` `DELETE VALUE)= @` `FIELD)= STATE AT DX` `STATE AT DX (165.5,16) will be stuffed with the STATE (5.12,3) value associated with the selected POSTAL CODE. If the POSTAL CODE AT DX value is a Canadian postal code or 88888 or 99999, this trigger cross-reference will` `not be executed.` CROSS-REFERENCE: `^^TRIGGER^165.5^8.1` `1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(0)=X I (X?5N)&(X'=88888)&(X'=99999) I X S X=DIV S Y(1)=$S($D(^ONCO(165.5,D0,1)):^(1),1:"") S X=$P(Y(1),U,12),X=X S DIU=X K Y S X=DIV S X=ONCCITY K ONCCITY X ^DD(165.5,9,1,3,1.4)` `1.4)= S DIH=$G(^ONCO(165.5,DIV(0),1)),DIV=X S $P(^(1),U,12)=DIV,DIH=165.5,DIG=8.1 D ^DICR` `2)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(0)=X I (X?5N)&(X'=88888)&(X'=99999) I X S X=DIV S Y(1)=$S($D(^ONCO(165.5,D0,1)):^(1),1:"") S X=$P(Y(1),U,12),X=X S DIU=X K Y S X="" X ^DD(165.5,9,1,3,2.4)` `2.4)= S DIH=$G(^ONCO(165.5,DIV(0),1)),DIV=X S $P(^(1),U,12)=DIV,DIH=165.5,DIG=8.1 D ^DICR` `CREATE CONDITION)= I (X?5N)&(X'=88888)&(X'=99999)` `CREATE VALUE)= S X=ONCCITY K ONCCITY` `DELETE CONDITION)= I (X?5N)&(X'=88888)&(X'=99999)` `DELETE VALUE)= @` `FIELD)= CITY/TOWN AT DX` `CITY/TOWN AT DX (165.5,8.1) will be stuffed with the CITY (5.12,1) value associated with the selected POSTAL CODE. If the POSTAL CODE AT DX value is a Canadian postal code or 88888 or 99999, this trigger cross-reference` `will not be executed.`
10	COUNTY AT DX	1;3	FREE TEXT	INPUT TRANSFORM: `D CCODE^XIPUTIL(X,.XIPC) K:(XIPC("COUNTY")="")&(X'=99998) X K XIPC` OUTPUT TRANSFORM: `I Y'="" K XIPC D CCODE^XIPUTIL(Y,.XIPC) S Y=$S(XIPC("COUNTY")'="":XIPC("COUNTY"),1:Y) K XIPC` LAST EDITED: `AUG 26, 2010` HELP-PROMPT: `Enter the 5-digit FIPS code (2-digit state code + 3 digit county code). If unknown, enter 99998 (Outside state/county code unknown) or 99999 (County unknown).` DESCRIPTION: `Identifies the county of the patient's residence at the time the reportable tumor is diagnosed.` `The COUNTY AT DX value will be triggered by the entry of a valid U. S. POSTAL CODE AT DX value. Canadian POSTAL CODE AT DX values will not trigger a COUNTY AT DX value.` `If unknown, enter 99998 (Outside state/county code unknown) or 99999 (County unknown).` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` `TRIGGERED by the POSTAL CODE AT DX field of the ONCOLOGY PRIMARY File`
11	MARITAL STATUS AT DX	1;5	SET	'1' FOR Single (never married); '2' FOR Married (including common law); '3' FOR Separated; '4' FOR Divorced; '5' FOR Widowed; '6' FOR Unmarried or Domestic Partner; '9' FOR Unknown; LAST EDITED: `MAR 14, 2011` HELP-PROMPT: `Enter the patient's marital status at the time of diagnosis.` DESCRIPTION: `This is the patient's marital status at the time of diagnosis for the reportable tumor. If the patient has multiple tumors, marital status may be different for each tumor.` GROUP: `ACOS-RECOMMENDED`
12	PALLIATIVE CARE	3.1;26	SET	'0' FOR No palliative care; '1' FOR Surgery; '2' FOR Radiation; '3' FOR Systemic tx; '4' FOR Pain management; '5' FOR Surg, rad, and/or systemic tx w/o pain mgt; '6' FOR Surg, rad, and/or systemic tx w pain mgt; '7' FOR Palliative care, type unknown; '9' FOR Unknown, not stated; LAST EDITED: `MAR 03, 2006` DESCRIPTION: `Identifies any care provided in an effort to palliate or alleviate symptoms. Palliative care is performed to relieve symptoms and may include surgery, radiation therapy, systemic therapy (chemotherapy, hormone therapy,` `or other systemic drugs), and/or pain management therapy.` `For further information see FORDS pages 189-190.` CROSS-REFERENCE: `165.5^AN^MUMPS` `1)= Q` `2)= D PP^ONCDTX`
13	PALLIATIVE CARE @FAC	3.1;27	SET	'0' FOR No palliative care; '1' FOR Surgery; '2' FOR Radiation; '3' FOR Systemic tx; '4' FOR Pain management; '5' FOR Surg, rad, and/or systemic tx w/o pain mgt; '6' FOR Surg, rad, and/or systemic tx w pain mgt; '7' FOR Palliative care, type unknown; '9' FOR Unknown, not stated; LAST EDITED: `MAY 20, 2004` DESCRIPTION: `Identifies care provided at this facility in an effort to palliate or alleviate symptoms. Palliative care is performed to relieve symptoms and may include surgery, radiation therapy, systemic therapy (chemotherapy,` `hormone therapy, or other systemic drugs), and/or other pain management therapy.` `For further information see FORDS page 191.`
14	READMISSION W/I 30 DAYS/SURG	3.1;28	SET	'0' FOR No surgery/not readmitted; '1' FOR Unplanned readmission; '2' FOR Planned readmission; '3' FOR Planned and unplanned readmission; '9' FOR Unknown if surgery or readmission; LAST EDITED: `JAN 08, 2003` DESCRIPTION: `Records a readmission to the same hospital within 30 days of discharge following a hospitalization for surgical resection of the primary site.` `For further information see FORDS page 146.`
15	SYSTEMIC/SURGERY SEQUENCE	3.1;39	SET	'0' FOR No systemic and/or surgery; '2' FOR Systemic before surgery; '3' FOR Systemic after surgery; '4' FOR Systemic before and after surgery; '5' FOR Intraoperative systemic; '6' FOR Intraoperative/other before or after surgery; '9' FOR Sequence unknown; LAST EDITED: `DEC 27, 2005` DESCRIPTION: `Records the sequencing of systemic therapy and surgical procedures given as part of the first course of treatment.`
16	STATE AT DX	1;4	POINTER TO STATE FILE (#5)	STATE(#5) LAST EDITED: `SEP 04, 2009` HELP-PROMPT: `Enter the patient's state of residence at the time of diagnosis.` DESCRIPTION: `Identifies the patient's state of residence at the time of diagnosis.` `For further information see FORDS page 45.` NOTES: `TRIGGERED by the POSTAL CODE AT DX field of the ONCOLOGY PRIMARY File`
17	SUSPENSE DATE	1;10	DATE	INPUT TRANSFORM: `D DFIT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `APR 03, 1997` HELP-PROMPT: `* SUSPENSE DATE MUST BE AFTER OR EQUAL TO THE DATE DX *` DESCRIPTION: `This is the date on which the primary was added to the suspense file.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
18	PRIMARY PAYER AT DX	1;11	POINTER TO PRIMARY PAYER AT DIAGNOSIS FILE (#160.3)	PRIMARY PAYER AT DIAGNOSIS(#160.3) OUTPUT TRANSFORM: `S:Y'="" Y=$P(^ONCO(160.3,Y,0),U,2)` LAST EDITED: `JUL 07, 2000` DESCRIPTION: `Identifies the patient's primary payer/insurance carrier at the time of initial diagnosis and/or treatment.` `For further information see FORDS pages 67-68.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
19	STAGED BY (CLINICAL STAGE)	3;32	POINTER TO ONCOLOGY STAGED BY CODES FILE (#165.7)	ONCOLOGY STAGED BY CODES(#165.7) OUTPUT TRANSFORM: `S:Y'="" Y=$P(^ONCO(165.7,Y,0),U,1)_" "_$P(^ONCO(165.7,Y,0),U,2)` LAST EDITED: `APR 06, 2017` HELP-PROMPT: `Record the role of the person who documented the Clinical AJCC staging data items and the Stage Group.` DESCRIPTION: `Identifies the person who recorded the clinical AJCC staging elements and the stage group in the patient's medical record.` `For further information refer to FORDS manual.`
20	PRIMARY SITE	2;1	POINTER TO ICDO TOPOGRAPHY FILE (#164)	**********************REQUIRED FIELD********************** ICDO TOPOGRAPHY(#164) INPUT TRANSFORM: `D TOPIT^ONCOSUR1` LAST EDITED: `NOV 06, 2002` HELP-PROMPT: `Record the ICD-O topography code for the site of origin.` DESCRIPTION: `Identifies the primary site.` `For further information see FORDS page 91.` EXECUTABLE HELP: `S ONCOX=164 D HP^ONCOHICD` GROUP: `ACOS-REQUIRED` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^BT^MUMPS` `1)= S ^ONCO(165.5,"C"_$E(X,3,4),DA)=""` `2)= K ^ONCO(165.5,"C"_$E(X,3,4),DA)` `Indexes the file by the whole number value of the ICD-O second edition topography code.` CROSS-REFERENCE: `165.5^AD^MUMPS` `1)= S $P(^ONCO(165.5,DA,0),U,22)=$E(X,1,4)` `2)= S $P(^ONCO(165.5,DA,0),U,22)=""` `Maintains the ICDO-SITE Field (#.022).` CROSS-REFERENCE: `165.5^E` `1)= S ^ONCO(165.5,"E",$E(X,1,30),DA)=""` `2)= K ^ONCO(165.5,"E",$E(X,1,30),DA)` `Indexes file by ICDO-TOPOGRAPHY.`
20.1	PRIMARY SITE CODE		COMPUTED	MUMPS CODE: `S X=$P($G(^ONCO(165.5,D0,2)),U),X=$S(X="":"",1:"C"_$E(X,3,4)_"."_$E(X,5))` ALGORITHM: `CUSTOM CODED` LAST EDITED: `NOV 06, 2002` DESCRIPTION: `Identifies the primary site ICD-O topography code.`
21	CASEFINDING SOURCE	1;6	POINTER TO CASEFINDING SOURCE FILE (#166)	**********************REQUIRED FIELD********************** CASEFINDING SOURCE(#166) OUTPUT TRANSFORM: `S:Y'="" Y=$P(^ONCO(166,Y,0),U,2)` LAST EDITED: `AUG 30, 2022` HELP-PROMPT: `Enter the appropriate code from the list.` DESCRIPTION: `This field codes the earliest source of identifying information.`
21.5	INFRA/SUPRA	2;7	SET	**********************REQUIRED FIELD********************** 'I' FOR INFRATENTORIAL; 'S' FOR SUPRATENTORIAL; LAST EDITED: `JUN 22, 1993` HELP-PROMPT: `This field applies to brain tumors only.` DESCRIPTION: `For brain tumors, enter 'I' or 'S' according to whether the tumor is infratentorial or supratentorial.` `This field does not apply to tumors other than brain tumors.`
21.51	IRIS/CILIARY BODY	2;22	SET	'I' FOR Iris; 'C' FOR Ciliary body; LAST EDITED: `JUN 30, 1993` DESCRIPTION: `This field is used to determine the appropriate TNM encoding for malignant melanomas of the uvea.`
21.52	UPPER/LOWER	24;4	SET	'U' FOR Upper 2/3; 'L' FOR Lower 1/3; LAST EDITED: `JUL 04, 1993` DESCRIPTION: `This field is used to determine the appropriate N coding for tumors of the vagina. Enter U or L according to whether the regional lymph node metastasis relates to the upper two-thirds or lower one-third of the vagina.`
22	HISTOLOGY (ICD-O-2)	2;3	POINTER TO ICD-O-2 MORPHOLOGY FILE (#164.1)	ICD-O-2 MORPHOLOGY(#164.1) INPUT TRANSFORM: `S DIC("S")="I ($P(^ONCO(165.5,DA,0),U,16)<2980101)!((Y<96002)!(Y>96423))&($P(^ONCO(165.5,DA,0),U,16)<3010101)" D ^DIC K DIC S DIC=DIE,X=+Y D HIST23^ONCOHICD K:Y<0 X` LAST EDITED: `JUN 12, 2003` HELP-PROMPT: `Enter the code, e.g. 81203 or 8120/3, or name, e.g. TRANSITIONAL CELL CA.` DESCRIPTION: `Record the histology using the ICD-O-2 codes.` SCREEN: `S DIC("S")="I ($P(^ONCO(165.5,DA,0),U,16)<2980101)!((Y<96002)!(Y>96423))&($P(^ONCO(165.5,DA,0),U,16)<3010101)"` EXPLANATION: `Codes 9600-9642 are not selectable for 1998 or later cases and this field is not editable at all for 2001 or later cases.` EXECUTABLE HELP: `S ONCOX=164.1 D HP^ONCOHICD` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^AH` `1)= S ^ONCO(165.5,"AH",$E(X,1,30),DA)=""` `2)= K ^ONCO(165.5,"AH",$E(X,1,30),DA)` `3)= DO NOT DELETE` `Cross Reference Histology, (pointer) used in hard-coded routines as FM will not use this index being a pointer.`
22.1	ICDO HISTOLOGY-CODE		COMPUTED	MUMPS CODE: `S X=$$HIST^ONCFUNC(D0),X=$S(X="":"",1:$E(X,1,4)_"/"_$E(X,5))` ALGORITHM: `S X=""` LAST EDITED: `MAY 22, 2001` DESCRIPTION: `Display the Histology Code value, based on the primary's date DX: If Date DX is before 2001 use the HISTOLOGY (ICD-O-2) value, if it is a 2001 or later case use the HISTOLOGY (ICD-O-3) value.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
22.2	PAPILLARY/FOLLICULAR	2;4	SET	'P' FOR PAPILLARY; 'F' FOR FOLLICULAR; LAST EDITED: `JUN 14, 1993` DESCRIPTION: `This code assists in the characterization of tumors of the thyroid gland. It is only significant for patients 45 years and over.` `If the tumor is neither papillary nor follicular, leave this field blank.` TECHNICAL DESCR: `For thyroid primaries only (C73.9), this field is set directly by the TBA cross-reference of the HISTOLOGY Field (#22).`
22.3	HISTOLOGY (ICD-O-3)	2.2;3	POINTER TO ICD-O-3 MORPHOLOGY FILE (#169.3)	ICD-O-3 MORPHOLOGY(#169.3) INPUT TRANSFORM: `D INIT^ONCCS` LAST EDITED: `MAY 31, 2005` DESCRIPTION: `Identifies the microscopic anatomy of cells for primaries diagnosed in 2001 or later.` `This field also contains the BEHAVIOR CODE which records the behavior of the tumor being reported. The fifth digit of the morphology code is the behavior code.` `For further information see FORDS pages 93-95.` EXECUTABLE HELP: `D ICDO3^ONCOHICD` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^AL^MUMPS` `1)= Q` `2)= S $P(^ONCO(165.5,DA,8),U,2)=""` `This cross-reference will delete the TEXT-HISTOLOGY TITLE (165.5,101) value if the HISTOLOGY (ICD-O-3) value is changed.`
22.4	BEHAVIOR CODE		COMPUTED	MUMPS CODE: `S Y(165.5,22.4,1)=$S($D(^ONCO(165.5,D0,2.2)):^(2.2),1:"") S X=$P(Y(165.5,22.4,1),U,3),X=X S X=X,Y(165.5,22.4,2)=$G(X) S X=5,X=$E(Y(165.5,22.4,2),X)` ALGORITHM: `$E(INTERNAL(HISTOLOGY (ICD-O-3)),5)` LAST EDITED: `SEP 21, 2023` DESCRIPTION: `This field records the behavior of the tumor being reported. The behavior code corresponds to the fifth digit of the morphology (HISTOLOGY ICD-O-3) so the field is calculated from there.`
23	RECONSTRUCTION/RESTORATION	3;33	FREE TEXT	INPUT TRANSFORM: `D RRDEFIT^ONCNTX1 K:+X'=X!(X>10)!(X<0)!(X?.E1"."1N.N) X I $D(X) S NTXDD=1 D RRIT^ONCRR Q` OUTPUT TRANSFORM: `D RROT^ONCRR` LAST EDITED: `SEP 21, 2004` DESCRIPTION: `RECONSTRUCTIVE/RESTORATION is a surgical procdure that improves the shape and appearance or function of body structures that are missing, defective, damaged or misshapen by cancer or its treatment.` `RECONSTRUCTION/RESTORATION is limited to procedures started during the first course of treatment.` `For further information see ROADS page 195.` EXECUTABLE HELP: `D RRHP^ONCRR` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
24	GRADE/DIFFERENTIATION	2;5	POINTER TO GRADE FILE (#164.43)	GRADE(#164.43) OUTPUT TRANSFORM: `S:Y'="" Y=$P(^ONCO(164.43,Y,0),U,1)` LAST EDITED: `FEB 23, 2010` DESCRIPTION: `Describes the tumor's resemblance to normal tissue. Well differentiated (Grade 1) is the most like normal tissue, and undifferentiated (Grade 4) is the least like normal tissue. Grades 5-8 define particular cell lines for` `lymphomas and leukemias.` `For further information see FORDS 2010 pages 112-113.`
24.1	GRADE PATH SYSTEM	2.3;1	SET	'2' FOR Two-Grade System; '3' FOR Three-Grade System; '4' FOR Four-Grade System; LAST EDITED: `OCT 01, 2009` HELP-PROMPT: `Leave blank if no GRADE PATH SYSTEM is noted on the pathology report.` DESCRIPTION: `Indicates whether a two, three or four grade system was used in the pathology report.` `Leave blank if no GRADE PATH SYSTEM is noted on the pathology report.`
24.2	GRADE PATH VALUE	2.3;2	SET	'1' FOR Recorded as Grade I or 1; '2' FOR Recorded as Grade II or 2; '3' FOR Recorded as Grade III or 3; '4' FOR Recorded as Grade IV or 4; LAST EDITED: `OCT 01, 2009` HELP-PROMPT: `Leave blank if no GRADE PATH SYSTEM is noted on the pathology report.` DESCRIPTION: `Describes the grade assigned according to the grading system in GRADE PATH SYSTEM.` `Leave blank if no GRADE PATH SYSTEM is noted on the pathology report.`
24.3	GRADE CLINICAL	2.3;12	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>1!($L(X)<1)!("1234589ABCDELHMS"'[X) X I $D(X) D IT^ONCSCHMG` `MAXIMUM LENGTH: 1` OUTPUT TRANSFORM: `D OT^ONCSCHMG` LAST EDITED: `MAR 13, 2019` HELP-PROMPT: `Answer must be 1 character in length. Allowable values are: 1,2,3,4,5,8,9,A,B,C,D,E,L,H,M,S` DESCRIPTION: `This data item records the grade of a solid primary tumor before any treatment (surgical resection or initiation of any treatment including neoadjuvant).` EXECUTABLE HELP: `D HLP^ONCSCHMG` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
24.4	GRADE PATHOLOGICAL	2.3;13	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>1!($L(X)<1)!("1234589ABCDELHMS"'[X) X I $D(X) D IT^ONCSCHMG` `MAXIMUM LENGTH: 1` OUTPUT TRANSFORM: `D OT^ONCSCHMG` LAST EDITED: `MAR 13, 2019` HELP-PROMPT: `Answer must be 1 character in length. Allowable values are: 1,2,3,4,5,8,9,A,B,C,D,E,L,H,M,S` DESCRIPTION: `This data item records the grade of a solid primary tumor that has been resected and for which no neoadjuvant therapy was administered.` EXECUTABLE HELP: `D HLP^ONCSCHMG` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
24.5	GRADE POST THERAPY PATH (YP)	2.3;14	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>1!($L(X)<1)!("1234589ABCDELHMS"'[X) X I $D(X) D IT^ONCSCHMG` `MAXIMUM LENGTH: 1` OUTPUT TRANSFORM: `D OT^ONCSCHMG` LAST EDITED: `JAN 14, 2021` HELP-PROMPT: `Answer must be 1 character in length. Allowable values are: 1,2,3,4,5,8,9,A,B,C,D,E,L,H,M,S` DESCRIPTION: `This data item records the grade of a solid primary tumor that has been resected following neoadjuvant therapy.` EXECUTABLE HELP: `D HLP^ONCSCHMG` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
24.6	GRADE POST THERAPY CLIN (YC)	2.3;15	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>1!($L(X)<1)!("1234589ABCDELHMS"'[X) X I $D(X) D IT^ONCSCHMG` `MAXIMUM LENGTH: 1` OUTPUT TRANSFORM: `D OT^ONCSCHMG` LAST EDITED: `JAN 14, 2021` HELP-PROMPT: `Answer must be 1 character in length. Allowable values are: 1,2,3,4,5,8,9,A,B,C,D,E,L,H,M,S` DESCRIPTION: `This data item records the grade of a solid primary tumor that has been microscopically sampled following neoadjuvant therapy or primary systemic/radiation therapy.` EXECUTABLE HELP: `D HLP^ONCSCHMG` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
25	TNM FORM ASSIGNED	7;7	FREE TEXT	INPUT TRANSFORM: `D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `SEP 21, 2006` HELP-PROMPT: `Enter the date on which the TNM form was assigned to the Managing Physician.` DESCRIPTION: `Records the date on which the TNM form was assigned to the Managing Physician.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
25.1	TUMOR MARKER 1	24;2	POINTER TO TUMOR MARKERS FILE (#164.15)	TUMOR MARKERS(#164.15) INPUT TRANSFORM: `S DIC("S")="D SCREEN^ONCOTM" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X` OUTPUT TRANSFORM: `S Y=$P($G(^ONCO(164.15,+Y,0)),U,2)` LAST EDITED: `FEB 27, 1998` DESCRIPTION: `Record prognostic indicators.` SCREEN: `S DIC("S")="D SCREEN^ONCOTM"` EXPLANATION: `4th edition: 0-3, 8, 9. 5th edition: 0-3, 4-6 (Testis only), 8, 9.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
25.2	TUMOR MARKER 2	24;3	POINTER TO TUMOR MARKERS FILE (#164.15)	TUMOR MARKERS(#164.15) INPUT TRANSFORM: `S DIC("S")="D SCREEN^ONCOTM" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X` OUTPUT TRANSFORM: `S Y=$P($G(^ONCO(164.15,+Y,0)),U,2)` LAST EDITED: `JAN 28, 1998` DESCRIPTION: `Record prognostic indicators.` SCREEN: `S DIC("S")="D SCREEN^ONCOTM"` EXPLANATION: `4th edition: 0-3, 8, 9. 5th edition: 0-3, 4-6 (Testis only), 8, 9.`
25.3	TUMOR MARKER 3	24;7	POINTER TO TUMOR MARKERS FILE (#164.15)	TUMOR MARKERS(#164.15) INPUT TRANSFORM: `S DIC("S")="D SCREEN^ONCOTM" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X` OUTPUT TRANSFORM: `S Y=$P($G(^ONCO(164.15,+Y,0)),U,2)` LAST EDITED: `JAN 28, 1998` DESCRIPTION: `Record LDH prognostic indicators for testicular cancer.` SCREEN: `S DIC("S")="D SCREEN^ONCOTM"` EXPLANATION: `4th edition: 0-3, 8, 9. 5th edition: 0-3, 4-6 (Testis only), 8, 9.`
26	DIAGNOSTIC CONFIRMATION	2;6	SET	'1' FOR Positive histology; '2' FOR Positive cytology; '3' FOR Pos hist + pos immunophenotyping + pos genetic; '4' FOR Positive microscopic; '5' FOR Positive lab test; '6' FOR Direct visual; '7' FOR Rad/other imaging; '8' FOR Clinical dx only; '9' FOR Unknown; LAST EDITED: `DEC 02, 2009` DESCRIPTION: `Records the best method of diagnostic confirmation of the cancer being reported at any time in the patient's history.` `For further information see FORDS 2010 pages 117-119.`
27	HISTO-MORPHOLOGY		COMPUTED	MUMPS CODE: `D HM^ONCOCOM` ALGORITHM: `D HM^ONCOCOM` LAST EDITED: `JUL 27, 2005` DESCRIPTION: `This field displays the HISTOLOGY ICD-O-3 (165.5,22.3) value concatinated with the GRADE/DIFFERENTIATION (165.5,24) value.`
28	LATERALITY	2;8	SET	'0' FOR Not a paired site; '1' FOR Right; '2' FOR Left; '3' FOR One side involved, right/left not specified; '4' FOR Bilateral involvement, side of origin unknown; '5' FOR Paired site, midline tumor; '9' FOR Paired site, no laterality information; LAST EDITED: `NOV 02, 2009` HELP-PROMPT: `Enter the primary site laterality.` DESCRIPTION: `Identifies the side of a paired organ or the side of the body on which the reportable tumor originated. This applies to the primary site only.` `For further information see FORDS page 92.`
29	TUMOR SIZE	2;9	NUMBER	INPUT TRANSFORM: `D STIT^ONCOOT` OUTPUT TRANSFORM: `D STOT^ONCOOT` LAST EDITED: `MAR 04, 2004` HELP-PROMPT: `Code the exact size of the primary in millimeters (mm).` DESCRIPTION: `Describes the largest dimension of the diameter of the primary tumor in millimeters (mm).` `Code the exact size of the primary tumor in millimeters (mm).` `EXCEPTION:` `For melanomas of the skin (C44.0-C44.9), vulva (C51.0-C51.9), penis` `(C60.0-C60.9), scrotum (C63.3), and conjunctiva (C69.0):` `- code the depth of invasion in HUNDRETHS of millimeters.` `- code 989 for melanomas which are 9.89 mm or greater in depth.` `Code 998 when the following terms describe tumor involvement in these specific sites:` `Esophagus (C15.0-C15.9): Entire circumference Stomach (C16.0-C16.9): Diffuse, widespread, 3/4 or more,` `linitis plastica Colorectal (C18.0-C20.9): Familial/multiple polyposis Lung (C34.0-C34.9): Diffuse, entire lobe of lung Breast (C50.0-C50.9): Inflammatory carcinoma; diffuse, widespread,` `3/4 or more of breast` `Code 999, unknown, if only one size is given for a mixed in situ and invasive tumor.` `Code 999 if the size of the tumor is unknown or the tumor size is not documented in the patient record.` `Code 999 for histologies or sites where size in not applicable:` `Unknown or ill-defined primary (C76.0-C76.8, C80.9) Hematopoietic, reticuloendothelial, immunoproliferative or` `myeloproliferative disease Multiple myeloma (9732) Letterer-Siwe disease (9754)` `For further information see FORDS pages 100-101.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
29.1	TUMOR SIZE/EXT EVAL (CS)	CS;1	FREE TEXT	INPUT TRANSFORM: `D INPUT^ONCWEBCS(3,1,D0)` `MAXIMUM LENGTH: 30` LAST EDITED: `FEB 27, 2024` HELP-PROMPT: `Answer must be 1 numeric.` DESCRIPTION: `Records how the codes for the two items TUMOR SIZE (CS) and EXTENSION (CS) were determined, based on the diagnostic methods employed.` EXECUTABLE HELP: `D HELP^ONCWEBCS(3,D0)` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
29.2	TUMOR SIZE (CS)	CS1;10	FREE TEXT	INPUT TRANSFORM: `D INPUT^ONCWEBCS(1,3,D0)` `MAXIMUM LENGTH: 30` LAST EDITED: `FEB 27, 2024` HELP-PROMPT: `Answer must be 3 numerics.` DESCRIPTION: `FOR MALIGNANT MELANOMA: Record the size of the tumor in TUMOR SIZE (CS), not depth or thickness. Depth or thickness is recorded in SITE-SPECIFIC FACTOR 1 (CS).` `Records the largest dimension or diameter of the primary tumor, and is always recorded in millimeters. To convert centimeters to millimeters, multiply the dimension by 10. If tumor size is given in tenths of millimeters,` `round down if between .1 and .5 mm, and round up if between .6 and .9 mm.` EXECUTABLE HELP: `D HELP^ONCWEBCS(1,D0)` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
29.3	TUMOR SIZE SUMMARY	2.1;20	NUMBER	INPUT TRANSFORM: `D TSCPSIT^ONCOOT` OUTPUT TRANSFORM: `D TSCPSOT^ONCOOT` LAST EDITED: `MAR 23, 2017` HELP-PROMPT: `Code the most accurate measurement of the primary tumor in millimeters (mm).` DESCRIPTION: `Records the most accurate measurement of a solid primary tumor, usually measured on the surgical resection specimen.` `000 No mass/tumor found 001 1 mm or described as less than 1 mm 002-998 Exact size in millimeters (2mm-998mm) 989 989 mm or larger 990 Microscopic focus or foci only and no size of focus is given` `998 SITE SPECIFIC CODES` `Alternate descriptions of tumor size for specific sites:` `Familial/multipl polyposis:` `Rectosigmoid and rectum (C19.9, C20.9)` `Colon (C18.0, C18.2-C18.9)` `If no size is documented:` `Circumferential:` `Esophagus (C15.0-C15.5, C15.8, C15.9)` `Diffuse; widespread: 3/4s or more; linitis plastica:` `Stomach and Esophagus GE Junction (C16.0-C16.6m, C16.8-C16.9)` `Diffuse, entire lung or NOS:` `Lung and main stem bronchus (C34.0-C34.3, C34.8-C34.9)` `Diffuse:` `Breast (C50.0-C50.6, C50.8-C50.9)` `999 Unknown; size not stated; Not documented in patient record; Size` `of tumor cannot be assessed; Not applicable` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
29.4	TUMOR SIZE CLINICAL	2.1;21	NUMBER	INPUT TRANSFORM: `D TSCPSIT^ONCOOT` OUTPUT TRANSFORM: `D TSCPSOT^ONCOOT` LAST EDITED: `MAR 23, 2017` HELP-PROMPT: `Code the size of the solid primary tumor before any treatment in mm.` DESCRIPTION: `Records the most accurate measurement of a solid primary tumor, usually measured on the surgical resection specimen.` `000 No mass/tumor found 001 1 mm or described as less than 1 mm 002-998 Exact size in millimeters (2mm-998mm) 989 989 mm or larger 990 Microscopic focus or foci only and no size of focus is given` `998 SITE SPECIFIC CODES` `Alternate descriptions of tumor size for specific sites:` `Familial/multipl polyposis:` `Rectosigmoid and rectum (C19.9, C20.9)` `Colon (C18.0, C18.2-C18.9)` `If no size is documented:` `Circumferential:` `Esophagus (C15.0-C15.5, C15.8, C15.9)` `Diffuse; widespread: 3/4s or more; linitis plastica:` `Stomach and Esophagus GE Junction (C16.0-C16.6m, C16.8-C16.9)` `Diffuse, entire lung or NOS:` `Lung and main stem bronchus (C34.0-C34.3, C34.8-C34.9)` `Diffuse:` `Breast (C50.0-C50.6, C50.8-C50.9)` `999 Unknown; size not stated; Not documented in patient record; Size` `of tumor cannot be assessed; Not applicable` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
29.5	TUMOR SIZE PATHOLOGIC	2.1;22	NUMBER	INPUT TRANSFORM: `D TSCPSIT^ONCOOT` OUTPUT TRANSFORM: `D TSCPSOT^ONCOOT` LAST EDITED: `MAR 23, 2017` HELP-PROMPT: `Code the size of the primary tumor that has been resected in mm.` DESCRIPTION: `Records the most accurate measurement of a solid primary tumor, usually measured on the surgical resection specimen.` `000 No mass/tumor found 001 1 mm or described as less than 1 mm 002-998 Exact size in millimeters (2mm-998mm) 989 989 mm or larger 990 Microscopic focus or foci only and no size of focus is given` `998 SITE SPECIFIC CODES` `Alternate descriptions of tumor size for specific sites:` `Familial/multipl polyposis:` `Rectosigmoid and rectum (C19.9, C20.9)` `Colon (C18.0, C18.2-C18.9)` `If no size is documented:` `Circumferential:` `Esophagus (C15.0-C15.5, C15.8, C15.9)` `Diffuse; widespread: 3/4s or more; linitis plastica:` `Stomach and Esophagus GE Junction (C16.0-C16.6m, C16.8-C16.9)` `Diffuse, entire lung or NOS:` `Lung and main stem bronchus (C34.0-C34.3, C34.8-C34.9)` `Diffuse:` `Breast (C50.0-C50.6, C50.8-C50.9)` `999 Unknown; size not stated; Not documented in patient record; Size` `of tumor cannot be assessed; Not applicable` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
29.9	EXTENSION LIST USED		COMPUTED	MUMPS CODE: `S X=$$GETLIST^ONCODEL(D0,"E","OUT")` ALGORITHM: `S X=$$GETLIST^ONCODEL(D0,"E","OUT")` LAST EDITED: `JUL 14, 1994` DESCRIPTION: `This is a brief description of the SEER extension code list that was selected by the system for this primary. It is used for audit by print template ONCO PRIMARY EXTENT CODE AUDIT.`
30	EXTENSION	2;10	NUMBER	INPUT TRANSFORM: `S ONCOX="E",ONCFLD=30 D IN^ONCODEL` OUTPUT TRANSFORM: `S ONCOX="E",ONCFLD=30 D OT^ONCODEL` LAST EDITED: `AUG 09, 2001` DESCRIPTION: `Seer Extent of Disease coding schema.` EXECUTABLE HELP: `S ONCOX="E",ONCFLD=30 D HP^ONCODEL` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
30.1	PATHOLOGIC EXTENSION	2.2;2	NUMBER	INPUT TRANSFORM: `K:(X>99)!(X<0)!(X?.E1"."1N.N) X I $D(X) S ONCOX="E",ONCFLD=30.1 D IN^ONCODEL` OUTPUT TRANSFORM: `S ONCOX="E",ONCFLD=30.1 D OT^ONCODEL` LAST EDITED: `MAR 25, 1999` DESCRIPTION: `Code the farthest documented pathologic extension of tumor from the prostate, either by contiguous extension or distant metastasis.` EXECUTABLE HELP: `S ONCOX="E",ONCFLD=30.1 D HP^ONCODEL` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
30.2	EXTENSION (CS)	CS;11	FREE TEXT	INPUT TRANSFORM: `D INPUT^ONCWEBCS(2,3,D0)` `MAXIMUM LENGTH: 30` LAST EDITED: `FEB 27, 2024` HELP-PROMPT: `Answer must be 3 numerics.` DESCRIPTION: `Identifies contiguous growth (extension) of the primary tumor within the organ of origin or its direct extension into neighboring organs.` EXECUTABLE HELP: `D HELP^ONCWEBCS(2,D0)` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
30.5	PERIPHERAL BLOOD INVOLVEMENT	24;5	SET	'B0' FOR Absence of significant involvement, 5% or less atypical; 'B0a' FOR Clone negative; 'B0b' FOR Clone positive; 'B1' FOR Low blood tumor burden, > 5% atypical; 'B1a' FOR Clone negative; 'B1b' FOR Clone positive; 'B2' FOR High blood tumor burden; LAST EDITED: `DEC 06, 2010` HELP-PROMPT: `Enter the code designating the peripheral blood involvement.` DESCRIPTION: `Identifies the percentage of circulating atypical cells of T-cell lymphoma. This information may be found as part of a blood smear differential. It is only associated with an histology of Mycosis fungoides or Sezary` `syndrome.`
30.9	LYMPH NODE LIST USED		COMPUTED	MUMPS CODE: `S X=$$GETLIST^ONCODEL(D0,"L","OUT")` ALGORITHM: `S X=$$GETLIST^ONCODEL(D0,"L","OUT")` LAST EDITED: `JUL 14, 1994` DESCRIPTION: `This is a brief description of the SEER lymph node code list that was selected by the system for this primary. It is used for audit by print template ONCO PRIMARY EXTENT CODE AUDIT.`
31	LYMPH NODES	2;11	NUMBER	INPUT TRANSFORM: `S ONCOX="L" D IN^ONCODEL` OUTPUT TRANSFORM: `S ONCOX="L" D OT^ONCODEL` LAST EDITED: `AUG 09, 2001` HELP-PROMPT: `Type a Number between 0 and 9, 0 Decimal Digits` DESCRIPTION: `Record SEER lymph node involvement.` EXECUTABLE HELP: `S ONCOX="L" D HP^ONCODEL` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^SS1^MUMPS` `1)= D SNHL^ONCOCRC` `2)= D KNHL^ONCOCRC` `Trigger to set SYSTEMIC SYMPTOMS field #843 for NON-HODGKIN'S LYMPHOMA'S.`
31.1	LYMPH NODES (CS)	CS;12	FREE TEXT	INPUT TRANSFORM: `D INPUT^ONCWEBCS(4,3,D0)` `MAXIMUM LENGTH: 30` LAST EDITED: `FEB 27, 2024` HELP-PROMPT: `Answer must be 3 numerics.` DESCRIPTION: `Identifies the regional lymph nodes involved with cancer at the time of diagnosis.` EXECUTABLE HELP: `D HELP^ONCWEBCS(4,D0)` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
32	REGIONAL LYMPH NODES POSITIVE	2;12	NUMBER	INPUT TRANSFORM: `K:X'?1.2N X I $D(X) S X=+X K:X>99!X<0 X I $D(X) K:(X>$P(^ONCO(165.5,D0,2),U,13))&($P(^ONCO(165.5,D0,2),U,13)<91)&(X<91) X I $D(X) K:($P(^ONCO(165.5,D0,2),U,13)=99)&(X'=99) X I $D(X) D RNPIT^ONCOIT` OUTPUT TRANSFORM: `D RNP^ONCOOT` LAST EDITED: `APR 22, 2004` HELP-PROMPT: `Regional Lymph Nodes Positive cannot exceed Regional Lymph Nodes Examined` DESCRIPTION: `Records the exact number of regional lymph nodes examined by the pathologist and found to contain metastases.` `00 All nodes examined are negative. 01-89 1-89 nodes are positive. (Code exact number of nodes positive)` `90 90 or more nodes are positive.` `95 Positive aspiration of lymph node(s) was performed.` `97 Positive nodes are documented, but the number is unspecified.` `98 No nodes were examined.` `99 It is unknown whether nodes are positive; not applicable;` `not stated in patient record.` `For further information see FORDS page 103.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
32.1	LYMPH NODES EVAL (CS)	CS;2	FREE TEXT	INPUT TRANSFORM: `D INPUT^ONCWEBCS(5,1,D0)` `MAXIMUM LENGTH: 30` LAST EDITED: `FEB 27, 2024` HELP-PROMPT: `Answer must be 1 numeric.` DESCRIPTION: `Records how the code for the item LYMPH NODES (CS) was determined, based on the diagnostic methods employed.` EXECUTABLE HELP: `D HELP^ONCWEBCS(5,D0)` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
33	REGIONAL LYMPH NODES EXAMINED	2;13	NUMBER	INPUT TRANSFORM: `K:X'?1.2N X I $D(X) S X=+X K:X>99!(X<0) X I $D(X) D RNEIT^ONCOIT` OUTPUT TRANSFORM: `D RNE^ONCOOT` LAST EDITED: `NOV 08, 2002` HELP-PROMPT: `Allowable Values: 00-90, 95-99` DESCRIPTION: `Records the total number of regional lymph nodes examined by the pathologist.` `00 No nodes were examined. 01-89 1-89 nodes were examined.` `(Code the exact number of regional lymph nodes examined.)` `90 90 or more nodes were examined.` `95 No regional nodes were removed, but aspiration of regional` `nodes was performed.` `96 Regional lymph node removal was documented as a sampling,` `and the number of nodes is unknown/not stated.` `97 Regional lymph node removal was documented as a dissection,` `and the number of nodes is unknown/not stated.` `98 Regional lymph nodes were surgically removed, but the number` `of lymph nodes is unknown/not stated and not documented as a` `sampling or dissection; nodes were examined but the number` `is unknown.` `99 It is unknown whether nodes were examined; not applicable or` `negative; not stated in patient record.` `For further information see FORDS page 102.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
33.1	#NODES EXAMINED		COMPUTED	MUMPS CODE: `S Y=$P($G(^ONCO(165.5,D0,2)),U,13),X=$S(Y=98:"# Not Specified",Y=99:"Unknown if examined",1:Y)` ALGORITHM: `S Y=$P($G(^ONCO(165.5,D0,2)),U,13),X=$S(Y=98:"# Not Specified",Y=99:"Unknown if examined",1:Y)` LAST EDITED: `AUG 10, 1993` DESCRIPTION: `RECORD THE NUMBER OF LYMPH NODES EXAMINED BY PATHOLOGIST.`
34	SITE OF DISTANT METASTASIS #1	2;14	SET	'0' FOR None; '1' FOR Peritoneum; '2' FOR Lung; '3' FOR Pleura; '4' FOR Liver; '5' FOR Bone; '6' FOR Central nervous system; '7' FOR Skin; '8' FOR Lymph nodes (distant); '9' FOR Other/Gen/Carcinomatosis/Unkn; LAST EDITED: `FEB 14, 2003` DESCRIPTION: `Code only the site(s) of distant metastasis identified during initial diagnosis and workup.` `For further information see ROADS pages 131-132.` GROUP: `ACOS-REQUIRED`
34.1	SITE OF DISTANT METASTASIS #2	2;15	SET	'0' FOR None; '1' FOR Peritoneum; '2' FOR Lung; '3' FOR Pleura; '4' FOR Liver; '5' FOR Bone; '6' FOR Central nervous system; '7' FOR Skin; '8' FOR Lymph nodes (distant); '9' FOR Other/Gen/Carcinomatosis/Unkn; LAST EDITED: `FEB 14, 2003` DESCRIPTION: `Code the second site of distant metastasis identified during initial diagnosis and workup.` `For further information see ROADS pages 133-134.` GROUP: `ACOS-REQUIRED`
34.2	SITE OF DISTANT METASTASIS #3	2;16	SET	'0' FOR None; '1' FOR Peritoneum; '2' FOR Lung; '3' FOR Pleura; '4' FOR Liver; '5' FOR Bone; '6' FOR Central nervous system; '7' FOR Skin; '8' FOR Lymph nodes (distant); '9' FOR Other/Gen/Carcinomatosis/Unkn; LAST EDITED: `FEB 14, 2003` DESCRIPTION: `Code the third site of distant metastasis identified during initial diagnosis and workup.` `For further information see ROADS pages 135-136.` GROUP: `ACOS-REQUIRED`
34.3	METS AT DX (CS)	CS;3	FREE TEXT	INPUT TRANSFORM: `D INPUT^ONCWEBCS(8,2,D0)` `MAXIMUM LENGTH: 30` LAST EDITED: `FEB 27, 2024` HELP-PROMPT: `Answer must be 2 numerics.` DESCRIPTION: `Identifies the distant site(s) of metastatic involvement at time of diagnosis.` EXECUTABLE HELP: `D HELP^ONCWEBCS(8,D0)` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
34.31	METS AT DX-BONE	CS1;20	SET	'0' FOR None; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `NOV 30, 2009` HELP-PROMPT: `Enter whether bone is an involved metastatic site.` DESCRIPTION: `Identifies the presence of distant metastatic involvement of bone at time of diagnosis.`
34.32	METS AT DX-BRAIN	CS1;21	SET	'0' FOR None; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `NOV 30, 2009` HELP-PROMPT: `Enter whether the brain is an involved metastatic site.` DESCRIPTION: `Identifies the presence of distant metastatic involvement of the brain at time of diagnosis.`
34.33	METS AT DX-LIVER	CS1;22	SET	'0' FOR None; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `NOV 30, 2009` HELP-PROMPT: `Enter whether the liver is an involved metastatic site.` DESCRIPTION: `Identifies the presence of distant metastatic involvement of the liver at time of diagnosis.`
34.34	METS AT DX-LUNG	CS1;23	SET	'0' FOR None; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `NOV 30, 2009` HELP-PROMPT: `Enter whether the lung is an involved metastatic site.` DESCRIPTION: `Identifies the presence of distant metastatic involvement of the lung at time of diagnosis.`
34.35	METS AT DX-DISTANT LN	CS1;24	SET	'0' FOR None; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `FEB 13, 2017` HELP-PROMPT: `Enter whether distant lymph nodes are an involved metastatic site.` DESCRIPTION: `Identifies the presence of distant metastatic involvement of the distant lymph nodes at time of diagnosis.`
34.36	METS AT DX-OTHER	CS1;25	SET	'0' FOR None; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `FEB 13, 2017` HELP-PROMPT: `Enter whether there is any other involved metastatic site.` DESCRIPTION: `Identifies the presence of distant metastatic involvement other than bone, brain, liver, lung or distant lymph nodes at time of diagnosis.`
34.4	METS EVAL (CS)	CS;4	FREE TEXT	INPUT TRANSFORM: `D INPUT^ONCWEBCS(9,1,D0)` `MAXIMUM LENGTH: 30` LAST EDITED: `FEB 27, 2024` HELP-PROMPT: `Answer must be 1 numeric.` DESCRIPTION: `Records how the code for the item METS AT DX (CS) was determined based on the diagnostic methods employed.` EXECUTABLE HELP: `D HELP^ONCWEBCS(9,D0)` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
35	SEER SUMMARY STAGE 2000	2;17	SET	'0' FOR In situ; '1' FOR Localized; '2' FOR Regional by direct extension; '3' FOR Regional to lymph nodes; '4' FOR Regional by extension & to nodes; '5' FOR Regional, NOS; '7' FOR Distant metastasis/systemic disease; '8' FOR NA/Benign; '9' FOR Unknown; LAST EDITED: `SEP 08, 2015` HELP-PROMPT: `Enter the code which indicates the extent of disease at time of diagnosis.` DESCRIPTION: `Provides a site-specific description of the extent of disease at diagnosis.` `For further information see FORDS page 124.` SCREEN: `S DIC("S")="I ('$$LYMPHOMA^ONCFUNC(D0))!((Y'=0)&(Y'=2)&(Y'=3)&(Y'=4)&(Y'=8))"` EXPLANATION: `Codes 0, 2, 3, 4 and 8 are not valid for HODGKIN AND NON-HODGKIN LYMPHOMAS.` GROUP: `ACOS-REQUIRED`
35.1	SEER SUMMARY STAGE ABBREVIATED		COMPUTED	MUMPS CODE: `S X="" D GSS^ONCOCOS` ALGORITHM: `S X="" D GSS^ONCOCOS` LAST EDITED: `DEC 19, 2006` DESCRIPTION: `This item abbreviates the SEER SUMMARY STAGE 2000 (165.5,35) output values for condensed display.`
36	AJCC STAGING BASIS	2;18	SET	'C' FOR Clinical-diagnostic; 'P' FOR Pathological (Post-surgical); 'R' FOR Retreatment Staging; 'A' FOR Autopsy; 'S' FOR Surgical Evaluative; LAST EDITED: `JUL 02, 1993` DESCRIPTION: `Record the most appropriate code to reflect the basis on which the case was staged.` `Clinical-diagnostic staging is used for those sites that are accessible, i.e. cervix, oral cavity, larynx, and for those organs where evaluation of extent must be made only on the basis of clinical-diagnostic findings.` `Clinical-diagnostic staging is based on the physical examination, diagnostic imaging, clinical pathology, and biopsy of the primary.` `Postsurgical pathological staging is a combination of all findings - clinical-diagnostic, surgical-evaluative, and postsurgical retreatment-pathological.` TECHNICAL DESCR: `This field is referenced direction by PATHSTAG^ONCOU55.` `SOURCE OF DATA: ACOS 3.53` GROUP: `ACOS-REQUIRED`
37	TNM CLINICAL		COMPUTED	MUMPS CODE: `S STGIND="C",X=$$TNMOUT^ONCOTNO(D0)` `9.2 = S Y(165.5,37,2)=$S($D(^ONCO(165.5,D0,2)):^(2),1:"") S X="T",Y(165.5,37,1)=X,Y(165.5,37,3)=X,Y=$P(Y(165.5,37,2),U,25) X:$D(^DD(165.5,37.1,2)) ^(2) S X=Y` `9.3 = X ^DD(165.5,37,9.2) S Y=X,X=Y(165.5,37,1),X=X_Y_" N",Y(165.5,37,4)=X,Y(165.5,37,5)=X,Y=$P(Y(165.5,37,2),U,26) X:$D(^DD(165.5,37.2,2)) ^(2) S X=Y` `9.4 = X ^DD(165.5,37,9.3) S Y=X,X=Y(165.5,37,4),X=X_Y_" M",Y(165.5,37,6)=X,Y(165.5,37,7)=X,Y=$P(Y(165.5,37,2),U,27) X:$D(^DD(165.5,37.3,2)) ^(2) S X=Y` ALGORITHM: `S STGIND="C",X=$$TNMOUT^ONCOTNO(D0)` LAST EDITED: `DEC 14, 2005` HELP-PROMPT: `Use 6-12 characters, e.g. T1N0M0, T2aN1bM0, or T3NXMX` DESCRIPTION: `This is the combined Clinical T, N, and M codes, formatted for display.` `SOURCE OF DATA: ACOS 3.54` GROUP: `ACOS-REQUIRED`
37.1	CLINICAL T	2;25	FREE TEXT	INPUT TRANSFORM: `I $D(X) K:$L(X)>4!($L(X)<1) X I $D(X) N ONCOX,STGIND S ONCOX="T",STGIND="C" D IN^ONCOTNM` `MAXIMUM LENGTH: 4` OUTPUT TRANSFORM: `NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!` LAST EDITED: `FEB 23, 2017` HELP-PROMPT: `Answer must be 1-4 characters in length.` DESCRIPTION: `Evaluates the primary tumor (T) and reflects the tumor size and/or extension of the tumor known prior to the start of any therapy.` EXECUTABLE HELP: `N ONCOX,STGIND S ONCOX="T",STGIND="C" D HP^ONCOTNM` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
37.2	CLINICAL N	2;26	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>8!($L(X)<1) X I $D(X) N ONCOX,STGIND S ONCOX="N",STGIND="C" D IN^ONCOTNM` OUTPUT TRANSFORM: `NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!` LAST EDITED: `FEB 23, 2017` HELP-PROMPT: `Answer must be 1-8 characters in length.` DESCRIPTION: `Identifies the absence or presence of regional lymph node (N) metastasis and describes the extent of regional lymph node metastasis of the tumor known prior to the start of any therapy.` EXECUTABLE HELP: `N ONCOX,STGIND S ONCOX="N",STGIND="C" D HP^ONCOTNM` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
37.3	CLINICAL M	2;27	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>8!($L(X)<1) X I $D(X) N ONCOX,STGIND S ONCOX="M",STGIND="C" D IN^ONCOTNM` OUTPUT TRANSFORM: `NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!` LAST EDITED: `FEB 23, 2017` HELP-PROMPT: `Answer must be 1-8 characters in length.` DESCRIPTION: `Identifies the presence or absence of distant metastasis (M) of the tumor known prior to the start of any therapy.` EXECUTABLE HELP: `N ONCOX,STGIND S ONCOX="M",STGIND="C" D HP^ONCOTNM` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
37.9	AUTOMATIC STAGING OVERRIDDEN	24;1	SET	'1' FOR Yes; '0' FOR No; LAST EDITED: `JUL 20, 1993` DESCRIPTION: `This field is set to 'Yes' by the abstracting option if the operator overrides automatic staging.` TECHNICAL DESCR: `This field is referenced directly by input template ONCO ABSTRACT-I.`
38	STAGE GROUP CLINICAL	2;20	FREE TEXT	INPUT TRANSFORM: `K:X[""""!($A(X)=45) X I $D(X) S ONCOX="S",STGIND="C" D IN^ONCOTNS I $D(X) D INNUM^ONCOTNS` OUTPUT TRANSFORM: `S X="" D OT^ONCOTNS` LAST EDITED: `DEC 14, 2005` DESCRIPTION: `Identifies the anatomic extent of disease based on the T , N, and M elements as recorded by the physician.` `For futher information see FORDS page 115.` EXECUTABLE HELP: `S ONCOX="S",STGIND="C" D HP^ONCOTNS` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^AS1^MUMPS` `1)= D CSSG^ONCOCRC` `2)= D KSG^ONCOCRC` `Maintains STAGE GROUPING-AJCC Field (#38.5).`
38.1	GP-I AJCC SUMMARY STAGE		COMPUTED	MUMPS CODE: `S X="" D SSG1^ONCOCOS` ALGORITHM: `S X="" D SSG1^ONCOCOS` LAST EDITED: `OCT 29, 1990` DESCRIPTION: `RECORD THE AJCC STAGE.`
38.2	GP-II AJCC SUMMARY STAGE		COMPUTED	MUMPS CODE: `S X="" D SSG2^ONCOCOS` ALGORITHM: `S X="" D SSG2^ONCOCOS` DESCRIPTION: `RECORD THE AJCC STAGE.`
38.3	GP-III AJCC SUMMARY STAGE		COMPUTED	MUMPS CODE: `S X="" D SSG3^ONCOCOS` ALGORITHM: `S X="" D SSG3^ONCOCOS` DESCRIPTION: `RECORD THE AJCC STAGE.`
38.4	GP-IV AJCC SUMMARY STAGE		COMPUTED	MUMPS CODE: `S X="" D SSG4^ONCOCOS` ALGORITHM: `S X="" D SSG4^ONCOCOS` DESCRIPTION: `RECORD THE AJCC STAGE.`
38.5	STAGE GROUPING-AJCC	2;28	SET	'0' FOR 0; 'I' FOR I; 'II' FOR II; 'III' FOR III; 'IV' FOR IV; 'U' FOR Unk/Uns; 'NA' FOR NA; LAST EDITED: `APR 06, 2021` DESCRIPTION: `This field is set by either the CLINICAL STAGE GROUP (38) or PATHOLOGIC STAGE GROUP (88) field depending on which takes precedence. For 2018+ cases the AJCC TNM CLIN STAGE GROUP (5004) and AJCC TNM PATH STAGE GROUP (5014)` `fields will be used instead. This field consists of the more general stage group values of 0, I, II, III, IV, Unk/Uns or NA.` CROSS-REFERENCE: `165.5^ASG` `1)= S ^ONCO(165.5,"ASG",$E(X,1,30),DA)=""` `2)= K ^ONCO(165.5,"ASG",$E(X,1,30),DA)` `Indexes file by STAGE GROUPING-AJCC.`
39	OTHER STAGING SYSTEM	2;21	POINTER TO OTHER STAGING FOR ONCOLOGY FILE (#164.3)	OTHER STAGING FOR ONCOLOGY(#164.3) INPUT TRANSFORM: `S DIC("S")="I (($P(^ONCO(165.5,DA,0),U,16)<3070000)!((Y>74)&(Y<78))!((Y>94)&(Y<100))!(Y>108))&((Y'=29)&(Y'=30)&(Y'=31)&(Y'=32)&(Y'=33))" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X` LAST EDITED: `FEB 12, 2009` HELP-PROMPT: `Enter an additional staging classification.` DESCRIPTION: `OTHER STAGING SYSTEM allows institutions the opportunity to collect additional staging classifications, for example, CDS, RAI, DS or FAB.` SCREEN: `S DIC("S")="I (($P(^ONCO(165.5,DA,0),U,16)<3070000)!((Y>74)&(Y<78))!((Y>94)&(Y<100))!(Y>108))&((Y'=29)&(Y'=30)&(Y'=31)&(Y'=32)&(Y'=33))"` EXPLANATION: `For 2007+ cases choose from CDS, RAI, DS or FAB entries.`
40	STAGE GROUP BEST		COMPUTED	MUMPS CODE: `S X="" D OT1^ONCOTNS` ALGORITHM: `S X="" D OT1^ONCOTNS` LAST EDITED: `DEC 14, 2005` DESCRIPTION: `This field displays the "best" stage group as determined by the clinical/pathological hierarchy rules.`
40.1	TNM BEST		COMPUTED	MUMPS CODE: `S X="" D OT1^ONCOTNS S X=HIERTNM` ALGORITHM: `S X="" D OT1^ONCOTNS S X=HIERTNM` LAST EDITED: `DEC 14, 2005` DESCRIPTION: `This field displays the "best" TNM string as determined by the clinical/pathological hierarchy rules.`
40.2	STAGED BY		COMPUTED	MUMPS CODE: `S X="" D STGBY^ONCOTNS` ALGORITHM: `S X="" D STGBY^ONCOTNS` LAST EDITED: `APR 23, 2003` DESCRIPTION: `Choose from:` `0 Not staged` `1 Managing MD` `2 Pathologist` `3 Pathologist & managing MD` `4 Committee chair, liaison MD, registry advisor` `5 Registrar` `6 Registrar & MD` `7 Another facility` `8 NA` `9 Unknown`
41	ASSOCIATED WITH HIV	2;23	SET	'1' FOR Yes; '2' FOR No; '999' FOR Unknown; LAST EDITED: `JUL 14, 1997` DESCRIPTION: `Record the presence/absence of HIV.`
42	TREATMENT ABBREVIATED		COMPUTED	MUMPS CODE: `S X="" D TXS^ONCOCOS` ALGORITHM: `S X="" D TXS^ONCOCOS` LAST EDITED: `JUL 10, 2006` DESCRIPTION: `TREATMENT ABBREVIATED lists the type(s) of therapies intended to modify or control the malignancy. All cancer-directed therapies specified in TREATMENT ABBREVIATED are a part of the FIRST COURSE OF TREATMENT.` `The therapies have been abbreviated to a 1-character designation:` `S - SURGERY OF PRIMARY SITE (F)` `R - RADIATION` `P - RADIATION THERAPY TO CNS` `C - CHEMOTHERAPY` `H - HORMONE THERAPY` `B - IMMUMOTHERAPY` `O - OTHER TREATMENT` `E - HEMA TRANS/ENDOCRINE PROC`
43	TREATMENT		COMPUTED	MUMPS CODE: `S X="" D TX^ONCOCOS` ALGORITHM: `S X="" D TX^ONCOCOS` LAST EDITED: `MAY 02, 1996` DESCRIPTION: `The treatment given to a patient, either curative or palliative in nature.`
44	TNM FORM COMPLETED	7;14	FREE TEXT	INPUT TRANSFORM: `D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT K:Y<1 X I $D(X) S %DT="E",%DT(0)=$$GET1^DIQ(165.5,D0,25,"I") S:(%DT(0)="0000000")!(%DT(0)=8888888)!(%DT(0)=9999999) %DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `MAR 25, 2009` HELP-PROMPT: `Enter the date on which the TNM form was completed by the Managing Physician. This date must be greater than or equal to TNM FORM ASSIGNED and may not be a future date.` DESCRIPTION: `Records the date on which the TNM form was completed by the Managing Physician.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
44.1	SSF1	CS;5	FREE TEXT	INPUT TRANSFORM: `D INPUT^ONCWEBCS(10,3,D0)` `MAXIMUM LENGTH: 30` OUTPUT TRANSFORM: `NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!` LAST EDITED: `FEB 27, 2024` HELP-PROMPT: `Answer must be 3 numerics, no decimal places.` DESCRIPTION: `Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.` EXECUTABLE HELP: `D HELP^ONCWEBCS(10,D0)` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
44.101	SSF10	CS2;4	FREE TEXT	INPUT TRANSFORM: `D INPUT^ONCWEBCS(19,3,D0)` `MAXIMUM LENGTH: 30` LAST EDITED: `FEB 27, 2024` HELP-PROMPT: `Answer must be 3 numerics, no decimal places.` DESCRIPTION: `Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.` EXECUTABLE HELP: `D HELP^ONCWEBCS(19,D0)` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
44.11	SSF11	CS2;5	FREE TEXT	INPUT TRANSFORM: `D INPUT^ONCWEBCS(20,3,D0)` `MAXIMUM LENGTH: 30` LAST EDITED: `FEB 27, 2024` HELP-PROMPT: `Answer must be 3 numerics, no decimal places.` DESCRIPTION: `Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.` EXECUTABLE HELP: `D HELP^ONCWEBCS(20,D0)` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
44.12	SSF12	CS2;6	FREE TEXT	INPUT TRANSFORM: `D INPUT^ONCWEBCS(21,3,D0)` `MAXIMUM LENGTH: 30` LAST EDITED: `FEB 27, 2024` HELP-PROMPT: `Answer must be 3 numerics, no decimal places.` DESCRIPTION: `Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.` EXECUTABLE HELP: `D HELP^ONCWEBCS(21,D0)` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
44.13	SSF13	CS2;7	FREE TEXT	INPUT TRANSFORM: `D INPUT^ONCWEBCS(22,3,D0)` `MAXIMUM LENGTH: 30` LAST EDITED: `FEB 27, 2024` HELP-PROMPT: `Answer must be 3 numerics, no decimal places.` DESCRIPTION: `Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.` EXECUTABLE HELP: `D HELP^ONCWEBCS(22,D0)` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
44.14	SSF14	CS2;8	FREE TEXT	INPUT TRANSFORM: `D INPUT^ONCWEBCS(23,3,D0)` `MAXIMUM LENGTH: 30` LAST EDITED: `FEB 27, 2024` HELP-PROMPT: `Answer must be 3 numerics, no decimal places.` DESCRIPTION: `Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.` EXECUTABLE HELP: `D HELP^ONCWEBCS(23,D0)` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
44.15	SSF15	CS2;9	FREE TEXT	INPUT TRANSFORM: `D INPUT^ONCWEBCS(24,3,D0)` `MAXIMUM LENGTH: 30` LAST EDITED: `FEB 27, 2024` HELP-PROMPT: `Answer must be 3 numerics, no decimal places.` DESCRIPTION: `Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.` EXECUTABLE HELP: `D HELP^ONCWEBCS(24,D0)` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
44.16	SSF16	CS2;10	FREE TEXT	INPUT TRANSFORM: `D INPUT^ONCWEBCS(25,3,D0)` `MAXIMUM LENGTH: 30` LAST EDITED: `FEB 27, 2024` HELP-PROMPT: `Answer must be 3 numerics, no decimal places.` DESCRIPTION: `Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.` EXECUTABLE HELP: `D HELP^ONCWEBCS(25,D0)` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
44.17	SSF17	CS2;11	FREE TEXT	INPUT TRANSFORM: `D INPUT^ONCWEBCS(26,3,D0)` `MAXIMUM LENGTH: 30` LAST EDITED: `FEB 27, 2024` HELP-PROMPT: `Answer must be 3 numerics, no decimal places.` DESCRIPTION: `Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.` EXECUTABLE HELP: `D HELP^ONCWEBCS(26,D0)` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
44.18	SSF18	CS2;12	FREE TEXT	INPUT TRANSFORM: `D INPUT^ONCWEBCS(27,3,D0)` `MAXIMUM LENGTH: 30` LAST EDITED: `FEB 27, 2024` HELP-PROMPT: `Answer must be 3 numerics, no decimal places.` DESCRIPTION: `Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.` EXECUTABLE HELP: `D HELP^ONCWEBCS(27,D0)` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
44.19	SSF19	CS2;13	FREE TEXT	INPUT TRANSFORM: `D INPUT^ONCWEBCS(28,3,D0)` `MAXIMUM LENGTH: 30` LAST EDITED: `FEB 27, 2024` HELP-PROMPT: `Answer must be 3 numerics, no decimal places.` DESCRIPTION: `Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.` EXECUTABLE HELP: `D HELP^ONCWEBCS(28,D0)` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
44.2	SSF2	CS;6	FREE TEXT	INPUT TRANSFORM: `D INPUT^ONCWEBCS(11,3,D0)` `MAXIMUM LENGTH: 30` OUTPUT TRANSFORM: `NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!` LAST EDITED: `FEB 27, 2024` HELP-PROMPT: `Answer must be 3 numerics, no decimal places.` DESCRIPTION: `Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.` EXECUTABLE HELP: `D HELP^ONCWEBCS(11,D0)` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
44.201	SSF20	CS2;14	FREE TEXT	INPUT TRANSFORM: `D INPUT^ONCWEBCS(29,3,D0)` `MAXIMUM LENGTH: 30` LAST EDITED: `FEB 27, 2024` HELP-PROMPT: `Answer must be 3 numerics, no decimal places.` DESCRIPTION: `Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.` EXECUTABLE HELP: `D HELP^ONCWEBCS(29,D0)` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
44.21	SSF21	CS2;15	FREE TEXT	INPUT TRANSFORM: `D INPUT^ONCWEBCS(30,3,D0)` `MAXIMUM LENGTH: 30` LAST EDITED: `FEB 27, 2024` HELP-PROMPT: `Answer must be 3 numerics, no decimal places.` DESCRIPTION: `Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.` EXECUTABLE HELP: `D HELP^ONCWEBCS(30,D0)` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
44.22	SSF22	CS2;16	FREE TEXT	INPUT TRANSFORM: `D INPUT^ONCWEBCS(31,3,D0)` `MAXIMUM LENGTH: 30` LAST EDITED: `FEB 27, 2024` HELP-PROMPT: `Answer must be 3 numerics, no decimal places.` DESCRIPTION: `Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.` EXECUTABLE HELP: `D HELP^ONCWEBCS(31,D0)` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
44.23	SSF23	CS2;17	FREE TEXT	INPUT TRANSFORM: `D INPUT^ONCWEBCS(32,3,D0)` `MAXIMUM LENGTH: 30` LAST EDITED: `FEB 27, 2024` HELP-PROMPT: `Answer must be 3 numerics, no decimal places.` DESCRIPTION: `Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.` EXECUTABLE HELP: `D HELP^ONCWEBCS(32,D0)` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
44.24	SSF24	CS2;18	FREE TEXT	INPUT TRANSFORM: `D INPUT^ONCWEBCS(33,3,D0)` `MAXIMUM LENGTH: 30` LAST EDITED: `FEB 27, 2024` HELP-PROMPT: `Answer must be 3 numerics, no decimal places.` DESCRIPTION: `Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.` EXECUTABLE HELP: `D HELP^ONCWEBCS(33,D0)` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
44.25	SSF25	CS2;19	FREE TEXT	INPUT TRANSFORM: `D INPUT^ONCWEBCS(34,3,D0)` `MAXIMUM LENGTH: 30` LAST EDITED: `FEB 27, 2024` HELP-PROMPT: `Answer must be 3 numerics, no decimal places.` DESCRIPTION: `Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.` EXECUTABLE HELP: `D HELP^ONCWEBCS(34,D0)` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` `TRIGGERED by the CS SCHEMA DISCRIMINATOR field of the ONCOLOGY PRIMARY File`
44.3	SSF3	CS;7	FREE TEXT	INPUT TRANSFORM: `D INPUT^ONCWEBCS(12,3,D0)` `MAXIMUM LENGTH: 30` OUTPUT TRANSFORM: `NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!` LAST EDITED: `FEB 27, 2024` HELP-PROMPT: `Answer must be 3 numerics, no decimal places.` DESCRIPTION: `Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.` EXECUTABLE HELP: `D HELP^ONCWEBCS(12,D0)` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
44.4	SSF4	CS;8	FREE TEXT	INPUT TRANSFORM: `D INPUT^ONCWEBCS(13,3,D0)` `MAXIMUM LENGTH: 30` OUTPUT TRANSFORM: `NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!` LAST EDITED: `FEB 27, 2024` HELP-PROMPT: `Answer must be 3 numerics, no decimal places.` DESCRIPTION: `Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.` EXECUTABLE HELP: `D HELP^ONCWEBCS(13,D0)` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
44.5	SSF5	CS;9	FREE TEXT	INPUT TRANSFORM: `D INPUT^ONCWEBCS(14,3,D0)` `MAXIMUM LENGTH: 30` OUTPUT TRANSFORM: `NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!` LAST EDITED: `FEB 27, 2024` HELP-PROMPT: `Answer must be 3 numerics, no decimal places.` DESCRIPTION: `Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.` EXECUTABLE HELP: `D HELP^ONCWEBCS(14,D0)` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
44.6	SSF6	CS;10	FREE TEXT	INPUT TRANSFORM: `D INPUT^ONCWEBCS(15,3,D0)` `MAXIMUM LENGTH: 30` OUTPUT TRANSFORM: `NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!` LAST EDITED: `FEB 27, 2024` HELP-PROMPT: `Answer must be 3 numerics, no decimal places.` DESCRIPTION: `Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.` EXECUTABLE HELP: `D HELP^ONCWEBCS(15,D0)` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
44.7	SSF7	CS2;1	FREE TEXT	INPUT TRANSFORM: `D INPUT^ONCWEBCS(16,3,D0)` `MAXIMUM LENGTH: 30` LAST EDITED: `FEB 27, 2024` HELP-PROMPT: `Answer must be 3 numerics, no decimal places.` DESCRIPTION: `Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.` EXECUTABLE HELP: `D HELP^ONCWEBCS(16,D0)` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
44.8	SSF8	CS2;2	FREE TEXT	INPUT TRANSFORM: `D INPUT^ONCWEBCS(17,3,D0)` `MAXIMUM LENGTH: 30` LAST EDITED: `FEB 27, 2024` HELP-PROMPT: `Answer must be 3 numerics, no decimal places.` DESCRIPTION: `Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.` EXECUTABLE HELP: `D HELP^ONCWEBCS(17,D0)` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
44.9	SSF9	CS2;3	FREE TEXT	INPUT TRANSFORM: `D INPUT^ONCWEBCS(18,3,D0)` `MAXIMUM LENGTH: 30` LAST EDITED: `FEB 27, 2024` HELP-PROMPT: `Answer must be 3 numerics, no decimal places.` DESCRIPTION: `Identifies additional information needed to generate stage, or prognostic factors that have an effect on stage or survival.` EXECUTABLE HELP: `D HELP^ONCWEBCS(18,D0)` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
45	PERFORMANCE STATUS	2;24	SET	'100' FOR NORMAL; '90' FOR MINOR SYMTOMS; '80' FOR ACTIVITY W EFFORT; '70' FOR NO WORK/SELF CARE; '60' FOR OCCASIONAL ASSIST; '50' FOR CONSIDERABLE ASSIST; '40' FOR DISABLED/SPECIAL CARE; '30' FOR SEVERLY DISABLED/HOSP; '20' FOR VERY SICK/HOSP; '10' FOR MORIBUND; '0' FOR DEAD; LAST EDITED: `SEP 23, 1992` HELP-PROMPT: `Enter Performance Status` DESCRIPTION: `This is the performance status of the patient.`
46	CAP PROTOCOL REVIEW	7;19	SET	'0' FOR Failed; '1' FOR Complied; '9' FOR NA or exempt; LAST EDITED: `JUL 13, 2006` DESCRIPTION: `The ACS (American College of Surgeons) requires CAP (College of American Pathologists) Protocol Review of cases with surgical resection only. Biopsy only cases are exempt from review.` `Records whether this case failed, complied with or was exempt from CAP Protocol Review.` `To use code 1 (Complied), ALL elements of the CAP Cancer Protocol Checklist must be documented on the pathology report.`
47	CAP TEXT	7;20	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>50!($L(X)<1) X` LAST EDITED: `JUL 19, 2006` HELP-PROMPT: `Answer must be 1-50 characters in length.` DESCRIPTION: `Records the reason for CAP (College of American Pathologists) Protocol non-compliance.`
48	OTHER PRIMARY SITES		COMPUTED	MUMPS CODE: `S X="" D SDP^ONCOCOM` ALGORITHM: `S X="" D SDP^ONCOCOM` LAST EDITED: `JUL 13, 1990` DESCRIPTION: `SITES OTHER THAN THE COMMON CANCER SITES ARE LISTED.`
49	FIRST COURSE OF TREATMENT DATE		COMPUTED	MUMPS CODE: `S X="" D DFC^ONCOCOM` ALGORITHM: `S X="" D DFC^ONCOCOM` LAST EDITED: `AUG 04, 1997` DESCRIPTION: `Records the date on which treatment (surgery, radiation, systemic, or other therapy) of the patient begain at any facility.` `For further information see FORDS pages 129-130.`
49.1	FIRST TREATMENT DT-DATE DX		COMPUTED	MUMPS CODE: `S X="" D DDX^ONCOCOM` ALGORITHM: `S X="" D DDX^ONCOCOM` LAST EDITED: `OCT 28, 2014` DESCRIPTION: `A computed field derives from FIRST COURSE OF TREATMENT DATE minus DATE DX.` TECHNICAL DESCR: `This is a computed field derives from FIRST COURSE OF TREATMENT DATE minus DATE DX.`
49.9	DATE INITIAL RX SEER		COMPUTED	MUMPS CODE: `S X="" D DRXS^ONCOCOM` ALGORITHM: `S X="" D DRXS^ONCOCOM` LAST EDITED: `FEB 09, 2022` DESCRIPTION: `Records the date of initiation of the first course therapy for the tumor being reported, using the SEER definition of first course.`
50	MOST DEFINITIVE SURG DATE	3;1	DATE	INPUT TRANSFORM: `D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `NOV 09, 2004` HELP-PROMPT: `* MOST DEFINITIVE SURG DATE MUST BE AFTER OR EQUAL TO DATE DX *` DESCRIPTION: `Records the date of the most definitive surgical resection of the primary site performed as part of the first course of treatment.` `For further information see FORDS pages 133-134.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^ATS^MUMPS` `1)= S ^ONCO(165.5,"ATX",DA,X_"S1")=""` `2)= K ^ONCO(165.5,"ATX",DA,X_"S1")` `Records most definitive surgical resection of the primary on the unified treatment index.`
50.1	SURGERY HOSPITAL	3;2	POINTER TO FACILITY FILE (#160.19)	FACILITY(#160.19) INPUT TRANSFORM: `S V="" D NT^ONCODSR` OUTPUT TRANSFORM: `S:Y'="" Y=$S($D(^ONCO(160.19,Y,0)):$P(^(0),U,2),1:Y)` LAST EDITED: `MAR 02, 1998` HELP-PROMPT: `Record the name of the institution providing treatment.` DESCRIPTION: `Record the name of the institution providing treatment.` EXECUTABLE HELP: `D HELP^ONCOFLF` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
50.2	SURGERY OF PRIMARY @FAC (R)	3.1;7	FREE TEXT	INPUT TRANSFORM: `S FIELD=50.2,SPSFLG=0 D SPSDFIT^ONCTXSM K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X),SPSFLG=0 S NTXDD=1 D SPSIT^ONCOSUR` OUTPUT TRANSFORM: `S FIELD=50.2 D SPSOT^ONCOSUR` LAST EDITED: `MAR 27, 2003` DESCRIPTION: `Records the surgical procedure(s) performed to the primary site at this facilty.` `For further information see ROADS page 190.` EXECUTABLE HELP: `S FIELD=50.2 D SPSHP^ONCOSUR` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^AT^MUMPS` `1)= Q` `2)= D SPSATF^ONCDTX1` `When the value of this field is deleted, the KILL logic will delete all of the associated field values.`
50.3	MOST DEFINITIVE SURG @FAC DATE	3.1;8	DATE	INPUT TRANSFORM: `D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `NOV 09, 2004` HELP-PROMPT: `* MOST DEFINITIVE SURG @FAC DATE MUST BE AFTER OR EQUAL TO DATE DX *` DESCRIPTION: `Records the date of the most definitive surgical resection of the primary site performed as part of the first course of treatment at this facility.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
51	DATE RADIATION STARTED	3;4	DATE	INPUT TRANSFORM: `D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `JAN 28, 2003` HELP-PROMPT: `* DATE RADIATION STARTED MUST BE AFTER OR EQUAL TO DATE DX *` DESCRIPTION: `Records the date on which radiation therapy began at any facility that is part of the first course of treatment.` `For further information see FORDS pages 148-149.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^ATR^MUMPS` `1)= S ^ONCO(165.5,"ATX",DA,X_"R")=""` `2)= K ^ONCO(165.5,"ATX",DA,X_"R")` `Records radiation date on the unified treatment index.`
51.1	RADIATION HOSPITAL	3;5	POINTER TO FACILITY FILE (#160.19)	FACILITY(#160.19) INPUT TRANSFORM: `S V="" D NT^ONCODSR` OUTPUT TRANSFORM: `S:Y'="" Y=$S($D(^ONCO(160.19,Y,0)):$P(^(0),U,2),1:Y)` LAST EDITED: `SEP 02, 1997` HELP-PROMPT: `Enter Facility performing Radiation Therapy` DESCRIPTION: `Record the name of the institution administering the therapy.` EXECUTABLE HELP: `D HELP^ONCOFLF` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
51.2	RADIATION	3;6	SET	'0' FOR None; '1' FOR Beam radiation; '2' FOR Radioactive implants; '3' FOR Radioisotopes; '4' FOR Beam + implants or radioisotopes; '5' FOR Radiation, NOS; '7' FOR Refused radiation; '8' FOR Recommended, unknown if given; '9' FOR Unknown if administered; INPUT TRANSFORM: `S V=0 D NT^ONCODSR` LAST EDITED: `SEP 12, 1997` DESCRIPTION: `Record the type of radiation administered to the primary site or any metastatic site. Include all procedures that are part of the first course of treatment, whether delivered at the reporting institution or at other` `institutions.` SCREEN: `S DIC("S")="I ($P(^ONCO(165.5,DA,0),U,16)<2960101)!((Y'=7)&(Y'=8))"` EXPLANATION: `Codes 7 and 8 should not be used for primaries with a DATE DX > 12/31/95.` GROUP: `ACOS-REQUIRED` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^AJ^MUMPS` `1)= Q` `2)= D RAD^ONCDTX` `When the value of this field is deleted, the KILL logic will delete the following associated field values:` `DATE RADIATION STARTED (165.5,51) LOCATION OF RADIATION TX (165.5,126) RADIATION TREATMENT VOLUME (165.5,125) REGIONAL TREATMENT MODALITY (165.5,363) REGIONAL DOSE:cGy (165.5,442) BOOST TREATMENT` `MODALITY (165.5,363.1) BOOST DOSE:cGy (165.5,443) NUMBER OF TXS TO THIS VOLUME (165.5,56) RADIATION/SURGERY SEQUENCE (165.5,51.3) DATE RADIATION ENDED (165.5,361) REASON FOR NO RADIATION` `(165.5,75) RX TEXT-RADIATION (165.5,109)`
51.3	RADIATION/SURGERY SEQUENCE	3;7	SET	'0' FOR No rad and/or surgery; '2' FOR Rad before surgery; '3' FOR Rad after surgery; '4' FOR Rad both before/after surgery; '5' FOR Intraoperative rad; '6' FOR Intraoperative rad w rad before/after surgery; '9' FOR Sequence unknown; INPUT TRANSFORM: `S V=0 D NT^ONCODSR` LAST EDITED: `SEP 02, 1997` DESCRIPTION: `Records the sequencing of radiation and surgical procedures given as part of the first course of treatment.` `For further information see FORDS pages 164-165.` GROUP: `ACOS-RECOMMENDED` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
51.4	RADIATION @FACILITY	3.1;12	SET	'0' FOR None; '1' FOR Beam radiation; '2' FOR Radioactive implants; '3' FOR Radioisotopes; '4' FOR Beam + implants or radioisotopes; '5' FOR Radiation, NOS; '7' FOR Refused radiation; '8' FOR Recommended, unknown if given; '9' FOR Unknown if administered; INPUT TRANSFORM: `S V=0 D NT^ONCODSR` LAST EDITED: `OCT 01, 1998` HELP-PROMPT: `Enter the type of radiation administered to the primary site or any metastatic site at this facility` DESCRIPTION: `Records the type of radiation administered to the primary site or any metastatic site AT THIS FACILITY. Includes all procedures that are part of the first course of treatment.` SCREEN: `S DIC("S")="I ($P(^ONCO(165.5,DA,0),U,16)<2960101)!((Y'=7)&(Y'=8))"` EXPLANATION: `Codes 7 and 8 should not be used for primaries with a DATE DX > 12/31/95.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^AU^MUMPS` `1)= Q` `2)= D RADATF^ONCDTX1` `NOREINDEX)= 1` `When the value of this field is deleted, the KILL logic will delete the following associated field value:` `RADIATION @FACILITY DATE (165.5,51.5)`
51.5	RADIATION @FACILITY DATE	3.1;13	DATE	INPUT TRANSFORM: `D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `JAN 21, 1999` HELP-PROMPT: `* RADIATION DATE AT THIS FACILITY MUST BE AFTER OR EQUAL TO DATE DX *` DESCRIPTION: `Record the date that the first course of radiation therapy performed AT THIS FACILITY was started.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
52	RADIATION THERAPY TO CNS DATE	3;8	DATE	INPUT TRANSFORM: `D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `OCT 24, 2005` HELP-PROMPT: `* RADIATION THERAPY TO CNS DATE MUST BE AFTER OR EQUAL TO DATE DX *` DESCRIPTION: `FOR LUNG AND LEUKEMIA ONLY: record the date radiation therapy to the brain and CNS was initiated.` `ALL OTHER SITES: not a valid entry.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^ATP^MUMPS` `1)= S ^ONCO(165.5,"ATX",DA,X_"P")=""` `2)= K ^ONCO(165.5,"ATX",DA,X_"P")` `Records brain/CNS radiation date on the unified treatment index.`
52.1	RADIATION THERAPY TO CNS HOSP	3;9	POINTER TO FACILITY FILE (#160.19)	FACILITY(#160.19) INPUT TRANSFORM: `S V="" D NT^ONCODSR` OUTPUT TRANSFORM: `S:Y'="" Y=$S($D(^ONCO(160.19,Y,0)):$P(^(0),U,2),1:Y)` LAST EDITED: `SEP 02, 1997` HELP-PROMPT: `Enter Facility giving the treatment.` DESCRIPTION: `Record the name of the institution administering the therapy. This field is used only for LUNGS and LEUKEMIAS.` EXECUTABLE HELP: `D HELP^ONCOFLF` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
52.2	RADIATION THERAPY TO CNS	3;10	SET	'0' FOR No radiation to CNS; '1' FOR Radiation; '7' FOR Patient refused radiation; '8' FOR Radiation recommended, unk if admin; '9' FOR Unknown/NA; INPUT TRANSFORM: `S V=0 D NT^ONCODSR` LAST EDITED: `AUG 11, 2003` HELP-PROMPT: `Code '9' unless this is a lung or leukemia case` DESCRIPTION: `These data are being kept for historical purposes. Do not code for cases diagnosed as of January 1, 1996. Case diagnosed on or after January 1, 1996 should be coded in the field RADIATION.` `Radiation treatment to the central nervous system (CNS) codes 0-8 are valid only for patients with lung or leukemia primaries. Code 9 (Unknown/NA) for all other cases.` GROUP: `SEER` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
53	CHEMOTHERAPY DATE	3;11	DATE	INPUT TRANSFORM: `D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `MAR 11, 1998` HELP-PROMPT: `* CHEMOTHERAPY DATE MUST BE AFTER OR EQUAL TO DATE DX *` DESCRIPTION: `Record the date first course of CHEMOTHERAPY was started.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^ATC^MUMPS` `1)= S ^ONCO(165.5,"ATX",DA,X_"C")=""` `2)= K ^ONCO(165.5,"ATX",DA,X_"C")` `Records chemotheraphy date on the unified treatment index.`
53.1	CHEMOTHERAPY HOSPITAL	3;12	POINTER TO FACILITY FILE (#160.19)	FACILITY(#160.19) INPUT TRANSFORM: `S V="" D NT^ONCODSR` OUTPUT TRANSFORM: `S:Y'="" Y=$S($D(^ONCO(160.19,Y,0)):$P(^(0),U,2),1:Y)` LAST EDITED: `SEP 19, 1997` HELP-PROMPT: `Enter the institution where CHEMOTHERPY was administered.` DESCRIPTION: `Record the name of the institution where CHEMOTHERAPY was given.` EXECUTABLE HELP: `D HELP^ONCOFLF` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
53.2	CHEMOTHERAPY	3;13	SET	'00' FOR None; '01' FOR Chemotherapy, NOS; '02' FOR Single-agent; '03' FOR Multiagent; '82' FOR Not administered/contraindicated; '85' FOR Pt died prior to tx; '86' FOR Recommended, not admin, no reason given; '87' FOR Refusal; '88' FOR Recommended, unknown if admin; '99' FOR Unknown; LAST EDITED: `SEP 09, 2003` DESCRIPTION: `Records the type of chemotherapy administered as first course of treatment at this and at all other facilities. If chemotherapy was not administered, then this item records the reason it was not administered to the` `patient. Chemotherapy consists of a group of anticancer drugs that inhibit the reproduction of cancer cells by interfering with DNA synthesis and mitosis.` `For further information see FORDS pages 171-172.` SCREEN: `S DIC("S")="I ($P(^ONCO(165.5,DA,0),U,16)<2960101)!((Y'=7)&(Y'=8))"` EXPLANATION: `Codes 7 and 8 should not be used for primaries with a DATE DX > 12/31/95.` GROUP: `ACOS-REQUIRED` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^AM^MUMPS` `1)= Q` `2)= D CHE^ONCDTX` `When the value of this field is deleted, the KILL logic will delete all of the associated field values.`
53.3	CHEMOTHERAPY @FAC	3.1;14	SET	'00' FOR None; '01' FOR Chemotherapy, NOS; '02' FOR Single-agent; '03' FOR Multiagent; '82' FOR Not administered/contraindicated; '85' FOR Pt died prior to tx; '86' FOR Recommended, not admin, no reason given; '87' FOR Refusal; '88' FOR Recommended, unknown if admin; '99' FOR Unknown; LAST EDITED: `FEB 11, 2016` HELP-PROMPT: `Enter the type of chemotherapy administered as first course of treatment at this facility` DESCRIPTION: `Records the type of chemotherapy administered as first course of treatment at this facility. If chemotherapy was not administered, then this item records the reason it was not administered to the patient. Chemotherapy` `consists of a group of anticancer drugs that inhibit the reproduction of cancer cells by interfering with DNA synthesis and mitosis.` `For further information see FORDS pages 173-174.` CROSS-REFERENCE: `165.5^AV^MUMPS` `1)= Q` `2)= D CHEMATF^ONCDTX1` `NOREINDEX)= 1` `When the value of this field is deleted, the KILL logic will delete all of the associated field values.`
53.4	CHEMOTHERAPY @FAC DATE	3.1;15	DATE	INPUT TRANSFORM: `D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `FEB 25, 2003` HELP-PROMPT: `* CHEMOTHERAPY @FAC DATE MUST BE AFTER OR EQUAL TO DATE DX *` DESCRIPTION: `Record the date chemotherapy was administered as first course of treatment at this facility.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
54	HORMONE THERAPY DATE	3;14	DATE	INPUT TRANSFORM: `D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `MAR 11, 1998` HELP-PROMPT: `* HORMONE THERAPY DATE MUST BE AFTER OR EQUAL TO DATE DX *` DESCRIPTION: `Record the date HORMONE THERAPY was started.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^ATH^MUMPS` `1)= S ^ONCO(165.5,"ATX",DA,X_"H")=""` `2)= K ^ONCO(165.5,"ATX",DA,X_"H")` `Records hormone therapy date on the unified treatment index.`
54.1	HORMONE THERAPY HOSPITAL	3;15	POINTER TO FACILITY FILE (#160.19)	FACILITY(#160.19) INPUT TRANSFORM: `S V="" D NT^ONCODSR` OUTPUT TRANSFORM: `S:Y'="" Y=$S($D(^ONCO(160.19,Y,0)):$P(^(0),U,2),1:Y)` LAST EDITED: `OCT 03, 1997` HELP-PROMPT: `Enter Hospital where Hormone Therapy was performed.` DESCRIPTION: `Record the name of the institution that administered the hormone therapy.` EXECUTABLE HELP: `D HELP^ONCOFLF` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
54.2	HORMONE THERAPY	3;16	SET	'00' FOR None; '01' FOR Hormone therapy; '82' FOR Not administered/contraindicated; '85' FOR Pt died prior to tx; '86' FOR Recommended, not admin, no reason given; '87' FOR Refusal; '88' FOR Recommended, unknown if admin; '99' FOR Unknown; LAST EDITED: `SEP 09, 2003` DESCRIPTION: `Records the type of hormone therapy administered as first course treatment at this and all other facilities. If hormone therapy was not administered, then this item records the reason it was not administered to the` `patient. Hormone therapy consists of a group of drugs that may affect the long-term control of a cancer's growth. It is not usually used as a curative measure.` `For further information see FORDS pages 175-176.` SCREEN: `S DIC("S")="I ($P(^ONCO(165.5,DA,0),U,16)<2960101)!((Y'=7)&(Y'=8))"` EXPLANATION: `Codes 7 and 8 should not be used for primaries with a DATE DX > 12/31/95.` GROUP: `ACOS-REQUIRED` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^AN^MUMPS` `1)= Q` `2)= D HOR^ONCDTX` `When the value of this field is deleted, the KILL logic will delete all of the associated field values.`
54.3	HORMONE THERAPY @FAC	3.1;16	SET	'00' FOR None; '01' FOR Hormone therapy; '82' FOR Not administered/contraindicated; '85' FOR Pt died prior to tx; '86' FOR Recommended, not admin, no reason given; '87' FOR Refusal; '88' FOR Recommended, unknown if admin; '99' FOR Unknown; LAST EDITED: `JUN 29, 2006` HELP-PROMPT: `Enter the type of hormone therapy administered as first course of treatment at this facility` DESCRIPTION: `Records the type of hormone therapy administered as first course treatment at this facility. If hormone therapy was not administered, then this item records the reason it was not administered to the patient. Hormone` `therapy consists of a group of drugs that may affect the long-term control of a cancer's growth. It is not usually used as a curative measure.` `For further information see FORDS pages 177-178.` CROSS-REFERENCE: `165.5^AW^MUMPS` `1)= Q` `2)= D HORATF^ONCDTX1` `NOREINDEX)= 1` `When the value of this field is deleted, the KILL logic will delete all of the associated field values.`
54.4	HORMONE THERAPY @FAC DATE	3.1;17	DATE	INPUT TRANSFORM: `D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `FEB 25, 2003` HELP-PROMPT: `* HORMONE THERAPY @FAC DATE MUST BE AFTER OR EQUAL TO DATE DX *` DESCRIPTION: `Records the date hormone therapy was administered as first course of treatment at this facility.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
55	IMMUNOTHERAPY DATE	3;17	DATE	INPUT TRANSFORM: `D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `MAR 11, 1998` HELP-PROMPT: `* IMMUNOTHERAPY DATE MUST BE AFTER OR EQUAL TO DATE DX *` DESCRIPTION: `The date immunotherapy was started.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^ATB^MUMPS` `1)= S ^ONCO(165.5,"ATX",DA,X_"B")=""` `2)= K ^ONCO(165.5,"ATX",DA,X_"B")` `Records biological response modifier date on the unified treatment index.`
55.1	IMMUNOTHERAPY HOSPITAL	3;18	POINTER TO FACILITY FILE (#160.19)	FACILITY(#160.19) INPUT TRANSFORM: `S V="" D NT^ONCODSR` OUTPUT TRANSFORM: `S:Y'="" Y=$S($D(^ONCO(160.19,Y,0)):$P(^(0),U,2),1:Y)` LAST EDITED: `SEP 23, 1997` HELP-PROMPT: `Record the ACOS number of the institution where immunotherapy was performed.` DESCRIPTION: `The ACOS number of the institution where immunotherapy was performed.` EXECUTABLE HELP: `D HELP^ONCOFLF` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
55.2	IMMUNOTHERAPY	3;19	SET	'00' FOR None; '01' FOR Immunotherapy; '82' FOR Not administered/contraindicated; '85' FOR Pt died prior to tx; '86' FOR Recommended, not admin, no reason given; '87' FOR Refusal; '88' FOR Recommended, unknown if admin; '99' FOR Unknown; OUTPUT TRANSFORM: `NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!` LAST EDITED: `SEP 09, 2003` DESCRIPTION: `Records the type of immunotherapy administered as first course treatment at this and all other facilities. If immunotherapy was not administered, then this item records the reason it was not administered to the patient.` `Immunotherapy consists of biological or chemical agents that alter the immune system or change the host's response to the tumor cells.` `For further information see FORDS pages 179-180.` SCREEN: `S DIC("S")="I ($P(^ONCO(165.5,DA,0),U,16)>2951231)!((Y'=3)&(Y'=4)&(Y'=5)&(Y'=6))"` EXPLANATION: `Codes 3, 4, 5 and 6 should only be used for primaries with a DATE DX > 12/31/95.` GROUP: `ACOS-REQUIRED` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^AO^MUMPS` `1)= Q` `2)= D IMM^ONCDTX` `When the value of this field is deleted, the KILL logic will delete all of the associated field values.`
55.3	IMMUNOTHERAPY @FAC	3.1;18	SET	'00' FOR None; '01' FOR Immunotherapy; '82' FOR Not administered/contraindicated; '85' FOR Pt died prior to tx; '86' FOR Recommended, not admin, no reason given; '87' FOR Refusal; '88' FOR Recommended, unknown if admin; '99' FOR Unknown; LAST EDITED: `JAN 29, 2003` HELP-PROMPT: `Enter the type of immunotherapy administered as first course of treatment at this facility` DESCRIPTION: `Records the type of immunotherapy administered as first course treatment at this facility. If immunotherapy was not administered, then this item records the reason it was not administered to the patient. Immunotherapy` `consists of biological or chemical agents that alter the immune system or change the host's response to the tumor cells.` `For further information see FORDS page 181.` CROSS-REFERENCE: `165.5^AX^MUMPS` `1)= Q` `2)= D IMMATF^ONCDTX1` `NOREINDEX)= 1` `When the value of this field is deleted, the KILL logic will delete all of the associated field values.`
55.4	IMMUNOTHERAPY @FAC DATE	3.1;19	DATE	INPUT TRANSFORM: `D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `FEB 25, 2003` HELP-PROMPT: `* IMMUNOTHERAPY @FAC DATE MUST BE AFTER OR EQUAL TO DATE DX *` DESCRIPTION: `Records the date immunotherapy was administered as first course of treatment at this facility.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
56	NUMBER OF TXS TO THIS VOLUME	3;20	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>999)!(X<0)!(X?.E1"."1N.N) X I $D(X) S V=0 D NT^ONCODSR` OUTPUT TRANSFORM: `S Y=$S(Y="000":"None",Y=999:"Unknown",1:Y)` LAST EDITED: `JUL 14, 2010` HELP-PROMPT: `Type a Number between 0 and 999, 0 Decimal Digits` DESCRIPTION: `Records the total number of treatment sessions (fractions) administered during the first course of treatment.` `For further information see FORDS page 163.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
57	OTHER TREATMENT START DATE	3;23	DATE	INPUT TRANSFORM: `D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `JAN 31, 2003` HELP-PROMPT: `* OTHER TREATMENT START DATE MUST BE AFTER OR EQUAL TO DATE DX *` DESCRIPTION: `Records the date on which other treatment began at any facility.` `For further information see FORDS pages 184-185.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^ATO^MUMPS` `1)= S ^ONCO(165.5,"ATX",DA,X_"O")=""` `2)= K ^ONCO(165.5,"ATX",DA,X_"O")` `Records other cancer-directed therapy date on the unified treatment index.`
57.1	OTHER TREATMENT HOSPITAL	3;24	POINTER TO FACILITY FILE (#160.19)	FACILITY(#160.19) INPUT TRANSFORM: `S V="" D NT^ONCODSR` OUTPUT TRANSFORM: `S:Y'="" Y=$S($D(^ONCO(160.19,Y,0)):$P(^(0),U,2),1:Y)` LAST EDITED: `SEP 23, 1997` HELP-PROMPT: `Enter facility where other treatment was given.` DESCRIPTION: `Record the name of the institution where other treatment was administered.` EXECUTABLE HELP: `D HELP^ONCOFLF` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
57.2	OTHER TREATMENT	3;25	SET	'0' FOR None; '1' FOR Other; '2' FOR Other - Experimental; '3' FOR Other - Double Blind; '6' FOR Other - Unproven; '7' FOR Refusal; '8' FOR Recommended, unknown if administered; '9' FOR Unknown; LAST EDITED: `SEP 09, 2003` DESCRIPTION: `Identifies other treatment that cannot be defined as surgery, radiation, or systemic therapy according to the defined data elements in the FORDS manual.` `For further information see FORDS page 186.` GROUP: `ACOS-REQUIRED` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^AP^MUMPS` `1)= Q` `2)= D OTH^ONCDTX` `When the value of this field is deleted, the KILL logic will delete all of the associated field values.`
57.3	OTHER TREATMENT @FAC	3.1;20	SET	'0' FOR None; '1' FOR Other; '2' FOR Other - Experimental; '3' FOR Other - Double Blind; '6' FOR Other - Unproven; '7' FOR Refusal; '8' FOR Recommended, unknown if administered; '9' FOR Unknown; LAST EDITED: `SEP 09, 2003` HELP-PROMPT: `Enter other treatment given at this facility that cannot be defined as surgery, radiation or systemic therapy` DESCRIPTION: `Identifies other treatment given at this facility that cannot be defined as surgery, radiation, or systemic therapy according to the defined data elements in the FORDS manual.` `For further information see FORDS page 187.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^AZ^MUMPS` `1)= Q` `2)= D OTHATF^ONCDTX1` `NOREINDEX)= 1` `When the value of this field is deleted, the KILL logic will delete all of the associated field values.`
57.4	OTHER TREATMENT @FACILITY DATE	3.1;21	DATE	INPUT TRANSFORM: `D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `JAN 21, 1999` HELP-PROMPT: `* OTHER TREATMENT AT THIS FACILITY DATE MUST BE AFTER OR EQUAL TO DATE DX *` DESCRIPTION: `Record the month, day, and year first course of other treatment performed AT THIS FACILITY was started.` `Collecting dates for each treatment modality allows sequencing of multiple treatments and aids evaluation of time intervals (from diagnosis to treatment and from treatment to recurrence).` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
58	REASON NO SURGERY OF PRIMARY	3;26	SET	'0' FOR Surgery performed; '1' FOR Not part of 1st course; '2' FOR Contraindicated; '5' FOR Pt died prior to surgery; '6' FOR Recommended, not performed, no reason given; '7' FOR Refusal; '8' FOR Recommended, unknown if performed; '9' FOR Unknown; INPUT TRANSFORM: `Q` LAST EDITED: `JAN 25, 2005` DESCRIPTION: `Records the reason that no surgery was performed on the primary site.` `For further information see FORDS page 147.`
58.1	SURGICAL DX/STAGING PROC	3;27	FREE TEXT	INPUT TRANSFORM: `D NCDSIT^ONCODSR` OUTPUT TRANSFORM: `D NCDSOT^ONCODSR` LAST EDITED: `NOV 08, 2002` DESCRIPTION: `Identifies the surgical procedure(s) performed in an effort to diagnose and/or stage disease.` `For further information see FORDS pages 109-110.` EXECUTABLE HELP: `D HP0^ONCODSR` GROUP: `SEER` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^AQ^MUMPS` `1)= Q` `2)= D NCDS^ONCDTX`
58.2	SURGERY OF PRIMARY (R)	3;38	NUMBER	INPUT TRANSFORM: `S FIELD=58.2,NTXDD=1 D SPSIT^ONCOSUR` OUTPUT TRANSFORM: `S FIELD=58.2 D SPSOT^ONCOSUR` LAST EDITED: `MAR 27, 2003` DESCRIPTION: `Records the surgical procedure(s) performed to the primary site.` `For further information see ROADS pages 187-189.` EXECUTABLE HELP: `S FIELD=58.2 D SPSHP^ONCOSUR` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^AI^MUMPS` `1)= Q` `2)= D SURR^ONCDTX`
58.3	SURGICAL DX/STAGING PROC DATE	3;31	DATE	INPUT TRANSFORM: `D DFIT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `MAR 29, 2007` HELP-PROMPT: `Enter the date the surgical diagnostic and/or staging procedure was performed.` DESCRIPTION: `Records the date on which the surgical diagnostic and/or staging procedure was performed.` `For further information see FORDS pages 107-108.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
58.4	SURG DX/STAGING PROC @FAC	3.1;5	FREE TEXT	INPUT TRANSFORM: `D NCDSIT^ONCODSR` OUTPUT TRANSFORM: `D NCDSOT^ONCODSR` LAST EDITED: `JAN 07, 2003` DESCRIPTION: `Identifies the surgical procedure(s) performed in an effort to diagnose and/or stage disease at this facility.` `For further information see FORDS page 111.` EXECUTABLE HELP: `D HP0^ONCODSR` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^AR^MUMPS` `1)= Q` `2)= D NCDSATF^ONCDTX1` `When the value of this field is deleted, the KILL logic will delete all of the associated field values.`
58.5	SURG DX/STAGING PROC @FAC DATE	3.1;6	DATE	INPUT TRANSFORM: `D DFIT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `MAR 29, 2007` HELP-PROMPT: `Enter the date the surgical diagnostic and/or staging procedure was performed at this facility.` DESCRIPTION: `Records the date on which the surgical diagnostic and/or staging procedure was performed at this facility.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
58.6	RX SUMM--SURG PRIMSITE 03-2022	3.1;29	FREE TEXT	INPUT TRANSFORM: `S FIELD=58.6,NTXDD=1 D SPSIT^ONCOSUR` `MAXIMUM LENGTH: 30` OUTPUT TRANSFORM: `S FIELD=58.6 D SPSOT^ONCOSUR` LAST EDITED: `AUG 26, 2024` HELP-PROMPT: `Enter the surgical procedure CODE. Alphabetic entries are prohibited.` DESCRIPTION: `Records the surgical procedure(s) performed to the primary site.` `For further information see FORDS page 135.` EXECUTABLE HELP: `S FIELD=58.6 D SPSHP^ONCOSUR` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^AI^MUMPS` `1)= Q` `2)= D SUR^ONCDTX` `If SURGICAL PROC OF PRIMARY is deleted, the associated surgery fields are also deleted.`
58.7	RX HOSP--SURG PRIMSITE 03-2022	3.1;30	FREE TEXT	INPUT TRANSFORM: `S SPSFLG=0 D SPSDFIT^ONCTXSM K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X),SPSFLG=0 S FIELD=58.7,NTXDD=1 D SPSIT^ONCOSUR` `MAXIMUM LENGTH: 2` OUTPUT TRANSFORM: `S FIELD=58.7 D SPSOT^ONCOSUR` LAST EDITED: `AUG 26, 2024` DESCRIPTION: `Records the surgical procedure(s) performed to the primary at this facility.` `For further information see FORDS page 136.` EXECUTABLE HELP: `S FIELD=58.7 D SPSHP^ONCOSUR` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^AT^MUMPS` `1)= Q` `2)= D SPSATF^ONCDTX1` `If SURGICAL PROC OF PRIMARY @FAC is deleted, the associated surgery @FAC fields are also deleted.`
58.8	RX HOSP--SURG PRIM SITE 2023	3.2;8	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>4!($L(X)<4) X I $D(X) D SPSIT23^ONCOSUR3` `MAXIMUM LENGTH: 4` LAST EDITED: `AUG 08, 2023` HELP-PROMPT: `Answer must be 4 characters in length. Format: First character must be 'A' or 'B' followed by 3 numbers. See Appendix A of STORE Manual 2023 for allowable values for each primary site.` DESCRIPTION: `Records the surgical procedure(s) performed to the primary site at this facility with a diagnosis year of 2023 and forward.` EXECUTABLE HELP: `D SPSHP23^ONCOSUR3` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
58.9	RX SUMM--SURG PRIM SITE 2023	3.2;9	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>4!($L(X)<4) X I $D(X) D SPSIT23^ONCOSUR3` `MAXIMUM LENGTH: 4` LAST EDITED: `AUG 08, 2023` HELP-PROMPT: `Answer must be 4 characters in length. Format: First character must be 'A' or 'B' followed by 3 numbers. See Appendix A of STORE Manual 2023 for allowable values for each primary site.` DESCRIPTION: `Surgery of Primary Site describes a surgical procedure that removes and/or destroys tissue of the primary site that is performed as part of the initial diagnostic and staging work-up or first course of therapy.` EXECUTABLE HELP: `D SPSHP23^ONCOSUR3` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
59	SURGICAL MARGINS	3;28	SET	'0' FOR No residual tumor; '1' FOR Residual tumor, NOS; '2' FOR Microscopic residual tumor; '3' FOR Macroscopic residual tumor; '7' FOR Margins not evaluable; '8' FOR No primary site surgery; '9' FOR Unknown or NA; LAST EDITED: `FEB 25, 2010` HELP-PROMPT: `Record the margin status as it appears in the pathology report.` DESCRIPTION: `Records the final status of the surgical margins after resection of the primary tumor.` `For further information see FORDS 2010 page 224.`
60	SUBSEQUENT COURSE OF TREATMENT	4;0	DATE Multiple #165.51	165.51 OUTPUT TRANSFORM: `NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!` LAST EDITED: `MAY 04, 1993` DESCRIPTION: `Enter subsequent therapy (therapy provided after completion of the first course of therapy).`
61	PID#		COMPUTED	MUMPS CODE: `S X="" D PID5^ONCOCOM` ALGORITHM: `S X="" D PID5^ONCOCOM` DESCRIPTION: `RECORD THE PATIENT'S IDENTIFICATION NUMBER.`
62	QA SELECTED	7;4	SET	'Y' FOR YES; LAST EDITED: `SEP 23, 1992` HELP-PROMPT: `Abstract has been selected for QA Review (from QA option)` DESCRIPTION: `Field is stuffed if randomly selected for QA review.`
63	QA REVIEW	7;8	SET	'N' FOR NO; 'Y' FOR YES; LAST EDITED: `SEP 23, 1992` HELP-PROMPT: `Enter if QReview was performed on the selected Abstract.` DESCRIPTION: `Field only used if Abstract was randomly selected for QA Review.`
64	QA DATE	7;9	DATE	INPUT TRANSFORM: `S %DT="EPX" D ^%DT S X=Y K:Y<1 X I $D(X) S DTDX=$P($G(^ONCO(165.5,D0,0)),"^",16) I DTDX'="" K:X` `OUTPUT TRANSFORM: S X=Y D DATEOT^ONCOES` `LAST EDITED: JUL 31, 2014` `HELP-PROMPT: * QA DATE MUST BE AFTER OR EQUAL TO DATE DX *` `DESCRIPTION:` `Date of QA Review if done on this Abstract.` `NOTES: XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
64.1	QA REVIEWER	7;18	POINTER TO NEW PERSON FILE (#200)	NEW PERSON(#200) LAST EDITED: `JUL 19, 1999` DESCRIPTION: `Select the name of the QA reviewer.`
64.2	QA FINDINGS	28;0	WORD-PROCESSING #165.54	DESCRIPTION: `Enter the QA FINDINGS of the QA review. Please limit your findings to 3 lines of text.` LAST EDITED: `JUL 27, 1999` DESCRIPTION: `Enter the QA FINDINGS of the QA review. Please limit your findings to 3 lines of text.`
65	PHYSICIAN'S STAGE	7;10	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>30!($L(X)<3) X` LAST EDITED: `JUL 17, 2003` HELP-PROMPT: `Answer must be 3-30 characters in length.` DESCRIPTION: `Records information regarding the physician's stage.`
66	PHYSICIAN STAGING	7;11	POINTER TO ONCOLOGY CONTACT FILE (#165)	ONCOLOGY CONTACT(#165) INPUT TRANSFORM: `S DIC("S")="I $P(^(0),U,2)=2" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X` LAST EDITED: `MAY 11, 1999` HELP-PROMPT: `Enter physician's name who did the staging` DESCRIPTION: `This is the name of the physician performing the staging.` SCREEN: `S DIC("S")="I $P(^(0),U,2)=2"` EXPLANATION: `Contact Type is MD` CROSS-REFERENCE: `165.5^ACP^MUMPS` `1)= S ^ONCO(165,"ACP",X,$P(^ONCO(165.5,DA,0),U,2))=""` `2)= K ^ONCO(165,"ACP",X,$P(^ONCO(165.5,DA,0),U,2))` `Creates a list under the Contact file of contacts, and associated patients orginating from the Primary file pointers to the Contact File.` CROSS-REFERENCE: `165.5^APC^MUMPS` `1)= S ^ONCO(165,"APC",$P(^ONCO(165.5,DA,0),U,2),X)=""` `2)= K ^ONCO(165,"APC",$P(^ONCO(165.5,DA,0),U,2),X)` `Creates a list under the contact file of patients, and associated contacts originating from the Primary file pointers to the contact file.` CROSS-REFERENCE: `165.5^APST^MUMPS` `1)= S ^ONCO(165.5,"APST",X,$P(^ONCO(165.5,DA,0),U,2),DA)=""` `2)= K ^ONCO(165.5,"APST",X,$P(^ONCO(165.5,DA,0),U,2),DA)` `Creates a list of CONTACTs and the ONCOLOGY PATIENTs who use them.`
67	ACOS #		COMPUTED	MUMPS CODE: `S X=$$IIN^ONCFUNC` ALGORITHM: `S X=$$IIN^ONCFUNC` LAST EDITED: `NOV 03, 1999` DESCRIPTION: `ACOS # is the equivalent of the INSTITUTION ID NUMBER as recorded in the ONCOLOGY SITE PARAMETERS file.`
68	STATE HOSPITAL #		COMPUTED	MUMPS CODE: `S X=$$SHN^ONCFUNC` ALGORITHM: `S X=$$SHN^ONCFUNC` LAST EDITED: `NOV 03, 1999` DESCRIPTION: `This is the state identification number.`
69	MULTIPLE TUMORS	2;31	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>999)!(X<0)!(X?.E1"."1N.N) X` LAST EDITED: `JUL 01, 1993` HELP-PROMPT: `If multiple tumors, enter a 1 or the exact number if known.` DESCRIPTION: `This field documents the existence and (if known) number of multiple tumors at an anatomic site.` `If there are NOT multiple tumors at this site, leave this field BLANK.` `If there ARE multiple tumors at this site, enter the exact number of tumors here if known, or a 1 if the exact number if not known.`
69.1	FAMILY HISTORY	2;32	SET	'0' FOR No; '1' FOR Yes; LAST EDITED: `JUL 01, 1993` DESCRIPTION: `If there is a known family history for this case, enter a 1.` `Otherwise, enter a 0 or leave blank.` `This field only applies to cancers of the retina.`
69.2	DIFFUSE RETINAL INVOLVEMENT	3;30	SET	'0' FOR No; '1' FOR Yes; LAST EDITED: `JUL 01, 1993` DESCRIPTION: `If there is diffuse retinal involvement without the formation of discrete masses, enter a 1.` `Otherwise, enter a 0 or leave blank.` `This field applies only to cancers of the retina.`
69.3	MULTIMODALITY THERAPY (CLIN)	7;16	SET	'Y' FOR Yes; 'N' FOR No; LAST EDITED: `MAY 30, 1997` DESCRIPTION: `The first method of therapy is other than cancer-directed surgery. The patient is first treated with radiation therapy, chemotherapy, hormone therapy, immunotherapy, "other" therapy, or any combination of these therapies.` `The stage is based on a pathologic resection of the primary done after at least one of the other therapies has started. The other therapy may or may not be complete. This stage should supplement the clinical AJCC stage,` `not replace it.`
69.4	MULTIMODALITY THERAPY	7;17	SET	'Y' FOR Yes; 'N' FOR No; LAST EDITED: `OCT 24, 2002` HELP-PROMPT: `Enter Yes to prefix the pTNM category with "y".` DESCRIPTION: `MULTIMODALITY THERAPY determines whether the pTNM category will have a "y Prefix" (eg yT1 N0 M0).` `The "y Prefix" indicates those cases in which classification is performed during or following initial multimodality therapy. The ypTNM categorizes the extent of tumor actually present at the time of that examination. The` `"y" category is not an estimate of the extent of tumor prior to multimodality therapy.`
70	DATE OF FIRST RECURRENCE	5;1	DATE	INPUT TRANSFORM: `S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" D DFIT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOPCE` LAST EDITED: `SEP 02, 2015` HELP-PROMPT: `* DATE OF FIRST RECURRENCE MUST BE AFTER OR EQUAL TO DATE DX *` DESCRIPTION: `Records the date of the first recurrence.` `For further information see FORDS pages 195-196.` GROUP: `ACOS-REQUIRED` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `^^TRIGGER^165.5^999.21` `1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,27)):^(27),1:"") S X=$P(Y(1),U,26),X=X S DIU=X K Y S X="" S DIH=$G(^ONCO(165.5,DIV(0),27)),DIV=X S $P(^(27),U,26)=DIV,DIH=165.5,DIG=999.21 D ^DICR` `2)= Q` `CREATE VALUE)= @` `DELETE VALUE)= NO EFFECT` `FIELD)= RECURRENCE DATE-1ST F` `If DATE OF FIRST RECURRENCE field is entered then delete the RECURRENCE DATE-1ST FLAG field value.`
71	TYPE OF FIRST RECURRENCE	5;2	POINTER TO TYPE OF RECURRENCE FILE (#160.12)	TYPE OF RECURRENCE(#160.12) INPUT TRANSFORM: `S DIC("S")="I ($P(^(0),U,1)'=11)&($P(^(0),U,1)'=""01"")" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X` OUTPUT TRANSFORM: `S:Y'="" Y=$P($G(^ONCO(160.12,Y,0)),U,2)` LAST EDITED: `FEB 04, 2003` DESCRIPTION: `Identifies the type of first recurrence after a period of documented disease-free intermission or remission.` `For further information see FORDS pages 197-198.` SCREEN: `S DIC("S")="I ($P(^(0),U,1)'=11)&($P(^(0),U,1)'=""01"")"` EXPLANATION: `ROADS codes 01 and 11 have been discontinued.`
71.1	DISTANT SITE 1	5;3	SET	'0' FOR None; '1' FOR Peritoneum; '2' FOR Lung; '3' FOR Pleura; '4' FOR Liver; '5' FOR Bone; '6' FOR Central Nervous System; '7' FOR Skin; '8' FOR Lymph Nodes (Distant); '9' FOR Other/Generalized/NOS; LAST EDITED: `JUL 09, 2004` DESCRIPTION: `Record the first site of distant recurrence.` GROUP: `ACOS-REQUIRED`
71.2	DISTANT SITE 2	5;4	SET	'0' FOR None; '1' FOR Peritoneum; '2' FOR Lung; '3' FOR Pleura; '4' FOR Liver; '5' FOR Bone; '6' FOR Central Nervous System; '7' FOR Skin; '8' FOR Lymph Nodes (Distant); '9' FOR Other/Generalized/NOS; LAST EDITED: `JUL 09, 2004` DESCRIPTION: `Record the second site of distant recurrence.` GROUP: `ACOS-REQUIRED`
71.3	DISTANT SITE 3	5;5	SET	'0' FOR None; '1' FOR Peritoneum; '2' FOR Lung; '3' FOR Pleura; '4' FOR Liver; '5' FOR Bone; '6' FOR Central Nervous System; '7' FOR Skin; '8' FOR Lymph Nodes (Distant); '9' FOR Other/Generalized/NOS; LAST EDITED: `JUL 09, 2004` DESCRIPTION: `Record the third site of distant recurrence.` GROUP: `ACOS-REQUIRED`
71.4	OTHER TYPE OF FIRST RECURRENCE	5;6	POINTER TO TYPE OF RECURRENCE FILE (#160.12)	TYPE OF RECURRENCE(#160.12) OUTPUT TRANSFORM: `S:Y'="" Y=$P(^ONCO(160.12,Y,0),"^",2)` LAST EDITED: `MAR 17, 2000` DESCRIPTION: `Record the OTHER TYPE OF FIRST RECURRENCE. The term "recurrence" means the return or reappearance of the cancer after a disease-free intermission or remission.` `The patient may have more than one site of recurrence (i.e., both regional and distant metastases). Code regional in the data field TYPE OF FIRST RECURRENCE, and distant in this field.` `If the patient has only one site of recurrence or has been disease-free since treatment, code 00.`
72	SUBSEQUENT RECURRENCES	23;0	DATE Multiple #165.572	165.572 OUTPUT TRANSFORM: `NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!` DESCRIPTION: `This multiple records information on subsequent recurrences of the tumor.`
73	TUMOR STATUS	TS;0	DATE Multiple #165.573	165.573 LAST EDITED: `MAR 09, 1993` DESCRIPTION: `This multiple is populated by the Post/Edit Follow-Up option of the Follow-Up Menu. It contains the date of each follow-up for this patient, and the tumor status at each follow-up.` TECHNICAL DESCR: `This field is set directly by STSMONE^ONCOFTS. This field is killed directly by KTSMONE^ONCOFTS.`
74	SURGICAL APPROACH (R)	3;34	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>9)!(X<0)!(X?.E1"."1N.N) X I $D(X) D SAIT^ONCOSUR` OUTPUT TRANSFORM: `D SAOT^ONCOSUR` LAST EDITED: `MAY 13, 2003` HELP-PROMPT: `Type a Number between 0 and 9, 0 Decimal Digits` DESCRIPTION: `SURGICAL APPROACH describes the method used to approach the organ of origin and/or primary tumor. Code the approach for surgery of the primary site only. If no primary site surgical procedure was done (SURGERY OF` `PRIMARY SITE is coded 00), SURGICAL APPROACH must be coded 0. If the field SURGERY OF PRIMARY SITE is 99 (Unknown if surgery performed; death certificate ONLY), code SURGICAL APPROACH 9 (Unknown; not stated; death` `certificate ONLY).` `For further information see ROADS page 186.` EXECUTABLE HELP: `D SAHP^ONCOSUR` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
75	REASON FOR NO RADIATION	3;35	SET	'0' FOR Radiation administered; '1' FOR Not part of 1st course; '2' FOR Contraindicated; '5' FOR Pt died prior to tx; '6' FOR Recommended, not admin, no reason given; '7' FOR Refusal; '8' FOR Recommended, unknown if admin; '9' FOR Unknown; OUTPUT TRANSFORM: `NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!` LAST EDITED: `JAN 28, 2003` DESCRIPTION: `Records the reason that no regional radiation therapy was administered to the primary site.` `For further information see FORDS page 168.`
76	REASON FOR NO CHEMOTHERAPY	3;36	SET	'0' FOR Chemo administered; '1' FOR Chemo not recommended; '2' FOR Contraindicated, autopsy-only cases; '6' FOR Reason unk; '7' FOR Pt refused chemo; '8' FOR Chemo recommended, unk if administered; '9' FOR Unk if administered, death cert-only cases; OUTPUT TRANSFORM: `NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!` LAST EDITED: `AUG 07, 1997` DESCRIPTION: `Record the reason the patient did not receive chemotherapy. REASON FOR NO CHEMOTHERAPY is useful in survival analysis. It is a quality assurance monitor of appropriateness of treatment.`
77	REASON FOR NO HORMONE THERAPY	3;37	SET	'0' FOR HT administered; '1' FOR HT not recommended; '2' FOR Contraindicated, autopsy-only cases; '6' FOR Reason unk; '7' FOR Pt refused HT; '8' FOR HT recommended, unk if administered; '9' FOR Unk if administered, death cert-only cases; OUTPUT TRANSFORM: `NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!` LAST EDITED: `AUG 07, 1997` DESCRIPTION: `The reason the patient did not receive hormone therapy.`
78	CONVERTED	24;6	SET	'Y' FOR YES; 'N' FOR NO; LAST EDITED: `FEB 01, 1996` DESCRIPTION: `If this field is "YES" it means that the primary has had the pointers in fields 5,6,7,50.1,51.1,52.1,53.1,54.1,55.1,56.1,57.1 and 60 subfield 2 converted from pointers to the ONCOLOGY CONTACT File (165) to pointers to the` `new ACOS NUMBER file (160.19) already, and should not try to convert.`
78.1	CONVERTED STAGED BY FIELDS	25;19	SET	'Y' FOR YES; LAST EDITED: `MAR 09, 2017` HELP-PROMPT: `Enter 'Y' if this record had it's STAGED BY (CLINICAL) and STAGED BY (PATHOLOGIC) fields converted to pointers to the Oncology Staged By Codes (#163) file.` DESCRIPTION: `This field will flag the record as having the STAGED BY CLINICAL (#19) and STAGED BY PATHOLOGIC (#89) fields converted for NAACCR Vol II V16. This conversion is done as part of Patch ONC2.26 and this field will ensure` `that already converted records do not get converted again.` TECHNICAL DESCR: `This field should not be modified by user. It is set by the Post- Init routine of Patch ONC2.26.`
78.2	CONVERTED TNM FIELDS	25;20	SET	'Y' FOR YES; LAST EDITED: `MAR 09, 2017` HELP-PROMPT: `Enter 'Y' if this record had its CLINICAL and PATHOLOGIC TNM fields converted to new NAACCR v16 format.` DESCRIPTION: `This field will flag the record as having already converted the 6 TNM fields: CLINICAL T (#37.1), CLINICAL N (#37.2), CLINICAL M (#37.3), PATHOLOGIC T (#85), PATHOLOGIC N (#86), PATHOLOGIC M (#87). This conversion is` `being done in Patch ONC2.26 as part of the update for NAACCR Vol II V16 and will ensure that records that have already been converted will not be converted again.` TECHNICAL DESCR: `This field should not be modified by user. It is set by the Post- Init routine of Patch ONC2.26.`
79	SCREENING DATE	0;24	DATE	INPUT TRANSFORM: `S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" S %DT="EP",%DT(0)="-NOW" D ^%DT S X=Y K:Y<1 X K %DT(0)` OUTPUT TRANSFORM: `D DATEOT^ONCOPCE` LAST EDITED: `JUL 08, 1997` DESCRIPTION: `Record the most recent date on which the patient participated in a screening program related to this primary cancer.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
80	RADIATION TREATMENT	6;0	Multiple #165.52	165.52 DESCRIPTION: `Record the type of radiation therapy.`
81	COMPLETED BY	7;12	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>3!($L(X)<2) X` LAST EDITED: `MAY 22, 1998` HELP-PROMPT: `Answer must be 2-3 characters in length.` DESCRIPTION: `Record the initials of the person who completed the PCE.`
82	REVIEWED BY CANCER COMMITTEE	7;13	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>3!($L(X)<2) X` LAST EDITED: `MAY 22, 1998` HELP-PROMPT: `Answer must be 2-3 characters in length.` DESCRIPTION: `As a method of quality control, it is recommended that a member of the cancer committee review the abstract for accuracy prior to the submission of data to the Commission on Cancer. Record the initials of the chairman or` `member of the cancer committee who reviewed the completed PCE.`
83	AFIP/JPC SUBMISSION	0;21	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JUN 02, 2011` HELP-PROMPT: `Record if this case was submitted to the AFIP or JPC for a second opinion.` DESCRIPTION: `AFIP/JPC SUBMISSION records whether the case was sent to the Armed Forces Institute of Pathology (AFIP) or Joint Pathology Center (JPC) for a second opinion.` `Effective April 1, 2011, all consultation cases must be sent to the Joint Pathology Center (JPC).`
84	PCE INDICATOR	7;15	SET	'BLA' FOR Bladder; 'THY' FOR Thyroid; 'STS' FOR Soft Tissue Sarcoma; 'PRO' FOR Prostate (1992); 'COL' FOR Colorectal; 'NHL' FOR Non-Hodgkins Lymphoma; 'BRE' FOR Breast; 'PRO2' FOR Prostate (1998); 'MEL' FOR Melanoma; 'HEP' FOR Hepatocellular; 'CNS' FOR Intracranial/CNS; 'GAS' FOR Gastric; 'LNG' FOR Lung; LAST EDITED: `FEB 23, 2001` DESCRIPTION: `This field indicates the existence of a PCE (Patient Care Evaluation) study.` CROSS-REFERENCE: `165.5^APCE` `1)= S ^ONCO(165.5,"APCE",$E(X,1,30),DA)=""` `2)= K ^ONCO(165.5,"APCE",$E(X,1,30),DA)` `This is a cross-reference of those primaries who have a PCE study.`
85	PATHOLOGIC T	2.1;1	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>4!($L(X)<1) X I $D(X) N ONCOX,STGIND S ONCOX="T",STGIND="P" D IN^ONCOTNM` OUTPUT TRANSFORM: `NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!` LAST EDITED: `FEB 23, 2017` HELP-PROMPT: `Answer must be 1-4 characters in length.` DESCRIPTION: `Evaluates the primary tumor (T) and reflects the tumor size and/or extension of the tumor known following the completion of surgical therapy.` EXECUTABLE HELP: `N ONCOX,STGIND S ONCOX="T",STGIND="P" D HP^ONCOTNM` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
86	PATHOLOGIC N	2.1;2	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>8!($L(X)<1) X I $D(X) N ONCOX,STGIND S ONCOX="N",STGIND="P" D IN^ONCOTNM` OUTPUT TRANSFORM: `NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!` LAST EDITED: `FEB 23, 2017` HELP-PROMPT: `Answer must be 1-8 characters in length.` DESCRIPTION: `Identifies the absence or presence of regional lymph node (N) metastasis and describes the extent of regional lymph node metastasis of the tumor known following the completion of surgical therapy.` EXECUTABLE HELP: `N ONCOX,STGIND S ONCOX="N",STGIND="P" D HP^ONCOTNM` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
87	PATHOLOGIC M	2.1;3	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>4!($L(X)<1) X I $D(X) N ONCOX,STGIND S ONCOX="M",STGIND="P" D IN^ONCOTNM` OUTPUT TRANSFORM: `NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!` LAST EDITED: `FEB 23, 2017` HELP-PROMPT: `Answer must be 1-4 characters in length.` DESCRIPTION: `Identifies the presence or absence of distant metastasis (M) of the tumor known following the completion of surgical therapy.` EXECUTABLE HELP: `N ONCOX,STGIND S ONCOX="M",STGIND="P" D HP^ONCOTNM` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
88	STAGE GROUP PATHOLOGIC	2.1;4	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>14!($L(X)<1) X I $D(X) S ONCOX="S",STGIND="P" D IN^ONCOTNS I $D(X) D INNUM^ONCOTNS` OUTPUT TRANSFORM: `S X="" D OT^ONCOTNS` LAST EDITED: `DEC 14, 2005` DESCRIPTION: `Identifies the anatomic extent of disease based on the T, N, and M elements as recorded by the physician.` `For futher information see FORDS page 121.` EXECUTABLE HELP: `S ONCOX="S",STGIND="P" D HP^ONCOTNS` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^AS2^MUMPS` `1)= D PSSG^ONCOCRC` `2)= D KSG^ONCOCRC` `Maintains STAGE GROUPING-AJCC field (#38.5).`
89	STAGED BY (PATHOLOGIC STAGE)	2.1;5	POINTER TO ONCOLOGY STAGED BY CODES FILE (#165.7)	ONCOLOGY STAGED BY CODES(#165.7) OUTPUT TRANSFORM: `S:Y'="" Y=$P(^ONCO(165.7,Y,0),U,1)_" "_$P(^ONCO(165.7,Y,0),U,2)` LAST EDITED: `APR 06, 2017` HELP-PROMPT: `Record the role of the person who documented the Pathologic AJCC staging items and the Stage Group.` DESCRIPTION: `Identifies the person who recorded the pathologic AJCC staging elements and the stage group in the patient's medical record.` `For further information refer to FORDS manual.`
89.1	TNM PATHOLOGIC		COMPUTED	MUMPS CODE: `S STGIND="P",X=$$TNMOUT^ONCOTNO(D0)` ALGORITHM: `S STGIND="P",X=$$TNMOUT^ONCOTNO(D0)` LAST EDITED: `DEC 14, 2005` DESCRIPTION: `This is the combined Pathologic T, N, and M codes, formatted for display.`
90	DATE CASE COMPLETED	7;1	DATE	INPUT TRANSFORM: `D DFIT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `JUL 01, 2021` HELP-PROMPT: `* DATE CASE COMPLETED MUST BE AFTER OR EQUAL TO DATE DX *` DESCRIPTION: `The date that: (1) the abstractor decided that the case was complete, and (2) the abstract passed all edit checks.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^AAD^MUMPS` `1)= S ^ONCO(165.5,"AAD",X,DA)=""` `2)= K ^ONCO(165.5,"AAD",X,DA)` `Used for QA - 10% abstracts completed in particular timeframe`
91	ABSTRACT STATUS	7;2	SET	'0' FOR Incomplete; '1' FOR Minimal data; '2' FOR Partial; '3' FOR Complete; 'A' FOR Accession only; 'D' FOR Pending delete; INPUT TRANSFORM: `D CHECK^ONCOEDC Q` LAST EDITED: `SEP 26, 2023` HELP-PROMPT: `Enter a code from the list that corresponds to the status of the abstract.` DESCRIPTION: `Enter the status of the abstract data entry.` EXECUTABLE HELP: `D PRINT^ONCOEDC` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^AS` `1)= S ^ONCO(165.5,"AS",$E(X,1,30),DA)=""` `2)= K ^ONCO(165.5,"AS",$E(X,1,30),DA)` `Allow sorting by status of abstract.`
92	ABSTRACTED BY	7;3	POINTER TO NEW PERSON FILE (#200)	**********************REQUIRED FIELD********************** NEW PERSON(#200) LAST EDITED: `FEB 11, 2003` DESCRIPTION: `Records the initials or assigned code of the individual abstracting the case.` `For further information see FORDS page 207.`
93	OTHER T	2.1;6	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>30!($L(X)<1) X I $D(X) S ONCOX="T",STGIND="O" D IN^ONCOTNM` OUTPUT TRANSFORM: `S ONCOX="T",STGIND="O" D OT^ONCOTNM` LAST EDITED: `OCT 10, 1996` HELP-PROMPT: `Answer must be appropriate "T" code from the AJCC Staging Manual` DESCRIPTION: `"Other T" evaluates the primary tumor and identifies tumor size and/or extension.` EXECUTABLE HELP: `S ONCOX="T",STGIND="O" D HP^ONCOTNM` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
94	REPORTING DATE	7;5	DATE	INPUT TRANSFORM: `D DFIT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `APR 03, 1997` HELP-PROMPT: `* REPORTING DATE MUST BE AFTER OR EQUAL TO DATE DX *` DESCRIPTION: `Records automatically the default date as reporting date.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
95	LAST TUMOR STATUS	7;6	POINTER TO PRIMARY CANCER STATUS CODE FILE (#164.42)	PRIMARY CANCER STATUS CODE(#164.42) LAST EDITED: `MAY 05, 1993` DESCRIPTION: `This field records the code that summarizes the cancer status.` TECHNICAL DESCR: `This field is populated by a call to LTS^ONCOU. This field is referenced directly by TRS^ONCOCOS.` `SOURCE OF DATA: ACOS 3.118` GROUP: `ACOS-REQUIRED` CROSS-REFERENCE: `165.5^ACS` `1)= S ^ONCO(165.5,"ACS",$E(X,1,30),DA)=""` `2)= K ^ONCO(165.5,"ACS",$E(X,1,30),DA)` `3)= NO DELTETE` `DEVELOPERS NOTE: Please read the Technical Documentation for this field before making any changes to this or any other cross-references for this field.`
95.1	V STATUS/LAST TUMOR STATUS		COMPUTED	MUMPS CODE: `S X="" D TRS^ONCOCOS` ALGORITHM: `S X="" D TRS^ONCOCOS` LAST EDITED: `DEC 08, 2010` DESCRIPTION: `This COMPUTED field concatenates STATUS (160,15) and LAST TUMOR STATUS (165.5,95).`
96	PSA DATE	PRO2;50	FREE TEXT	INPUT TRANSFORM: `D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `SEP 21, 2006` HELP-PROMPT: `Record the date on which the PSA test was performed.` DESCRIPTION: `Records the date on which the Prostate Specific Antigen (PSA) test was performed.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
97	ABSTRACT INCOMPLETE		BOOLEAN COMPUTED	MUMPS CODE: `S Y(165.5,97,1)=$S($D(^ONCO(165.5,D0,7)):^(7),1:"") S X=$P(Y(165.5,97,1),U,2),X=X S X=X=0` `9.2 = S Y(165.5,97,2)=$C(59)_$S($D(^DD(165.5,91,0)):$P(^(0),U,3),1:""),Y(165.5,97,1)=$S($D(^ONCO(165.5,D0,7)):^(7),1:"")` ALGORITHM: `INTERNAL(#91)=0` LAST EDITED: `AUG 10, 1990` DESCRIPTION: `RECORD THE ABSTRACT STATUS AS INCOMPLETE WHEN DATA IS MISSING.` TECHNICAL DESCR: `Looks at Internal value of field #91 (ABstract status) for those values=0`
98	OTHER N	2.1;7	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>30!($L(X)<1) X I $D(X) S ONCOX="N",STGIND="O" D IN^ONCOTNM` OUTPUT TRANSFORM: `S ONCOX="N",STGIND="O" D OT^ONCOTNM` LAST EDITED: `OCT 10, 1996` HELP-PROMPT: `Answer must be appropriate "N" code from the AJCC Staging Manual` DESCRIPTION: `"Other N" classifies the regional lymph nodes and describes the absence or presence and the extent of node metastases.` EXECUTABLE HELP: `S ONCOX="N",STGIND="O" D HP^ONCOTNM` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
99	OTHER M	2.1;8	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>30!($L(X)<1) X I $D(X) S ONCOX="M",STGIND="O" D IN^ONCOTNM` OUTPUT TRANSFORM: `S ONCOX="M",STGIND="O" D OT^ONCOTNM` LAST EDITED: `JAN 15, 1997` HELP-PROMPT: `Answer must be appropriate "M" code from the AJCC Staging Manual` DESCRIPTION: `"Other M" records the presence or absence of distant metastases. Choose the lower (less advanced) M category when there is any uncertainty.` EXECUTABLE HELP: `S ONCOX="M",STGIND="O" D HP^ONCOTNM` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
100	TEXT-PRIMARY SITE TITLE	8;1	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>40!($L(X)<1) X` LAST EDITED: `OCT 12, 2000` HELP-PROMPT: `ANSWER MUST BE 1-40 CHARACTERS IN LENGTH` DESCRIPTION: `Text area for description of primary site in natural language.`
101	TEXT-HISTOLOGY TITLE	8;2	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>40!($L(X)<1) X` LAST EDITED: `OCT 12, 2000` HELP-PROMPT: `Answer must be 1-40 characters in length.` DESCRIPTION: `Text area for description of histologic type, behavior, and grade in natural language.`
102	DRE +/-	24;10	SET	'0' FOR Clinically normal; '1' FOR Clinically abnormal; '9' FOR Not done/not documented; LAST EDITED: `AUG 15, 2007` HELP-PROMPT: `Enter the DRE (Digital Rectal Examination) results.` DESCRIPTION: `A clinically inapparent tumor is one that is neither palpable nor reliably visible by imaging. An apparent tumor is palpable or visible by imaging.` `DO NOT INFER inapparent or apparent tumor based on the registrar's interpretation of terms in the DRE or imaging reports. A physician assignment of cT1C or cT2 is a clear statement of inapparent or apparent respectively.`
103	TEXT-DX PROC-OP	9;0	WORD-PROCESSING #165.5103	DESCRIPTION: `Free text field.`
104	TEXT-DX PROC-PE	10;0	WORD-PROCESSING #165.5104	DESCRIPTION: `Text area for information from history and physical examinations.`
105	TEXT-DX PROC-X-RAY/SCAN	11;0	WORD-PROCESSING #165.5105	DESCRIPTION: `Free text field.`
106	TEXT-DX PROC-SCOPES	12;0	WORD-PROCESSING #165.5106	DESCRIPTION: `Free text field.`
107	TEXT-DX PROC-PATH	13;0	WORD-PROCESSING #165.5107	DESCRIPTION: `Free text field.`
108	RX TEXT-SURGERY	14;0	WORD-PROCESSING #165.5108	LAST EDITED: `OCT 13, 2000` DESCRIPTION: `Free text field.`
109	RX TEXT-RADIATION	15;0	WORD-PROCESSING #165.5109	LAST EDITED: `JUN 04, 2003` DESCRIPTION: `Free text field.`
110	RX TEXT-RADIATION OTHER	16;0	WORD-PROCESSING #165.53	LAST EDITED: `OCT 13, 2000` DESCRIPTION: `Free text field.`
111	RX TEXT-CHEMO	17;0	WORD-PROCESSING #165.5111	LAST EDITED: `OCT 13, 2000` DESCRIPTION: `Free text field.`
112	RX TEXT-HORMONE	18;0	WORD-PROCESSING #165.5112	LAST EDITED: `OCT 13, 2000` DESCRIPTION: `Free text field.`
113	TEXT-REMARKS	19;0	WORD-PROCESSING #165.5113	LAST EDITED: `MAY 18, 1990` DESCRIPTION: `Free text field.`
114	RX TEXT-BRM	20;0	WORD-PROCESSING #165.5114	LAST EDITED: `OCT 13, 2000` DESCRIPTION: `Free text field.`
115	RX TEXT-OTHER	21;0	WORD-PROCESSING #165.5115	LAST EDITED: `OCT 13, 2000` DESCRIPTION: `Free text field.`
116	TEXT-DX PROC-LAB TESTS	22;0	WORD-PROCESSING #165.5116	LAST EDITED: `OCT 13, 2000` DESCRIPTION: `Text area for information from laboratory examinations other than cytology and histopatholgy.`
117	OTHER STAGE GROUP	2.1;9	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>14!($L(X)<1) X S ONCOX="S",STGIND="O" D IN^ONCOTNS I $D(X) D INNUM^ONCOTNS` OUTPUT TRANSFORM: `S X="" D OT^ONCOTNS` LAST EDITED: `NOV 24, 1997` HELP-PROMPT: `Answer with the appropriate stage from the AJCC Staging Manual.` DESCRIPTION: `Record the apparent extent of disease in accordance with AJCC staging requirements.` `Stage codes:` `0 IB III IVB 0A IC IIIA IVC Occult II IIIB Not applicable 0is IIA IIIC Unknown I IIB IV IA IIC IVA` EXECUTABLE HELP: `S ONCOX="S",STGIND="O" D HP^ONCOTNS` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
118	STAGED BY (OTHER STAGE)	2.1;10	SET	'0' FOR Not staged; '1' FOR Managing physician; '2' FOR Pathologist; '3' FOR Other physician; '4' FOR Any combination of 1, 2, or 3; '5' FOR Registrar; '6' FOR Any combination of 5 with 1, 2, or 3; '7' FOR Other; '8' FOR Staged, individual not specified; '9' FOR Unk if staged; LAST EDITED: `APR 19, 1999` DESCRIPTION: `"Staged By (Other Stage)" identifies the person who documented the other AJCC staging elements and the stage group. The Commission requires analytic cases to be staged by the managing physician. Compliance with` `Commission-approved program requirements can be analyzed using this data.`
119	SCREENING RESULT	0;25	SET	'0' FOR Within normal limits; '1' FOR Abnormal/not suggestive of cancer; '2' FOR Abnormal/suggestive of cancer; '3' FOR Equivocal/no followup necessary; '4' FOR Equivocal/evaluation recommended; '8' FOR NA; '9' FOR Unknown result, not specified; LAST EDITED: `JUL 16, 1997` DESCRIPTION: `This item categorizes findings from the most recent screening(s), serves as a triage for patient notification, and acts as a tickler file to aid the institution in meeting patient notification requirements.`
120	PRESENTATION AT CANCER CONF	0;26	SET	'0' FOR Not presented; '1' FOR Prospective (diagnostic); '2' FOR Prospective (treatment); '3' FOR Prospective (follow-up); '4' FOR Prospective (combinations); '5' FOR Prospective, NOS; '6' FOR Retrospective; '7' FOR Follow-up; '8' FOR Presentation, NOS; '9' FOR Unknown; LAST EDITED: `NOV 12, 1996` DESCRIPTION: `This item documents case presentation at a cancer conference and the type or format of presentation. The number of cancer conferences, sites presented, and types of presentation can be analyzed and reported for` `administrative use, quality control, and survey preperation.`
121	DATE OF CANCER CONF	0;27	DATE	INPUT TRANSFORM: `S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" S %DT="EP",%DT(0)="-NOW" D ^%DT S X=Y K:Y<1 X K %DT(0) W:'$D(X) !,"Future dates are not allowed"` OUTPUT TRANSFORM: `D DATEOT^ONCOPCE` LAST EDITED: `JAN 30, 2001` HELP-PROMPT: `Enter the Date of Cancer Conference` DESCRIPTION: `Enter the date on which the case was first presented at a cancer conference. The number of cancer conferences, sites presented, types of presentations, and dates can be analyzed and reported for administration, quality` `control, and Commission on Cancer survey preparation. Update this item if a patient is presented at a subsequent cancer conference.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
122	REFERRAL TO SUPPORT SERVICES	0;28	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `NOV 12, 1996` DESCRIPTION: `Record if the patient was referred to any of the following services.` `Enterostomal/stomal therapy` `Home care` `Hospice` `Infusion/parenteral therapy` `Nutritionist` `Occupational therapy` `Other` `Patient services (American Cancer Society)` `Patient services (other)` `Patient support group (American Cancer Society)` `Patient support group (hospital operated)` `Patient support group (other organization/agency)` `Physical therapy` `Referral; service unspecified` `Rehabilitation facility` `Respiratory therapy` `Speech therapy` `Visiting nurse assistance`
123	INPATIENT/OUTPATIENT STATUS	0;23	SET	'1' FOR Inpatient only; '2' FOR Outpatient only; '3' FOR In and outpatient; '8' FOR Other, including physician's office; '9' FOR Unknown; LAST EDITED: `DEC 20, 1996` DESCRIPTION: `"Inpatient/Outpatient Status" allows the facility to identify points of access used to initially diagnose and/or treat the patient.`
124	DATE OF NO TREATMENT	2.1;11	DATE	INPUT TRANSFORM: `D NTIT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `OCT 28, 1997` HELP-PROMPT: `* DATE OF NO TREATMENT MUST BE AFTER OR EQUAL TO DATE DX *` DESCRIPTION: `If, for any reason, the patient is not treated, record the date of this decision as the DATE OF NO TREATMENT. The physician may decide not to treat the patient because of comorbid conditions, advanced disease, or because` `the accepted management of the cancer is to observe until the disease progresses or until the patient becomes symptomatic. The patient may also refuse treatment.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^ATN^MUMPS` `1)= S ^ONCO(165.5,"ATX",DA,X_"N")=""` `2)= K ^ONCO(165.5,"ATX",DA,X_"N")` `Records NO TREATMENT DECISION DATE on the unified treatment index.` CROSS-REFERENCE: `165.5^AK^MUMPS` `1)= Q` `2)= S NTDEL="" D DEL^ONCDTX`
125	RADIATION TREATMENT VOLUME	3;21	POINTER TO RADIATION TREATMENT VOLUME FILE (#164.7)	RADIATION TREATMENT VOLUME(#164.7) INPUT TRANSFORM: `S V=1 D NT^ONCODSR` OUTPUT TRANSFORM: `S:Y'="" Y=$P(^ONCO(164.7,Y,0),"^",2)` LAST EDITED: `SEP 02, 1997` DESCRIPTION: `Identifies the volume or anatomic target of the most clinically significant regional radiation therapy delivered to the patient during the first course of treatment.` `For further information see FORDS pages 151-154.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
126	LOCATION OF RADIATION TX	3;22	SET	'0' FOR No radiation tx; '1' FOR All radiation tx at this fac; '2' FOR Regional tx at this fac, boost elsewhere; '3' FOR Boost at this fac, regional elsewhere; '4' FOR All radiation tx elsewhere; '8' FOR Other; '9' FOR Unknown; INPUT TRANSFORM: `S V=0 D NT^ONCODSR` LAST EDITED: `JAN 09, 2003` DESCRIPTION: `Identifies the location of the facility where radiation therapy was administered during the first course of treatment.` `For further information see FORDS page 150.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
127	INTENT OF RADIATION	3;29	SET	'0' FOR No radiation; '1' FOR Curative (primary); '2' FOR Curative (adjuvant); '4' FOR Palliative (pain control); '5' FOR Palliative (other, cosmetic); '6' FOR Prophylactic (no symptoms, preventive); '8' FOR Other, NOS; '9' FOR Unknown; LAST EDITED: `APR 02, 2012` DESCRIPTION: `Code the intent of radiation treatment.` `This item is useful in assessing the appropriateness of treatment and correlating outcome with original intent of the treatment. The choice in this data field is subjective.` `The responsible radiation oncologist is the best person to provide this information.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `^^TRIGGER^165.5^262` `1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,12),X=X S DIU=X K Y S X=DIV S:(X'=0) X=DIU S:(X=0) X=0 X ^DD(165.5,127,1,1,1.4)` `1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,12)=DIV,DIH=165.5,DIG=262 D ^DICR` `2)= Q` `CREATE VALUE)= S:(X'=0) X=DIU S:(X=0) X=0` `DELETE VALUE)= NO EFFECT` `FIELD)= #262` CROSS-REFERENCE: `^^TRIGGER^165.5^260` `1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,10),X=X S DIU=X K Y S X=DIV S:(X'=0) X=DIU S:(X=0) X=0 X ^DD(165.5,127,1,2,1.4)` `1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,10)=DIV,DIH=165.5,DIG=260 D ^DICR` `2)= Q` `CREATE VALUE)= S:(X'=0) X=DIU S:(X=0) X=0` `DELETE VALUE)= NO EFFECT` `FIELD)= #260`
128	RADIATION COMPLETION STATUS	3;39	POINTER TO RADIATION COMPLETION STATUS FILE (#164.8)	RADIATION COMPLETION STATUS(#164.8) INPUT TRANSFORM: `S V=1 D NT^ONCODSR` OUTPUT TRANSFORM: `S:Y'="" Y=$P(^ONCO(164.8,Y,0),U,2)` LAST EDITED: `JUN 03, 1998` DESCRIPTION: `RADIATION COMPLETION STATUS is useful in evaluating treatment outcomes and the appropriateness of the initial decision to treat.` `This field indicates whether the patient's radiation therapy was completed as outlined in the initial treatment plan. This information is generally available only in the radiation treatment chart.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
129	RADIATION AUXILIARY VOLUME	3.1;1	POINTER TO RADIATION TREATMENT VOLUME FILE (#164.7)	RADIATION TREATMENT VOLUME(#164.7) INPUT TRANSFORM: `S V=1 D NT^ONCODSR` OUTPUT TRANSFORM: `S:Y'="" Y=$P(^ONCO(164.7,Y,0),"^",2)` LAST EDITED: `SEP 29, 1998` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
130	RADIATION AUXILIARY DATE	3.1;2	DATE	INPUT TRANSFORM: `D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `MAR 11, 1998` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
131	RADIATION AUXILIARY TEXT	15.1;0	WORD-PROCESSING #165.5131	LAST EDITED: `AUG 25, 1997`
132	RADIATION LOCAL CONTROL STATUS	3.1;3	SET	'0' FOR No radiation; '1' FOR Tumor control status not evaluable; '2' FOR Tumor/symptoms controlled; '3' FOR Tumor/symptoms returned; '4' FOR Tumor/symptoms never controlled; '8' FOR Other, NOS; '9' FOR Unknown; INPUT TRANSFORM: `S V=0 D NT^ONCODSR` LAST EDITED: `OCT 03, 1997` DESCRIPTION: `RADIATION LOCAL CONTROL STATUS records the radiation treatment results in terms of disease control within the irradiated volume. The data may be used in quality assurance studies to assess the effectiveness of treatment.` `This is a dynamic data item. To be clinically useful, this data must be evaluated at each follow-up.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
133	YEAR PUT ON PROTOCOL	3.1;4	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>4!($L(X)<4)!'(X?4N) X` LAST EDITED: `MAR 18, 1998` HELP-PROMPT: `Answer must be a 4-digit year.` DESCRIPTION: `Record the year in which the patient was entered into a protocol.`
134	CLINICAL RISK FACTORS	2.1;12	SET	'0' FOR None; '1' FOR hCG > 100,000 IU/24-hour urine; '2' FOR Detection > 6 mo from term of pregnancy; '3' FOR Both; 'U' FOR Unknown; 'L' FOR Low risk; 'H' FOR High risk; LAST EDITED: `AUG 19, 2010` DESCRIPTION: `For Gestational Trophoblastic Tumors FIGO added nonsurgical-pathologic prognostic risk factors to the classic anatomic staging system. These include B-hCG levels of greater than 100,000 and the detection of disease more` `than 6 months from termination of the antecedent pregnancy. These risk factors affect staging.` SCREEN: `S DIC("S")="N ONCOED S ONCOED=$$TNMED^ONCOU55(D0) I ((ONCOED<6)&(Y?1N))!((ONCOED>5)&(Y?1A))"` EXPLANATION: `For 1st-5th edition staging use codes 0-3. For 6th or greater edition staging use codes U, L and H.`
135	PATHOLOGIC RISK FACTORS	2.1;13	SET	'0' FOR None; '1' FOR hCG > 100,000 IU/24-hour urine; '2' FOR Detection > 6 mo from term of pregnancy; '3' FOR Both; 'U' FOR Unknown; 'L' FOR Low risk; 'H' FOR High risk; LAST EDITED: `AUG 19, 2010` DESCRIPTION: `For Gestational Trophoblastic Tumors FIGO added nonsurgical-pathologic prognostic risk factors to the classic anatomic staging system. These include B-hCG levels of greater than 100,000 and the detection of disease more` `than 6 months from termination of the antecedent pregnancy. These risk factors affect staging.` SCREEN: `S DIC("S")="N ONCOED S ONCOED=$$TNMED^ONCOU55(D0) I ((ONCOED<6)&(Y?1N))!((ONCOED>5)&(Y?1A))"` EXPLANATION: `For 1st-5th edition staging use codes 0-3. For 6th or greater edition staging use codes U, L and H.`
136	SERUM TUMOR MARKERS	24;8	SET	'SX' FOR Not available; 'S0' FOR Normal; 'S1' FOR LDH < 1.5XN, hCG < 5000 mIU/ml, AFP < 1000 ng/ml; 'S2' FOR LDH 1.5-10XN or hCG 5000-50,000 mIu/ml or AFP 1000-10,000 ng/ml; 'S3' FOR LDH > 10XN or hCG > 50,000 mIu/ml or AFP > 10,000 ng/ml; OUTPUT TRANSFORM: `S FILNUM=165.5,FLDNUM=136 D SOC^ONCOOT` LAST EDITED: `JAN 29, 1998` DESCRIPTION: `Serum Tumor Markers (S)` `SX Marker studies not available or not performed S0 Marker study levels within normal limits* S1 LDH < 1.5 X N AND` `hCG (mIU/ml) < 5000 AND` `AFP (ng/ml) < 1000 S2 LDH 1.5-10 X N OR` `hCG (mIu/ml) 5000-50,000 OR` `AFP (ng/ml) 1000-10,000 S3 LDH > 10 X N OR` `hCG (mIu/ml) > 50,000 OR` `AFP (ng/ml) > 10,000` `N indicates the upper limit of normal for the LDH assay. * Check with your laboratory for normal limits values.`
137	DATE OF 1ST POSITIVE BIOPSY	2.2;1	DATE	INPUT TRANSFORM: `D DFIT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `FEB 04, 1998` DESCRIPTION: `Record the date of the first positive incisional or excisional biopsy. The biopsy may be taken from the primary or a secondary site. This data item refers to a tissue biopsy/positive histology only. The first positive` `biopsy may be at any time during the disease course. It may be non cancer-directed or cancer-directed surgery.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
138	SCOPE OF LN SURGERY (R)	3;40	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>9)!(X<0)!(X?.E1"."1N.N) X I $D(X) S FIELD=138,NTXDD=1 D SCIT^ONCOSUR1` OUTPUT TRANSFORM: `S FIELD=138 D SCOT^ONCOSUR1 K FIELD` LAST EDITED: `MAR 27, 2003` DESCRIPTION: `Record the scope of regional lymph node surgery.` `For further information see ROADS page 192.` EXECUTABLE HELP: `S FIELD=138 D SCHP^ONCOSUR1 K FIELD` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^ASC^MUMPS` `1)= Q` `2)= D SCOPE^ONCDTX`
138.1	SCOPE OF LN SURGERY @FAC (R)	3.1;9	FREE TEXT	INPUT TRANSFORM: `S SCPFLG=0 D SCPDFIT^ONCTXSM K:$L(X)>1!($L(X)<1)!'(X?1N) X I $D(X),SCPFLG=0 S FIELD=138.1,NTXDD=1 D SCIT^ONCOSUR1` OUTPUT TRANSFORM: `S FIELD=138.1 D SCOT^ONCOSUR1 K FIELD` LAST EDITED: `APR 03, 2007` DESCRIPTION: `Record the scope of regional lymph node surgery done AT THIS FACILITY.` `For further information see ROADS page 190.` EXECUTABLE HELP: `S FIELD=138.1 D SCHP^ONCOSUR1 K FIELD` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^ASCF^MUMPS` `1)= Q` `2)= D SCPATF^ONCDTX1` `When the value of this field is deleted, the KILL logic will delete all of the associated field values.`
138.2	SCOPE OF LN SURGERY DATE	3.1;22	DATE	INPUT TRANSFORM: `D DFIT^ONCODSR I $D(X) S V="0000000",ONC138P2="YES" D NT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `MAY 31, 2022` HELP-PROMPT: `* SCOPE OF LN SURGERY DATE MUST BE AFTER OR EQUAL TO DATE DX *` DESCRIPTION: `Record the date that SCOPE OF LN SURGERY was performed.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^ATSC^MUMPS` `1)= S ^ONCO(165.5,"ATX",DA,X_"S2")=""` `2)= K ^ONCO(165.5,"ATX",DA,X_"S2")` `Records the scope of regional lymph node surgery date on the unified treatment index.`
138.3	SCOPE OF LN SURGERY @FAC DATE	3.1;23	DATE	INPUT TRANSFORM: `D DFIT^ONCODSR I $D(X) S V="0000000",ONC138P2="YES" D NT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `MAY 31, 2022` HELP-PROMPT: `* SCOPE OF LN SURGERY @FAC DATE MUST BE AFTER OR EQUAL TO DATE DX *` DESCRIPTION: `Record the date that SCOPE OF LN SURGERY @FAC was performed.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
138.4	SCOPE OF LN SURGERY (F)	3.1;31	SET	'0' FOR None; '1' FOR Bx/aspiration, NOS; '2' FOR Sentinel Bx; '3' FOR Nodes removed, num unk; '4' FOR 1-3 nodes removed; '5' FOR 4 or more nodes removed; '6' FOR Sentinel + 3, 4 or 5, timing not stated; '7' FOR Sentinel + 3, 4, or 5, diff times; '9' FOR Unknown/NA; LAST EDITED: `MAR 19, 2003` DESCRIPTION: `Identifies the removal, biopsy, or aspiration of regional lymph node(s) at the time of surgery of the primary site or during a separate surgical event.` `For further information see FORDS pages 138-139.` CROSS-REFERENCE: `165.5^ASC^MUMPS` `1)= Q` `2)= D SCOPE^ONCDTX` `When the value of this field is deleted, the KILL logic will delete all of the associated field values.`
138.5	SCOPE OF LN SURGERY @FAC (F)	3.1;32	SET	'0' FOR None; '1' FOR Bx/aspiration, NOS; '2' FOR Sentinel Bx; '3' FOR Nodes removed, num unk; '4' FOR 1-3 nodes removed; '5' FOR 4 or more nodes removed; '6' FOR Sentinel + 3, 4 or 5, timing not stated; '7' FOR Sentinel + 3, 4, or 5, diff times; '9' FOR Unknown/NA; LAST EDITED: `MAR 19, 2003` DESCRIPTION: `Identifies the removal, biopsy, or aspiration of regional lymph node(s) at the time of surgery of the primary site or during a separate surgical event at this facility.` `For further information see FORDS pages 140-141.` CROSS-REFERENCE: `165.5^ASCF^MUMPS` `1)= Q` `2)= D SCPATF^ONCDTX1` `When the value of this field is deleted, the KILL logic will delete all of the associated field values.`
139	SURG PROC/OTHER SITE (R)	3;41	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>9)!(X<0)!(X?.E1"."1N.N) X I $D(X) S FIELD=139,NTXDD=1 D SOIT^ONCOSUR1` OUTPUT TRANSFORM: `S FIELD=139 D SOOT^ONCOSUR1 K FIELD` LAST EDITED: `APR 01, 2003` DESCRIPTION: `Enter the code for surgery of other regional site(s), distant site(s) or distant lymph node(s).` `For further information see ROADS page 194.` EXECUTABLE HELP: `S FIELD=139 D SOHP^ONCOSUR1 K FIELD` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^ASO^MUMPS` `1)= Q` `2)= D SOSNR^ONCDTX`
139.1	SURG PROC/OTHER SITE @FAC (R)	3.1;10	FREE TEXT	INPUT TRANSFORM: `S SOSFLG=0 D SOSDFIT^ONCTXSM K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X),SOSFLG=0 S FIELD=139.1,NTXDD=1 D SOIT^ONCOSUR1` OUTPUT TRANSFORM: `S FIELD=139.1 D SOOT^ONCOSUR1 K FIELD` LAST EDITED: `MAR 27, 2003` DESCRIPTION: `Enter the code for surgery of other regional site(s), distant site(s) or distant lymph node(s) performed AT THIS FACILITY.` `For further information see ROADS page 190.` EXECUTABLE HELP: `S FIELD=139.1 D SOHP^ONCOSUR1 K FIELD` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^ASOF^MUMPS` `1)= Q` `2)= D SOSNATF^ONCDTX1` `When the value of this field is deleted, the KILL logic will delete all of the associated field values.`
139.2	SURG PROC/OTHER SITE DATE	3.1;24	DATE	INPUT TRANSFORM: `D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `NOV 05, 2004` HELP-PROMPT: `* SURG PROC/OTHER SITE DATE MUST BE AFTER OR EQUAL TO DATE DX *` DESCRIPTION: `Records the date of surgical removal of distant lymph nodes or other tissue(s)/organ(s) beyond the primary site.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^ATSO^MUMPS` `1)= S ^ONCO(165.5,"ATX",DA,X_"S3")=""` `2)= K ^ONCO(165.5,"ATX",DA,X_"S3")` `Records the surgery of other sites/nodes date on the unified treatment index.`
139.3	SURG PROC/OTHER SITE @FAC DATE	3.1;25	DATE	INPUT TRANSFORM: `D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `JAN 07, 2003` HELP-PROMPT: `* SURG PROC/OTHER SITE @FAC DATE MUST BE AFTER OR EQUAL TO DATE DX *` DESCRIPTION: `Record the date that SURG PROC/OTHER SITE @FAC was performed.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
139.4	SURG PROC/OTHER SITE (F)	3.1;33	SET	'0' FOR None; '1' FOR Nonprimary surg proc performed; '2' FOR Nonprimary surg proc/other regional sites; '3' FOR Nonprimary surg proc/distant lymph node(s); '4' FOR Nonprimary surg proc/distant site; '5' FOR Combination of codes; '9' FOR Unknown; LAST EDITED: `MAR 19, 2003` DESCRIPTION: `Records the surgical removal of distant lymph nodes or other issue(s)/organ(s) beyond the primary site.` `For further information see FORDS page 142.` CROSS-REFERENCE: `165.5^ASO^MUMPS` `1)= Q` `2)= D SOSN^ONCDTX` `When the value of this field is deleted, the KILL logic will delete all of the associated field values.`
139.5	SURG PROC/OTHER SITE @FAC (F)	3.1;34	SET	'0' FOR None; '1' FOR Nonprimary surg proc performed; '2' FOR Nonprimary surg proc/other regional sites; '3' FOR Nonprimary surg proc/distant lymph node(s); '4' FOR Nonprimary surg proc/distant site; '5' FOR Combination of codes; '9' FOR Unknown; LAST EDITED: `MAR 19, 2003` DESCRIPTION: `Records the surgical removal of distant lymph nodes or other tissue(s)/organ(s) beyond the primary site at this facility.` `For further information see FORDS page 143.` CROSS-REFERENCE: `165.5^ASOF^MUMPS` `1)= Q` `2)= D SOSNATF^ONCDTX1` `When the value of this field is deleted, the KILL logic will delete all of the associated field values.`
139.6	METS SITE RESECTED	3.1;41	SET	'1' FOR Peritoneum; '2' FOR Lung; '3' FOR Pleura; '4' FOR Liver; '5' FOR Bone; '6' FOR Brain; '7' FOR Skin; '8' FOR Distant LNS; '9' FOR Other; LAST EDITED: `AUG 07, 2013` HELP-PROMPT: `Enter the appropriate site from the list.` DESCRIPTION: `This is the Metastatic Site Resected for the First Course of Treatment.`
139.7	METS SITE RESECTED DATE	3.2;1	DATE	INPUT TRANSFORM: `S %DT="E" D ^%DT S X=Y K:Y<1 X` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `JAN 23, 2014` HELP-PROMPT: `Enter the date the Metastatic Site was resected.` DESCRIPTION: `This is the date the Metastatic Site was resected. The date must be after or equal to the DATE DX (#3) field.`
140	NUMBER OF LN REMOVED (R)	3;42	NUMBER	INPUT TRANSFORM: `K:X'?1.2N X I $D(X) S NTXDD=1 S X=+X K:X>99!(X<0) X I $D(X) D NRIT^ONCOSUR1` OUTPUT TRANSFORM: `D NROT^ONCOSUR1` LAST EDITED: `MAR 19, 2003` HELP-PROMPT: `Type a Number between 0 and 99, 0 Decimal Digits` DESCRIPTION: `Record the number of regional lymph nodes that were microscopically examined and identified in the pathology report FOR THIS SURGICAL PROCEDURE ONLY. DO NOT add numbers of nodes removed during different surgical events.` `00 for No nodes removed` `01 for 1 node removed` `02 for 2 nodes removed` `...` `90 for 90 or more nodes removed` `95 for No nodes removed, aspiration performed` `96 for Node removal as a sampling, number unknown` `97 for Node removal as dissection, number unknown` `98 for Nodes surgically removed, number unknown` `99 for Unknown, not stated, death cert ONLY` `For further information see ROADS page 193.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
140.1	NUMBER OF LN REMOVED @FAC (R)	3.1;11	FREE TEXT	INPUT TRANSFORM: `D NUMDFIT^ONCTXSM K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S NTXDD=1 S X=+X K:X>99!(X<0) X I $D(X) D NRIT^ONCOSUR1` OUTPUT TRANSFORM: `D NROT^ONCOSUR1` LAST EDITED: `JAN 07, 2003` HELP-PROMPT: `Type a Number between 0 and 99, 0 Decimal Digits` DESCRIPTION: `Record the number of regional lymph nodes that were microscopically examined and identified at this facility in the pathology report FOR THIS SURGICAL PROCEDURE ONLY. DO NOT add numbers of nodes removed during different` `surgical events.` `00 for No nodes removed` `01 for 1 node removed` `02 for 2 nodes removed` `...` `90 for 90 or more nodes removed` `95 for No nodes removed, aspiration performed` `96 for Node removal as a sampling, number unknown` `97 for Node removal as dissection, number unknown` `98 for Nodes surgically removed, number unknown` `99 for Unknown, not stated, death cert ONLY` `For further information see ROADS page 190.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
141	BIOPSY PROCEDURE	2.1;14	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>9)!(X<0)!(X?.E1"."1N.N) X I $D(X) D BP^ONCOIT` OUTPUT TRANSFORM: `D BP^ONCOOT` LAST EDITED: `JUL 10, 2001` DESCRIPTION: `Records the biopsy procedure if the primary site is breast or prostate.` EXECUTABLE HELP: `D BP^ONCOHELP` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
142	GUIDANCE	2.1;15	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>9)!(X<0)!(X?.E1"."1N.N) X I $D(X) D GUIT^ONCOTNMX` OUTPUT TRANSFORM: `D GUOT^ONCOTNMX` LAST EDITED: `AUG 27, 1998` HELP-PROMPT: `Type a Number between 0 and 9, 0 Decimal Digits` DESCRIPTION: `Records the guidance if the primary site is breast or prostate.` EXECUTABLE HELP: `D GUHP^ONCOTNMX` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
143	PALPABILITY OF PRIMARY	2.1;16	SET	'0' FOR Not palpable; '1' FOR Palpable; '9' FOR Not stated/death cert only; LAST EDITED: `FEB 04, 1998` DESCRIPTION: `Records the palpability of primary if the primary site is breast.`
144	FIRST DETECTED BY	2.1;17	SET	'0' FOR Not a breast primary; '1' FOR Patient felt lump/nipple discharge; '2' FOR Physician felt lump; '3' FOR Mammography - routine; '4' FOR Occult, incidental finding; '9' FOR Unknown; LAST EDITED: `FEB 04, 1998` DESCRIPTION: `Records how it was first detected if the primary site is breast.`
145	APPROACH FOR BIOPSY OF PRIMARY	2.1;18	SET	'0' FOR No biopsy; '1' FOR Transrectal; '2' FOR Transperineal; '3' FOR Transurethral; '4' FOR Laparoscopic; '5' FOR Open (laparotomy); '9' FOR Unknown/death cert only; LAST EDITED: `FEB 09, 1998` DESCRIPTION: `Records the approach for biopsy of primary if the primary site is prostate.`
146	BIOPSY OF OTHER THAN PRIMARY	2.1;19	SET	'0' FOR None; '1' FOR Seminal vesicle(s), NOS; '2' FOR Unilateral; '3' FOR Bilateral; '4' FOR Other than seminal vesicle; '5' FOR 4 + 1; '6' FOR 4 + 2; '7' FOR 4 + 3; '9' FOR Unknown/death cert only; LAST EDITED: `FEB 09, 1998` DESCRIPTION: `Records the biopsy of other than primary site if the primary site is prostate.`
147	CENSUS TRACT	0;29	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>6!($L(X)<1)!'(X?1.6N) X` LAST EDITED: `JUN 27, 2000` HELP-PROMPT: `Answer must be 6 characters in length, all numeric.` DESCRIPTION: `CENSUS TRACT identifies the patient's usual residence at the time the tumor was diagnosed.` `A CENSUS TRACT is a small statistical subdivision of a county.` `To code CENSUS TRACT, assume the decimal point is between the fourth and fifth positions of the field. Add zeros to fill all six positions.` `Example: CENSUS TRACT 409.6 would be coded 040960, and CENSUS TRACT` `516.21 would be coded 051621.` `000000 Area is not census tracted 999999 Area is census tracted, but census tract is not available`
148	OTHER CANCER	0;30	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `APR 24, 2009` HELP-PROMPT: `Answer 'Yes' if the patient has other reportable malignancies.` DESCRIPTION: `Records if the patient has other reportable malignancies.`
148.1	CANCER #1	0;31	POINTER TO SITE-GROUP FOR ONCOLOGY FILE (#164.2)	SITE-GROUP FOR ONCOLOGY(#164.2) LAST EDITED: `APR 24, 2009` HELP-PROMPT: `If not applicable for this patient, choose NOT APPLICABLE.` DESCRIPTION: `Records the 1st OTHER CANCER associated with this patient.` `If not applicable for this patient, choose NOT APPLICABLE.`
148.2	CANCER #2	0;32	POINTER TO SITE-GROUP FOR ONCOLOGY FILE (#164.2)	SITE-GROUP FOR ONCOLOGY(#164.2) LAST EDITED: `JAN 24, 2003` HELP-PROMPT: `If not applicable for this patient, choose NOT APPLICABLE.` DESCRIPTION: `Records the 2nd OTHER CANCER associated with this patient.` `If not applicable for this patient, choose NOT APPLICABLE.`
148.3	CANCER #3	0;33	POINTER TO SITE-GROUP FOR ONCOLOGY FILE (#164.2)	SITE-GROUP FOR ONCOLOGY(#164.2) LAST EDITED: `JAN 24, 2003` HELP-PROMPT: `If not applicable for this patient, choose NOT APPLICABLE.` DESCRIPTION: `Records the 3rd OTHER CANCER associated with this patient.` `If not applicable for this patient, choose NOT APPLICABLE.`
148.4	CANCER #4	0;34	POINTER TO SITE-GROUP FOR ONCOLOGY FILE (#164.2)	SITE-GROUP FOR ONCOLOGY(#164.2) LAST EDITED: `JAN 24, 2003` HELP-PROMPT: `If not applicable for this patient, choose NOT APPLICABLE.` DESCRIPTION: `Records the 4th OTHER CANCER associated with this patient.` `If not applicable for this patient, choose NOT APPLICABLE.`
149	LYMPH-VASCULAR INVASION (L)	2;19	SET	'0' FOR Not present; '1' FOR LVI present-NOT for C73-C74; '2' FOR Lym&sm vessel inv only OR lym only (C73-C74 ONLY); '3' FOR Ven OR Angio (C73-C74 ONLY); '4' FOR Lym&sm & ven/lg vessel inv OR lymph & angioinv (C73-C74 ONLY); '8' FOR N/A; '9' FOR UNK; LAST EDITED: `AUG 01, 2022` HELP-PROMPT: `Enter the appropriate code. Allowable values are based on schema ID; refer to STORE manual pp. 152-156 for instructions for 2018+ cases.` DESCRIPTION: `Indicates the presence or absence of tumor cells in lymphatic channels (not lymph nodes) or blood vessels within the primary tumor as noted microscopically by the pathologist. LVI includes lymphatic invasion, vascular` `invasion, and lymphovascular invasion.` `Codes: 0 Lymphovascular Invasion stated as Not Present 1 Lymphovascular Invasion Present/Identified (NOT` `used for thyroid and adrenal) 2 Lymphatic and small vessel invasion only (L)` `OR` `Lymphatic invasion only (thyroid and adrenal only) 3 Venous (large vessel) invasion only (V)` `OR` `Angioinvasion (thyroid and adrenal gland only) 4 BOTH lymphatic and small vessel AND venous (large` `vessel) invasion` `OR` `BOTH lymphatic AND angioinvasion (thyroid and` `adrenal only) 8 Not Applicable 9 Unknown/Indeterminate/not mentioned in path report` SCREEN: `S DIC("S")="D SCRNLV^ONCSCHMM"` EXPLANATION: `For <2018 cases only 0,1,8,9 are selectable; For 2018+ cases codes depend on Schema`
150	FOLLOW-UP HISTORY		COMPUTED	MUMPS CODE: `S X="" D FHP^ONCODLF` ALGORITHM: `S X="" D FHP^ONCODLF` DESCRIPTION: `RECORDS ALL FOLLOW SUCCESSFULLY COMPLETED.`
151	VENOUS INVASION (V)	2;29	SET	'X' FOR Venous invasion cannot be assessed; '0' FOR No venous invasion; '1' FOR Microscopic venous invasion; '2' FOR Macroscopic venous invasion; LAST EDITED: `OCT 22, 2002` DESCRIPTION: `VENOUS INVASION records whether venous invasion was involved.`
152	DATE SYSTEMIC THERAPY STARTED		COMPUTED	MUMPS CODE: `S X="" D DSTS^ONCOCOM` ALGORITHM: `S X="" D DSTS^ONCOCOM` LAST EDITED: `FEB 10, 2003` DESCRIPTION: `Records the date of initiation for systemic therapy that is part of the first course of treatment. Systemic therapy includes the administration of chemotherapy agents, hormonal agents, biological response modifiers, bone` `marrow transplants, stem cell harvests, and surgical and/or radiation endocrine therapy.` `For further information see FORDS pages 169-170.`
153	HEMA TRANS/ENDOCRINE PROC	3.1;36	POINTER TO HEMATOLOGIC TRANSPLANT/ENDOCRINE PROCEDURES FILE (#167)	HEMATOLOGIC TRANSPLANT/ENDOCRINE PROCEDURES(#167) OUTPUT TRANSFORM: `I Y'="" S Y=$P($G(^ONCO(167,Y,0)),U,2)` LAST EDITED: `MAY 16, 2003` DESCRIPTION: `Identifies systemic therapeutic procedures administered as part of the first course of treatment at this and all other facilities. If none of these procedures were administered, then this item records the reason they` `were not performed. These include bone marrow transplants, stem cell harvests, surgical and/or radiation endocrine therapy.` `For further information see FORDS pages 182-183.` CROSS-REFERENCE: `165.5^AE^MUMPS` `1)= Q` `2)= D HTEP^ONCDTX`
153.1	HEMA TRANS/ENDOCRINE PROC DATE	3.1;35	DATE	INPUT TRANSFORM: `D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `MAY 15, 2003` HELP-PROMPT: `* HEMA TRANS/ENDOCRINE PROC DATE MUST BE AFTER OR EQUAL TO DATE DX *` DESCRIPTION: `Records the date on which hematologic transplant and endocrine procedures were performed.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^ATE^MUMPS` `1)= S ^ONCO(165.5,"ATX",DA,X_"E")=""` `2)= K ^ONCO(165.5,"ATX",DA,X_"E")` `Records the hematologic transplant and endocrine procedures date on the unified treatment index.`
153.2	HEMA TRANS/ENDOCRINE PROC @FAC	3.2;2	POINTER TO HEMATOLOGIC TRANSPLANT/ENDOCRINE PROCEDURES FILE (#167)	HEMATOLOGIC TRANSPLANT/ENDOCRINE PROCEDURES(#167) OUTPUT TRANSFORM: `I Y'="" S Y=$P($G(^ONCO(167,Y,0)),U,2)` LAST EDITED: `FEB 10, 2016` HELP-PROMPT: `Enter a Hematologic Transplant Endocrine Procedure at this facility administered for this primary.` DESCRIPTION: `Identifies systemic therapeutic procedures administered as part of the first course of treatment at this and all other facilities. If none of these procedures were administered, then this item records the reason they` `were not performed. These include bone marrow transplants, stem cell harvests, surgical and/or radiation endocrine therapy.` `For further information see FORDS pages 182-183.` CROSS-REFERENCE: `165.5^AE^MUMPS` `1)= Q` `2)= D HTEATF^ONCDTX1` `NOREINDEX)= 1` `When the value of this field is deleted, the KILL logic will delete all of the associated field values.`
153.3	HEMA TRANS/ENDOCRINE PR@FAC DT	3.2;3	DATE	INPUT TRANSFORM: `D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `FEB 10, 2016` HELP-PROMPT: `* HEMATOLOGIC TRANSPLANT ENDOCRINE PROCEDURE AT THIS FACILITY DATE MUST BE AFTER OR EQUAL TO DATE DX *` DESCRIPTION: `Records the date on which hematologic transplant and endocrine procedures were performed.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
154	PAIN ASSESSMENT	3.1;37	SET	'0' FOR No pain assessment; '1' FOR No need for palliative care; '2' FOR Need for palliative care, no referral; '3' FOR Need for palliative care, referral; '9' FOR Unknown; LAST EDITED: `JAN 31, 2003` DESCRIPTION: `Records whether or not a pain assessment was performed to determine the need for palliative care.` `For further information see FORDS page 188.`
155	DATE OF FIRST CONTACT	0;35	DATE	**********************REQUIRED FIELD********************** INPUT TRANSFORM: `D FADIT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `JUN 21, 2022` HELP-PROMPT: `Enter the date of first contact with the reporting facility.` DESCRIPTION: `Date of first contact with the reporting facility for diagnosis and/or treatment of this cancer.` `If this is an autopsy-only or death certificate-only case, then use the date of death.` `When it is unknown when the first patient contact occurred use 99/99/9999 or 99999999.` `00/00/0000 is not allowed.` `For further information see FORDS page 87.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^AFC` `1)= S ^ONCO(165.5,"AFC",$E(X,1,30),DA)=""` `2)= K ^ONCO(165.5,"AFC",$E(X,1,30),DA)` `This cross-reference was added in patch ONC2.1148. It enables the user to select a DATE OF FIRST CONTACT date range for the [TIME Timeliness Report] option.`
156	DRE DATE	24;11	FREE TEXT	INPUT TRANSFORM: `D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `SEP 21, 2006` HELP-PROMPT: `Record the date on which the DRE was performed.` DESCRIPTION: `Records the date on which the DRE (Digital Rectal Examination) was performed.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
157	ELAPSED DAYS TO COMPLETION		COMPUTED	MUMPS CODE: `D ET^ONCOCOM` ALGORITHM: `D ET^ONCOCOM` LAST EDITED: `OCT 04, 2006` DESCRIPTION: `Computes the time interval in days between DATE OF FIRST CONTACT (165.5,155) and DATE CASE COMPLETED (165.5,90).`
157.1	ELAPSED MONTHS TO COMPLETION		COMPUTED	MUMPS CODE: `D EM^ONCOCOM` ALGORITHM: `D EM^ONCOCOM` LAST EDITED: `AUG 05, 2008` DESCRIPTION: `Computes the time interval in months between DATE OF FIRST CONTACT (165.5,155) and DATE CASE COMPLETED (165.5,90).`
159	AMBIGUOUS TERMINOLOGY DX	24;12	SET	'0' FOR Conclusive term; '1' FOR Ambiguous term only; '2' FOR Ambiguous term followed by conclusive term; '9' FOR Unknown term; LAST EDITED: `JAN 17, 2007` DESCRIPTION: `Identifies cases for which an ambiguous term is the most definitive word or phrase used to establish a cancer diagnosis (i.e., to determine whether or not the case is reportable). Do not include cases where a definite` `statement of malignancy is made within two months following the original/initial diagnosis. (This does not include the use of ambiguous terminology from cancer screening followed by a positive cancer confirmation that is` `follow-up to the screening.)`
160	DERIVED AJCC-6 T	CS1;1	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<2) X` OUTPUT TRANSFORM: `D TOT^ONCCSOT` LAST EDITED: `NOV 13, 2009` HELP-PROMPT: `Answer must be 2 characters in length.` DESCRIPTION: `This is the AJCC 6th edition "T" component that is derived from CS coded fields, using the CS algorithm, effective with 2004 diagnosis.`
160.7	DERIVED AJCC-7 T	CS1;13	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<2) X` OUTPUT TRANSFORM: `D TOT^ONCCSOT` LAST EDITED: `FEB 03, 2010` HELP-PROMPT: `Answer must be 2 characters in length.` DESCRIPTION: `This is the AJCC 7th edition "T" component that is derived from CS coded fields, using the CS algorithm, effective with 2010 diagnosis.`
161	DERIVED AJCC-6 T DESCRIPTOR	CS1;2	SET	'c' FOR clinical; 'p' FOR pathological; 'a' FOR autopsy only; 'y' FOR y prefix; 'N' FOR Not applicable; '0' FOR Not derived; LAST EDITED: `NOV 13, 2009` DESCRIPTION: `This is the AJCC 6th edition "T Descriptor" component that is derived from CS coded fields, using the CS algorithm, effective with 2004 diagnosis.`
161.7	DERIVED AJCC-7 T DESCRIPTOR	CS1;14	SET	'c' FOR clinical; 'p' FOR pathological; 'a' FOR autopsy only; 'y' FOR yp prefix; 'N' FOR Not applicable; '0' FOR Not derived; LAST EDITED: `FEB 03, 2010` DESCRIPTION: `This is the AJCC 7th edition "T Descriptor" component that is derived from CS coded fields, using the CS algorithm, effective with 2010 diagnosis.`
162	DERIVED AJCC-6 N	CS1;3	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<2) X` OUTPUT TRANSFORM: `D NOT^ONCCSOT` LAST EDITED: `NOV 13, 2009` HELP-PROMPT: `Answer must be 2 characters in length.` DESCRIPTION: `This is the AJCC 6th edition "N" component that is derived from CS coded fields, using the CS algorithm, effective with 2004 diagnosis.`
162.7	DERIVED AJCC-7 N	CS1;15	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<2) X` OUTPUT TRANSFORM: `D NOT^ONCCSOT` LAST EDITED: `FEB 03, 2010` HELP-PROMPT: `Answer must be 2 characters in length.` DESCRIPTION: `This is the AJCC 7th edition "N" component that is derived from CS coded fields, using the CS algoritm, effective with 2010 diagnosis.`
163	DERIVED AJCC-6 N DESCRIPTOR	CS1;4	SET	'c' FOR clinical; 'p' FOR pathological; 'a' FOR autopsy only; 'y' FOR y prefix; 'N' FOR Not applicable; '0' FOR Not derived; LAST EDITED: `NOV 13, 2009` DESCRIPTION: `This is the AJCC 6th edition "N Descriptor" component that is derived from CS coded fields, using the CS algorithm, effective with 2004 diagnosis.`
163.7	DERIVED AJCC-7 N DESCRIPTOR	CS1;16	SET	'c' FOR clinical; 'p' FOR pathological; 'a' FOR autopsy only; 'y' FOR yp prefix; 'N' FOR Not applicable; '0' FOR Not derived; LAST EDITED: `FEB 03, 2010` DESCRIPTION: `This is the AJCC 7th edition "N Descriptor" component that is derived from CS coded fields, using the CS algorithm, effective with 2010 diagnosis.`
164	DERIVED AJCC-6 M	CS1;5	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<2) X` OUTPUT TRANSFORM: `D MOT^ONCCSOT` LAST EDITED: `NOV 13, 2009` HELP-PROMPT: `Answer must be 2 characters in length.` DESCRIPTION: `This is the AJCC 6th edition "N" component that is derived from CS coded fields, using the CS algorithm, effective with 2004 diagnosis.`
164.7	DERIVED AJCC-7 M	CS1;17	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<2) X` OUTPUT TRANSFORM: `D MOT^ONCCSOT` LAST EDITED: `FEB 03, 2010` HELP-PROMPT: `Answer must be 2 characters in length.` DESCRIPTION: `This is the AJCC 7th edition "N" component that is derived from CS coded fields, using the CS algorithm, effective with 2010 diagnosis.`
165	DERIVED AJCC-6 M DESCRIPTOR	CS1;6	SET	'c' FOR clinical; 'p' FOR pathological; 'a' FOR autopsy only; 'y' FOR y prefix; 'N' FOR Not applicable; '0' FOR Not derived; LAST EDITED: `NOV 13, 2009` DESCRIPTION: `This is the AJCC 6th edition "M Descriptor" component that is derived from CS coded fields, using the CS algorithm, effective with 2004 diagnosis.`
165.7	DERIVED AJCC-7 M DESCRIPTOR	CS1;18	SET	'c' FOR clinical; 'p' FOR pathological; 'a' FOR autopsy only; 'y' FOR yp prefix; 'N' FOR Not applicable; '0' FOR Not derived; LAST EDITED: `FEB 03, 2010` DESCRIPTION: `This is the AJCC 7th edition "M Descriptor" component that is derived from CS coded fields, using the CS algorithm, effective with 2010 diagnosis.`
166	DERIVED AJCC-6 STAGE GROUP	CS1;7	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<2) X` OUTPUT TRANSFORM: `D SGOT^ONCCSOT` LAST EDITED: `NOV 13, 2009` HELP-PROMPT: `Answer must be 2 characters in length.` DESCRIPTION: `This is the AJCC 6th edition "Stage Group" component that is derived from the CS detailed site-specific codes, using the CS from the CS algorithm effective with 2004 diagnosis.`
166.7	DERIVED AJCC-7 STAGE GROUP	CS1;19	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<2) X` OUTPUT TRANSFORM: `D SGOT^ONCCSOT` LAST EDITED: `FEB 01, 2010` HELP-PROMPT: `Answer must be 2 characters in length.` DESCRIPTION: `This is the AJCC 7th edition "Stage Group" component that is derived from the CS detailed site-specific codes, using the CS from the CS algorithm effective with 2010 diagnosis.`
167	DERIVED SS1977	CS1;8	SET	'0' FOR In situ; '1' FOR Localized; '2' FOR Regional, direct extension; '3' FOR Regional, lymph nodes only; '4' FOR Regional, extension and nodes; '5' FOR Regional, NOS; '7' FOR Distant; '8' FOR NA; '9' FOR Unknown/Unstaged; LAST EDITED: `MAR 10, 2004` DESCRIPTION: `This is the derived "SEER Summary Stage 1977" from the CS algorithm (or EOD codes) effective with 2004 diagnosis.`
168	DERIVED SS2000	CS1;9	SET	'0' FOR In situ; '1' FOR Localized; '2' FOR Regional, direct extension; '3' FOR Regional, lymph nodes only; '4' FOR Regional, extension and nodes; '5' FOR Regional, NOS; '7' FOR Distant; '8' FOR NA; '9' FOR Unknown/Unstaged; LAST EDITED: `MAR 09, 2004` DESCRIPTION: `This is the derived "SEER Summary Stage 2000" from the CS algorithm (or EOD codes) effective with 2004 diagnosis.`
169	CS VERSION DERIVED	CS1;11	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>6!($L(X)<6) X` LAST EDITED: `MAR 31, 2009` HELP-PROMPT: `Enter the 6 character version number of the most recently used CS version.` DESCRIPTION: `This item indicates the Collaborative Staging (CS) version used most recently to derive the CS output fields.`
169.1	CS VERSION INPUT ORIGINAL	CS1;12	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>6!($L(X)<6) X` LAST EDITED: `NOV 04, 2009` HELP-PROMPT: `Enter the 6 character version number of the CS version initially used.` DESCRIPTION: `This item indicates the number of the version initially used to code Collaborative Staging (CS) fields.`
170	DATE FIRST SURGICAL PROCEDURE	3.1;38	DATE	INPUT TRANSFORM: `D DFIT^ONCODSR I $D(X) D DFSPIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `NOV 05, 2004` HELP-PROMPT: `* DATE FIRST SURGICAL PROCEDURE MUST BE AFTER OR EQUAL TO DATE DX *` DESCRIPTION: `Records the earliest date on which any first course surgical procedure was performed.` `For further information see FORDS pages 131-132.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^ATSF^MUMPS` `1)= S ^ONCO(165.5,"ATX",DA,X_"S0")=""` `2)= K ^ONCO(165.5,"ATX",DA,X_"S0")` `Records the earliest date on which any first course surgical procedure was performed on the unified treatment index.`
171	DATE OF FIRST SYMPTOMS	2.2;4	FREE TEXT	INPUT TRANSFORM: `D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `SEP 21, 2006` HELP-PROMPT: `Enter the date of first symptoms or abnormal test results.` DESCRIPTION: `Records the date on which the patient was first seen with symptoms or had abnormal test results which began the workup which led to the diagnosis of cancer. This date would be before or equal to the DATE DX.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
172	DATE START OF WORKUP ORDERED	2.2;5	FREE TEXT	INPUT TRANSFORM: `D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `SEP 21, 2006` HELP-PROMPT: `Enter the date the physician ordered diagnostic tests.` DESCRIPTION: `Records the date the physician placed consult to specialty clinic OR ordered diagnostic procedures or tests.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
173	DATE WORKUP STARTED	2.2;6	FREE TEXT	INPUT TRANSFORM: `D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `SEP 21, 2006` HELP-PROMPT: `Enter the date the patient started diagnostic tests.` DESCRIPTION: `Records the date when the patient was seen in the specialty clinic OR had diagnostic procedures or tests performed.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
174	BLOOD IN SPUTUM PER PT	2.2;7	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown/Not documented; LAST EDITED: `MAY 23, 2005` DESCRIPTION: `Record the presence of blood in the patient's sputum as reported by the patient.`
174.1	DATE OF BLOOD IN SPUTUM PER PT	2.2;18	FREE TEXT	INPUT TRANSFORM: `D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `SEP 21, 2006` HELP-PROMPT: `Enter the date of blood in the patient's sputum.` DESCRIPTION: `Records the date of the presence of blood in the patient's sputum (as reported by the patient).` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
175	CHEST X-RAY	2.2;8	SET	'0' FOR Not done; '1' FOR Abnormal; '2' FOR Within normal limits; '9' FOR Unknown/not documented; LAST EDITED: `APR 04, 2005` DESCRIPTION: `Record the results of the diagnostic test CHEST X-RAY. If this test was not done, record a '0'.`
175.1	DATE OF CHEST X-RAY	2.2;19	FREE TEXT	INPUT TRANSFORM: `D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `SEP 21, 2006` HELP-PROMPT: `Enter the date of the diagnostic test CHEST X-RAY.` DESCRIPTION: `Records the date of the diagnostic test CHEST X-RAY.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
176	CT SCAN	2.2;9	SET	'0' FOR Not done; '1' FOR Abnormal; '2' FOR Within normal limits; '9' FOR Unknown/not documented; LAST EDITED: `APR 05, 2005` DESCRIPTION: `Record the results of the diagnostic test CT SCAN. If this test was not done, record a '0'.`
176.1	DATE OF CT SCAN	2.2;20	FREE TEXT	INPUT TRANSFORM: `D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `SEP 21, 2006` HELP-PROMPT: `Enter the date of the diagnostic test CT SCAN.` DESCRIPTION: `Records the date of the diagnostic test CT SCAN.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
177	BRONCHOSCOPY	2.2;10	SET	'0' FOR Not done; '1' FOR Abnormal; '2' FOR Within normal limits; '9' FOR Unknown/not documented; LAST EDITED: `APR 05, 2005` DESCRIPTION: `Record the results of the diagnostic test BRONCHOSCOPY. If this test was not done, record a '0'.`
177.1	DATE OF BRONCHOSCOPY	2.2;21	FREE TEXT	INPUT TRANSFORM: `D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `SEP 21, 2006` HELP-PROMPT: `Enter the date of the diagnostic test BRONCHOSCOPY.` DESCRIPTION: `Records the date of the diagnostic test BRONCHOSCOPY.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
178	MEDIASTINOSCOPY	2.2;11	SET	'0' FOR Not done; '1' FOR Abnormal; '2' FOR Within normal limits; '9' FOR Unknown/not documented; LAST EDITED: `APR 05, 2005` DESCRIPTION: `Record the results of the diagnostic test MEDIASTINOSCOPY. If this test was not done, record a '0'.`
178.1	DATE OF MEDIASTINOSCOPY	2.2;22	FREE TEXT	INPUT TRANSFORM: `D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `SEP 21, 2006` HELP-PROMPT: `Enter the date of the diagnostic test MEDIASTINOSCOPY.` DESCRIPTION: `Records the date of the diagnostic test MEDIASTINOSCOPY.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
179	PET SCAN	2.2;12	SET	'0' FOR Not done; '1' FOR Abnormal; '2' FOR Within normal limits; '9' FOR Unknown/not documented; LAST EDITED: `APR 05, 2005` DESCRIPTION: `Record the results of the diagnostic test PET SCAN. If this test was not done, record a '0'.`
179.1	DATE OF PET SCAN	2.2;23	FREE TEXT	INPUT TRANSFORM: `D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `SEP 21, 2006` HELP-PROMPT: `Enter the date of the diagnostic test PET SCAN.` DESCRIPTION: `Records the date of the diagnostic test PET SCAN.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
180	CHANGE IN BOWEL HABITS PER PT	2.2;13	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown/not documented; LAST EDITED: `MAY 23, 2005` DESCRIPTION: `Record all changes in bowel habits as reported by the patient.`
180.1	DATE OF CHANGE IN BOWEL HABITS	2.2;24	FREE TEXT	INPUT TRANSFORM: `D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `SEP 21, 2006` HELP-PROMPT: `Enter the date of a change in bowel habits.` DESCRIPTION: `Records the date of a change in bowel habits (as reported by the patient).` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
181	FECAL OCCULT BLOOD TEST (FOBT)	2.2;14	SET	'0' FOR Not done; '1' FOR Positive (3-card sample); '2' FOR Negative (3-card sample); '3' FOR Positive (6-card sample); '4' FOR Negative (6-card sample); '5' FOR FIT Test; '9' FOR Unknown/not documented; LAST EDITED: `MAY 25, 2005` DESCRIPTION: `Record the results of the diagnostic test FECAL OCCULT BLOOD TEST (FOBT). If this test was not done, record a '0'.`
181.1	DATE OF FOBT	2.2;25	FREE TEXT	INPUT TRANSFORM: `D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `SEP 21, 2006` HELP-PROMPT: `Enter the date of the diagnostic test FOBT.` DESCRIPTION: `Records the date of the diagnostic test FECAL OCCULT BLOOD TEST (FOBT).` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
182	BARIUM ENEMA	2.2;15	SET	'0' FOR Not done; '1' FOR Abnormal; '2' FOR Within normal limits; '9' FOR Unknown/not documented; LAST EDITED: `APR 05, 2005` DESCRIPTION: `Record the results of the diagnostic test BARIUM ENEMA. If this test was not done, record a '0'.`
182.1	DATE OF BARIUM ENEMA	2.2;27	FREE TEXT	INPUT TRANSFORM: `D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `SEP 21, 2006` HELP-PROMPT: `Enter the results of the diagnostic test BARIUM ENEMA.` DESCRIPTION: `Records the results of the diagnostic test BARIUM ENEMA.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
183	SIGMOIDOSCOPY	2.2;16	SET	'0' FOR Not done; '1' FOR Abnormal; '2' FOR Within normal limits; '9' FOR Unknown/not documented; LAST EDITED: `MAY 23, 2005` DESCRIPTION: `Record the results of the diagnostic test SIGMOIDOSCOPY. If this test was not done, record a '0'.`
183.1	DATE OF SIGMOIDOSCOPY	2.2;28	FREE TEXT	INPUT TRANSFORM: `D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `SEP 21, 2006` HELP-PROMPT: `Enter the date of the diagnostic test SIGMOIDOSCOPY.` DESCRIPTION: `Records the date of the diagnostic test SIGMOIDOSCOPY.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
184	CT OF ABDOMEN/PELVIS	2.2;17	SET	'0' FOR Not done; '1' FOR Abnormal; '2' FOR Within normal limits; '9' FOR Unknown/not documented; LAST EDITED: `MAY 23, 2005` DESCRIPTION: `Record the results of the diagnostic test CT OF ABDOMEN/PELVIS. If this test was not done, record a '0'.`
184.1	DATE OF CT OF ABDOMEN/PELVIS	2.2;31	FREE TEXT	INPUT TRANSFORM: `D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `SEP 21, 2006` HELP-PROMPT: `Enter the date of the diagnostic test CT OF ABDOMEN/PELVIS.` DESCRIPTION: `Records the date of the diagnostic test CT OF ABDOMEN/PELVIS.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
185	COLONOSCOPY	2.2;29	SET	'0' FOR Not done; '1' FOR Abnormal; '2' FOR Within normal limits; '9' FOR Unknown/not documented; LAST EDITED: `MAY 23, 2005` DESCRIPTION: `Record the results of the diagnostic test COLONOSCOPY. If this test was not done, record a '0'.`
185.1	DATE OF COLONOSCOPY	2.2;30	FREE TEXT	INPUT TRANSFORM: `D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `SEP 21, 2006` HELP-PROMPT: `Enter the date of the diagnostic test COLONOSCOPY.` DESCRIPTION: `Records the date of the diagnostic test COLONOSCOPY. If this test was not done, record a '0'.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
186	DYSPNEA	2.2;32	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown/not documented; LAST EDITED: `JUN 03, 2005` DESCRIPTION: `Record whether the patient experienced dyspnea.`
186.1	DATE OF DYSPNEA	2.2;33	FREE TEXT	INPUT TRANSFORM: `D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `SEP 21, 2006` HELP-PROMPT: `Enter the date on which the patient was affected by dyspnea.` DESCRIPTION: `Records the date on which the patient was affected by dyspnea.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
187	INCREASED COUGH	2.2;34	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown/not documented; LAST EDITED: `MAY 23, 2005` DESCRIPTION: `Record whether the patient experienced increased coughing.`
187.1	DATE OF INCREASED COUGH	2.2;35	FREE TEXT	INPUT TRANSFORM: `D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `SEP 21, 2006` HELP-PROMPT: `Enter the date on which the patient experienced increased coughing.` DESCRIPTION: `Records the date on which the patient experienced increased coughing.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
188	FEVER	2.2;36	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown/not documented; LAST EDITED: `MAY 23, 2005` DESCRIPTION: `Record whether the patient experienced a fever.`
188.1	DATE OF FEVER	2.2;37	FREE TEXT	INPUT TRANSFORM: `D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `SEP 21, 2006` HELP-PROMPT: `Enter the date on which the patient experienced a fever.` DESCRIPTION: `Records the date on which the patient experienced a fever.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
189	NIGHT SWEATS	2.2;38	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown/not documented; LAST EDITED: `JUN 03, 2005` DESCRIPTION: `Record whether the patient experienced night sweats.`
189.1	DATE OF NIGHT SWEATS	2.2;39	FREE TEXT	INPUT TRANSFORM: `D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `SEP 21, 2006` HELP-PROMPT: `Enter the date on which the patient experienced night sweats.` DESCRIPTION: `Records the date on which the patient experienced night sweats.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
190	WEIGHT LOSS PER PT	2.2;40	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown/not documented; LAST EDITED: `MAY 23, 2005` DESCRIPTION: `Record weight loss as reported by the patient.`
191	ULCERATIVE COLITIS (UC)	2.2;41	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown/not documented; LAST EDITED: `MAY 24, 2005` DESCRIPTION: `Record whether the patient was affected by ulcerative colitis (UC).`
192	SPORADIC POLYPS	2.2;42	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown/not documented; LAST EDITED: `JUN 03, 2005` DESCRIPTION: `Sporadic polyps can also develop in people with no family history of colon cancer. They are called "sporadic" to distinguish them from the familial kind. Certain types of sporadic polyps do increase the risk of colon` `cancer. These polyps, known as adenomas, often can be removed during a colonoscopic examination.` `Record the existence of sporadic polyps.`
193	DATE OF CONCLUSIVE DX	24;13	FREE TEXT	INPUT TRANSFORM: `D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X I $D(X) D DCD^ONCOCOM` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `JAN 24, 2007` HELP-PROMPT: `Enter the date of a definite state of malignancy.` DESCRIPTION: `Documents the date when a conclusive cancer diagnosis (definite statement of malignancy) is made following an initial diagnosis that was based only on ambiguous terminology. The date of the conclusive diagnosis must be` `greater than two months following the initial (ambiguous terminology only) diagnosis.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
194	MULT TUM RPT AS ONE PRIM	24;14	POINTER TO TYPE OF MULTIPLE TUMORS FILE (#169)	TYPE OF MULTIPLE TUMORS(#169) OUTPUT TRANSFORM: `S:Y'="" Y=$P(^ONCO(169,Y,0),U,2)` LAST EDITED: `JAN 24, 2007` DESCRIPTION: `This data item is used to identify cases with multiple tumors that are abstracted ans reported as a single primary.` `Codes Description` `----- -----------` `00 Single tumor 10 At least two benign tumors in same organ/primary site` `(Intracranial and CNS sites only) 11 At least two borderline tumors in the same organ/primary site` `(Intracranial and CNS sites only) 12 Benign and borderline tumors in the same organ/primary site` `(Intracranial and CNS sites only) 20 At least two in situ tumors in the same organ/primary site 30 One or more in situ and one or more invasive tumors in the same` `organ/primary site 31 One or more in situ/invasive adenocarcinoma in a polyp and one` `or more frank adenocarcinoma in one segment of colon 32 Familial polyposis with one or more in situ/invasive carcinoma 40 At least two invasive tumors in the same organ (Includes one` `or more invasive tumor with histology "NOS" and one or more` `separate invasive tumor with a more specific histology) 80 Multiple tumors present in the same organ/primary site, unknown` `if in situ or invasive 88 Information on multiple tumors not collected/not applicable for` `this site 99 Unknown`
195	DATE OF MULTIPLE TUMORS	24;15	FREE TEXT	INPUT TRANSFORM: `D ZS9S^ONCODSR Q:ZS9S=1 S %DT="E",%DT(0)="-NOW" D ^%DT K %DT S X=Y K:Y<1 X` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `JAN 24, 2007` HELP-PROMPT: `Enter the date the patient was diagnosed with multiple tumors reported as a single primary.` DESCRIPTION: `This data item is used to identify the month, day and year the patient is diagnosed with multiple tumors reported as a single primary. Use the multiple primary rules for that specific site to determine whether the tumors` `are a single primary or multiple primaries.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
196	MULTIPLICITY COUNTER	24;16	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<2)!'(X?2N)!((X>89)&(X<99)) X` LAST EDITED: `MAR 16, 2011` HELP-PROMPT: `Answer must be a 2-digit number. Allowable Values: 00-89, 99.` DESCRIPTION: `Records the number of tumors (multiplicity) reported as a single primary.` `Codes 00 No primary tumor identified 01 One tumor only 02 Two tumors present; bilateral ovaries involved with cystic carcinoma 03 Three tumors present` `..` `..` `88 Information on multiple tumors not collected/not applicable for this` `site 89 Multicentric, multifocal, number unknown 99 Unknown if multiple tumors; not documented` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
197	EDITS CHECKSUM	EDITS;1	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>20!($L(X)<1) X` LAST EDITED: `MAR 06, 2007` HELP-PROMPT: `Answer must be 1-20 characters in length.` DESCRIPTION: `Provides a checksum value for the NAACCR record associated with this abstract. This checksum will be used to detect changes to the NAACCR record once the ABSTRACT STATUS (165.5,91) has been set to 3 (Complete).`
197.1	CHECKSUM VERSION	EDITS;2	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>10!($L(X)<1) X` LAST EDITED: `JAN 12, 2010` HELP-PROMPT: `Answer must be 1-10 characters in length.` DESCRIPTION: `Identifies the NAACCR version that was used to calculate EDITS CHECKSUM (165.5,197).`
198	DATE CASE LAST CHANGED	7;21	DATE	INPUT TRANSFORM: `S %DT="ESTX" D ^%DT S X=Y K:Y<1 X` OUTPUT TRANSFORM: `S X=Y D DATECLC^ONCOES` LAST EDITED: `MAR 27, 2024` HELP-PROMPT: `Record the date in which this case was last changed or updated.` DESCRIPTION: `Date the case was last changed or updated.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^AAE` `1)= S ^ONCO(165.5,"AAE",$E(X,1,30),DA)=""` `2)= K ^ONCO(165.5,"AAE",$E(X,1,30),DA)` `This cross-reference will be used to facilitate the extraction of the data from specified start/end dates.` CROSS-REFERENCE: `^^TRIGGER^165.5^199` `1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,7)):^(7),1:"") S X=$P(Y(1),U,22),X=X S DIU=X K Y S X=DIV S X=DUZ S DIH=$G(^ONCO(165.5,DIV(0),7)),DIV=X S $P(^(7),U,22)=DIV,DIH=165.5,DIG=199 D ^DICR` `2)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,7)):^(7),1:"") S X=$P(Y(1),U,22),X=X S DIU=X K Y S X="" S DIH=$G(^ONCO(165.5,DIV(0),7)),DIV=X S $P(^(7),U,22)=DIV,DIH=165.5,DIG=199 D ^DICR` `CREATE VALUE)= S X=DUZ` `DELETE VALUE)= @` `FIELD)= CASE LAST CHANGED BY` `This trigger cross-reference is used to set the CASE LAST CHANGED BY (#199) field to the DUZ of the user who created/modified the case.`
199	CASE LAST CHANGED BY	7;22	POINTER TO NEW PERSON FILE (#200)	NEW PERSON(#200) LAST EDITED: `MAR 26, 2007` DESCRIPTION: `Records the name of the individual who last changed the case.` NOTES: `TRIGGERED by the DATE CASE LAST CHANGED field of the ONCOLOGY PRIMARY File`
200	DATE LAST CONTACT		COMPUTED	MUMPS CODE: `S X="" D PDLC^ONCOCRF,DATEOT^ONCOES` ALGORITHM: `S X=""" D PDLC^ONCOCRF,DATEOT^ONCOES` LAST EDITED: `FEB 26, 1997` DESCRIPTION: `Date last contact with the patient - computed from file #160.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
201	SURVIVAL DAYS		COMPUTED	MUMPS CODE: `S X="" D SDA^ONCOCRF S X=$J(X,0,0)` ALGORITHM: `S X="" D SDA^ONCOCRF (ALWAYS 0 DECIMAL DIGITS)` LAST EDITED: `SEP 11, 1990` DESCRIPTION: `COMPUTED SURVIVAL DATA IN DAYS.`
202	SURVIVAL MONTHS		COMPUTED	MUMPS CODE: `S X="" D SUR^ONCOCRF S X=$J(X,0,1)` `9.2 = X $P(^DD(165.5,200,0),U,5,99) S Y(165.5,202,1)=X S Y(165.5,202,2)=$S($D(^ONCO(165.5,D0,0)):^(0),1:"") S X=Y(165.5,202,1),X1=X,X2=$P(Y(165.5,202,2),U,16),X="" D:X2 ^%DTC:X1 S X=X` ALGORITHM: `S X="" D SUR^ONCOCRF (ALWAYS 1 DECIMAL DIGITS)` LAST EDITED: `SEP 11, 1990` DESCRIPTION: `COMPUTED SURVIVAL DATA IN MONTHS.`
203	SURVIVAL (YEARS)		COMPUTED	MUMPS CODE: `S X="" D SYR^ONCOCRF S X=$J(X,0,1)` `9.2 = X $P(^DD(165.5,200,0),U,5,99) S Y(165.5,203,1)=X S Y(165.5,203,2)=$S($D(^ONCO(165.5,D0,0)):^(0),1:"") S X=Y(165.5,203,1),X1=X,X2=$P(Y(165.5,203,2),U,16),X="" D:X2 ^%DTC:X1 S X=X` ALGORITHM: `S X="" D SYR^ONCOCRF (ALWAYS 1 DECIMAL DIGITS)` LAST EDITED: `SEP 11, 1990` DESCRIPTION: `COMPUTED SURVIVAL DATA IN YEARS.`
204	WEEKS of FOLLOW-UP		COMPUTED	MUMPS CODE: `S X="" D SWK^ONCOCRF S X=$J(X,0,0)` `9.2 = X $P(^DD(165.5,201,0),U,5,99) S Y(165.5,204,1)=X S Y(165.5,204,3)=$S($D(^ONCO(165.5,D0,0)):^(0),1:"") S X=Y(165.5,204,1),Y(165.5,204,2)=X S X=$P(Y(165.5,204,3),U,16)` ALGORITHM: `S X="" D SWK^ONCOCRF (ALWAYS 0 DECIMAL DIGITS)` LAST EDITED: `SEP 11, 1990` DESCRIPTION: `FOLLOW UP IN WEEKS.`
205	OVER-RIDE AGE/SITE/MORPH	OVRD;1	SET	'1' FOR Reviewed; '2' FOR Reviewed, Dx in utero; '3' FOR Reviewed, Codes 1 and 2 both apply; LAST EDITED: `MAR 25, 2009` HELP-PROMPT: `Enter the appropriate code to override this edit.` DESCRIPTION: `Used with CoC Metafile and the EDITS software to override the edit Age, Primary Site, Morphology (Coc) and/or the edit Age, Primary Site, Morphology ICD-O-3 (CoC).` `For further information see FORDS page 215.`
206	OVER-RIDE SEQNO/DXCONF	OVRD;2	SET	'1' FOR Reviewed; LAST EDITED: `NOV 30, 2000` DESCRIPTION: `This is one of the thirteen flags used to override certain interfield and interrecord edits defined by SEER.`
207	OVER-RIDE SITE/LAT/SEQNO	OVRD;3	SET	'1' FOR Reviewed; LAST EDITED: `NOV 30, 2000` DESCRIPTION: `This is one of the thirteen flags used to override certain interfield and interrecord edits defined by SEER.`
208	OVER-RIDE SURG/DXCONF	OVRD;4	SET	'1' FOR Reviewed; LAST EDITED: `NOV 30, 2000` DESCRIPTION: `This is one of the thirteen flags used to override certain interfield and interrecord edits defined by SEER.`
209	OVER-RIDE SITE/TYPE	OVRD;5	SET	'1' FOR Reviewed; LAST EDITED: `NOV 30, 2000` DESCRIPTION: `This is one of the thirteen flags used to override certain interfield and interrecord edits defined by SEER.`
210	OVER-RIDE HISTOLOGY	OVRD;6	SET	'1' FOR Reviewed - allow flags Morphology-Type & Behavior; '2' FOR Reviewed - allow flags Dx Conf, Behavior Code; '3' FOR Reviewed - conditions 1 & 2 both apply; LAST EDITED: `NOV 30, 2000` DESCRIPTION: `This is one of the thirteen flags used to override certain interfield and interrecord edits defined by SEER.`
211	OVER-RIDE REPORT SOURCE	OVRD;7	SET	'1' FOR Reviewed; LAST EDITED: `NOV 30, 2000` DESCRIPTION: `This is one of the thirteen flags used to override certain interfield and interrecord edits defined by SEER.`
212	OVER-RIDE ILL-DEFINE SITE	OVRD;8	SET	'1' FOR Reviewed; LAST EDITED: `NOV 30, 2000` DESCRIPTION: `This is one of the thirteen flags used to override certain interfield and interrecord edits defined by SEER.`
213	OVER-RIDE LEUK,LYMPHOMA	OVRD;9	SET	'1' FOR Reviewed; LAST EDITED: `NOV 30, 2000` DESCRIPTION: `This is one of the thirteen flags used to override certain interfield and interrecord edits defined by SEER.`
214	OVER-RIDE SITE/BEHAVIOR	OVRD;10	SET	'1' FOR Reviewed; LAST EDITED: `NOV 30, 2000` DESCRIPTION: `This is one of the thirteen flags used to override certain interfield and interrecord edits defined by SEER.`
215	OVER-RIDE SITE/EOD/DX DT	OVRD;11	SET	'1' FOR Reviewed; LAST EDITED: `NOV 30, 2000` DESCRIPTION: `This is one of the thirteen flags used to override certain interfield and interrecord edits defined by SEER.`
216	OVER-RIDE SITE/LAT/EOD	OVRD;12	SET	'1' FOR Reviewed; LAST EDITED: `NOV 30, 2000` DESCRIPTION: `This is one of the thirteen flags used to override certain interfield and interrecord edits defined by SEER.`
217	OVER-RIDE SITE/LAT/MORPH	OVRD;13	SET	'1' FOR Reviewed; LAST EDITED: `NOV 30, 2000` DESCRIPTION: `This is one of the thirteen flags used to override certain interfield and interrecord edits defined by SEER.`
218	OVER-RIDE SS/NODESPOS	OVRD;14	SET	'1' FOR Reviewed; LAST EDITED: `JUL 27, 2001` DESCRIPTION: `This is one of the flags used to override certain interfield and interrecord edits defined by NAACCR.`
219	OVER-RIDE SS/TNM-N	OVRD;15	SET	'1' FOR Reviewed; LAST EDITED: `JUL 27, 2001` DESCRIPTION: `This is one of the flags used to override certain interfield and interrecord edits defined by NAACCR.`
220	OVER-RIDE SS/TNM-M	OVRD;16	SET	'1' FOR Reviewed; LAST EDITED: `JUL 27, 2001` DESCRIPTION: `This is one of the flags used to override certain interfield and interrecord edits defined by NAACCR.`
221	OVER-RIDE SS/DISMET1	OVRD;17	SET	'1' FOR Reviewed; LAST EDITED: `JUL 27, 2001` DESCRIPTION: `This is one of the flags used to override certain interfield and interrecord edits defined by NAACCR.`
222	OVER-RIDE ACSN/CLASS/SEQ	OVRD;18	SET	'1' FOR Reviewed; LAST EDITED: `JUL 27, 2001` DESCRIPTION: `This is one of the flags used to override certain interfield and interrecord edits defined by NAACCR.`
223	OVER-RIDE HOSPSEQ/DXCONF	OVRD;19	SET	'1' FOR Reviewed; LAST EDITED: `JUL 27, 2001` DESCRIPTION: `This is one of the flags used to override certain interfield and interrecord edits defined by NAACCR.`
224	OVER-RIDE COC-SITE/TYPE	OVRD;20	SET	'1' FOR Reviewed; LAST EDITED: `JUL 27, 2001` DESCRIPTION: `This is one of the flags used to override certain interfield and interrecord edits defined by NAACCR.`
225	OVER-RIDE HOSPSEQ/SITE	OVRD;21	SET	'1' FOR Reviewed; LAST EDITED: `JUL 27, 2001` DESCRIPTION: `This is one of the flags used to override certain interfield and interrecord edits defined by NAACCR.`
226	OVER-RIDE SITE/TNM-STGGRP	OVRD;22	SET	'1' FOR Reviewed; LAST EDITED: `JUL 27, 2001` DESCRIPTION: `This is one of the flags used to override certain interfield and interrecord edits defined by NAACCR.`
227	PERFORMANCE STATUS AT DX	1;7	SET	'0' FOR ECOG 0; '1' FOR ECOG 1; '2' FOR ECOG 2; '3' FOR ECOG 3; '4' FOR ECOG 4; '5' FOR ECOG 5; '9' FOR UNKNOWN; '10' FOR KPS 10; '20' FOR KPS 20; '30' FOR KPS 30; '40' FOR KPS 40; '50' FOR KPS 50; '60' FOR KPS 60; '70' FOR KPS 70; '80' FOR KPS 80; '90' FOR KPS 90; '100' FOR KPS 100; LAST EDITED: `MAR 25, 2016` HELP-PROMPT: `Enter the score which indicates the patient's general well-being.` DESCRIPTION: `Records an attempt to quantify the patient's general well-being.` `ECOG 0 - Fully active, able to carry on all pre-disease` `activities without restriction` `ECOG 1 - Restricted in physically strenuous activity but ambulatory` `and able to carry out work of a light or sedentary nature.` `For example, light housework, office work` `ECOG 2 - Ambulatory and capable of all self care but unable to carry out` `and any work activities. Up and about more than 50% of waking` `hours` `ECOG 3 - Capable of only limited self-care, confined to bed or chair` `50% or more of waking hours` `ECOG 4 - Completely disabled. Cannot carry on any self-care.` `Totally confined to bed or chair)` `UNKNOWN - Unknown/not documented` `KPS 100 - Normal, no complaints; no evidence of disease` `KPS 90 - Able to carry on normal activity; minor signs or symptoms` `of disease` `KPS 80 - Normal activity with effort, some signs or symptoms of disease` `KPS 70 - Cares for self but unable to carry on normal activity or` `to do active work` `KPS 60 - Requires occasional assistance but is able to care` `for most of personal needs` `KPS 50 - Requires considerable assistance and frequent medical care` `KPS 40 - Disabled; requires special care and assistance` `KPS 30 - Severely disabled; hospitalization is indicated` `although death not imminent` `KPS 20 - Very ill; hospitalization and active` `supportive care necessary` `KPS 10 - Moribund`
228	TREATMENT GUIDELINE #1	24;17	SET	'0' FOR None; '1' FOR NCCN; '2' FOR ASCO; '3' FOR ASH; '4' FOR AUA; '5' FOR PDQ; '6' FOR SSO; '7' FOR Other; '8' FOR NA; '99' FOR Unknown; LAST EDITED: `APR 12, 2010` HELP-PROMPT: `Enter the first guideline used to determine the first course of treatment.` DESCRIPTION: `Identifies the first guideline used to determine the first course of treatment.` `NCCN (National Comprehensive Cancer Network) ASCO (American Society of Clinical Oncology) ASH (American Society of Hematology) AUA (American Urologic Association) PDQ (Physician Data Query) SSO (The Society of Surgical` `Oncology)`
229	TREATMENT GUIDELINE #2	24;18	SET	'0' FOR None; '1' FOR NCCN; '2' FOR ASCO; '3' FOR ASH; '4' FOR AUA; '5' FOR PDQ; '6' FOR SSO; '7' FOR Other; '8' FOR NA; '99' FOR Unknown; LAST EDITED: `APR 12, 2010` HELP-PROMPT: `Enter the second guideline used to determine the first course of treatment.` DESCRIPTION: `Identifies the second guideline used to determine the first course of treatment.` `NCCN (National Comprehensive Cancer Network) ASCO (American Society of Clinical Oncology) ASH (American Society of Hematology) AUA (American Urologic Association) PDQ (Physician Data Query) SSO (The Society of Surgical` `Oncology)`
230	TREATMENT GUIDELINE #3	24;19	SET	'0' FOR None; '1' FOR NCCN; '2' FOR ASCO; '3' FOR ASH; '4' FOR AUA; '5' FOR PDQ; '6' FOR SSO; '7' FOR Other; '8' FOR NA; '99' FOR Unknown; LAST EDITED: `APR 12, 2010` HELP-PROMPT: `Enter the third guideline used to determine the first course of treatment.` DESCRIPTION: `Identifies the third guideline used to determine the first course of treatment.` `NCCN (National Comprehensive Cancer Network) ASCO (American Society of Clinical Oncology) ASH (American Society of Hematology) AUA (American Urologic Association) PDQ (Physician Data Query) SSO (The Society of Surgical` `Oncology)`
231	TREATMENT GUIDELINE LOCATION	24;20	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>30!($L(X)<1) X` LAST EDITED: `JUN 12, 2009` HELP-PROMPT: `Answer must be 1-30 characters in length.` DESCRIPTION: `Identifies where the treatment guidelines used in treatment planning are documented in the medical record.`
232	TREATMENT GUIDELINE DOC DATE	24;21	DATE	INPUT TRANSFORM: `S %DT="E" D ^%DT S X=Y K:Y<1 X` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `JUL 07, 2009` HELP-PROMPT: `Enter the date treatment guidelines were documented in the medical record.` DESCRIPTION: `Records the date when treatment guidelines were documented in the medical record.`
233	INPATIENT STATUS	2.3;3	SET	'0' FOR Patient was never an inpatient; '1' FOR Patient was inpatient; '9' FOR Unknown if patient was an inpatient; LAST EDITED: `OCT 09, 2009` HELP-PROMPT: `Enter the appropriate INPATIENT STATUS code.` DESCRIPTION: `This data item records whether there was an inpatient admission for the most definitive therapy, or in the absence of therapy, for diagnostic evaluation.`
234	RX HOSP--SURG APP 2010	2.3;4	SET	'0' FOR No surgery/Dx at autopsy; '1' FOR Robotic assisted; '2' FOR Robotic converted to open; '3' FOR Endoscopic/Laparoscopic; '4' FOR Endoscopic/Laparoscopic converted to open; '5' FOR Open/Approach, NOS; '9' FOR Not stated/Death cert only; LAST EDITED: `JUL 27, 2022` HELP-PROMPT: `Enter the appropriate code to describe the surgical method used to approach the primary site.` DESCRIPTION: `This item is used to describe the surgical method used to approach the primary site for patients undergoing surgery of the primary site at this facility. If the patient has multiple surgeries to the primary site, this` `item describes the approach used for the most invasive, definitive surgery.`
235	TREATMENT STATUS	2.3;5	SET	'0' FOR No treatment given; '1' FOR Treatment given; '2' FOR Active surveillance (watchful waiting); '9' FOR Unknown if treatment was given; LAST EDITED: `OCT 14, 2009` HELP-PROMPT: `Enter the appropriate TREATMENT STATUS code.` DESCRIPTION: `This data item summarizes whether the patient received any treatment or the tumor was under active surveillance.`
236	DATE CASE INITIATED	2.3;6	DATE	INPUT TRANSFORM: `S %DT="EX" D ^%DT S X=Y K:Y<1 X` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `MAY 05, 2010` HELP-PROMPT: `Enter the date the abstract was initiated in the reporting facility's cancer registry database.` DESCRIPTION: `Date the electronic abstract is initiated in the reporting facility's cancer registry database.`
237	FEE BASIS	2.3;7	SET	'0' FOR No; '1' FOR Yes; LAST EDITED: `JUN 05, 2024` HELP-PROMPT: `Enter "Yes" if the patient was referred to a FEE BASIS/CONTRACT facility.` DESCRIPTION: `Indicates if the patient was referred to another facility for treatment or to a facility closer to the patient's residence either on a "Fee Basis" or via a CONTRACT with the reporting facility.`
237.1	FEE BASIS LOCATION	2.3;11	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>30!($L(X)<3) X` LAST EDITED: `MAY 24, 2012` HELP-PROMPT: `Answer must be 3-30 characters in length.` DESCRIPTION: `In many cases the FACILITY REFERRED TO may not be the same place that the FEE BASIS treatment was performed. Therefore, this field enables facilities to track where the patient was referred to. This field is available` `to be displayed on ad hoc reports.` `Enter the name of the FEE BASIS LOCATION in free text.`
238	OUTSIDE SLIDES REVIEWED	2.3;8	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `NOV 25, 2009` HELP-PROMPT: `Enter whether tissue slides diagnosed elsewhere were reviewed at this facility.` DESCRIPTION: `Identifies if tissue slides diagnosed at another facility were reviewed at this facility.` `0 (No) Outside tissue diagnosis done, slides not reviewed` `at this facility. 1 (Yes) Outside tissue diagnosis done, slides requested and` `reviewed at this facility. 8 (NA) Not applicable. No outside tissue diagnosis done. 9 (Unknown) Unknown if outside tissue diagnosis done.`
239	MITOTIC RATE	2.3;9	SET	'L' FOR Low <5/50 HPF; 'H' FOR High >5/50 HPF; 'U' FOR Unknown; LAST EDITED: `DEC 21, 2009` HELP-PROMPT: `Enter the code for MITOTIC RATE.` DESCRIPTION: `Identifies the rate or speed of cell division.`
240	CS SCHEMA DISCRIMINATOR	CS3;1	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>3!($L(X)<3) X I $D(X) D IN^ONCSUBS` LAST EDITED: `NOV 03, 2010` HELP-PROMPT: `Answer must be 3 characters in length.` DESCRIPTION: `This case requires a CS SCHEMA DISCRIMINATOR to determine the correct tables for CSv2 (Collaborative Staging v2) calculations.` `For example, Melanomas of CILIARY BODY AND IRIS (C69.4) require a CS SCHEMA DISCRIMINATOR to discriminate between tumors arising in either ciliary body or iris, both coded C69.4 but requiring different CS schemas.` `For melanomas of the ciliary body CS SCHEMA DISCRIMINATOR should be coded 010. For melanomas of the Iris CS SCHEMA DISCRIMINATOR should be coded 020.` `CS SCHEMA DISCRIMINATOR values will be stuffed into SSF25 for use in CS calculations.` EXECUTABLE HELP: `D HELP^ONCSUBS` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `^^TRIGGER^165.5^44.25` `1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"CS2")):^("CS2"),1:"") S X=$P(Y(1),U,19),X=X S DIU=X K Y S X=DIV S SSF25=X S DIH=$G(^ONCO(165.5,DIV(0),"CS2")),DIV=X S $P(^("CS2"),U,19)=DIV,DIH=165.5,DIG=44.25` `D ^DICR` `2)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"CS2")):^("CS2"),1:"") S X=$P(Y(1),U,19),X=X S DIU=X K Y S X="" S DIH=$G(^ONCO(165.5,DIV(0),"CS2")),DIV=X S $P(^("CS2"),U,19)=DIV,DIH=165.5,DIG=44.25 D ^DICR` `CREATE VALUE)= S SSF25=X` `DELETE VALUE)= @` `FIELD)= SSF25` `SSF25 (165.5,44.25) will be stuffed with the CS SCHEMA DISCRIMINATOR value.`
241	TNM CLIN DESCRIPTOR	24;22	SET	'0' FOR None; '1' FOR E (Extranodal); '2' FOR S (Spleen); '3' FOR M (Multiple primary tumors in a single site); '5' FOR E&S (Extranodal and spleen); '9' FOR Unknown, not stated in patient record; LAST EDITED: `FEB 04, 2016` HELP-PROMPT: `Enter the appropriate descriptor suffix.` DESCRIPTION: `Identifies the AJCC clinical stage (suffix) descriptor as recorded by the physician. AJCC stage descriptors identify special cases that need separate data analysis. The descriptors are adjuncts to and do not change the` `stage group.` `0 - None: There are no prefix or suffix descriptors that would be used` `for this case` `1 E - Extranodal, lymphomas only: A lymphoma case involving an` `extranodal site.` `2 S - Spleen, lymphomas only: A lymphoma case involving the spleen` `3 M - Multiple primary tumors in a single site: This is one primary` `with multiple tumors in the organ of origin at the time` `of diagnosis` `5 E&S - Extranodal and spleen, lymphomas only: A lymphoma case with` `involvement of both an extranodal site and the spleen` `9 - Unknown, not stated in patient record: A prefix or suffix would` `describe this stage, but it is not known which would be correct`
242	TNM PATH DESCRIPTOR	24;23	SET	'0' FOR None; '1' FOR E (Extranodal); '2' FOR S (Spleen); '3' FOR M (Multiple primary tumors); '4' FOR Y (Initial multimodality therapy); '5' FOR E&S (Extranodal and spleen); '6' FOR M&Y (Multiple and multimodality); '9' FOR Unknown; LAST EDITED: `FEB 04, 2016` HELP-PROMPT: `Enter the appropriate descriptor suffix.` DESCRIPTION: `Identifies the AJCC clinical stage (suffix) descriptor as recorded by the physician. AJCC stage descriptors identify special cases that need separate data analysis. The descriptors are adjuncts to and do not change the` `stage group.` `0 - None: There are no prefix or suffix descriptors that would be used` `for this case` `1 E - Extranodal, lymphomas only: A lymphoma case involving an` `extranodal site` `2 S - Spleen, lymphomas only: A lymphoma case involving the spleen` `3 M - Multiple primary tumors in a single site: This is one primary` `with multiple tumors in the organ of origin at the time` `of diagnosis` `4 Y - Classification during or after initial multimodality therapy` `5 E&S - Extranodal and spleen, lymphomas only: A lymphoma case` `with involvement of both an extranodal site and the spleen` `6 M&Y - Multiple primary tumors and initial multimodality therapy:` `A case meeting the parameters of both codes 3 and 4` `9 - Unknown, not stated in patient record: A prefix or suffix would` `describe this stage, but it's not known which would be correct`
244	INITIATED BY	2.3;10	POINTER TO NEW PERSON FILE (#200)	NEW PERSON(#200) LAST EDITED: `MAR 08, 2011` HELP-PROMPT: `Enter the name of the person initiating the abstract.` DESCRIPTION: `The name of the person initiating the abstract in the reporting facility's cancer registry database.` `This field is stuffed with the user's DUZ when a new entry is added to this file. No user interaction is required and it may not be changed.`
245	NEOADJUVANT THERAPY (PRE-2021)	3.1;40	SET	'0' FOR Not recommended/NA; '1' FOR Radiation; '2' FOR Chemotherapy; '3' FOR Hormone therapy; '4' FOR Immunotherapy; '5' FOR Combination of neoadjuvant tx; '7' FOR Refusal; '8' FOR Recommended but not done; '9' FOR Unknown if recommended or done; LAST EDITED: `MAR 08, 2021` HELP-PROMPT: `Enter if NEOADJUVANT THERAPY was performed.` DESCRIPTION: `Neoadjuvant therapy is the administration of therapeutic agents before the main treatment. This field documents if neoadjuvant therapy was performed for this patient and, if so, the type of neoadjuvant therapy performed.`
245.1	NEOADJUVANT THERAPY	EOD;5	SET	'0' FOR No neoadjuvant therapy; '1' FOR Neoadjuvant therapy completed; '2' FOR Neoadjuvant therapy started, but not completed/unk if completed; '3' FOR Limited systemic exposure; '9' FOR Unknown; LAST EDITED: `MAR 08, 2021` HELP-PROMPT: `Enter the code describing the patient's neoadjuvant therapy` DESCRIPTION: `This data item records whether the patient had neoadjuvant therapy prior to planned definitive surgical resection of the primary site.` `Rationale This data items provides information related to the quality of care and describes whether a patient had neoadjuvant therapy.` `For the purposes of this data item, neoadjuvant therapy is defined as systemic treatment (chemotherapy, endocrine / hormone therapy, targeted therapy, immunotherapy, or biological therapy) and/or radiation therapy before` `intended or performed surgical resection to improve local therapy and long term outcomes. Codes 0 No neoadjuvant therapy, no treatment before surgery, surgical resection` `not part of first course of treatment plan` `Autopsy only 1 Neoadjuvant therapy completed according to treatment plan and guidelines 2 Neoadjuvant therapy started, but not completed OR unknown if completed 3 Limited systemic exposure when the intent was not` `neoadjuvant; treatment` `did not meet the definition of neoadjuvant therapy 9 Unknown if neoadjuvant therapy performed` `Death Certificate only (DCO)`
245.2	NEOADJUVANT THERAPY-CLIN RESP	EOD;6	SET	'0' FOR Not given; '1' FOR Complete CR; '2' FOR Partial CR; '3' FOR Progressive Disease; '4' FOR Stable disease; '5' FOR No response; '6' FOR Done, interpretation not available; '7' FOR Path Report; '8' FOR Not documented; '9' FOR Unknown; LAST EDITED: `JAN 28, 2021` HELP-PROMPT: `Enter the neoadjuvant therapy-clinical response for the patient` DESCRIPTION: `This data item records the clinical outcomes of neoadjuvant therapy prior to planned surgical resection. Rationale: This data items provides information related to the quality of care and describes the clinical outcomes` `after neoadjuvant therapy. This data item provides prognostically relevant information by quantifying the extent of therapy-induced tumor regression. Therefore, this item can provide a better risk stratification for` `patients who received neoadjuvant therapy. In addition, this data item can contribute to assessments of cancer care quality.` `This data item records the clinical outcomes of neoadjuvant therapy as determined by the managing physician (oncologic surgeon, radiation oncologist or medical oncologist).` `For the purposes of this data item, neoadjuvant therapy is defined as systemic treatment (chemotherapy, endocrine/hormone therapy, targeted therapy, immunotherapy, or biological therapy) and/or radiation therapy given to` `shrink a tumor before surgical resection. Codes: 0 Neoadjuvant therapy not given 1 Complete clinical response (CR)(per managing/treating` `physician statement) 2 Partial clinical response (PR) (per managing/treating` `physician statement) 3 Progressive disease (PD)(per managing/treating` `physician statement) 4 Stable disease (SD)(per managing/treating physician statement) 5 No response (NR) (per managing/treating physician statement` `Not stated as progressive disease (PD) or stable disease (SD) 6 Neoadjuvant therapy done, managing/treating physician` `interpretation not available, treatment response inferred` `from imaging, biomarkers, or yc stage 7 Complete clinical response based on pathology report (per` `pathologist assessment) 8 Neoadjuvant therapy done, response not documented or unknown 9 Unknown if neoadjuvant therapy performed` `Death Certificate only (DCO)`
245.3	NEOADJUVANT THERAPY-TX EFFECT	EOD;7	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>9)!(X<0)!(X?.E1"."1N.N) X I $D(X) D NEOIT^ONCOEOD1` LAST EDITED: `JAN 28, 2021` HELP-PROMPT: `Type a number between 0 and 9, 0 decimal digits.` DESCRIPTION: `This data item records the pathologist's statement of neoadjuvant treatment effect on the primary tumor from the surgical pathology report. Whenever treatment effect definitions are recommended by or available in CAP` `Cancer Protocols, this data item follows the CAP definitions indicating absent or present effect. When specific CAP definitions are not available, registrars should use treatment effect general use categories. Rationale:` `This data item provides information related to the quality of care and describes the pathological outcomes after neoadjuvant therapy. This data item provides prognostically relevant information by quantifying the extent` `of therapy-induced tumor regression. Therefore, this item can provide a better risk stratification for patients who received neoadjuvant therapy. In addition, this data item can contribute to assessments of cancer care` `quality. Codes: 0 Neoadjuvant therapy not given/no known presurgical therapy 1-4 Site-specific code; type of response 6 Neoadjuvant therapy completed and surgical resection` `performed, response not documented or unknown` `Cannot be determined 7 Neoadjuvant therapy completed and planned surgical` `resection not performed 9 Unknown if neoadjuvant therapy performed` `Unknown if planned surgical procedure performed after` `completion of neoadjuvant therapy` `Death Certificate only (DCO)` EXECUTABLE HELP: `D NEOHLP^ONCOEOD1` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
247	CS REVIEW REQUIRED	CS3;2	SET	'0' FOR Reviewed; '1' FOR Needs review; LAST EDITED: `APR 14, 2011` HELP-PROMPT: `Enter 'Reviewed' once this case has been reviewed for accuracy.` DESCRIPTION: `When a new version of Collaborative Staging (CS) is implemented some cases require manual review/conversion by the registrar.` `This field identifies cases for which Collaborative Staging review is either required or recommended in accordance with the Collaborative Staging Conversion Specifications.` `When the patch implementing the new CS version is installed the post-install program will flag any cases needing manual review by setting CS REVIEW REQUIRED to 1 (Needs review).` `Once a case has been reviewed by the registrar, the review flag can be cleared by setting CS REVIEW REQUIRED to 0 (Reviewed).`
248	NOTE TITLE	25;1	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>30!($L(X)<1) X` LAST EDITED: `JUN 17, 2011` HELP-PROMPT: `Answer must be 1-30 characters in length.` DESCRIPTION: `Records the name of the note which documents cancer staging in the medical record.`
249	NOTE DATE	25;2	DATE	INPUT TRANSFORM: `S %DT="E",%DT(0)="-NOW" D ^%DT S X=Y K:Y<1 X` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `FEB 15, 2012` HELP-PROMPT: `Enter the date of the note used for staging. Future dates are not allowed.` DESCRIPTION: `Records the date of the note which documents cancer staging in the medical record.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
250	GLEASON SCORE (PATHOLOGIC)	25;3	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<1) X` OUTPUT TRANSFORM: `S Y=$S(Y=99:"99 Unknown, not reported, or NA",1:Y)` LAST EDITED: `AUG 05, 2011` HELP-PROMPT: `Answer must be 1-2 characters in length.` DESCRIPTION: `Record the pathologic Gleason Score. Gleason Score (pathologic) is obtained from a curative prostatectomy specimen.` `For cases where Gleason Score is unknown, not reported or not applicable, code 99.`
251	NSLC STAGE 1-3 PATH LN STAGING	PM;1	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA (Stage 0 and 4); '9' FOR Unknown; LAST EDITED: `APR 02, 2012` HELP-PROMPT: `Enter whether mediastinal lymph node staging was performed at the reporting facility.` DESCRIPTION: `Documents if mediastinal lymph node staging was performed at the reporting facility.` CROSS-REFERENCE: `^^TRIGGER^165.5^253` `1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,3),X=X S DIU=X K Y S X=DIV S:(X=0) X="0000000" S:(X=9) X="9999999" S:(X=1)!(X=8) X=DIU X ^DD(165.5,251,1,1,1.4)` `1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,3)=DIV,DIH=165.5,DIG=253 D ^DICR` `2)= Q` `CREATE VALUE)= S:(X=0) X="0000000" S:(X=9) X="9999999" S:(X=1)!(X=8) X=DIU` `DELETE VALUE)= NO EFFECT` `FIELD)= #253` CROSS-REFERENCE: `^^TRIGGER^165.5^255` `1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,5),X=X S DIU=X K Y S X=DIV S:(X=0) X="0000000" S:(X=9) X="9999999" S:(X=1)!(X=8) X=DIU X ^DD(165.5,251,1,2,1.4)` `1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,5)=DIV,DIH=165.5,DIG=255 D ^DICR` `2)= Q` `CREATE VALUE)= S:(X=0) X="0000000" S:(X=9) X="9999999" S:(X=1)!(X=8) X=DIU` `DELETE VALUE)= NO EFFECT` `FIELD)= #255` CROSS-REFERENCE: `^^TRIGGER^165.5^256` `1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,6),X=X S DIU=X K Y S X=DIV S:(X=0) X="0000000" S:(X=9) X="9999999" S:(X=1)!(X=8) X=DIU X ^DD(165.5,251,1,3,1.4)` `1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,6)=DIV,DIH=165.5,DIG=256 D ^DICR` `2)= Q` `CREATE VALUE)= S:(X=0) X="0000000" S:(X=9) X="9999999" S:(X=1)!(X=8) X=DIU` `DELETE VALUE)= NO EFFECT` `FIELD)= #256` CROSS-REFERENCE: `^^TRIGGER^165.5^264` `1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,14),X=X S DIU=X K Y S X=DIV S:(X=0) X="0000000" S:(X=9) X="9999999" S:(X=1)!(X=8) X=DIU X ^DD(165.5,251,1,4,1.4)` `1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,14)=DIV,DIH=165.5,DIG=264 D ^DICR` `2)= Q` `CREATE VALUE)= S:(X=0) X="0000000" S:(X=9) X="9999999" S:(X=1)!(X=8) X=DIU` `DELETE VALUE)= NO EFFECT` `FIELD)= #264` CROSS-REFERENCE: `^^TRIGGER^165.5^265` `1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,15),X=X S DIU=X K Y S X=DIV S:(X=0) X="0000000" S:(X=9) X="9999999" S:(X=1)!(X=8) X=DIU X ^DD(165.5,251,1,5,1.4)` `1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,15)=DIV,DIH=165.5,DIG=265 D ^DICR` `2)= Q` `CREATE VALUE)= S:(X=0) X="0000000" S:(X=9) X="9999999" S:(X=1)!(X=8) X=DIU` `DELETE VALUE)= NO EFFECT` `FIELD)= #265` CROSS-REFERENCE: `^^TRIGGER^165.5^266` `1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,16),X=X S DIU=X K Y S X=DIV S:(X=0) X="0000000" S:(X=9) X="9999999" S:(X=1)!(X=8) X=DIU X ^DD(165.5,251,1,6,1.4)` `1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,16)=DIV,DIH=165.5,DIG=266 D ^DICR` `2)= Q` `CREATE VALUE)= S:(X=0) X="0000000" S:(X=9) X="9999999" S:(X=1)!(X=8) X=DIU` `DELETE VALUE)= NO EFFECT` `FIELD)= #266` CROSS-REFERENCE: `^^TRIGGER^165.5^252` `1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,2),X=X S DIU=X K Y S X=DIV S:(X'=1) X=DIU S:(X=1) X=8 X ^DD(165.5,251,1,7,1.4)` `1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,2)=DIV,DIH=165.5,DIG=252 D ^DICR` `2)= Q` `CREATE VALUE)= S:(X'=1) X=DIU S:(X=1) X=8` `DELETE VALUE)= NO EFFECT` `FIELD)= #252`
252	REASON FOR NO LN BIOPSY	PM;2	SET	'1' FOR Contraindicated; '2' FOR Patient declined; '3' FOR Patient transferred; '4' FOR Patient expired; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `MAR 06, 2012` HELP-PROMPT: `Enter the reason mediastinal lymph nodes were not biopsied at the reporting facility.` DESCRIPTION: `Records the reason that mediastinal lymph nodes were not biopsied at the reporting facility.` NOTES: `TRIGGERED by the NSLC STAGE 1-3 PATH LN STAGING field of the ONCOLOGY PRIMARY File`
253	DATE OF SURGERY CONSULT	PM;3	DATE	INPUT TRANSFORM: `D DFIT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `APR 02, 2012` HELP-PROMPT: `Enter the surgery consult date.` DESCRIPTION: `Records the surgery consult date. If NO surgery consult was ordered or not DONE, enter 00/00/0000; if UNKNOWN, enter 99/99/9999.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` `TRIGGERED by the NSLC STAGE 1-3 PATH LN STAGING field of the ONCOLOGY PRIMARY File` CROSS-REFERENCE: `^^TRIGGER^165.5^254` `1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,4),X=X S DIU=X K Y S X=DIV S:(X'="0000000") X=DIU S:(X="0000000") X=0 X ^DD(165.5,253,1,1,1.4)` `1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,4)=DIV,DIH=165.5,DIG=254 D ^DICR` `2)= Q` `CREATE VALUE)= S:(X'="0000000") X=DIU S:(X="0000000") X=0` `DELETE VALUE)= NO EFFECT` `FIELD)= #254`
254	INTENT OF SURGERY	PM;4	SET	'0' FOR No surgery; '1' FOR Curative (primary); '2' FOR Curative (adjuvant); '4' FOR Palliative (pain control); '5' FOR Palliative (other); '6' FOR Prophylactic (no symptoms, preventive); '8' FOR Other, NOS; '9' FOR Unknown; LAST EDITED: `FEB 21, 2012` HELP-PROMPT: `Enter the intent of the surgery performed.` DESCRIPTION: `Code the intent of surgical treatment.` `This item is useful in assessing the appropriateness of treatment and correlating outcome with original intent of the treatment.` NOTES: `TRIGGERED by the DATE OF SURGERY CONSULT field of the ONCOLOGY PRIMARY File`
255	DATE ONCOLOGY CONSULT ORDERED	PM;5	DATE	INPUT TRANSFORM: `D DFIT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `APR 02, 2012` HELP-PROMPT: `Enter the date the oncology consult was ordered.` DESCRIPTION: `Records the date the oncology consult was ordered. If NO oncology consult was ordered or not DONE, enter 00/00/0000; if UNKNOWN, enter 99/99/9999.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` `TRIGGERED by the NSLC STAGE 1-3 PATH LN STAGING field of the ONCOLOGY PRIMARY File` CROSS-REFERENCE: `^^TRIGGER^165.5^256` `1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,6),X=X S DIU=X K Y S X=DIV S:(X'="0000000") X=DIU S:(X="0000000") X="0000000" X ^DD(165.5,255,1,1,1.4)` `1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,6)=DIV,DIH=165.5,DIG=256 D ^DICR` `2)= Q` `CREATE VALUE)= S:(X'="0000000") X=DIU S:(X="0000000") X="0000000"` `DELETE VALUE)= NO EFFECT` `FIELD)= #256`
256	DATE ONCOLOGY CONSULT DONE	PM;6	DATE	INPUT TRANSFORM: `D DFIT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `MAR 06, 2012` HELP-PROMPT: `Enter the oncology consult date.` DESCRIPTION: `Records the date the oncology consult was done. If NO oncology consult was done, enter 00/00/0000; if UNKNOWN, enter 99/99/9999.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` `TRIGGERED by the NSLC STAGE 1-3 PATH LN STAGING field of the ONCOLOGY PRIMARY File` `TRIGGERED by the DATE ONCOLOGY CONSULT ORDERED field of the ONCOLOGY PRIMARY File`
257	CHEMOTHERAPY RECOMMENDED	PM;7	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown/not documented; LAST EDITED: `APR 02, 2012` HELP-PROMPT: `Record if there is documentation that chemotherapy was recommended.` DESCRIPTION: `Records if there is documentation that chemotherapy was recommended.` CROSS-REFERENCE: `^^TRIGGER^165.5^258` `1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,8),X=X S DIU=X K Y S X=DIV S:(X'=0) X=DIU S:(X=0) X=0 X ^DD(165.5,257,1,1,1.4)` `1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,8)=DIV,DIH=165.5,DIG=258 D ^DICR` `2)= Q` `CREATE VALUE)= S:(X'=0) X=DIU S:(X=0) X=0` `DELETE VALUE)= NO EFFECT` `FIELD)= #258` CROSS-REFERENCE: `^^TRIGGER^165.5^259` `1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,9),X=X S DIU=X K Y S X=DIV S:(X'=0) X=DIU S:(X=0) X=0 X ^DD(165.5,257,1,2,1.4)` `1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,9)=DIV,DIH=165.5,DIG=259 D ^DICR` `2)= Q` `CREATE VALUE)= S:(X'=0) X=DIU S:(X=0) X=0` `DELETE VALUE)= NO EFFECT` `FIELD)= #259` CROSS-REFERENCE: `^^TRIGGER^165.5^261` `1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,11),X=X S DIU=X K Y S X=DIV S:(X'=0) X=DIU S:(X=0) X=8 X ^DD(165.5,257,1,3,1.4)` `1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,11)=DIV,DIH=165.5,DIG=261 D ^DICR` `2)= Q` `CREATE VALUE)= S:(X'=0) X=DIU S:(X=0) X=8` `DELETE VALUE)= NO EFFECT` `FIELD)= #261` CROSS-REFERENCE: `^^TRIGGER^165.5^382` `1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"BLA2")):^("BLA2"),1:"") S X=$P(Y(1),U,41),X=X S DIU=X K Y S X=DIV S:(X'=0) X=DIU S:(X=0) X=0 X ^DD(165.5,257,1,4,1.4)` `1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"BLA2")),DIV=X S $P(^("BLA2"),U,41)=DIV,DIH=165.5,DIG=382 D ^DICR` `2)= Q` `CREATE VALUE)= S:(X'=0) X=DIU S:(X=0) X=0` `DELETE VALUE)= NO EFFECT` `FIELD)= #382`
258	INTENT OF CHEMOTHERAPY	PM;8	SET	'0' FOR No chemotherapy; '1' FOR Curative (primary); '2' FOR Curative (adjuvant); '4' FOR Palliative (pain control); '5' FOR Palliative (other); '6' FOR Prophylactic (no symptoms, preventive); '8' FOR Other, NOS; '9' FOR Unknown; LAST EDITED: `JUN 12, 2012` HELP-PROMPT: `Enter the documented intent of chemotherapy.` DESCRIPTION: `Code the intent of chemotherapy treatment.` `This item is useful in assessing the appropriateness of treatment and correlating outcome with original intent of the treatment.` NOTES: `TRIGGERED by the CHEMOTHERAPY RECOMMENDED field of the ONCOLOGY PRIMARY File` CROSS-REFERENCE: `^^TRIGGER^165.5^259` `1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(0)=X S X=Y(0),X=X S X=X=0 I X S X=DIV S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,9),X=X S DIU=X K Y S X=DIV S X="0" X ^DD(165.5,258,1,1,1.4)` `1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,9)=DIV,DIH=165.5,DIG=259 D ^DICR` `2)= Q` `CREATE CONDITION)= INTERNAL(INTENT OF CHEMOTHERAPY)=0` `CREATE VALUE)= "0"` `DELETE VALUE)= NO EFFECT` `FIELD)= #259` CROSS-REFERENCE: `^^TRIGGER^165.5^382` `1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(0)=X S X=Y(0),X=X S X=X=0 I X S X=DIV S Y(1)=$S($D(^ONCO(165.5,D0,"BLA2")):^("BLA2"),1:"") S X=$P(Y(1),U,41),X=X S DIU=X K Y S X=DIV S X="0" X ^DD(165.5,258,1,2,1.4)` `1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"BLA2")),DIV=X S $P(^("BLA2"),U,41)=DIV,DIH=165.5,DIG=382 D ^DICR` `2)= Q` `CREATE CONDITION)= INTERNAL(INTENT OF CHEMOTHERAPY)=0` `CREATE VALUE)= "0"` `DELETE VALUE)= NO EFFECT` `FIELD)= #382` CROSS-REFERENCE: `^^TRIGGER^165.5^272` `1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(0)=X S X=Y(0),X=X S X=X=0 I X S X=DIV S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,21),X=X S DIU=X K Y S X=DIV S X="0000000" X ^DD(165.5,258,1,3,1.4)` `1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,21)=DIV,DIH=165.5,DIG=272 D ^DICR` `2)= Q` `CREATE CONDITION)= INTERNAL(INTENT OF CHEMOTHERAPY)=0` `CREATE VALUE)= "0000000"` `DELETE VALUE)= NO EFFECT` `FIELD)= #272`
259	TYPE OF CHEMOTHERAPY	PM;9	SET	'0' FOR No chemotherapy; '1' FOR Adjuvant; '2' FOR Neoadjuvant; '3' FOR Concomitant or concurrent; '4' FOR Palliative; '9' FOR Unknown; LAST EDITED: `AUG 18, 2011` HELP-PROMPT: `Enter the type of chemotherapy administered.` DESCRIPTION: `Records the type of chemotherapy administered.` `Adjuvant - refers to additional treatment, usually given after surgery where all detectable disease has been removed, but where there remains a statistical risk of relapse due to occult disease.` `Neoadjuvant - in contrast to adjuvant therapy, is given prior to primary treatment, for example, before surgery to remove the tumor. The most common reason for neoadjuvant therapy is to reduce the size of the tumor so as` `to facilitate more effective surgery.` `Concomitant or concurrent - chemotherapy at the same time as other therapies, such as radiation.` `Palliative - chemotherapy given without expectation of a cure.` NOTES: `TRIGGERED by the CHEMOTHERAPY RECOMMENDED field of the ONCOLOGY PRIMARY File` `TRIGGERED by the INTENT OF CHEMOTHERAPY field of the ONCOLOGY PRIMARY File`
260	REASON RADIATION STOPPED	PM;10	SET	'0' FOR Treatment completed, NA; '1' FOR Complications; '2' FOR Disease progression; '3' FOR Recommended but medically contraindicated; '8' FOR Other; '9' FOR Unknown; LAST EDITED: `SEP 27, 2011` HELP-PROMPT: `Enter the reason radiation therapy was discontinued.` DESCRIPTION: `Record the reason radiation therapy was discontinued. If therapy ended when treatment was complete, or if the patient never received radiation therapy code 0 (treatment completed, NA).` NOTES: `TRIGGERED by the INTENT OF RADIATION field of the ONCOLOGY PRIMARY File`
261	DOC FOR NO PLAT-BASED CHEMO	PM;11	SET	'0' FOR No documentation; '1' FOR Documentation; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `AUG 24, 2011` HELP-PROMPT: `Enter if there is documentation why platinum-based chemotherapy was not recommended.` DESCRIPTION: `Records if there is a documented reason in the Progress Notes stating why platinum-based chemotherapy was not recommended.` NOTES: `TRIGGERED by the CHEMOTHERAPY RECOMMENDED field of the ONCOLOGY PRIMARY File`
262	MULTIMODALITY RADIATION TYPE	PM;12	SET	'0' FOR No multimodality radiation therapy; '1' FOR Adjuvant; '2' FOR Neoadjuvant; '3' FOR Concomitant or concurrent; '4' FOR Palliative; '9' FOR Unknown; LAST EDITED: `MAY 06, 2013` HELP-PROMPT: `Enter the type of multimodality radiation therapy administered.` DESCRIPTION: `Records the type of radiation therapy administered.` `Adjuvant - refers to additional treatment, usually given after surgery where all detectable disease has been removed, but where there remains a statistical risk of relapse due to occult disease.` `Neoadjuvant - in contrast to adjuvant therapy, is given prior to primary treatment, for example, before surgery to remove the tumor. The most common reason for neoadjuvant therapy is to reduce the size of the tumor so as` `to facilitate more effective surgery.` `Concomitant or concurrent - radiation therapy at the same time as chemotherapy.` `Palliative - radiation therapy given without expectation of a cure.` NOTES: `TRIGGERED by the INTENT OF RADIATION field of the ONCOLOGY PRIMARY File`
263	REASON HORMONE THERAPY STOPPED	PM;28	SET	'0' FOR Treatment completed, NA; '1' FOR Complications; '2' FOR Disease progression; '3' FOR Recommended but medically contraindicated; '8' FOR Other; '9' FOR Unknown; LAST EDITED: `SEP 27, 2011` HELP-PROMPT: `Enter the reason hormone therapy was discontinued.` DESCRIPTION: `Record the reason hormone therapy was discontinued. If therapy ended when treatment was complete, or if the patient never received hormone therapy code 0 (treatment completed, NA).`
264	DATE HOSPICE CONSULT INITIATED	PM;14	DATE	INPUT TRANSFORM: `D DFIT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `APR 02, 2012` HELP-PROMPT: `Enter the date a hospice consult was initiated.` DESCRIPTION: `Records the date a hospice consult was initiated. If NO date a hospice consult was initiated or not DONE, enter 00/00/0000; if UNKNOWN, enter 99/99/9999.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` `TRIGGERED by the NSLC STAGE 1-3 PATH LN STAGING field of the ONCOLOGY PRIMARY File` CROSS-REFERENCE: `^^TRIGGER^165.5^265` `1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,15),X=X S DIU=X K Y S X=DIV S:(X'="0000000") X=DIU S:(X="0000000") X="0000000" X ^DD(165.5,264,1,1,1.4)` `1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,15)=DIV,DIH=165.5,DIG=265 D ^DICR` `2)= Q` `CREATE VALUE)= S:(X'="0000000") X=DIU S:(X="0000000") X="0000000"` `DELETE VALUE)= NO EFFECT` `FIELD)= #265` CROSS-REFERENCE: `^^TRIGGER^165.5^266` `1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,16),X=X S DIU=X K Y S X=DIV S:(X'="0000000") X=DIU S:(X="0000000") X="0000000" X ^DD(165.5,264,1,2,1.4)` `1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,16)=DIV,DIH=165.5,DIG=266 D ^DICR` `2)= Q` `CREATE VALUE)= S:(X'="0000000") X=DIU S:(X="0000000") X="0000000"` `DELETE VALUE)= NO EFFECT` `FIELD)= #266`
265	DATE HOSPICE CONSULT COMPLETED	PM;15	DATE	INPUT TRANSFORM: `D DFIT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `MAR 06, 2012` HELP-PROMPT: `Enter the date the hospice consult was completed.` DESCRIPTION: `Records the date the hospice consult was created. If NO hospice consult created or DONE, enter 00/00/0000; if UNKNOWN, enter 99/99/9999.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` `TRIGGERED by the NSLC STAGE 1-3 PATH LN STAGING field of the ONCOLOGY PRIMARY File` `TRIGGERED by the DATE HOSPICE CONSULT INITIATED field of the ONCOLOGY PRIMARY File`
266	DATE HOSPICE CARE INITIATED	PM;16	DATE	INPUT TRANSFORM: `D DFIT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `MAR 06, 2012` HELP-PROMPT: `Enter the date the patient entered hospice care.` DESCRIPTION: `Records the date the patient entered hospice care. If there is NO date entered in hospice care or not DONE, enter 00/00/0000; if UNKNOWN, enter 99/99/9999.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` `TRIGGERED by the NSLC STAGE 1-3 PATH LN STAGING field of the ONCOLOGY PRIMARY File` `TRIGGERED by the DATE HOSPICE CONSULT INITIATED field of the ONCOLOGY PRIMARY File`
267	EGFR MUTATION TESTING	PM;17	SET	'0' FOR No testing; '1' FOR EGFR mutation positive, NOS; '2' FOR EGFR mutation negative; '8' FOR NA; '9' FOR Unknown/not documented; LAST EDITED: `JUN 19, 2012` HELP-PROMPT: `Enter if an Epidermal Growth Factor Receptor (EGFR) mutation test was performed and the results.` DESCRIPTION: `Records if the Pathology Department performed an EGFR (Epidermal Growth Factor Receptor) mutation test and the results.` CROSS-REFERENCE: `^^TRIGGER^165.5^268` `1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(0)=X S X=Y(0),X=X S X=X="0" I X S X=DIV S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,18),X=X S DIU=X K Y S X=DIV S X="9" X ^DD(165.5,267,1,1,1.4)` `1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,18)=DIV,DIH=165.5,DIG=268 D ^DICR` `2)= Q` `CREATE CONDITION)= INTERNAL(EGFR MUTATION TESTING)="0"` `CREATE VALUE)= "9"` `DELETE VALUE)= NO EFFECT` `FIELD)= #268` CROSS-REFERENCE: `^^TRIGGER^165.5^269` `1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(0)=X S X=Y(0),X=X S X=X="0" I X S X=DIV S Y(1)=$S($D(^ONCO(165.5,D0,"PM")):^("PM"),1:"") S X=$P(Y(1),U,19),X=X S DIU=X K Y S X=DIV S X="9" X ^DD(165.5,267,1,2,1.4)` `1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"PM")),DIV=X S $P(^("PM"),U,19)=DIV,DIH=165.5,DIG=269 D ^DICR` `2)= Q` `CREATE CONDITION)= INTERNAL(EGFR MUTATION TESTING)="0"` `CREATE VALUE)= "9"` `DELETE VALUE)= NO EFFECT` `FIELD)= #269`
268	EGFR MUTATION 1	PM;18	SET	'1' FOR Wild type; '2' FOR G719 (exon 18); '3' FOR Exon 19 deletion; '4' FOR Exon 20 insertion; '5' FOR T790M (exon 20); '6' FOR L858R (exon 21); '7' FOR L861Q (exon 21); '8' FOR Other; '9' FOR Unknown; LAST EDITED: `FEB 07, 2012` HELP-PROMPT: `Enter the first EGFR mutation type.` DESCRIPTION: `Records the first EGFR (Epidermal Growth Factor Receptor) mutation type.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` `TRIGGERED by the EGFR MUTATION TESTING field of the ONCOLOGY PRIMARY File`
269	EGFR MUTATION 2	PM;19	SET	'1' FOR Wild type; '2' FOR G719 (exon 18); '3' FOR Exon 19 deletion; '4' FOR Exon 20 insertion; '5' FOR T790M (exon 20); '6' FOR L858R (exon 21); '7' FOR L861Q (exon 21); '8' FOR Other; '9' FOR Unknown; LAST EDITED: `FEB 07, 2012` HELP-PROMPT: `Enter the second EGFR mutation type.` DESCRIPTION: `Records the second EGFR (Epidermal Growth Factor Receptor) mutation type.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` `TRIGGERED by the EGFR MUTATION TESTING field of the ONCOLOGY PRIMARY File`
270	PREOP OBSTRUCTING LESION	PM;13	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA (in situ lesion/non-invasive polyp); '9' FOR Unknown/not documented; LAST EDITED: `SEP 26, 2011` HELP-PROMPT: `Enter if a preoperative obstructing lesion was found.` DESCRIPTION: `Records if a preoperative obstructing lesion was found.`
271	ONCOLOGY REFERRAL	PM;20	SET	'1' FOR Referred; '2' FOR Not referred, no reason stated; '3' FOR Not referred, reason documented in notes; '8' FOR NA (in situ lesion/non-invasive polyp); '9' FOR Unknown if referred; LAST EDITED: `SEP 26, 2011` HELP-PROMPT: `Enter if the patient was referred to Oncology.` DESCRIPTION: `Records if the patient was referred to Oncology.`
272	DATE CHEMOTHERAPY RECOMMENDED	PM;21	DATE	INPUT TRANSFORM: `D DFIT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `APR 24, 2012` HELP-PROMPT: `Enter the date on which chemotherapy was recommended.` DESCRIPTION: `Records the date on which chemotherapy was recommended.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` `TRIGGERED by the INTENT OF CHEMOTHERAPY field of the ONCOLOGY PRIMARY File`
273	ANTI-EGFR MoAB THERAPY	PM;22	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA (Stage < 4); '9' FOR Unknown/not documented; LAST EDITED: `SEP 27, 2011` HELP-PROMPT: `Enter if anti-EFGR MoAB therapy was administered.` DESCRIPTION: `For metastatic colorectal cancer, records if anti-EGFR (Epidermal Growth Factor Receptor) MoAb (monoclonal antibody) therapy was administered. e.g. Cetuximab/Panitumumab`
274	PERIRECTAL LN INVOLVEMENT	PM;23	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA (no surgery); '9' FOR Unknown/not documented; LAST EDITED: `SEP 26, 2011` HELP-PROMPT: `Enter if perirectal lymph node involvement was indicated.` DESCRIPTION: `Records the detection of perirectal lymph node involvement.`
275	RISK OF RECURRENCE	PM;24	SET	'1' FOR Low; '2' FOR Medium; '3' FOR High; '8' FOR NA; '9' FOR Unknown/not documented; LAST EDITED: `SEP 26, 2011` HELP-PROMPT: `Enter the risk of recurrence after treatment value.` DESCRIPTION: `Records the risk of recurrence after treatment as documented on the Progress Notes.`
276	ANDROGEN DEPRIVATION THERAPY	PM;25	SET	'0' FOR ADT not administered; '1' FOR GnRH/LHRH agonist; '2' FOR Antiandrogen; '3' FOR CYP17 inhibitor; '4' FOR Combination; '5' FOR Orchiectomy; '8' FOR NA; '9' FOR Unknown/not documented; LAST EDITED: `DEC 17, 2012` HELP-PROMPT: `Enter the type of ADT administered.` DESCRIPTION: `Records the type of ADT (Androgen Deprivation Therapy) administered.` `1 GnRH/LHRH agonist` `Goserelin Acetate` `Leuprolide Acetate` `2 Antiandrogen` `Bicalutamide` `Flutamide` `Nilutamide` `3 CYP17 inhibitor` `Abiraterone acetate` `Ketoconazole` `4 Combination` `5 Orchiectomy`
277	DATE ADT INITIATED	PM;26	DATE	INPUT TRANSFORM: `D DFIT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `APR 24, 2012` HELP-PROMPT: `Enter the date Androgen Deprivation Therapy was initiated.` DESCRIPTION: `Records the date on which ADT (Androgen Deprivation Therapy) was initiated.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
278	NON-ADT CHEMOTHERAPY	PM;27	SET	'0' FOR No non-ADT chemotherapy administered; '1' FOR Docetaxel; '2' FOR Cabazitaxel; '3' FOR Sipuleucel-T; '4' FOR Other; '9' FOR Unknown/not documented; LAST EDITED: `SEP 27, 2011` HELP-PROMPT: `Enter the type of non-ADT chemotherapy administered.` DESCRIPTION: `Records whether non-ADT (Androgen Deprivation Therapy) chemotherapy was administered and, if so, what chemotherapeutic agent was used.`
279	CLINICAL TRIALS DISCUSSION	25;4	SET	'0' FOR NA (Not discussed); '1' FOR With patient; '2' FOR With Tumor Board; '3' FOR With both patient and Tumor Board; '9' FOR Unknown; LAST EDITED: `OCT 05, 2011` HELP-PROMPT: `Enter if clinical trials were discussed with the patient and/or the Tumor Board.` DESCRIPTION: `Records if clinical trials were discussed with the patient and/or the Tumor Board.`
280	CLIN TNM DOCUMENTATION PRE-TX	25;5	SET	'1' FOR Yes; '2' FOR No; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `FEB 16, 2012` HELP-PROMPT: `Enter whether this case had a clinical stage documented prior to treatment.` DESCRIPTION: `Records whether this case had a clinical stage documented prior to treatment.`
280.1	CL TNM DOCUMENTATION LOCATION	25;7	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>30!($L(X)<3) X` LAST EDITED: `FEB 16, 2012` HELP-PROMPT: `Answer must be 3-30 characters in length. Enter the location of pre-treatment clinical stage documentation.` DESCRIPTION: `Records the location of pre-treatment clinical stage documentation.`
280.2	CL TNM DOCUMENTATION DATE	25;8	DATE	INPUT TRANSFORM: `S %DT="E",%DT(0)="-NOW" D ^%DT S X=Y K:Y<1 X` LAST EDITED: `FEB 21, 2012` HELP-PROMPT: `Enter the date of pre-treatment clinical stage documentation.` DESCRIPTION: `Records the date of pre-treatment clinical stage documentation.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
281	TX GUIDELINES DISCUSSION	25;6	SET	'0' FOR NA (Not eligible); '1' FOR Eligible; '2' FOR Eligible but not discussed; '3' FOR Discussed; '9' FOR Unknown; LAST EDITED: `OCT 05, 2011` HELP-PROMPT: `Enter if this case was eligible for a treatment guidelines discussion.` DESCRIPTION: `Records if this case was eligible for a treatment guidelines discussion.`
282	VACCR EXTRACT INDICATOR	EDITS;3	SET	'N' FOR New; 'U' FOR Update; LAST EDITED: `OCT 19, 2011` HELP-PROMPT: `Enter N (New) for newly completed cases. Enter U (Update) for changes to completed cases.` DESCRIPTION: `Records whether this case has been newly 'Completed' or is an update to an already 'Completed' case.`
283	CS FIELD NEEDING REVIEW	CS3;3	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>70!($L(X)<1) X` LAST EDITED: `NOV 09, 2011` HELP-PROMPT: `Answer must be 1-70 characters in length.` DESCRIPTION: `Records the CS (Collaborative Staging) item(s) which need manual review/recoding by a registrar after the CS conversion.`
284	UDF1	25;9	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>10!($L(X)<1) X` LAST EDITED: `OCT 22, 2015` HELP-PROMPT: `Answer must be 1-10 characters in length.` DESCRIPTION: `This will be a User Defined Field.`
284.1	UDF2	25;10	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>10!($L(X)<1) X` LAST EDITED: `OCT 22, 2015` HELP-PROMPT: `Answer must be 1-10 characters in length.` DESCRIPTION: `This will be a User Defined Field.`
284.2	UDF3	25;11	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>10!($L(X)<1) X` LAST EDITED: `OCT 22, 2015` HELP-PROMPT: `Answer must be 1-10 characters in length.` DESCRIPTION: `This will be a User Defined Field.`
284.3	UDF4	25;12	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>10!($L(X)<1) X` LAST EDITED: `OCT 22, 2015` HELP-PROMPT: `Answer must be 1-10 characters in length.` DESCRIPTION: `This will be a User Defined Field.`
284.4	UDF5	25;13	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>10!($L(X)<1) X` LAST EDITED: `OCT 22, 2015` HELP-PROMPT: `Answer must be 1-10 characters in length.` DESCRIPTION: `This will be a User Defined Field.`
284.5	UDF6	25;14	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>10!($L(X)<1) X` LAST EDITED: `OCT 22, 2015` HELP-PROMPT: `Answer must be 1-10 characters in length.` DESCRIPTION: `This will be a User Defined Field.`
284.6	UDF7	25;15	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>10!($L(X)<1) X` LAST EDITED: `OCT 22, 2015` HELP-PROMPT: `Answer must be 1-10 characters in length.` DESCRIPTION: `This will be a User Defined Field.`
284.7	UDF8	25;16	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>10!($L(X)<1) X` LAST EDITED: `OCT 22, 2015` HELP-PROMPT: `Answer must be 1-10 characters in length.` DESCRIPTION: `This will be a User Defined Field.`
284.8	UDF9	25;17	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>10!($L(X)<1) X` LAST EDITED: `OCT 22, 2015` HELP-PROMPT: `Answer must be 1-10 characters in length.` DESCRIPTION: `This will be a User Defined Field.`
284.9	UDF10	25;18	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>10!($L(X)<1) X` LAST EDITED: `OCT 22, 2015` HELP-PROMPT: `Answer must be 1-10 characters in length.` DESCRIPTION: `This will be a User Defined Field.`
285	TEXT-STAGING	22.1;0	WORD-PROCESSING #165.5285	DESCRIPTION: `Text area for information related to the new NAACCR 2018 staging guidelines for the primary site.` LAST EDITED: `APR 09, 2018` HELP-PROMPT: `Enter any text relating to the staging of the primary.` DESCRIPTION: `This field will store any text relating to the staging of the primary.`
286	TEXT-SITE SPECIFIC DATA ITEMS	22.2;0	WORD-PROCESSING #165.5286	DESCRIPTION: `Text area for information related to the Site Specific Data Items (SSDI) for the primary site. The SSDI are a new data item introduced in NAACCR 2018.` LAST EDITED: `APR 09, 2018` HELP-PROMPT: `Enter text relating to the Site Specific Data items for the primary.` DESCRIPTION: `This field will store any text relating to the site specific data items for the primary.`
287	TEXT-COVID-19	22.3;0	WORD-PROCESSING #165.5287	DESCRIPTION: `This word-processing field records any notes or descriptions relevant or related to COVID-19 for the patient.` LAST EDITED: `FEB 02, 2021` HELP-PROMPT: `Enter text relating to the COVID-19 NCDB data items` DESCRIPTION: `This word-processing field will store any text related to the COVID-19 data items.`
288	TOBACCO USE SMOKING STATUS	25;21	SET	'0' FOR Never smoker; '1' FOR Current smoker (or if quit within 30 days prior to dx); '2' FOR Former smoker (must have quit 31 days or more prior to dx); '3' FOR Smoker, current status unknown; '9' FOR Unknown if ever smoked; LAST EDITED: `SEP 26, 2023` HELP-PROMPT: `Enter a code from the list that corresponds to the smoking status for this patient.` DESCRIPTION: `Instructions for Coding (see SEER Program Coding and Staging Manual 2023 for complete instructions) Tobacco smoking history can be obtained from sections such as the Nursing Interview Guide, Flow Chart, Vital Stats or` `Nursing Assessment section, or other available sources from the patient's hospital medical record or physician office record.` `- Record the past or current use of tobacco. Tobacco use includes cigarette, cigar, and/or pipe. - Do not record the patient's past or current use of e-cigarette vaping devices. - Assign code 2 when the medical record` `indicates patient has smoked tobacco in the past but does not smoke now - If there is evidence in the medical record that the patient quit recently (within 30 days prior to diagnosis), assign code 1, current smoker. The 30` `days prior information, if available, is intended to differentiate patients who may have quit recently due to symptoms that lead to a cancer diagnosis. - Assign code 9 when the medical record only indicates "No". This` `data item is for the specific use of tobacco products. Electronic cigarettes are not considered tobacco use as they use liquid nicotine and do not contain tobacco. However, these users may have a history of tobacco use` `that should be considered. Smoking, vaping or consuming products other than tobacco, such as liquid nicotine, CBD or marijuana is not included.`
289	TEXT-HIV, SCA, DRUG & ETOH	22.4;0	WORD-PROCESSING #165.5289	LAST EDITED: `SEP 26, 2023` HELP-PROMPT: `Enter information regarding HIV/AIDS, Sickle Cell Anemia, Drug and Alcohol Abuse.` DESCRIPTION: `TEXT-HIV, SCA, DRUG & ETOH is a VA ONLY text field for medical conditions covered by 38 U.S.C. Section 7332, which prohibits the sharing of information regarding HIV/AIDS, Sickle Cell Anemia and Drug and Alcohol abuse` `with outside entities. This optional field is to record relevant information associated with these conditions, if applicable.`
300	PATIENT REFERRED FOR TREATMENT	BLA1;1	SET	'1' FOR Another hospital; '2' FOR Staff physician office; '3' FOR Non-staff physician office; '4' FOR Free standing facility; '5' FOR Other; '8' FOR Not applicable; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `If the patient was referred elsewhere for part or all of the first course of therapy, record the type of facility to which the referral was made.`
301	LENGTH OF STAY	BLA1;2	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>999)!(X<0)!(X?.E1"."1N.N) X` OUTPUT TRANSFORM: `S Y=$S(Y=888:"Never an inpatient",Y=999:"Unknown",Y=1:Y_" day",1:Y_" days")` LAST EDITED: `SEP 06, 1996` HELP-PROMPT: `Type a Number between 0 and 999, 0 Decimal Digits` DESCRIPTION: `Record the length of stay in days for inpatient cases only. If the patient has multiple inpatient stays, record the length of the admission for the most definitive treatment. If the patient was never an inpatient at your` `institution, record 888. If the length of stay cannot be determined, code as 999 (unknown).`
302	HISTORY OF CERVIX CA (PT)	BLA1;3	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record whether cervix cancer was diagnosed prior to the patient's bladder cancer or simultaneously with the bladder cancer. Simultaneous diagnosis is within six months of the diagnosis of bladder cancer.`
303	HISTORY OF COLON CA (PT)	BLA1;4	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record whether colon cancer was diagnosed prior to the patient's bladder cancer or simultaneously with the bladder cancer. Simultaneous diagnosis is within six months of the diagnosis of bladder cancer.`
304	HISTORY OF BLADDER CA (PT)	BLA1;5	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record whether bladder cancer was diagnosed prior to the patient's bladder cancer or simultaneously with the bladder cancer. Simultaneous diagnosis is within six months of the diagnosis of bladder cancer.`
305	HISTORY OF HEAD & NECK CA (PT)	BLA1;6	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record whether head and neck cancer was diagnosed prior to the patient's bladder cancer or simultaneously with the bladder cancer. Simultaneous diagnosis is within six months of the diagnosis of bladder cancer.`
306	HISTORY OF KIDNEY CA (PT)	BLA1;7	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record whether kidney cancer was diagnosed prior to the patient's bladder cancer or simultaneously with the bladder cancer. Simultaneous diagnosis is within six months of the diagnosis of bladder cancer.`
307	HISTORY OF PROSTATE CA (PT)	BLA1;8	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record whether prostate cancer was diagnosed prior to the patient's bladder cancer or simultaneously with the bladder cancer. Simultaneous diagnosis is within six months of the diagnosis of bladder cancer.`
308	HISTORY OF OTHER CA (PT)	BLA1;9	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record whether other cancer was diagnosed prior to the patient's bladder cancer or simultaneously with the bladder cancer. Simultaneous diagnosis is within six months of the diagnosis of bladder cancer.`
309	HISTORY OF BLADDER CA (FAM)	BLA1;10	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record any familial history of bladder cancer documented in the medical record. If the record does not mention familial history of bladder cancer, code 9 (unknown).`
310	HISTORY OF COLON CA (FAM)	BLA1;11	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record any familial history of colon cancer documented in the medical record. If the record does not mention familial history of colon cancer, code 9 (unknown).`
311	HISTORY OF LUNG CA (FAM)	BLA1;12	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record any familial history of lung cancer documented in the medical record. If the record does not mention familial history of lung cancer, code 9 (unknown).`
312	HISTORY OF PROSTATE CA (FAM)	BLA1;13	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record any familial history of prostate cancer documented in the medical record. If the record does not mention familial history of prostate cancer, code 9 (unknown).`
313	HISTORY OF OTHER CA (FAM)	BLA1;14	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record any familial history of other cancer documented in the medical record. If the record does not mention familial history of other cancer, code 9 (unknown).`
314	SMOKING HISTORY	BLA1;15	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` OUTPUT TRANSFORM: `S Y=$S(Y=0:"Never smoked",$L(Y)=1:"0"_Y,Y=98:"98 Currently does not smoke, but did previously",Y=99:"99 Unknown",1:Y)` LAST EDITED: `APR 24, 1997` HELP-PROMPT: `Type a Number between 0 and 99, 0 Decimal Digits` DESCRIPTION: `Record the actual number of packs of cigarettes smoked per day. A zero must precede single-digit packs. If one or less packs per day are smoked, code as 01. If the patient was never a smoker, code 00. If the patient` `currently does not smoke, but did previously, code as 98. If the medical record does not mention tobacco use, code as 99 (unknown).`
315	DURATION OF SMOKING HISTORY	BLA1;16	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` OUTPUT TRANSFORM: `S Y=$S(Y=0:"Never smoked",$L(Y)=1:"0"_Y_" years",Y=98:"Currently does not smoke, but did previously",Y=99:"Unknown",1:Y_" years")` LAST EDITED: `SEP 06, 1996` HELP-PROMPT: `Type a Number between 0 and 99, 0 Decimal Digits` DESCRIPTION: `Record the number of years the patient has smoked. A zero must precede single-digit years. If the patient never smoked, code 00. If the medical record does not mention duration of years, code 99 (unknown).`
316	DURATION OF SMOKE FREE HISTORY	BLA1;17	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` OUTPUT TRANSFORM: `S Y=$S(Y=0:"Never smoked",Y=88:"Not applicable",Y=99:"Unknown",Y=1:Y_" year",1:Y_" years")` LAST EDITED: `SEP 06, 1996` HELP-PROMPT: `Type a Number between 0 and 99, 0 Decimal Digits` DESCRIPTION: `If the patient was a previous smoker and no longer smokes, record the number of years since his/her last cigarette. A zero must precede single- digit years. If the patient never smoked, code 00. If the patient never` `stopped smoking code 88 (not applicable). If the duration is unknown, code 99 (unknown).`
317	GROSS HEMATURIA	BLA1;18	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record whether the patient was presented with a clinical finding of gross hematuria. If not present, code 0 (no).`
318	MICROSCOPIC HEMATURIA	BLA1;19	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record whether the patient was presented with a clinical finding of microscopic hematuria. If not present, code 0 (no).`
319	URINARY FREQUENCY	BLA1;20	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record whether the patient was presented with a clinical finding of urinary frequency. If not present, code 0 (no).`
320	BLADDER IRRITABILITY	BLA1;21	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record whether the patient was presented with a clinical finding of bladder irritability. If not present, code 0 (no).`
321	DYSURIA	BLA1;22	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record whether the patient was presented with a clinical finding of dysuria. If not present, code 0 (no).`
322	OTHER CLINICAL DETECTIONS	BLA1;23	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record whether the patient was presented with other clinical findings. If not present, code 0 (no).`
323	ONSET OF SYMPTOMS	BLA1;24	DATE	INPUT TRANSFORM: `S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" S %DT="EP",%DT(0)="-NOW" D ^%DT S X=Y K:Y<1 X K %DT(0) W !,"Future dates are not allowed"` OUTPUT TRANSFORM: `D DATEOT^ONCOPCE` LAST EDITED: `OCT 15, 1997` DESCRIPTION: `Record the date (mm/dd/ccyy) on which the symptoms were noted to begin. If the patient did not experience any symptoms, or if the documentation of symptoms was not recorded, enter date as 00/00/0000. If symptoms were` `present, but date of onset was unknown, record date as 99/99/9999.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
324	DURATION OF GROSS HEMATURIA	BLA1;25	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` OUTPUT TRANSFORM: `S Y=$S(Y=0:"Symptoms not present",Y=1:Y_" month",Y=99:"Unknown",1:Y_" months")` LAST EDITED: `SEP 06, 1996` HELP-PROMPT: `Type a Number between 0 and 99, 0 Decimal Digits` DESCRIPTION: `Record the duration (in months) of the patient's symptoms of gross hematuria prior to the diagnosis of cancer. If symptoms were not present, code 00. If symptoms were present and the duration unknown, code 99.`
325	DURATION OF DYSURIA	BLA1;26	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` OUTPUT TRANSFORM: `S Y=$S(Y=0:"Symptoms not present",Y=1:Y_" month",Y=99:"Unknown",1:Y_" months")` LAST EDITED: `SEP 06, 1996` HELP-PROMPT: `Type a Number between 0 and 99, 0 Decimal Digits` DESCRIPTION: `Record the duration (in months) of the patient's symptoms of dysuria prior to the diagnosis of cancer. If symptoms were not present, code 00. If symptoms were present and the duration unknown, code 99.`
326	BIMANAUL EXAM OF BLADDER	BLA1;27	SET	'0' FOR Not done; '1' FOR Done; '9' FOR Unknown if done; LAST EDITED: `SEP 18, 1996` DESCRIPTION: `Record whether a bimanual examination of the bladder was used to diagnose the bladder cancer. If the procedure was not performed, code 0 (not done).`
327	CYSTOSCOPY WITH BIOPSY	BLA1;28	SET	'0' FOR Not done; '1' FOR Done; '9' FOR Unknown if done; LAST EDITED: `SEP 18, 1996` DESCRIPTION: `Record whether a cystoscopy with biopsy was used to diagnose the bladder cancer. If the procedure was not performed, code 0 (not done).`
328	CYSTOSCOPY WITHOUT BIOPSY	BLA1;29	SET	'0' FOR Not done; '1' FOR Done; '9' FOR Unknown if done; LAST EDITED: `SEP 18, 1996` DESCRIPTION: `Record whether a cystoscopy without biopsy was used to diagnose the bladder cancer. If the procedure was not performed, code 0 (not done).`
329	FLOW CYTOMETRY	BLA1;30	SET	'0' FOR Not done; '1' FOR Done; '9' FOR Unknown if done; LAST EDITED: `SEP 18, 1996` DESCRIPTION: `Record whether a flow cytometry was used to diagnose this cancer. If the procedure was not performed, code 0 (not done).`
330	INTRAVENOUS PYELOGRAM (BLA)	BLA1;31	SET	'0' FOR Not done; '1' FOR Done; '9' FOR Unknown if done; LAST EDITED: `FEB 13, 1997` DESCRIPTION: `Record whether an intravenous pyelogram was used to diagnose the bladder cancer. If the procedure was not performed, code 0 (not done).`
331	URINE CYTOLOGY	BLA1;32	SET	'0' FOR Not done; '1' FOR Done; '9' FOR Unknown if done; LAST EDITED: `SEP 18, 1996` DESCRIPTION: `Record whether a urine cytology was used to diagnose the bladder cancer. If the procedure was not performed, code 0 (not done).`
332	URINALYSIS	BLA1;33	SET	'0' FOR Not done; '1' FOR Done; '9' FOR Unknown if done; LAST EDITED: `SEP 18, 1996` DESCRIPTION: `Record whether a urinalysis was used to diagnose the bladder cancer. If the procedure was not performed, code 0 (not done).`
333	OTHER DIAGNOSTIC PROCEDURES	BLA1;34	SET	'0' FOR Not done; '1' FOR Done; '9' FOR Unknown if done; LAST EDITED: `SEP 18, 1996` DESCRIPTION: `Record whether other diagnostic procedures were used to diagnose the bladder cancer. If no other procedure was performed, code 0 (not done).`
334	SPECIALTY MAKING DIAGNOSIS	BLA1;35	SET	'0' FOR Internal Medicine; '1' FOR Family Practice; '2' FOR General Surgeon; '3' FOR Surgical Oncologist; '4' FOR Urologist; '5' FOR Urologic Oncologist; '6' FOR Medical Oncologist; '7' FOR Radiation Oncologist; '8' FOR Other; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Provide the specialty of the practitioner (other than the pathologist) who diagnosed this case of bladder cancer.`
335	ABDOMINAL ULTRASOUND	BLA1;36	SET	'0' FOR Not done; '1' FOR Done; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record whether an abdominal ultrasound procedure was performed to stage this case.`
336	BONE IMAGING	BLA1;37	SET	'0' FOR Not done; '1' FOR Done; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record whether a bone imaging procedure was performed to stage this case.`
337	CHEST X-RAY (BLADDER)	BLA1;38	SET	'0' FOR Not done; '1' FOR Done; '9' FOR Unknown; LAST EDITED: `OCT 25, 1996` DESCRIPTION: `Record whether a chest x-ray was performed to stage this case.`
338	CT CHEST/LUNG	BLA1;39	SET	'0' FOR Not done; '1' FOR Done; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record whether a CT chest/lung procedure was performed to stage this case.`
339	CT ABDOMEN/PELVIS	BLA1;40	SET	'0' FOR Not done; '1' FOR Done; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record whether a CT abdomen/pelvis procedure was performed to stage this case.`
340	CT OTHER	BLA1;41	SET	'0' FOR Not done; '1' FOR Done; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record whether other CT procedures were performed to stage this case.`
341	MRI PELVIS/ABDOMEN	BLA1;42	SET	'0' FOR Not done; '1' FOR Done; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record whether an MRI pelvis/abdomen procedure was performed to stage this case.`
342	MRI OTHER	BLA1;43	SET	'0' FOR Not done; '1' FOR Done; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record whether other MRI procedures were performed to stage this case.`
343	OTHER STAGING PROCEDURES	BLA1;44	SET	'0' FOR Not done; '1' FOR Done; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record whether other staging procedures were performed to stage this case.`
344	PRESENCE OF HYDRONEPHROSIS	BLA1;45	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record whether the patient was noted at any time to have hydronephrosis. If the medical record does not mention hydronephrosis, code as 9 (unknown).`
345	PRESENCE OF MULTIPLE TUMORS	BLA1;46	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record whether the presence of multiple primary bladder tumors was detected either clinically or pathologically.`
346	PROTOCOL ELIGIBILITY STATUS	BLA2;1	SET	'0' FOR Not available; '1' FOR On protocol; '2' FOR Ineligible (age,stage,etc.); '3' FOR Ineligible (comorbidity, preexist cond); '4' FOR Entered but withdrawn; '6' FOR Eligible, not entered; '7' FOR Eligible, refused; '8' FOR Not recommended; '9' FOR Unknown; LAST EDITED: `MAY 22, 1997` DESCRIPTION: `Record the eligibility status of the patient to be entered into a protocol. Analysis of protocol eligibility status assists program planning.`
347	MANAGING PHYSICIAN (PRIMARY)	BLA2;2	POINTER TO BLADDER PHYSICIAN SPECIALTY FILE (#166.12)	BLADDER PHYSICIAN SPECIALTY(#166.12) OUTPUT TRANSFORM: `S Y=$P($G(^ONCO(166.12,+Y,0)),"^",2)` LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record the specialty of the primary-care physician who managed the patient upon discharge. If it cannot be determined who the primary managing physician is, code 99 (unknown).`
348	MANAGING PHYSICIAN (SECONDARY)	BLA2;3	POINTER TO BLADDER PHYSICIAN SPECIALTY FILE (#166.12)	BLADDER PHYSICIAN SPECIALTY(#166.12) OUTPUT TRANSFORM: `S Y=$P($G(^ONCO(166.12,+Y,0)),"^",2)` LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record the specialty of the secondary-care physician who managed the patient upon discharge. If it cannot be determined who the secondary managing physician is, code 99 (unknown).`
349	TUMOR RESECTION DURING TURB	BLA2;4	SET	'1' FOR Visibly complete resection; '2' FOR Visibly incomplete resection; '8' FOR Not applicable; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `For all bladder cases undergoing a transurethral resection of the bladder (code 10) for the first course of treatment, record whether or not a tumor was grossly visible or not after resection. This information should be` `found in the operative report. For primary tumors of the prostatic utricle (C68.0), code 8 (not applicable).`
350	TYPE OF URINARY DIVERSION	BLA2;5	SET	'1' FOR Ileoconduit; '2' FOR Continent cutaneous; '3' FOR Neobladder; '8' FOR Not applicable; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `If cancer-directed surgery codes 20-70 are reported, code the type of urinary diversion performed. This information should be found in the operative report. For primary tumors of the prostatic utricle (C68.0), code 8` `(not applicable).`
351	PELVIC LYMPH NODE DISSECT (BL)	BLA2;6	SET	'0' FOR Not done; '1' FOR Done; '8' FOR Not applicable; '9' FOR Unknown; LAST EDITED: `OCT 25, 1996` DESCRIPTION: `If cancer-directed surgery code 70 is reported, code whether a pelvic lymph node dissection for radical surgery was performed. This information should be obtained from the operative and pathology reports. If the patient` `had a type of cancer-directed surgery other than a code 70, code 8 (not applicable).`
352	BLEEDING REQUIRING TRANSFUSION	BLA2;7	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record whether this surgical complication resulted from operation. If this complication did not occur, code 0 (none).`
353	DEEP VENOUS THROMBOSIS	BLA2;8	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record whether this surgical complication resulted from operation. If this complication did not occur, code 0 (none).`
354	MYOCARDIAL INFARCTION (MI)	BLA2;9	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 14, 2000` DESCRIPTION: `This field describes a patient's prior medical condition.`
355	PELVIC ABSCESS	BLA2;10	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record whether this surgical complication resulted from operation. If this complication did not occur, code 0 (none).`
356	PNEUMONIA REQ ANTIBIOTICS	BLA2;11	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record whether this surgical complication resulted from operation. If this complication did not occur, code 0 (none).`
357	POST-OPERATIVE DEATH	BLA2;12	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record whether this surgical complication resulted from operation. If this complication did not occur, code 0 (none).`
358	PULMONARY EMBOLISM/THROMBOSIS	BLA2;13	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record whether this surgical complication resulted from operation. If this complication did not occur, code 0 (none).`
359	REOPERATION	BLA2;14	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record whether this surgical complication resulted from operation. If this complication did not occur, code 0 (none).`
360	OTHER SURGICAL COMPLICATIONS	BLA2;15	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, surgery not performed; '9' FOR Unknown; LAST EDITED: `MAR 27, 2000` DESCRIPTION: `This field describes a complication or event that occurred after surgery of the primary site and before the date of patient discharge from the hospital.`
361	DATE RADIATION ENDED	BLA2;16	DATE	INPUT TRANSFORM: `D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `MAR 31, 2000` HELP-PROMPT: `* DATE RADIATION ENDED MUST BE AFTER OR EQUAL TO DATE DX *` DESCRIPTION: `The date on which the patient completes or receives the last radiation treatment at any facility.` `For further information see FORDS pages 166-167.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
362	TOTAL RAD (cGy/rad) DOSE	BLA2;17	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99999)!(X<0)!(X?.E1"."1N.N) X` OUTPUT TRANSFORM: `S Y=$S($L(Y)=1:"0000"_Y,$L(Y)=2:"000"_Y,$L(Y)=3:"00"_Y,$L(Y)=4:"0"_Y,1:Y)` LAST EDITED: `AUG 29, 1996` HELP-PROMPT: `Type a Number between 0 and 99999, 0 Decimal Digits` DESCRIPTION: `Record the total external rad dose and brachytherapy dosage given to all sites treated, including boost dosage. If the patient did not receive radiation therapy, code 00000. If it is known that the patient received` `radiation therapy but the amount is unknown, code 99999.`
363	REGIONAL TREATMENT MODALITY	BLA2;18	POINTER TO REGIONAL TREATMENT MODALITY FILE (#166.13)	REGIONAL TREATMENT MODALITY(#166.13) INPUT TRANSFORM: `S DIC("S")="I ((+$P(^(0),U,1)<1)!(+$P(^(0),U,1)>16)),(($P(^ONCO(165.5,DA,0),U,16)<3030101)!((Y'=46)&(Y'=47)))" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X` OUTPUT TRANSFORM: `S Y=$P($G(^ONCO(166.13,+Y,0)),U,2)` LAST EDITED: `NOV 22, 2004` DESCRIPTION: `Records the dominant modality of radiation therapy used to deliver the most clinically significant regional dose to the primary volume of interest during the first course of treatment.` `For further information see FORDS pages 155-157.` SCREEN: `S DIC("S")="I ((+$P(^(0),U,1)<1)!(+$P(^(0),U,1)>16)),(($P(^ONCO(165.5,DA,0),U,16)<3030101)!((Y'=46)&(Y'=47)))"` EXPLANATION: `Codes 01-16 have been discontinued. Codes 80 and 85 are prohibited for 2003+ cases.`
363.1	BOOST TREATMENT MODALITY	24;9	POINTER TO REGIONAL TREATMENT MODALITY FILE (#166.13)	REGIONAL TREATMENT MODALITY(#166.13) INPUT TRANSFORM: `S DIC("S")="I (+$P(^(0),U,1)<1)!(+$P(^(0),U,1)>16)" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X I $D(X) S V=1 D NT^ONCODSR` OUTPUT TRANSFORM: `S Y=$P($G(^ONCO(166.13,+Y,0)),U,2)` LAST EDITED: `JAN 09, 2003` DESCRIPTION: `Records the dominant modality of radiation therapy used to deliver the most clinically significant boost dose to the primary volume of interest during the first course of treatment. This is accomplished with external` `beam fields of reduced size (relative to the regional treatment fields), implants, stereotactic radiosurgery, conformal therapy, or IMRT. External beam boosts may consist of two or more successive phases with` `progressively smaller fields generally coded as a single entry.` `For further information see FORDS pages 159-161.` SCREEN: `S DIC("S")="I (+$P(^(0),U,1)<1)!(+$P(^(0),U,1)>16)"` EXPLANATION: `ROADS codes 01-16 have been discontinued.`
364	URINARY INCONTINENCE	BLA2;19	SET	'0' FOR None; '1' FOR Yes; '8' FOR Not applicable; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record whether the patient experienced any urinary incontinence as a result of radiation therapy. If the patient did not receive radiation therapy, code 8 (not applicable).`
365	HEMATURIA	BLA2;20	SET	'0' FOR None; '1' FOR Yes; '8' FOR Not applicable; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record whether the patient experienced any hematuria as a result of radiation therapy. If the patient did not receive radiation therapy, code 8 (not applicable).`
366	RADIATION BOWEL INJURY	BLA2;21	SET	'0' FOR None; '1' FOR Yes; '8' FOR Not applicable; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record whether the patient experienced a radiation bowel injury as a result of radiation therapy. If the patient did not receive radiation therapy, enter 8 (not applicable).`
367	DATE CHEMOTHERAPY ENDED	BLA2;22	DATE	INPUT TRANSFORM: `S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" D DFIT^ONCODSR` OUTPUT TRANSFORM: `D DATEOT^ONCOPCE` LAST EDITED: `APR 03, 1997` HELP-PROMPT: `* DATE CHEMOTHERAPY ENDED MUST BE AFTER OR EQUAL TO DATE DX *` DESCRIPTION: `Record the date on which the entire first course of chemotherapy was completed. If chemotherapy was not given, code date as 00/00/0000.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
368	ROUTE CHEMOTHERAPY ADMIN	BLA2;23	SET	'0' FOR No chemotherapy; '1' FOR Systemic; '2' FOR Intravesicle; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record the route by which the chemotherapy was administered. If the patient did not receive chemotherapy, code 0 (no chemotherapy).`
369	ADRIAMYCIN	BLA2;24	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record whether the chemotherapeutic agent, Adriamycin, was given. If no chemotherapy was given, code as 0 (no).`
370	CARBOPLATINUM	BLA2;25	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record whether the chemotherapeutic agent, Carboplatinum, was given. If no chemotherapy was given, code as 0 (no).`
371	CISPLATIN	BLA2;26	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, chemotherapy not administered; '9' FOR Unknown; LAST EDITED: `APR 20, 2000` DESCRIPTION: `This field describes one type of chemotherapeutic agent administered to the patient.`
372	CYCLOPHOSPHAMIDE	BLA2;27	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, chemotherapy not administered; '9' FOR Unknown; LAST EDITED: `APR 20, 2000` DESCRIPTION: `This field describes one type of chemotherapeutic agent administered to the patient.`
373	5-FLUOROURACIL	BLA2;28	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record whether the chemotherapeutic agent, 5-fluorouracil, was given. If no chemotherapy was given, code as 0 (no).`
374	GALLIUM NITRATE	BLA2;29	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record whether the chemotherapeutic agent, Gallium Nitrate, was given. If no chemotherapy was given, code as 0 (no).`
375	IFOSFAMIDE	BLA2;30	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 13, 1996` DESCRIPTION: `Record whether the chemotherapeutic agent, Ifosfamide, was given. If no chemotherapy was given, code as 0 (no).`
376	METHOTREXATE	BLA2;31	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, chemotherapy not administered; '9' FOR Unknown; LAST EDITED: `APR 20, 2000` DESCRIPTION: `This field describes one type of chemotherapeutic agent administered to the patient.`
377	TAXOL	BLA2;32	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record whether the chemotherapeutic agent, Taxol, was given. If no chemotherapy was given, code as 0 (no).`
378	THIOTEPA	BLA2;33	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record whether the chemotherapeutic agent, Thiotepa, was given. If no chemotherapy was given, code as 0 (no).`
379	VINBLASTINE	BLA2;34	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record whether the chemotherapeutic agent, Vinblastine, was given. If no chemotherapy was given, code as 0 (no).`
380	OTHER CHEMOTHERAPEUTIC AGENTS	BLA2;35	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, no chemotherapy administered; '9' FOR Unknown; LAST EDITED: `APR 20, 2000` DESCRIPTION: `This field describes one type of chemotherapeutic agent administered to the patient.`
381	INDICATION FOR ADMIN OF AGENTS	BLA2;36	SET	'0' FOR No agents administered, NA; '1' FOR Metastatic disease; '2' FOR Adjuvant therapy; '3' FOR Neoadjuvant therapy; '8' FOR Other; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record the reason for chemotherapy. If the patient never received chemotherapy, code 0 (no agents administered, na).`
382	REASON CHEMOTHERAPY STOPPED	BLA2;41	SET	'0' FOR Treatment completed, NA; '1' FOR Complications; '2' FOR Disease progression; '3' FOR Recommended but medically contraindicated; '8' FOR Other; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` HELP-PROMPT: `Enter the reason chemotherapy treatment was discontinued.` DESCRIPTION: `Record the reason chemotherapy was discontinued. If therapy ended when treatment was complete, or if the patient never received chemotherapy, code 0 (treatment completed, NA).` NOTES: `TRIGGERED by the CHEMOTHERAPY RECOMMENDED field of the ONCOLOGY PRIMARY File` `TRIGGERED by the INTENT OF CHEMOTHERAPY field of the ONCOLOGY PRIMARY File`
383	BCG	BLA2;37	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 14, 1999` DESCRIPTION: `Record whether BCG immunotherapy was administered for the first course of therapy.`
384	INTERFERON	BLA2;38	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, chemotherapy not administered; '9' FOR Unknown; LAST EDITED: `APR 20, 2000` DESCRIPTION: `This field describes one type of chemotherapeutic agent administered to the patient.`
385	INTERLEUKIN-2	BLA2;39	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `JAN 14, 1999` DESCRIPTION: `Record whether Interleukin-2 immunotherapy was administered for the first course of therapy.` SCREEN: `S DIC("S")="I ($P($G(^ONCO(165.5,DA,0)),U,16)>2981231)!(Y'=8)"` EXPLANATION: `Code 8 should not be used for cases with a DATE DX < 1/1/1999`
386	OTHER TYPE OF IMMUNOTHERAPY	BLA2;40	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `JAN 14, 1999` DESCRIPTION: `Record whether other immunotherapy was administered for the first course of therapy.` SCREEN: `S DIC("S")="I ($P($G(^ONCO(165.5,DA,0)),U,16)>2981231)!(Y'=8)"` EXPLANATION: `Code 8 should not be used for cases with a DATE DX < 1/1/1999`
387	TYPE OF 1ST RECURRENCE/BLADDER	BLA2;42	SET	'0' FOR No recurrence; '1' FOR Bladder, superficial; '2' FOR Bladder, muscle invasion; '3' FOR Bladder, NOS; '4' FOR Pelvis; '5' FOR Distant; '8' FOR Never disease-free; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record the type of the first recurrence. "Pelvic recurrence" is tumor that has invaded any of the following sites: prostate, uterus, vagina, pelvic wall, or abdominal wall. "Distant recurrence" occurs in a site` `considered distant from the organ or origin as presented in most staging schemes.`
400	HISTORY OF THYROID CA (FAM)	THY1;1	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `FEB 10, 1997` DESCRIPTION: `Record any familial history of thyroid cancer documented in the medical record. If the record does not mention familial history of thyroid cancer, code 9 (unknown).`
401	HISTORY OF LYMPHOMA (PT)	THY1;2	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record whether the patient has a history of Lymphoma, including Hodgkin's Disease.`
402	HISTORY OF CHILDHOOD MALIG	THY1;3	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record whether the patient has a history of childhood malignancies, other than lymphoma.`
403	PRIOR EXPOSURE TO RADIATION	THY1;4	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 09, 1996` DESCRIPTION: `This field describes a patient's known prior radiation exposure. Exposure to fluoroscopy, exposure to radioactive isotopes, or actual radiation treatments should be considered prior radiation exposure. Do not consider` `routine chest or dental x-rays as prior radiation exposure.`
404	HISTORY OF GOITER (PT)	THY1;5	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 09, 1996` DESCRIPTION: `Record history of enlarged thyroid gland for a period of greater than 5 years prior to diagnosis.`
405	HISTORY OF GOITER (FAM)	THY1;6	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 09, 1996` DESCRIPTION: `Record any familial history of thyroid enlargement (goiter), Graves Disease or thyroiditis.`
406	HISTORY OF GRAVES DISEASE (PT)	THY1;7	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 09, 1996` DESCRIPTION: `Record whether the patient has a history of Graves Disease, i.e., autoimmune hyperthyroidism with or withour eye symptoms.`
407	HISTORY OF THYROIDITIS (PT)	THY1;8	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 09, 1996` DESCRIPTION: `Record whether the patient has a history of Hashimoto's thyroiditis or any other type of thyroiditis. Thyroiditis is often associated with hypothyroidism.`
408	DYSPHAGIA	THY1;9	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 09, 1996` DESCRIPTION: `Record whether the sign/symptom 'DYSPHAGIA' was present at the time of diagnosis.`
409	HOARSENESS OR VOICE CHANGE	THY1;10	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 09, 1996` DESCRIPTION: `Record whether the sign/symptom 'HOARSENESS OR VOICE CHANGE' was present at the time of diagnosis.`
410	NECK NODAL MASS	THY1;11	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 09, 1996` DESCRIPTION: `Record whether the sign/symptom 'NECK NODAL MASS' was present at the time of diagnosis.`
411	PAIN, BONE	THY1;12	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 09, 1996` DESCRIPTION: `Record whether the sign/symptom 'PAIN, BONE' was present at the time of diagnosis.`
412	PAIN, NECK	THY1;13	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 09, 1996` DESCRIPTION: `Record whether the sign/symptom 'PAIN, NECK' was present at the time of diagnosis.`
413	PATHOLOGIC FRACTURE	THY1;14	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 09, 1996` DESCRIPTION: `Record whether the sign/symptom 'PATHOLOGIC FRACTURE' was present at the time of diagnosis.`
414	STRIDOR/DIFFICULTY BREATHING	THY1;15	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 09, 1996` DESCRIPTION: `Record whether the sign/symptom 'STRIDOR OR DIFFICULTY BREATHING' was present at the time of diagnosis.`
415	THYROID MASS	THY1;16	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 09, 1996` DESCRIPTION: `Record whether the sign/symptom 'THYROID MASS' was present at the time of diagnosis.`
416	WEIGHT LOSS	THY1;17	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 09, 1996` DESCRIPTION: `Record whether the sign/symptom 'WEIGHT LOSS' was present at the time of diagnosis.`
417	OTHER SIGNS/SYMPTOMS	THY1;18	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 09, 1996` DESCRIPTION: `Record whether any OTHER signs/symptoms were present at the time of diagnosis.`
418	BONE SCAN (THYROID)	THY1;19	SET	'0' FOR Test not done; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `SEP 09, 1996` DESCRIPTION: `Record the results of the Diagnostic/Surgical Work-up 'BONE SCAN', if it was performed to evaluate this Thyroid cancer. If this test was not done record a '0'.`
419	CHEST X-RAY (THYROID)	THY1;20	SET	'0' FOR Test not done; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `SEP 09, 1996` DESCRIPTION: `Record the results of the Diagnostic/Surgical Work-up 'CHEST X-RAY', if it was performed to evaluate this Thyroid cancer. If this test was not done record a '0'.`
420	CT SCAN OF NECK (THYROID)	THY1;21	SET	'0' FOR Test not done; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `SEP 09, 1996` DESCRIPTION: `Record the results of the Diagnostic/Surgical Work-up 'CT SCAN OF NECK', if it was performed to evaluate this Thyroid cancer. If this test was not done record a '0'.`
421	CT SCAN OF CHEST	THY1;22	SET	'0' FOR Test not done; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `FEB 13, 1997` DESCRIPTION: `Record the results of the Diagnostic/Surgical Work-up 'CT SCAN OF CHEST', if it was performed to evaluate this cancer. If this test was not done record a '0'.`
422	INCISIONAL BIOPSY OF THYROID	THY1;23	SET	'0' FOR Test not done; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `SEP 09, 1996` DESCRIPTION: `Record the results of the Diagnostic/Surgical Work-up 'INCISIONAL BIOPSY OF THYROID', if it was performed to evaluate this Thyroid cancer. If this test was not done record a '0'.`
423	LARYNGOSCOPY	THY1;24	SET	'0' FOR Test not done; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `SEP 09, 1996` DESCRIPTION: `Record the results of the Diagnostic/Surgical Work-up 'LARYNGOSCOPY', if it was performed to evaluate this Thyroid cancer. If this test was not done record a '0'.`
424	NECK X-RAY (AP & LATERAL)	THY1;25	SET	'0' FOR Test not done; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `SEP 09, 1996` DESCRIPTION: `Record the results of the Diagnostic/Surgical Work-up 'NECK X-RAY (AP & LATERAL)', if it was performed to evaluate this Thyroid cancer. If this test was not done record a '0'.`
425	NEEDLE ASPIRATION OF NECK NODE	THY1;26	SET	'0' FOR Test not done; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `SEP 09, 1996` DESCRIPTION: `Record the results of the Diagnostic/Surgical Work-up 'NEEDLE ASPIRATION OF NECK NODE', if it was performed to evaluate this Thyroid cancer. If this test was not done record a '0'.`
426	NEEDLE ASPIRATION OF THYROID	THY1;27	SET	'0' FOR Test not done; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `SEP 09, 1996` DESCRIPTION: `Record the results of the Diagnostic/Surgical Work-up 'NEEDLE ASPIRATION OF THYROID', if it was performed to evaluate this Thyroid cancer. If this test was not done record a '0'.`
427	MRI OF NECK	THY1;28	SET	'0' FOR Test not donw; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `SEP 09, 1996` DESCRIPTION: `Record the results of the Diagnostic/Surgical Work-up 'MRI OF NECK', if it was performed to evaluate this Thyroid cancer. If this test was not done record a '0'.`
428	THYROID SCAN	THY1;29	SET	'0' FOR Test not done; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `SEP 09, 1996` DESCRIPTION: `Record the results of the Diagnostic/Surgical Work-up 'THYROID SCAN', if it was performed to evaluate this Thyroid cancer. If this test was not done record a '0'.`
429	ULTRASOUND OF THYROID	THY1;30	SET	'0' FOR Test not done; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `SEP 09, 1996` DESCRIPTION: `Record the results of the Diagnostic/Surgical Work-up 'ULTRASOUND OF THYROID', if it was performed to evaluate this Thyroid cancer. If this test was not done record a '0'.`
430	OTHER DIAGNOSTIC/SURGICAL TEST	THY1;31	SET	'0' FOR Test not done; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if other test done; LAST EDITED: `SEP 09, 1996` DESCRIPTION: `Record the results of any OTHER Diagnostic/Surgical Work-ups done, if any were performed to evaluate this Thyroid cancer. If other test were not done record a '0'.`
431	BLOOD VESSEL INVASION	THY1;32	SET	'0' FOR No invasion; '1' FOR Yes; '8' FOR No surgery, not applicable; '9' FOR Unknown; LAST EDITED: `SEP 09, 1996` DESCRIPTION: `Record the presence of blood vessel invasion. NOTE: This refers to the presence of tumor cells inside blood vessels of a caliber larger than capil- laries, located in the tumor capsule or beyond. The tumor cells should` `be attached to the vessel wall.`
432	EXTRA-THYROIDAL EXTENSION	THY1;33	SET	'0' FOR No extension; '1' FOR Esophagus; '2' FOR Trachea; '3' FOR Larynx; '4' FOR Strap muscles; '5' FOR Soft tissue; '6' FOR Multiple sites; '7' FOR Extension, NOS; '8' FOR Not applicable, no surgery; '9' FOR Unknown; LAST EDITED: `SEP 09, 1996` DESCRIPTION: `Record any gross or microscopic extension beyond thyroid capsule. NOTE: Do not code invasion of the tumor capsule around a follicular cancer as an extra-thyroidal extension.`
433	MULTIFOCAL	THY1;34	SET	'0' FOR No; '1' FOR Microscopic; '2' FOR Gross; '3' FOR Multifocal, NOS; '9' FOR Unknown; LAST EDITED: `AUG 29, 1996` DESCRIPTION: `Record whether the tumor was multifocal. Pathologic confirmation is required.`
434	LOCATION OF POSITIVE NODES	THY1;35	SET	'0' FOR No positive nodes; '1' FOR Perithyroid only; '2' FOR Lateral neck only; '3' FOR Mediastinum only; '4' FOR Multiple regions; '5' FOR Other; '8' FOR Not applicable; '9' FOR Unknown; LAST EDITED: `AUG 29, 1996` DESCRIPTION: `Record the location of regional nodes if they are positive.`
435	DATE MOST DEFINITIVE SURG DIS	THY1;36	DATE	INPUT TRANSFORM: `D DFIT^ONCODSR I $D(X) S V="0000000" D NT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `APR 29, 2013` HELP-PROMPT: `Enter the date the patient was discharged following primary site surgery.` DESCRIPTION: `Source of Standard: NAACCR Item #: 3180 This is the date the patient was discharged following primary site surgery. The date must be after or equal to the DATE DX (#3) field. The date corresponds to the event recorded` `in SURGERY OF PRIMARY (F) (#58.6) and MOST DEFINITIVE SURG DATE (#50) fields.` `For further information see FORDS pages 144-145.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
436	AIRWAY PROBLEM	THY1;37	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `APR 04, 1997` DESCRIPTION: `Record whether the patient had the surgical complication 'AIRWAY PROBLEM REQUIRING TRACHEOSTOMY', which resulted from cancer-directed surgery. If no cancer-directed surgery was performed, code 8 (not applicable).`
437	BLEEDING/HEMATOMA	THY1;38	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `APR 04, 1997` DESCRIPTION: `Record whether the patient had the surgical complication 'BLEEDING HEMATOMA', which resulted from cancer-directed surgery. If no cancer-directed surgery was performed, code 8 (not applicable).`
438	HYPOCALCEMIA	THY1;39	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `APR 04, 1997` DESCRIPTION: `Record whether the patient had the surgical complication 'HYPOCALCEMIA (NEEDS ORAL CALCIUM', which resulted from cancer-directed surgery. If no cancer- directed surgery was performed, code 8 (not applicable).`
439	RECURRENT NERVE INJURY	THY1;40	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `APR 04, 1997` DESCRIPTION: `Record whether the patient had the surgical complication 'RECURRENT NERVE INJURY (OR VOCAL CORD PARESIS)', which resulted from cancer-directed surgery. If no cancer-directed surgery was performed, code 8 (not applicable).`
440	WOUND INFECTION	THY1;41	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `APR 04, 1997` DESCRIPTION: `Record whether the patient had the surgical complication 'WOUND INFECTION', which resulted from cancer-directed surgery. If no cancer-directed surgery was performed, code 8 (not applicable).`
441	POSTOPERATIVE DEATH	THY1;42	SET	'0' FOR No; '1' FOR Yes; '8' FOR Not applicable, no surgery; '9' FOR Unknown; LAST EDITED: `AUG 30, 1996` DESCRIPTION: `Record operative death occurring within 30 days of the cancer-directed surgery. If no cancer-directed surgery was performed, code 8 (not applicable).`
442	REGIONAL DOSE: cGy	THY1;43	NUMBER	INPUT TRANSFORM: `K:X'=X!(X>99999)!(X<0)!(X?.E1"."1N.N) X I $D(X) S V=0 D NT^ONCODSR I $D(X) S ONCL=5 D RDIT^ONCOIT` OUTPUT TRANSFORM: `S Y=$S(Y="00000":"Radiation tx not administered",Y=88888:"NA, brachytherapy/radioisotopes administered",Y=99999:"Dose unknown/unknown if administered",1:Y)` LAST EDITED: `JAN 09, 2003` HELP-PROMPT: `Type a Number between 0 and 99999` DESCRIPTION: `Records the dominant or most clinically significant total dose of regional radiation therapy delivered to the patient during the first course of treatment. The unit of measure is centiGray (cGy).` `Code 88888 (NA, brachytherapy/radioisotopes administered) if not applicable or when brachytherapy or radioisotopes were administered to the patient.` `For further information see FORDS page 248.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
443	BOOST DOSE: cGy	THY1;44	NUMBER	INPUT TRANSFORM: `K:X'=X!(X>99999)!(X<0)!(X?.E1"."1N.N) X I $D(X) S V=0 D NT^ONCODSR I $D(X) S ONCL=5 D RDIT^ONCOIT` OUTPUT TRANSFORM: `S Y=$S(Y="00000":"Boost tx not administered",Y=88888:"NA, brachytherapy/radioisotopes administered",Y=99999:"Dose unknown/unknown if administered",1:Y)` LAST EDITED: `FEB 21, 2003` HELP-PROMPT: `Type a Number between 0 and 99999, 0 Decimal Digits` DESCRIPTION: `Records the additional boost dosage delivered to that part of the treatment volume encompassed by the boost fields or devices. The unit of measure is centiGray (cGy).` `Code 88888 (NA, brachytherapy/radioisotopes administered) if not applicable or when brachytherapy or radioisotopes were administered to the patient.` `For further information see FORDS page 252.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
444	INITIAL DOSE OF RADIOIODINE	THY1;45	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99999)!(X<0)!(X?.E1"."1N.N) X` OUTPUT TRANSFORM: `S Y=$S($L(Y)=1:"0000"_Y,$L(Y)=2:"000"_Y,$L(Y)=3:"00"_Y,$L(Y)=4:"0"_Y,1:Y)` LAST EDITED: `SEP 03, 1996` HELP-PROMPT: `Type a Number between 0 and 99999, 0 Decimal Digits` DESCRIPTION: `Record the total Millicuries (mCi) of radioiodine given as part of initial therapy, whether for the purpose of ablation or therapy. If none received, code 00000. If unknown, code 99999.`
445	SECOND DOSE OF RADIOIODINE	THY1;46	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99999)!(X<0)!(X?.E1"."1N.N) X` OUTPUT TRANSFORM: `S Y=$S($L(Y)=1:"0000"_Y,$L(Y)=2:"000"_Y,$L(Y)=3:"00"_Y,$L(Y)=4:"0"_Y,1:Y)` LAST EDITED: `SEP 03, 1996` HELP-PROMPT: `Type a Number between 0 and 99999, 0 Decimal Digits` DESCRIPTION: `Record the total Millicuries (mCi) of radioiodine given as second dose within the next 6 months after date of diagnosis. If none received, code 00000. If unknown, code 99999.`
446	ADJUVANT CHEMOTHERAPY (THY)	THY1;47	SET	'0' FOR No concomitant treatment; '1' FOR Radiation treatment and concomitant adjuvant chemotherapy; '9' FOR Unknown if therapy concomitant; LAST EDITED: `FEB 21, 1997` DESCRIPTION: `Record the Adjuvant Chemotherapy with Concomitant External Beam Radiation. If patient receives chemotherapy at any time during radiation as a radio- sensitizing agent, code 1. If chemotherapy is stopped more than 2 days` `prior to radiation therapy and not given until external beam therapy is completed, code 0. If unknown, code 9.`
500	HISTORY OF SOFT TIS SARC (FAM)	STS1;1	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 09, 1996` DESCRIPTION: `Record any familial history of soft tissue sarcoma documented in the medical record. If the record does not mention familial history of soft tissue sarcoma, code 9 (unknown).`
501	HISTORY OF ANY CANCER (PT)	STS1;2	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record the personal history of any cancer documented in the medical record. If the record does not mention personal history of any cancer, code 9 (unknown).`
502	ANGIOGRAM OF PRIMARY	STS1;3	SET	'0' FOR Test not done; '1' FOR Positive for cancer; '2' FOR Negative for cancer; '3' FOR Equivocal, suggestive of cancer; '7' FOR Test attempted but not completed; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `SEP 24, 1996` DESCRIPTION: `Record the results of the Diagnostic Workup 'Angiogram for Primary', if it was performed to evaluate this soft tissue sarcoma. If this test was not done, record a '0'.`
503	BONE MARROW ASPIRATE OR BIOPSY	STS1;4	SET	'0' FOR Test not done; '1' FOR Positive for cancer; '2' FOR Negative for cancer; '3' FOR Equivocal, suggestive of cancer; '7' FOR Test attempted but not completed; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `SEP 06, 1996` DESCRIPTION: `Record the results of the Diagnostic Workup 'Bone marrow aspirate and/or Biopsy', if it was performed to evaluate this soft tissue sarcoma. If this test was not done, record a '0'.`
504	BONE SCAN (SOFT TIS SARCOMA)	STS1;5	SET	'0' FOR Test not done; '1' FOR Positive for cancer; '2' FOR Negative for cancer; '3' FOR Equivocal, suggestive of cancer; '7' FOR Test attempted but not completed; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `OCT 25, 1996` DESCRIPTION: `Record the results of the Diagnostic Workup 'Bone scan', if it was performed to evaluate this soft tissue sarcoma. If this test was not done, record a '0'.`
505	CHEST X-RAY (STS/NHL)	STS1;6	SET	'0' FOR Test not done; '1' FOR Positive for cancer; '2' FOR Negative for cancer; '3' FOR Equivocal, suggestive of cancer; '7' FOR Test attempted but not completed; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `MAR 18, 1997` DESCRIPTION: `Record the results of the Diagnostic Workup 'Chest X-RAY', if it was performed to evaluate this primary. If this test was not done, record a '0'.`
506	CT SCAN OF CHEST (STS)	STS1;7	SET	'0' FOR Test not done; '1' FOR Positive for cancer; '2' FOR Negative for cancer; '3' FOR Equivocal, suggestive of cancer; '7' FOR Test attempted but not completed; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `SEP 09, 1996` DESCRIPTION: `Record the results of the Diagnostic Workup 'CT scan of chest', if it was performed to evaluate this soft tissue sarcoma. If this test was not done, record a '0'.`
507	CT SCAN OF PRIMARY	STS1;8	SET	'0' FOR Test not done; '1' FOR Positive for cancer; '2' FOR Negative for cancer; '3' FOR Equivocal, suggestive of cancer; '7' FOR Test attempted but not completed; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `SEP 09, 1996` DESCRIPTION: `Record the results of the Diagnostic Workup 'CT scan of primary', if it was performed to evaluate this soft tissue sarcoma. If this test was not done, record a '0'.`
508	LIVER FUNCTION STUDIES (STS)	STS1;9	SET	'0' FOR Test not done; '1' FOR Positive for cancer; '2' FOR Negative for cancer; '3' FOR Equivocal, suggestive of cancer; '7' FOR Test attempted but not completed; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `MAR 20, 1997` DESCRIPTION: `Record the results of the Diagnostic Workup 'Liver Function Studies', if it was performed to evaluate this soft tissue sarcoma. If this test was not done, record a '0'.`
509	LYMPHANGIOGRAM	STS1;10	SET	'0' FOR Test not done; '1' FOR Positive for cancer; '2' FOR Negative for cancer; '3' FOR Equivocal, suggestive of cancer; '7' FOR Test attempted but not completed; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `SEP 09, 1996` DESCRIPTION: `Record the results of the Diagnostic Workup 'Lymphangiogram', if it was performed to evaluate this soft tissue sarcoma. If this test was not done, record a '0'.`
510	MRI OF PRIMARY	STS1;11	SET	'0' FOR Test not done; '1' FOR Positive for cancer; '2' FOR Negative for cancer; '3' FOR Equivocal, suggestive of cancer; '7' FOR Test attempted but not completed; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `SEP 09, 1996` DESCRIPTION: `Record the results of the Diagnostic Workup 'MRI of primary', if it was performed to evaluate this soft tissue sarcoma. If this test was not done, record a '0'.`
511	MRI OF OTHER	STS1;12	SET	'0' FOR Test not done; '1' FOR Positive for cancer; '2' FOR Negative for cancer; '3' FOR Equivocal, suggestive of cancer; '7' FOR Test attempted but not completed; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `SEP 09, 1996` DESCRIPTION: `Record the results of the Diagnostic Workup 'MRI of other', if it was performed to evaluate this soft tissue sarcoma. If this test was not done, record a '0'.`
512	SKELETAL X-RAY	STS1;13	SET	'0' FOR Test not done; '1' FOR Positive for cancer; '2' FOR Negative for cancer; '3' FOR Equivocal, suggestive of cancer; '7' FOR Test attempted but not completed; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `SEP 09, 1996` DESCRIPTION: `Record the results of the Diagnostic Workup 'Skeletal X-RAY', if it was performed to evaluate this soft tissue sarcoma. If this test was not done, record a '0'.`
513	SONOGRAM	STS1;14	SET	'0' FOR Test not done; '1' FOR Positive for cancer; '2' FOR Negative for cancer; '3' FOR Equivocal, suggestive of cancer; '7' FOR Test attempted but not completed; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `SEP 09, 1996` DESCRIPTION: `Record the results of the Diagnostic Workup 'Sonogram', if it was performed to evaluate this soft tissue sarcoma. If this test was not done, record a '0'.`
514	CYTOGENETICS	STS1;15	SET	'0' FOR Not done; '1' FOR Done; '9' FOR Unknown if done; LAST EDITED: `SEP 09, 1996` DESCRIPTION: `Record whether the 'Cytogenetics' test was performed to evaluate this primary. If this test was not done, record a '0'.`
515	ELECTRON MICROSCOPY	STS1;16	SET	'0' FOR Not done; '1' FOR Done; '9' FOR Unknown if done; LAST EDITED: `SEP 09, 1996` DESCRIPTION: `Record whether the Histologic Workup 'Electron microscopy' was performed to evaluate this soft tissue sarcoma. If this test was not done, record a '0'.`
516	IMMUNOHISTOCHEMISTRY	STS1;17	SET	'0' FOR Not done; '1' FOR Done; '9' FOR Unknown if done; LAST EDITED: `SEP 09, 1996` DESCRIPTION: `Record whether the 'Immunohistochemistry/Tumor Surface Marker' test was performed to evaluate this primary. If this test was not done, record a '0'.`
517	IN SITU HYBRIDIZATION	STS1;18	SET	'0' FOR Not done; '1' FOR Done; '9' FOR Unknown if done; LAST EDITED: `SEP 09, 1996` DESCRIPTION: `Record whether the Histologic Workup 'In situ hybridization' was performed to evaluate this soft tissue sarcoma. If this test was not done, record a '0'.`
518	OUTSIDE CONFIRMATION REQUESTED	STS1;19	SET	'0' FOR No; '1' FOR Yes; '8' FOR Not applicable; '9' FOR Unknown; LAST EDITED: `SEP 10, 1996` DESCRIPTION: `Record whether an outside confirmation of a biopsy was requested.`
519	SUBSITE	STS1;20	POINTER TO ONCOLOGY SUBSITE FILE (#166.3)	ONCOLOGY SUBSITE(#166.3) LAST EDITED: `SEP 10, 1996` DESCRIPTION: `Record the appropriate subsite code.`
520	TYPE OF ADDITIONAL CODING SYS	STS1;21	SET	'1' FOR 1 to 3 system; '2' FOR 1 to 2 or high/low system; '8' FOR Not applicable; '9' FOR Unknown; LAST EDITED: `SEP 10, 1996` DESCRIPTION: `If your institution uses an additional grade coding system, record the additional system that is used. Code '1' if the coding system is a 1 to 3 scale. Code '2' if the coding system is a 1 to 2 or high/low scale. If not` `applicable code '8', and if unknown, code '9'.`
521	VALUE OF ADDITIONAL CODING SYS	STS1;22	SET	'1' FOR 1; '2' FOR 2; '3' FOR 3; '5' FOR Low; '6' FOR High; '8' FOR Not applicable; '9' FOR Unknown; LAST EDITED: `SEP 10, 1996` DESCRIPTION: `Enter the numeric (1,2 or 3) value from the additional coding system. If code is 'low', code '5'; if code is 'high', code 6. If not applicable code '8', and if unknown, code '9'.`
522	PATHOLOGIC SIZE OF TUMOR	STS1;23	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>999)!(X<0)!(X?.E1"."1N.N) X` OUTPUT TRANSFORM: `S Y=$S($L(Y)=1:"00"_Y,$L(Y)=2:"0"_Y,1:Y)` LAST EDITED: `SEP 24, 1996` HELP-PROMPT: `Type a Number between 0 and 999, 0 Decimal Digits` DESCRIPTION: `Record the largest diameter of the primary tumor in milimeters (1 cm = 10 mm) as specified in the pathology report. If there is more than one tumor in the same primary site (multifocal), record the largest diameter of the` `largest tumor. Do not use size of the entire specimen for tumor size. In cases where the tumor diameter is not specified in the pathology report, size of tumor should be obtained from the operative report, followed by` `x-rays, or physical examinations.`
523	DEPTH OF TUMOR	STS1;24	SET	'1' FOR Superficial (above muscle fascia); '2' FOR Deep (all else); '8' FOR Not applicable; '9' FOR Unknown; LAST EDITED: `SEP 10, 1996` DESCRIPTION: `Tumor depth is applicable for extremity, trunk and head and neck lesions. Code 8 if not applicable and 9 if unknown.`
524	CONSULTATIONS (MED ONCOLOGIST)	STS1;25	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 10, 1996` DESCRIPTION: `Enter whether there was a consultation with a medical oncologist.`
525	CONSULTATIONS (RAD ONCOLOGIST)	STS1;26	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 10, 1996` DESCRIPTION: `Enter whether there was a consultation with a radiation oncologist.`
526	TREATING SURGEON	STS2;1	SET	'1' FOR General surgeon; '2' FOR Orthopedic surgeon; '3' FOR Urologist; '4' FOR Gynecologist; '5' FOR ENT (ear, nose and throat); '6' FOR Other; '8' FOR Not applicable, no surgery; '9' FOR Unknown; LAST EDITED: `SEP 10, 1996` DESCRIPTION: `Record the appropriate code for the type of treating surgeon.`
527	ASA CLASS	STS2;2	SET	'1' FOR No systemic disturbance; '2' FOR Mild to moderate systemic disturbance; '3' FOR Severe systemic disturbance; '4' FOR Life-threatening disturbance; '5' FOR Moribund with little chance of survival; '9' FOR Class unknown or not applicable; LAST EDITED: `SEP 20, 1996` DESCRIPTION: `Record appropriate code from anesthesiologist's report. If no organic, physiologic, biochemical or psychiatric disturbance, code 1. If not recorded or if the patient did not receive surgery, code 9.`
528	FINE NEEDLE ASPIRATION	STS1;27	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>999999)!(X<0)!(X?.E1"."1N.N)!($L(X)<6) X` OUTPUT TRANSFORM: `S Y=$E(Y,1,4)_"/"_$E(Y,5)_"/"_$E(Y,6)` LAST EDITED: `SEP 11, 1996` HELP-PROMPT: `Type a Number between 000000 and 999999, 0 Decimal Digits. Must be 6 characters long.` DESCRIPTION: `Enter the morphology code for this biopsy if it was performed. The first 4 digits should represent the HISTOLOGY, the 5th digit should represent the BEHAVIOR, and the 6th digit should represent the GRADE. For example, if` `this biopsy was performed and the HISTOLOGY was '8693', the BEHAVIOR was '3' and the GRADE was '1', then enter "869331". This will display as "8693/3/1".` `If the biopsy was not done code 8's (ie - 888888), if it is unknown whether the biopsy was done code 9's (ie - 999999). If the biopsy was done but one or more items are unknown, code 7's where unknown. For example,` `if the HISTOLOGY is '8693' and the behavior is '3' , but the GRADE is unknown, then enter "869337".` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
529	CORE NEEDLE BIOPSY	STS1;28	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>999999)!(X<0)!(X?.E1"."1N.N)!($L(X)<6) X` OUTPUT TRANSFORM: `S Y=$E(Y,1,4)_"/"_$E(Y,5)_"/"_$E(Y,6)` LAST EDITED: `SEP 11, 1996` HELP-PROMPT: `Type a Number between 0 and 999999, 0 Decimal Digits. Must be 6 characters long.` DESCRIPTION: `Enter the morphology code for this biopsy if it was performed. The first 4 digits should represent the HISTOLOGY, the 5th digit should represent the BEHAVIOR, and the 6th digit should represent the GRADE. For example, if` `this biopsy was performed and the HISTOLOGY was '8693', the BEHAVIOR was '3' and the GRADE was '1', then enter "869331". This will display as "8693/3/1".` `If the biopsy was not done code 8's (ie - 888888), if it is unknown whether the biopsy was done code 9's (ie - 999999). If the biopsy was done but one or more items are unknown, code 7's where unknown. For example,` `if the HISTOLOGY is '8693' and the behavior is '3' , but the GRADE is unknown, then enter "869337".` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
530	INCISIONAL BIOPSY (STS PCE)	STS1;29	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>999999)!(X<0)!(X?.E1"."1N.N)!($L(X)<6) X` OUTPUT TRANSFORM: `S Y=$E(Y,1,4)_"/"_$E(Y,5)_"/"_$E(Y,6)` LAST EDITED: `SEP 11, 1996` HELP-PROMPT: `Type a Number between 0 and 999999, 0 Decimal Digits. Must be 6 characters long.` DESCRIPTION: `Enter the morphology code for this biopsy if it was performed. The first 4 digits should represent the HISTOLOGY, the 5th digit should represent the BEHAVIOR, and the 6th digit should represent the GRADE. For example, if` `this biopsy was performed and the HISTOLOGY was '8693', the BEHAVIOR was '3' and the GRADE was '1', then enter "869331". This will display as "8693/3/1".` `If the biopsy was not done code 8's (ie - 888888), if it is unknown whether the biopsy was done code 9's (ie - 999999). If the biopsy was done but one or more items are unknown, code 7's where unknown. For example,` `if the HISTOLOGY is '8693' and the behavior is '3' , but the GRADE is unknown, then enter "869337".` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
531	EXCISIONAL BIOPSY	STS1;30	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>999999)!(X<0)!(X?.E1"."1N.N)!($L(X)<6) X` OUTPUT TRANSFORM: `S Y=$E(Y,1,4)_"/"_$E(Y,5)_"/"_$E(Y,6)` LAST EDITED: `SEP 11, 1996` HELP-PROMPT: `Type a Number between 0 and 999999, 0 Decimal Digits. Must be 6 characters long.` DESCRIPTION: `Enter the morphology code for this biopsy if it was performed. The first 4 digits should represent the HISTOLOGY, the 5th digit should represent the BEHAVIOR, and the 6th digit should represent the GRADE. For example, if` `this biopsy was performed and the HISTOLOGY was '8693', the BEHAVIOR was '3' and the GRADE was '1', then enter "869331". This will display as "8693/3/1".` `If the biopsy was not done code 8's (ie - 888888), if it is unknown whether the biopsy was done code 9's (ie - 999999). If the biopsy was done but one or more items are unknown, code 7's where unknown. For example,` `if the HISTOLOGY is '8693' and the behavior is '3' , but the GRADE is unknown, then enter "869337".` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
532	EXTERNAL BEAM RADIATION	STS2;3	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 12, 1996` DESCRIPTION: `Record whether any external beam radiation therapy was performed.`
533	EXTERNAL BEAM RAD FRACTIONS	STS2;4	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>999)!(X<0)!(X?.E1"."1N.N) X` OUTPUT TRANSFORM: `S Y=$S($L(Y)=1:"00"_Y,$L(Y)=2:"0"_Y,1:Y)` LAST EDITED: `SEP 13, 1996` HELP-PROMPT: `Type a Number between 0 and 999, 0 Decimal Digits` DESCRIPTION: `Record the number of fractions for external beam radiation.`
534	EXTERNAL BEAM RADIATION ENERGY	STS2;5	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` OUTPUT TRANSFORM: `S Y=$S($L(Y)=1:"0"_Y,1:Y)` LAST EDITED: `SEP 12, 1996` HELP-PROMPT: `Type a Number between 0 and 99, 0 Decimal Digits` DESCRIPTION: `Record the units (MV) of radiation energy if external beam radiation was performed .`
535	INTRAOPERATIVE RADIATION	STS2;6	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 12, 1996` DESCRIPTION: `Record whether intraoperative radiation was performed.`
536	INTRAOPERATIVE RADIATION DOSE	STS2;7	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99999)!(X<0)!(X?.E1"."1N.N) X` OUTPUT TRANSFORM: `S Y=$S($L(Y)=1:"0000"_Y,$L(Y)=2:"000"_Y,$L(Y)=3:"00"_Y,$L(Y)=4:"0"_Y,1:Y)` LAST EDITED: `SEP 12, 1996` HELP-PROMPT: `Type a Number between 0 and 99999, 0 Decimal Digits` DESCRIPTION: `Record the total intraoperative radiation dose given. If the patient did not receive this type of radiation therapy, code 0's. If it is known that the patient received this type of radiation therapy but the dose is not` `known, code 9's.`
537	INTRAOPERATIVE RADIATION ENER	STS2;8	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` OUTPUT TRANSFORM: `S Y=$S($L(Y)=1:"0"_Y,1:Y)` LAST EDITED: `SEP 12, 1996` HELP-PROMPT: `Type a Number between 0 and 99, 0 Decimal Digits` DESCRIPTION: `Record the units (MV) of intraoperative radiation energy if this was performed.`
538	BRACHYTHERAPY	STS2;9	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 13, 1996` DESCRIPTION: `Record whether brachytherapy was performed.`
539	BRACHYTHERAPY DAYS	STS2;10	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>999)!(X<0)!(X?.E1"."1N.N) X` OUTPUT TRANSFORM: `S Y=$S($L(Y)=1:"00"_Y,$L(Y)=2:"0"_Y,1:Y)` LAST EDITED: `SEP 13, 1996` HELP-PROMPT: `Type a Number between 0 and 999, 0 Decimal Digits` DESCRIPTION: `Record the number of days brachytherapy was given.`
540	BRACHYTHERAPY RADIATION DOSE	STS2;11	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99999)!(X<0)!(X?.E1"."1N.N) X` OUTPUT TRANSFORM: `S Y=$S($L(Y)=1:"0000"_Y,$L(Y)=2:"000"_Y,$L(Y)=3:"00"_Y,$L(Y)=4:"0"_Y,1:Y)` LAST EDITED: `SEP 13, 1996` HELP-PROMPT: `Type a Number between 0 and 99999, 0 Decimal Digits` DESCRIPTION: `Record the total brachytherapy radiation dose given. If the patient did not receive this type of radiation therapy, code 0's. If it is known that the patient received this type of radiation therapy, but the dose is` `unknown, code 9's.`
541	DATE BRACHYTHERAPY STARTED	STS2;12	DATE	INPUT TRANSFORM: `S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" D DBTS^ONCODSR` OUTPUT TRANSFORM: `D DATEOT^ONCOPCE` LAST EDITED: `APR 04, 1997` HELP-PROMPT: `* DATE BRACHYTHERAPY STARTED MUST BE AFTER OR EQUAL TO THE DATE DX, AND BEFORE OR EQUAL TO THE DATE BRACHYTHERAPY ENDED *` DESCRIPTION: `Record the date on which brachytherapy was started. If brachytherapy was not given, code the date as 00/00/00. If it is unknown code as 99/99/99.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
542	DATE BRACHYTHERAPY ENDED	STS2;13	DATE	INPUT TRANSFORM: `S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" D DBTE^ONCODSR` OUTPUT TRANSFORM: `D DATEOT^ONCOPCE` LAST EDITED: `APR 07, 1997` HELP-PROMPT: `* DATE BRACHYTHERAPY ENDED MUST BE AFTER OR EQUAL TO THE DATE BRACHYTHERAPY STARTED *` DESCRIPTION: `Record the date on which brachytherapy ended. If brachytherapy was not given, code the date as 00/00/00. If it is unknown code as 99/99/99.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
543	CYTOXAN	STS2;14	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 13, 1996` DESCRIPTION: `Record whether the chemotherapeutic agent, Cytoxan, was given. If no chemotherapy was given, code as 0.`
544	DTIC	STS2;15	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 13, 1996` DESCRIPTION: `Record whether the chemotherapeutic agent, DTIC, was administered. If no chemotherapy was given, code as 0.`
545	DOXORUBICIN (STS)	STS2;16	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `MAR 31, 1997` DESCRIPTION: `Record whether the chemotherapeutic agent, Doxorubicin, was administered. If no chemotherapy was given, code as 0.`
546	ETOPOSIDE	STS2;17	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 13, 1996` DESCRIPTION: `Record whether the chemotherapeutic agent, Etoposide, was administered. If no chemotherapy was given, code as 0.`
547	CISPLATIN METHOD OF DELIVERY	STS2;18	SET	'1' FOR Bolus; '2' FOR Infusion; '8' FOR Not applicable; '9' FOR Unknown; LAST EDITED: `SEP 13, 1996` DESCRIPTION: `Record the method of delivery for this agent, bolus or infusion. If not applicable cade 8, and if unknown code 9.`
548	CYTOXAN METHOD OF DELIVERY	STS2;19	SET	'1' FOR Bolus; '2' FOR Infusion; '8' FOR Not applicable; '9' FOR Unknown; LAST EDITED: `SEP 13, 1996` DESCRIPTION: `Record the method of delivery for this agent, bolus or infusion. If not applicable cade 8, and if unknown code 9.`
549	DTIC METHOD OF DELIVERY	STS2;20	SET	'1' FOR Bolus; '2' FOR Infusion; '8' FOR Not applicable; '9' FOR Unknown; LAST EDITED: `SEP 13, 1996` DESCRIPTION: `Record the method of delivery for this agent, bolus or infusion. If not applicable cade 8, and if unknown code 9.`
550	DOXORUBICIN METHOD OF DELIVERY	STS2;21	SET	'1' FOR Bolus; '2' FOR Infusion; '8' FOR Not applicable; '9' FOR Unknown; LAST EDITED: `SEP 13, 1996` DESCRIPTION: `Record the method of delivery for this agent, bolus or infusion. If not applicable cade 8, and if unknown code 9.`
551	ETOPOSIDE METHOD OF DELIVERY	STS2;22	SET	'1' FOR Bolus; '2' FOR Infusion; '8' FOR Not applicable; '9' FOR Unknown; LAST EDITED: `SEP 13, 1996` DESCRIPTION: `Record the method of delivery for this agent, bolus or infusion. If not applicable cade 8, and if unknown code 9.`
552	IFOSFAMIDE METHOD OF DELIVERY	STS2;23	SET	'1' FOR Bolus; '2' FOR Infusion; '8' FOR Not applicable; '9' FOR Unknown; LAST EDITED: `SEP 13, 1996` DESCRIPTION: `Record the method of delivery for this agent, bolus or infusion. If not applicable cade 8, and if unknown code 9.`
553	CISPLATIN LOCATION	STS2;24	SET	'1' FOR Intra-arterial; '2' FOR Intravenous; '3' FOR Oral; '8' FOR Not applicable; '9' FOR Unknown; LAST EDITED: `SEP 13, 1996` DESCRIPTION: `Record the location of this agent, whether intra-arterial, intravenous or oral. If not applicable, code 8, and if unknown code 9.`
554	CYTOXAN LOCATION	STS2;25	SET	'1' FOR Intra-arterial; '2' FOR Intravenous; '3' FOR Oral; '8' FOR Not applicable; '9' FOR Unknown; LAST EDITED: `SEP 13, 1996` DESCRIPTION: `Record the location of this agent, whether intra-arterial, intravenous or oral. If not applicable, code 8, and if unknown code 9.`
555	DTIC LOCATION	STS2;26	SET	'1' FOR Intra-arterial; '2' FOR Intravenous; '3' FOR Oral; '8' FOR Not applicable; '9' FOR Unknown; LAST EDITED: `SEP 13, 1996` DESCRIPTION: `Record the location of this agent, whether intra-arterial, intravenous or oral. If not applicable, code 8, and if unknown code 9.`
556	DOXORUBICIN LOCATION	STS2;27	SET	'1' FOR Intra-arterial; '2' FOR Intravenous; '3' FOR Oral; '8' FOR Not applicable; '9' FOR Unknown; LAST EDITED: `SEP 13, 1996` DESCRIPTION: `Record the location of this agent, whether intra-arterial, intravenous or oral. If not applicable, code 8, and if unknown code 9.`
557	ETOPOSIDE LOCATION	STS2;28	SET	'1' FOR Intra-arterial; '2' FOR Intravenous; '3' FOR Oral; '8' FOR Not applicable; '9' FOR Unknown; LAST EDITED: `SEP 13, 1996` DESCRIPTION: `Record the location of this agent, whether intra-arterial, intravenous or oral. If not applicable, code 8, and if unknown code 9.`
558	IFOSFAMIDE LOCATION	STS2;29	SET	'1' FOR Intra-arterial; '2' FOR Intravenous; '3' FOR Oral; '8' FOR Not applicable; '9' FOR Unknown; LAST EDITED: `SEP 13, 1996` DESCRIPTION: `Record the location of this agent, whether intra-arterial, intravenous or oral. If not applicable, code 8, and if unknown code 9.`
559	COLONY STIMULATING FACTORS	STS2;30	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `JAN 14, 1999` DESCRIPTION: `Record whether colony stimulating factors were used.` SCREEN: `S DIC("S")="I ($P($G(^ONCO(165.5,DA,0)),U,16)>2981231)!(Y'=8)"` EXPLANATION: `Code 8 should not be used for cases with a DATE DX < 1/1/1999`
560	PROTOCOL PARTICIPATION	STS2;31	SET	'00' FOR Not on/NA; '01' FOR NSABP; '02' FOR GOG; '03' FOR RTOG; '04' FOR SWOG; '05' FOR ECOG; '06' FOR POG; '07' FOR CCG; '08' FOR CALGB; '09' FOR NCI; '10' FOR ACS; '11' FOR National protocol, NOS; '12' FOR Local protocol, NOS; '99' FOR Unknown; LAST EDITED: `JAN 11, 1999` DESCRIPTION: `Record whether the patient was enrolled in and treated on a protocol. A physician may treat a patient following the guidelines of an established protocol; however, the patient is not enrolled into the protocol. For these` `patients, use code 00 (Not on/NA).` SCREEN: `S DIC("S")="I ($P($G(^ONCO(165.5,DA,0)),U,16)>2981231)!(Y'=12)"` EXPLANATION: `Code 12 should not be used for cases with a DATE DX < 1/1/1999`
561	OTHER PROTOCOL	STS2;32	SET	'0' FOR Not on protocol/not applicable; '1' FOR In house protocol; '2' FOR Non-cooperative, multi-institutional protocol; '3' FOR On protocol, type unknown; '9' FOR Unknown; LAST EDITED: `SEP 16, 1996` DESCRIPTION: `Record whether therapy was given under another protocol.`
562	REFERRED TO REHAB SERVICES	STS2;33	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 16, 1996` DESCRIPTION: `Record whether the patient was referred to rehabilitation services.`
563	PHYSICAL THERAPY/REHABILTATION	STS2;34	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 16, 1996` DESCRIPTION: `Record whether the patient was referred to physical therapy or rehabilitation service.`
564	TRANSFERRED TO REHABILITATION	STS2;35	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `SEP 16, 1996` DESCRIPTION: `Record whether the patient was transferred to a rehabilitation facility after being released from the hospital.`
565	NUMBER OF HOSPITALIZATIONS	STS2;36	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` OUTPUT TRANSFORM: `S Y=$S($L(Y)=1:"0"_Y,1:Y)` LAST EDITED: `SEP 16, 1996` HELP-PROMPT: `Type a Number between 0 and 99, 0 Decimal Digits` DESCRIPTION: `Record the number of hospitalizations for this patient, counting only overnight stays during the first six months after diagnosis. Do not count stays for 23 hour observation. If unknown, code 9's.`
566	TOTAL LENGTH OF STAYS	STS2;37	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>999)!(X<0)!(X?.E1"."1N.N) X` OUTPUT TRANSFORM: `S Y=$S($L(Y)=1:"00"_Y,$L(Y)=2:"0"_Y,1:Y)` LAST EDITED: `SEP 16, 1996` HELP-PROMPT: `Type a Number between 0 and 999, 0 Decimal Digits` DESCRIPTION: `Add all days for each overnight hospitalization together to get a cumulative total for all stays during the first six months after diagnosis. Do not count stays for 23 hour observation. If unknown, code 9's.`
567	DATE EXT BEAM RAD STARTED	STS2;38	DATE	INPUT TRANSFORM: `S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" D DFIT^ONCODSR` OUTPUT TRANSFORM: `D DATEOT^ONCOPCE` LAST EDITED: `APR 03, 1997` HELP-PROMPT: `* DATE EXT BEAM RADIATION STARTED MUST BE AFTER OR EQUAL TO DATE DX *` DESCRIPTION: `Record the date external beam radiation therapy was started. Code 0's if not given. Code 9's if unknown.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
600	CLINICAL DX WITH BONE LESION	PRO1;1	SET	'1' FOR Yes; '2' FOR No; '9' FOR Unknown; LAST EDITED: `OCT 25, 1996` DESCRIPTION: `Record whether the Method of Diagnosis: CLINICAL DIAGNOSIS WITH BONE LESION was used to diagnose this case of prostate cancer.`
601	CLINICAL DX BY RECTAL EXAM	PRO1;2	SET	'1' FOR Yes; '2' FOR No; '9' FOR Unknown; LAST EDITED: `OCT 25, 1996` DESCRIPTION: `Record whether the Method of Diagnosis: CLINICAL DIAGNOSIS BY RECTAL EXAM was used to diagnose this case of prostate cancer.`
602	CYTOLOGY	PRO1;3	SET	'1' FOR Yes; '2' FOR No; '9' FOR Unknown; LAST EDITED: `OCT 25, 1996` DESCRIPTION: `Record whether the Method of Diagnosis: CYTOLOGY was used to diagnose this case of prostate cancer.`
603	INCIDENTAL FINDING IN TURP	PRO1;4	SET	'1' FOR Yes; '2' FOR No; '9' FOR Unknown; LAST EDITED: `OCT 25, 1996` DESCRIPTION: `Record whether the Method of Diagnosis: INCIDENTAL FINDING IN TRANSURETHRAL RESECTION OF PROSTATE (TURP) FOR BENIGN DISEASE was used to diagnose this case of prostate cancer.`
604	NEEDLE ASPIRATION BIOPSY	PRO1;5	SET	'1' FOR Yes; '2' FOR No; '9' FOR Unknown; LAST EDITED: `OCT 25, 1996` DESCRIPTION: `Record whether the Method of Diagnosis: NEEDLE ASPIRATION BIOPSY was used to diagnose this case of prostate cancer.`
605	NEEDLE BIOPSY, NOS	PRO1;6	SET	'1' FOR Yes; '2' FOR No; '9' FOR Unknown; LAST EDITED: `OCT 25, 1996` DESCRIPTION: `Record whether the Method of Diagnosis: NEEDLE BIOPSY, NOS was used to diagnose this case of prostate cancer.`
606	PERINEAL BIOPSY	PRO1;7	SET	'1' FOR Yes; '2' FOR No; '9' FOR Unknown; LAST EDITED: `OCT 25, 1996` DESCRIPTION: `Record whether the Method of Diagnosis: PERINEAL BIOPSY was used to diagnose this case of prostate cancer.`
607	TRANSRECTAL BIOPSY	PRO1;8	SET	'1' FOR Yes; '2' FOR No; '9' FOR Unknown; LAST EDITED: `OCT 25, 1996` DESCRIPTION: `Record whether the Method of Diagnosis: TRANSRECTAL BIOPSY was used to diagnose this case of prostate cancer.`
608	TRUS	PRO1;9	SET	'1' FOR Yes; '2' FOR No; '9' FOR Unknown; LAST EDITED: `OCT 25, 1996` DESCRIPTION: `Record whether the Method of Diagnosis: TRANSRECTAL ULTRASONOGRAPHICALLY GUIDED BIOPSY (TRUS) was used to diagnose this case of prostate cancer.`
609	TRANSURETHRAL RESECTION	PRO1;10	SET	'1' FOR Yes; '2' FOR No; '9' FOR Unknown; LAST EDITED: `OCT 25, 1996` DESCRIPTION: `Record whether the Method of Diagnosis: TRANSURETHRAL RESECTION OF PROSTATE, NOS was used to diagnose this case of prostate cancer.`
610	OTHER METHOD OF DX (PROSTATE)	PRO1;11	SET	'1' FOR Yes; '2' FOR No; '9' FOR Unknown; LAST EDITED: `OCT 25, 1996` DESCRIPTION: `Record whether the Method of Diagnosis: OTHER was used to diagnose this case of prostate cancer.`
611	BONE MARROW ASPIRATION	PRO1;12	SET	'1' FOR Normal; '2' FOR Abnormal/elevated; '8' FOR Test not done/unknown if done; '9' FOR Test done, results unknown; LAST EDITED: `OCT 25, 1996` DESCRIPTION: `Record the results of the BONE MARROW ASPIRATION diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 9 (Test done, results unknown).`
612	BONE SCAN (PROSTATE)	PRO1;13	SET	'1' FOR Normal; '2' FOR Abnormal/elevated; '8' FOR Test not done/unknown if done; '9' FOR Test done, results unknown; LAST EDITED: `OCT 25, 1996` DESCRIPTION: `Record the results of the BONE SCAN diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 9 (Test done, results unknown).`
613	BONE X-RAY	PRO1;14	SET	'1' FOR Normal; '2' FOR Abnormal/elevated; '8' FOR Test not done/unknown if done; '9' FOR Test done, results unknown; LAST EDITED: `OCT 25, 1996` DESCRIPTION: `Record the results of the BONE X-RAY diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 9 (Test done, results unknown).`
614	CHEST X-RAY (PROSTATE)	PRO1;15	SET	'1' FOR Normal; '2' FOR Abnormal/elevated; '8' FOR Test not done/unknown if done; '9' FOR Test done, results unknown; LAST EDITED: `OCT 25, 1996` DESCRIPTION: `Record the results of the CHEST X-RAY diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 9 (Test done, results unknown).`
615	CT SCAN OF PRIMARY SITE	PRO1;16	SET	'1' FOR Normal; '2' FOR Abnormal/elevated; '8' FOR Test not done/unknown if done; '9' FOR Test done, results unknown; LAST EDITED: `OCT 25, 1996` DESCRIPTION: `Record the results of the CT SCAN OF PRIMARY SITE diagnostic test performed to evaluate the prostate tumor. If a scan of the abdomen was performed by computed tomography (CT), record the results under CT SCAN OF PRIMARY` `SITE. If the study was done and the results cannot be determined, code 9 (Test done, results unknown).`
616	INTRAVENOUS PYELOGRAM (PRO)	PRO1;17	SET	'1' FOR Normal; '2' FOR Abnormal/elevated; '8' FOR Test not done/unknown if done; '9' FOR Test done, results unknown; LAST EDITED: `FEB 13, 1997` DESCRIPTION: `Record the results of the INTRAVENOUS PYELOGRAM (IVP) diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 9 (Test done, results unknown).`
617	LIVER SCAN	PRO1;18	SET	'1' FOR Normal; '2' FOR Abnormal/elevated; '8' FOR Test not done/unknown if done; '9' FOR Test done, results unknown; LAST EDITED: `OCT 25, 1996` DESCRIPTION: `Record the results of the LIVER SCAN diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 9 (Test done, results unknown).`
618	MRI (PRO)	PRO1;19	SET	'1' FOR Normal; '2' FOR Abnormal/elevated; '8' FOR Test not done/unknown if done; '9' FOR Test done, results unknown; LAST EDITED: `FEB 14, 1997` DESCRIPTION: `Record the results of the MAGNETIC RESONANCE IMAGING (MRI) diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 9 (Test done, results unknown).`
619	PELVIC LYMPH NODE DISSECT (PR)	PRO1;20	SET	'1' FOR Normal; '2' FOR Abnormal/elevated; '8' FOR Test not done/unknown if done; '9' FOR Test done, results unknown; LAST EDITED: `OCT 25, 1996` DESCRIPTION: `Record the results of the PELVIC LYMPH NODE DISSECTION diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 9 (Test done, results unknown).`
620	PROSTATIC ACID PHOSPHATASE	PRO1;21	SET	'1' FOR Normal; '2' FOR Abnormal/elevated; '8' FOR Test not done/unknown if done; '9' FOR Test done, results unknown; LAST EDITED: `OCT 25, 1996` DESCRIPTION: `Record the results of the PROSTATIC ACID PHOSPHATASE (PAP) diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 9 (Test done, results unknown).`
621	PROSTATE SPECIFIC ANTIGEN	PRO1;22	SET	'1' FOR Normal; '2' FOR Abnormal/elevated; '8' FOR Test not done/unknown if done; '9' FOR Test done, results unknown; LAST EDITED: `OCT 25, 1996` DESCRIPTION: `Record the results of the PROSTATE SPECIFIC ANTIGEN (PSA) diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 9 (Test done, results unknown).`
622	OTHER DIAGNOSTIC INFORMATION	PRO1;23	SET	'1' FOR Normal; '2' FOR Abnormal/elelvated; '8' FOR Test not done/unknown if done; '9' FOR Test done, results unknown; LAST EDITED: `OCT 25, 1996` DESCRIPTION: `Record the results of OTHER diagnostic tests performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 9 (Test done, results unknown).`
623	GLEASON SCORE (CLINICAL)	PRO1;24	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<1) X` OUTPUT TRANSFORM: `S Y=$S(Y=99:"99 Unknown, not reported, or NA",1:Y)` LAST EDITED: `AUG 05, 2011` HELP-PROMPT: `Answer must be 1-2 characters in length.` DESCRIPTION: `Record the clinical Gleason Score. Gleason Score (clinical) is obtained from a needle biopsy or TURP specimen.` `For cases where Gleason Score is unknown, not reported or not applicable, code 99.`
623.1	PREDOMINANT PATTERN (02-40)	PRO2;43	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X=6)!(X=7)!(X=8)!($L(X)>1)!(X<0)!(X?.E1"."1N.N) X` LAST EDITED: `MAY 11, 1998` HELP-PROMPT: `Type a Number between 0 and 5, 0 Decimal Digits` DESCRIPTION: `Record the predominant (primary) pattern of tumor for Biopsy, Local Resection, or Simple Prostatectomy, surgical codes 02-40. Gleason's grading system assigns histologic grade ranging from 1-5 to predominant pattern of` `tumor. Record the predominant pattern as stated in the pathology report. If the grade is not provided and only a Gleason score is available, enter a '0'.`
623.2	LESSER PATTERN (02-40)	PRO2;44	NUMBER	INPUT TRANSFORM: `D LP25^ONCOIT` LAST EDITED: `MAY 12, 1998` HELP-PROMPT: `Type a Number between 0 and 5, 0 Decimal Digits` DESCRIPTION: `Record the lesser (secondary) pattern of tumor for Biopsy, Local Resection, or Simple Prostatectomy, surgical codes 02-40. Gleason's grading system assigns histologic grade ranging from 1-5 to lesser pattern of tumor.` `Record the lesser pattern as stated in the pathology report. If the grade is not provided and only a Gleason score is available, enter a '0'.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
623.3	GLEASON'S SCORE (50-70)	PRO2;45	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!'(X?1.2N&(((+X>1)&(X<11))!(X=99))) X` OUTPUT TRANSFORM: `S Y=$S($L(Y)=1:"0"_Y,Y=99:"99 Unknown, not reported, or NA",1:Y)` LAST EDITED: `MAY 12, 1998` HELP-PROMPT: `Answer 02-10 or 99 (Score unknown, not reported or NA)` DESCRIPTION: `Record the Gleason's score for Radical Prostatectomy, surgical codes 50-70. Gleason's grading system assigns histologic grade ranging from 1-5 to predominant (primary) and lesser (secondary) patterns of tumor. The grade` `numbers of the two patterns are added to obtain the Gleason score, which ranges from 02 to 10. Record the Gleason's score by adding the predominant and lesser patterns as stated in the pathology report. For example, if` `predominant pattern is 3 and lesser pattern is 4, then Gleason's score is 3 + 4 = 7. For cases where Gleason's score is unknown, not reported or not applicable, code 99.`
623.4	PREDOMINANT PATTERN (50-70)	PRO2;46	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X=6)!(X=7)!(X=8)!($L(X)>1)!(X<0)!(X?.E1"."1N.N) X` LAST EDITED: `MAY 11, 1998` HELP-PROMPT: `Type a Number between 0 and 5, 0 Decimal Digits` DESCRIPTION: `Record the predominant (primary) pattern of tumor for Radical Prostatectomy, surgical codes 50-70. Gleason's grading system assigns histologic grade ranging from 1-5 to predominant pattern of tumor. Record the` `predominant pattern as stated in the pathology report. If the grade is not provided and only a Gleason score is available, enter a '0'.`
623.5	LESSER PATTERN (50-70)	PRO2;47	NUMBER	INPUT TRANSFORM: `D LP26^ONCOIT` LAST EDITED: `MAY 13, 1998` HELP-PROMPT: `Type a Number between 0 and 5, 0 Decimal Digits` DESCRIPTION: `Record the lesser (secondary) pattern of tumor for Radical Prostatectomy, surgical codes 50-70. Gleason's grading system assigns histologic grade ranging from 1-5 to lesser pattern of tumor. Record the lesser pattern as` `stated in the pathology report. If the grade is not provided and only a Gleason score is available, enter a '0'.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
624	RESEARCH PROTOCOL	PRO1;25	SET	'1' FOR In-house; '2' FOR Cooperative group; '3' FOR Not in a protocol; '9' FOR Unknown; LAST EDITED: `OCT 25, 1996` DESCRIPTION: `Record whether the patient was entered into a protocol.`
625	RAD THERAPY PLANNED/GIVEN	PRO1;26	SET	'1' FOR Yes; '2' FOR No, not recommended; '3' FOR Patient refused radiation therapy; '4' FOR Radiation was planned, but not given; '9' FOR Unknown; LAST EDITED: `OCT 25, 1996` DESCRIPTION: `Record whether the patient received radiation therapy.`
626	INTERSTITIAL RAD PLANNED/GIVEN	PRO1;27	SET	'1' FOR Yes; '2' FOR No, not recommended; '3' FOR Patient refused radiation therapy; '4' FOR Radiation was planned, but not given; '9' FOR Unknown; LAST EDITED: `OCT 25, 1996` DESCRIPTION: `Record whether the patient received interstitial radiation.`
627	IODINE 125	PRO1;28	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `MAR 13, 2000` DESCRIPTION: `Record whether the isotope IODINE 125 was administered interstitially.`
628	GOLD 198	PRO1;29	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `MAR 13, 2000` DESCRIPTION: `Record whether the isotope GOLD 198 was administered interstitially.`
629	PALLADIUM 103	PRO1;30	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `MAR 13, 2000` DESCRIPTION: `Record whether the isotope PALLADIUM 103 was administered interstitially.`
630	IRIDIUM 192	PRO1;31	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `MAR 13, 2000` DESCRIPTION: `Record whether the isotope IRIDIUM 192 was administered interstitially.`
631	OTHER INTERSTITIAL, NOS	PRO1;32	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `MAR 13, 2000` DESCRIPTION: `Record whether OTHER INTERSTITIAL, NOS isotopes were administered.`
632	EXTERNAL RAD PLANNED/GIVEN	PRO1;33	SET	'1' FOR Yes; '2' FOR No, not recommended; '3' FOR Patient refused external radiation; '4' FOR Radiation was planned, but not given; '9' FOR Unknown; LAST EDITED: `OCT 29, 1996` DESCRIPTION: `Record whether the patient received external radiation.`
633	PROSTATE REGION ONLY	PRO1;34	SET	'0' FOR No, region/site not targeted; '1' FOR Yes; '8' FOR NA, external radiation not administered; '9' FOR Unknown; LAST EDITED: `MAR 13, 2000` DESCRIPTION: `Record whether the PROSTATE REGION ONLY was irradiated.`
634	PROSTATE AND PELVIC NODES	PRO1;35	SET	'0' FOR No, region/site not targeted; '1' FOR Yes; '8' FOR NA, external radiation not administered; '9' FOR Unknown; LAST EDITED: `MAR 13, 2000` DESCRIPTION: `Record whether PROSTATE AND PELVIC NODES were irradiated.`
635	PROSTATE & PELVIC PARA-AORTIC	PRO1;36	SET	'0' FOR No, region/site not targeted; '1' FOR Yes; '8' FOR NA, external radiation not administered; '9' FOR Unknown; LAST EDITED: `MAR 13, 2000` DESCRIPTION: `Record whether PROSTATE AND PELVIC PARA-AORTIC NODES were irradiated.`
636	DISTANT METASTATIC SITES	PRO1;37	SET	'0' FOR No, region/site not targeted; '1' FOR Yes; '8' FOR NA, external radiation not administered; '9' FOR Unknown; LAST EDITED: `MAR 13, 2000` DESCRIPTION: `Record whether DISTANT METASTATIC SITES were irradiated.`
637	OTHER EXTERNAL SITES, NOS	PRO1;38	SET	'0' FOR No, region/site not targeted; '1' FOR Yes; '8' FOR NA, external radiation not administered; '9' FOR Unknown; LAST EDITED: `MAR 13, 2000` DESCRIPTION: `Record whether OTHER EXTERNAL SITES, NOS were irradiated.`
638	TOTAL RAD DOSE (PROSTATE)	PRO1;39	SET	'1' FOR Less than 1999 rad; '2' FOR 2000-3000 rad; '3' FOR 3001-4000 rad; '4' FOR 4001-5000 rad; '5' FOR 5001-6000 rad; '6' FOR 6001-7000 rad; '7' FOR More than 7001 rad; '8' FOR Not given; '9' FOR Rad does unknown; LAST EDITED: `OCT 29, 1996` DESCRIPTION: `Record the TOTAL (external) RAD DOSE given to the PROSTATE; this includes boost dosage. Do not include interstitial rad dose. If it is known that the patient received radiation therapy, but the amount given is unknown,` `code 9 (rad dose unknown).`
639	TOTAL RAD DOSE (PELVIC NODES)	PRO1;40	SET	'1' FOR Less than 1999 rad; '2' FOR 2000-3000 rad; '3' FOR 3001-4000 rad; '4' FOR 4001-5000 rad; '5' FOR More than 5001 rad; '8' FOR Not given; '9' FOR Rad dose unknown; LAST EDITED: `OCT 29, 1996` DESCRIPTION: `Record the TOTAL (external) RAD DOSE given to the PELVIC NODES; this includes boost dosage. Do not include interstitial rad dose. If it is known that the patient received radiation therapy, but the amount given is` `unknown, code 9 (rad dose unknown).`
640	TOTAL RAD DOSE (PARA-AORTIC)	PRO1;41	SET	'1' FOR Less than 1999 rad; '2' FOR 2000-3000 rad; '3' FOR 3001-4000 rad; '5' FOR More than 5001 rad; '8' FOR Not given; '9' FOR Rad dose unknown; LAST EDITED: `OCT 29, 1996` DESCRIPTION: `Record the TOTAL (external) RAD DOSE given to the PARA-AORTIC NODES; this includes boost dosage. Do not include interstitial rad dose. If it is known that the patient received radiation therapy, but the amount given is` `unknown, code 9 (rad dose unknown).`
641	RESEARCH PROTOCOL (RADIATION)	PRO1;42	SET	'1' FOR In-house; '2' FOR Cooperative group; '3' FOR Not in a protocol; '9' FOR Unknown; LAST EDITED: `OCT 29, 1996` DESCRIPTION: `Record the patient was entered into a protocol.`
642	HORMONE THERAPY PLANNED/GIVEN	PRO1;43	SET	'1' FOR Yes; '2' FOR No, not recommended; '3' FOR Patient refused hormonal therapy; '4' FOR Hormonal therapy was planned, but not given; '9' FOR Unknown; LAST EDITED: `OCT 29, 1996` DESCRIPTION: `Record whether the patient received hormonal therapy.`
643	ESTROGENS	PRO1;44	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; '2' FOR No; LAST EDITED: `MAY 22, 1998` DESCRIPTION: `Record all types of hormonal drugs given.` SCREEN: `S DIC("S")="I ($P(^ONCO(165.5,DA,0),U,7)'=1998)!(Y'=2)"` EXPLANATION: `Record all types of hormonal drugs given.`
644	ANTIANDROGENS	PRO1;45	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; '2' FOR No; LAST EDITED: `MAY 22, 1998` DESCRIPTION: `Record all types of hormonal drugs given.` SCREEN: `S DIC("S")="I ($P(^ONCO(165.5,DA,0),U,7)'=1998)!(Y'=2)"` EXPLANATION: `Record all types of hormonal drugs given.`
645	PROGESTATIONAL AGENTS	PRO1;46	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; '2' FOR No; LAST EDITED: `MAY 22, 1998` DESCRIPTION: `Record all types of hormonal drugs given.` SCREEN: `S DIC("S")="I ($P(^ONCO(165.5,DA,0),U,7)'=1998)!(Y'=2)"` EXPLANATION: `Record all types of hormonal drugs given.`
646	LUTEINIZING HORMONES	PRO1;47	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; '2' FOR No; LAST EDITED: `MAY 22, 1998` DESCRIPTION: `Record all types of hormonal drugs given.` SCREEN: `S DIC("S")="I ($P(^ONCO(165.5,DA,0),U,7)'=1998)!(Y'=2)"` EXPLANATION: `Record all types of hormonal drugs given.`
647	ORCHIECTOMY	PRO1;48	SET	'1' FOR Yes; '2' FOR No; '9' FOR Unknown; LAST EDITED: `OCT 29, 1996` DESCRIPTION: `Record whether an ORCHIECTOMY was administered. Code 2 (No) if an ORCHIECTOMY was not given.`
648	OTHER EXOGENOUS HORMONE AGENTS	PRO1;49	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; '2' FOR No; LAST EDITED: `MAY 22, 1998` DESCRIPTION: `Record all types of hormonal drugs given.` SCREEN: `S DIC("S")="I ($P(^ONCO(165.5,DA,0),U,7)'=1998)!(Y'=2)"` EXPLANATION: `Record all types of hormonal drugs given.`
649	BACKACHE (1ST RECURRENCE)	PRO1;50	SET	'1' FOR Yes; '2' FOR No; '9' FOR Unknown; LAST EDITED: `OCT 30, 1996` DESCRIPTION: `Record whether a BACKACHE was used to diagnose the first recurrence.`
650	BONE SCAN (1ST RECURRENCE)	PRO1;51	SET	'1' FOR Yes; '2' FOR No; '9' FOR Unknown; LAST EDITED: `OCT 30, 1996` DESCRIPTION: `Record if a BONE SCAN was used to diagnose the first recurrence.`
651	LETHARGY	PRO1;52	SET	'1' FOR Yes; '2' FOR No; '9' FOR Unknown; LAST EDITED: `OCT 30, 1996` DESCRIPTION: `Record if LETHARGY was used to diagnose the first recurrence.`
652	RECTAL EXAM (1ST RECURRENCE)	PRO1;53	SET	'1' FOR Yes; '2' FOR No; '9' FOR Unknown; LAST EDITED: `OCT 30, 1996` DESCRIPTION: `Record whether a RECTAL EXAMINATION FOLLOWED BY NEEDLE BIOPSY was used to diagnose the first recurrence.`
653	TUMOR MARKER (1ST RECURRENCE)	PRO1;54	SET	'1' FOR Yes; '2' FOR No; '9' FOR Unknown; LAST EDITED: `OCT 30, 1996` DESCRIPTION: `Record whether TUMOR MARKER ELEVATION was used to diagnose the first recurrence.`
654	WEIGHT LOSS (1ST RECURRENCE)	PRO1;55	SET	'1' FOR Yes; '2' FOR No; '9' FOR Unknown; LAST EDITED: `OCT 30, 1996` DESCRIPTION: `Record whether WEIGHT LOSS was used to diagnose the first recurrence.`
655	OTHER METHODS (1ST RECURRENCE)	PRO1;56	SET	'1' FOR Yes; '2' FOR No; '9' FOR Unknown; LAST EDITED: `OCT 30, 1996` DESCRIPTION: `Record whether OTHER methods were used to diagnose the first recurrence.`
656	REASON FOR 2ND COURSE	PRO1;57	SET	'1' FOR Recurrence; '2' FOR Progression of disease; '8' FOR No therapy; '9' FOR Unknown; LAST EDITED: `OCT 31, 1996` DESCRIPTION: `Record whether the patient received treatment for recurrence or progression of disease.`
657	FAM HIST OF PROSTATE CA (PR98)	PRO2;1	SET	'0' FOR No; '1' FOR Yes, 1st degree relative; '2' FOR Yes, relative other than 1st degree; '3' FOR Yes, degree of relative unknown; '9' FOR Unknown; LAST EDITED: `MAY 13, 1998` DESCRIPTION: `Record any familial history of prostate cancer documented in the medical record. First degree relatives include the patient's father, brother, or son. A grandfather, uncle, or cousin would not be considered a first` `degree relative.`
658	HEMATURIA (PR98)	PRO2;2	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `MAY 13, 1998` DESCRIPTION: `Record all symptoms specific to prostate cancer that were reported by the patient and included in the medical chart.`
659	LOWER BACK PAIN (PR98)	PRO2;3	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `MAY 13, 1998` DESCRIPTION: `Record all symptoms specific to prostate cancer that were reported by the patient and included in the medical chart.`
660	TROUBLE URINATING (PR98)	PRO2;4	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `MAY 13, 1998` DESCRIPTION: `Record all symptoms specific to prostate cancer that were reported by the patient and included in the medical chart.`
661	CLIN DX W/ BONE LESION (PR98)	PRO2;5	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `NOV 30, 1998` DESCRIPTION: `Record whether the Initial Method of Diagnosis: CLINICAL DIAGNOSIS WITH BONE LESION was performed to diagnose this case of prostate cancer.`
662	CLIN DX BY RECTAL EXAM (PR98)	PRO2;6	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `NOV 30, 1998` DESCRIPTION: `Record whether the Initial Method of Diagnosis: CLINICAL DIAGNOSIS BY RECTAL EXAM was performed to diagnose this case of prostate cancer.`
663	CYTOLOGY (PR98)	PRO2;7	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `NOV 30, 1998` DESCRIPTION: `Record whether the Initial Method of Diagnosis: CYTOLOGY was performed to diagnose this case of prostate cancer.`
664	DIGITAL TRANSRECTAL BIO (PR98)	PRO2;8	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `NOV 30, 1998` DESCRIPTION: `Record whether the Initial Method of Diagnosis: DIGITAL TRANSRECTAL BIOPSY was performed to diagnose this case of prostate cancer.`
665	INCIDENTAL FIND IN TURP (PR98)	PRO2;9	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `NOV 30, 1998` DESCRIPTION: `Record whether the Method of Diagnosis: INCIDENTAL FINDING IN TRANSURETHRAL RESECTION OF PROSTATE (TURP) FOR BENIGN DISEASE was performed to diagnose this case of prostate cancer.`
666	NEEDLE BIOPSY, NOS (PR98)	PRO2;10	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `NOV 30, 1998` DESCRIPTION: `Record whether the Initial Method of Diagnosis: NEEDLE BIOPSY, NOS was performed to diagnose this case of prostate cancer.`
667	PERINEAL BIOPSY (PR98)	PRO2;11	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `NOV 30, 1998` DESCRIPTION: `Record whether the Initial Method of Diagnosis: PERINEAL BIOPSY was performed to diagnose this case of prostate cancer.`
668	PSA METHOD OF DIAGNOSIS (PR98)	PRO2;12	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `NOV 30, 1998` DESCRIPTION: `Record whether the Initial Method of Diagnosis: PROSTATIC SPECIFIC ANTIGEN (PSA) was performed to diagnose this case of prostate cancer.`
669	TRANSRECTAL BIOPSY (PR98)	PRO2;13	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `NOV 30, 1998` DESCRIPTION: `Record whether the Initial Method of Diagnosis: TRANSRECTAL ULTRASONOGRAPHICALLY GUIDED BIOPSY (TRUS) was performed to diagnose this case of prostate cancer.`
670	TRANSURETHRAL RESECTION (PR98)	PRO2;14	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `NOV 30, 1998` DESCRIPTION: `Record whether the Initial Method of Diagnosis: TRANSURETHRAL RESECTION OF PROSTATE, NOS was performed to diagnose this case of prostate cancer.`
671	BONE MARROW ASPIRATION (PR98)	PRO2;15	SET	'0' FOR Test not done; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `MAY 08, 1998` DESCRIPTION: `Record the results of the BONE MARROW ASPIRATION diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 8 (Test done, results unknown). If it is` `unknown if the test was done code 9 (Unknown if test done).`
672	BONE SCAN (PR98)	PRO2;16	SET	'0' FOR Test not done; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `MAY 08, 1998` DESCRIPTION: `Record the results of the BONE SCAN diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 8 (Test done, results unknown). If it is unknown if the test` `was done code 9 (Unknown if test done).`
673	BONE X-RAY (PR98)	PRO2;17	SET	'0' FOR Test not done; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `MAY 08, 1998` DESCRIPTION: `Record the results of the BONE X-RAY diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 8 (Test done, results unknown). If it is unknown if the` `test was done code 9 (Unknown if test done).`
674	CHEST X-RAY (PR98)	PRO2;18	SET	'0' FOR Test not done; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `MAY 08, 1998` DESCRIPTION: `Record the results of the CHEST X-RAY diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 8 (Test done, results unknown). If it is unknown if the` `test was done code 9 (Unknown if test done).`
675	CT SCAN OF ABDOMEN (PR98)	PRO2;19	SET	'0' FOR Test not done; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `MAY 08, 1998` DESCRIPTION: `Record the results of the CT SCAN OF ABDOMEN diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 8 (Test done, results unknown). If it is unknown if` `the test was done code 9 (Unknown if test done).`
676	CT SCAN OF PELVIS (PR98)	PRO2;20	SET	'0' FOR Test not done; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `MAY 08, 1998` DESCRIPTION: `Record the results of the CT SCAN OF PELVIS diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 8 (Test done, results unknown). If it is unknown if` `the test was done code 9 (Unknown if test done).`
677	INTRAVENOUS PYELOGRAM (PR98)	PRO2;21	SET	'0' FOR Test not done; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `MAY 08, 1998` DESCRIPTION: `Record the results of the INTRAVENOUS PYELOGRAM (IVP) diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 8 (Test done, results unknown). If it is` `unknown if the test was done code 9 (Unknown if test done).`
678	MRI (PR98)	PRO2;22	SET	'0' FOR Test not done; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `MAY 08, 1998` DESCRIPTION: `Record the results of the MAGNETIC RESONANCE IMAGING (MRI) diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 8 (Test done, results unknown). If it` `is unknown if the test was done code 9 (Unknown if test done).`
679	PELVIC LYMPH ND DISSECT (PR98)	PRO2;23	SET	'0' FOR Test not done; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `MAY 08, 1998` DESCRIPTION: `Record the results of the PELVIC LYMPH NODE DISSECTION diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 8 (Test done, results unknown). If it is` `unknown if the test was done code 9 (Unknown if test done).`
680	POLYMERASE CHAIN REACT (PR98)	PRO2;24	SET	'0' FOR Test not done; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `MAY 08, 1998` DESCRIPTION: `Record the results of the POLYMERASE CHAIN REACTION ASSAY (PCR) diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 8 (Test done, results unknown).` `If it is unknown if the test was done code 9 (Unknown if test done).`
681	PROSTATIC ACID PHOSPH (PR98)	PRO2;25	SET	'0' FOR Test not done; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `MAY 08, 1998` DESCRIPTION: `Record the results of the PROSTATIC ACID PHOSPHATASE (PAP) diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 8 (Test done, results unknown). If it` `is unknown if the test was done code 9 (Unknown if test done).`
682	PSA DIAGNOSTIC EVAL (PR98)	PRO2;26	SET	'0' FOR Test not done; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `MAY 08, 1998` DESCRIPTION: `Record the results of the PROSTATE SPECIFIC ANTIGEN (PSA) diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 8 (Test done, results unknown). If it` `is unknown if the test was done code 9 (Unknown if test done).`
683	ULTRASOUND OF ABDOMEN (PR98)	PRO2;27	SET	'0' FOR Test not done; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `MAY 08, 1998` DESCRIPTION: `Record the results of the ULTRASOUND OF ABDOMEN diagnostic test performed to evaluate the prostate tumor. If the study was done and the results cannot be determined, code 8 (Test done, results unknown). If it is unknown` `if the test was done code 9 (Unknown if test done).`
684	PSA	PRO2;28	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>5!($L(X)<1) X I $D(X) D PSA^ONCOIT` OUTPUT TRANSFORM: `D PSA^ONCOOT` LAST EDITED: `OCT 29, 2002` HELP-PROMPT: `Answer must be between 000.0 and 999.9, up to 1 decimal digit` DESCRIPTION: `Records the results of the highest pre-treatment Prostate Specific Antigen (PSA) test given within the last 12 months.` `If the first course of treatment was Watchful Waiting, the date the decision was made is considered the first course of treatment. Round the test result to the nearest single decimal point.` `Record 999.6 if PSA value was 999.6 or higher. Record 999.7 if no PSA test was performed. Record 999.8 if the test was done and results are unknown/not reported. Record 999.9 if it is unknown if the test was performed.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
685	WATCHFUL WAITING (PR98)	PRO2;29	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `MAY 08, 1998` DESCRIPTION: `Record whether or not the patient chose to forego surgery, radiation therapy, chemotherapy, and hormone therapy in favor of no immediate medical intervention.`
686	LENGTH OF STAY (PR98)	PRO2;30	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` OUTPUT TRANSFORM: `S Y=$S($L(Y)=1:"0"_Y,1:Y) S Y=$S(Y=88:Y_" NA",Y=99:Y_" Unknown",Y="01":Y_" day",1:Y_" days")` LAST EDITED: `MAY 13, 1998` HELP-PROMPT: `Type a Number between 0 and 99, 0 Decimal Digits` DESCRIPTION: `Record the number of days the patient remained in the hospital following cancer-directed surgery. Include the day on which the patient was admitted to the hospital for treatment, and the day before the patient was` `discharged from the hospital. For example, if patient was admitted 1/12/98 and discharged 1/18/98, the length of stay is 6 days. If not applicable code, 88. If unknown, code 99.`
687	LAPAROSCOPIC (PR98)	PRO2;31	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `MAY 13, 1998` DESCRIPTION: `Record whether the LAPAROSCOPIC Type of Regional Lymph Node surgery was performed. If not applicable, code 8. If unknown, code 9.`
688	OPEN (PR98)	PRO2;32	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `MAY 13, 1998` DESCRIPTION: `Record whether the OPEN Type of Regional Lymph Node surgery was performed. If not applicable, code 8. If unknown, code 9.`
689	PERMANENT RECTAL INJURY (PR98)	PRO2;33	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, no surgery; '9' FOR Unknown; LAST EDITED: `MAY 15, 1998` DESCRIPTION: `Record whether permanent rectal injury was a surgical complication which was reported within 30 days of first course of treatment cancer- directed surgery. If not applicable, code 8. If unknown, code 9.`
690	THROMBOEMBOLISM (PR98)	PRO2;34	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, no surgery; '9' FOR Unknown; LAST EDITED: `MAY 15, 1998` DESCRIPTION: `Record whether thromboembolism was a surgical complication which was reported within 30 days of first course of treatment cancer- directed surgery. If not applicable, code 8. If unknown, code 9.`
691	URETHRAL STRICTURE (PR98)	PRO2;35	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, no surgery; '9' FOR Unknown; LAST EDITED: `MAY 15, 1998` DESCRIPTION: `Record whether urethral stricture was a surgical complication which was reported within 30 days of first course of treatment cancer- directed surgery. If not applicable, code 8. If unknown, code 9.`
692	RADIATION FACILITY	PRO2;36	SET	'1' FOR Reporting hospital; '2' FOR Other hospital; '3' FOR Freestanding facility; '4' FOR NOS; '8' FOR NA, radiation not administered; '9' FOR Unknown; LAST EDITED: `MAY 22, 1998` DESCRIPTION: `Record whether radiation was administered at reporting hospital or administered elsewhere. Record 8 if no radiation administered. Record 9 if the radiation facility is unknown.`
693	ROUTE OF INTERSTITIAL RAD	PRO2;37	SET	'1' FOR Perineal; '2' FOR Open; '8' FOR NA, not administered; '9' FOR Unknown; LAST EDITED: `MAY 22, 1998` DESCRIPTION: `Record the route by which interstitial radiation/brachytherapy was administered. Record 8 if not applicable. Record 9 if unknown.`
694	TYPE OF RADIATION ADMIN	PRO2;38	SET	'1' FOR Conformal therapy; '2' FOR Standard; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `MAY 22, 1998` DESCRIPTION: `Record the method by which external beam radiation was administered. Conformal therapy is a three dimensional radiation technique that minimizes exposure to normal tissue. Record 8 if not applicable. Record 9 if` `unknown.`
695	GASTROINTESTINAL COMPLICATIONS	PRO2;39	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `MAY 22, 1998` DESCRIPTION: `Record whether or not acute gastrointestinal complications were reported within 90 days of the start of radiation therapy. Record 8 if not applicable. Record 9 if unknown.`
696	GASTROURINARY COMPLICATIONS	PRO2;40	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `MAY 22, 1998` DESCRIPTION: `Record whether or not acute gastrourinary complications were reported within 90 days of the start of radiation therapy. Record 8 if not applicable. Record 9 if unknown.`
697	ANORECTAL COMPLICATIONS	PRO2;41	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `MAY 22, 1998` DESCRIPTION: `Record whether or not anorectal complications were reported within 90 days of the start of radiation therapy. Record 8 if not applicable. Record 9 if unknown.`
698	CHRONIC COMPLICATIONS	PRO2;42	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `MAY 22, 1998` DESCRIPTION: `Record whether or not chronic complications requiring surgery or prolonged hospitalization were reported within 90 days of the start of radiation therapy. Record 8 if not applicable. Record 9 if unknown.`
699	URETHRAL/BLADDER COMPLICATIONS	PRO2;48	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `MAY 22, 1998` DESCRIPTION: `Record whether or not urethral or bladder complications were reported within 90 days of the start of radiation therapy. Record 8 if not applicable. Record 9 if unknown.`
699.1	DATE OF ORCHIECTOMY	PRO2;49	DATE	INPUT TRANSFORM: `S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" D DFIT^ONCODSR` OUTPUT TRANSFORM: `D DATEOT^ONCOPCE` LAST EDITED: `MAY 22, 1998` HELP-PROMPT: `* DATE OF ORCHIECTOMY MUST BE AFTER OR EQUAL TO DATE DX *` DESCRIPTION: `Record the date of the orchiectomy. If no orchiectomy was performed, code 00/00/0000. If an orchiectomy was performed, but the month, day or year is unknown, code the unknown item with 9's.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
700	HISTORY OF COLORECTAL CA (FAM)	COL1;1	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `FEB 10, 1997` DESCRIPTION: `Record any familial history of colorectal cancer documented in the medical record.`
701	HISTORY OF COLORECTAL CA (PT)	COL1;2	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `FEB 10, 1997` DESCRIPTION: `Record and personal history of a previous colorectal cancer documented in the medical record prior to 1997.`
702	MULTIPLE COLORECTAL PRIMARIES	COL1;3	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `FEB 10, 1997` DESCRIPTION: `Record if a second colorectal primary was diagnosed in addition to this reported cancer. If a patient has more than one colorectal primary and more than one record will be submitted, answer 'yes' on all records submitted` `for the patient.` `Note: If a second primary is accessioned late in the year, please remember to change the data item on any earlier records.`
703	HISTORY OF BREAST CA (PT)	COL1;4	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `FEB 10, 1997` DESCRIPTION: `Record whether the patient has a history of breast cancer.`
704	HISTORY OF LUNG CA (PT)	COL1;5	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `FEB 10, 1997` DESCRIPTION: `Record whether the patient has a history of lung cancer.`
705	HISTORY OF OVARIAN CA (PT)	COL1;6	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `FEB 10, 1997` DESCRIPTION: `Record whether the patient has a history of ovarian cancer.`
706	HISTORY OF OVARIAN CARCINOMA	COL1;7	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `FEB 10, 1997` DESCRIPTION: `Record whether the patient has a history of ovarian carcinoma, peritoneal site. Note: Ovarian carcinoma, peritoneal site does not refer to metastatic disease. It is a primary ovarian cancer arising in the peritoneum, not` `in the ovary.`
707	HISTORY OF STOMACH CA (PT)	COL1;8	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `FEB 10, 1997` DESCRIPTION: `Record whether the patient has a history of stomach cancer.`
708	HISTORY OF THYROID CA (PT)	COL1;9	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `FEB 10, 1997` DESCRIPTION: `Record whether the patient has a history of thyroid cancer.`
709	HISTORY OF UTERUS CA (PT)	COL1;10	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `FEB 10, 1997` DESCRIPTION: `Record whether the patient has a history of uterus cancer.`
710	PREVIOUS TAH/BSO	COL1;11	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `FEB 10, 1997` DESCRIPTION: `TAH/BSO (Total abdominal hysterectomy/bilateral salpingo-oophorectomy) Record the appropriate code.`
711	FAMILIAL ADENOMATOUS POLYPS	COL1;12	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown/not documented; LAST EDITED: `MAY 24, 2005` DESCRIPTION: `Record whether the patient was affected by FAP (Familial adenomatous polyposis).`
712	HNPCC	COL1;13	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown/not documented; LAST EDITED: `MAY 24, 2005` DESCRIPTION: `Record whether the patient is affected by hereditary nonpolyposis colon cancer (HNPCC) syndrome.`
713	INFLAMMATORY BOWEL DISEASE	COL1;14	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown/not documented; LAST EDITED: `MAY 24, 2005` DESCRIPTION: `Record whether the patient was affected by inflammatory bowel disease (IBD).`
714	PRIOR POLYPS	COL1;15	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `FEB 11, 1997` DESCRIPTION: `Record the appropriate code for prior polyps.`
715	POLYPS	COL1;16	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` OUTPUT TRANSFORM: `S Y=$S($L(Y)=1:"0"_Y,Y=88:"NA, no adenomas",Y=90:"Unknown number",Y=99:"Unknown if adenomas",1:Y)` LAST EDITED: `FEB 11, 1997` HELP-PROMPT: `Type a Number between 0 and 99, 0 Decimal Digits` DESCRIPTION: `Record number of adenomas. If no adenomas, record 88. If number of adenomas unknown, record 90. If unknown if adenomas, record 99.`
716	DURATION OF ANEMIA	COL1;17	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` OUTPUT TRANSFORM: `S:$L(Y)=1 Y="0"_Y S Y=$S(Y="00":"Not present",Y="01":"1 month or less",Y=97:"Chart stated patient w/o symptom",Y=98:"Symptom present, duration unknown",Y=99:"Symptom not recorded in chart, unknown",1:Y_" months")` LAST EDITED: `FEB 12, 1997` HELP-PROMPT: `Type a Number between 0 and 99, 0 Decimal Digits` DESCRIPTION: `Record all anemia symptoms specific to the colorectal cancer that were reported by the patient and included in the medical chart. Round down to the nearest whole number if months fall into a range. For example, if the` `patient had symptoms for two to three months, record 02. If a symptom was not reported in the chart, code 99 (Unknown).`
717	DURATION OF BOWEL OBSTRUCTION	COL1;18	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` OUTPUT TRANSFORM: `S:$L(Y)=1 Y="0"_Y S Y=$S(Y="00":"Not present",Y="01":"1 month or less",Y=97:"Chart stated patient w/o symptom",Y=98:"Symptom present, duration unknown",Y=99:"Symptom not recorded in chart, unknown",1:Y_" months")` LAST EDITED: `FEB 12, 1997` HELP-PROMPT: `Type a Number between 0 and 99, 0 Decimal Digits` DESCRIPTION: `Record all bowel obstruction symptoms specific to the colorectal cancer that were reported by the patient and included in the medical chart. Round down to the nearest whole number if months fall into a range. For` `example, if the patient had symptoms for two to three months, record 02. If a symptom was not reported in the chart, code 99 (Unknown).`
718	DURATION OF BOWEL HABIT CHANGE	COL1;19	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` OUTPUT TRANSFORM: `S:$L(Y)=1 Y="0"_Y S Y=$S(Y="00":"Not present",Y="01":"1 month or less",Y=97:"Chart stated patient w/o symptom",Y=98:"Symptom present, duration unknown",Y=99:"Symptom not recorded in chart, unknown",1:Y_" months")` LAST EDITED: `FEB 12, 1997` HELP-PROMPT: `Type a Number between 0 and 99, 0 Decimal Digits` DESCRIPTION: `Record all change in bowel habit symptoms specific to the colorectal cancer that were reported by the patient and included in the medical chart. Round down to the nearest whole number if months fall into a range. For` `example, if the patient had symptoms for two to three months, record 02. If a symptom was not reported in the chart, code 99 (Unknown).`
719	DURATION OF EMERGENCY PRES-OBS	COL1;20	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` OUTPUT TRANSFORM: `S:$L(Y)=1 Y="0"_Y S Y=$S(Y="00":"Not present",Y="01":"1 month or less",Y=97:"Chart stated patient w/o symptom",Y=98:"Symptom present, duration unknown",Y=99:"Symptom not recorded in chart, unknown",1:Y_" months")` LAST EDITED: `FEB 12, 1997` HELP-PROMPT: `Type a Number between 0 and 99, 0 Decimal Digits` DESCRIPTION: `Record all emergency presentation-obstruction symptoms specific to the colorectal cancer that were reported by the patient and included in the medical chart. Round down to the nearest whole number if months fall into a` `range. For example, if the patient had symptoms for two to three months, record 02. If a symptom was not reported in the chart, code 99 (Unknown).`
720	DURATION OF JAUNDICE	COL1;21	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` OUTPUT TRANSFORM: `S:$L(Y)=1 Y="0"_Y S Y=$S(Y="00":"Not present",Y="01":"1 month or less",Y=97:"Chart stated patient w/o symptom",Y=98:"Symptom present, duration unknown",Y=99:"Symptom not recorded in chart, unknown",1:Y_" months")` LAST EDITED: `FEB 12, 1997` HELP-PROMPT: `Type a Number between 0 and 99, 0 Decimal Digits` DESCRIPTION: `Record all jaundice symptoms specific to the colorectal cancer that were reported by the patient and included in the medical chart. Round down to the nearest whole number if months fall into a range. For example, if the` `patient had symptoms for two to three months, record 02. If a symptom was not reported in the chart, code 99 (Unknown).`
721	DURATION OF MALAISE	COL1;22	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` OUTPUT TRANSFORM: `S:$L(Y)=1 Y="0"_Y S Y=$S(Y="00":"Not present",Y="01":"1 month or less",Y=97:"Chart stated patient w/o symptom",Y=98:"Symptom present, duration unknown",Y=99:"Symptom not recorded in chart, unknown",1:Y_" months")` LAST EDITED: `FEB 12, 1997` HELP-PROMPT: `Type a Number between 0 and 99, 0 Decimal Digits` DESCRIPTION: `Record all malaise symptoms specific to the colorectal cancer that were reported by the patient and included in the medical chart. Round down to the nearest whole number if months fall into a range. For example, if the` `patient had symptoms for two to three months, record 02. If a symptom was not reported in the chart, code 99 (Unknown).`
722	DURATION OF BLOOD IN STOOL	COL1;23	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` OUTPUT TRANSFORM: `S:$L(Y)=1 Y="0"_Y S Y=$S(Y="00":"Not present",Y="01":"1 month or less",Y=97:"Chart stated patient w/o symptom",Y=98:"Symptom present, duration unknown",Y=99:"Symptom not recorded in chart, unknown",1:Y_" months")` LAST EDITED: `FEB 12, 1997` HELP-PROMPT: `Type a Number between 0 and 99, 0 Decimal Digits` DESCRIPTION: `Record all occult blood in stool symptoms specific to the colorectal cancer that were reported by the patient and included in the medical chart. Round down to the nearest whole number if months fall into a range. For` `example, if the patient had symptoms for two to three months, record 02. If a symptom was not reported in the chart, code 99 (Unknown).`
723	DURATION OF PAIN (ABDOMINAL)	COL1;24	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` OUTPUT TRANSFORM: `S:$L(Y)=1 Y="0"_Y S Y=$S(Y="00":"Not present",Y="01":"1 month or less",Y=97:"Chart stated patient w/o symptom",Y=98:"Symptom present, duration unknown",Y=99:"Symptom not recorded in chart, unknown",1:Y_" months")` LAST EDITED: `FEB 12, 1997` HELP-PROMPT: `Type a Number between 0 and 99, 0 Decimal Digits` DESCRIPTION: `Record all abdominal pain symptoms specific to the colorectal cancer that were reported by the patient and included in the medical chart. Round down to the nearest whole number if months fall into a range. For example,` `if the patient had symptoms for two to three months, record 02. If a symptom was not reported in the chart, code 99 (Unknown).`
724	DURATION OF PAIN (PELVIC)	COL1;25	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` OUTPUT TRANSFORM: `S:$L(Y)=1 Y="0"_Y S Y=$S(Y="00":"Not present",Y="01":"1 month or less",Y=97:"Chart stated patient w/o symptom",Y=98:"Symptom present, duration unknown",Y=99:"Symptom not recorded in chart, unknown",1:Y_" months")` LAST EDITED: `FEB 12, 1997` HELP-PROMPT: `Type a Number between 0 and 99, 0 Decimal Digits` DESCRIPTION: `Record all pelvic pain symptoms specific to the colorectal cancer that were reported by the patient and included in the medical chart. Round down to the nearest whole number if months fall into a range. For example, if` `the patient had symptoms for two to three months, record 02. If a symptom was not reported in the chart, code 99 (Unknown).`
725	DURATION OF RECTAL BLEEDING	COL1;26	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` OUTPUT TRANSFORM: `S:$L(Y)=1 Y="0"_Y S Y=$S(Y="00":"Not present",Y="01":"1 month or less",Y=97:"Chart stated patient w/o symptom",Y=98:"Symptom present, duration unknown",Y=99:"Symptom not recorded in chart, unknown",1:Y_" months")` LAST EDITED: `FEB 12, 1997` HELP-PROMPT: `Type a Number between 0 and 99, 0 Decimal Digits` DESCRIPTION: `Record all rectal bleeding symptoms specific to the colorectal cancer that were reported by the patient and included in the medical chart. Round down to the nearest whole number if months fall into a range. For example,` `if the patient had symptoms for two to three months, record 02. If a symptom was not reported in the chart, code 99 (Unknown).`
726	DURATION OF OTHER	COL1;27	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` OUTPUT TRANSFORM: `S:$L(Y)=1 Y="0"_Y S Y=$S(Y="00":"Not present",Y="01":"1 month or less",Y=97:"Chart stated patient w/o symptom",Y=98:"Symptom present, duration unknown",Y=99:"Symptom not recorded in chart, unknown",1:Y_" months")` LAST EDITED: `FEB 12, 1997` HELP-PROMPT: `Type a Number between 0 and 99, 0 Decimal Digits` DESCRIPTION: `Record all other symptoms specific to the colorectal cancer that were reported by the patient and included in the medical chart. Round down to the nearest whole number if months fall into a range. For example, if the` `patient had symptoms for two to three months, record 02. If a symptom was not reported in the chart, code 99 (Unknown).`
727	ENDOSCOPIC METHOD	COL1;28	SET	'0' FOR Not done; '1' FOR Done; '9' FOR Unknown if done; LAST EDITED: `FEB 13, 1997` DESCRIPTION: `Record whether 'endoscopic' initial method of diagnosis was performed. If unknown, code a '9'.`
728	RADIOGRAPHIC METHOD	COL1;29	SET	'0' FOR Not done; '1' FOR Done; '9' FOR Unknown if done; LAST EDITED: `FEB 13, 1997` DESCRIPTION: `Record whether 'radiographic' initial method of diagnosis was performed. If unknown, code a '9'.`
729	SCREENING DIGITAL RECTAL EXAM	COL1;30	SET	'0' FOR Not done; '1' FOR Done; '9' FOR Unknown if done; LAST EDITED: `FEB 13, 1997` DESCRIPTION: `Record whether 'screening digital rectal exam' initial method of diagnosis was performed. If unknown, code a '9'.`
730	SCREENING PHYSICAL EXAM METHOD	COL1;31	SET	'0' FOR Not done; '1' FOR Done; '9' FOR Unknown if done; LAST EDITED: `FEB 13, 1997` DESCRIPTION: `Record whether 'screening physical exam' initial method of diagnosis was performed. If unknown, code a '9'.`
731	OTHER INITIAL METHOD	COL1;32	SET	'0' FOR Not done; '1' FOR Done; '9' FOR Unknown if done; LAST EDITED: `FEB 13, 1997` DESCRIPTION: `Record whether other initial method of diagnosis was performed. If unknown, code a '9'.`
732	REASON LEADING TO EVENTUAL DX	COL1;33	SET	'0' FOR General screening (endoscopy, hemocult); '1' FOR Symptoms; '2' FOR Familial history; '3' FOR Genetic test; '4' FOR Other; '9' FOR Unknown; LAST EDITED: `FEB 13, 1997` DESCRIPTION: `Record the appropriate code for the precipitating reason or procedure which eventually lead to diagnosing this patient with this cancer. If unknown, code a '9'.`
733	BARIUM ENEMA, DOUBLE CONTRAST	COL1;34	SET	'0' FOR Test not done; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `FEB 13, 1997` DESCRIPTION: `Record the results of the Diagnostic Test 'BARIUM ENEMA, DOUBLE CONTRAST', if it was performed to evaluate this cancer. If this test was not done record a '0'.`
734	BARIUM ENEMA, SINGLE CONTRAST	COL1;35	SET	'0' FOR Test not done; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `FEB 13, 1997` DESCRIPTION: `Record the results of the Diagnostic Test 'BARIUM ENEMA, SINGLE CONTRAST', if it was performed to evaluate this cancer. If this test was not done record a '0'.`
735	BARIUM ENEMA, NOS	COL1;36	SET	'0' FOR Test not done; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `FEB 13, 1997` DESCRIPTION: `Record the results of the Diagnostic Test 'BARIUM ENEMA, NOS', if it was performed to evaluate this cancer. If this test was not done record a '0'.`
736	BIOPSY OF PRIMARY SITE	COL1;37	SET	'0' FOR Test not done; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `FEB 13, 1997` DESCRIPTION: `Record the results of the Diagnostic Test 'BIOPSY OF PRIMARY SITE', if it was performed to evaluate this cancer. If this test was not done record a '0'.`
737	BIOPSY OF METASTATIC SITE	COL1;38	SET	'0' FOR Test not done; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `FEB 13, 1997` DESCRIPTION: `Record the results of the Diagnostic Test 'BIOPSY OF METASTATIC SITE', if it was performed to evaluate this cancer. If this test was not done record a '0'.`
738	CT SCAN OF LIVER	COL1;39	SET	'0' FOR Test not done; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `FEB 13, 1997` DESCRIPTION: `Record the results of the Diagnostic Test 'CT SCAN OF LIVER', if it was performed to evaluate this cancer. If this test was not done record a '0'.`
739	CT SCAN OF PRIMARY SITE (COL)	COL1;40	SET	'0' FOR Test not done; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `FEB 13, 1997` DESCRIPTION: `Record the results of the Diagnostic Test 'CT SCAN OF PRIMARY SITE', if it was performed to evaluate this cancer. If this test was not done record a '0'.`
740	CARCINOEMBRYONIC ANTIGEN (CEA)	COL1;41	SET	'0' FOR Test not done; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `FEB 13, 1997` DESCRIPTION: `Record the results of the Diagnostic Test 'CARCINOEMBRYONIC ANTIGEN (CEA)', if it was performed to evaluate this cancer. If this test was not done record a '0'.`
741	CHEST ROENTGENOGRAM	COL1;42	SET	'0' FOR Test not done; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `FEB 13, 1997` DESCRIPTION: `Record the results of the Diagnostic Test 'CHEST ROENTGENOGRAM', if it was performed to evaluate this cancer. If this test was not done record a '0'.`
742	COLONOSCOPY	COL1;43	SET	'0' FOR Test not done; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `FEB 13, 1997` DESCRIPTION: `Record the results of the Diagnostic Test 'COLONOSCOPY', if it was performed to evaluate this cancer. If this test was not done record a '0'.`
743	DIGITAL RECTAL EXAM	COL1;44	SET	'0' FOR Test not done; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `FEB 13, 1997` DESCRIPTION: `Record the results of the Diagnostic Test 'DIGITAL RECTAL EXAM', if it was performed to evaluate this cancer. If this test was not done record a '0'.`
744	FLEXIBLE SIGMOIDOSCOPY	COL1;45	SET	'0' FOR Test not done; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `FEB 13, 1997` DESCRIPTION: `Record the results of the Diagnostic Test 'FLEXIBLE SIGMOIDOSCOPY', if it was performed to evaluate this cancer. If this test was not done record a '0'.`
745	INTRAVENOUS PYELOGRAM (COL)	COL1;46	SET	'0' FOR Test not done; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `FEB 14, 1997` DESCRIPTION: `Record the results of the Diagnostic Test 'INTRAVENOUS PYELOGRAM (IVP)', if it was performed to evaluate this cancer. If this test was not done record a '0'.`
746	SERUM-LIVER FUNCTION TEST	COL1;47	SET	'0' FOR Test not done; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `FEB 14, 1997` DESCRIPTION: `Record the results of the Diagnostic Test 'SERUM-LIVER FUNCTION TEST', if it was performed to evaluate this cancer. If this test was not done record a '0'.`
747	MRI (COL)	COL1;48	SET	'0' FOR Test not done; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `FEB 14, 1997` DESCRIPTION: `Record the results of the Diagnostic Test 'MAGNETIC RESONANCE IMAGING (MRI)', if it was performed to evaluate this cancer. If this test was not done record a '0'.`
748	PROCTOSCOPY (RIGID)	COL1;49	SET	'0' FOR Test not done; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `FEB 14, 1997` DESCRIPTION: `Record the results of the Diagnostic Test 'PROCTOSCOPY (RIGID)', if it was performed to evaluate this cancer. If this test was not done record a '0'.`
749	STOOL GUAIAC (OCCULT BLOOD)	COL1;50	SET	'0' FOR Test not done; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `FEB 14, 1997` DESCRIPTION: `Record the results of the Diagnostic Test 'STOOL GUAIAC (OCCULT BLOOD)', if it was performed to evaluate this cancer. If this test was not done record a '0'.`
750	ULTRASOUND, LIVER, ABDOMEN	COL1;51	SET	'0' FOR Test not done; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `FEB 14, 1997` DESCRIPTION: `Record the results of the Diagnostic Test 'ULTRASOUND, LIVER, ABDOMEN', if it was performed to evaluate this cancer. If this test was not done record a '0'.`
751	ULTRASOUND, ENDORECTAL	COL1;52	SET	'0' FOR Test not done; '1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Procedure attempted and incomplete; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `FEB 14, 1997` DESCRIPTION: `Record the results of the Diagnostic Test 'ULTRASOUND, ENDORECTAL', if it was performed to evaluate this cancer. If this test was not done record a '0'.`
752	TUMOR LEVEL-ENDOSCOPIC EXAM	COL2;1	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` OUTPUT TRANSFORM: `D TLEEOT^ONCOES` LAST EDITED: `FEB 14, 1997` HELP-PROMPT: `Type a Number between 0 and 99, 0 Decimal Digits` DESCRIPTION: `Record the level of tumor from anal verge by endoscopic exam in centimeters if less than 61 centimeters. If greater than 60 centi- meters, record the appropriate code for tumor site in colon. If examination performed but` `tumor not visualized, record a '70'. If examination was performed, but results unknown, record '80'. If unknown whether examination was performed, record '99'. If this exam- ination was not performed code '00'.`
753	LEVEL OF RECTAL TUMOR	COL2;2	SET	'0' FOR Not measured; '1' FOR Low (0-5 cm); '2' FOR Medium (6-10 cm); '3' FOR High (11-15 cm); '7' FOR Measured but results unknown; '8' FOR NA, not a rectal tumor; '9' FOR Unknown if measured; LAST EDITED: `FEB 19, 1997` DESCRIPTION: `Record the appropriate code for the level of rectal tumor. If level not measured, record '0'. If level measured, but results unknown, record '7'. If not applicable, record '8'. Record '9' if unknown if measured.`
754	PROXIMAL MARGIN OF RESECTION	COL2;3	SET	'0' FOR Negative; '1' FOR Microscopically positive; '2' FOR Grossly positive; '8' FOR NA; '9' FOR Unknown, not described; LAST EDITED: `MAR 19, 1997` DESCRIPTION: `Record the appropriate code for the Proximal margin of resection.`
755	DISTAL MARGIN OF RESECTION	COL2;4	SET	'0' FOR Negative; '1' FOR Microscopically positive; '2' FOR Grossly positive; '8' FOR NA; '9' FOR Unknown, not described; LAST EDITED: `MAR 19, 1997` DESCRIPTION: `Record the appropriate code for the Distal margin of resection.`
756	RADIAL MARGIN OF RESECTION	COL2;5	SET	'0' FOR Negative; '1' FOR Microscopically positive; '2' FOR Grossly positive; '8' FOR NA; '9' FOR Unknown, not described; LAST EDITED: `MAR 19, 1997` DESCRIPTION: `Record the appropriate code for the Radial margin of resection.`
757	DIST TO CLOSEST MUCOSAL MARGIN	COL2;6	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` OUTPUT TRANSFORM: `S:$L(Y)=1 Y="0"_Y S Y=$S(Y=88:"Not applicable",Y=99:"Unknown",1:Y_" mm")` LAST EDITED: `FEB 18, 1997` HELP-PROMPT: `Type a Number between 0 and 99, 0 Decimal Digits` DESCRIPTION: `Record the distance in millimeters (mm) to the closest mucosal margin (or to dentate for abdominal perineal resection). This may also be described as the lateral or circumferential margin. Record the distance in` `millimeters. Record 88 if not applicable. If unknown, record 99.`
758	DIST TO CLOSEST RADIAL MARGIN	COL2;7	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` OUTPUT TRANSFORM: `S:$L(Y)=1 Y="0"_Y S Y=$S(Y=88:"Not applicable",Y=99:"Unknown",1:Y_" mm")` LAST EDITED: `FEB 18, 1997` HELP-PROMPT: `Type a Number between 0 and 99, 0 Decimal Digits` DESCRIPTION: `Record the distance in millimeters (mm) to the closest radial margin (or to the base of excision, if polyp). Record the distance in millimeters. Record 88 if not applicable. If unknown, record 99.`
759	BLOOD VESSEL OR LYMPHATIC INV	COL2;8	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `FEB 18, 1997` DESCRIPTION: `Record the appropriate code for blood vessel or lymphatic invasion.`
760	EXTRAMURAL VENOUS INVASION	COL2;9	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `FEB 18, 1997` DESCRIPTION: `Record the appropriate code for extramural venous invasion.`
761	PROMINENT LYMPHOID INFILTRATE	COL2;10	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `FEB 18, 1997` DESCRIPTION: `Record the appropriate code for prominent lymphoid infiltrate (Crohn's lymphoid follicle).`
762	PHYS PROVIDING DEF TREATMENT	COL2;11	SET	'1' FOR Colorectal board certified surgeon; '2' FOR Gastroenterologist; '3' FOR General surgeon; '4' FOR Radiation therapist; '5' FOR Other; '9' FOR Unknown; LAST EDITED: `FEB 19, 1997` DESCRIPTION: `Record the appropriate code representing the physician that provided the definitive treatment.`
763	ADDITIONAL SURGICAL PROCEDURES	COL2;12	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X I $D(X) D ASPIT^ONCOES` OUTPUT TRANSFORM: `D ASPOT^ONCOES` LAST EDITED: `FEB 20, 1997` HELP-PROMPT: `Type a Number between 0 and 99, 0 Decimal Digits` DESCRIPTION: `Enter any modified or additional surgical procedures for primary rectosigmoid or rectal cancer. Record the appropriate code if any of the specified procedures were performed. Please note that these codes do not represent` `the procedures as defined for the required surgery codes. For this field, these codes identify only the specified procedures. Record 88 for not applicable, not performed. Record 99 for unknown if performed.` EXECUTABLE HELP: `D ASPHP^ONCOES` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
764	LAPAROSCOPY USED DURING CDS	COL2;13	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `MAR 19, 1997` DESCRIPTION: `Record whether a laparoscopic procedure was used during cancer- directed surgery. Record an '8' if not applicable.`
765	METHOD OF ANASTOMOSIS	COL2;14	SET	'0' FOR Not done; '1' FOR Staple; '2' FOR Created by hand; '8' FOR Method not recorded; '9' FOR Unknown if done; LAST EDITED: `FEB 20, 1997` DESCRIPTION: `Record the appropriate code for the method of anastomosis.`
766	CM FROM ANASTOMOSIS TO DENTATE	COL2;15	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."2N.N) X` LAST EDITED: `FEB 20, 1997` HELP-PROMPT: `Type a Number between 0 and 99, 1 Decimal Digit` DESCRIPTION: `Record the distance in centimeters of anastomosis from dentate.`
767	COLOSTOMY	COL2;16	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `FEB 20, 1997` DESCRIPTION: `Record whether a colonscopy was performed.`
768	OOPHORECTOMY	COL2;17	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `FEB 20, 1997` DESCRIPTION: `Record whether an oophorectomy was performed. If an oophorectomy was performed, record the pathological status in the pathological status field.`
769	PATHOLOGICAL STATUS	COL2;18	SET	'0' FOR Not involved; '1' FOR Involved; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `MAR 19, 1997` DESCRIPTION: `Record the appropriate code. If an oophorectomy was performed, then record the pathological status in this field. If not performed, code an '8' (NA).`
770	ABDOMINAL INFECTION	COL2;19	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `APR 04, 1997` DESCRIPTION: `Record whether the patient had the surgical complication 'BLEEDING/HEMATOMA', which resulted from treatment. If the complication did not occur, code a '0' (no). If no treatment was performed, code 8 (NA).`
771	ABSCESS	COL2;20	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `APR 04, 1997` DESCRIPTION: `Record whether the patient had the surgical complication 'ABSCESS', which resulted from treatment. If the complication did not occur, code a '0' (no). If no treatment was performed, code 8 (NA).`
772	ADMISSION FOR NEUTROPENIA	COL2;21	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `APR 04, 1997` DESCRIPTION: `Record whether the patient had the surgical complication 'ADMISSION FOR NEUTROPENIA', which resulted from treatment. If the complication did not occur, code a '0' (no). If no treatment was performed, code 8 (NA).`
773	ANASTOMOTIC DEHISCENCE	COL2;22	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `APR 04, 1997` DESCRIPTION: `Record whether the patient had the surgical complication 'ANASTOMOTIC DEHISCENCE', which resulted from treatment. If the complication did not occur, code a '0' (no). If no treatment was performed, code 8 (NA).`
774	DEHYDRATION	COL2;23	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `APR 04, 1997` DESCRIPTION: `Record whether the patient had the surgical complication 'DEHYDRATION', which resulted from treatment. If the complication did not occur, code a '0' (no). If no treatment was performed, code 8 (NA).`
775	DIARRHEA	COL2;24	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `APR 04, 1997` DESCRIPTION: `Record whether the patient had the surgical complication 'DIARRHEA', which resulted from treatment. If the complication did not occur, code a '0' (no). If no treatment was performed, code 8 (NA).`
776	EARLY BOWEL OBSTRUCTION	COL2;25	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `APR 04, 1997` DESCRIPTION: `Record whether the patient had the surgical complication 'EARLY BOWEL OBSTRUCTION', which resulted from treatment. If the complication did not occur, code a '0' (no). If no treatment was performed, code 8 (NA).`
777	PERINEAL INFECTION	COL2;26	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `APR 04, 1997` DESCRIPTION: `Record whether the patient had the surgical complication 'PERINEAL INFECTION', which resulted from treatment. If the complication did not occur, code a '0' (no). If no treatment was performed, code 8 (NA).`
778	PNEUMONIA (COL)	COL2;27	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `APR 04, 1997` DESCRIPTION: `Record whether the patient had the surgical complication 'PNEUMONIA', which resulted from treatment. If the complication did not occur, code a '0' (no). If no treatment was performed, code 8 (NA).`
779	PROCTITIS	COL2;28	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `APR 04, 1997` DESCRIPTION: `Record whether the patient had the surgical complication 'PROCTITIS', which resulted from treatment. If the complication did not occur, code a '0' (no). If no treatment was performed, code 8 (NA).`
780	PULMONARY EMBOLISM (COL)	COL2;29	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `APR 04, 1997` DESCRIPTION: `Record whether the patient had the surgical complication 'PULMONARY EMBOLISM', which resulted from treatment. If the complication did not occur, code a '0' (no). If no treatment was performed, code 8 (NA).`
781	RADIATION ENTERITIS	COL2;30	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `APR 04, 1997` DESCRIPTION: `Record whether the patient had the surgical complication 'RADIATION ENTERITIS', which resulted from treatment. If the complication did not occur, code a '0' (no). If no treatment was performed, code 8 (NA).`
782	STOMA COMPLICATION	COL2;31	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `APR 04, 1997` DESCRIPTION: `Record whether the patient had the surgical complication 'STOMA COMPLICATION', which resulted from treatment. If the complication did not occur, code a '0' (no). If no treatment was performed, code 8 (NA).`
783	URINARY TRACT INFECTION	COL2;32	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `APR 04, 1997` DESCRIPTION: `Record whether the patient had the surgical complication 'URINARY TRACT INFECTION', which resulted from treatment. If the complication did not occur, code a '0' (no). If no treatment was performed, code 8 (NA).`
784	ENDOCAVITARY RADIATION (ECRT)	COL2;33	SET	'0' FOR None; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `FEB 21, 1997` DESCRIPTION: `Record the appropriate code for whether endocavitary radiation (ECRT) was given. ECRT refers to contact radiation delivered through the bowel lumen, usually proctoscopically, especially for rectal cancer.`
785	INTRA-OPERATIVE RAD THERAPY	COL2;34	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `FEB 21, 1997` DESCRIPTION: `Record the appropriate code for whether intra-operative radiation therapy (IORT) was given. IORT is beam radiation and/or radioactive implants and/or radioisotopes at time of surgery.`
786	PRIMARY TUMOR RAD DOSE (cGy)	COL2;35	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99999)!(X<0)!(X?.E1"."1N.N) X` OUTPUT TRANSFORM: `D PTRDOT^ONCOES` LAST EDITED: `FEB 21, 1997` HELP-PROMPT: `Type a Number between 0 and 99999, 0 Decimal Digits` DESCRIPTION: `Record the primary tumor total rad dose (cGy) given, including boost. If the patient did not receive radiation therapy, code 00000. If it is known that the patient received radiation therapy but the dose is unknown, code` `88888. If it is unknown if patient received radiation, code 99999.`
787	NUMBER OF RADIATION TREATMENTS	COL2;36	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` OUTPUT TRANSFORM: `S:$L(Y)=1 Y="0"_Y S Y=$S(Y="00":"None",Y=88:"Given but number unknown",Y=99:"Unknown if radiation given",1:Y)` LAST EDITED: `FEB 21, 1997` HELP-PROMPT: `Type a Number between 0 and 99, 0 Decimal Digits` DESCRIPTION: `Record the number of radiation treatments. If none, record 00. If given, but number unknown, record 88. If unknown if radiation given, record 99.`
788	ADJUVANT CHEMOTHERAPY (COL)	COL2;37	SET	'0' FOR No concomitant treatment; '1' FOR Radiation and concomitant bolus chemo; '2' FOR Radiation and concomitant infusion chemo; '9' FOR Unknown if therapy concomitant; LAST EDITED: `MAR 27, 1997` DESCRIPTION: `Record the Adjuvant Chemotherapy with Concomitant External Beam Radiation. If patient receives chemotherapy at any time during radiation as a radio- sensitizing agent, code 1. If chemotherapy is stopped more than 2 days` `prior to radiation therapy and not given until external beam therapy is completed, code 0. If unknown, code 9.`
789	5 FU (FLUOROURACIL)	COL2;38	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `FEB 21, 1997` DESCRIPTION: `Record whether the adjuvant therapy 5 FU (Fluorouracil) was given. If it is unknown if it was given, record a 9.`
790	LEUCOVORIN	COL2;39	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `FEB 21, 1997` DESCRIPTION: `Record whether the adjuvant therapy Leucovorin was given. If it is unknown if it was given, record a 9.`
791	LEVAMISOLE	COL2;40	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `JAN 14, 1999` DESCRIPTION: `Record whether the adjuvant therapy Levamisole was given. If it is unknown if it was given, record a 9.` SCREEN: `S DIC("S")="I ($P($G(^ONCO(165.5,DA,0)),U,16)>2981231)!(Y'=8)"` EXPLANATION: `Code 8 should not be used for cases with a DATE DX < 1/1/1999`
792	CPT 11	COL2;41	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `FEB 21, 1997` DESCRIPTION: `Record whether the adjuvant therapy CPT 11 was given. If it is unknown if it was given, record a 9.`
793	OTHER ADJUVANT THERAPY	COL2;42	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `FEB 21, 1997` DESCRIPTION: `Record whether any other adjuvant therapy was given. If it is unknown if any was given, record a 9.`
794	DURATION OF ADJUVANT THERAPY	COL2;43	SET	'0' FOR No adjuvant therapy; '1' FOR 1 to 6 months; '2' FOR 7 to 12 months; '8' FOR Therapy given but duration unknown; '9' FOR Unknown if therapy given; LAST EDITED: `FEB 21, 1997` DESCRIPTION: `Record the appropriate code for the duration of adjuvant therapy.`
795	COMPLETED DURATION OF THERAPY	COL2;44	SET	'0' FOR No (0-1 cycle); '1' FOR Yes (2 or more cycles); '7' FOR No therapy planned, not applicable; '8' FOR Unknown if therapy completed; '9' FOR Unknown if therapy given; LAST EDITED: `FEB 21, 1997` DESCRIPTION: `Record the appropriate code. If one or less than one cycle completed, record 0. If two or more cycles completed, record 1. If there was no adjuvant therapy planned, record 7. If therapy was given, but unknown if` `completed, record 8. If unknown if therapy given, record 9.`
796	NUTRITIONAL CONSULTATION	COL2;45	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `FEB 21, 1997` DESCRIPTION: `Record whether the other referral, nutritional consultation was made. If unknown, record 9.`
797	OCCUPATIONAL THERAPY	COL2;46	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `FEB 21, 1997` DESCRIPTION: `Record whether the other referral, occupational therapy was made. If unknown, record 9.`
798	OSTOMY CONSULTATION	COL2;47	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `FEB 21, 1997` DESCRIPTION: `Record whether the other referral, ostomy consultation was made. If unknown, record 9.`
799	PSYCHOSOCIAL	COL2;48	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `FEB 21, 1997` DESCRIPTION: `Record whether the other referral, psychosocial was made. If unknown, record 9.`
800	HISTORY OF LEUKEMIA (FAM)	NHL1;1	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `FEB 25, 1997` DESCRIPTION: `Record any familial history of leukemia documented in the medical record. If the record does not mention familial history of cancer, code 9 (unknown).`
801	HISTORY OF NON-HODGKIN'S LYMPH	NHL1;2	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `FEB 25, 1997` DESCRIPTION: `Record any familial history of Non-Hodgkin's lymphoma documented in the medical record. If the record does not mention familial history of cancer, code 9 (unknown).`
802	HISTORY OF HODGKIN'S LYMPHOMA	NHL1;3	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `FEB 25, 1997` DESCRIPTION: `Record any familial history of Hodgkin's lymphoma documented in the medical record. If the record does not mention familial history of cancer, code 9 (unknown).`
803	1ST PRIMARY SITE	NHL1;4	POINTER TO ICDO TOPOGRAPHY FILE (#164)	ICDO TOPOGRAPHY(#164) OUTPUT TRANSFORM: `S Y=$P($G(^ONCO(164,+Y,0)),U,2)_" "_$P($G(^ONCO(164,+Y,0)),U,1)` `9.1 = D CHFPS^ONCOMNI` LAST EDITED: `OCT 07, 1997` DESCRIPTION: `Record the ICD-O-2 code for the first site of any personal history of cancer documented in the medical record. If not applicable record 8's. If record does not mention personal history of any cancer, record 9's.` `WRITE AUTHORITY: ^`
804	1ST PRIMARY HISTOLOGY	NHL1;5	POINTER TO ICD-O-2 MORPHOLOGY FILE (#164.1)	ICD-O-2 MORPHOLOGY(#164.1) OUTPUT TRANSFORM: `S Y=$P($G(^ONCO(164.1,+Y,0)),U,2)_" "_$P($G(^ONCO(164.1,+Y,0)),U,1)` `9.1 = D CHFPH^ONCOMNI` LAST EDITED: `OCT 07, 1997` DESCRIPTION: `Record the 5-digit histology (including behavior) code for the first histology of any personal history of cancer documented in the medical record. If not applicable record 8's. If record does not mention personal history` `of any cancer, record 9's.` `WRITE AUTHORITY: ^`
805	2ND PRIMARY SITE	NHL1;6	POINTER TO ICDO TOPOGRAPHY FILE (#164)	ICDO TOPOGRAPHY(#164) OUTPUT TRANSFORM: `S Y=$P($G(^ONCO(164,+Y,0)),U,2)_" "_$P($G(^ONCO(164,+Y,0)),U,1)` `9.1 = D CHSPS^ONCOMNI` LAST EDITED: `OCT 07, 1997` DESCRIPTION: `Record the ICD-O-2 code for the second site of any personal history of cancer documented in the medical record. If not applicable record 8's. If record does not mention personal history of any cancer, record 9's.` `WRITE AUTHORITY: ^`
806	2ND PRIMARY HISTOLOGY	NHL1;7	POINTER TO ICD-O-2 MORPHOLOGY FILE (#164.1)	ICD-O-2 MORPHOLOGY(#164.1) OUTPUT TRANSFORM: `S Y=$P($G(^ONCO(164.1,+Y,0)),U,2)_" "_$P($G(^ONCO(164.1,+Y,0)),U,1)` `9.1 = D CHSPH^ONCOMNI` LAST EDITED: `OCT 07, 1997` DESCRIPTION: `Record the 5-digit histology (including behavior) code for the second histology of any personal history of cancer documented in the medical record. If not applicable record 8's. If record does not mention personal` `history of any cancer, record 9's.` `WRITE AUTHORITY: ^`
807	ORGAN TRANSPLANT	NHL1;8	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `FEB 27, 1997` DESCRIPTION: `Record the appropriate code for whether an organ transplant was a pre-existing condition. If unknown, code 9.`
808	HIV POSITIVE	NHL1;9	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `FEB 27, 1997` DESCRIPTION: `Record the appropriate code for whether being HIV positive was a pre-existing condition. If unknown, code 9.`
809	CROHN'S DISEASE	NHL1;10	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown/not documented; LAST EDITED: `MAY 24, 2005` DESCRIPTION: `Record whether Crohn's disease was a pre-existing condition.`
810	HASHIMOTO'S THYROIDITIS	NHL1;11	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `MAR 06, 1997` DESCRIPTION: `Record the appropriate code for whether Hashimoto's thyroiditis was a pre-existing condition. If unknown, code 9.`
811	SYSTEMIC LUPUS ERYTHEMATOSUS	NHL1;12	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `MAR 06, 1997` DESCRIPTION: `Record the appropriate code for whether systemic lupus erythematosus was a pre-existing condition. If unknown, code 9.`
812	RHEUMATOID ARTHRITIS	NHL1;13	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `MAR 06, 1997` DESCRIPTION: `Record the appropriate code for whether rheumatoid arthritis, including Sjogren's syndrome was a pre-existing condition. If unknown, code 9.`
813	PNEUMOCYSTIS CARINII	NHL1;14	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `MAR 06, 1997` DESCRIPTION: `Record the appropriate code for whether pneumocystis carinii was a pre-existing condition. If unknown, code 9.`
814	CMV INFECTION	NHL1;15	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `MAR 06, 1997` DESCRIPTION: `Record the appropriate code for whether CMV infection was a pre-existing condition. If unknown, code 9.`
815	TUBERCULOSIS	NHL1;16	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `MAR 06, 1997` DESCRIPTION: `Record the appropriate code for whether tuberculosis was a pre-existing condition. If unknown, code 9.`
816	MYCOBACTERIUM AVIUM	NHL1;17	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `MAR 06, 1997` DESCRIPTION: `Record the appropriate code for whether mycobacterium avium was a pre-existing condition. If unknown, code 9.`
817	OTHER PARASITIC INFECTIONS	NHL1;18	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `MAR 06, 1997` DESCRIPTION: `Record the appropriate code for whether there were any other parasitic infections that were pre-existing conditions. If unknown, code 9.`
818	OTHER CONGENITAL DISEASES	NHL1;19	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `MAR 06, 1997` DESCRIPTION: `Record the appropriate code for whether there were any other congenital diseases that were pre-existing conditions. If unknown, code 9.`
819	OPPORTUNISTIC DISEASE	NHL1;20	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `MAR 06, 1997` DESCRIPTION: `Record the appropriate code for whether opportunistic disease was a pre-existing condition, ONLY IF IT WAS WITHIN THE LAST 2 YEARS. If unknown, code 9.`
820	PREVIOUS CHEMOTHERAPY	NHL1;21	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `MAR 11, 1997` DESCRIPTION: `Record the appropriate code for whether the patient received any previous chemotherapy. If unknown, code 9.`
821	PREVIOUS RADIATION THERAPY	NHL1;22	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `MAR 11, 1997` DESCRIPTION: `Record the appropriate code for whether the patient received any previous radiation therapy. If unknown, code 9.`
822	AIDS RISK CATEGORY	NHL1;23	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>9)!(X<0)!(X?.E1"."1N.N) X I $D(X) S Y=X D ARCHP^ONCOMNI W " ",Y K Y` OUTPUT TRANSFORM: `D ARCHP^ONCOMNI` LAST EDITED: `APR 23, 1997` DESCRIPTION: `Record the appropriate code. The risk categories listed (1-8) only apply to those patients who are HIV positive. Record 0 if the patient is not HIV positive. Record 7 if the patient has more than one risk category` `(2-6). Record 8 if the patient's risk category is other or unknown. Record 9 if it is unknown if the patient is HIV positive.` EXECUTABLE HELP: `D ARCHHLP^ONCOMNI` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
823	CT SCAN OF BRAIN	NHL1;24	SET	'0' FOR Test not done; '1' FOR Positive for cancer; '2' FOR Negative for cancer; '3' FOR Equivocal, suggestive of cancer; '7' FOR Test attempted but not completed; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `MAR 19, 1997` DESCRIPTION: `Record the results of the CT SCAN OF BRAIN if the test was performed to evaluate this non-Hodgkin's Lymphoma. If the test was not done, code 0. Do not leave blank.`
824	CT SCAN OF ABDOMEN/PELVIS	NHL1;25	SET	'0' FOR Test not done; '1' FOR Positive for cancer; '2' FOR Negative for cancer; '3' FOR Equivocal, suggestive of cancer; '7' FOR Test attempted but not completed; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `MAR 19, 1997` DESCRIPTION: `Record the results of the CT SCAN OF ABDOMEN/PELVIS if the test was performed to evaluate this non-Hodgkin's Lymphoma. If the test was not done, code 0. Do not leave blank.`
825	MRI OF BRAIN	NHL1;26	SET	'0' FOR Test not done; '1' FOR Positive for cancer; '2' FOR Negative for cancer; '3' FOR Equivocal, suggestive of cancer; '7' FOR Test attempted but not completed; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `MAR 19, 1997` DESCRIPTION: `Record the results of the MRI OF BRAIN if the test was performed to evaluate this non-Hodgkin's Lymphoma. If the test was not done, code 0. Do not leave blank.`
826	MRI OF CHEST	NHL1;27	SET	'0' FOR Test not done; '1' FOR Positive for cancer; '2' FOR Negative for cancer; '3' FOR Equivocal, suggestive of cancer; '7' FOR Test attempted but not completed; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `MAR 19, 1997` DESCRIPTION: `Record the results of the MRI OF CHEST if the test was performed to evaluate this non-Hodgkin's Lymphoma. If the test was not done, code 0. Do not leave blank.`
827	MRI OF ABDOMEN/PELVIS	NHL1;28	SET	'0' FOR Test not done; '1' FOR Positive for cancer; '2' FOR Negative for cancer; '3' FOR Equivocal, suggestive of cancer; '7' FOR Test attempted but not completed; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `MAR 19, 1997` DESCRIPTION: `Record the results of the MRI OF ABDOMEN/PELVIS if the test was performed to evaluate this non-Hodgkin's Lymphoma. If the test was not done, code 0. Do not leave blank.`
828	GALLIUM SCAN	NHL1;29	SET	'0' FOR Test not done; '1' FOR Positive for cancer; '2' FOR Negative for cancer; '3' FOR Equivocal, suggestive of cancer; '7' FOR Test attempted but not completed; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `MAR 19, 1997` DESCRIPTION: `Record the results of the GALLIUM SCAN if the test was performed to evaluate this non-Hodgkin's Lymphoma. If the test was not done, code 0. Do not leave blank.`
829	PET SCAN	NHL1;30	SET	'0' FOR Test not done; '1' FOR Positive for cancer; '2' FOR Negative for cancer; '3' FOR Equivocal, suggestive of cancer; '7' FOR Test attempted but not completed; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `MAR 19, 1997` DESCRIPTION: `Record the results of the PET SCAN if the test was performed to evaluate this non-Hodgkin's Lymphoma. If the test was not done, code 0. Do not leave blank.`
830	LUMBAR PUNCTURE	NHL1;31	SET	'0' FOR Test not done; '1' FOR Positive for cancer; '2' FOR Negative for cancer; '3' FOR Equivocal, suggestive of cancer; '7' FOR Test attempted but not completed; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `MAR 19, 1997` DESCRIPTION: `Record the results of the LUMBAR PUNCTURE if the test was performed to evaluate this non-Hodgkin's Lymphoma. If the test was not done, code 0. Do not leave blank.`
831	HEMOGLOBIN/HEMATOCRIT	NHL1;32	SET	'0' FOR Test not done; '1' FOR Normal; '2' FOR Higher than normal; '3' FOR Lower than normal; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `MAR 20, 1997` DESCRIPTION: `Record the appropriate code for the results of the hemoglobin/hematocrit laboratory test, if it was performed. If the test was not performed, record a '0'.`
832	WHITE COUNT	NHL1;33	SET	'0' FOR Test not done; '1' FOR Normal; '2' FOR Higher than normal; '3' FOR Lower than normal; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `MAR 20, 1997` DESCRIPTION: `Record the appropriate code for the results of the white count laboratory test, if it was performed. If the test was not performed, record a '0'.`
833	PLATELET COUNT	NHL1;34	SET	'0' FOR Test not done; '1' FOR Normal; '2' FOR Higher than normal; '3' FOR Lower than normal; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `MAR 20, 1997` DESCRIPTION: `Record the appropriate code for the results of the platelet count laboratory test, if it was performed. If the test was not performed, record a '0'.`
834	LACTIC DEHYDROGENASE (LDH)	NHL1;35	SET	'0' FOR Test not done; '1' FOR Normal; '2' FOR Higher than normal; '3' FOR Lower than normal; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `MAR 20, 1997` DESCRIPTION: `Record the appropriate code for the results of the lactic dehydrogenase (LDH) laboratory test, if it was performed. If the test was not performed, record a '0'.`
835	LIVER FUNCTION STUDIES (NHL)	NHL1;36	SET	'0' FOR Test not done; '1' FOR Normal; '2' FOR Higher than normal; '3' FOR Lower than normal; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `MAR 20, 1997` DESCRIPTION: `Record the appropriate code for the results of the liver function studies laboratory test, if it was performed. If the test was not performed, record a '0'.`
836	TOTAL PROTEIN/ALBUMIN	NHL1;37	SET	'0' FOR Test not done; '1' FOR Normal; '2' FOR Higher than normal; '3' FOR Lower than normal; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `MAR 20, 1997` DESCRIPTION: `Record the appropriate code for the results of the total protein/albumin laboratory test, if it was performed. If the test was not performed, record a '0'.`
837	GENE REARRANGEMENTS	NHL1;38	SET	'0' FOR Not done; '1' FOR Done; '9' FOR Unknown if test done; LAST EDITED: `MAR 20, 1997` DESCRIPTION: `Record whether the 'Gene rearrangements' test was performed to evaluate this primary. If this test was not done, record a '0'.`
838	REVIEW OF PATHOLOGY/OTHER INST	NHL1;39	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown if done; LAST EDITED: `MAY 28, 1997` DESCRIPTION: `Record the appropriate code for whether there was a review of pathology at another institution by another pathologist.`
839	LYMPH NODE BIOPSY	NHL1;40	SET	'0' FOR Test not done; '1' FOR Positive for cancer; '2' FOR Negative for cancer; '3' FOR Equivocal, suggestive of cancer; '7' FOR Test attempted but not completed; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `MAR 20, 1997` DESCRIPTION: `Record the appropriate code for lymph node biopsy, if it was performed. If this biopsy was not performed record a '0'.`
840	BONE MARROW BIOPSY	NHL1;41	SET	'0' FOR Test not done; '1' FOR Positive for cancer; '2' FOR Negative for cancer; '3' FOR Equivocal, suggestive of cancer; '7' FOR Test attempted but not completed; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `MAR 20, 1997` DESCRIPTION: `Record the appropriate code for bone marrow biopsy, if it was performed. If this biopsy was not performed record a '0'.`
841	CSF CYTOLOGY	NHL1;42	SET	'0' FOR Test not done; '1' FOR Positive for cancer; '2' FOR Negative for cancer; '3' FOR Equivocal, suggestive of cancer; '7' FOR Test attempted but not completed; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `MAR 20, 1997` DESCRIPTION: `Record the appropriate code for CSF cytology biopsy, if it was performed. If this biopsy was not performed record a '0'.`
842	OTHER SITE BIOPSY	NHL1;43	SET	'0' FOR Test not done; '1' FOR Positive for cancer; '2' FOR Negative for cancer; '3' FOR Equivocal, suggestive of cancer; '7' FOR Test attempted but not completed; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `MAR 20, 1997` DESCRIPTION: `Record the appropriate code for other site biopsy, if it was performed. If this biopsy was not performed record a '0'.`
843	SYSTEMIC SYMPTOMS	NHL1;44	SET	'1' FOR A (no symptoms); '2' FOR B (defined systemic symptoms); '9' FOR Unknown whether A or B; LAST EDITED: `MAR 20, 1997` DESCRIPTION: `Record whether the patient was category A (without defined systemic symptoms) or B (with defined systemic symptoms). These symptoms include unexplained weight loss of at least 10% within 6 months prior to diagnosis,` `unexplained fever above 38 C, and drenching night sweats. Neither pruritus alone or short febrile illness associated with infection qualify within these systemic symptoms.`
844	CD4 COUNT	NHL1;45	SET	'0' FOR Test not done; '1' FOR < 1,000 copies/ml; '2' FOR 1,000 to 9,999 copies/ml; '3' FOR > or = to 10,000 copies/ml; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `APR 15, 1997` DESCRIPTION: `Record the appropriate code for CD4 count, a diagnostic test specifically related to HIV disease. If the test was not performed, record a '0'.`
845	HIV VIRAL LOADS	NHL1;46	SET	'0' FOR Test not done; '1' FOR < 10,000 copies/ml; '2' FOR > or = to 10,000 copies/ml; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `APR 15, 1997` DESCRIPTION: `Record the appropriate code for HIV viral loads, a diagnostic test specifically related to HIV disease. If the test was not performed, record a '0'.`
846	SPECIFIC HISTOLOGIC INFO	NHL2;1	SET	'1' FOR Mantle cell lymphoma; '2' FOR MALT lymphoma; '3' FOR Peripheral T-cell lymphoma; '4' FOR Anaplastic, large cell (Ki-1) lymphoma; '8' FOR NA, no additional histologies noted; '9' FOR Unknown if any histologies noted; LAST EDITED: `APR 15, 1997` DESCRIPTION: `This field is used to record any additional specific histologic data. For this field record the appropriate code (1-4) if any of the specified histologies were noted. (Please note that 1-Mantle cell lymphoma is not the` `same histology as mantle zone lymphoma which is listed in the ICD-0-2 code book as 9673). Record '8' for not applicable, if none of these listed were noted. Record '9' if unknown if any of these histologies were noted.`
847	CELL TYPE OF LYMPHOMA	NHL2;2	SET	'1' FOR T cell; '2' FOR B cell; '3' FOR Null cell; '4' FOR N X cell (natural killer cell); '9' FOR Cell type unknown; LAST EDITED: `MAR 21, 1997` DESCRIPTION: `Record the appropriate code for the cell type of the lymphoma. If the cell type is unknown, record a '9'.`
848	PATIENT STATUS AT DIAGNOSIS	NHL2;3	SET	'0' FOR Bedridden < or = to 50%; '1' FOR Bedridden > 50%; '9' FOR Unknown; LAST EDITED: `APR 15, 1997` DESCRIPTION: `Record the appropriate code for the patient's status at diagnosis. If completely ambulatory, record a '0'. If unknown, record a '9'.`
849	TYPE OF STAGING SYSTEM (PED)	NHL2;4	POINTER TO TYPE OF STAGING SYSTEM (PEDIATRIC) FILE (#164.6)	TYPE OF STAGING SYSTEM (PEDIATRIC)(#164.6) OUTPUT TRANSFORM: `S Y=$S(Y'="":$P($G(^ONCO(164.6,Y,0)),"^",2),1:"")` LAST EDITED: `APR 29, 1997` DESCRIPTION: `If recording a pediatric case, enter the type of staging system used to stage this patient. If not applicable, code '88'. If unknown, code '99'.`
850	PEDIATRIC STAGE	NHL2;5	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<1) X I $D(X) S STGIND="X" D IN^ONCOTNS` OUTPUT TRANSFORM: `S X="" D OT^ONCOTNS` LAST EDITED: `MAY 01, 1997` HELP-PROMPT: `Answer with the appropriate stage from the AJCC Staging Manual.` DESCRIPTION: `Enter the pediatric stage as specified in the pediatric staging system selected. If not applicable, code '88'. If the pediatric stage is unknown, code '99'.` EXECUTABLE HELP: `S STGIND="X" D HP^ONCOTNS` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
851	STAGED BY (PEDIATRIC STAGE)	NHL2;6	SET	'0' FOR Not staged; '1' FOR Managing physician; '2' FOR Pathologist; '3' FOR Other physician; '4' FOR Any combination of 1,2 or 3; '5' FOR Registrar; '6' FOR Any combination of 5 w/ 1,2 or 3; '7' FOR Other; '8' FOR Staged, individual not specified; '9' FOR Unknown if staged; LAST EDITED: `APR 18, 1997` DESCRIPTION: `Record the appropriate code for the individual who staged this pediatric case. If the patient was not staged, code '0'.`
852	EXTRANODAL SITE 1	NHL2;7	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>20!($L(X)<1) X I $D(X) D EXNSIT^ONCOMNI` OUTPUT TRANSFORM: `D EXNSOT^ONCOMNI` LAST EDITED: `MAR 26, 1997` DESCRIPTION: `Provide ICD-O-2 site codes for the 1st clinically and/or pathologically involved extranodal site (in addition to the primary site). If no 1st extranodal site, code 8's. If unknown, code 9's.` EXECUTABLE HELP: `D XHP^ONCOMNI` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
853	EXTRANODAL SITE 2	NHL2;8	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>20!($L(X)<1) X I $D(X) D EXNSIT^ONCOMNI` OUTPUT TRANSFORM: `D EXNSOT^ONCOMNI` LAST EDITED: `MAR 26, 1997` DESCRIPTION: `Provide ICD-O-2 site codes for the 2nd clinically and/or pathologically involved extranodal site (in addition to the primary site). If no 2nd extranodal site, code 8's. If unknown, code 9's.` EXECUTABLE HELP: `D XHP^ONCOMNI` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
854	EXTRANODAL SITE 3	NHL2;9	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>20!($L(X)<1) X I $D(X) D EXNSIT^ONCOMNI` OUTPUT TRANSFORM: `D EXNSOT^ONCOMNI` LAST EDITED: `MAR 26, 1997` DESCRIPTION: `Provide ICD-O-2 site codes for the 3rd clinically and/or pathologically involved extranodal site (in addition to the primary site). If no 3rd extranodal site, code 8's. If unknown, code 9's.` EXECUTABLE HELP: `D XHP^ONCOMNI` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
855	EXTRANODAL SITE W/C-D SURGERY	NHL2;10	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>20!($L(X)<1) X I $D(X) D EXNSIT^ONCOMNI` OUTPUT TRANSFORM: `D EXNSOT^ONCOMNI` LAST EDITED: `MAR 26, 1997` DESCRIPTION: `Record the ICD-O-2 site code for any extranodal cancer-directed surgery, other than the primary-site surgery. If no additional cancer-directed surgery to an extranodal site, code 8's. If unknown, code 9's.` EXECUTABLE HELP: `D XHP^ONCOMNI` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
856	EXTRANODAL SITE SURGICAL PROC	NHL2;11	NUMBER	INPUT TRANSFORM: `D ESSPIT^ONCODSR` OUTPUT TRANSFORM: `D ESSPOT^ONCODSR` LAST EDITED: `MAR 28, 1997` HELP-PROMPT: `Type a Number between 0 and 90, 0 Decimal Digits` DESCRIPTION: `Record the appropriate cancer-directed surgical code for the first extranodal site. If there is no additional cancer-directed surgical procedure to an extranodal site, code '00'.` EXECUTABLE HELP: `D ESSHP^ONCODSR` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
857	LYMPH NODES ABOVE DIAPHRAGM	NHL2;12	SET	'1' FOR Irradiated; '2' FOR Not irradiated; '8' FOR NA, unknown if radiation therapy given; '9' FOR Radiation given, unknown if irradiated; LAST EDITED: `APR 18, 1997` DESCRIPTION: `Record the appropriate code for whether the lymph nodes above the diaphragm were irradiated. Please see the "Lymph Node Location Relative to Diaphragm" handout for additional information.`
858	LYMPH NODES BELOW DIAPHRAGM	NHL2;13	SET	'1' FOR Irradiated; '2' FOR Not irradiated; '8' FOR NA, unknown if radiation therapy given; '9' FOR Radiation therapy administered, unknown if this field irradiated; LAST EDITED: `MAR 31, 1997` DESCRIPTION: `Record the appropriate code for whether the lymph nodes below the diaphragm were irradiated. Please see the "Lymph Node Location Relative to Diaphragm" handout for additional information.`
859	BRAIN	NHL2;14	SET	'1' FOR Irradiated; '2' FOR Not irradiated; '8' FOR NA, unknown if radiation therapy given; '9' FOR Radiation therapy administered, unknown if this field irradiated; LAST EDITED: `MAR 28, 1997` DESCRIPTION: `Record the appropriate code for whether the brain was irradiated. If it is unknown if radiation therapy was given, code 8. If radiation therapy was administered but it is unknown if the brain was irradiated, code 9.`
860	OTHER EXTRANODAL SITE(S)	NHL2;15	SET	'1' FOR Irradiated; '2' FOR Not irradiated; '8' FOR NA, unknown if radiation therapy given; '9' FOR Radiation therapy administered, unknown if this field irradiated; LAST EDITED: `MAR 28, 1997` DESCRIPTION: `Record the appropriate code for whether other extranodal site(s) were irradiated. If it is unknown if radiation therapy was given, code 8. If radiation therapy was administered but it is unknown if other extranodal sites` `were irradiated, code 9.`
861	TOTAL BODY	NHL2;16	SET	'1' FOR Irradiated; '2' FOR Not irradiated; '8' FOR NA, unknown if radiation therapy given; '9' FOR Radiation therapy administered, unknown if this field irradiated; LAST EDITED: `MAR 31, 1997` DESCRIPTION: `Record the appropriate code for whether the total body was irradiated. If it is unknown if radiation therapy was given, code 8. If radiation therapy was administered but it is unknown if the total body was irradiated,` `code 9.`
862	RADIATION/CHEMO SEQUENCE	NHL2;17	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>9)!(X<0)!(X?.E1"."1N.N) X I $D(X) D RCSIT^ONCOMNI` OUTPUT TRANSFORM: `D RCSOT^ONCOMNI` LAST EDITED: `MAR 28, 1997` HELP-PROMPT: `Type a Number between 0 and 9, 0 Decimal Digits` DESCRIPTION: `Record the appropriate code for radiation/chemotherapy sequence.` EXECUTABLE HELP: `D RCSHP^ONCOMNI` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
863	PROTOCOL	NHL2;18	SET	'0' FOR Not on protocol; '1' FOR Cancer cooperative group trial; '2' FOR Other investigative, IRB-approved protocol; '9' FOR Unknown if on protocol; LAST EDITED: `MAR 31, 1997` DESCRIPTION: `Record the appropriate code for systemic and/or intrathecal chemotherapy. If unknown, code 9.`
864	SYSTEMIC CHEMOTHERAPY	NHL2;19	SET	'0' FOR None; '1' FOR Systemic chemotherapy, NOS; '2' FOR Systemic chemotherapy, single agent; '3' FOR Systemic chemotherapy, multiple agents; '9' FOR Unknown if administered; LAST EDITED: `APR 22, 1997` DESCRIPTION: `Record the appropriate code for the administration of systemic chemotherapy. If unknown if administered, code 9.`
865	SYSTEMIC CHEMOTHERAPY DATE	NHL2;20	DATE	INPUT TRANSFORM: `S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" D DFIT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `APR 03, 1997` HELP-PROMPT: `* SYSTEMIC CHEMOTHERAPY DATE MUST BE AFTER OR EQUAL TO DATE DX *` DESCRIPTION: `Record the first date on which systemic chemotherapy was administered.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
866	SYSTEMIC CHEMOTHERAPY CYCLES	NHL2;21	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` OUTPUT TRANSFORM: `S:$L(Y)=1 Y="0"_Y S Y=$S(Y="01":Y_" cycle",Y=88:"NA",Y=97:"Given but number unknown",Y=98:"No termination date assigned at onset of chemotherapy",Y=99:"Unknown if chemotherapy given",1:Y_" cycles")` LAST EDITED: `APR 22, 1997` HELP-PROMPT: `Type a Number between 0 and 99, 0 Decimal Digits` DESCRIPTION: `Record the number of planned cycles of systemic chemotherapy. If not applicable (no systemic chemotherapy given), code 88. If given, but number unknown, code 97. If no termination date assigned at onset of systemic` `chemotherapy, code 98. If unknown if systemic chemotherapy was administered, code 99.`
867	CHLORAMBUCIL	NHL2;22	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown if given; LAST EDITED: `APR 22, 1997` DESCRIPTION: `Record whether this chemotherapeutic agent was administered during systemic chemotherapy. If not applicable (chemotherapy not given), code 8. If unknown if given, code 9.`
868	CYCLOPHOSPHAMIDE (NHL)	NHL2;23	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown if given; LAST EDITED: `APR 22, 1997` DESCRIPTION: `Record whether this chemotherapeutic agent was administered during systemic chemotherapy. If not applicable (chemotherapy not given), code 8. If unknown if given, code 9.`
869	DOXORUBICIN (NHL)	NHL2;24	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown if given; LAST EDITED: `APR 22, 1997` DESCRIPTION: `Record whether this chemotherapeutic agent was administered during systemic chemotherapy. If not applicable (chemotherapy not given), code 8. If unknown if given, code 9.`
870	FLUDARABINE	NHL2;25	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown if given; LAST EDITED: `APR 22, 1997` DESCRIPTION: `Record whether this chemotherapeutic agent was administered during systemic chemotherapy. If not applicable (chemotherapy not given), code 8. If unknown if given, code 9.`
871	CHOP	NHL2;26	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown if given; LAST EDITED: `APR 22, 1997` DESCRIPTION: `Record whether the combination chemotherapy agents, CHOP were administered during systemic chemotherapy. If not applicable (chemotherapy not given), code 8. If unknown if given, code 9.`
872	CVP	NHL2;27	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown if given; LAST EDITED: `APR 22, 1997` DESCRIPTION: `Record whether the combination chemotherapy agents, CVP were administered during systemic chemotherapy. If not applicable (chemotherapy not given), code 8. If unknown if given, code 9.`
873	COMLA	NHL2;28	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown if given; LAST EDITED: `APR 22, 1997` DESCRIPTION: `Record whether the combination chemotherapy agents, COMLA were administered during systemic chemotherapy. If not applicable (chemotherapy not given), code 8. If unknown if given, code 9.`
874	MACOP-B	NHL2;29	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown if given; LAST EDITED: `APR 22, 1997` DESCRIPTION: `Record whether the combination chemotherapy agents, MACOP-B were administered during systemic chemotherapy. If not applicable (chemotherapy not given), code 8. If unknown if given, code 9.`
875	M-BACOD	NHL2;30	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown if given; LAST EDITED: `APR 22, 1997` DESCRIPTION: `Record whether the combination chemotherapy agents, M-BACOD were administered during systemic chemotherapy. If not applicable (chemotherapy not given), code 8. If unknown if given, code 9.`
876	PRO-MACE-Cyta BOM	NHL2;31	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown if given; LAST EDITED: `APR 22, 1997` DESCRIPTION: `Record whether the combination chemotherapy agents, PRO-MACE-Cyta BOM were administered during systemic chemotherapy. If not applicable (chemotherapy not given), code 8. If unknown if given, code 9.`
877	OTHER SYSTEMIC CHEMO AGENTS	NHL2;32	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown if given; LAST EDITED: `APR 22, 1997` DESCRIPTION: `Record whether any other combination chemotherapy agents were administered during systemic chemotherapy. If not applicable (chemotherapy not given), code 8. If unknown if given, code 9.`
878	HIGH DOSE SYSTEMIC CHEMO	NHL2;33	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown if given; LAST EDITED: `APR 01, 1997` DESCRIPTION: `Record the appropriate code for whether high dose systemic chemotherapy with stem cell rescue was done. If unknown if done, code 9.`
879	INTRATHECAL CHEMOTHERAPY	NHL2;34	SET	'0' FOR None; '1' FOR Administered; '9' FOR Unknown if administered; LAST EDITED: `APR 23, 1997` DESCRIPTION: `Record the appropriate code for whether intrathecal chemotherapy was administered. If unknown if administered, code 9.`
880	PURPOSE OF INTRATHECAL CHEMO	NHL2;35	SET	'1' FOR Treatment; '2' FOR Prophylaxis; '7' FOR NA, not administered; '8' FOR Administered, purpose unknown; '9' FOR Unknown if administered; LAST EDITED: `APR 23, 1997` DESCRIPTION: `Record the appropriate code for the purpose of intrathecal chemotherapy. If not applicable, intrathecal chemetherapy not administered, code 7. If intrathecal chemotherapy administered, but purpose unknown, code 8. If` `unknown whether intrathecal chemotherapy administered, code 9.`
881	INTERFERON (NHL)	NHL2;36	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 14, 1999` DESCRIPTION: `Record the appropriate code for whether this type of immunotherapy was performed. If unknown if performed, code 9.`
882	INTERLEUKIN-2 (IL-2) (NHL)	NHL2;37	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 14, 1999` DESCRIPTION: `Record the appropriate code for whether this type of immunotherapy was performed. If unknown if performed, code 9.`
883	MONOCLONAL ANTIBODIES	NHL2;38	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 14, 1999` DESCRIPTION: `Record the appropriate code for whether this type of immunotherapy was performed. If unknown if performed, code 9.`
884	VACCINE THERAPY	NHL2;39	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `JAN 14, 1999` DESCRIPTION: `Record the appropriate code for whether this type of immunotherapy was performed. If unknown if performed, code 9.` SCREEN: `S DIC("S")="I ($P($G(^ONCO(165.5,DA,0)),U,16)>2981231)!(Y'=8)"` EXPLANATION: `Code 8 should not be used for cases with a DATE DX < 1/1/1999`
900	DAUGHTER (BR98)	BRE1;1	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `MAY 15, 1998` DESCRIPTION: `Record any familial history of breast cancer documented in the medical record. Record 8 if not applicable. Record 9 if unknown.`
901	MATERNAL AUNT (BR98)	BRE1;2	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `MAY 15, 1998` DESCRIPTION: `Record any familial history of breast cancer documented in the medical record. Record 8 if not applicable. Record 9 if unknown.`
902	MATERNAL GRANDMOTHER (BR98)	BRE1;3	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `MAY 15, 1998` DESCRIPTION: `Record any familial history of breast cancer documented in the medical record. Record 8 if not applicable. Record 9 if unknown.`
903	MOTHER (BR98)	BRE1;4	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `MAY 15, 1998` DESCRIPTION: `Record any familial history of breast cancer documented in the medical record. Record 8 if not applicable. Record 9 if unknown.`
904	ONE SISTER (BR98)	BRE1;5	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `MAY 15, 1998` DESCRIPTION: `Record any familial history of breast cancer documented in the medical record. Record 8 if not applicable. Record 9 if unknown.`
905	MORE THAN ONE SISTER (BR98)	BRE1;6	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `MAY 15, 1998` DESCRIPTION: `Record any familial history of breast cancer documented in the medical record. Record 8 if not applicable. Record 9 if unknown.`
906	FATHER (BR98)	BRE1;7	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `MAY 15, 1998` DESCRIPTION: `Record any familial history of breast cancer documented in the medical record. Record 8 if not applicable. Record 9 if unknown.`
907	BROTHER (BR98)	BRE1;8	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `MAY 15, 1998` DESCRIPTION: `Record any familial history of breast cancer documented in the medical record. Record 8 if not applicable. Record 9 if unknown.`
908	FAM HISTORY BREAST CA (BR98)	BRE1;9	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `MAY 15, 1998` DESCRIPTION: `Record any familial history of breast cancer documented in the medical record. Record 8 if not applicable. Record 9 if unknown.`
909	HISTORY OF BREAST CA (BR98)	BRE1;10	SET	'0' FOR None; '1' FOR Invasive; '2' FOR Ductal carcinoma in situ; '3' FOR Lobular carcinoma in situ; '4' FOR Other histology; '8' FOR History of breast ca, type unknown; '9' FOR Unknown; LAST EDITED: `JUN 25, 1998` DESCRIPTION: `For females, record any personal history of breast cancer not synchronous (diagnosed 6 months or more prior) with the current breast cancer. For males, leave this field blank.`
910	SYNCHRONOUS BREAST CA (BR98)	BRE1;11	SET	'0' FOR No; '1' FOR Ipsilateral; '2' FOR Contralateral; '3' FOR Both; '8' FOR Yes, but laterality unknown; '9' FOR Unknown; LAST EDITED: `JUN 02, 1998` DESCRIPTION: `Record any synchronous breast cancer diagnosed up to but not including 6 months prior to current breast cancer.`
911	COLON (BR98)	BRE1;12	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `JUN 04, 1998` DESCRIPTION: `Record whether the patient had colon cancer diagnosed either prior to this breast cancer or at the same time that this breast cancer was diagnosed.`
912	OVARY (BR98)	BRE1;13	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `JUN 04, 1998` DESCRIPTION: `Record whether the patient had ovarian cancer diagnosed either prior to this breast cancer or at the same time that this breast cancer was diagnosed. If the patient is a male leave this field blank.`
913	UTERUS (BR98)	BRE1;14	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `JUN 04, 1998` DESCRIPTION: `Record whether the patient had uterine cancer diagnosed either prior to this breast cancer or at the same time that this breast cancer was diagnosed. If the patient is a male leave this field blank.`
914	PROSTATE (BR98)	BRE1;15	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `JUN 04, 1998` DESCRIPTION: `Record whether the patient had prostate cancer diagnosed either prior to this breast cancer or at the same time that this breast cancer was diagnosed. If the patient is a female leave this field blank.`
915	OTHER (BR98)	BRE1;16	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `JUN 04, 1998` DESCRIPTION: `Record whether the patient had other cancer diagnosed either prior to this breast cancer or at the same time that this breast cancer was diagnosed.`
916	HORMONE REPLACEMENT TPY (BR98)	BRE1;17	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JUN 05, 1998` DESCRIPTION: `Record whether the patient was/is on hormone replacement therapy (estrogen/progesterone). If the patient is a male leave this field blank.`
917	HORMONE REPLACEMENT YRS (BR98)	BRE1;18	SET	'1' FOR Less than 5 years; '2' FOR 5 to 9 years; '3' FOR 10 years or more; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `JUN 08, 1998` DESCRIPTION: `Record the appropriate code for the number of years of hormone replacement therapy the patient had. If patient is not on this therapy, code 8, not applicable. If the patient is a male leave this field blank.`
918	UNKNOWN MAMMOGRAM (BR98)	BRE1;19	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JUN 05, 1998` DESCRIPTION: `For FEMALE patients ONLY, record the appropriate code for whether a mammogram was given, but the type was unknown. If the type is known then record a 0. If the patient is male, leave this field blank.`
919	UNKNOWN MAMMOGRAM DT (BR98)	BRE1;20	DATE	INPUT TRANSFORM: `S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" D DFIT^ONCODSR` OUTPUT TRANSFORM: `D DATEOT^ONCOPCE` LAST EDITED: `JUN 05, 1998` HELP-PROMPT: `* UNKNOWN MAMMOGRAM DATE MUST BE AFTER OR EQUAL TO DATE DX *` DESCRIPTION: `For FEMALE patients ONLY, record the date the mammogram was given if the type of mammogram is unknown. Use the most recent date if this unknown type of mammogram was done more than once. Record 0's if this type of` `mammogram was not given. Record 9's if it is unknown if this type was given. If the patient is male, leave this field blank.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
920	SCREENING MAMMOGRAM (BR98)	BRE1;21	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JUN 05, 1998` DESCRIPTION: `For FEMALE patients ONLY, record the appropriate code for whether a screening mammogram was given. If the patient is male, leave this field blank.`
921	SCREENING MAMMOGRAM DT (BR98)	BRE1;22	DATE	INPUT TRANSFORM: `S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" D DFIT^ONCODSR` OUTPUT TRANSFORM: `D DATEOT^ONCOPCE` LAST EDITED: `JUN 05, 1998` HELP-PROMPT: `* SCREENING MAMMOGRAM DATE MUST BE AFTER OR EQUAL TO DATE DX *` DESCRIPTION: `For FEMALE patients ONLY, record the date the screening mammogram was given. Use the most recent date if screening mammogram was done more than once. Record 0's if screening mammogram was not given. Record 9's if it is` `unknown if screening mammogram was given. If the patient is male, leave this field blank.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
922	DIAGNOSTIC MAMMOGRAM (BR98)	BRE1;23	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JUN 05, 1998` DESCRIPTION: `For FEMALE patients ONLY, record the appropriate code for whether a diagnostic mammogram was given. If the patient is male, leave this field blank.`
923	DIAGNOSTIC MAMMOGRAM DT (BR98)	BRE1;24	DATE	INPUT TRANSFORM: `S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" D DFIT^ONCODSR` OUTPUT TRANSFORM: `D DATEOT^ONCOPCE` LAST EDITED: `JUN 05, 1998` HELP-PROMPT: `* DIAGNOSTIC MAMMOGRAM DATE MUST BE AFTER OR EQUAL TO DATE DX *` DESCRIPTION: `For FEMALE patients ONLY, record the date the diagnostic mammogram was given. Use the most recent date if diagnostic mammogram was done more than once. Record 0's if diagnostic mammogram was not given. Record 9's if it` `is unknown if diagnostic mammogram was given. If the patient is male, leave this field blank.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
924	MAGNIFICATION MAMMOGRAM (BR98)	BRE1;25	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JUN 05, 1998` DESCRIPTION: `For FEMALE patients ONLY, record the appropriate code for whether a magnification mammogram was given. A magnification mammogram can be identified by finding the word "magnification" or "compression" in the title or body` `of the report. If the patient is male, leave this field blank.`
925	MAGNIFICATION MAMM DT (BR98)	BRE1;26	DATE	INPUT TRANSFORM: `S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" D DFIT^ONCODSR` OUTPUT TRANSFORM: `D DATEOT^ONCOPCE` LAST EDITED: `JUN 05, 1998` HELP-PROMPT: `* MAGNIFICATION MAMMOGRAM DATE MUST BE AFTER OR EQUAL TO DATE DX *` DESCRIPTION: `For FEMALE patients ONLY, record the date the magnification mammogram was given. Use the most recent date if magnification mammogram was done more than once. Record 0's if magnification mammogram was not given. Record` `9's if it is unknown if magnification mammogram was given. If the patient is male, leave this field blank.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
926	MAMMOGRAM (BR98)	BRE1;27	SET	'0' FOR Test not done; '1' FOR Results positive for cancer; '2' FOR Results negative for cancer; '8' FOR Test done, results equivocal/unknown; '9' FOR Unknown if test done; LAST EDITED: `JUN 08, 1998` DESCRIPTION: `For MALES ONLY, record the results of the mammogram performed to evaluate the extent of breast cancer. If the mammogram was done but the results cannot be determined, code 8. If it is unknown if a mammogram was` `performed, code 9. If no mammogram was done, code 0.`
927	ULTRASOUND (BR98)	BRE1;28	SET	'0' FOR Test not done; '1' FOR Results positive for cancer; '2' FOR Results negative for cancer; '8' FOR Test done, results equivocal/unknown; '9' FOR Unknown if test done; LAST EDITED: `JUN 08, 1998` DESCRIPTION: `Record the results of the ultrasound if one was performed to evaluate the extent of breast cancer. If the ultrasound was done but the results cannot be determined, code 8. If it is unknown if an ultrasound was` `performed, code 9. If no ultrasound was done, code 0.`
928	MOST DEFINITIVE MAMM (BR98)	BRE1;29	SET	'0' FOR Negative/no abnormality; '1' FOR Localized calcifications; '2' FOR Diffuse calcifications; '3' FOR Mass, no calcifications; '4' FOR Mass plus one quad calcification; '5' FOR Mass plus multiple quad calcifications; '6' FOR NOS; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `JUN 08, 1998` DESCRIPTION: `For FEMALES ONLY, record the results of the patient's most definitive mammogram in this field. If no mammogram was done record 8, not applicable. For males, leave this field blank.`
929	DATE OF PATHOLOGIC DX (BR98)	BRE1;30	DATE	INPUT TRANSFORM: `S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" D DFIT^ONCODSR` OUTPUT TRANSFORM: `D DATEOT^ONCOPCE` LAST EDITED: `JUN 08, 1998` HELP-PROMPT: `* DATE OF PATHOLOGIC DX MUST BE AFTER OR EQUAL TO DATE DX *` DESCRIPTION: `Record the date that this breast cancer was first pathologically diagnosed.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
930	DCSI ALSO PRESENT (BR98)	BRE1;31	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>1!($L(X)<1) X I $D(X) D DCISIT^ONCOOT` OUTPUT TRANSFORM: `D DCISOT^ONCOOT` LAST EDITED: `JUN 09, 1998` HELP-PROMPT: `Answer must be 1 character in length.` DESCRIPTION: `If invasive ductal carcinoma is reported (Behavior code = 3), code if ductal carcinoma in situ (DCIS) is also present. If DCIS is not present, code 0. If DCIS is also present as a separate, simultaneous tumor, record 1.` `If DCIS is also present as mixed histology (in situ/invasive) in one tumor, record 2. If DCIS is also present, both as a separate tumor and in a tumor with mixed histology, record 3. If DCIS is also present, but unknown` `whether as a separate tumor or mixed histology, record 4. If reported tumor is not invasive ductal carcinoma, record 8, not applicable. If unknown whether DCIS is also present, record 9.` EXECUTABLE HELP: `D DCISHP^ONCOOT` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
931	ARCHITECTURE PATTERN (BR98)	BRE1;32	SET	'1' FOR Cribriform; '2' FOR Micro papillary; '3' FOR Comedo; '4' FOR Solid; '5' FOR Other; '6' FOR NOS; '7' FOR Mixed (any combination); '8' FOR NA, not DCIS; '9' FOR Pattern unknown; LAST EDITED: `JUN 12, 1998` DESCRIPTION: `Record the architecture pattern, if DCIS is present (either as the reported tumor, or as a separate tumor simultaneous with an invasive ductal carcinoma, or as a tumor with mixed histology - in situ/invasive ductal` `carcinoma). This information is found on the pathology report, often under the histology description, or it may be found in the diagnostic report.`
932	NUCLEAR GRADE (BR98)	BRE1;33	SET	'1' FOR Low; '2' FOR Intermediate; '3' FOR High; '4' FOR NOS; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `JUN 12, 1998` DESCRIPTION: `Record the nuclear grade, if DCIS is present (either as the reported tumor, or as a separate tumor simultaneous with an invasive ductal carcinoma, or as a tumor with mixed histology - in situ/invasive ductal carcinoma).` `This information is found on the pathology report, often under the histology description, or it may be in the diagnostic report. It is identified by the terms low, intermediate and high.`
933	SKIN INVOLVEMENT (BR98)	BRE1;34	SET	'0' FOR No involvement; '1' FOR Involvement; '9' FOR Unknown; LAST EDITED: `JUN 12, 1998` DESCRIPTION: `For male patients, record the extent of involvement of the skin. For female patients, leave this field blank.`
934	CHEST WALL INVOLVEMENT (BR98)	BRE1;35	SET	'0' FOR No involvement; '1' FOR Involvement; '9' FOR Unknown; LAST EDITED: `JUN 12, 1998` DESCRIPTION: `For male patients, record the extent of involvement of the chest wall. For female patients, leave this field blank.`
935	PECTORAL INVOLVEMENT (BR98)	BRE1;36	SET	'0' FOR No involvement; '1' FOR Involvement; '9' FOR Unknown; LAST EDITED: `JUN 12, 1998` DESCRIPTION: `For male patients, record the extent of involvement of the pectoral muscles. For female patients, leave this field blank.`
936	DERMAL/LYMPHATIC INV (BR98)	BRE1;37	SET	'0' FOR No involvement; '1' FOR Involvement; '9' FOR Unknown; LAST EDITED: `JUN 12, 1998` DESCRIPTION: `For male patients, record the extent of dermal/lymphatic involvement. For female patients, leave this field blank.`
937	DNA INDEX/PLOIDY (BR98)	BRE1;38	SET	'0' FOR Test not done; '1' FOR Diploid; '2' FOR Non-diploid; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `JUN 12, 1998` DESCRIPTION: `For male patients, record the DNA Index/Ploidy. This is usually determined by flow symmetry. For females, leave this field blank.`
940	ANDROGEN RECEPTOR (BR98)	BRE1;41	SET	'0' FOR Not done; '1' FOR Positive; '2' FOR Negative; '3' FOR Low borderline; '7' FOR NA; '8' FOR Test done, results unknown; '9' FOR Unknown if test done; LAST EDITED: `JUN 12, 1998` DESCRIPTION: `For male patients, record the results of the androgen receptor protein test. The results of these tests are sometimes shown as percents. For females, leave this field blank.`
941	TYPE OF TEST (BR98)	BRE1;42	SET	'0' FOR Neither ERA nor PRA was done; '1' FOR Immunohistochemical test; '2' FOR Biochemical test; '8' FOR ERA or PSA was done, type of test unknown; '9' FOR Unknown if ERA/PRA was done; LAST EDITED: `JUN 18, 1998` DESCRIPTION: `If possible to determine, indicate which type of test was used for the ERA/PRA. Answer for estrogen receptor protein (ERA) first, and if that was not done, then answer for progesterone receptor protein (PRA). If neither` `ERA or PRA tests were done, record 0.`
942	SIZE OF DCIS TUMOR (MM) (BR98)	BRE1;43	NUMBER	INPUT TRANSFORM: `K:X>999!(X<0)!(X?.E1"."1N.N) X I $D(X) D DCSZIT^ONCOOT` OUTPUT TRANSFORM: `D DCSZOT^ONCOOT` LAST EDITED: `JUN 19, 1998` HELP-PROMPT: `Type a Number between 0 and 999, 0 Decimal Digits` DESCRIPTION: `Record the size of DCIS tumor. If the tumor being reported is coded as invasive ductal carcinoma and ductal carcinoma in situ is also present either as a separate, simultaneous tumor or in a tumor with mixed histology` `(in situ/invasive), record the largest dimension or diameter of the DCIS tumor in millimeters. Do not guess the size of the tumor. Do not use specimen size. Use size as recorded in the pathology report, if it is present.` `If invasive ductal carcinoma is reported but DCIS is not present, record 000. If invasive ductal carcinoma is not reported, record 888, not applicable. If invasive ductal carcinoma is reported and DCIS is also present` `but its size is not known, record 988. If ductal carcinoma is reported but presence of DCIS is unknown, record 999.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
943	SENTINEL NODE BIOPSY	BRE1;44	SET	'0' FOR No; '1' FOR Yes, positive; '2' FOR Yes, negative; '3' FOR Yes, results unknown; '4' FOR Attempted, unsuccessful; '8' FOR NA, not done, ocular site; '9' FOR Unknown; LAST EDITED: `JAN 29, 1999` DESCRIPTION: `Record whether a sentinel node biopsy was performed. The sentinel node is the first lymph node(s) in the axillary lymph node basin receiving the lymphatic drainage of the breast. There may be one or several sentinel` `nodes identified by radionuclide injection, dye injection, or combination of the two. If surgeon could not find a sentinel node, record 4 - attempted, unsuccessful.` SCREEN: `S DIC("S")="I ($P($G(^ONCO(165.5,DA,0)),U,16)>2981231)!(Y'=8)"` EXPLANATION: `Code 8 should not be used for cases with a DATE DX < 1/1/1999.`
944	SENTINEL NODES EXAMINED (BR98)	BRE1;45	SET	'0' FOR None; '1' FOR 1 node examined; '2' FOR 2 nodes examined; '3' FOR 3 nodes examined; '4' FOR 4 nodes examined; '5' FOR 5 nodes examined; '6' FOR 6 nodes examined; '7' FOR 7 or more nodes examined; '8' FOR Examined, number unknown; '9' FOR Unknown if examined; LAST EDITED: `JUN 17, 1998` DESCRIPTION: `Enter the number of sentinel nodes examined. Record 0 if no sentinel nodes examined. Record 8 if nodes examined, but the number is unknown and record 9 if it is unknown if sentinel nodes were examined.`
945	SENTINEL NODES POSITIVE (BR98)	BRE1;46	SET	'0' FOR None positive; '1' FOR 1 positive node; '2' FOR 2 positive nodes; '3' FOR 3 positive nodes; '4' FOR 4 positive nodes; '5' FOR 5 positive nodes; '6' FOR 6 or more positive nodes; '7' FOR None examined; '8' FOR Positive, number unknown; '9' FOR Unknown if positive; LAST EDITED: `JUN 17, 1998` DESCRIPTION: `Enter the number of sentinel nodes positive. Record 0 if none are positive. Record 7 if none were examined. Record 8 if the positive number is unknown, and record 9 if it is unknown if any were positive.`
946	SENTINEL NODES DETECTED (BR98)	BRE1;47	SET	'1' FOR Vital blue dye; '2' FOR Radionuclide; '3' FOR Combination; '8' FOR NA, not done; '9' FOR Method unknown; LAST EDITED: `JUN 17, 1998` DESCRIPTION: `Record the method by which the sentinel node was detected.`
947	SPECIMEN RADIOGRAPH (BR98)	BRE1;48	SET	'0' FOR Not done; '1' FOR Calcification; '2' FOR Mass; '3' FOR Both calcification and mass; '4' FOR Radiograph done, results NOS; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `JUN 18, 1998` DESCRIPTION: `Record the results of the radiograph. The radiograph is a film of the excised specimen.`
948	SUBMITTED TO PATHOLOGY (BR98)	BRE1;49	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `JUN 18, 1998` DESCRIPTION: `Record whether the entire specimen was submitted to pathology.`
949	MARGIN DISTANCE (BR98)	BRE1;50	SET	'0' FOR Margins not free, involved; '1' FOR Less than 1 mm; '2' FOR 1 to 2 mm; '3' FOR 3 to 5 mm; '4' FOR Greater than 5 mm; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `JUN 18, 1998` DESCRIPTION: `If margins are free, record the distance in millimeters from the tumor to the edge of the specimen (margin).`
950	RE-EXCISION (BR98)	BRE1;51	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `JUN 18, 1998` DESCRIPTION: `Record whether a re-excision was performed following examination of the margins. Record 8 if margins were clear, not applicable. (NOTE: A mastectomy after an excisional biopsy does not count as a re-excision).`
951	MICROSCOPIC STATUS (BR98)	BRE1;52	SET	'0' FOR Uninvolved; '1' FOR Involved; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `JUN 18, 1998` DESCRIPTION: `Record the microscopic status of final margin after re-excision. If re-excision was performed indicate the status. If re-excision was not done, record 8, not applicable.`
952	PRE-RADIATION MAMMOGRAM (BR98)	BRE1;53	SET	'0' FOR Not done; '1' FOR Done, and entire lesion removed; '2' FOR Done, and entire lesion not removed; '8' FOR Done, but status of lesion unknown; '9' FOR Unknown if done; LAST EDITED: `JUN 18, 1998` DESCRIPTION: `Record whether there was a pre-radiation therapy mammogram of the patient. If unknown, record 9.`
953	SITES IRRADIATED (BR98)	BRE1;54	SET	'0' FOR No radiation; '1' FOR Breast only; '2' FOR Breast and regional lymphatics; '3' FOR Other; '8' FOR Radiation, sites unknown; '9' FOR Unknown if radiation; LAST EDITED: `JUN 19, 1998` DESCRIPTION: `Record the sites which were irradiated. Regional lymphatics includes axilla, chest wall, internal mammary lymph nodes and supraclavicular lymph nodes. Breast refers to 'whole' or 'entire' breast. If radiation was` `given, but site(s) unknown, record 8. If it is unknown if radiation was given, record 9.`
954	cGy DOSE TO BREAST (BR98)	BRE1;55	NUMBER	INPUT TRANSFORM: `K:X>99999!(X<0)!(X?.E1"."1N.N) X I $D(X) D CGYIT^ONCOOT` OUTPUT TRANSFORM: `D CGYOT^ONCOOT` LAST EDITED: `JUN 19, 1998` HELP-PROMPT: `Type a Number between 0 and 99999, 0 Decimal Digits` DESCRIPTION: `For female patients ONLY, record the cGy dose (00001-88887) given to the whole breast or chest wall. Do not include boost dose. If the patient did not receive radiation therapy, code 00000. If it is known that the` `patient received radiation therapy, but the dose is unknown, code 88888. If it is unknown if the patient raceived radiation, code 99999. For male patients, leave this field blank.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
955	SPECIFIC HORMONE THPY (BR98)	BRE1;56	SET	'0' FOR None; '1' FOR Tamoxifen; '2' FOR Orchiectomy; '3' FOR Estrogen; '4' FOR Other; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `JUN 19, 1998` DESCRIPTION: `For male patients ONLY, record the specific hormone treatment. Estrogen includes Diethylstilbestrol. For females, leave blank.`
956	CHEMOTHERAPY REGIME (BR98)	BRE1;57	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, no chemotherapy; '9' FOR Unknown; LAST EDITED: `JUN 19, 1998` DESCRIPTION: `Record the chemotherapeutic regime containing doxorubicin. Doxorubicin includes Adriamycin, Adriamycin-TM, Adriblastina, FT-106, 14-hydroxy daunomycin and Rubex.`
993	REGIONAL TX MODALITY CONV FLAG	27;7	SET	'Y' FOR YES; LAST EDITED: `FEB 06, 2003` DESCRIPTION: `This field will flag this record as having its REGIONAL TREATMENT MODALITY values converted from ROADS TO FORDS. The purpose of this field is to avoid converting already converted values.`
994	TYPE OF FIRST RECUR CONV FLAG	27;6	SET	'Y' FOR YES; LAST EDITED: `JAN 31, 2003` DESCRIPTION: `This field will flag this record as having its TYPE OF FIRST RECURRENCE values converted from ROADS TO FORDS. The purpose of this field is to avoid converting already converted values.`
995	STAGED BY CONV FLAG	27;5	SET	'Y' FOR YES; LAST EDITED: `JAN 06, 2003` DESCRIPTION: `This field will flag this record as having its STAGED BY (CLINICAL STAGE and STAGED BY (PATHOLOGIC STAGE) values converted from ROADS to FORDS. The purpose of this field is to avoid converting already converted values.`
996	SURGICAL MARGINS CONV FLAG	27;2	SET	'Y' FOR YES; LAST EDITED: `JAN 06, 2003` DESCRIPTION: `This field will flag this record as having its SURGICAL MARGINS value converted from ROADS to FORDS. The purpose of this field is to avoid converting already converted values.`
997	STAGE FLAG	27;1	SET	'Y' FOR YES; 'N' FOR NO; LAST EDITED: `OCT 04, 1996` DESCRIPTION: `Staging conversion flag.`
998	SCOPE OF LN SURGERY CONV FLAG	27;3	SET	'Y' FOR YES; LAST EDITED: `JAN 06, 2003` DESCRIPTION: `This field will flag this record as having its SCOPE OF LYMPH NODE SURGERY and SCOPE OF LN SURG @FACILITY values converted from ROADS to FORDS. The purpose of this field is to avoid converting already`
999	SURGICAL PROC/OTHER CONV FLAG	27;4	SET	'Y' FOR YES; LAST EDITED: `JAN 06, 2003` DESCRIPTION: `This field will flag this record as having its SURGICAL PROC/OTHER SITE and SURGICAL PROC/OTHER SITE @FAC values converted from ROADS to FORDS. The purpose of this field is to avoid converting already converted values.`
999.1	DATE OF DIAGNOSIS FLAG	27;8	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` LAST EDITED: `MAY 29, 2013` HELP-PROMPT: `Type a number between 0 and 99, 0 decimal digits.` DESCRIPTION: `Source of Standard: NAACCR Item #: 391 This field is a flag that explains why no appropriate value is entered for DATE DX (#3) field.` EXECUTABLE HELP: `S ONCITM=391 D DTFLGHLP^ONCOHELP`
999.11	RX DATE SURG DISCH FLAG	27;17	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` LAST EDITED: `MAY 29, 2013` HELP-PROMPT: `Type a number between 0 and 99, 0 decimal digits.` DESCRIPTION: `Source of Standard: NAACCR Item #: 3181 This field is a flag that explains why no appropriate value is entered for DATE MOST DEFINITIVE SURG DIS (#435) field.` EXECUTABLE HELP: `S ONCITM=3181 D DTFLGHLP^ONCOHELP`
999.12	RX DATE-RADIATION FLAG	27;18	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` LAST EDITED: `MAY 29, 2013` HELP-PROMPT: `Type a number between 0 and 99, 0 decimal digits.` DESCRIPTION: `Source of Standard: NAACCR Item #: 1211 This field is a flag that explains why no appropriate value is entered for DATE RADIATION STARTED (#51) field.` EXECUTABLE HELP: `S ONCITM=1211 D DTFLGHLP^ONCOHELP`
999.13	RX DATE RAD ENDED FLAG	27;19	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` LAST EDITED: `MAY 29, 2013` HELP-PROMPT: `Type a number between 0 and 99, 0 decimal digits.` DESCRIPTION: `Source of Standard: NAACCR Item #: 3221 This field is a flag that explains why no appropriate value is entered for DATE RADIATION ENDED (#361) field.` EXECUTABLE HELP: `S ONCITM=3221 D DTFLGHLP^ONCOHELP`
999.14	RX DATE SYSTEMIC FLAG	27;20	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` LAST EDITED: `MAY 29, 2013` HELP-PROMPT: `Type a number between 0 and 99, 0 decimal digits.` DESCRIPTION: `Source of Standard: NAACCR Item #: 3231 This field is a flag that explains why no appropriate value is entered for DATE SYSTEMIC THERAPY STARTED (#152) field.` EXECUTABLE HELP: `S ONCITM=3231 D DTFLGHLP^ONCOHELP`
999.15	RX DATE-CHEMO FLAG	27;21	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` LAST EDITED: `MAY 29, 2013` HELP-PROMPT: `Type a number between 0 and 99, 0 decimal digits.` DESCRIPTION: `Source of Standard: NAACCR Item #: 1221 This field is a flag that explains why no appropriate value is entered for CHEMOTHERAPY DATE (#53) field.` EXECUTABLE HELP: `S ONCITM=1221 D DTFLGHLP^ONCOHELP`
999.16	RX DATE-HORMONE FLAG	27;22	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` LAST EDITED: `MAY 29, 2013` HELP-PROMPT: `Type a number between 0 and 99, 0 decimal digits.` DESCRIPTION: `Source of Standard: NAACCR Item #: 1231 This field is a flag that explains why no appropriate value is entered for HORMONE THERAPY DATE (#54) field.` EXECUTABLE HELP: `S ONCITM=1231 D DTFLGHLP^ONCOHELP`
999.17	RX DATE-BRM FLAG	27;23	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` LAST EDITED: `MAY 29, 2013` HELP-PROMPT: `Type a number between 0 and 99, 0 decimal digits.` DESCRIPTION: `Source of Standard: NAACCR Item #: 1241 This field is a flag that explains why no appropriate value is entered for IMMUNOTHERAPY DATE (#55) field.` EXECUTABLE HELP: `S ONCITM=1241 D DTFLGHLP^ONCOHELP`
999.18	RX DATE-OTHER FLAG	27;24	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` LAST EDITED: `MAY 29, 2013` HELP-PROMPT: `Type a number between 0 and 99, 0 decimal digits.` DESCRIPTION: `Source of Standard: NAACCR Item #: 1251 This field is a flag that explains why no appropriate value is entered for OTHER TREATMENT START DATE (#57) field.` EXECUTABLE HELP: `S ONCITM=1251 D DTFLGHLP^ONCOHELP`
999.19	RX DATE-DX/STG PROC FLAG	27;25	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` LAST EDITED: `MAY 29, 2013` HELP-PROMPT: `Type a number between 0 and 99, 0 decimal digits.` DESCRIPTION: `Source of Standard: NAACCR Item #: 1281 This field is a flag that explains why no appropriate value is entered for SURGICAL DX/STAGING PROC DATE (#58.3) field.` EXECUTABLE HELP: `S ONCITM=1281 D DTFLGHLP^ONCOHELP`
999.2	DATE CONCLUSIVE DX FLAG	27;9	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` LAST EDITED: `MAY 29, 2013` HELP-PROMPT: `Type a number between 0 and 99, 0 decimal digits.` DESCRIPTION: `Source of Standard: NAACCR ITEM #: 448 This field is a flag that explains why no appropriate value is entered for DATE OF CONCLUSIVE DX (#193) field.` EXECUTABLE HELP: `S ONCITM=448 D DTFLGHLP^ONCOHELP`
999.21	RECURRENCE DATE-1ST FLAG	27;26	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` LAST EDITED: `MAY 29, 2013` HELP-PROMPT: `Type a number between 0 and 99, 0 decimal digits.` DESCRIPTION: `Source of Standard: NAACCR Item #: 1861 This field is a flag that explains why no appropriate value is entered for DATE OF FIRST RECURRENCE (#70) field.` EXECUTABLE HELP: `S ONCITM=1861 D DTFLGHLP^ONCOHELP` NOTES: `TRIGGERED by the DATE OF FIRST RECURRENCE field of the ONCOLOGY PRIMARY File`
999.22	DATE OF LAST CONTACT FLAG	27;27	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` LAST EDITED: `MAY 29, 2013` HELP-PROMPT: `Type a number between 0 and 99, 0 decimal digits.` DESCRIPTION: `Source of Standard: NAACCR Item #: 1751 This field is a flag that explains why no appropriate value is entered for the FOLLOW-UP (#400) multiple of the ONCOLOGY PATIENT (#160) file.` EXECUTABLE HELP: `S ONCITM=1751 D DTFLGHLP^ONCOHELP`
999.23	SUBSQ RX 2ND CRS DATE FLAG	27;28	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` LAST EDITED: `MAY 29, 2013` HELP-PROMPT: `Type a number between 0 and 99, 0 decimal digits.` DESCRIPTION: `Source of Standard: NAACCR Item #: 1661 This field is a flag that explains why no appropriate value is entered for SUBSEQUENT COURSE OF TREATMENT (#60) multiple field.` EXECUTABLE HELP: `S ONCITM=1661 D DTFLGHLP^ONCOHELP`
999.24	SUBSQ RX 3RD CRS DATE FLAG	27;29	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` LAST EDITED: `MAY 29, 2013` HELP-PROMPT: `Type a number between 0 and 99, 0 decimal digits.` DESCRIPTION: `Source of Standard: NAACCR Item #: 1681 This field is a flag that explains why no appropriate 2nd value is entered for SUBSEQUENT COURSE OF TREATMENT (#60) multiple field.` EXECUTABLE HELP: `S ONCITM=1681 D DTFLGHLP^ONCOHELP`
999.25	SUBSQ RX 4TH CRS DATE FLAG	27;30	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` LAST EDITED: `MAY 29, 2013` HELP-PROMPT: `Type a number between 0 and 99, 0 decimal digits.` DESCRIPTION: `Source of Standard: NAACCR Item #: 1701 This field is a flag that explains why no appropriate 3rd value is entered for SUBSEQUENT COURSE OF TREATMENT (#60) multiple field.` EXECUTABLE HELP: `S ONCITM=1701 D DTFLGHLP^ONCOHELP`
999.26	ADDRESS AT DX--STATE	27;31	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<2)!'(X?2U) X` LAST EDITED: `AUG 26, 2014` HELP-PROMPT: `Answer must be 2 characters in length.` DESCRIPTION: `Source of Standard: NAACCR Item #: 80 This field is for the patient's State from their Address at time of Diagnosis.`
999.27	ADDRESS AT DX--COUNTRY	27;32	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>3!($L(X)<3)!'(X?3U) X` LAST EDITED: `AUG 26, 2014` HELP-PROMPT: `Answer must be 3 characters in length.` DESCRIPTION: `Source of Standard: NAACCR Item #: 102 This field is for the patient's Country from their Address at the time of diagnosis.`
999.28	ADDRESS CURRENT--STATE	27;33	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<2)!'(X?2U) X` LAST EDITED: `AUG 26, 2014` HELP-PROMPT: `Answer must be 2 characters in length.` DESCRIPTION: `Source of Standard: NAACCR Item #: 1820 This field is for the patient's State from their current Address.`
999.289	ADDRESS CURRENT--POSTAL CODE	27;35	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>9!($L(X)<5) X` `MAXIMUM LENGTH: 9` LAST EDITED: `AUG 13, 2021` HELP-PROMPT: `Answer must be 5-9 characters in length.` DESCRIPTION: `Source of Standard: NAACCR Item #: 1830. Address current Postal Code of the patient. This data field is an override field of the patient zip code.`
999.29	ADDRESS CURRENT--COUNTRY	27;34	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>3!($L(X)<3)!'(X?3U) X` LAST EDITED: `AUG 26, 2014` HELP-PROMPT: `Answer must be 3 characters in length.` DESCRIPTION: `Source of Standard: NAACCR Item #: 1832 This field is for the patient's Country from their current Address.`
999.3	DATE OF MULT TUMORS FLAG	27;10	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` LAST EDITED: `MAY 29, 2013` HELP-PROMPT: `Type a number between 0 and 99, 0 decimal digits.` DESCRIPTION: `Source of Standard: NAACCR Item #: 439 This field is a flag that explains why no appropriate value is entered for DATE OF MULTIPLE TUMORS (#195) field.` EXECUTABLE HELP: `S ONCITM=439 D DTFLGHLP^ONCOHELP`
999.4	DATE OF FIRST CONTACT FLAG	27;11	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` LAST EDITED: `MAY 29, 2013` HELP-PROMPT: `Type a number between 0 and 99, 0 decimal digits.` DESCRIPTION: `Source of Standard: NAACCR Item #: 581 This field is a flag that explains why no appropriate value is entered for DATE OF FIRST CONTACT (#155) field.` EXECUTABLE HELP: `S ONCITM=581 D DTFLGHLP^ONCOHELP`
999.5	DATE OF INPT ADM FLAG	27;12	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` LAST EDITED: `MAY 29, 2013` HELP-PROMPT: `Type a number between 0 and 99, 0 decimal digits.` DESCRIPTION: `Source of Standard: NAACCR Item #: 591 This field is a flag that explains why no appropriate value is entered for DATE OF INPATIENT ADMISSION (#1) field.` EXECUTABLE HELP: `S ONCITM=591 D DTFLGHLP^ONCOHELP`
999.6	DATE OF INPT DISCH FLAG	27;13	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` LAST EDITED: `MAY 29, 2013` HELP-PROMPT: `Type a number between 0 and 99, 0 decimal digits.` DESCRIPTION: `Source of Standard: NAACCR Item #: 601 This field is a flag that explains why no appropriate value is entered for DATE OF INPATIENT DISCHARGE (#1.1) field.` EXECUTABLE HELP: `S ONCITM=601 D DTFLGHLP^ONCOHELP`
999.7	DATE 1ST CRS RX FLAG	27;14	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` LAST EDITED: `JUL 18, 2013` HELP-PROMPT: `Type a number between 0 and 99, 0 decimal digits.` DESCRIPTION: `Source of Standard: NAACCR Item #: 1271 This field is a flag that explains why no appropriate value is entered for FIRST COURSE OF TREATMENT DATE (#49) field.` EXECUTABLE HELP: `S ONCITM=1271 D DTFLGHLP^ONCOHELP`
999.8	RX DATE-SURGERY FLAG	27;15	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` LAST EDITED: `MAY 29, 2013` HELP-PROMPT: `Type a number between 0 and 99, 0 decimal digits.` DESCRIPTION: `Source of Standard: NAACCR Item #: 1201 This field is a flag that explains why no appropriate value is entered for DATE FIRST SURGICAL PROCEDURE (#170) field.` EXECUTABLE HELP: `S ONCITM=1201 D DTFLGHLP^ONCOHELP`
999.9	RX DATE MST DEFN SRG FLAG	27;16	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<0)!(X?.E1"."1N.N) X` LAST EDITED: `MAY 29, 2013` HELP-PROMPT: `Type a number between 0 and 99, 0 decimal digits.` DESCRIPTION: `Source of Standard: NAACCR Item #: 3171 This field is a flag that explains why no appropriate value is entered for MOST DEFINITIVE SURG DATE (#50) field.` EXECUTABLE HELP: `S ONCITM=3171 D DTFLGHLP^ONCOHELP`
1000	ORAL CONTRACEPTIVES	HEP1;1	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 06, 2000` DESCRIPTION: `This field describes whether the patient was receiving prescribed hormonal therapy at the time of diagnosis. This information can typically be found in either the patient's clinic chart or the managing physician's notes.`
1001	ESTROGEN REPLACEMENT	HEP1;2	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 06, 2000` DESCRIPTION: `This field describes whether the patient was receiving prescribed hormonal therapy at the time of diagnosis. This information can typically be found in either the patient's clinic chart or the managing physician's notes.`
1002	TAMOXIFEN	HEP1;3	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 06, 2000` DESCRIPTION: `This field describes whether the patient was receiving prescribed hormonal therapy at the time of diagnosis. This information can typically be found in either the patient's clinic chart or the managing physician's notes.`
1003	OTHER HORMONES	HEP1;4	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 06, 2000` DESCRIPTION: `This field describes whether the patient was receiving prescribed hormonal therapy at the time of diagnosis. This information can typically be found in either the patient's clinic chart or the managing physician's notes.`
1004	ASCITES	HEP1;5	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 06, 2000` DESCRIPTION: `This field describes all conditions relevant to liver cancer which were reported as occurring in the patient at the time of diagnosis. This information can typically be found in the managing physician's notes.`
1005	CIRRHOSIS	HEP1;6	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 06, 2000` DESCRIPTION: `This field describes all conditions relevant to liver cancer which were reported as occurring in the patient at the time of diagnosis. This information can typically be found in the managing physician's notes.`
1006	CHILD'S CLASS A	HEP1;7	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 06, 2000` DESCRIPTION: `This field describes all conditions relevant to liver cancer which were reported as occurring in the patient at the time of diagnosis. This information can typically be found in the managing physician's notes.`
1007	CHILD'S CLASS B	HEP1;8	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 06, 2000` DESCRIPTION: `This field describes all conditions relevant to liver cancer which were reported as occurring in the patient at the time of diagnosis. This information can typically be found in the managing physician's notes.`
1008	CHILD'S CLASS C	HEP1;9	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 06, 2000` DESCRIPTION: `This field describes all conditions relevant to liver cancer which were reported as occurring in the patient at the time of diagnosis. This information can typically be found in the managing physician's notes.`
1009	HEPATITIS B	HEP1;10	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 06, 2000` DESCRIPTION: `This field describes all conditions relevant to liver cancer which were reported as occurring in the patient at the time of diagnosis. This information can typically be found in the managing physician's notes.`
1010	HEPATITIS C	HEP1;11	SET	'0' FOR Patient screened, negative results; '1' FOR Patient screened, positive results for Hep C; '8' FOR Patient refused; '9' FOR Unknown if patient screened; LAST EDITED: `APR 16, 2003` DESCRIPTION: `This field describes all conditions relevant to liver cancer which were reported as occurring in the patient at the time of diagnosis. This information can typically be found in the managing physician's notes.`
1011	HEMOCHROMATOSIS	HEP1;12	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 06, 2000` DESCRIPTION: `This field describes all conditions relevant to liver cancer which were reported as occurring in the patient at the time of diagnosis. This information can typically be found in the managing physician's notes.`
1012	ALCOHOL CONSUMPTION	HEP1;13	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S X=$S($L(X)=1:"00"_X,$L(X)=2:"0"_X,1:X) W:X="000" " Never consumed alcohol" W:X="999" " Number of drinks unknown"` OUTPUT TRANSFORM: `S Y=$S(Y="000":"Never consumed alcohol",Y=999:"Number of drinks unknown",1:Y)` LAST EDITED: `JUN 30, 2000` HELP-PROMPT: `Enter 000-Never consumed alcohol; 001-998; 999-Number of drinks unknown` DESCRIPTION: `This field describes the number of drinks (beer, wine, other alcohol) consumed by the patient per week. If the patient has never consumed alcohol, code 000. If the number of drinks per week is unknown, code 999. This` `information can typically be found in either the patient's clinic chart or the managing physician's notes.`
1013	AFP (IU/ml)	HEP1;14	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>5!($L(X)<1)!'(X?1.5N) X` OUTPUT TRANSFORM: `S Y=$S($L(Y)=1:"0000"_Y,$L(Y)=2:"000"_Y,$L(Y)=3:"00"_Y,$L(Y)=4:"0"_Y,1:Y)` LAST EDITED: `JAN 06, 2000` HELP-PROMPT: `Type a Number between 0 and 99999, 0 Decimal Digits` DESCRIPTION: `This field describes the absolute value of each tumor marker test administered to the patient prior to the start of the first course of treatment. Tumor markers considered in this study include: AFP (IU/ml); CEA (mg/ml);` `and CA19.9 (U/ml). This information can typically be found in either the patient's hospital chart or laboratory records. Record tumor markers as whole numbers, round decimals to the nearest integer; for example 12.5` `would be rounded up to 13, and 4.4 would be rounded down to 4. If a particular tumor marker test was not administered code 00000. If a test was administered but the results is unknown, code 99999.`
1014	CEA (mg/ml)	HEP1;15	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>5!($L(X)<1)!'(X?1.5N) X` OUTPUT TRANSFORM: `S Y=$S($L(Y)=1:"0000"_Y,$L(Y)=2:"000"_Y,$L(Y)=3:"00"_Y,$L(Y)=4:"0"_Y,1:Y)` LAST EDITED: `JAN 06, 2000` HELP-PROMPT: `Type a Number between 0 and 99999, 0 Decimal Digits` DESCRIPTION: `This field describes the absolute value of each tumor marker test administered to the patient prior to the start of the first course of treatment. Tumor markers considered in this study include: AFP (IU/ml); CEA (mg/ml);` `and CA19.9 (U/ml). This information can typically be found in either the patient's hospital chart or laboratory records. Record tumor markers as whole numbers, round decimals to the nearest integer; for example 12.5` `would be rounded up to 13, and 4.4 would be rounded down to 4. If a particular tumor marker test was not administered code 00000. If a test was administered but the results is unknown, code 99999.`
1015	CA19.9 (U/ml)	HEP1;16	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>5!($L(X)<1)!'(X?1.5N) X` OUTPUT TRANSFORM: `S Y=$S($L(Y)=1:"0000"_Y,$L(Y)=2:"000"_Y,$L(Y)=3:"00"_Y,$L(Y)=4:"0"_Y,1:Y)` LAST EDITED: `JAN 06, 2000` HELP-PROMPT: `Type a Number between 0 and 99999, 0 Decimal Digits` DESCRIPTION: `This field describes the absolute value of each tumor marker test administered to the patient prior to the start of the first course of treatment. Tumor markers considered in this study include: AFP (IU/ml); CEA (mg/ml);` `and CA19.9 (U/ml). This information can typically be found in either the patient's hospital chart or laboratory records. Record tumor markers as whole numbers, round decimals to the nearest integer; for example 12.5` `would be rounded up to 13, and 4.4 would be rounded down to 4. If a particular tumor marker test was not administered code 00000. If a test was administered but the results is unknown, code 99999.`
1016	PROTIME (sec)	HEP1;17	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>5!($L(X)<1)!'(X?1.5N) X` OUTPUT TRANSFORM: `S Y=$S($L(Y)=1:"0000"_Y,$L(Y)=2:"000"_Y,$L(Y)=3:"00"_Y,$L(Y)=4:"0"_Y,1:Y)` LAST EDITED: `JAN 07, 2000` HELP-PROMPT: `Type a Number between 0 and 99999, 0 Decimal Digits` DESCRIPTION: `This field describes the absolute value of each liver function test administered to the patient prior to the start of the first course of treatment. This information can typically be found in either the patient's` `hospital chart or laboratory records. Record test results as whole numbers, round decimals to the nearest integer; for example 12.5 would be rounded up to 13, and 4.4 would be rounded down to 4. If a particular test was` `not administered, code 00000. If a test was administered but the result unknown, code 99999.`
1017	BILIRUBIN (mg/ml)	HEP1;18	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>5!($L(X)<1)!'(X?1.5N) X` OUTPUT TRANSFORM: `S Y=$S($L(Y)=1:"0000"_Y,$L(Y)=2:"000"_Y,$L(Y)=3:"00"_Y,$L(Y)=4:"0"_Y,1:Y)` LAST EDITED: `JAN 07, 2000` HELP-PROMPT: `Type a Number between 0 and 99999, 0 Decimal Digits` DESCRIPTION: `This field describes the absolute value of each liver function test administered to the patient prior to the start of the first course of treatment. This information can typically be found in either the patient's` `hospital chart or laboratory records. Record test results as whole numbers, round decimals to the nearest integer; for example 12.5 would be rounded up to 13, and 4.4 would be rounded down to 4. If a particular test was` `not administered, code 00000. If a test was administered but the result unknown, code 99999.`
1018	ALBUMIN (g/dl)	HEP1;19	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>5!($L(X)<1)!'(X?1.5N) X` OUTPUT TRANSFORM: `S Y=$S($L(Y)=1:"0000"_Y,$L(Y)=2:"000"_Y,$L(Y)=3:"00"_Y,$L(Y)=4:"0"_Y,1:Y)` LAST EDITED: `JAN 07, 2000` HELP-PROMPT: `Type a Number between 0 and 99999, 0 Decimal Digits` DESCRIPTION: `This field describes the absolute value of each liver function test administered to the patient prior to the start of the first course of treatment. This information can typically be found in either the patient's` `hospital chart or laboratory records. Record test results as whole numbers, round decimals to the nearest integer; for example 12.5 would be rounded up to 13, and 4.4 would be rounded down to 4. If a particular test was` `not administered, code 00000. If a test was administered but the result unknown, code 99999.`
1019	LDH (U/I)	HEP1;20	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>5!($L(X)<1)!'(X?1.5N) X` OUTPUT TRANSFORM: `S Y=$S($L(Y)=1:"0000"_Y,$L(Y)=2:"000"_Y,$L(Y)=3:"00"_Y,$L(Y)=4:"0"_Y,1:Y)` LAST EDITED: `JAN 07, 2000` HELP-PROMPT: `Type a Number between 0 and 99999, 0 Decimal Digits` DESCRIPTION: `This field describes the absolute value of each liver function test administered to the patient prior to the start of the first course of treatment. This information can typically be found in either the patient's` `hospital chart or laboratory records. Record test results as whole numbers, round decimals to the nearest integer; for example 12.5 would be rounded up to 13, and 4.4 would be rounded down to 4. If a particular test was` `not administered, code 00000. If a test was administered but the result unknown, code 99999.`
1020	CT ARTERIAL PORT-PERFORMED	HEP1;21	SET	'0' FOR Not performed; '1' FOR Performed; '9' FOR Unknown; LAST EDITED: `JAN 07, 2000` DESCRIPTION: `This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether` `the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This` `information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.`
1021	CT ARTERIAL PORT-CIRRHOSIS	HEP1;22	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `JAN 07, 2000` DESCRIPTION: `This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether` `the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This` `information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.`
1022	CT ARTERIAL PORT-VASCULAR INV	HEP1;23	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `JAN 07, 2000` DESCRIPTION: `This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether` `the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This` `information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.`
1023	CT ARTERIAL PORT-BILOBAR DIS	HEP1;24	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `JAN 07, 2000` DESCRIPTION: `This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether` `the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This` `information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.`
1024	CT ARTERIAL PORT-LYMPH NODES	HEP1;25	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `JAN 07, 2000` DESCRIPTION: `This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether` `the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This` `information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.`
1025	CT ARTERIAL PORT-SIZE OF TUMOR	HEP1;26	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S X=$S($L(X)=1:"00"_X,$L(X)=2:"0"_X,1:X) W:X="000" " Not performed" W:X="999" " Performed, size unknown"` OUTPUT TRANSFORM: `S Y=$S(Y="000":"Not performed",Y=999:"Performed, size unknown",1:Y)` LAST EDITED: `JAN 07, 2000` HELP-PROMPT: `Enter 000-Not performed; 001-998; 999 Performed, size unknown` DESCRIPTION: `This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether` `the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This` `information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.` `The size of the dominant tumor describes the dimension or diameter of the largest identified tumor in millimeters (1 cm = 10 mm). If the tumor has multiple measurements, code the largest size. For example, if the dominant` `or largest tumor is reported as measuring 3x4.4x2.5 cm, then code as 044.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1026	CT ARTERIAL PORT-NUM 0F TUMORS	HEP1;27	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S X=$S($L(X)=1:"0"_X,1:X) W:X="00" " Not performed" W:X="99" " Performed, number unknown"` OUTPUT TRANSFORM: `S Y=$S(Y="00":"Not performed",Y=99:"Performed, number unknown",1:Y)` LAST EDITED: `JAN 07, 2000` HELP-PROMPT: `Enter 00-Not performed; 01-98; 99-Performed, number unknown` DESCRIPTION: `This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether` `the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This` `information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1027	SPIRAL CT-PERFORMED	HEP1;28	SET	'0' FOR Not performed; '1' FOR Performed; '9' FOR Unknown; LAST EDITED: `JAN 07, 2000` DESCRIPTION: `This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether` `the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This` `information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.`
1028	SPIRAL CT-CIRRHOSIS	HEP1;29	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `JAN 07, 2000` DESCRIPTION: `This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether` `the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This` `information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.`
1029	SPIRAL CT-VASCULAR INV	HEP1;30	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `JAN 07, 2000` DESCRIPTION: `This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether` `the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This` `information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.`
1030	SPIRAL CT-BILOBAR DIS	HEP1;31	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `JAN 07, 2000` DESCRIPTION: `This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether` `the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This` `information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.`
1031	SPIRAL CT-LYMPH NODES	HEP1;32	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `JAN 07, 2000` DESCRIPTION: `This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether` `the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This` `information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.`
1032	SPIRAL CT-SIZE OF TUMOR	HEP1;33	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S X=$S($L(X)=1:"00"_X,$L(X)=2:"0"_X,1:X) W:X="000" " Not performed" W:X="999" " Performed, size unknown"` OUTPUT TRANSFORM: `S Y=$S(Y="000":"Not performed",Y=999:"Performed, size unknown",1:Y)` LAST EDITED: `JAN 07, 2000` HELP-PROMPT: `Enter 000-Not performed; 001-998; 999 Performed, size unknown` DESCRIPTION: `This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether` `the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This` `information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.` `The size of the dominant tumor describes the dimension or diameter of the largest identified tumor in millimeters (1 cm = 10 mm). If the tumor has multiple measurements, code the largest size. For example, if the dominant` `or largest tumor is reported as measuring 3x4.4x2.5 cm, then code as 044.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1033	SPIRAL CT-NUM OF TUMORS	HEP1;34	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S X=$S($L(X)=1:"0"_X,1:X) W:X="00" " Not performed" W:X="99" " Performed, number unknown"` OUTPUT TRANSFORM: `S Y=$S(Y="00":"Not performed",Y=99:"Performed, number unknown",1:Y)` LAST EDITED: `JAN 07, 2000` HELP-PROMPT: `Enter 00-Not performed; 01-98; 99-Performed, number unknown` DESCRIPTION: `This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether` `the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This` `information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1034	INCREMENTAL CT-PERFORMED	HEP1;35	SET	'0' FOR Not performed; '1' FOR Performed; '9' FOR Unknown; LAST EDITED: `JAN 07, 2000` DESCRIPTION: `This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether` `the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This` `information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.`
1035	INCREMENTAL CT-CIRRHOSIS	HEP1;36	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `JAN 07, 2000` DESCRIPTION: `This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether` `the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This` `information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.`
1036	INCREMENTAL CT-VASCULAR INV	HEP1;37	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `JAN 07, 2000` DESCRIPTION: `This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether` `the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This` `information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.`
1037	INCREMENTAL CT-BILOBAR DIS	HEP1;38	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `JAN 07, 2000` DESCRIPTION: `This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether` `the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This` `information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.`
1038	INCREMENTAL CT-LYMPH NODES	HEP1;39	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `JAN 07, 2000` DESCRIPTION: `This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether` `the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This` `information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.`
1039	INCREMENTAL CT-SIZE OF TUMOR	HEP1;40	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S X=$S($L(X)=1:"00"_X,$L(X)=2:"0"_X,1:X) W:X="000" " Not performed" W:X="999" " Performed, size unknown"` OUTPUT TRANSFORM: `S Y=$S(Y="000":"Not performed",Y=999:"Performed, size unknown",1:Y)` LAST EDITED: `JAN 07, 2000` HELP-PROMPT: `Enter 000-Not performed; 001-998; 999 Performed, size unknown` DESCRIPTION: `This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether` `the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This` `information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.` `The size of the dominant tumor describes the dimension or diameter of the largest identified tumor in millimeters (1 cm = 10 mm). If the tumor has multiple measurements, code the largest size. For example, if the dominant` `or largest tumor is reported as measuring 3x4.4x2.5 cm, then code as 044.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1040	INCREMENTAL CT-NUM 0F TUMORS	HEP1;41	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S X=$S($L(X)=1:"0"_X,1:X) W:X="00" " Not performed" W:X="99" " Performed, number unknown"` OUTPUT TRANSFORM: `S Y=$S(Y="00":"Not performed",Y=99:"Performed, number unknown",1:Y)` LAST EDITED: `JAN 07, 2000` HELP-PROMPT: `Enter 00-Not performed; 01-98; 99-Performed, number unknown` DESCRIPTION: `This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether` `the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This` `information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1041	ULTRASOUND-PERFORMED	HEP1;42	SET	'0' FOR Not performed; '1' FOR Performed; '9' FOR Unknown; LAST EDITED: `JAN 07, 2000` DESCRIPTION: `This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether` `the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This` `information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.`
1042	ULTRASOUND-CIRRHOSIS	HEP1;43	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `JAN 07, 2000` DESCRIPTION: `This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether` `the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This` `information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.`
1043	ULTRASOUND-VASCULAR INV	HEP1;44	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `JAN 07, 2000` DESCRIPTION: `This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether` `the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This` `information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.`
1044	ULTRASOUND-BILOBAR DIS	HEP1;45	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `JAN 07, 2000` DESCRIPTION: `This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether` `the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This` `information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.`
1045	ULTRASOUND-LYMPH NODES	HEP1;46	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `JAN 07, 2000` DESCRIPTION: `This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether` `the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This` `information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.`
1046	ULTRASOUND-SIZE OF TUMOR	HEP1;47	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S X=$S($L(X)=1:"00"_X,$L(X)=2:"0"_X,1:X) W:X="000" " Not performed" W:X="999" " Performed, size unknown"` OUTPUT TRANSFORM: `S Y=$S(Y="000":"Not performed",Y=999:"Performed, size unknown",1:Y)` LAST EDITED: `JAN 07, 2000` HELP-PROMPT: `Enter 000-Not performed; 001-998; 999 Performed, size unknown` DESCRIPTION: `This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether` `the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This` `information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.` `The size of the dominant tumor describes the dimension or diameter of the largest identified tumor in millimeters (1 cm = 10 mm). If the tumor has multiple measurements, code the largest size. For example, if the dominant` `or largest tumor is reported as measuring 3x4.4x2.5 cm, then code as 044.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1047	ULTRASOUND-NUM 0F TUMORS	HEP1;48	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S X=$S($L(X)=1:"0"_X,1:X) W:X="00" " Not performed" W:X="99" " Performed, number unknown"` OUTPUT TRANSFORM: `S Y=$S(Y="00":"Not performed",Y=99:"Performed, number unknown",1:Y)` LAST EDITED: `JAN 07, 2000` HELP-PROMPT: `Enter 00-Not performed; 01-98; 99-Performed, number unknown` DESCRIPTION: `This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether` `the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This` `information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1048	MRI-PERFORMED	HEP1;49	SET	'0' FOR Not performed; '1' FOR Performed; '9' FOR Unknown; LAST EDITED: `JAN 07, 2000` DESCRIPTION: `This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether` `the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This` `information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.`
1049	MRI-CIRRHOSIS	HEP1;50	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `JAN 07, 2000` DESCRIPTION: `This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether` `the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This` `information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.`
1050	MRI-VASCULAR INV	HEP1;51	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `JAN 07, 2000` DESCRIPTION: `This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether` `the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This` `information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.`
1051	MRI-BILOBAR DIS	HEP1;52	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `JAN 07, 2000` DESCRIPTION: `This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether` `the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This` `information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.`
1052	MRI-LYMPH NODES	HEP1;53	SET	'0' FOR NO; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `JAN 07, 2000` DESCRIPTION: `This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether` `the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This` `information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.`
1053	MRI-SIZE OF TUMOR	HEP1;54	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S X=$S($L(X)=1:"00"_X,$L(X)=2:"0"_X,1:X) W:X="000" " Not performed" W:X="999" " Performed, size unknown"` OUTPUT TRANSFORM: `S Y=$S(Y="000":"Not performed",Y=999:"Performed, size unknown",1:Y)` LAST EDITED: `JAN 07, 2000` HELP-PROMPT: `Enter 000-Not performed; 001-998; 999 Performed, size unknown` DESCRIPTION: `This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether` `the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This` `information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.` `The size of the dominant tumor describes the dimension or diameter of the largest identified tumor in millimeters (1 cm = 10 mm). If the tumor has multiple measurements, code the largest size. For example, if the dominant` `or largest tumor is reported as measuring 3x4.4x2.5 cm, then code as 044.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1054	MRI-NUM 0F TUMORS	HEP1;55	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S X=$S($L(X)=1:"0"_X,1:X) W:X="00" " Not performed" W:X="99" " Performed, number unknown"` OUTPUT TRANSFORM: `S Y=$S(Y="00":"Not performed",Y=99:"Performed, number unknown",1:Y)` LAST EDITED: `JAN 07, 2000` HELP-PROMPT: `Enter 00-Not performed; 01-98; 99-Performed, number unknown` DESCRIPTION: `This field describes the findings from each type of radiological imaging technique utilized in the evaluation of the patient. Record four pieces of information, 1) whether the imaging technique was performed; 2) whether` `the presence of cirrhosis, bilobar disease, vascular invasion, or enlarged lymph nodes were noted; 3) record the size of the dominant (largest) tumor in millimeters, and 4) the number of tumor nodules present. This` `information can typically be found in either the patient's hospital chart, the managing physician's notes, or the managing radiologist's notes.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1055	DEFINITIVE DIAGNOSIS	HEP1;56	SET	'1' FOR Percutaneous biopsy; '2' FOR At definitive cancer-directed surgery; '3' FOR Incidental at liver transplantation; '9' FOR Unknown; LAST EDITED: `JAN 10, 2000` DESCRIPTION: `This field describes whether the DEFINITIVE DIAGNOSIS was achieved by percutaneous biopsy; at the time of the definitive cancer-directed surgical procedure; or at the time of pathologic examination of an explanted liver` `specimen. This information can typically by found in either the patient's hospital or clinical chart, or operative note.`
1056	RADIO-FREQUENCY DESTRUCTION	HEP1;57	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `JAN 10, 2000` DESCRIPTION: `This field describes cancer-directed surgery of the primary site which does not appear as part of the Commission on Cancer's required surgical codes. If SURGERY OF PRIMARY SITE (question 36) was coded 17 then record` `whether the patient received RADIO-FREQUENCY DESTRUCTION of the tumor.`
1057	ABLATION & RESECTION	HEP1;58	SET	'00' FOR Ablation & resection not administered; '11' FOR Photodynamic therapy; '12' FOR Electrocautery, fulguration; '13' FOR Cryosurgery; '14' FOR Laser; '15' FOR Alcohol; '16' FOR Heat; '17' FOR Radio-frequency; '18' FOR Other; '88' FOR NA; '99' FOR Ablation administered, type unknown; LAST EDITED: `JAN 10, 2000` DESCRIPTION: `This field describes the combination of ablative surgery and resection administered to the primary site. If the patient received both ablation and resection, record the ablative surgical therapy administered. If the` `patient did not receive a combination of surgical ablation and resection, code 00. If no cancer-directed surgery was administered, code 88.`
1058	DISTANCE TO CLOSEST MARGIN	HEP1;59	SET	'0' FOR Margins involved; '1' FOR Negative margins, < 1cm; '2' FOR Negative margins, 1cm - 2cm; '3' FOR Negative margins, > 2cm; '8' FOR NA; '9' FOR Unknown, not described; LAST EDITED: `JAN 10, 2000` DESCRIPTION: `This field describes the distance from the resected tumor to the closest margin. Code distance of margin ONLY if the tumor was surgically resected, this includes tumors which were ablated and resected. If no` `cancer-directed surgery was administered, or if the tumor was surgically ablated only, code 8.`
1059	ABLATION	HEP1;60	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `JAN 10, 2000` DESCRIPTION: `This field describes the surgical treatment of either microscopic or macroscopic residual tumor remaining AFTER the most definitive surgery of the primary site. Record whether this remaining tumor was ablated and/or` `resected. Ablation includes: photodynamic therapy; electrocautery; fulguration; cryosurgery; laser; alcohol; heat; radio-frequency; ultra- sound; acetic acid.`
1060	RESECTION	HEP1;61	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `JAN 10, 2000` DESCRIPTION: `This field describes the surgical treatment of either microscopic or macroscopic residual tumor remaining AFTER the most definitive surgery of the primary site. Record whether this remaining tumor was ablated and/or` `resected. Resection includes: wedge resection, NOS; segmental resection; lobectomy, NOS (simple and extended); total hepatectomy with transplant; hepatectomy, NOS.`
1061	CISPLATIN	HEP1;62	SET	'0' FOR No; '1' FOR Yes; '8' FOR Recommended, not known if administered; '9' FOR Unknown if recommended or administered; LAST EDITED: `JAN 11, 2000` DESCRIPTION: `This field describes whether this type of chemotherapeutic agent was administered. This information can typically be found in either the patient's hospital chart or the managing medical oncologist's notes.`
1062	FUDR	HEP1;63	SET	'0' FOR No; '1' FOR Yes; '8' FOR Recommended, not known if administered; '9' FOR Unknown if recommended or administered; LAST EDITED: `JAN 11, 2000` DESCRIPTION: `This field describes whether this type of chemotherapeutic agent was administered. This information can typically be found in either the patient's hospital chart or the managing medical oncologist's notes.`
1063	5-FU	HEP1;64	SET	'0' FOR No; '1' FOR Yes; '8' FOR Recommended, not known if administered; '9' FOR Unknown if recommended or administered; LAST EDITED: `JAN 11, 2000` DESCRIPTION: `This field describes whether this type of chemotherapeutic agent was administered. This information can typically be found in either the patient's hospital chart or the managing medical oncologist's notes.`
1064	FU & LEUCOVORIN	HEP1;65	SET	'0' FOR No; '1' FOR Yes; '8' FOR Recommended, not known if administered; '9' FOR Unknown if recommended or administered; LAST EDITED: `JAN 11, 2000` DESCRIPTION: `This field describes whether this type of chemotherapeutic agent was administered. This information can typically be found in either the patient's hospital chart or the managing medical oncologist's notes.`
1065	IRINOTECAN (CPT-11)	HEP1;66	SET	'0' FOR No; '1' FOR Yes; '8' FOR Recommended, not known if administered; '9' FOR Unknown if recommended or administered; LAST EDITED: `JAN 11, 2000` DESCRIPTION: `This field describes whether this type of chemotherapeutic agent was administered. This information can typically be found in either the patient's hospital chart or the managing medical oncologist's notes.`
1066	MITOMYCIN C	HEP1;67	SET	'0' FOR No; '1' FOR Yes; '8' FOR Recommended, now known if administered; '9' FOR Unknown if recommended or administered; LAST EDITED: `JAN 11, 2000` DESCRIPTION: `This field describes whether this type of chemotherapeutic agent was administered. This information can typically be found in either the patient's hospital chart or the managing medical oncologist's notes.`
1067	OXALIPLATIN	HEP1;68	SET	'0' FOR No; '1' FOR Yes; '8' FOR Recommended, not known if administered; '9' FOR Unknown if recommended or administered; LAST EDITED: `JAN 11, 2000` DESCRIPTION: `This field describes whether this type of chemotherapeutic agent was administered. This information can typically be found in either the patient's hospital chart or the managing medical oncologist's notes.`
1068	GEMCITABINE	HEP1;69	SET	'0' FOR No; '1' FOR Yes; '8' FOR Recommended, not known if administered; '9' FOR Unknown if recommended or administered; LAST EDITED: `JAN 11, 2000` DESCRIPTION: `This field describes whether this type of chemotherapeutic agent was administered. This information can typically be found in either the patient's hospital chart or the managing medical oncologist's notes.`
1069	ROUTE CHEMO ADMIN	HEP1;70	SET	'01' FOR Intrathecal; '02' FOR Intra-arterial, bolus; '03' FOR Intravenous inf; '04' FOR Hepatic inf; '05' FOR Intra-arterial chemoembolization; '06' FOR Intratumoral inj of alcohol; '07' FOR Portal inf; '08' FOR Orally; '09' FOR Intramuscular; '88' FOR NA; '99' FOR Chemo admin, route unk; LAST EDITED: `JAN 11, 2000` DESCRIPTION: `This field describes the route/method by which chemotherapy was administered. This information can typically be found in either the patient's hospital chart or the managing medical oncologist's notes.`
1070	CHEMOTHERAPY/SURGERY SEQUENCE	HEP1;71	SET	'0' FOR No chemotherapy and/or no surgery; '1' FOR Chemotherapy before surgery; '2' FOR Chemotherapy after surgery; '3' FOR Chemotherapy before and after surgery; '9' FOR Chemotherapy and surgery, sequence unknown; LAST EDITED: `JAN 11, 2000` DESCRIPTION: `This field describes the sequence in which chemotherapy and primary tumor cancer-directed surgery were administered.`
1071	ARTERIAL EMBOLIZATION	HEP1;72	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 11, 2000` DESCRIPTION: `This field describes whether the patient had their tumor embolized without chemotherapy. This procedure involves the embolizing or clotting of a portion of the hepatic artery to disrupt the blood flow to the tumor.` `Information about this treatment modality can be found in the Vascular/Interventional Radiology procedure notes.`
1072	DEATH W/I 30 DAYS START TX	HEP1;73	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 11, 2000` DESCRIPTION: `This field describes whether the patient died from any cause within 30 days of the start of cancer-directed therapy.`
1100	HISTORY OF MELANOMA (PT)	MEL1;1	SET	'0' FOR None; '1' FOR Yes, synchronous or <2 months; '2' FOR Yes, 2 months to <4 years; '3' FOR Yes, 4 years to <7 years; '4' FOR Yes, 7 years to <15 years; '5' FOR Yes, 15 years or more; '6' FOR Yes, time period unknown; '9' FOR Unk if history of melanoma exists; LAST EDITED: `JAN 06, 1999` DESCRIPTION: `Record if patient had or currently has any personal history of other melanoma and, if so, how far back it occurred in relation to the present melanoma.`
1101	HISTORY OF OTHER CANCER (PT)	MEL1;2	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 08, 1999` DESCRIPTION: `Record if the patient had any history of other types of cancer.`
1102	FIRST SITE CODE	MEL1;3	POINTER TO ICDO TOPOGRAPHY FILE (#164)	ICDO TOPOGRAPHY(#164) OUTPUT TRANSFORM: `S Y=$P($G(^ONCO(164,+Y,0)),U,2)_" "_$P($G(^ONCO(164,+Y,0)),U,1)` LAST EDITED: `JAN 07, 1999` DESCRIPTION: `Record the primary site of the most recent other cancer with which the patient has been diagnosed, if any. If no previous cancer was diagnosed, code 000. If a previous cancer was diagnosed, but the site is unknown, code` `888. If it is unknown whether a history of other cancers exists for the patient, code 999.`
1103	FIRST SITE DIAGNOSIS DATE	MEL1;4	DATE	INPUT TRANSFORM: `D CHDTIT^ONCOPCE` OUTPUT TRANSFORM: `D CHDTOT^ONCOPCE` LAST EDITED: `JAN 08, 1999` DESCRIPTION: `Record the date on which the most recent other cancer was diagnosed. If no previous cancer was diagnosed, code the date with 0's. If a previous cancer was diagnosed, but the date is unknown, code the date with 8's. If` `it is unknown whether a history of other cancers exists for the patient, code the date with 9's.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1104	SECOND SITE CODE	MEL1;5	POINTER TO ICDO TOPOGRAPHY FILE (#164)	ICDO TOPOGRAPHY(#164) OUTPUT TRANSFORM: `S Y=$P($G(^ONCO(164,+Y,0)),U,2)_" "_$P($G(^ONCO(164,+Y,0)),U,1)` LAST EDITED: `JAN 07, 1999` DESCRIPTION: `Record the primary site of the second most recent other cancer with which the patient has been diagnosed, if any. If no previous cancer was diagnosed, code 000. If a previous cancer was diagnosed, but the site is` `unknown, code 888. If it is unknown whether a history of other cancers exists for the patient, code 999.`
1105	SECOND SITE DIAGNOSIS DATE	MEL1;6	DATE	INPUT TRANSFORM: `D CHDTIT^ONCOPCE` OUTPUT TRANSFORM: `D CHDTOT^ONCOPCE` LAST EDITED: `JAN 08, 1999` DESCRIPTION: `Record the date on which the second most recent other cancer was diagnosed. If no previous cancer was diagnosed, code the date 00/00/00. If a previous cancer was diagnosed, but the date is unknown, code the date` `88/88/88. If it is unknown whether a history of other cancers exists for the patient, code the date 99/99/99.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1106	PREGNANCY AT INITIAL DIAGNOSIS	MEL1;7	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, male; '9' FOR Unknown; LAST EDITED: `JAN 08, 1999` DESCRIPTION: `Record whether the patient was pregnant at the time of initial diagnosis.`
1107	EXOGENOUS HORMONES	MEL1;8	SET	'0' FOR None; '1' FOR Yes, HRT (hormone replacement therapy); '2' FOR Yes, OC (oral contraceptives); '3' FOR Yes, both HRT and OC; '4' FOR Yes, type unknown; '8' FOR NA, male; '9' FOR Unknown; LAST EDITED: `JAN 12, 1999` DESCRIPTION: `Record whether the patient was receiving prescribed exogenous therapy at the time of initial diagnosis and the number of years of therapy. For this question, exogenous hormones are estrogen`
1108	DISEASE PRESENTATION LOCATION	MEL1;9	SET	'1' FOR Solitary cutaneous/subcutaneous; '2' FOR Multiple cutaneous/subcutaneous; '3' FOR Nodal; '4' FOR Visceral; '5' FOR Other; '8' FOR NA, primary site known; '9' FOR Unknown; LAST EDITED: `JAN 08, 1999` DESCRIPTION: `Record the location of the disease presentation. If the primary site is known, code as 8, not applicable.`
1109	TYPE OF BIOPSY	MEL1;10	SET	'0' FOR No biopsy performed; '1' FOR Excisional; '2' FOR Punch; '3' FOR Incisional; '4' FOR Shave; '5' FOR Saucerization; '6' FOR Fine needle aspiration; '8' FOR NA, non-cutaneous melanoma; '9' FOR Unknown; LAST EDITED: `JAN 11, 1999` DESCRIPTION: `Record the appropriate code for cutaneous melanomas only. Code 8, not applicable, for non-cutaneous sites.`
1110	EXTRANODAL EXTENSION	MEL1;11	SET	'0' FOR None; '1' FOR Microscopic, 2mm or less; '2' FOR Gross, greater than 2mm; '3' FOR Present, size unknown; '8' FOR NA, no nodes examined; '9' FOR Unknown; LAST EDITED: `JAN 08, 1999` DESCRIPTION: `Record whether extranodal extension was determined on gross (greater than 2mm) observation or microscopic (2mm or less) observation.`
1111	MICROSATELLITOSIS	MEL1;12	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, non-cutaneous melanoma; '9' FOR Unknown; LAST EDITED: `JAN 08, 1999` DESCRIPTION: `Record the presence of microsatellitosis. They are visualized with the aid of a microscope and defined as discrete nests of melanoma cells >0.05mm, noncontiguous and clearly separated from the main body of the tumor by` `normal reticular dermal collagen or subcutaneous fat.`
1112	NUMBER OF SATELLITE NODULES	MEL1;13	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<1) X I $D(X) D NSNIT^ONCOMNI` OUTPUT TRANSFORM: `D NSNOT^ONCOMNI` LAST EDITED: `JAN 08, 1999` HELP-PROMPT: `Answer must be 1-2 numbers, no decimal point.` DESCRIPTION: `Record the number of satellite nodules within 2 cm of the primary tumor. If there were no satellite nodules, microsatellitosis not present, record 00. If there were multiple nodules but an exact number is not stated,` `record 97. Record 98 if not applicable, non- cutaneous melanoma. Record 99 if it is unknown whether there were satellite nodules.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1113	LOCATION OF IN-TRANSIT NODULES	MEL1;14	SET	'0' FOR None; '1' FOR Regional; '2' FOR Distant; '3' FOR Other; '4' FOR Present, location unknown; '8' FOR NA, non-cutaneous melanoma; '9' FOR Unknown; LAST EDITED: `JAN 08, 1999` DESCRIPTION: `Record the location of in-transit nodules that were farthest from the primary lesion but not beyond the site of primary lymph node drainage.`
1114	BRESLOW'S THICKNESS	MEL1;15	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>3!($L(X)<1) X I $D(X) D BTIT^ONCOMNI` OUTPUT TRANSFORM: `D BTOT^ONCOMNI` LAST EDITED: `JAN 08, 1999` HELP-PROMPT: `Answer must be 1-3 numbers, no decimal point.` DESCRIPTION: `Record the thickness of the primary lesion in millimeters using Breslow's method to measure the depth of the invasion. Record from the pathology report. Record 997 if cutaneous melanoma, Breslow's thickness unknown.` `Record 998, not applicable if non-cutaneous melanoma. Record 999 if cutaneous melanoma, but the primary site is unknown.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1115	CLARK'S LEVEL OF INVASION	MEL1;16	SET	'1' FOR I; '2' FOR II; '3' FOR III; '4' FOR IV; '5' FOR V; '8' FOR NA, primary site unknown; '9' FOR Unknown; LAST EDITED: `JAN 08, 1999` DESCRIPTION: `There are 5 levels of invasion. Convert level from Roman to Arabic numerals. Code 8, not applicable, if primary site unknown or non- cutaneous melanoma. Code 9 if Clark's level is unknown.` `1. Level I: All tumor cells confined to the epidermis with no invasion` `through the basement membrane (in situ melanoma).` `2. Level II: Tumor cells penetrating through the basement membrane into` `the papillary dermis but not extending to the reticular dermis.` `3. Level III: Tumor cells filling the papillary dermis and abutting against` `the reticular dermis but not invading it.` `4. Level IV: Extension of tumor cells between the bundles of collagen` `characteristic of the reticular dermis.` `5. Level V: Invasion into the subcutaneous tissue.`
1116	ANGIOLYMPHATIC INVASION	MEL1;17	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, site unknown or ocular; '9' FOR Unknown; LAST EDITED: `JAN 29, 1999` DESCRIPTION: `Record if this histologic feature was noted in the pathology report. Angiolymphatic invasion can be pathologically evaluated using either the whole tissue specimen or tissue taken from a core biopsy. Code 8, not` `applicable, in situations in which either there was no specimen, a specimen was not adequately large enough to determine these factors, or the primary site was unknown.`
1117	PERINEURAL INVASION	MEL1;18	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, site unknown or ocular; '9' FOR Unknown; LAST EDITED: `JAN 29, 1999` DESCRIPTION: `Record if this histologic feature was noted in the pathology report. Perineural invasion can be pathologically evaluated using either the whole tissue specimen or tissue taken from a core biopsy. Code 8, not applicable,` `in situations in which either there was no specimen, a specimen was not adequately large enough to determine these factors, or the primary site was unknown.`
1118	ULCERATION	MEL1;19	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, site unknown or ocular; '9' FOR Unknown; LAST EDITED: `JAN 29, 1999` DESCRIPTION: `Record whether the primary site was ulcerated. Ulceration is defined as a microscopic interruption of the surface epithelium involved by tumor. This does not alter the staging procedure but is typically associated with` `a worse prognosis. Code 8, not applicable, if a primary site is mucosal, occular or unknown.`
1119	CLINICALLY AMELANOTIC	MEL1;20	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, site unknown or ocular; '9' FOR Unknown; LAST EDITED: `JAN 29, 1999` DESCRIPTION: `Record whether the primary site was lacking in melanin. Frequently, terms such as brownish, black, blue or tan are used to describe a primary site with melanin. Primary sites lacking melanin may be described as` `non-pigmented or not dark. Primary sites which are reported to appear red or have redness should be considered amelanotic. Code 8, not applicable, if primary site is mucosal, ocular or unknown.`
1120	MARGIN DISTANCE (MEL)	MEL1;21	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>3!($L(X)<1) X I $D(X) D MDIT^ONCOMNI` OUTPUT TRANSFORM: `D MDOT^ONCOMNI` LAST EDITED: `JAN 12, 1999` HELP-PROMPT: `Answer must be 1-3 numbers, no decimal point.` DESCRIPTION: `If margins are free according to the operative report, record the shortest distance in millimeters from the tumor to the edge of specimen (margin).` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1121	SURGICAL CLOSURE	MEL1;22	SET	'1' FOR Primary or suture closure; '2' FOR Split-thickness skin graft; '3' FOR Flap; '4' FOR Full-thickness skin graft; '5' FOR Other, NOS; '8' FOR NA, surgery not performed; '9' FOR Unknown; LAST EDITED: `JAN 12, 1999` DESCRIPTION: `Record the type of surgical closure. Code 8, not applicable if surgery was not performed for this site.`
1122	PRE-OP LYMPHOSCINTIGRAPHY	MEL1;23	SET	'0' FOR No; '1' FOR Yes, unidirectional flow; '2' FOR Yes, multidirectional flow; '3' FOR Yes, flow unknown; '8' FOR NA, ocular site; '9' FOR Unknown; LAST EDITED: `JAN 12, 1999` DESCRIPTION: `Record whether lymphoscintigraphy was performed, and if done, what was the flow. Unidirectional flow indicates that only one lynph node basin drained the site. Multidirectional flow indicates that more than one lymph` `node basin drained the site.`
1123	SENTINEL NODES DETECTED BY	MEL1;24	SET	'0' FOR Not done; '1' FOR Vital blue die; '2' FOR Radiolabeled colloid; '3' FOR Combination of 1 and 2; '4' FOR Done, method unknown; '8' FOR NA, not done, ocular site; '9' FOR Unknown; LAST EDITED: `JAN 29, 1999` DESCRIPTION: `Record the method of detecion of the sentinel node.`
1124	SENTINEL NODES EXAMINED (MEL)	MEL1;25	SET	'0' FOR No nodes; '1' FOR 1 node; '2' FOR 2 nodes; '3' FOR 3 nodes; '4' FOR 4 nodes; '5' FOR 5 nodes; '6' FOR 6 or more nodes; '7' FOR Nodes examined, number unknown; '8' FOR NA, not done, ocular site; '9' FOR Unknown; LAST EDITED: `JAN 29, 1999` DESCRIPTION: `Enter the exact number of sentinel nodes examined.`
1125	SENTINEL NODES POSITIVE (MEL)	MEL1;26	SET	'0' FOR No nodes; '1' FOR 1 node; '2' FOR 2 nodes; '3' FOR 3 nodes; '4' FOR 4 nodes; '5' FOR 5 nodes; '6' FOR 6 or more nodes; '7' FOR Nodes positive, number unknown; '8' FOR NA, not done, no exam, ocular site; '9' FOR Unknown; INPUT TRANSFORM: `D SNPIT^ONCOMNI` LAST EDITED: `FEB 26, 1999` DESCRIPTION: `Enter the exact number of sentinel nodes positive.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1126	METHOD OF PATHOLOGIC EXAM	MEL1;27	SET	'0' FOR Not examined; '1' FOR Routine staining; '2' FOR Immunochemistry; '3' FOR Serial sectioning; '4' FOR PCR; '5' FOR Other; '6' FOR Any comb of 1,2,3,4; '7' FOR Examined, method unknown; '8' FOR NA, not done, ocular site; '9' FOR Unknown; LAST EDITED: `FEB 05, 1999` DESCRIPTION: `Record the method of pathological examination of the sentinel node.`
1127	LYMPH NODE DISSECTION	MEL1;28	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, not done, no + nodes, ocular site; '9' FOR Unknown; LAST EDITED: `FEB 05, 1999` DESCRIPTION: `If sentinel node(s) positive, record if a complete node dissection was performed. A complete node dissection is the dissection of all nodes found in a particular basin.`
1128	NUMBER OF BASINS DISSECTED	MEL1;29	SET	'0' FOR No basins; '1' FOR 1 basin; '2' FOR 2 basins; '3' FOR 3 basins; '4' FOR 4 basins; '5' FOR 5 basins; '6' FOR 6 or more basins; '7' FOR Basins dissected, number unknown; '8' FOR NA, not done, no + nodes, ocular site; 'Unknown' FOR Unknown; LAST EDITED: `FEB 05, 1999` DESCRIPTION: `If sentinel node(s) positive, record the number of basins dissected.`
1129	NUMBER OF BASINS POSITIVE	MEL1;30	SET	'0' FOR No basins; '1' FOR 1 basin; '2' FOR 2 basins; '3' FOR 3 basins; '4' FOR 4 basins; '5' FOR 5 basins; '6' FOR 6 or more basins; '7' FOR Basins positive, number unknown; '8' FOR NA, not done, no basins dissected, ocular; '9' FOR Unknown; INPUT TRANSFORM: `D NBPIT^ONCOMNI` LAST EDITED: `MAR 08, 1999` DESCRIPTION: `If sentinel node(s) positive, record the number of basins positive. A positive basin is one in which at least one lymph node, other than the sentinel node, is determined to be positive.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1130	INTRAVENOUS THERAPY	MEL1;31	SET	'1' FOR Yes, systemic; '2' FOR Yes, regional; '3' FOR Yes, combination of 1 and 2; '7' FOR Yes, type unknown; '8' FOR NA, chemotherapy not administered; '9' FOR Unknown if chemotherapy administered; LAST EDITED: `MAR 01, 1999` DESCRIPTION: `Record how the intravenous therapy was given.`
1131	GENE THERAPY	MEL1;32	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA; '9' FOR Unknown; LAST EDITED: `JAN 14, 1999` DESCRIPTION: `Record whether the patient received this adjuvant immunotherapy.`
1132	SIZE OF TUMOR (MELANOMA)	MEL1;33	NUMBER	INPUT TRANSFORM: `D STMIT^ONCOOT` OUTPUT TRANSFORM: `S Y=$S($L(Y)=1:"00"_Y,$L(Y)=2:"0"_Y,1:Y) D STMOT^ONCOOT` LAST EDITED: `APR 28, 1999` HELP-PROMPT: `Record the largest dimension or diameter, not depth, of the primary tumor.` DESCRIPTION: `SIZE OF TUMOR (MELANOMA) is the largest dimension, or the diameter of the primary tumor, and is always recorded in millimeters. Record the largest diameter of the primary tumor for cutaneous melanomas. Record the tumor` `size for clinically diagnosed ocular melanoma. Record 998 for mucosal melanomas. Record 999 when the primary site is unknown or tumor size is not recorded or not available.` `IMPORTANT NOTE: Do NOT confuse this item with SIZE OF TUMOR in ROADS. For malignant melanoma SIZE OF TUMOR in ROADS records "depth of invasion" and is equivalent to PCE item #30 (BRESLOW'S THICKNESS). SIZE OF TUMOR` `(MELANOMA) records the largest dimension or diameter of the primary tumor.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1200	HANDEDNESS	CNS1;1	SET	'1' FOR Left handed; '2' FOR Right handed; '3' FOR Ambidextrous; '9' FOR Unknown; LAST EDITED: `JAN 14, 2000` DESCRIPTION: `This field describes whether the patient is left handed, right handed or ambidextrous.`
1201	HYPERTENSION	CNS1;2	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 14, 2000` DESCRIPTION: `This field describes a patient's prior medical condition.`
1202	MULTIPLE SCLEROSIS (MS)	CNS1;3	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 14, 2000` DESCRIPTION: `This field describes a patient's prior medical condition.`
1203	DIABETES	CNS1;4	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 14, 2000` DESCRIPTION: `This field describes a patient's prior medical condition.`
1204	CEREBROVASCULAR DISEASE	CNS1;5	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 14, 2000` DESCRIPTION: `This field describes a patient's prior medical condition.`
1205	BRAIN	CNS1;6	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 14, 2000` DESCRIPTION: `This field describes a patient's prior history of any cancers.`
1206	BREAST	CNS1;7	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 14, 2000` DESCRIPTION: `This field describes a patient's prior history of any cancers.`
1207	PROSTATE	CNS1;8	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 14, 2000` DESCRIPTION: `This field describes a patient's prior history of any cancers.`
1208	MALIGNANT MELANOMA	CNS1;9	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 14, 2000` DESCRIPTION: `This field describes a patient's prior history of any cancers.`
1209	OTHER SKIN CANCER	CNS1;10	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 14, 2000` DESCRIPTION: `This field describes a patient's prior history of any cancers.`
1210	LEUKEMIA	CNS1;11	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 14, 2000` DESCRIPTION: `This field describes a patient's prior history of any cancers.`
1211	COLON OR OTHER GI CANCERS	CNS1;12	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 14, 2000` DESCRIPTION: `This field describes a patient's prior history of any cancers.`
1212	OTHER PERSONAL HISTORY OF CA	CNS1;13	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 27, 2000` DESCRIPTION: `This field describes a patient's prior history of any cancers.`
1213	NEUROFIBROMATOSIS	CNS1;14	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 18, 2000` DESCRIPTION: `This field describes a patient's predispostion to brain/CNS tumors.`
1214	VON HIPPEL-LINDAU DISEASE	CNS1;15	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 18, 2000` DESCRIPTION: `This field describes a patient's predispostion to brain/CNS tumors.`
1215	TUBEROUS SCLEROSIS	CNS1;16	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 18, 2000` DESCRIPTION: `This field describes a patient's predispostion to brain/CNS tumors.`
1216	TURCOT SYNDROME	CNS1;17	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 18, 2000` DESCRIPTION: `This field describes a patient's predispostion to brain/CNS tumors.`
1217	LI-FRAUMENI SYNDROME	CNS1;18	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 18, 2000` DESCRIPTION: `This field describes a patient's predispostion to brain/CNS tumors.`
1218	KOWDEN DISEASE	CNS1;19	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 18, 2000` DESCRIPTION: `This field describes a patient's predispostion to brain/CNS tumors.`
1219	NEVOID BASAL CELL CARCINOMA	CNS1;20	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 18, 2000` DESCRIPTION: `This field describes a patient's predispostion to brain/CNS tumors.`
1220	HEADACHE	CNS1;21	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown, not stated; LAST EDITED: `JAN 18, 2000` DESCRIPTION: `This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.`
1221	NAUSEA/VOMITING	CNS1;22	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown, not stated; LAST EDITED: `JAN 18, 2000` DESCRIPTION: `This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.`
1222	CHANGE IN SENSE OF SMELL/TASTE	CNS1;23	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown, not stated; LAST EDITED: `JAN 18, 2000` DESCRIPTION: `This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.`
1223	ALTERED ALERTNESS	CNS1;24	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown, not stated; LAST EDITED: `JAN 18, 2000` DESCRIPTION: `This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.`
1224	FATIGUE	CNS1;25	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown, not stated; LAST EDITED: `JAN 18, 2000` DESCRIPTION: `This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.`
1225	SPEECH DISTURBANCE	CNS1;26	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown, not stated; LAST EDITED: `JAN 18, 2000` DESCRIPTION: `This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.`
1226	PERSONALITY CHANGES	CNS1;27	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown, not stated; LAST EDITED: `JAN 18, 2000` DESCRIPTION: `This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.`
1227	DEPRESSION	CNS1;28	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown, not stated; LAST EDITED: `JAN 18, 2000` DESCRIPTION: `This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.`
1228	MEMORY LOSS	CNS1;29	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown, not stated; LAST EDITED: `JAN 18, 2000` DESCRIPTION: `This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.`
1229	LACK OF CONCENTRATION	CNS1;30	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown, not stated; LAST EDITED: `JAN 18, 2000` DESCRIPTION: `This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.`
1230	DOUBLE VISION	CNS1;31	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown, not stated; LAST EDITED: `JAN 18, 2000` DESCRIPTION: `This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.`
1231	OTHER VISUAL DISTURBANCE	CNS1;32	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown, not stated; LAST EDITED: `JAN 18, 2000` DESCRIPTION: `This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.`
1232	DECREASED HEARING	CNS1;33	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown, not stated; LAST EDITED: `JAN 18, 2000` DESCRIPTION: `This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.`
1233	VERTIGO	CNS1;34	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown, not stated; LAST EDITED: `JAN 18, 2000` DESCRIPTION: `This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.`
1234	TINNITUS	CNS1;35	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown, not stated; LAST EDITED: `JAN 18, 2000` DESCRIPTION: `This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.`
1235	NUMBNESS/TINGLING	CNS1;36	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown, not stated; LAST EDITED: `JAN 18, 2000` DESCRIPTION: `This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.`
1236	WEAKNESS OR PARALYSIS	CNS1;37	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown, not stated; LAST EDITED: `JAN 18, 2000` DESCRIPTION: `This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.`
1237	DIFFICULTY IN COORD/BALANCE	CNS1;38	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown, not stated; LAST EDITED: `JAN 18, 2000` DESCRIPTION: `This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.`
1238	GENERALIZED SEIZURE	CNS1;39	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown, not stated; LAST EDITED: `JAN 18, 2000` DESCRIPTION: `This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.`
1239	FOCAL SEIZURE	CNS1;40	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown, not stated; LAST EDITED: `JAN 18, 2000` DESCRIPTION: `This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.`
1240	BLADDER INCONTINENCE	CNS1;41	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown, not stated; LAST EDITED: `JAN 18, 2000` DESCRIPTION: `This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.`
1241	BOWEL INCONTINENCE	CNS1;42	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown, not stated; LAST EDITED: `JAN 18, 2000` DESCRIPTION: `This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.`
1242	PAIN (OTHER THAN HEADACHE)	CNS1;43	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown, not stated; LAST EDITED: `JAN 18, 2000` DESCRIPTION: `This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.`
1243	WEIGHT CHANGE	CNS1;44	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown, not stated; LAST EDITED: `JAN 18, 2000` DESCRIPTION: `This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.`
1244	OTHER SYMPTOMS	CNS1;45	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown, not stated; LAST EDITED: `JAN 18, 2000` DESCRIPTION: `This field describes one of the symptoms specific to the brain tumor as reported by the patient or recorded in the medical chart.`
1245	ALERTNESS	CNS1;46	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, examination not done; '9' FOR Unknown; LAST EDITED: `JAN 19, 2000` DESCRIPTION: `Record all findings from the neurological examination that evaluated the status of the tumor.`
1246	SPEECH	CNS1;47	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, examination not done; '9' FOR Unknown; LAST EDITED: `JAN 19, 2000` DESCRIPTION: `Record all findings from the neurological examination that evaluated the status of the tumor.`
1247	PERSONALITY	CNS1;48	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, examination not done; '9' FOR Unknown; LAST EDITED: `JAN 19, 2000` DESCRIPTION: `Record all findings from the neurological examination that evaluated the status of the tumor.`
1248	MEMORY OR JUDGEMENT	CNS1;49	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, examination not done; '9' FOR Unknown; LAST EDITED: `JAN 19, 2000` DESCRIPTION: `Record all findings from the neurological examination that evaluated the status of the tumor.`
1249	VISUAL ACUITY	CNS1;50	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, examination not done; '9' FOR Unknown; LAST EDITED: `JAN 19, 2000` DESCRIPTION: `Record all findings from the neurological examination that evaluated the status of the tumor.`
1250	VISUAL FIELDS	CNS1;51	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, examination not done; '9' FOR Unknown; LAST EDITED: `JAN 19, 2000` DESCRIPTION: `Record all findings from the neurological examination that evaluated the status of the tumor.`
1251	EYE MOVEMENTS (EOM)	CNS1;52	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, examination not done; '9' FOR Unknown; LAST EDITED: `JAN 19, 2000` DESCRIPTION: `Record all findings from the neurological examination that evaluated the status of the tumor.`
1252	FACIAL SENSATION	CNS1;53	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, examination not done; '9' FOR Unknown; LAST EDITED: `JAN 24, 2000` DESCRIPTION: `Record all findings from the neurological examination that evaluated the status of the tumor.`
1253	FACIAL MOVEMENT	CNS1;54	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, examination not done; '9' FOR Unknown; LAST EDITED: `JAN 24, 2000` DESCRIPTION: `Record all findings from the neurological examination that evaluated the status of the tumor.`
1254	HEARING	CNS1;55	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, examination not done; '9' FOR Unknown; LAST EDITED: `JAN 24, 2000` DESCRIPTION: `Record all findings from the neurological examination that evaluated the status of the tumor.`
1255	GAG REFLEX	CNS1;56	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, examination not done; '9' FOR Unknown; LAST EDITED: `JAN 24, 2000` DESCRIPTION: `Record all findings from the neurological examination that evaluated the status of the tumor.`
1256	STERNOCLEIDOMASTOID/SHLD STR	CNS1;57	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, examination not done; '9' FOR Unknown; LAST EDITED: `JAN 25, 2000` DESCRIPTION: `Record all findings from the neurological examination that evaluated the status of the tumor.`
1257	ARTICULATION OR ENUNCIATION	CNS1;58	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, examination not done; '9' FOR Unknown; LAST EDITED: `JAN 25, 2000` DESCRIPTION: `Record all findings from the neurological examination that evaluated the status of the tumor.`
1258	PAPILLEDEMA	CNS1;59	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, examination not done; '9' FOR Unknown; LAST EDITED: `JAN 25, 2000` DESCRIPTION: `Record all findings from the neurological examination that evaluated the status of the tumor.`
1259	TONGUE FASCICULATIONS/ATROPHY	CNS1;60	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, examination not done; '9' FOR Unknown; LAST EDITED: `JAN 25, 2000` DESCRIPTION: `Record all findings from the neurological examination that evaluated the status of the tumor.`
1260	DECREASE IN SENSATION/ANY SITE	CNS1;61	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, examination not done; '9' FOR Unknown; LAST EDITED: `JAN 25, 2000` DESCRIPTION: `Record all findings from the neurological examination that evaluated the status of the tumor.`
1261	CORTICAL SENSORY DEFICIT	CNS1;62	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, examination not done; '9' FOR Unknown; LAST EDITED: `JAN 26, 2000` DESCRIPTION: `Record all findings from the neurological examination that evaluated the status of the tumor.`
1262	WEAKNESS/ATROPHY/FASCICULATION	CNS1;63	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, examination not done; '9' FOR Unknown; LAST EDITED: `JAN 26, 2000` DESCRIPTION: `Record all findings from the neurological examination that evaluated the status of the tumor.`
1263	ATAXIA OF GAIT	CNS1;64	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, examination not done; '9' FOR Unknown; LAST EDITED: `JAN 26, 2000` DESCRIPTION: `Record all findings from the neurological examination that evaluated the status of the tumor.`
1264	TRUNCAL ATAXIA	CNS1;65	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, examination not done; '9' FOR Unknown; LAST EDITED: `JAN 26, 2000` DESCRIPTION: `Record all findings from the neurological examination that evaluated the status of the tumor.`
1265	DYSMETRIA	CNS1;66	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, examination not done; '9' FOR Unknown; LAST EDITED: `JAN 26, 2000` DESCRIPTION: `Record all findings from the neurological examination that evaluated the status of the tumor.`
1266	RAPID ALTERNATING MOVEMENTS	CNS1;67	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, examination not done; '9' FOR Unknown; LAST EDITED: `JAN 26, 2000` DESCRIPTION: `Record all findings from the neurological examination that evaluated the status of the tumor.`
1267	FINGER TO FINGER NOSE TESTING	CNS1;68	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, examination not done; '9' FOR Unknown; LAST EDITED: `JAN 26, 2000` DESCRIPTION: `Record all findings from the neurological examination that evaluated the status of the tumor.`
1268	HEEL TO KNEE TO SHIN TESTING	CNS1;69	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, examination not done; '9' FOR Unknown; LAST EDITED: `JAN 26, 2000` DESCRIPTION: `Record all findings from the neurological examination that evaluated the status of the tumor.`
1269	DEEP TENDON REFLEXES/UPPER EXT	CNS1;70	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, examination not done; '9' FOR Unknown; LAST EDITED: `JAN 26, 2000` DESCRIPTION: `Record all findings from the neurological examination that evaluated the status of the tumor.`
1270	DEEP TENDON REFLEXES/LOWER EXT	CNS1;71	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, examination not done; '9' FOR Unknown; LAST EDITED: `JAN 26, 2000` DESCRIPTION: `Record all findings from the neurological examination that evaluated the status of the tumor.`
1271	BABINSKI SIGN	CNS1;72	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, examination not done; '9' FOR Unknown; LAST EDITED: `JAN 26, 2000` DESCRIPTION: `Record all findings from the neurological examination that evaluated the status of the tumor.`
1272	HOFFMAN REFLEX	CNS1;73	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, examination not done; '9' FOR Unknown; LAST EDITED: `JAN 26, 2000` DESCRIPTION: `Record all findings from the neurological examination that evaluated the status of the tumor.`
1273	OTHER ABNORMAL REFLEXES	CNS1;74	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, examination not done; '9' FOR Unknown; LAST EDITED: `JAN 26, 2000` DESCRIPTION: `Record all findings from the neurological examination that evaluated the status of the tumor.`
1274	ANGIOGRAPHY	CNS1;75	SET	'0' FOR Results -, no evidence of brain tumor; '1' FOR Results +, some indication of disease; '2' FOR Results unknown, equivocal/inconclusive; '8' FOR NA, test not done; '9' FOR Unknown if test done; LAST EDITED: `JUN 07, 2000` DESCRIPTION: `This field describes the results of a neurodiagnostic study performed to evaluate the patient's tumor.`
1275	COMPUTED TOMOGRAPHY (CT) SCAN	CNS1;76	SET	'0' FOR Results -, no evidence of brain tumor; '1' FOR Results +, some indication of disease; '2' FOR Results unknown, equivocal/inconclusive; '8' FOR NA, test not done; '9' FOR Unknown if test done; LAST EDITED: `JAN 26, 2000` DESCRIPTION: `This field describes the results of a neurodiagnostic study performed to evaluate the patient's tumor.`
1276	CT SCAN OF SPINE	CNS1;77	SET	'0' FOR Results -, no evidence of brain tumor; '1' FOR Results +, some indication of disease; '2' FOR Results unknown, equivocal/inconclusive; '8' FOR NA, test not done; '9' FOR Unknown if test done; LAST EDITED: `JAN 26, 2000` DESCRIPTION: `This field describes the results of a neurodiagnostic study performed to evaluate the patient's tumor.`
1277	ELECTROENCEPHALOGRAPHY (EEG)	CNS1;78	SET	'0' FOR Results -, no evidence of brain tumor; '1' FOR Results +, some indication of disease; '2' FOR Results unknown, equivocal/inconclusive; '8' FOR NA, test not done; '9' FOR Unknown if test done; LAST EDITED: `JAN 26, 2000` DESCRIPTION: `This field describes the results of a neurodiagnostic study performed to evaluate the patient's tumor.`
1278	ISOTOPE BRAIN SCAN	CNS1;79	SET	'0' FOR Results -, no evidence of brain tumor; '1' FOR Results +, some indication of disease; '2' FOR Results unknown, equivocal/inconclusive; '8' FOR NA, test not done; '9' FOR Unknown if test done; LAST EDITED: `JAN 26, 2000` DESCRIPTION: `This field describes the results of a neurodiagnostic study performed to evaluate the patient's tumor.`
1279	POSITRON EMISSION TOMOGRAPHY	CNS1;80	SET	'0' FOR Results -, no evidence of brain tumor; '1' FOR Results +, some indication of disease; '2' FOR Results unknown, equivocal/inconclusive; '8' FOR NA, test not done; '9' FOR Unknown if test done; LAST EDITED: `JAN 26, 2000` DESCRIPTION: `This field describes the results of a neurodiagnostic study performed to evaluate the patient's tumor.`
1280	SPECT SCAN	CNS1;81	SET	'0' FOR Results -, no evidence of brain tumor; '1' FOR Results +, some indication of disease; '2' FOR Results unknown, equivocal/inconclusive; '8' FOR NA, test not done; '9' FOR Unknown if test done; LAST EDITED: `JAN 26, 2000` DESCRIPTION: `This field describes the results of a neurodiagnostic study performed to evaluate the patient's tumor.`
1281	MRI OF BRAIN	CNS1;82	SET	'0' FOR Results -, no evidence of brain tumor; '1' FOR Results +, some indication of disease; '2' FOR Results unknown, equivocal/inconclusive; '8' FOR NA, test not done; '9' FOR Unknown if test done; LAST EDITED: `JAN 26, 2000` DESCRIPTION: `This field describes the results of a neurodiagnostic study performed to evaluate the patient's tumor.`
1282	MRI OF SPINE	CNS1;83	SET	'0' FOR Results -, no evidence of brain tumor; '1' FOR Results +, some indication of disease; '2' FOR Results unknown, equivocal/inconclusive; '8' FOR NA, test not done; '9' FOR Unknown if test done; LAST EDITED: `JAN 26, 2000` DESCRIPTION: `This field describes the results of a neurodiagnostic study performed to evaluate the patient's tumor.`
1283	FUNCTIONAL MRI	CNS1;84	SET	'0' FOR Results -, no evidence of brain tumor; '1' FOR Results +, some indication of disease; '2' FOR Results unknown, equivocal/inconclusive; '8' FOR NA, test not done; '9' FOR Unknown if test done; LAST EDITED: `JAN 26, 2000` DESCRIPTION: `This field describes the results of a neurodiagnostic study performed to evaluate the patient's tumor.`
1284	MYELOGRAPHY	CNS1;85	SET	'0' FOR Results -, no evidence of brain tumor; '1' FOR Results +, some indication of disease; '2' FOR Results unknown, equivocal/inconclusive; '8' FOR NA, test not done; '9' FOR Unknown if test done; LAST EDITED: `JAN 26, 2000` DESCRIPTION: `This field describes the results of a neurodiagnostic study performed to evaluate the patient's tumor.`
1285	MAGNETIC RES SPECTROSCOPY	CNS1;86	SET	'0' FOR Results -, no evidence of brain tumor; '1' FOR Results +, some indication of disease; '2' FOR Results unknown, equivocal/inconclusive; '8' FOR NA, test not done; '9' FOR Unknown if test done; LAST EDITED: `JAN 26, 2000` DESCRIPTION: `This field describes the results of a neurodiagnostic study performed to evaluate the patient's tumor.`
1286	FRONTAL LOBE	CNS2;1	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 27, 2000` DESCRIPTION: `This field describes a location involved by the tumor. If more than one location is involved, record all locations involved by the tumor.`
1287	TEMPORAL LOBE	CNS2;2	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 27, 2000` DESCRIPTION: `This field describes a location involved by the tumor. If more than one location is involved, record all locations involved by the tumor.`
1288	PARIETAL LOBE	CNS2;3	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 27, 2000` DESCRIPTION: `This field describes a location involved by the tumor. If more than one location is involved, record all locations involved by the tumor.`
1289	OCCIPITAL LOBE	CNS2;4	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 27, 2000` DESCRIPTION: `This field describes a location involved by the tumor. If more than one location is involved, record all locations involved by the tumor.`
1290	OPTIC NERVES	CNS2;5	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 27, 2000` DESCRIPTION: `This field describes a location involved by the tumor. If more than one location is involved, record all locations involved by the tumor.`
1291	PITUITARY GLAND	CNS2;6	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 27, 2000` DESCRIPTION: `This field describes a location involved by the tumor. If more than one location is involved, record all locations involved by the tumor.`
1292	PINEAL GLAND	CNS2;7	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 27, 2000` DESCRIPTION: `This field describes a location involved by the tumor. If more than one location is involved, record all locations involved by the tumor.`
1293	CEREBELLUM	CNS2;8	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 27, 2000` DESCRIPTION: `This field describes a location involved by the tumor. If more than one location is involved, record all locations involved by the tumor.`
1294	BRAIN STEM	CNS2;9	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 27, 2000` DESCRIPTION: `This field describes a location involved by the tumor. If more than one location is involved, record all locations involved by the tumor.`
1295	SKULL BASE	CNS2;10	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 27, 2000` DESCRIPTION: `This field describes a location involved by the tumor. If more than one location is involved, record all locations involved by the tumor.`
1296	OTHER SKULL	CNS2;11	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 27, 2000` DESCRIPTION: `This field describes a location involved by the tumor. If more than one location is involved, record all locations involved by the tumor.`
1297	SPINAL CORD	CNS2;12	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 27, 2000` DESCRIPTION: `This field describes a location involved by the tumor. If more than one location is involved, record all locations involved by the tumor.`
1298	CEREBRAL SPINAL FLUID (CSF)	CNS2;13	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 27, 2000` DESCRIPTION: `This field describes a location involved by the tumor. If more than one location is involved, record all locations involved by the tumor.`
1299	CRANIAL MENINGES	CNS2;14	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 27, 2000` DESCRIPTION: `This field describes a location involved by the tumor. If more than one location is involved, record all locations involved by the tumor.`
1300	SPINAL MENINGES	CNS2;15	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 27, 2000` DESCRIPTION: `This field describes a location involved by the tumor. If more than one location is involved, record all locations involved by the tumor.`
1301	OTHER TUMOR LOC/INVOLVEMENT	CNS2;16	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 27, 2000` DESCRIPTION: `This field describes a location involved by the tumor. If more than one location is involved, record all locations involved by the tumor.`
1302	LEFT	CNS2;17	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 27, 2000` DESCRIPTION: `This field describes which side of the brain the tumor is located. Some tumors typically involve midline structures, such as pineal and pituitary gland tumors, and extend to the left or right. For these tumors code` `midline yes and indicate the side of the brain into which the tumor extends. Bilateral tumors should be coded as left and right.`
1303	RIGHT	CNS2;18	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 27, 2000` DESCRIPTION: `This field describes which side of the brain the tumor is located. Some tumors typically involve midline structures, such as pineal and pituitary gland tumors, and extend to the left or right. For these tumors code` `midline yes and indicate the side of the brain into which the tumor extends. Bilateral tumors should be coded as left and right.`
1304	MIDLINE	CNS2;19	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `JAN 27, 2000` DESCRIPTION: `This field describes which side of the brain the tumor is located. Some tumors typically involve midline structures, such as pineal and pituitary gland tumors, and extend to the left or right. For these tumors code` `midline yes and indicate the side of the brain into which the tumor extends. Bilateral tumors should be coded as left and right.`
1305	NUMBER OF TUMORS	CNS2;20	SET	'1' FOR One tumor only; '2' FOR Multiple tumors; '9' FOR Unknown; LAST EDITED: `JAN 27, 2000` DESCRIPTION: `This field describes whether the tumor is singular or multiple.`
1306	DATE OF FIRST SYMPTOMS	CNS2;21	DATE	INPUT TRANSFORM: `S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" S %DT="EP",%DT(0)="-NOW" D ^%DT S X=Y K:Y<1 X K %DT(0) W:'$D(X) !,"Future dates are not allowed"` OUTPUT TRANSFORM: `D DATEOT^ONCOPCE` LAST EDITED: `FEB 01, 2000` DESCRIPTION: `This field describes the date of the first onset of symptoms. This information can typically be found in the patient's history & physical. If the date can not be determined or is unknown, code 99999999.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1307	DATE OF PATHOLOGIC DIAGNOSIS	CNS2;22	DATE	INPUT TRANSFORM: `S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" S %DT="EP",%DT(0)="-NOW" D ^%DT S X=Y K:Y<1 X K %DT(0) W:'$D(X) !,"Future dates are not allowed"` OUTPUT TRANSFORM: `D DATEOT^ONCOPCE` LAST EDITED: `FEB 01, 2000` DESCRIPTION: `This field describes the month, day, and year that this cancer was first pathologically diagnosed. If no pathologic diagnosis was determined, code 00000000; if the date of pathologic diagnosis is unknown or cannot be` `determined, code 99999999.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1308	WHO HISTOLOGICAL CL	CNS2;23	POINTER TO WHO HISTOLOGICAL CLASSIFICATION FILE (#164.9)	WHO HISTOLOGICAL CLASSIFICATION(#164.9) LAST EDITED: `MAR 06, 2000` DESCRIPTION: `This field describes the WHO histological classfication of the tumor. Report the appropriate WHO code that corresponds to the written description of the tumor appearing on the pathology report.`
1309	MOLECULAR MARKERS	CNS2;24	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, no pathologic diagnosis; '9' FOR Unknown if molecular markers used; LAST EDITED: `MAR 06, 2000` DESCRIPTION: `This field describes whether molecular markers were used in the pathologic evaluation of the tumor. The most commonly used markers are GFAP, DNA analysis, and KI-67 (MIB antibody). If a pathologic diagnosis was not` `made, code 8.`
1310	TUMOR SIZE (SOURCE)	CNS2;25	SET	'0' FOR Size not recorded; '1' FOR CT scan w or w/o contrast; '2' FOR MRI w/o contrast; '3' FOR MRI w contrast; '4' FOR PET scan; '5' FOR SPECT scan; '6' FOR Operative report; '7' FOR Other; '9' FOR Size recorded, source unknown; LAST EDITED: `MAR 06, 2000` DESCRIPTION: `This field describes the source of the data from which the reported size of tumor was documented. DO NOT use the pathology report to determine tumor size.`
1311	KARNOFSKY'S RATING PRIOR TO TX	CNS2;26	POINTER TO KARNOFSKY'S RATING FILE (#164.17)	KARNOFSKY'S RATING(#164.17) INPUT TRANSFORM: `S DIC("S")="I $P(^(0),U,1)'=888" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X` LAST EDITED: `JUL 19, 2000` DESCRIPTION: `This field describes the physical status of the patient prior to the beginning of intial treatment using Karnofsky's Rating. This is prior to any definitive therapy. If the rating is not recorded, assign a rating based` `upon the best available information.` SCREEN: `S DIC("S")="I $P(^(0),U,1)'=888"` EXPLANATION: `Enter the appropriate Karnofsky's Rating.`
1312	PROTOCOL PARTICIPATION (CNS)	CNS2;27	SET	'00' FOR Not on; '01' FOR RTOG; '02' FOR SWOG; '03' FOR ECOG; '04' FOR POG; '05' FOR CCG; '06' FOR NCI; '07' FOR NABTT; '08' FOR NABTC; '09' FOR National protcol, NOS; '10' FOR Other institutional protocols; LAST EDITED: `MAR 10, 2000` DESCRIPTION: `This field describes whether the patient was enrolled in and treated on a protocol. A physician may treat a patient following the guidelines of an established protocol but not enroll the patient. For these cases, code` `00.`
1313	PROTOCOL PHASE	CNS2;28	SET	'0' FOR Not on; '1' FOR Phase I; '2' FOR Phase I/II; '3' FOR Phase II; '4' FOR Phase III; '9' FOR On protocol, phase unknown; LAST EDITED: `MAR 10, 2000` DESCRIPTION: `This field describes the phase of the protocol in which the patient is enrolled. If the patient is not enrolled into a protocol, code 0.`
1314	NONE, NO NON-CA DIR SURGERY	CNS2;29	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `MAR 17, 2000` DESCRIPTION: `This field describes one of the surgical procedures performed to diagnose/ stage disease (exploratory) or for the relief of symptoms (palliative) which are non-cancer directed surgery.`
1315	VENTRICULOSTOMY/EXT VENT DRAIN	CNS2;30	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `MAR 17, 2000` DESCRIPTION: `This field describes one of the surgical procedures performed to diagnose/ stage disease (exploratory) or for the relief of symptoms (palliative) which are non-cancer directed surgery.`
1316	CSF SHUNT/VENTRICULOPERITONEAL	CNS2;31	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `MAR 20, 2000` DESCRIPTION: `This field describes one of the surgical procedures performed to diagnose/ stage disease (exploratory) or for the relief of symptoms (palliative) which are non-cancer directed surgery.`
1317	CSF SHUNT/3RD VENTRICULOSTOMY	CNS2;32	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `MAR 20, 2000` DESCRIPTION: `This field describes one of the surgical procedures performed to diagnose/ stage disease (exploratory) or for the relief of symptoms (palliative) which are non-cancer directed surgery.`
1318	CSF SHUNT/OTHER	CNS2;33	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `MAR 20, 2000` DESCRIPTION: `This field describes one of the surgical procedures performed to diagnose/ stage disease (exploratory) or for the relief of symptoms (palliative) which are non-cancer directed surgery.`
1319	STEREOTACTIC BIOPSY	CNS2;34	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `MAR 20, 2000` DESCRIPTION: `This field describes one of the surgical procedures performed to diagnose/ stage disease (exploratory) or for the relief of symptoms (palliative) which are non-cancer directed surgery.`
1320	OPEN BRAIN BIOPSY	CNS2;35	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `MAR 20, 2000` DESCRIPTION: `This field describes one of the surgical procedures performed to diagnose/ stage disease (exploratory) or for the relief of symptoms (palliative) which are non-cancer directed surgery.`
1321	OPEN BX OF SPINCAL CORD TUMOR	CNS2;36	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `MAR 20, 2000` DESCRIPTION: `This field describes one of the surgical procedures performed to diagnose/ stage disease (exploratory) or for the relief of symptoms (palliative) which are non-cancer directed surgery.`
1322	LAMINECTOMY W/O RESECT/DURA	CNS2;37	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `MAR 20, 2000` DESCRIPTION: `This field describes one of the surgical procedures performed to diagnose/ stage disease (exploratory) or for the relief of symptoms (palliative) which are non-cancer directed surgery.`
1323	LAMINECTOMY W/O RESECT W DURA	CNS2;38	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `MAR 20, 2000` DESCRIPTION: `This field describes one of the surgical procedures performed to diagnose/ stage disease (exploratory) or for the relief of symptoms (palliative) which are non-cancer directed surgery.`
1324	SURGERY, NOS	CNS2;39	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `MAR 20, 2000` DESCRIPTION: `This field describes one of the surgical procedures performed to diagnose/ stage disease (exploratory) or for the relief of symptoms (palliative) which are non-cancer directed surgery.`
1325	UNKNOWN IF SURGERY DONE	CNS2;40	SET	'0' FOR No; '1' FOR Yes; '9' FOR Unknown; LAST EDITED: `MAR 20, 2000` DESCRIPTION: `This field describes one of the surgical procedures performed to diagnose/ stage disease (exploratory) or for the relief of symptoms (palliative) which are non-cancer directed surgery.`
1326	SURGICAL APPROACH (CNS)	CNS2;41	SET	'0' FOR None, no ca-directed surgery; '1' FOR Craniotomy/craniectomy, w/o stereotactic/image guidance; '2' FOR Craniotomy/craniectomy, w sterotactic/image guidance; '3' FOR Endoscopy; '4' FOR Laminectomy; '5' FOR Other; '9' FOR Surgical approach unknown; LAST EDITED: `MAR 23, 2000` DESCRIPTION: `This field describes the method used to approach the organ of origin and/or primary tumor. Code the approach for cancer-directed surgery of the primary site only. Stereotactic image guidance, with regard to SURGICAL` `APPROACH, is not the same as stereotactic radiosurgery, a method of radiation therapy. Stereotactic radiosurgery is addressed in question 57. BCNU wafer implants are surgically placed following resection of tumor.` `Report whether a wafer implantation occurred in questions 63 & 64.`
1327	EXTENT OF SURGICAL RESECTION	CNS2;42	SET	'0' FOR None, no surgery performed; '1' FOR Subtotal resection; '2' FOR Total or gross resection; '3' FOR Lobectomy; '4' FOR Surgery, NOS; '9' FOR Unknown if surgery performed; LAST EDITED: `MAR 23, 2000` DESCRIPTION: `This field describes only surgeries of the primary site. Record the most definitive surgery performed to the primary site. Biospy procedures are addressed in question 42. Codes 0, 1, 2, 4 and 9 may apply to brain and` `spinal cord tumors. Code 3 applies to brain tumors only.`
1328	SIZE OF RESIDUAL TUMOR	CNS2;43	NUMBER	INPUT TRANSFORM: `D SRPTIT^ONCOOT` OUTPUT TRANSFORM: `S Y=$S($L(Y)=1:"00"_Y,$L(Y)=2:"0"_Y,1:Y) D SRPTOT^ONCOOT` LAST EDITED: `MAR 24, 2000` HELP-PROMPT: `Record the size of the remaining primary tumor AFTER the most definitive therapy.` DESCRIPTION: `This field describes the size of remaining primary tumor AFTER the most definitive therapy. Record the largest dimension or diameter of the residual primary tumor in millimeters (1 cm = 10 mm). If the residual tumor has` `multiple measurements, code the largest size. For example, a residual tumor measuring 3 x 4.4 x 2.5 cm is coded as 044. Use information from postoperative or follow-up imaging studies (MRI, CT, PET, SPECT) to determine` `tumor size. Do not guess at the size of tumor.` `000-No residual tumor` `995-Size not specified, tumor judged smaller` `996-Size not specified, tumor judged unchanged` `997-Size not specified, tumor judged larger` `998-NA, surgical treatment not administered` `999-Unknown, tumor not evaluated` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1329	SIZE OF RES TUMOR (SOURCE)	CNS2;44	SET	'0' FOR Size not recorded; '1' FOR CT scan w or w/o contrast; '2' FOR MRI w/o contrast; '3' FOR MRI w contrast; '4' FOR PET scan; '5' FOR SPECT scan; '6' FOR Operative report; '7' FOR Other; '9' FOR Size recorded, source unknown; LAST EDITED: `MAR 24, 2000` DESCRIPTION: `This field describes the source of the data from which the reported size of the residual tumor was documented.`
1330	ANESTHETIC PROBLEM	CNS2;45	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, surgery not performed; '9' FOR Unknown; LAST EDITED: `MAR 27, 2000` DESCRIPTION: `This field describes a complication or event that occurred after surgery of the primary site and before the date of patient discharge from the hospital.`
1331	HEMORRHAGE AT OPERATIVE SITE	CNS2;46	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, surgery not performed; '9' FOR Unknown; LAST EDITED: `MAR 27, 2000` DESCRIPTION: `This field describes a complication or event that occurred after surgery of the primary site and before the date of patient discharge from the hospital.`
1332	SEIZURE	CNS2;47	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, surgery not performed; '9' FOR Unknown; LAST EDITED: `MAR 27, 2000` DESCRIPTION: `This field describes a complication or event that occurred after surgery of the primary site and before the date of patient discharge from the hospital.`
1333	INFECTION(S)	CNS2;48	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, surgery not performed; '9' FOR Unknown; LAST EDITED: `MAR 27, 2000` DESCRIPTION: `This field describes a complication or event that occurred after surgery of the primary site and before the date of patient discharge from the hospital.`
1334	DVT (DEEP VENOUS THROMBOSIS)	CNS2;49	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, surgery not performed; '9' FOR Unknown; LAST EDITED: `MAR 27, 2000` DESCRIPTION: `This field describes a complication or event that occurred after surgery of the primary site and before the date of patient discharge from the hospital.`
1335	PERSISTENT NEUROL WORSENING	CNS2;50	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, surgery not performed; '9' FOR Unknown; LAST EDITED: `MAR 27, 2000` DESCRIPTION: `This field describes a complication or event that occurred after surgery of the primary site and before the date of patient discharge from the hospital.`
1336	TOTAL RADIATION DOSE (cGy)	CNS2;51	SET	'0' FOR No radiation administered; '1' FOR Less than 3000 cGy; '2' FOR 3000-3999 cGy; '3' FOR 4000-4999 cGy; '4' FOR 5000-5999 cGy; '5' FOR 6000-6999 cGy; '6' FOR 7000-7999 cGy; '7' FOR 8000-8999 cGy; '8' FOR 10000 or more cGy; '9' FOR Dose unknown; LAST EDITED: `MAR 31, 2000` DESCRIPTION: `This field describes the total dose delivered to the primary volume of interest, include any boost doses.`
1337	TYPE OF EXT BEAM RADIATION	CNS2;52	SET	'0' FOR No radiation therapy; '1' FOR Cobalt; '2' FOR >=2 and <4 MV X-rays; '3' FOR >=4 and <6 MV X-rays; '4' FOR >=6 and <10 MV X-rays; '5' FOR >=10 MV X-rays; '6' FOR Protons; '7' FOR Neutrons; '9' FOR Unknown; LAST EDITED: `MAR 31, 2000` DESCRIPTION: `This field describes the type of external beam radiation therapy delivered to the primary volume of interest.`
1338	INTERSTITIAL RAD/BRACHYTHERAPY	CNS2;53	SET	'0' FOR None, brachytherapy not given; '1' FOR Iodine-125; '2' FOR Iridium-192; '3' FOR Other; '9' FOR Unknown; LAST EDITED: `MAR 31, 2000` DESCRIPTION: `This field describes any radioactive implant used to treat the patient.`
1339	STEREOTACTIC RADIOSURGERY	CNS2;54	SET	'0' FOR None, not administered; '1' FOR Gamma knife; '2' FOR Linear accelerator (linac); '3' FOR Other; '9' FOR Unknown; LAST EDITED: `APR 20, 2000` DESCRIPTION: `This field describes the type of delivery of the external radiation dose. Stereotactic radiosurgery is a method by which the focus and target of the radiation beam is precisely directed, and is different from external` `beam radiation which is a less controlled means of radiation therapy delivery.`
1340	SKIN REACTIONS	CNS2;55	SET	'0' FOR No, not present; '1' FOR Present, no tx delay, not req medication; '2' FOR Present, no tx delay, req medication; '3' FOR Present, tx delay or cessation; '8' FOR NA, radiation tx not administered; '9' FOR Unknown; LAST EDITED: `APR 20, 2000` DESCRIPTION: `This field describes a complication that resulted during or subsequent to radiation therapy.`
1341	ANOREXIA	CNS2;56	SET	'0' FOR No, not present; '1' FOR Present, no tx delay, not req medication; '2' FOR Present, no tx delay, req medication; '3' FOR Present, tx delay or cessation; '8' FOR NA, radiation tx not administered; '9' FOR Unknown; LAST EDITED: `APR 18, 2000` DESCRIPTION: `This field describes a complication that resulted during or subsequent to radiation therapy.`
1342	NAUSEA OR VOMITING	CNS2;57	SET	'0' FOR No, not present; '1' FOR Present, no tx delay, not req medication; '2' FOR Present, no tx delay, req medication; '3' FOR Present, tx delay or cessation; '8' FOR NA, radiation tx not administered; '9' FOR Unknown; LAST EDITED: `APR 18, 2000` DESCRIPTION: `This field describes a complication that resulted during or subsequent to radiation therapy.`
1343	FATIGUE	CNS2;58	SET	'0' FOR No, not present; '1' FOR Present, no tx delay, not req medication; '2' FOR Present, no tx delay, req medication; '3' FOR Present, tx delay or cessation; '8' FOR NA, radiation tx not administered; '9' FOR Unknown; LAST EDITED: `APR 18, 2000` DESCRIPTION: `This field describes a complication that resulted during or subsequent to radiation therapy.`
1344	NEUROLOGIC WORSENING	CNS2;59	SET	'0' FOR No, not present; '1' FOR Present, no tx delay, not req medication; '2' FOR Present, no tx delay, req medication; '3' FOR Present, tx delay or cessation; '8' FOR NA, radiation tx not administered; '9' FOR Unknown; LAST EDITED: `APR 18, 2000` DESCRIPTION: `This field describes a complication that resulted during or subsequent to radiation therapy.`
1345	RADIATION THERAPY	CNS2;60	SET	'0' FOR None; '1' FOR Ext beam; '2' FOR RA implants (brachytherapy); '3' FOR Radioisotopes; '4' FOR Stereotactic radiosurgery; '5' FOR Ext beam/RA implants or radioisotopes; '6' FOR Ext beam/stereotactic radiosurgery; '7' FOR Radiation, NOS; '9' FOR Unk, death cert cases only; LAST EDITED: `APR 18, 2000` DESCRIPTION: `This field describes the type of radiation administered to the primary site. Include all procedures that are part of the first course of treatment, whether delivered at the reporting institution or at other institutions.`
1346	PROCARBAZINE	CNS2;61	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, chemotherapy not administered; '9' FOR Unknown; LAST EDITED: `APR 20, 2000` DESCRIPTION: `This field describes one type of chemotherapeutic agent administered to the patient.`
1347	CCNU	CNS2;62	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, chemotherapy not administered; '9' FOR Unknown; LAST EDITED: `APR 20, 2000` DESCRIPTION: `This field describes one type of chemotherapeutic agent administered to the patient.`
1348	VINCRISTINE	CNS2;63	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, chemotherapy not administered; '9' FOR Unknown; LAST EDITED: `APR 20, 2000` DESCRIPTION: `This field describes one type of chemotherapeutic agent administered to the patient.`
1349	HYDROXYUREA	CNS2;64	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, chemotherapy not administered; '9' FOR Unknown; LAST EDITED: `APR 20, 2000` DESCRIPTION: `This field describes one type of chemotherapeutic agent administered to the patient.`
1350	BCNU	CNS2;65	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, chemotherapy not administered; '9' FOR Unknown; LAST EDITED: `APR 20, 2000` DESCRIPTION: `This field describes one type of chemotherapeutic agent administered to the patient.`
1351	BCNU WAFER IMPLANT	CNS2;66	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, chemotherapy not administered; '9' FOR Unknown; LAST EDITED: `APR 20, 2000` DESCRIPTION: `This field describes one type of chemotherapeutic agent administered to the patient.`
1352	VP-16	CNS2;67	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, chemotherapy not administered; '9' FOR Unknown; LAST EDITED: `APR 20, 2000` DESCRIPTION: `This field describes one type of chemotherapeutic agent administered to the patient.`
1353	CARBOPLATIN	CNS2;68	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, chemotherapy not administered; '9' FOR Unknown; LAST EDITED: `APR 20, 2000` DESCRIPTION: `This field describes one type of chemotherapeutic agent administered to the patient.`
1354	TEMOZOLOMIDE	CNS2;69	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, chemotherapy not administered; '9' FOR Unknown; LAST EDITED: `APR 20, 2000` DESCRIPTION: `This field describes one type of chemotherapeutic agent administered to the patient.`
1355	CPT-11	CNS2;70	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, chemotherapy not administered; '9' FOR Unknown; LAST EDITED: `APR 20, 2000` DESCRIPTION: `This field describes one type of chemotherapeutic agent administered to the patient.`
1356	TAMOXIFEN	CNS2;71	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, chemotherapy not administered; '9' FOR Unknown; LAST EDITED: `APR 20, 2000` DESCRIPTION: `This field describes one type of chemotherapeutic agent administered to the patient.`
1357	CYTARABINE (ARA-C)	CNS2;72	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, chemotherapy not administered; '9' FOR Unknown; LAST EDITED: `APR 20, 2000` DESCRIPTION: `This field describes one type of chemotherapeutic agent administered to the patient.`
1358	CHEMOTHERAPEUTIC ROUTE	CNS2;73	SET	'1' FOR Intrathecal; '2' FOR Intra-arterial; '3' FOR Intravenous; '4' FOR Orally; '5' FOR Intramuscular; '6' FOR BCNU wafer implant; '8' FOR NA, chemotherapy not administered; '9' FOR Unknown; LAST EDITED: `APR 20, 2000` DESCRIPTION: `This field describes the route or method used to administer the chemotherapy.`
1359	HEARING LOSS	CNS2;74	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, chemotherapy not administered; '9' FOR Unknown; LAST EDITED: `APR 20, 2000` DESCRIPTION: `This field describes one of the complications which resulted from the administration of chemotherapy.`
1360	INFECTION	CNS2;75	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, chemotherapy not administered; '9' FOR Unknown; LAST EDITED: `APR 20, 2000` DESCRIPTION: `This field describes one of the complications which resulted from the administration of chemotherapy.`
1361	NAUSEA AND VOMITING	CNS2;76	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, chemotherapy not administered; '9' FOR Unknown; LAST EDITED: `APR 20, 2000` DESCRIPTION: `This field describes one of the complications which resulted from the administration of chemotherapy.`
1362	BLOOD COUNT DROP/BLEEDING	CNS2;77	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, chemotherapy not administered; '9' FOR Unknown; LAST EDITED: `APR 20, 2000` DESCRIPTION: `This field describes one of the complications which resulted from the administration of chemotherapy.`
1363	PERIPHERAL NEUROPATHY	CNS2;78	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, chemotherapy not administered; '9' FOR Unknown; LAST EDITED: `APR 20, 2000` DESCRIPTION: `This field describes one of the complications which resulted from the administration of chemotherapy.`
1364	RENAL FAILURE	CNS2;79	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, chemotherapy not administered; '9' FOR Unknown; LAST EDITED: `APR 20, 2000` DESCRIPTION: `This field describes one of the complications which resulted from the administration of chemotherapy.`
1365	PULMONARY TOXICITY	CNS2;80	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, chemotherapy not administered; '9' FOR Unknown; LAST EDITED: `APR 20, 2000` DESCRIPTION: `This field describes one of the complications which resulted from the administration of chemotherapy.`
1366	OTHER CHEMO COMPLICATIONS	CNS2;81	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, chemotherapy not administered; '9' FOR Unknown; LAST EDITED: `APR 20, 2000` DESCRIPTION: `This field describes one of the complications which resulted from the administration of chemotherapy.`
1367	KARNOFSKY'S RATING @ DIS/TRANS	CNS2;82	POINTER TO KARNOFSKY'S RATING FILE (#164.17)	KARNOFSKY'S RATING(#164.17) INPUT TRANSFORM: `S DIC("S")="I $P(^(0),U,1)'=888" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X` LAST EDITED: `JUL 19, 2000` DESCRIPTION: `This field describes the physical status of the patient at the time of discharge or transfer from the treating facility following definitive therapy. In some cases, the patient may be discharged from the treating` `facility and transferred to another care facility; use codes 030 and 020 to describe these cases. If rating is not recorded, assign a rating based upon the best available information.` SCREEN: `S DIC("S")="I $P(^(0),U,1)'=888"` EXPLANATION: `Enter the appropriate Karnofsky's Rating.`
1368	DATE OF PROGRESSION	CNS2;83	DATE	INPUT TRANSFORM: `S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" S %DT="EP",%DT(0)="-NOW" D ^%DT S X=Y K:Y<1 X K %DT(0) W:'$D(X) !,"Future dates are not allowed"` OUTPUT TRANSFORM: `D DATEOT^ONCOPCE` LAST EDITED: `APR 21, 2000` DESCRIPTION: `This field describes the date the medical practitioner determines that the tumor has progressed and that the first course of therapy has failed, necessitating consideration of a subsequent course of treatment. Patients` `with tumor progression were never disease free following the first course of treatment. Record the month, day and year of the determined progression, based on the best available information. If the patient was disease` `free following the first course of treatment, code 00000000; if no progression was noted or first course of therapy was not administered, code 88888888; if the date of tumor progression is unknown, code 99999999.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1369	TYPE OF PROGRESSION	CNS2;84	SET	'0' FOR None, disease-free; '1' FOR Local; '2' FOR Regional, same hemisphere; '3' FOR Regional, opposite hemisphere; '4' FOR Distant, spine/spinal cord; '5' FOR Distant, abdomen; '6' FOR Distant, other; '8' FOR NA, no progression, or no 1st course; '9' FOR Unknown if progressed; LAST EDITED: `APR 24, 2000` DESCRIPTION: `This field describes the progression of the cancer after the completion of the first course of therapy.`
1370	RECURRENCE/PROGRESSION DOC	CNS2;85	SET	'0' FOR No recurrence/progression; '1' FOR Neurological or Karnofsky's deterioration; '2' FOR CT scan; '3' FOR MRI scan; '4' FOR Comb of 1 + 2, or 1 + 3; '5' FOR Other; '9' FOR Unknown; LAST EDITED: `APR 24, 2000`
1371	KARNOFSKY'S RATING RECURRENCE	CNS2;86	POINTER TO KARNOFSKY'S RATING FILE (#164.17)	KARNOFSKY'S RATING(#164.17) LAST EDITED: `APR 24, 2000` DESCRIPTION: `This field describes the patient's physical status at the time that either recurrence or progression was noted.`
1372	TYPE OF 1ST RECURRENCE/CNS	CNS2;87	SET	'0' FOR None, disease free; '1' FOR Local; '2' FOR Regional, same hemisphere; '3' FOR Regional, opposite hemisphere; '4' FOR Distant, spine/spincal cord; '5' FOR Distant, abdomen; '6' FOR Distant, other; '8' FOR NA, never disease free; '9' FOR Unknown if recurred; LAST EDITED: `APR 24, 2000` DESCRIPTION: `This field describes the return or reappearance of the cancer after a disease free intermission or remission. Record the type of the first recurrence. If the patient has been disease-free since treatment, code 0.`
1373	PROTOCOL PARTICIPATION (SUBTX)	CNS2;88	SET	'00' FOR Not on; '01' FOR RTOG; '02' FOR SWOG; '03' FOR ECOG; '04' FOR POG; '05' FOR CCG; '06' FOR NCI; '07' FOR NABTT; '08' FOR NABTC; '09' FOR National protcol, NOS; '10' FOR Other institutional protocols; LAST EDITED: `APR 27, 2000` DESCRIPTION: `This field describes whether the patient was enrolled in and treated on a protocol as part of their treatment for progression or recurrence of disease. A physician may treat a patient following the guidelines of an` `established protocol but not enroll the patient. For these cases, code 00.`
1374	TYPE OF SUBSEQUENT SURGICAL TX	CNS2;89	SET	'0' FOR None, no subsequent surgery; '1' FOR Subtotal resection; '2' FOR Total or gross resection; '3' FOR Lobectomy; '4' FOR Surgery, NOS; '9' FOR Unknown if subsequent surgery performed; LAST EDITED: `APR 27, 2000` DESCRIPTION: `This field describes subsequent surgical treatment administered to the patient. Subsequent therapy begins after the first course of therapy is complete, stopped, or changed.`
1375	TYPE OF SUBSEQUENT RADIATION	CNS2;90	SET	'0' FOR None; '1' FOR Beam radiation; '2' FOR RA implants; '3' FOR Radioisotopes; '4' FOR Stereotactic radiosurgery; '5' FOR Beam rad/RA implants or radioisotopes; '6' FOR Beam rad/stereotactic radiosurgery; '7' FOR Radiation, NOS; '9' FOR Unknown if administered; LAST EDITED: `NOV 24, 2004` DESCRIPTION: `This field describes subsequent radiation treatment administered to the patient. Subsequent therapy begins after the first course of therapy is complete, stopped, or changed.`
1376	PROCARBAZINE (SUB TX)	CNS3;1	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, chemotherapy not administered; '9' FOR Unknown; LAST EDITED: `APR 27, 2000` DESCRIPTION: `This field describes one type of subsequent chemotherapy administered to the patient. Subsequent therapy begins after the first course of therapy is complete, stopped, or changed.`
1377	CCNU (SUB TX)	CNS3;2	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, chemotherapy not administered; '9' FOR Unknown; LAST EDITED: `APR 27, 2000` DESCRIPTION: `This field describes one type of subsequent chemotherapy administered to the patient. Subsequent therapy begins after the first course of therapy is complete, stopped, or changed.`
1378	VINCRISTINE (SUB TX)	CNS3;3	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, chemotherapy not administered; '9' FOR Unknown; LAST EDITED: `APR 27, 2000` DESCRIPTION: `This field describes one type of subsequent chemotherapy administered to the patient. Subsequent therapy begins after the first course of therapy is complete, stopped, or changed.`
1379	HYDROXYUREA (SUB TX)	CNS3;4	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, chemotherapy not administered; '9' FOR Unknown; LAST EDITED: `APR 27, 2000` DESCRIPTION: `This field describes one type of subsequent chemotherapy administered to the patient. Subsequent therapy begins after the first course of therapy is complete, stopped, or changed.`
1380	METHOTREXATE (SUB TX)	CNS3;5	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, chemotherapy not administered; '9' FOR Unknown; LAST EDITED: `APR 27, 2000` DESCRIPTION: `This field describes one type of subsequent chemotherapy administered to the patient. Subsequent therapy begins after the first course of therapy is complete, stopped, or changed.`
1381	CISPLATIN (SUB TX)	CNS3;6	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, chemotherapy not administered; '9' FOR Unknown; LAST EDITED: `APR 27, 2000` DESCRIPTION: `This field describes one type of subsequent chemotherapy administered to the patient. Subsequent therapy begins after the first course of therapy is complete, stopped, or changed.`
1382	BCNU (SUB TX)	CNS3;7	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, chemotherapy not administered; '9' FOR Unknown; LAST EDITED: `APR 27, 2000` DESCRIPTION: `This field describes one type of subsequent chemotherapy administered to the patient. Subsequent therapy begins after the first course of therapy is complete, stopped, or changed.`
1383	BCNU WAFER IMPLANT (SUB TX)	CNS3;8	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, chemotherapy not administered; '9' FOR Unknown; LAST EDITED: `APR 27, 2000` DESCRIPTION: `This field describes one type of subsequent chemotherapy administered to the patient. Subsequent therapy begins after the first course of therapy is complete, stopped, or changed.`
1384	VP-16 (SUB TX)	CNS3;9	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, chemotherapy not administered; '9' FOR Unknown; LAST EDITED: `APR 27, 2000` DESCRIPTION: `This field describes one type of subsequent chemotherapy administered to the patient. Subsequent therapy begins after the first course of therapy is complete, stopped, or changed.`
1385	CARBOPLATIN (SUB TX)	CNS3;10	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, chemotherapy not administered; '9' FOR Unknown; LAST EDITED: `APR 27, 2000` DESCRIPTION: `This field describes one type of subsequent chemotherapy administered to the patient. Subsequent therapy begins after the first course of therapy is complete, stopped, or changed.`
1386	TEMOZOLOMIDE (SUB TX)	CNS3;11	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, chemotherapy not administered; '9' FOR Unknown; LAST EDITED: `APR 27, 2000` DESCRIPTION: `This field describes one type of subsequent chemotherapy administered to the patient. Subsequent therapy begins after the first course of therapy is complete, stopped, or changed.`
1387	CYCLOPHOSPHAMIDE (SUB TX)	CNS3;12	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, chemotherapy not administered; '9' FOR Unknown; LAST EDITED: `APR 27, 2000` DESCRIPTION: `This field describes one type of subsequent chemotherapy administered to the patient. Subsequent therapy begins after the first course of therapy is complete, stopped, or changed.`
1388	CPT-11 (SUB TX)	CNS3;13	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, chemotherapy not administered; '9' FOR Unknown; LAST EDITED: `APR 27, 2000` DESCRIPTION: `This field describes one type of subsequent chemotherapy administered to the patient. Subsequent therapy begins after the first course of therapy is complete, stopped, or changed.`
1389	TAMOXIFEN (SUB TX)	CNS3;14	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, chemotherapy not administered; '9' FOR Unknown; LAST EDITED: `APR 27, 2000` DESCRIPTION: `This field describes one type of subsequent chemotherapy administered to the patient. Subsequent therapy begins after the first course of therapy is complete, stopped, or changed.`
1390	INTERFERON (SUB TX)	CNS3;15	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, chemotherapy not administered; '9' FOR Unknown; LAST EDITED: `APR 27, 2000` DESCRIPTION: `This field describes one type of subsequent chemotherapy administered to the patient. Subsequent therapy begins after the first course of therapy is complete, stopped, or changed.`
1391	CYTARABINE (ARA-C) (SUB TX)	CNS3;16	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, chemotherapy not administered; '9' FOR Unknown; LAST EDITED: `APR 27, 2000` DESCRIPTION: `This field describes one type of subsequent chemotherapy administered to the patient. Subsequent therapy begins after the first course of therapy is complete, stopped, or changed.`
1392	OTHER CHEMOTHERAPY (SUB TX)	CNS3;17	SET	'0' FOR No; '1' FOR Yes; '8' FOR NA, chemotherapy not administered; '9' FOR Unknown; LAST EDITED: `APR 27, 2000` DESCRIPTION: `This field describes one type of subsequent chemotherapy administered to the patient. Subsequent therapy begins after the first course of therapy is complete, stopped, or changed.`
1393	OTHER SUBSEQUENT TREATMENT	CNS3;18	SET	'0' FOR No other tx; '1' FOR Ca-directed tx, NOS; '2' FOR Monoclonal antibodies; '3' FOR Other experimental ca-dir tx; '4' FOR Double-blind clin trial; '6' FOR Unproven tx; '7' FOR Patient refused tx; '8' FOR Other tx rec, unk if admin; '9' FOR Unk if administered; LAST EDITED: `APR 28, 2000` DESCRIPTION: `This field describes other types of subsequent treatment administered to the patient. Subsequent therapy begins after the first course of therapy is complete, stopped, or changed.`
1394	TUMOR SIZE	CNS3;19	NUMBER	INPUT TRANSFORM: `D TSIT^ONCOOT` OUTPUT TRANSFORM: `S Y=$S($L(Y)=1:"00"_Y,$L(Y)=2:"0"_Y,1:Y) D TSOT^ONCOOT` LAST EDITED: `JAN 10, 2001` HELP-PROMPT: `Record the tumor size from the most significant imaging test.` DESCRIPTION: `This field describes the largest dimension or diameter of the primary tumor in millimeters (1 cm = 10 mm). If the tumor has multiple measurements, code the largest size. For example, a tumor measuring 3 x 4.4 x 2.5 cm` `is coded as 044. If there are multiple tumors, code the size of the largest tumor. For example, if the first tumor measures 2 x .5 cm and the second measures 1 x .5 cm, code 020. See ROADS for instructions on converting` `centimeters to millimeters. Use information from preoperative imaging (MRI, CT, PET, SPECT) to determine TUMOR SIZE. DO NOT use the pathology report to determine TUMOR SIZE. DO NOT guess at the TUMOR SIZE. Code 999 if` `TUMOR SIZE cannot be determined.` `Codes: 001 thru 997 - tumor size (mm)` `999 - Unknown, cannot be determined, not recorded` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1400	LNG CO-MORBID CONDITION 1	LUN1;1	POINTER TO ICD DIAGNOSIS FILE (#80)	ICD DIAGNOSIS(#80) INPUT TRANSFORM: `S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0" D ^DIC K DIC S DIC=$G(DIE),X=+Y K:Y<0 X` OUTPUT TRANSFORM: `I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(ONCICD,U,4)` LAST EDITED: `JUN 08, 2012` DESCRIPTION: `This field records a pre-existing medical condition that was present at the time of diagnosis for this cancer or the patient was first seen at your facility following diagnosis. Report the ICD-CM code. Pre- existing` `conditions should be coded; do NOT code conditions which the patient acquired while being treated for this condition.` `Allowable Codes: 000.00` `001.00 thru 994.90 (valid ICD-CM codes)` `If no co-morbid conditions were documented, answer "No" to the CO-MORBID CONDITIONS (YES/NO) prompt.` SCREEN: `S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0"` EXPLANATION: `If the CO-MORBID CONDITIONS (Y/N) field is set to "NO", then no editing of this field is allowed.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1400.1	LNG CO-MORBID CONDITION 2	LUN1;2	POINTER TO ICD DIAGNOSIS FILE (#80)	ICD DIAGNOSIS(#80) INPUT TRANSFORM: `S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0" D ^DIC K DIC S DIC=$G(DIE),X=+Y K:Y<0 X` OUTPUT TRANSFORM: `I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(ONCICD,U,4)` LAST EDITED: `JUN 08, 2012` DESCRIPTION: `This field records a pre-existing medical condition that was present at the time of diagnosis for this cancer or the patient was first seen at your facility following diagnosis. Report the ICD-CM code. Pre- existing` `conditions should be coded; do NOT code conditions which the patient acquired while being treated for this condition.` `Allowable Codes: 001.00 thru 994.90 (valid ICD-CM codes)` `If there was only one co-morbid condition, leave this field blank.` SCREEN: `S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0"` EXPLANATION: `If the CO-MORBID CONDITIONS (Y/N) field is set to "NO", then no editing of this field is allowed.`
1400.2	LNG CO-MORBID CONDITION 3	LUN1;3	POINTER TO ICD DIAGNOSIS FILE (#80)	ICD DIAGNOSIS(#80) INPUT TRANSFORM: `S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X` OUTPUT TRANSFORM: `I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(ONCICD,U,4)` LAST EDITED: `JUN 08, 2012` DESCRIPTION: `This field records a pre-existing medical condition that was present at the time of diagnosis for this cancer or the patient was first seen at your facility following diagnosis. Report the ICD-CM code. Pre- existing` `conditions should be coded; do NOT code conditions which the patient acquired while being treated for this condition.` `Allowable Codes: 001.00 thru 994.90 (valid ICD-CM codes)` `If there was only one co-morbid condition, leave this field blank.` SCREEN: `S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0"` EXPLANATION: `If the CO-MORBID CONDITIONS (Y/N) field is set to "NO", then no editing of this field is allowed.`
1400.3	LNG CO-MORBID CONDITION 4	LUN1;4	POINTER TO ICD DIAGNOSIS FILE (#80)	ICD DIAGNOSIS(#80) INPUT TRANSFORM: `S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X` OUTPUT TRANSFORM: `I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(ONCICD,U,4)` LAST EDITED: `JUN 08, 2012` DESCRIPTION: `This field records a pre-existing medical condition that was present at the time of diagnosis for this cancer or the patient was first seen at your facility following diagnosis. Report the ICD-CM code. Pre- existing` `conditions should be coded; do NOT code conditions which the patient acquired while being treated for this condition.` `Allowable Codes: 001.00 thru 994.90 (valid ICD-CM codes)` `If there was only one co-morbid condition, leave this field blank.` SCREEN: `S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0"` EXPLANATION: `If the CO-MORBID CONDITIONS (Y/N) field is set to "NO", then no editing of this field is allowed.`
1400.4	LNG CO-MORBID CONDITION 5	LUN1;5	POINTER TO ICD DIAGNOSIS FILE (#80)	ICD DIAGNOSIS(#80) INPUT TRANSFORM: `S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X` OUTPUT TRANSFORM: `I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(ONCICD,U,4)` LAST EDITED: `JUN 08, 2012` DESCRIPTION: `This field records a pre-existing medical condition that was present at the time of diagnosis for this cancer or the patient was first seen at your facility following diagnosis. Report the ICD-CM code. Pre- existing` `conditions should be coded; do NOT code conditions which the patient acquired while being treated for this condition.` `Allowable Codes: 001.00 thru 994.90 (valid ICD-CM codes)` `If there was only one co-morbid condition, leave this field blank.` SCREEN: `S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0"` EXPLANATION: `If the CO-MORBID CONDITIONS (Y/N) field is set to "NO", then no editing of this field is allowed.`
1400.5	LNG CO-MORBID CONDITION 6	LUN1;6	POINTER TO ICD DIAGNOSIS FILE (#80)	ICD DIAGNOSIS(#80) INPUT TRANSFORM: `S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X` OUTPUT TRANSFORM: `I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(ONCICD,U,4)` LAST EDITED: `JUN 08, 2012` DESCRIPTION: `This field records a pre-existing medical condition that was present at the time of diagnosis for this cancer or the patient was first seen at your facility following diagnosis. Report the ICD-CM code. Pre- existing` `conditions should be coded; do NOT code conditions which the patient acquired while being treated for this condition.` `Allowable Codes: 001.00 thru 994.90 (valid ICD-CM codes)` `If there was only one co-morbid condition, leave this field blank.` SCREEN: `S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0"` EXPLANATION: `If the CO-MORBID CONDITIONS (Y/N) field is set to "NO", then no editing of this field is allowed.`
1400.6	LNG CO-MORBID CONDITION Y/N	LUN1;76	SET	**********************REQUIRED FIELD********************** '0' FOR No; '1' FOR Yes; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `Are CO-MORBID CONDITIONS associated with this cancer (Yes/No)?` `This item records if there were pre-existing medical conditions present at the time of diagnosis for this cancer.` `Answering "Yes" will prompt you for CO-MORBID CONDITIONS #1-6.` `Answering "No" will code CO-MORBID CONDITION #1 with 000.00 and leave the remaining co-morbid fields blank.`
1401	LNG DURATION OF TOBACCO USE	LUN1;7	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S ONCL=2 D DTU^ONCOIT` OUTPUT TRANSFORM: `S Y=$S(Y="00":"Never used tobacco",Y=99:"Not documented",Y="01":Y_" year",1:Y_" years")` LAST EDITED: `MAY 01, 2001` HELP-PROMPT: `Type a Number between 00 and 99` DESCRIPTION: `This item describes the number of known years the patient used some form of tobacco, even if the patient is not presently using tobacco. If the patient has never used tobacco, code 00. If the patient's tobacco use` `cannot be determined, or if the duration of use is not known, code 99.` `Allowable Codes: 00 - never used tobacco` `01 thru 98 - one or more years of tobacco use` `99 - duration of tobacco use not documented` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1402	LNG DATE OF FIRST TISSUE DX	LUN1;8	DATE	INPUT TRANSFORM: `S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" S %DT="EP",%DT(0)="-NOW" D ^%DT S X=Y K:Y<1 X K %DT(0) D:'$D(X) EN^DDIOL("Future dates are not allowed")` OUTPUT TRANSFORM: `D DATEOT^ONCOPCE` LAST EDITED: `JUL 19, 2001` DESCRIPTION: `This item describes the month, day, and year (MMDDCCYY) that this primary cancer was first diagnosed using a tissue sample to arrive at a positive histologic or cytologic evaluation of the tumor.` `If a positive histologic or cytologic evaluation was made but the date is unknown code 99/99/9999.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1403	LNG PERSONAL HIST OTH MALIG	LUN1;9	POINTER TO ICDO TOPOGRAPHY FILE (#164)	ICDO TOPOGRAPHY(#164) OUTPUT TRANSFORM: `S Y=$P($G(^ONCO(164,+Y,0)),U,2)_" "_$P($G(^ONCO(164,+Y,0)),U,1)` LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes the patient's prior history of other invasive malignancies. If the patient has a history of other malignancies report the ICD-O-3 site code for the most recently diagnosed disease. If the patient has` `no personal history of other cancer, code C88.8. If the patient's personal history of other invasive malignancies is not documented, code C99.9.` `Allowable Codes: C00.0 thru C80.9 - valid ICD-0-3 site (topography) codes` `C88.8 - no personal history of other cancer` `C99.9 - personal history of other cancer not documented` EXECUTABLE HELP: `D ITEM3^ONCLPC1`
1404	LNG COUGH	LUN1;10	SET	'1' FOR Present; '2' FOR Not present; '9' FOR Not documented if present; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes the presence of a cough specific to lung (NSCLC) cancer that was recorded in the medical chart.`
1404.1	LNG SHORTNESS OF BREATH	LUN1;11	SET	'1' FOR Present; '2' FOR Not present; '9' FOR Not documented if present; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes the presence of shortness of breath specific to lung (NSCLC) cancer that was recorded in the medical chart.`
1404.2	LNG WEIGHT LOSS	LUN1;12	SET	'1' FOR Present; '2' FOR Not present; '9' FOR Not documented if present; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes the presence of weight loss specific to lung (NSCLC) cancer that was recorded in the medical chart.`
1404.3	LNG HEMOPTYSIS	LUN1;13	SET	'1' FOR Present; '2' FOR Not present; '9' FOR Not documented if present; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes the presence of hemoptysis specific to lung (NSCLC) cancer that was recorded in the medical chart.`
1404.4	LNG PALPABLE LYMPH NODES	LUN1;14	SET	'1' FOR Present; '2' FOR Not present; '9' FOR Not documented if present; LAST EDITED: `APR 30, 2002` DESCRIPTION: `This item describes the presence of palpable lymph nodes specific to lung (NSCLC) cancer that was recorded in the medical chart.`
1405	LNG CHEST X-RAY	LUN1;15	SET	'1' FOR Used; '2' FOR Not used; '9' FOR Not documented if used; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item identifies patients who are screened routinely or due to a high risk history of cardiac and/or pulmonary disease. Record whether a chest x-ray method was used.`
1405.1	LNG CT SCAN	LUN1;16	SET	'1' FOR Used; '2' FOR Not used; '9' FOR Not documented if used; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item identifies patients who are screened routinely or due to a high risk history of cardiac and/or pulmonary disease. Record whether a CT scan method was used.`
1405.2	LNG BRONCHOSCOPY	LUN1;17	SET	'1' FOR Used; '2' FOR Not used; '9' FOR Not documented if used; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item identifies patients who are screened routinely or due to a high risk history of cardiac and/or pulmonary disease. Record whether a bronchoscopy method was used.`
1406	LNG HISTORY AND PHYSICAL	LUN1;18	SET	'1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal results; '8' FOR Not performed, not mentioned in record; '9' FOR Done, results not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes the methods and results of the history and physical performed to evaluate and or diagnose the primary tumor before definitive therapy.`
1406.1	LNG BRONCHOSCOPY PRE-THERAPY	LUN1;19	SET	'1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal results; '8' FOR Not performed, not mentioned in record; '9' FOR Done, results not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes the methods and results of the bronchoscopy performed to evaluate and or diagnose the primary tumor before definitive therapy.`
1406.2	LNG FNAB	LUN1;20	SET	'1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal results; '8' FOR Not performed, not mentioned in record; '9' FOR Done, results not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes the methods and results of the FNAB (fine needle aspiration biopsy) performed to evaluate and or diagnose the primary tumor before definitive therapy.`
1406.3	LNG MEDIASTINOSCOPY	LUN1;21	SET	'1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal results; '8' FOR Not performed, not mentioned in record; '9' FOR Done, results not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes the methods and results of the mediastinoscopy performed to evaluate and or diagnose the primary tumor before definitive therapy.`
1406.4	LNG THOROCOTOMY/OPEN BIOPSY	LUN1;22	SET	'1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal results; '8' FOR Not performed, not mentioned in record; '9' FOR Done, results not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes the methods and results of the thorocotomy/open biopsy (open technique) performed to evaluate and or diagnose the primary tumor before definitive therapy.`
1406.5	LNG VATS	LUN1;23	SET	'1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal results; '8' FOR Not performed, not mentioned in record; '9' FOR Done, results not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes the methods and results of the VATS (visual assisted thorocotomy surgery) performed to evaluate and or diagnose the primary tumor before definitive therapy.`
1407	LNG FVC	LUN1;24	NUMBER	INPUT TRANSFORM: `K:X>9.99!(X<0)!(X?.E1"."3N.N) X I $D(X) S ONCL=1,ONCF=2 D PFT^ONCOIT` OUTPUT TRANSFORM: `S Y=$S(Y="0.00":"Not done",Y=9.98:"Done, results not documented",Y=9.99:"Not documented if performed",1:Y_" liter(s)")` LAST EDITED: `MAY 01, 2001` HELP-PROMPT: `Type a Number between 0.00 and 9.99, 2 Decimal Digits` DESCRIPTION: `This item describes the results of the FVC (forced vital capacity) pulmonary function test (PFT). Record the absolute value of the result in liters (L). Record results to the precision of 2 decimal points and record` `zeros in unused positions; for example 2.54L would be coded as 2.54; 1.2L would be coded as 1.20; 0.5L would be coded as 0.50. If a test was administered but the result is not documented, code 9.98; if it's not documented` `whether the test was administered, code 9.99.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1407.1	LNG FEV	LUN1;25	NUMBER	INPUT TRANSFORM: `K:X>9.99!(X<0)!(X?.E1"."3N.N) X I $D(X) S ONCL=1,ONCF=2 D PFT^ONCOIT` OUTPUT TRANSFORM: `S Y=$S(+Y=0:"Not done",Y=9.98:"Done, results not documented",Y=9.99:"Not documented if performed",1:Y_" liter(s)")` LAST EDITED: `MAY 01, 2001` HELP-PROMPT: `Type a Number between 0.00 and 9.99, 2 Decimal Digits` DESCRIPTION: `This item describes the results of the FEV (forced expiratory volume) pulmonary function test (PFT). Record the absolute value of the result in liters (L). Record results to the precision of 2 decimal points and record` `zeros in unused positions; for example 2.54L would be coded as 2.54; 1.2L would be coded as 1.20; 0.5L would be coded as 0.50. If a test was administered but the result is not documented, code 9.98; if it's not documented` `whether the test was administered, code 9.99.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1408	LNG LIVER FUNCTION TESTS	LUN1;26	SET	'1' FOR Abnormal results, for at least one test; '2' FOR Normal results on all tests; '8' FOR Test(s) not performed, not mentioned; '9' FOR Test(s) done, results not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes the results of any test performed to evaluate the patient's liver function. Liver function tests typically include protime, bilirubin, albumin and LDH. If ANY of these tests were performed and were` `documented with abnormal results, code 1. If ALL liver function tests had normal results, code 2.`
1409	LNG BONE SCAN	LUN1;27	SET	'1' FOR Performed; '2' FOR Not performed; '9' FOR Requested, not documented if performed; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item records whether or not a bone scan was performed.`
1409.1	LNG EMPHYSEMA (BONE SCAN)	LUN1;28	SET	'1' FOR Present; '2' FOR Absent; '8' FOR NA, test not performed; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item records the presence or absence of emphysema as detected in the bone scan.`
1409.2	LNG VASCULAR INV (BONE SCAN)	LUN1;29	SET	'1' FOR Present; '2' FOR Absent; '8' FOR NA, test not performed; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item records the presence or absence of vascular invasion as detected in the bone scan.`
1409.3	LNG MEDIASTINAL LN (BONE SCAN)	LUN1;30	SET	'1' FOR Present; '2' FOR Absent; '8' FOR NA, test not performed; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item records the presence or absence of enlarged mediastinal lymph nodes as detected in the bone scan.`
1409.4	LNG TUMOR SIZE (BONE SCAN)	LUN1;31	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S ONCL=3 D RE^ONCOIT` OUTPUT TRANSFORM: `D RE^ONCOOT` LAST EDITED: `MAY 01, 2001` HELP-PROMPT: `Type a Number between 000 and 999` DESCRIPTION: `Record the size in millimeters of the dominant (largest) tumor as detected by the bone scan.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1409.5	LNG NUM OF TUMORS (BONE SCAN)	LUN1;32	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S ONCL=2 D RE^ONCOIT` OUTPUT TRANSFORM: `D RE^ONCOOT` LAST EDITED: `MAY 01, 2001` HELP-PROMPT: `Type a Number between 00 and 99` DESCRIPTION: `Record the number of tumor nodules found (or identified) by the bone scan.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1409.6	LNG METASTASIS (BONE SCAN)	LUN1;33	SET	'1' FOR Present; '2' FOR Absent; '8' FOR NA, test not performed; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item records the presence or absence of metastasis as detected in the bone scan.`
1410	LNG CT SCAN OF CHEST	LUN1;34	SET	'1' FOR Performed; '2' FOR Not performed; '9' FOR Requested, not documented if performed; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item records whether or not a CT scan of the chest was performed.`
1410.1	LNG EMPHYSEMA (CHEST CT)	LUN1;35	SET	'1' FOR Present; '2' FOR Absent; '8' FOR NA, test not performed; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item records the presence or absence of emphysema as detected in the CT scan of the chest.`
1410.2	LNG VASCULAR INV (CHEST CT)	LUN1;36	SET	'1' FOR Present; '2' FOR Absent; '8' FOR NA, test not performed; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item records the presence or absence of vascular invasion as detected in the CT scan of the chest.`
1410.3	LNG MEDIASTINAL LN (CHEST CT)	LUN1;37	SET	'1' FOR Present; '2' FOR Absent; '8' FOR NA, test not performed; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item records the presence or absence of enlarged mediastinal lymph nodes as detected in the CT scan of the chest.`
1410.4	LNG TUMOR SIZE (CHEST CT)	LUN1;38	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S ONCL=3 D RE^ONCOIT` OUTPUT TRANSFORM: `D RE^ONCOOT` LAST EDITED: `MAY 01, 2001` HELP-PROMPT: `Type a Number between 000 and 999` DESCRIPTION: `Record the size in millimeters of the dominant (largest) tumor as detected by the CT scan of the chest.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1410.5	LNG NUM OF TUMORS (CHEST CT)	LUN1;39	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S ONCL=2 D RE^ONCOIT` OUTPUT TRANSFORM: `D RE^ONCOOT` LAST EDITED: `MAY 01, 2001` HELP-PROMPT: `Type a Number between 00 and 99` DESCRIPTION: `Record the number of tumor nodules found (or identified) by the CT scan of the chest.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1410.6	LNG METASTASIS (CHEST CT)	LUN1;40	SET	'1' FOR Present; '2' FOR Absent; '8' FOR NA, test not performed; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item records the presence or absence of metastasis as detected in the CT scan of the chest.`
1411	LNG CT SCAN OF BRAIN	LUN1;41	SET	'1' FOR Performed; '2' FOR Not performed; '9' FOR Requested, not documented if performed; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item records whether or not a CT scan of the brain was performed.`
1411.1	LNG EMPHYSEMA (BRAIN CT)	LUN1;42	SET	'1' FOR Present; '2' FOR Absent; '8' FOR NA, test not performed; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item records the presence or absence of emphysema as detected in the CT scan of the brain.`
1411.2	LNG VASCULAR INV (BRAIN CT)	LUN1;43	SET	'1' FOR Present; '2' FOR Absent; '8' FOR NA, test not performed; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item records the presence or absence of vascular invasion as detected in the CT scan of the brain.`
1411.3	LNG MEDIASTINAL LN (BRAIN CT)	LUN1;44	SET	'1' FOR Present; '2' FOR Absent; '8' FOR NA, test not performed; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item records the presence or absence of enlarged mediastinal lymph nodes as detected in the CT scan of the brain.`
1411.4	LNG TUMOR SIZE (BRAIN CT)	LUN1;45	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S ONCL=3 D RE^ONCOIT` OUTPUT TRANSFORM: `D RE^ONCOOT` LAST EDITED: `MAY 01, 2001` HELP-PROMPT: `Type a Number between 000 and 999` DESCRIPTION: `Record the size in millimeters of the dominant (largest) tumor as detected by the CT scan of the brain.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1411.5	LNG NUM OF TUMORS (BRAIN CT)	LUN1;46	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S ONCL=2 D RE^ONCOIT` OUTPUT TRANSFORM: `D RE^ONCOOT` LAST EDITED: `MAY 01, 2001` HELP-PROMPT: `Type a Number between 00 and 99` DESCRIPTION: `Record the number of tumor nodules found (or identified) by the CT scan of the brain.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1411.6	LNG METASTASIS (BRAIN CT)	LUN1;47	SET	'1' FOR Present; '2' FOR Absent; '8' FOR NA, test not performed; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item records the presence or absence of metastasis as detected in the CT scan of the brain.`
1412	LNG MRI SCAN OF CHEST	LUN1;48	SET	'1' FOR Performed; '2' FOR Not performed; '9' FOR Requested, not documented if performed; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item records whether or not a MRI scan of the chest was performed.`
1412.1	LNG EMPHYSEMA (CHEST MRI)	LUN1;49	SET	'1' FOR Present; '2' FOR Absent; '8' FOR NA, test not performed; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item records the presence or absence of emphysema as detected in the MRI of the chest.`
1412.2	LNG VASCULAR INV (CHEST MRI)	LUN1;50	SET	'1' FOR Present; '2' FOR Absent; '8' FOR NA, test not performed; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item records the presence or absence of vascular invasion as detected in the MRI scan of chest.`
1412.3	LNG MEDIASTINAL LN (CHEST MRI)	LUN1;51	SET	'1' FOR Present; '2' FOR Absent; '8' FOR NA, test not performed; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item records the presence or absence of enlarged mediastinal lymph nodes as detected in the MRI scan of the chest.`
1412.4	LNG TUMOR SIZE (CHEST MRI)	LUN1;52	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S ONCL=3 D RE^ONCOIT` OUTPUT TRANSFORM: `D RE^ONCOOT` LAST EDITED: `MAY 01, 2001` HELP-PROMPT: `Type a Number between 000 and 999` DESCRIPTION: `Record the size in millimeters of the dominant (largest) tumor as detected by the MRI scan of the chest.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1412.5	LNG NUM OF TUMORS (CHEST MRI)	LUN1;53	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S ONCL=2 D RE^ONCOIT` OUTPUT TRANSFORM: `D RE^ONCOOT` LAST EDITED: `MAY 01, 2001` HELP-PROMPT: `Type a Number between 00 and 99` DESCRIPTION: `Record the number of tumor nodules found (or identified) by the MRI scan of the chest.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1412.6	LNG METASTASIS (CHEST MRI)	LUN1;54	SET	'1' FOR Present; '2' FOR Absent; '8' FOR NA, test not performed; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item records the presence or absence of metastasis as detected in the MRI scan of the chest.`
1413	LNG MRI SCAN OF BRAIN	LUN1;55	SET	'1' FOR Performed; '2' FOR Not performed; '9' FOR Requested, not documented if performed; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item records whether or not a MRI scan of the brain was performed.`
1413.1	LNG EMPHYSEMA (BRAIN MRI)	LUN1;56	SET	'1' FOR Present; '2' FOR Absent; '8' FOR NA, test not performed; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item records the presence or absence of emphysema as detected in the MRI of the brain.`
1413.2	LNG VASCULAR INV (BRAIN MRI)	LUN1;57	SET	'1' FOR Present; '2' FOR Absent; '8' FOR NA, test not performed; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item records the presence or absence of vascular invasion as detected in the MRI scan of the brain.`
1413.3	LNG MEDIASTINAL LN (BRAIN MRI)	LUN1;58	SET	'1' FOR Present; '2' FOR Absent; '8' FOR NA, test not performed; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item records the presence or absence of enlarged mediastinal lymph nodes as detected in the MRI scan of the brain.`
1413.4	LNG TUMOR SIZE (BRAIN MRI)	LUN1;59	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S ONCL=3 D RE^ONCOIT` OUTPUT TRANSFORM: `D RE^ONCOOT` LAST EDITED: `MAY 01, 2001` HELP-PROMPT: `Type a Number between 000 and 999` DESCRIPTION: `Record the size in millimeters of the dominant (largest) tumor as detected by the MRI scan of the brain.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1413.5	LNG NUM OF TUMORS (BRAIN MRI)	LUN1;60	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S ONCL=2 D RE^ONCOIT` OUTPUT TRANSFORM: `D RE^ONCOOT` LAST EDITED: `MAY 01, 2001` HELP-PROMPT: `Type a Number between 00 and 99` DESCRIPTION: `Record the number of tumor nodules found (or identified) by the MRI scan of the brain.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1413.6	LNG METASTASIS (BRAIN MRI)	LUN1;61	SET	'1' FOR Present; '2' FOR Absent; '8' FOR NA, test not performed; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item records the presence or absence of metastasis as detected in the MRI scan of the brain.`
1414	LNG PET SCAN	LUN1;62	SET	'1' FOR Performed; '2' FOR Not performed; '9' FOR Requested, not documented if performed; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item records whether or not a PET (positron emission tomography) scan was performed.`
1414.1	LNG EMPHYSEMA (PET SCAN)	LUN1;63	SET	'1' FOR Present; '2' FOR Absent; '8' FOR NA, test not performed; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item records the presence or absence of emphysema as detected in the PET (positron emission tomography) scan.`
1414.2	LNG VASCULAR INV (PET SCAN)	LUN1;64	SET	'1' FOR Present; '2' FOR Absent; '8' FOR NA, test not performed; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item records the presence or absence of vascular invasion as detected in the PET (positron emission tomography) scan.`
1414.3	LNG MEDIASTINAL LN (PET SCAN)	LUN1;65	SET	'1' FOR Present; '2' FOR Absent; '8' FOR NA, test not performed; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item records the presence or absence of enlarged mediastinal lymph nodes as detected in the PET (positron emission tomography) scan.`
1414.4	LNG TUMOR SIZE (PET SCAN)	LUN1;66	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S ONCL=3 D RE^ONCOIT` OUTPUT TRANSFORM: `D RE^ONCOOT` LAST EDITED: `MAY 01, 2001` HELP-PROMPT: `Type a Number between 000 and 999` DESCRIPTION: `Record the size in millimeters of the dominant (largest) tumor as detected by the PET (positron emission tomography) scan.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1414.5	LNG NUM OF TUMORS (PET SCAN)	LUN1;67	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S ONCL=2 D RE^ONCOIT` OUTPUT TRANSFORM: `D RE^ONCOOT` LAST EDITED: `MAY 01, 2001` HELP-PROMPT: `Type a Number between 00 and 99` DESCRIPTION: `Record the number of tumor nodules found (or identified) by the PET (positron emission tomography) scan.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1414.6	LNG METASTASIS (PET SCAN)	LUN1;68	SET	'1' FOR Present; '2' FOR Absent; '8' FOR NA, test not performed; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item records the presence or absence of metastasis as detected in the PET (positron emission tomography) scan.`
1415	LNG X-RAY OF CHEST	LUN1;69	SET	'1' FOR Performed; '2' FOR Not performed; '9' FOR Requested, not documented if performed; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item records whether or not a chest x-ray was performed.`
1415.1	LNG EMPHYSEMA (CHEST XRAY)	LUN1;70	SET	'1' FOR Present; '2' FOR Absent; '8' FOR NA, test not performed; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item records the presence or absence of emphysema as detected in the X-Ray of the chest.`
1415.2	LNG VASCULAR INV (CHEST XRAY)	LUN1;71	SET	'1' FOR Present; '2' FOR Absent; '8' FOR NA, test not performed; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item records the presence or absence of vascular invasion as detected in the X-ray of the chest.`
1415.3	LNG MEDIASTINAL (CHEST XRAY)	LUN1;72	SET	'1' FOR Present; '2' FOR Absent; '8' FOR NA, test not performed; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item records the presence or absence of enlarged mediastinal lymph nodes as detected in the X-ray of the chest.`
1415.4	LNG TUMOR SIZE (CHEST XRAY)	LUN1;73	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S ONCL=3 D RE^ONCOIT` OUTPUT TRANSFORM: `D RE^ONCOOT` LAST EDITED: `MAY 01, 2001` HELP-PROMPT: `Type a Number between 000 and 999` DESCRIPTION: `Record the size in millimeters of the dominant (largest) tumor as detected by the X-ray of the chest.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1415.5	LNG NUM OF TUMORS (CHEST XRAY)	LUN1;74	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S ONCL=2 D RE^ONCOIT` OUTPUT TRANSFORM: `D RE^ONCOOT` LAST EDITED: `MAY 01, 2001` HELP-PROMPT: `Type a Number between 00 and 99` DESCRIPTION: `Record the number of tumor nodules found (or identified) by the X-ray of the chest.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1415.6	LNG METASTASIS (CHEST XRAY)	LUN1;75	SET	'1' FOR Present; '2' FOR Absent; '8' FOR NA, test not performed; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item records the presence or absence of metastasis as detected in the X-ray of the chest.`
1416	LNG HIGH MEDIASTINAL (PRE-OP)	LUN2;1	SET	'1' FOR No nodes sampled; '2' FOR Sampled, no evidence of positive nodes; '3' FOR Sampled, evidence of positive nodes; '4' FOR Node sampling not mentioned; '5' FOR Sampled, results not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes whether the highest mediastinal (level 1) nodes were sampled prior to the first course of therapy and if so, whether any positive nodes were found.`
1416.1	LNG UPPER PARATRACH (PRE-OP)	LUN2;2	SET	'1' FOR No nodes sampled; '2' FOR Sampled, no evidence of positive nodes; '3' FOR Sampled, evidence of positive nodes; '4' FOR Node sampling not mentioned; '5' FOR Sampled, results not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes whether the upper paratracheal (level 2) nodes were sampled prior to the first course of therapy and if so, whether any positive nodes were found.`
1416.2	LNG PREVASC/RETRO (PRE-OP)	LUN2;3	SET	'1' FOR No nodes sampled; '2' FOR Sampled, no evidence of positive nodes; '3' FOR Sampled, evidence of positive nodes; '4' FOR Node sampling not mentioned; '5' FOR Sampled, results not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes whether the prevascular and retrotracheal (level 3) nodes were sampled prior to the first course of therapy and if so, whether any positive nodes were found.`
1416.3	LNG LOWER PARATRACH (PRE-OP)	LUN2;4	SET	'1' FOR No nodes sampled; '2' FOR Sampled, no evidence of positive nodes; '3' FOR Sampled, evidence of positive nodes; '4' FOR Node sampling not mentioned; '5' FOR Sampled, results not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes whether the lower paratracheal (level 4) nodes were sampled prior to the first course of therapy and if so, whether any positive nodes were found.`
1416.4	LNG SUBAORTIC (PRE-OP)	LUN2;5	SET	'1' FOR No nodes sampled; '2' FOR Sampled, no evidence of positive nodes; '3' FOR Sampled, evidence of positive nodes; '4' FOR Node sampling not mentioned; '5' FOR Sampled, results not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes whether the subaortic (level 5) nodes were sampled prior to the first course of therapy and if so, whether any positive nodes were found.`
1416.5	LNG PARAORTIC (PRE-OP)	LUN2;6	SET	'1' FOR No nodes sampled; '2' FOR Sampled, no evidence of positive nodes; '3' FOR Sampled, evidence of positive nodes; '4' FOR Node sampling not mentioned; '5' FOR Sampled, results not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes whether the paraortic (level 6) nodes were sampled prior to the first course of therapy and if so, whether any positive nodes were found.`
1416.6	LNG SUBCARINAL (PRE-OP)	LUN2;7	SET	'1' FOR No nodes sampled; '2' FOR Sampled, no evidence of positive nodes; '3' FOR Sampled, evidence of positive nodes; '4' FOR Node sampling not mentioned; '5' FOR Sampled, results not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes whether the subcarinal (level 7) nodes were sampled prior to the first course of therapy and if so, whether any positive nodes were found.`
1416.7	LNG PARAESOPHAGEAL (PRE-OP)	LUN2;8	SET	'1' FOR No nodes sampled; '2' FOR Sampled, no evidence of positive nodes; '3' FOR Sampled, evidence of positive nodes; '4' FOR Node sampling not mentioned; '5' FOR Sampled, results not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes whether the paraesophageal (level 8) nodes were sampled prior to the first course of therapy and if so, whether any positive nodes were found.`
1416.8	LNG PULMONARY LIG (PRE-OP)	LUN2;9	SET	'1' FOR No nodes sampled; '2' FOR Sampled, no evidence of positive nodes; '3' FOR Sampled, evidence of positive nodes; '4' FOR Node sampling not mentioned; '5' FOR Sampled, results not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes whether the pulmonary ligament (level 9) nodes were sampled prior to the first course of therapy and if so, whether any positive nodes were found.`
1417	LNG FROZEN SECTION	LUN2;10	SET	'1' FOR Surgery performed, no frozen section taken; '2' FOR Surgery performed, frozen section taken; '8' FOR NA, no surgery; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes whether or not a frozen section was taken according to the pathology report.`
1418	LNG VASCULAR INVASION	LUN2;11	SET	'1' FOR Structure not involved; '2' FOR Yes, structure involved; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes any tumor invasion of the vascular structure.`
1418.1	LNG LYMPHATICS INVASION	LUN2;12	SET	'1' FOR Structure not involved; '2' FOR Yes, structure involved; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes any tumor invasion of the lymphatics structure.`
1418.2	LNG PLEURA INVASION	LUN2;13	SET	'1' FOR Structure not involved; '2' FOR Yes, structure involved; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes any tumor invasion of the pleura structure.`
1418.3	LNG CHEST WALL INVASION	LUN2;14	SET	'1' FOR Structure not involved; '2' FOR Yes, structure involved; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes any tumor invasion of the chest wall.`
1418.4	LNG OTHER INVASION	LUN2;15	SET	'1' FOR Structure not involved; '2' FOR Yes, structure involved; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes any tumor invasion of any other structure.`
1419	LNG HIGH MEDIASTINAL (SCOPE)	LUN2;16	SET	'1' FOR Nodes not sampled; '2' FOR Nodes sampled, but not removed en bloc; '3' FOR Nodes removed en bloc; '9' FOR Lymph node assessment not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes the scope of operative mediastinal lymph node assessment during surgery of the primary site. Record whether the highest mediastinal (level 1) nodes were sampled or taken en bloc.`
1419.1	LNG UPPER PARATRACHEAL (SCOPE)	LUN2;17	SET	'1' FOR Nodes not sampled; '2' FOR Nodes sampled, but not removed en bloc; '3' FOR Nodes removed en bloc; '9' FOR Lymph node assessment not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes the scope of operative mediastinal lymph node assessment during surgery of the primary site. Record whether the upper paratracheal (level 2) nodes were sampled or taken en bloc.`
1419.2	LNG PREVASC/RETROTRACH (SCOPE)	LUN2;18	SET	'1' FOR Nodes not sampled; '2' FOR Nodes sampled, but not removed en bloc; '3' FOR Nodes removed en bloc; '9' FOR Lymph node assessment not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes the scope of operative mediastinal lymph node assessment during surgery of the primary site. Record whether the prevascular & retrotracheal (level 3) nodes were sampled or taken en bloc.`
1419.3	LNG LOWER PARATRACHEAL (SCOPE)	LUN2;19	SET	'1' FOR Nodes not sampled; '2' FOR Nodes sampled, but not removed en bloc; '3' FOR Nodes removed en bloc; '9' FOR Lymph node assessment not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes the scope of operative mediastinal lymph node assessment during surgery of the primary site. Record whether the lower paratracheal (level 4) nodes were sampled or taken en bloc.`
1419.4	LNG SUBAORTIC (SCOPE)	LUN2;20	SET	'1' FOR Nodes not sampled; '2' FOR Nodes sampled, but not removed en bloc; '3' FOR Nodes removed en bloc; '9' FOR Lymph node assessment not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes the scope of operative mediastinal lymph node assessment during surgery of the primary site. Record whether the subaortic (level 5) nodes were sampled or taken en bloc.`
1419.5	LNG PARAORTIC (SCOPE)	LUN2;21	SET	'1' FOR Nodes not sampled; '2' FOR Nodes sampled, but not removed en bloc; '3' FOR Nodes removed en bloc; '9' FOR Lymph node assessment not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes the scope of operative mediastinal lymph node assessment during surgery of the primary site. Record whether the paraortic (level 6) nodes were sampled or taken en bloc.`
1419.6	LNG SUBCARINAL (SCOPE)	LUN2;22	SET	'1' FOR Nodes not sampled; '2' FOR Nodes sampled, but not removed en bloc; '3' FOR Nodes removed en bloc; '9' FOR Lymph node assessment not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes the scope of operative mediastinal lymph node assessment during surgery of the primary site. Record whether the subcarinal (level 7) nodes were sampled or taken en bloc.`
1419.7	LNG PARAESOPHAGEAL (SCOPE)	LUN2;23	SET	'1' FOR Nodes not sampled; '2' FOR Nodes sampled, but not removed en bloc; '3' FOR Nodes removed en bloc; '9' FOR Lymph node assessment not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes the scope of operative mediastinal lymph node assessment during surgery of the primary site. Record whether the paraesophageal (level 8) nodes were sampled or taken en bloc.`
1419.8	LNG PULMONARY LIGAMENT (SCOPE)	LUN2;24	SET	'1' FOR Nodes not sampled; '2' FOR Nodes sampled, but not removed en bloc; '3' FOR Nodes removed en bloc; '9' FOR Lymph node assessment not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes the scope of operative mediastinal lymph node assessment during surgery of the primary site. Record whether the pulmonary ligament (level 9) nodes were sampled or taken en bloc.`
1420	LNG PERI-OPERATIVE BLOOD REP	LUN2;25	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S ONCL=2 D TPBR^ONCOIT` OUTPUT TRANSFORM: `S Y=$S(Y="00":"No transfusion",Y=98:"Transfusion, # of units not documented",Y=99:"Not recorded if transfusion done",Y="01":Y_" unit",1:Y_" units")` LAST EDITED: `MAY 01, 2001` HELP-PROMPT: `Type a Number between 00 and 99` DESCRIPTION: `This item describes the total number of units of blood transfused within 30 days of operation. If the patient was transfused but the number of units is unknown, code 98.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1421	LNG PERI-OPERATIVE DEATH	LUN2;26	SET	'1' FOR Died within same hospitalization; '2' FOR Died within 30 days of surgery; '3' FOR Both 1 & 2; '4' FOR Discharged/alive 30 days after surgery; '9' FOR Unknown; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes whether or not the patient died peri-operatively.`
1422	LNG BOOST DOSE (cGy)	LUN2;27	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>5!($L(X)<1)!'(X?1.5N) X I $D(X) S ONCL=5 D BD^ONCOIT` OUTPUT TRANSFORM: `S Y=$S(Y="00000":"Not administered",Y=99999:Not documented",1:Y)` LAST EDITED: `MAY 01, 2001` HELP-PROMPT: `Type a Number between 00000 and 99999` DESCRIPTION: `This item describes the boost dose of radiation administered to the central tumor field of the patient. If radiation was administered but boost dose is unknown, code 99999.` `Allowable Codes: 00000 - no radiation boost dose administered` `00001 thru 99998 - boost dose administered (cGy)` `99999- boost dose administered, dose not documented` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1423	CHEMOTHERAPEUTIC AGENT #1	LUN2;28	POINTER TO CHEMOTHERAPEUTIC DRUGS FILE (#164.18)	CHEMOTHERAPEUTIC DRUGS(#164.18) LAST EDITED: `SEP 13, 2007` HELP-PROMPT: `Enter the first chemotherapeutic agent administered to the patient.` DESCRIPTION: `Records the first chemotherapeutic agent administered to the patient as part of the first course of therapy.` `Each chemotherapeutic agent is assigned a 6-digit NSC (National Service Center) number.`
1423.1	CHEMOTHERAPEUTIC AGENT #2	LUN2;29	POINTER TO CHEMOTHERAPEUTIC DRUGS FILE (#164.18)	CHEMOTHERAPEUTIC DRUGS(#164.18) LAST EDITED: `SEP 13, 2007` HELP-PROMPT: `Enter the second chemotherapeutic agent administered to the patient.` DESCRIPTION: `Records the second chemotherapeutic agent administered to the patient as part of the first course of therapy.` `Each chemotherapeutic agent is assigned a 6-digit NSC (National Service Center) number.`
1423.2	CHEMOTHERAPEUTIC AGENT #3	LUN2;30	POINTER TO CHEMOTHERAPEUTIC DRUGS FILE (#164.18)	CHEMOTHERAPEUTIC DRUGS(#164.18) LAST EDITED: `SEP 13, 2007` HELP-PROMPT: `Enter the third chemotherapeutic agent administered to the patient.` DESCRIPTION: `Records the third chemotherapeutic agent administered to the patient as part of the first course of therapy.` `Each chemotherapeutic agent is assigned a 6-digit NSC (National Service Center) number.`
1423.3	CHEMOTHERAPEUTIC AGENT #4	LUN2;44	POINTER TO CHEMOTHERAPEUTIC DRUGS FILE (#164.18)	CHEMOTHERAPEUTIC DRUGS(#164.18) LAST EDITED: `SEP 12, 2007` HELP-PROMPT: `Enter the fourth chemotherapeutic agent administered to the patient.` DESCRIPTION: `Records the fourth chemotherapeutic agent administered to the patient as part of the first course of therapy.` `Each chemotherapeutic agent is assigned a 6-digit NSC (National Service Center) number.`
1423.4	CHEMOTHERAPEUTIC AGENT #5	LUN2;45	POINTER TO CHEMOTHERAPEUTIC DRUGS FILE (#164.18)	CHEMOTHERAPEUTIC DRUGS(#164.18) LAST EDITED: `SEP 12, 2007` HELP-PROMPT: `Enter the fifth chemotherapeutic agent administered to the patient.` DESCRIPTION: `Records the fifth chemotherapeutic agent administered to the patient as part of the first course of therapy.` `Each chemotherapeutic agent is assigned a 6-digit NSC (National Service Center) number.`
1424	LNG CHEMOTHERAPEUTIC TOXICITY	LUN2;31	SET	'1' FOR Chemo discontinued due to toxicity; '2' FOR No chemo toxicity; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes whether the administration of chemotherapy was discontinued as a result of toxicity.`
1425	LNG CHEMOTHERAPY/SURG SEQUENCE	LUN2;32	SET	'1' FOR Chemo before surgery; '2' FOR Chemo after surgery; '3' FOR Chemo before and after surgery; '8' FOR Chemo administered, no surgery; '9' FOR Chemo and surgery, sequence unknown; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This data item describes the sequence in which chemotherapy and surgery of the primary site were administered.`
1426	LNG COMPLICATION #1	LUN2;33	POINTER TO ICD DIAGNOSIS FILE (#80)	ICD DIAGNOSIS(#80) INPUT TRANSFORM: `S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0" D ^DIC K DIC S DIC=$G(DIE),X=+Y K:Y<0 X` OUTPUT TRANSFORM: `I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(ONCICD,U,4)` LAST EDITED: `JUN 08, 2012` DESCRIPTION: `This item describes the first medical complication acquired by the patient during or resulting from the first course of therapy. Record valid ICD-CM codes.` `Allowable Codes: 001.00 - 999.90 (valid ICD-CM codes)` `E930.0 - E949.7 (valid ICD-CM adverse effect codes)` SCREEN: `S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0"` EXPLANATION: `If the COMPLICATIONS (YES/NO) field is set to "No", then no editing of this field is allowed.`
1426.1	LNG COMPLICATION #2	LUN2;34	POINTER TO ICD DIAGNOSIS FILE (#80)	ICD DIAGNOSIS(#80) INPUT TRANSFORM: `S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X` OUTPUT TRANSFORM: `I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(ONCICD,U,4)` LAST EDITED: `JUN 08, 2012` DESCRIPTION: `This item describes the second medical complication acquired by the patient during or resulting from the first course of therapy.` `Allowable Codes: 001.00 - 999.90 (valid ICD-CM codes)` `E930.0 - E949.7 (valid ICD-CM adverse effect codes)` SCREEN: `S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0"` EXPLANATION: `If the COMPLICATIONS (YES/NO) field is set to "No", then no editing of this field is allowed.`
1426.2	LNG COMPLICATION #3	LUN2;35	POINTER TO ICD DIAGNOSIS FILE (#80)	ICD DIAGNOSIS(#80) INPUT TRANSFORM: `S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X` OUTPUT TRANSFORM: `I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(ONCICD,U,4)` LAST EDITED: `JUN 08, 2012` DESCRIPTION: `This item describes the third medical complication acquired by the patient during or resulting from the first course of therapy.` `Allowable Codes: 001.00 - 999.90 (valid ICD-CM codes)` `E930.0 - E949.7 (valid ICD-CM adverse effect codes)` SCREEN: `S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0"` EXPLANATION: `If the COMPLICATIONS (YES/NO) field is set to "No", then no editing of this field is allowed.`
1426.3	LNG COMPLICATION #4	LUN2;36	POINTER TO ICD DIAGNOSIS FILE (#80)	ICD DIAGNOSIS(#80) INPUT TRANSFORM: `S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X` OUTPUT TRANSFORM: `I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(ONCICD,U,4)` LAST EDITED: `JUN 08, 2012` DESCRIPTION: `This item describes the fourth medical complication acquired by the patient during or resulting from the first course of therapy.` `Allowable Codes: 001.00 - 999.90 (valid ICD-CM codes)` `E930.0 - E949.7 (valid ICD-CM adverse effect codes)` SCREEN: `S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0"` EXPLANATION: `If the COMPLICATIONS (YES/NO) field is set to "No", then no editing of this field is allowed.`
1426.4	LNG COMPLICATION #5	LUN2;37	POINTER TO ICD DIAGNOSIS FILE (#80)	ICD DIAGNOSIS(#80) INPUT TRANSFORM: `S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X` OUTPUT TRANSFORM: `I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(ONCICD,U,4)` LAST EDITED: `JUN 08, 2012` DESCRIPTION: `This item describes the fifth medical complication acquired by the patient during or resulting from the first course of therapy.` `Allowable Codes: 001.00 - 999.90 (valid ICD-CM codes)` `E930.0 - E949.7 (valid ICD-CM adverse effect codes)` SCREEN: `S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0"` EXPLANATION: `If the COMPLICATIONS (YES/NO) field is set to "No", then no editing of this field is allowed.`
1426.5	LNG TREATMENT COMPLICATION Y/N	LUN2;40	SET	**********************REQUIRED FIELD********************** '0' FOR No; '1' FOR Yes; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item records if there were medical complications acquired by the patient during or resulting from first course of therapy for this cancer.` `If no complications are listed, answer "No". COMPLICATION #1 will be automatically coded 000.00 with the remaining complication fields left blank.`
1427	LNG CASE ABSTRACTOR INITIALS	LUN2;38	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>3!($L(X)<1) X` LAST EDITED: `MAY 01, 2001` HELP-PROMPT: `Answer must be 1-3 characters in length.` DESCRIPTION: `This item records the initials of the person responsible for abstracting this case and having reviewed all the special study items for completeness and validity.`
1428	LNG DATE CASE WAS ABSTRACTED	LUN2;39	DATE	INPUT TRANSFORM: `S %DT="EX" D ^%DT S X=Y K:Y<1 X` LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes the month, day and year (in the MMDDCCYY format) that this case was reviewed for completeness and validity by the case abstractor.`
1429	LNG PROXIMAL MARGIN	LUN2;41	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S ONCL=3 D DMCM^ONCOIT` OUTPUT TRANSFORM: `S Y=$S(Y="000":"No free margins",Y=998:"NA, no surgery of primary site",Y=999:"Unknown, not documented",1:Y_" mm")` LAST EDITED: `MAY 08, 2001` HELP-PROMPT: `Type a number between 0 and 999` DESCRIPTION: `This item describes the distance of the closest proximal free margin in millimeters of the resected primary tumor specimen. This information can be obtained from the pathology report. If surgery of primary site was` `performed but the extent of the free margin is unknown, code 999.` `Allowable Codes: 000 - no free margins in this segment` `001 thru 997 - distance of closest free margin (mm)` `998 - NA, no surgery of primary site` `999 - unknown, extent of free margin not documented` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1429.1	LNG DISTAL MARGIN	LUN2;42	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S ONCL=3 D DMCM^ONCOIT` OUTPUT TRANSFORM: `S Y=$S(Y="000":"No free margins",Y=998:"NA, no surgery of primary site",Y=999:"Unknown, not documented",1:Y_" mm")` LAST EDITED: `MAY 08, 2001` HELP-PROMPT: `Type a Number between 0 and 999` DESCRIPTION: `This item describes the distance of the closest distal free margin in millimeters of the resected primary tumor specimen. This information can be obtained from the pathology report. If surgery of primary site was` `performed but the extent of the free margin is unknown, code 999.` `Allowable Codes: 000 - no free margins in this segment` `001 thru 997 - distance of closest free margin (mm)` `998 - NA, no surgery of primary site` `999 - unknown, extent of free margin not documented` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1430	LNG HCT VAL BEFORE TRANSFUSION	LUN2;43	NUMBER	INPUT TRANSFORM: `K:(X>99.9)!(X<0)!(X?.E1"."2N.N) X I $D(X) S ONCL=2,ONCF=1 D HVBT^ONCOIT` OUTPUT TRANSFORM: `S Y=$S(+Y=0:"No transfusion",Y=99.9:"Transfusion, % Hct not documented",1:Y_"% Hct")` LAST EDITED: `MAY 08, 2001` HELP-PROMPT: `Type a Number between 0.00 and 99.9, 1 Decimal Digit` DESCRIPTION: `This item describes the percent (%) of hematocrit before the first transfusion. Record results to the precision of one decimal point, record zeros in unused positions; for example 9.5% would be coded as 09.5. If the` `patient was transfused but hematocrit value is not documented, code 99.9.` `Allowable Codes: 00.0 - no transfusion` `00.1 thru 99.0 - % Hct` `99.9 - transfusion, % Hct not documented` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1500	GAS PRIOR EXPOSURE TO RAD	GAS1;1	SET	'1' FOR Documented exposure; '2' FOR Documented no exposure; '9' FOR Not documented; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes a patient's known prior radiation exposure. Exposure to fluoroscopy, exposure to radioactive isotopes, or actual radiation treatments should be considered prior radiation exposure. Occupational` `exposure to radiation should be considered: radioisotope lab worker; radiation therapist; radiology technician; miner. Do not code routine chest or dental x-rays as prior radiation exposure.`
1501	GAS ALCOHOL COMSUMPTION	GAS1;2	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S ONCL=2 D AC^ONCOIT` OUTPUT TRANSFORM: `S Y=$S(Y="00":"Never consumed alcohol",Y=97:"97 or more drinks per week",Y=98:"Yes, number of drinks unknown",Y=99:"Not documented",1:Y_" drink(s) per week")` LAST EDITED: `APR 30, 2001` HELP-PROMPT: `Type a Number between 00 and 99` DESCRIPTION: `This item describes the number of drinks (beer, wine, other alcohol) consumed by the patient per week. If the patient has never consumed alcohol, code 00. If the number of drinks per week is not documented, code 99.` `This information can typically be found in either the patient's clinic chart or the managing physician's notes.` `Allowable Codes: 00 - never consumed alcohol` `01 thru 96 - 1 or more drinks up to 96 drinks per week` `97 - 97 or more drinks per week` `98 - alcohol consumption, number of drinks unknown` `99 - alcohol consumption not documented` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1502	GAS MENOPAUSAL STATUS/HOR TX	GAS1;3	SET	'1' FOR Menopause, no hormome tx; '2' FOR Menopause, hormone tx stopped before dx; '3' FOR Menopause, hormone tx at dx; '8' FOR NA, male patient; '9' FOR Menopause not documented; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes whether a female patient has experienced menopause and, if so, whether or not she was receiving prescribed hormone replacement therapy. Menopause may occur naturally or as a result of a hysterectomy.` `If the patient is male, code 8. If the woman's menopausal status can not be determined, code 9. This information can typically be found in either the patient's clinic chart or the managing physician's notes.`
1503	GAS H2 BLOCKER/PROTON PUMP	GAS1;4	SET	'1' FOR H2 blocker; '2' FOR Proton pump inhibitor; '3' FOR Both; '8' FOR Neither; '9' FOR Not documented; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes whether the patient was either self-medicating or taking prescribed H2 blocker or proton pump inhibitor drugs to suppress gastric acidity and control reflux. Common drug names for H2 blocker include:` `Pepcid (famotidine), Tagamet (cimetidine), Zantac (ranitidine), and Axid (nizatidine). Common names for proton pump inhibitors include: Prilosec (omeprazole), Prevacid (lansoprazole), Protonix (pantaprazol), Aciphex` `(rebeprazol), and Nexium (es-omeprazole).`
1504	GAS FAMILY HIST OF GASTRIC CA	GAS1;5	SET	'1' FOR No 1st or 2nd deg relatives; '2' FOR 1 1st deg relative; '3' FOR 2 1st deg relatives; '4' FOR 3 or more 1st deg relatives; '5' FOR 1 or more 2nd deg relatives; '6' FOR Both 1st and 2nd deg relatives; '9' FOR Familial history, relation not indicated; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes whether there is any familial history of gastric cancer. Record familial history of gastric cancer in first degree relatives (parent, siblings, and child) or 2nd degree relatives (1st cousins, aunt,` `uncle, grandparent, grandchild).`
1505	GAS H-PYLORI INFECTION	GAS1;6	SET	'1' FOR Past history, present at dx; '2' FOR No past history, present at dx; '3' FOR Past history, not present at dx; '4' FOR Documented never present; '9' FOR Unknown, not documented; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes whether the patient had at any time the following associated benign gastric condition:` `Helicobacter pylori (H-pylori) infection`
1506	GAS DUODENAL ULCER	GAS1;7	SET	'1' FOR Past history, present at dx; '2' FOR No past history, present at dx; '3' FOR Past history, not present at dx; '4' FOR Documented never present; '9' FOR Unknown, not documented; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes whether the patient had at any time the following associated benign gastric condition:` `Duodenal ulcer`
1507	GAS GASTRIC ULCER	GAS1;8	SET	'1' FOR Past history, present at dx; '2' FOR No past history, present at dx; '3' FOR Past history, not present at dx; '4' FOR Documented never present; '9' FOR Unknown, not documented; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes whether the patient had at any time the following associated benign gastric condition:` `Gastric ulcer`
1508	GAS HEARTBURN (BENIGN COND)	GAS1;9	SET	'1' FOR Past history, present at dx; '2' FOR No past history, present at dx; '3' FOR Past history, not present at dx; '4' FOR Documented never present; '9' FOR Unknown, not documented; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes whether the patient had at any time the following associated benign gastric condition:` `Heartburn`
1509	GAS PERNICIOUS ANEMIA	GAS1;10	SET	'1' FOR Past history, present at dx; '2' FOR No past history, present at dx; '3' FOR Past history, not present at dx; '4' FOR Documented never present; '9' FOR Unknown, not documented; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes whether the patient had at any time the following associated benign gastric condition:` `Pernicious anemia`
1510	GAS POLYPS OF STOMACH	GAS1;11	SET	'1' FOR Past history, present at dx; '2' FOR No past history, present at dx; '3' FOR Past history, not present at dx; '4' FOR Documented never present; '9' FOR Unknown, not documented; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes whether the patient had at any time the following associated benign gastric condition:` `Polyps of stomach`
1511	GAS POLYPOSIS OF BOWEL	GAS1;12	SET	'1' FOR Past history, present at dx; '2' FOR No past history, present at dx; '3' FOR Past history, not present at dx; '4' FOR Documented never present; '9' FOR Unknown, not documented; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes whether the patient had at any time the following associated benign gastric condition:` `Polyposis of small or large bowel`
1512	GAS BARRET'S ESOPHAGUS	GAS1;13	SET	'1' FOR Past history, present at dx; '2' FOR No past history, present at dx; '3' FOR Past history, not present at dx; '4' FOR Documented never present; '9' FOR Unknown, not documented; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes whether the patient had at any time the following associated benign gastric condition:` `Barret's esophagus`
1513	GAS ATROPHIC GASTRITIS	GAS1;14	SET	'1' FOR Past history, present at dx; '2' FOR No past history, present at dx; '3' FOR Past history, not present at dx; '4' FOR Documented never present; '9' FOR Unknown, not documented; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes whether the patient had at any time the following associated benign gastric condition:` `Atrophic gastritis`
1514	GAS GASTRIC METAPLASIA	GAS1;15	SET	'1' FOR Past history, present at dx; '2' FOR No past history, present at dx; '3' FOR Past history, not present at dx; '4' FOR Documented never present; '9' FOR Unknown, not documented; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes whether the patient had at any time the following associated benign gastric condition:` `Gastric metaplasia`
1515	GAS ANTIBIOTICS	GAS1;16	SET	'1' FOR Regimen given; '2' FOR H-pylori present, regimen not given; '8' FOR H-pylori not present; '9' FOR Not documented; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item records the use of antibiotics for H-pylori infection prior to diagnosis of gastric cancer. Examples of antibiotics include: ampicillin, amoxicillin, clarithromycin, etc.`
1516	GAS PROTON PUMP INHIBITORS	GAS1;17	SET	'1' FOR Regimen given; '2' FOR H-pylori present, regimen not given; '8' FOR H-pylori not present; '9' FOR Not documented; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item records the use of proton pump inhibitors for H-pylori infection prior to diagnosis of gastric cancer. Examples of proton pump inhibitors include: omeprazole, lansoprazole, rabeprazole, pantoprazol,` `es-omeprazole.`
1517	GAS H2 BLOCKERS	GAS1;18	SET	'1' FOR Regimen given; '2' FOR H-pylori present, regimen not given; '8' FOR H-pylori not present; '9' FOR Not documented; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item records the use of H2 blockers for H-pylori infection prior to diagnosis of gastric cancer. Examples of H2 blockers include: ranitidine (Zantac), famotidine (Pepcid), nizatidine (Axid), cimetidine (Tagamet).`
1518	GAS BISMUTH COMPOUNDS	GAS1;19	SET	'1' FOR Regimen given; '2' FOR H-pylori present, regimen not given; '8' FOR H-pylori not present; '9' FOR Not documented; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item records the use of bismuth compounds for H-pylori infection prior to diagnosis of gastric cancer. Examples of bismuth compounds include: Pepo Bismol, prescription bismuth drugs.`
1519	GAS PRIOR INTRA-ABDOMINAL SURG	GAS1;20	SET	'1' FOR Documented; '2' FOR Documented No; '9' FOR Not mentioned; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes whether the patient had undergone any intra- abdominal surgery including a prior gastric resection, before the diagnosis of this cancer. Do not record retroperitoneal or extraperitoneal procedures as` `intra-abdominal surgeries.`
1520	GAS YEAR OF GASTRIC RESECTION	GAS1;21	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>4!($L(X)<4)!'(X?4N) X I $D(X) D GYGR^ONCOIT` OUTPUT TRANSFORM: `S Y=$S(Y="0000":"No prior gastric resection",Y=9999:"Not documented",1:Y)` LAST EDITED: `JUL 19, 2001` HELP-PROMPT: `Type a Number between 0000 and 9999` DESCRIPTION: `This item describes the year that the patient received a gastric resection prior to this diagnosis. If the patient has a documented prior abdominal surgical resection indicate whether that surgery included a gastric` `resection by coding the year the resection occurred. If the patient has received more than one gastric resection, code the earliest (first) year.` `Allowable Codes: 0000 - documented no prior gastric resection` `1901 thru 2001 - year of prior gastric resection` `9999 - not documented whether there was prior gastric` `resection` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1521	GAS PERFORMANCE STATUS AT DX	GAS1;22	SET	'1' FOR Normal, no symptoms; '2' FOR Symptoms/ambulatory/min limits; '3' FOR Out of bed > 50% of day/mod limits; '4' FOR In bed > 50% of day/severe limits; '5' FOR Bedridden/moribund; '9' FOR Not documented; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes the performance status of the patient at initial diagnosis. The scale used in this study is widely known as the ECOG performance status.`
1522	GAS HEARTBURN (SYMPTOMS)	GAS1;23	SET	'1' FOR Present; '2' FOR Not present; '9' FOR Not documented; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes the presence of heartburn specific to gastric cancer that was recorded in the medical chart.`
1523	GAS FEVER/NIGHT SWEATS	GAS1;24	SET	'1' FOR Present; '2' FOR Not present; '9' FOR Not documented; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes the presence of fever/night sweats specific to gastric cancer that was recorded in the medical chart.`
1524	GAS ACUTE HEMATEMESIS	GAS1;25	SET	'1' FOR Present; '2' FOR Not present; '9' FOR Not documented; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes the presence of acute hematemesis specific to gastric cancer that was recorded in the medical chart.`
1525	GAS TRANSFUSIONS FOR BLD LOSS	GAS1;26	SET	'1' FOR Present; '2' FOR Not present; '9' FOR Not documented; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes the presence of transfusions for blood loss specific to gastric cancer that were recorded in the medical chart.`
1526	GAS MELENA	GAS1;27	SET	'1' FOR Present; '2' FOR Not present; '9' FOR Not documented; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes the presence of melena specific to gastric cancer that was recorded in the medical chart.`
1527	GAS PAIN	GAS1;28	SET	'1' FOR Present; '2' FOR Not present; '9' FOR Not documented; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes the presence of pain specific to gastric cancer that was recorded in the medical chart.`
1528	GAS EARLY SATIETY	GAS1;29	SET	'1' FOR Present; '2' FOR Not present; '9' FOR Not documented; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes the presence of early satiety specific to gastric cancer that was recorded in the medical chart.`
1529	GAS CT SCAN OF ABDOMEN	GAS1;30	SET	'1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Not performed; '8' FOR Performed, results not documented; '9' FOR Not documented; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes the results of a CT scan of abdomen performed to evaluate the primary tumor.`
1530	GAS CT SCAN OF CHEST	GAS1;31	SET	'1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Not performed; '8' FOR Performed, results not documented; '9' FOR Not documented; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes the results of a CT scan of chest performed to evaluate the primary tumor.`
1531	GAS CT PELVIS	GAS1;32	SET	'1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Not performed; '8' FOR Performed, results not documented; '9' FOR Not documented; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes the results of a CT pelvis performed to evaluate the primary tumor.`
1532	GAS CHEST X-RAY	GAS1;33	SET	'1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Not performed; '8' FOR Performed, results not documented; '9' FOR Not documented; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes the results of a chest x-ray performed to evaluate the primary tumor.`
1533	GAS GALLIUM SCAN	GAS1;34	SET	'1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Not performed; '8' FOR Performed, results not documented; '9' FOR Not documented; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes the results of a gallium scan performed to evaluate the primary tumor.`
1534	GAS BIPEDAL LYMPHANGIOGRAM	GAS1;35	SET	'1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Not performed; '8' FOR Performed, results not documented; '9' FOR Not documented; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes the results of a bipedal lymphangiogram (LAB) performed to evaluate the primary tumor.`
1535	GAS MRI	GAS1;36	SET	'1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Not performed; '8' FOR Performed, results not documented; '9' FOR Not documented; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes the results of an MRI performed to evaluate the primary tumor.`
1536	GAS PET SCAN	GAS1;37	SET	'1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Not performed; '8' FOR Performed, results not documented; '9' FOR Not documented; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes the results of a PET scan performed to evaluate the primary tumor.`
1537	GAS LAPAROSCOPY	GAS1;38	SET	'1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Not performed; '8' FOR Performed, results not documented; '9' FOR Not documented; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes the results of a laparoscopy performed to evaluate the primary tumor.`
1538	GAS EUS	GAS1;39	SET	'1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Not performed; '8' FOR Performed, results not documented; '9' FOR Not documented; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes the results of an EUS (endoscopic ultrasound) performed to evaluate the primary tumor.`
1539	GAS PERITONEAL LAVAGE	GAS1;40	SET	'1' FOR Abnormal, suggestive of cancer; '2' FOR Abnormal, not suggestive of cancer; '3' FOR Normal; '4' FOR Not performed; '8' FOR Performed, results not documented; '9' FOR Not documented; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes the results of a peritoneal lavage performed to evaluate the primary tumor.`
1540	GAS LDH (IU/L)	GAS1;41	NUMBER	INPUT TRANSFORM: `K:X>9999.9!(X<0)!(X?.E1"."2N.N) X I $D(X) S ONCL=4,ONCF=1 D LS^ONCOIT` OUTPUT TRANSFORM: `S Y=$S(Y="0000.0":"Test not administered",Y="8888.8":"Test administered, results unknown",Y="9999.9":"Not documented",1:Y)` LAST EDITED: `APR 30, 2001` HELP-PROMPT: `Type a Number between 0000.0 and 9999.9, 1 Decimal Digit` DESCRIPTION: `This item describes the absolute value of the LDH (IU/L) study administered to the patient prior to the start of the first course of treatment. This information can typically be found in either the patient's hospital` `chart or laboratory records. Record results to the precision of one decimal point; record zeros in unused positions; for example 12.5 would be coded as 0012.5, and 4.4 would be coded as 0004.4. If a particular test was` `not administered, code 0000.0; if a test was administered but the result is unknown, code 8888.8; if it is not documented whether a test is administered, code 9999.9.` `Allowable Codes: 0000.0 - test not administered` `0000.1 thru 8888.7 - absolute value of test` `8888.8 - test administered, results unknown` `9999.9 - not documented if test administered` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1541	GAS CEA (ng/ml)	GAS1;42	NUMBER	INPUT TRANSFORM: `K:X>9999.9!(X<0)!(X?.E1"."2N.N) X I $D(X) S ONCL=4,ONCF=1 D LS^ONCOIT` OUTPUT TRANSFORM: `S Y=$S(Y="0000.0":"Test not administered",Y="8888.8":"Test administered, results unknown",Y="9999.9":"Not documented",1:Y)` LAST EDITED: `APR 30, 2001` HELP-PROMPT: `Type a Number between 0000.0 and 9999.9, 1 Decimal Digit` DESCRIPTION: `This item describes the absolute value of the Carcinoembryonic antigen, CEA (ng/ml) study administered to the patient prior to the start of the first course of treatment. This information can typically be found in either` `the patient's hospital chart or laboratory records. Record results to the precision of one decimal point; record zeros in unused positions; for example 12.5 would be coded as 0012.5, and 4.4 would be coded as 0004.4. If` `a particular test was not administered, code 0000.0; if a test was administered but the result is unknown, code 8888.8; if it is not documented whether a test is administered, code 9999.9.` `Allowable Codes: 0000.0 - test not administered` `0000.1 thru 8888.7 - absolute value of test` `8888.8 - test administered, results unknown` `9999.9 - not documented if test administered` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1542	GAS CA125 (U/ml)	GAS1;43	NUMBER	INPUT TRANSFORM: `K:X>9999.9!(X<0)!(X?.E1"."2N.N) X I $D(X) S ONCL=4,ONCF=1 D LS^ONCOIT` OUTPUT TRANSFORM: `S Y=$S(Y="0000.0":"Test not administered",Y="8888.8":"Test administered, results unknown",Y="9999.9":"Not documented",1:Y)` LAST EDITED: `APR 30, 2001` HELP-PROMPT: `Type a Number between 0000.0 and 9999.9, 1 Decimal Digit` DESCRIPTION: `This item describes the absolute value of the CA125 (U/ml) study administered to the patient prior to the start of the first course of treatment. This information can typically be found in either the patient's hospital` `chart or laboratory records. Record results to the precision of one decimal point; record zeros in unused positions; for example 12.5 would be coded as 0012.5, and 4.4 would be coded as 0004.4. If a particular test was` `not administered, code 0000.0; if a test was administered but the result is unknown, code 8888.8; if it is not documented whether a test is administered, code 9999.9.` `Allowable Codes: 0000.0 - test not administered` `0000.1 thru 8888.7 - absolute value of test` `8888.8 - test administered, results unknown` `9999.9 - not documented if test administered` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1543	GAS BETA2 MICROGLOBULIN	GAS1;44	NUMBER	INPUT TRANSFORM: `K:X>9999.9!(X<0)!(X?.E1"."2N.N) X I $D(X) S ONCL=4,ONCF=1 D LS^ONCOIT` OUTPUT TRANSFORM: `S Y=$S(Y="0000.0":"Test not administered",Y="8888.8":"Test administered, results unknown",Y="9999.9":"Not documented",1:Y)` LAST EDITED: `APR 30, 2001` HELP-PROMPT: `Type a Number between 0000.0 and 9999.9, 1 Decimal Digit` DESCRIPTION: `This item describes the absolute value of the Beta2 microglobulin (ng/ml) study administered to the patient prior to the start of the first course of treatment. This information can typically be found in either the` `patient's hospital chart or laboratory records. Record results to the precision of one decimal point; record zeros in unused positions; for example 12.5 would be coded as 0012.5, and 4.4 would be coded as 0004.4. If a` `particular test was not administered, code 0000.0; if a test was administered but the result is unknown, code 8888.8; if it is not documented whether a test is administered, code 9999.9.` `Allowable Codes: 0000.0 - test not administered` `0000.1 thru 8888.7 - absolute value of test` `8888.8 - test administered, results unknown` `9999.9 - not documented if test administered` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1544	GAS URINARY 5-HIAA (mg/24hr)	GAS1;45	NUMBER	INPUT TRANSFORM: `K:X>9999.9!(X<0)!(X?.E1"."2N.N) X I $D(X) S ONCL=4,ONCF=1 D LS^ONCOIT` OUTPUT TRANSFORM: `S Y=$S(Y="0000.0":"Test not administered",Y="8888.8":"Test administered, results unknown",Y="9999.9":"Not documented",1:Y)` LAST EDITED: `APR 30, 2001` HELP-PROMPT: `Type a Number between 0000.0 and 9999.9, 1 Decimal Digit` DESCRIPTION: `This item describes the absolute value of the Urinary 5-HIAA (mg/24hr) study administered to the patient prior to the start of the first course of treatment. This information can typically be found in either the` `patient's hospital chart or laboratory records. Record results to the precision of one decimal point; record zeros in unused positions; for example 12.5 would be coded as 0012.5, and 4.4 would be coded as 0004.4. If a` `particular test was not administered, code 0000.0; if a test was administered but the result is unknown, code 8888.8; if it is not documented whether a test is administered, code 9999.9.` `Allowable Codes: 0000.0 - test not administered` `0000.1 thru 8888.7 - absolute value of test` `8888.8 - test administered, results unknown` `9999.9 - not documented if test administered` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1545	GAS CLINICAL/VISUAL EXAM	GAS1;46	SET	'1' FOR Results positive for cancer; '2' FOR Results negative for caner; '8' FOR Not performed; '9' FOR Not documented, exam type not mentioned; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes the most definitive results of a gastroscopic clinical/visual examination.`
1545.1	GAS BIOPSY	GAS1;47	SET	'1' FOR Results positive for cancer; '2' FOR Results negative for cancer; '8' FOR Not performed; '9' FOR Not documented, exam type not mentioned; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes the most definitive results of a gastrscopic biopsy.`
1546	GAS GASTRO-ESOPHAGEAL JUNCTION	GAS1;48	SET	'1' FOR Siewart II <= 2cm from squamocolunmar junc; '2' FOR Siewart III > 2cm from squamocolumnar junc; '9' FOR No documented Siewart type or distance; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item distinguishes tumors that clearly arise within the stomach (type III) from those that start at or near the esophageal gastric junction (type II). Siewert type I tumors are excluded from this study as these are` `considered esophageal (C15.0-C15.9). This information may be obtained from the pathology report.`
1547	GAS STOMACH	GAS1;49	SET	'1' FOR Site of initial histologic dx; '2' FOR Not site of initial histologic dx; '9' FOR Site not documented; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes the site(s) of the initial histologic diagnosis of this cancer.`
1547.1	GAS LIVER	GAS1;50	SET	'1' FOR Site of initial histologic dx; '2' FOR Not site of initial histologic dx; '9' FOR Site not documented; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes the site(s) of the initial histologic diagnosis of this cancer.`
1547.2	GAS EXTRA-ABDOMINAL	GAS1;51	SET	'1' FOR Site of initial histologic dx; '2' FOR Not site of initial histologic dx; '9' FOR Site not documented; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes the site(s) of the initial histologic diagnosis of this cancer.`
1547.3	GAS LYMPH NODES	GAS1;52	SET	'1' FOR Site of initial histologic dx; '2' FOR Not site of initial histologic dx; '9' FOR Site not documented; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes the site(s) of the initial histologic diagnosis of this cancer.`
1547.4	GAS PERITONEUM	GAS1;53	SET	'1' FOR Site of initial histologic dx; '2' FOR Not site of initial histologic dx; '9' FOR Site not documented; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes the site(s) of the initial histologic diagnosis of this cancer.`
1548	GAS DATE OF FIRST TISSUE DX	GAS1;54	DATE	INPUT TRANSFORM: `S ITFLAG="NO" D DATEIT^ONCOPCE Q:ITFLAG="YES" S %DT="EP",%DT(0)="-NOW" D ^%DT S X=Y K:Y<1 X K %DT(0) D:'$D(X) EN^DDIOL("Future dates are not allowed")` OUTPUT TRANSFORM: `D DATEOT^ONCOPCE` LAST EDITED: `JUL 19, 2001` DESCRIPTION: `This item describes the month, day, and year (MMDDCCYY) that this primary cancer was first diagnosed using a tissue sample to arrive at a positive histologic or cytologic evaluation of the tumor.` `If a positive histologic or cytologic evaluation was made but the date is unknown code 99/99/9999.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1549	GAS LAUREN'S CLASSIFICATION	GAS1;55	SET	'1' FOR Diffuse; '2' FOR Intestinal; '3' FOR Mixed; '4' FOR Other; '9' FOR Not documented; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes Lauren's classification which divides gastric carcinoma into two main histologic types, diffuse or intestinal. Record the classification if it is stated in the pathology report.`
1550	GAS GOSEKI'S CLASSIFICATION	GAS1;56	SET	'1' FOR Type I tubular diff well/mucin poor; '2' FOR Type II tubular diff well/mucin rich; '3' FOR Type III tubular diff poor/mucin poor; '3' FOR Type IV tubular diff poor/mucin rich; '9' FOR Not documented; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes Goseki's classification which divides gastric carcinoma into four histologic types, depending upon the degree of tubular differentiation and mucin content. It is thought that this classification` `scheme can aid in predicting a tumor's mode of extension, recurrence and conditions of metastasis. This information may not appear on the pathology report. Request assistance from the attending pathologist to determine` `the appropriate code.`
1551	GAS GASTRIN	GAS1;57	SET	'1' FOR Used in pathologic evaluation; '2' FOR Not used; '8' FOR NA, pathologic dx not made; '9' FOR Not documented if used; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes whether molecular marker gastrin was used in the pathologic evaluation of the tumor. If a pathologic diagnosis was not made, code 8.`
1551.1	GAS 5-HIAA	GAS1;58	SET	'1' FOR Used in pathologic evaluation; '2' FOR Not used; '8' FOR NA, pathologic dx not made; '9' FOR Not documented if used; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes whether molecular marker 5-HIAA was used in the pathologic evaluation of the tumor. If a pathologic diagnosis was not made, code 8.`
1551.2	GAS CEA	GAS1;59	SET	'1' FOR Used in pathologic evaluation; '2' FOR Not used; '8' FOR NA, pathologic dx not made; '9' FOR Not documented if used; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes whether molecular marker CEA was used in the pathologic evaluation of the tumor. If a pathologic diagnosis was not made, code 8.`
1551.3	GAS CA125	GAS1;60	SET	'1' FOR Used in pathologic evaluation; '2' FOR Not used; '8' FOR NA, pathologic dx not made; '9' FOR Not documented if used; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes whether molecular marker CA124 was used in the pathologic evaluation of the tumor. If a pathologic diagnosis was not made, code 8.`
1551.4	GAS OTHER MOLECULAR MARKER	GAS1;61	SET	'1' FOR Used in pathologic evaluation; '2' FOR Not used; '8' FOR NA, pathologic dx not made; '9' FOR Not documented if used; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes whether other molecular markers were used in the pathologic evaluation of the tumor. If a pathologic diagnosis was not made, code 8.`
1552	GAS MITOTIC RATE	GAS1;62	SET	'1' FOR < or equal to 2/10 HPF; '2' FOR > 2 and < 5/10 HPF; '3' FOR Equal to or > 5/10 HPF; '9' FOR Not documented; LAST EDITED: `APR 30, 2001` DESCRIPTION: `This item describes the number of mitoses per high power field (HPF).`
1553	GAS TUMOR NECROSIS	GAS1;63	SET	'1' FOR Frequent, larger areas; '2' FOR Few small areas (rare/scattered); '3' FOR No tumor cell necrosis; '9' FOR Not documented; LAST EDITED: `MAR 07, 2001` DESCRIPTION: `This item describes the presence and degree of tumor necrosis.`
1554	GAS FLOW CYTOMETRY/FRESH TISS	GAS1;64	SET	'1' FOR Used; '2' FOR Not used; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This data item describes if the flow cytometry on fresh tissue phenotype modality was performed on the lymphoma tissue in this case.`
1554.1	GAS IMMUNOHISTOCHEM/FROZEN TIS	GAS1;65	SET	'1' FOR Used; '2' FOR Not used; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This data item describes if the immunohistochemistry on frozen tissue phenotype modality was performed on the lymphoma tissue in this case.`
1554.2	GAS IMMUNOHISTOCHEM/PARAFFIN	GAS1;66	SET	'1' FOR Used; '2' FOR Not used; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This data item describes if the immunohistochemistry on paraffin embedded tissue phenotype modality was performed on the lymphoma tissue in this case.`
1554.3	GAS MOLECULAR GENETICS	GAS1;67	SET	'1' FOR Used; '2' FOR Not used; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This data item describes if the molecular genetics phenotype modality was performed on the lymphoma tissue in this case.`
1554.4	GAS POLYMERASE CHAIN REACTION	GAS1;68	SET	'1' FOR Used; '2' FOR Not used; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This data item describes if the polymerase chain reaction technique phenotype modality was performed on the lymphoma tissue in this case.`
1554.5	GAS SOUTHERN BLOT TECHNIQUE	GAS1;69	SET	'1' FOR Used; '2' FOR Not used; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This data item describes if the Southern blot technique phenotype modality was performed on the lymphoma tissue in this case.`
1555	GAS ANN ARBOR STAGING	GAS1;70	SET	'1' FOR Stage IE (stomach); '2' FOR Stage IIEi (stomach/perigastric ln); '3' FOR Stage IIEii (stomach/periaortic ln); '4' FOR Stage III (spleen tumor); '5' FOR Stage IV (distant/liver/bone marrow); '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `Gastric lymphoma staging is performed differently than adenocarcinoma staging, using a modification of the Ann Arbor System with Stage IE confined to the stomach, Stage IIEi confined to the stomach and perigastric lymph` `nodes, Stage IIEii confined to stomach and periaortic lymph nodes, Stage III involvement of the spleen, tumor on both sides of diaphragm and Stage IV involvement of distant sites (liver, bone marrow).`
1556	GAS ADHERENCE OF RESECTED PRIM	GAS1;71	SET	'1' FOR No tumor adherence; '2' FOR Tumor adherence lysed w/o resection; '3' FOR Tumor adherence, adj organ resected en bloc; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item evaluates adherence of the resected primary specimen to other structures.`
1557	GAS MARGIN STAT OF RESECT PRIM	GAS1;72	SET	'1' FOR Negative proximal and distal; '2' FOR Positive proximal, negative distal; '3' FOR Negative proximal, positive distal; '4' FOR Positive proximal and distal; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item evaluates the margin status of the resected primary specimen.`
1558	GAS PROXIMAL MARGIN	GAS1;73	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S ONCL=3 D EFM^ONCOIT` OUTPUT TRANSFORM: `S Y=$S(Y="000":"No free margins",Y=999:"Not documented",1:Y_" mm")` LAST EDITED: `MAY 01, 2001` HELP-PROMPT: `Type a Number between 0 and 999` DESCRIPTION: `This item describes the extent of the proximal free margin around the resected primary tumor specimen. Record the extent of the closest free margin in millimeters. If surgery of primary site was performed but the extent` `of the free margin is not documented, code 999. This information can be obtained from the pathology report.` `Allowable Codes: 000 - no free margins in this segment` `001 thru 997 - extent of free margin (mm)` `999 - extent of free margin not documented` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1558.1	GAS DISTAL MARGIN	GAS1;74	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) S ONCL=3 D EFM^ONCOIT` OUTPUT TRANSFORM: `S Y=$S(Y="000":"No free margins",Y=999:"Not documented",1:Y_" mm")` LAST EDITED: `MAY 01, 2001` HELP-PROMPT: `Type a Number between 0 and 999` DESCRIPTION: `This item describes the extent of the distal free margin around the resected primary tumor specimen. Record the extent of the closest free margin in millimeters. If surgery of primary site was performed but the extent` `of the free margin is not documented, code 999. This information can be obtained from the pathology report.` `Allowable Codes: 000 - no free margins in this segment` `001 thru 997 - extent of free margin (mm)` `999 - extent of free margin not documented` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1559	GAS SPLEEN	GAS2;1	SET	'1' FOR Resected, tumor adherence; '2' FOR Resected, no tumor adherence; '3' FOR Not resected, tumor adherence; '4' FOR Not resected, no tumor adherence; '9' FOR Extent of resection not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes the removal of an organ or lymph node structure beyond the stomach and if there was tumor adherence to this structure. This information should be obtained from both the surgical and pathology report.`
1559.1	GAS TRANSVERSE COLON	GAS2;2	SET	'1' FOR Resected, tumor adherence; '2' FOR Resected, no tumor adherence; '3' FOR Not resected, tumor adherence; '4' FOR Not resected, no tumor adherence; '9' FOR Extent of resection not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes the removal of an organ or lymph node structure beyond the stomach and if there was tumor adherence to this structure. This information should be obtained from both the surgical and pathology report.`
1559.2	GAS LIVER	GAS2;3	SET	'1' FOR Resected, tumor adherence; '2' FOR Resected, no tumor adherence; '3' FOR Not resected, tumor adherence; '4' FOR Not resected, no tumor adherence; '9' FOR Extent of resection not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes the removal of an organ or lymph node structure beyond the stomach and if there was tumor adherence to this structure. This information should be obtained from both the surgical and pathology report.`
1559.3	GAS DIAPHRAGM	GAS2;4	SET	'1' FOR Resected, tumor adherence; '2' FOR Resected, no tumor adherence; '3' FOR Not resected, tumor adherence; '4' FOR Not resected, no tumor adherence; '9' FOR Extent of resection not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes the removal of an organ or lymph node structure beyond the stomach and if there was tumor adherence to this structure. This information should be obtained from both the surgical and pathology report.`
1559.4	GAS PANCREAS	GAS2;5	SET	'1' FOR Resected, tumor adherence; '2' FOR Resected, no tumor adherence; '3' FOR Not resected, tumor adherence; '4' FOR Not resected, no tumor adherence; '9' FOR Extent of resection not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes the removal of an organ or lymph node structure beyond the stomach and if there was tumor adherence to this structure. This information should be obtained from both the surgical and pathology report.`
1559.5	GAS ABDOMINAL WALL	GAS2;6	SET	'1' FOR Resected, tumor adherence; '2' FOR Resected, no tumor adherence; '3' FOR Not resected, tumor adherence; '4' FOR Not resected, no tumor adherence; '9' FOR Extent of resection not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes the removal of an organ or lymph node structure beyond the stomach and if there was tumor adherence to this structure. This information should be obtained from both the surgical and pathology report.`
1559.6	GAS ADRENAL GLAND	GAS2;7	SET	'1' FOR Resected, tumor adherence; '2' FOR Resected, no tumor adherence; '3' FOR Not resected, tumor adherence; '4' FOR Not resected, no tumor adherence; '9' FOR Extent of resection not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes the removal of an organ or lymph node structure beyond the stomach and if there was tumor adherence to this structure. This information should be obtained from both the surgical and pathology report.`
1559.7	GAS KIDNEY	GAS2;8	SET	'1' FOR Resected, tumor adherence; '2' FOR Resected, no tumor adherence; '3' FOR Not resected, tumor adherence; '4' FOR Not resected, no tumor adherence; '9' FOR Extent of resection not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes the removal of an organ or lymph node structure beyond the stomach and if there was tumor adherence to this structure. This information should be obtained from both the surgical and pathology report.`
1559.8	GAS SMALL INTESTINE	GAS2;9	SET	'1' FOR Resected, tumor adherence; '2' FOR Resected, no tumor adherence; '3' FOR Not resected, tumor adherence; '4' FOR Not resected, no tumor adherence; '9' FOR Extent of resection not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes the removal of an organ or lymph node structure beyond the stomach and if there was tumor adherence to this structure. This information should be obtained from both the surgical and pathology report.`
1559.9	GAS RETROPERITONEUM	GAS2;10	SET	'1' FOR Resected, tumor adherence; '2' FOR Resected, no tumor adherence; '3' FOR Not resected, tumor adherence; '4' FOR Not resected, no tumor adherence; '9' FOR Extent of resection not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes the removal of an organ or lymph node structure beyond the stomach and if there was tumor adherence to this structure. This information should be obtained from both the surgical and pathology report.`
1560	GAS PERIGASTRIC LYMPH NODES	GAS2;11	SET	'2' FOR Resected; '4' FOR Not resected; '9' FOR Extent of resection not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes the removal of an organ or lymph node structure beyond the stomach and if there was tumor adherence to this structure. This information should be obtained from both the surgical and pathology report.`
1560.1	GAS COMMON HEPATIC LYMPH NODES	GAS2;12	SET	'2' FOR Resected; '4' FOR Not resected; '9' FOR Extent of resection not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes the removal of an organ or lymph node structure beyond the stomach and if there was tumor adherence to this structure. This information should be obtained from both the surgical and pathology report.`
1560.2	GAS CELIAC LYMPH NODES	GAS2;13	SET	'2' FOR Resected; '4' FOR Not resected; '9' FOR Extent of resection not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes the removal of an organ or lymph node structure beyond the stomach and if there was tumor adherence to this structure. This information should be obtained from both the surgical and pathology report.`
1560.3	GAS SPLENIC LYMPH NODES	GAS2;14	SET	'2' FOR Resected; '4' FOR Not resected; '9' FOR Extent of resection not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes the removal of an organ or lymph node structure beyond the stomach and if there was tumor adherence to this structure. This information should be obtained from both the surgical and pathology report.`
1560.4	GAS OTHER INTRA-ABDOMINAL NDES	GAS2;15	SET	'2' FOR Resected; '4' FOR Not resected; '9' FOR Extent of resection not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes the removal of an organ or lymph node structure beyond the stomach and if there was tumor adherence to this structure. This information should be obtained from both the surgical and pathology report.`
1561	GAS GROSSLY INVOLVED REG LN	GAS2;16	SET	'1' FOR Resected; '2' FOR Not resected; '9' FOR Resection not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes whether regional nodes were grossly involved at surgical resection. This information should only be recorded from the operative report. Do not report pathologically involved nodes.`
1562	GAS HCT VAL BEFORE TRANSFUSION	GAS2;17	NUMBER	INPUT TRANSFORM: `K:(X>99.9)!(X<0)!(X?.E1"."2N.N) X I $D(X) S ONCL=2,ONCF=1 D HVBT^ONCOIT` OUTPUT TRANSFORM: `S Y=$S(+Y=0:"No transfusion",Y=99.9:"Not documented",1:Y_"% Hct")` LAST EDITED: `MAY 01, 2001` HELP-PROMPT: `Type a Number between 00.0 and 99.9, 1 Decimal Digit` DESCRIPTION: `This item describes the percent (%) of hematocrit before the first transfusion. Record results to the precision of one decimal point, record zeros in unused positions; for example 9.5% would be coded as 09.5. If the` `patient was transfused but hematocrit value is not documented, code 99.9.` `Allowable Codes: 00.0 - no transfusion` `00.1 thru 99.0 - % Hct` `99.9 - transfusion, % Hct not documented` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1563	GAS TOTAL OPERATIVE BLOOD REPL	GAS2;18	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S X=$S($L(X)=1:"0"_X,1:X) D GTOBR^ONCOIT` OUTPUT TRANSFORM: `S Y=$S(Y="00":"No transfusion",Y=98:"Transfusion, # of units not documented",Y=99:"Not recorded if transfusion done",1:Y_" unit(s) tranfused")` LAST EDITED: `JUL 19, 2001` HELP-PROMPT: `Type a Number between 00 and 99` DESCRIPTION: `This item describes the total number of units of blood transfused during the surgery of primary site and within 24 hours postoperatively. If the patient was transfused but the number of units is not documented, code 99.` `Allowable Codes: 00 - no transfusion performed` `01 thru 97 - units transfused` `98 - transfusion, # of units not documented` `99 - not recorded if transfusion done` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1564	GAS INTRA/PERI-OPERATIVE DEATH	GAS2;19	SET	'1' FOR Pt died intra-operatively; '2' FOR Pt died w/i 30 days while hospitalized ; '3' FOR Pt died > 30 days while hospitalized; '4' FOR Pt died w/i 30 days/discharged; '5' FOR Pt alive and discharged 30 days following; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes whether or not the patient died intra-operatively or peri-operatively.`
1565	GAS ANASTOMATIC LEAK	GAS2;20	SET	'1' FOR Caused re-operation; '2' FOR Did not cause re-operation; '3' FOR Did not occur; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes whether an anastomotic leak required re-operation during the same hospitalization.`
1565.1	GAS STUMP LEAK	GAS2;21	SET	'1' FOR Caused re-operation; '2' FOR Did not cause re-operation; '3' FOR Did not occur; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes whether a stump leak required re-operation during the same hospitalization.`
1565.2	GAS BLEEDING	GAS2;22	SET	'1' FOR Caused re-operation; '2' FOR Did not cause re-operation; '3' FOR Did not occur; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes whether bleeding required re-operation during the same hospitalization.`
1565.3	GAS WOUND INFECTION	GAS2;23	SET	'1' FOR Caused re-operation; '2' FOR Did not cause re-operation; '3' FOR Did not occur; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes whether a wound infection required re-operation during the same hospitalization.`
1565.4	GAS SEPSIS	GAS2;24	SET	'1' FOR Caused re-operation; '2' FOR Did not cause re-operation; '3' FOR Did not occur; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes whether sepsis required re-operation during the same hospitalization.`
1565.5	GAS PANCREATITIS	GAS2;25	SET	'1' FOR Caused re-operation; '2' FOR Did not cause re-operation; '3' FOR Did not occur; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes whether pancreatitis required re-operation during the same hospitalization.`
1565.6	GAS DEAD BOWEL	GAS2;26	SET	'1' FOR Caused re-operation; '2' FOR Did not cause re-operation; '3' FOR Did not occur; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes whether a dead bowel required re-operation during the same hospitalization.`
1565.7	GAS OTHER COMPLICATIONS	GAS2;27	SET	'1' FOR Caused re-operation; '2' FOR Did not cause re-operation; '3' FOR Did not occur; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes whether other complications required re-operation during the same hospitalization.`
1566	GAS DATE OF SURGICAL DISCHARGE	GAS2;28	DATE	INPUT TRANSFORM: `S %DT="EX" D ^%DT S X=Y K:Y<1 X` LAST EDITED: `MAY 01, 2001` DESCRIPTION: `The date of surgical discharge is used to calculate a patient's length of stay in the hospital and is the month, day, and year that the patient was discharged from the hospital following surgery of primary site. Surgical` `treatment is defined as the surgical event which corresponds to the procedure recorded in the ROADS data item "Date of Surgery and includes surgical procedures of the primary site, scope of regional lymph nodes, or surgery` `to other regional sites, distant sites or distant lymph nodes.`
1567	GAS INTRA-OPERATIVE RADIATION	GAS2;29	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>5!($L(X)<1)!'(X?1.5N) X I $D(X) S ONCL=5 D IRTD^ONCOIT` OUTPUT TRANSFORM: `S Y=$S(Y="00000":"Not administered",Y=88888:"Administered, dose not documented",Y=99999:"Not documented",1:Y)` LAST EDITED: `MAY 01, 2001` HELP-PROMPT: `Type a Number between 00000 and 99999` DESCRIPTION: `This item describes the intra-operative dose of radiation was administered to the patient. The intra-operative dose may not be the dominant or most clinically significant dose delivered (data item #38), record the` `intra-operative dose separately from the dose recorded in data item #38. If intra-operative radiation therapy was not administered, code 00000. If intra-operative radiation was administered but the dose is not documented,` `code 88888.` `Allowable Codes: 00000 - no intraoperative radiation therapy` `00001 thru 99998 - intraoperative dose administered` `88888 - intraoperative radiation administered,` `dose not documented` `99999 - not documented if administered` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1568	GAS CONCURRENT CHEMOTHERAPY	GAS2;30	SET	'1' FOR Chemo concurrent with radiation; '2' FOR Chemo not concurrent with radiation; '8' FOR No chemo/unknown if chemo administered; '9' FOR Timing of chemo not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes whether radiation therapy and chemotherapy were administered to the patient at the same time during the first course of treatment.`
1569	GAS INTRAPERITONEAL CMX	GAS2;31	SET	'1' FOR Catheter, mitoycin; '2' FOR Catheter, 5-fluorouracil; '3' FOR Catheter, other; '4' FOR Portal vein, mitomycin; '5' FOR Portal vein, 5-fluorouracil; '6' FOR Portal vein, other; '8' FOR Administered, method not documented; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes the method of intraperitoneal chemotherapy administration and the chemotherapy agent used.`
1570	GAS ADMIN OF INTERFERON	GAS2;32	SET	'1' FOR Administered; '2' FOR Not administered; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes whether the patient was administered Interferon to treat the primary tumor.`
1571	GAS CO-MORBID CONDITION 1	GAS2;33	POINTER TO ICD DIAGNOSIS FILE (#80)	ICD DIAGNOSIS(#80) INPUT TRANSFORM: `S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0" D ^DIC K DIC S DIC=$G(DIE),X=+Y K:Y<0 X` OUTPUT TRANSFORM: `I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(ONCICD,U,4)` LAST EDITED: `JUN 08, 2012` DESCRIPTION: `This field records a pre-existing medical condition that was present at the time of diagnosis for this cancer or the patient was first seen at your facility following diagnosis. Report the ICD-CM code. Pre- existing` `conditions should be coded; do NOT code conditions which the patient acquired while being treated for this condition.` `Allowable Codes: 000.00` `001.00 thru 994.90 (valid ICD-CM codes)` `If no co-morbid conditions were documented, then code 000.00 in this field and leave the remaining co-morbid fields blank.` SCREEN: `S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0"` EXPLANATION: `Enter the ICD-CM code.`
1571.1	GAS CO-MORBID CONDITION 2	GAS2;34	POINTER TO ICD DIAGNOSIS FILE (#80)	ICD DIAGNOSIS(#80) INPUT TRANSFORM: `S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0" D ^DIC K DIC S DIC=$G(DIE),X=+Y K:Y<0 X` OUTPUT TRANSFORM: `I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(ONCICD,U,4)` LAST EDITED: `JUN 08, 2012` DESCRIPTION: `This field records a pre-existing medical condition that was present at the time of diagnosis for this cancer or the patient was first seen at your facility following diagnosis. Report the ICD-CM code. Pre- existing` `conditions should be coded; do NOT code conditions which the patient acquired while being treated for this condition.` `Allowable Codes: 000.00` `001.00 thru 994.90 (valid ICD-CM codes)` `If no co-morbid conditions were documented, then code 000.00 in this field and leave the remaining co-morbid fields blank.` SCREEN: `S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0"` EXPLANATION: `Enter the ICD-CM code.`
1571.2	GAS CO-MORBID CONDITION 3	GAS2;35	POINTER TO ICD DIAGNOSIS FILE (#80)	ICD DIAGNOSIS(#80) INPUT TRANSFORM: `S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0" D ^DIC K DIC S DIC=$G(DIE),X=+Y K:Y<0 X` OUTPUT TRANSFORM: `I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(ONCICD,U,4)` LAST EDITED: `JUN 08, 2012` DESCRIPTION: `This field records a pre-existing medical condition that was present at the time of diagnosis for this cancer or the patient was first seen at your facility following diagnosis. Report the ICD-CM code. Pre- existing` `conditions should be coded; do NOT code conditions which the patient acquired while being treated for this condition.` `Allowable Codes: 000.00` `001.00 thru 994.90 (valid ICD-CM codes)` `If no co-morbid conditions were documented, then code 000.00 in this field and leave the remaining co-morbid fields blank.` SCREEN: `S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0"` EXPLANATION: `Enter the ICD-CM code.`
1571.3	GAS CO-MORBID CONDITION 4	GAS2;36	POINTER TO ICD DIAGNOSIS FILE (#80)	ICD DIAGNOSIS(#80) INPUT TRANSFORM: `S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0" D ^DIC K DIC S DIC=$G(DIE),X=+Y K:Y<0 X` OUTPUT TRANSFORM: `I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(ONCICD,U,4)` LAST EDITED: `JUN 08, 2012` DESCRIPTION: `This field records a pre-existing medical condition that was present at the time of diagnosis for this cancer or the patient was first seen at your facility following diagnosis. Report the ICD-CM code. Pre- existing` `conditions should be coded; do NOT code conditions which the patient acquired while being treated for this condition.` `Allowable Codes: 000.00` `001.00 thru 994.90 (valid ICD-CM codes)` `If no co-morbid conditions were documented, then code 000.00 in this field and leave the remaining co-morbid fields blank.` SCREEN: `S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0"` EXPLANATION: `Enter the ICD-CM code.`
1571.4	GAS CO-MORBID CONDITION 5	GAS2;37	POINTER TO ICD DIAGNOSIS FILE (#80)	ICD DIAGNOSIS(#80) INPUT TRANSFORM: `S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0" D ^DIC K DIC S DIC=$G(DIE),X=+Y K:Y<0 X` OUTPUT TRANSFORM: `I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(ONCICD,U,4)` LAST EDITED: `JUN 08, 2012` DESCRIPTION: `This field records a pre-existing medical condition that was present at the time of diagnosis for this cancer or the patient was first seen at your facility following diagnosis. Report the ICD-CM code. Pre- existing` `conditions should be coded; do NOT code conditions which the patient acquired while being treated for this condition.` `Allowable Codes: 000.00` `001.00 thru 994.90 (valid ICD-CM codes)` `If no co-morbid conditions were documented, then code 000.00 in this field and leave the remaining co-morbid fields blank.` SCREEN: `S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0"` EXPLANATION: `Enter the ICD-CM code.`
1571.5	GAS CO-MORBID CONDITION 6	GAS2;38	POINTER TO ICD DIAGNOSIS FILE (#80)	ICD DIAGNOSIS(#80) INPUT TRANSFORM: `S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0" D ^DIC K DIC S DIC=$G(DIE),X=+Y K:Y<0 X` OUTPUT TRANSFORM: `I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(ONCICD,U,4)` LAST EDITED: `JUN 08, 2012` DESCRIPTION: `This field records a pre-existing medical condition that was present at the time of diagnosis for this cancer or the patient was first seen at your facility following diagnosis. Report the ICD-CM code. Pre- existing` `conditions should be coded; do NOT code conditions which the patient acquired while being treated for this condition.` `Allowable Codes: 000.00` `001.00 thru 994.90 (valid ICD-CM codes)` `If no co-morbid conditions were documented, then code 000.00 in this field and leave the remaining co-morbid fields blank.` SCREEN: `S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN1"")),U,76)'=0"` EXPLANATION: `Enter the ICD-CM code.`
1572	GAS DURATION OF TOBACCO USE	GAS2;39	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) S ONCL=2 D DTU^ONCOIT` OUTPUT TRANSFORM: `S Y=$S(Y="00":"Never used tobacco",Y=99:"Not documented",Y="01":Y_" year",1:Y_" years")` LAST EDITED: `MAY 01, 2001` HELP-PROMPT: `Type a Number between 00 and 99` DESCRIPTION: `This item describes the number of known years the patient used some form of tobacco, even if the patient is not presently using tobacco. If the patient has never used tobacco, code 00. If the patient's tobacco use` `cannot be determined, or if the duration of use is not known, code 99.` `Allowable Codes: 00 - never used tobacco` `01 thru 98 - one or more years of tobacco use` `99 - duration of tobacco use not documented` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1573	GAS PERSONAL HIST OTH MALIG	GAS2;40	POINTER TO ICDO TOPOGRAPHY FILE (#164)	ICDO TOPOGRAPHY(#164) OUTPUT TRANSFORM: `S Y=$P($G(^ONCO(164,+Y,0)),U,2)_" "_$P($G(^ONCO(164,+Y,0)),U,1)` LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes the patient's prior history of other invasive malignancies. If the patient has a history of other malignancies report the ICD-O-3 site code for the most recently diagnosed disease. If the patient has` `no personal history of other cancer, code C88.8. If the patient's personal history of other invasive malignancies is not documented, code C99.9.` `Allowable Codes: C00.0 thru C80.9 - valid ICD-0-3 site (topography) codes` `C88.8 - no personal history of other cancer` `C99.9 - personal history of other cancer not documented` EXECUTABLE HELP: `D ITEM3^ONCLPC1`
1574	GAS WEIGHT LOSS	GAS2;41	SET	'1' FOR Present; '2' FOR Not present; '9' FOR Not documented; LAST EDITED: `MAY 01, 2001` DESCRIPTION: `This item describes the presence of weight loss specific to gastric cancer that was recorded in the medical chart.`
1575	GAS BOOST DOSE (cGy)	GAS2;42	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>5!($L(X)<1)!'(X?1.5N) X I $D(X) S ONCL=5 D BD^ONCOIT` LAST EDITED: `MAY 01, 2001` HELP-PROMPT: `Type a Number between 00000 and 99999` DESCRIPTION: `This item describes the boost dose of radiation administered to the central tumor field of the patient. If radiation was administered but boost dose is unknown, code 99999.` `Allowable Codes: 00000 - no radiation boost dose administered` `00001 thru 99998 - boost dose administered (cGy)` `99999- boost dose administered, dose not documented` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1576	GAS CHEMOTHERAPEUTIC AGENT #1	GAS2;43	POINTER TO CHEMOTHERAPEUTIC DRUGS FILE (#164.18)	CHEMOTHERAPEUTIC DRUGS(#164.18) OUTPUT TRANSFORM: `S Y=$P($G(^ONCO(164.18,Y,0)),"^",2)_" "_$P($G(^ONCO(164.18,Y,0)),"^",1)` LAST EDITED: `MAY 02, 2001` DESCRIPTION: `This item records the first chemotherapeutic agent administered to the patient as part of the first course of therapy. If chemotherapy was administered but the type(s) of agent(s) are unknown, code 999999.` `Allowable Codes: Valid NSC (National Service Center) number for` `chemotherapeutic agents listed in the Self` `Instructional Manual for Tumor Registrars, Book 8,` `Surveillance, Epidemiology and End Results Program,` `National Cancer Institute.`
1576.1	GAS CHEMOTHERAPEUTIC AGENT #2	GAS2;44	POINTER TO CHEMOTHERAPEUTIC DRUGS FILE (#164.18)	CHEMOTHERAPEUTIC DRUGS(#164.18) OUTPUT TRANSFORM: `S Y=$P($G(^ONCO(164.18,Y,0)),"^",2)_" "_$P($G(^ONCO(164.18,Y,0)),"^",1)` LAST EDITED: `MAY 02, 2001` DESCRIPTION: `This item records the second chemotherapeutic agent administered to the patient as part of the first course of therapy. If chemotherapy was administered but the type(s) of agent(s) are unknown, code 999999.` `Allowable Codes: Valid NSC (National Service Center) number for` `chemotherapeutic agents listed in the Self` `Instructional Manual for Tumor Registrars, Book 8,` `Surveillance, Epidemiology and End Results Program,` `National Cancer Institute.`
1576.2	GAS CHEMOTHERAPEUTIC AGENT #3	GAS2;45	POINTER TO CHEMOTHERAPEUTIC DRUGS FILE (#164.18)	CHEMOTHERAPEUTIC DRUGS(#164.18) OUTPUT TRANSFORM: `S Y=$P($G(^ONCO(164.18,Y,0)),"^",2)_" "_$P($G(^ONCO(164.18,Y,0)),"^",1)` LAST EDITED: `MAY 02, 2001` DESCRIPTION: `This item records the third chemotherapeutic agent administered to the patient as part of the first course of therapy. If chemotherapy was administered but the type(s) of agent(s) are unknown, code 999999.` `Allowable Codes: Valid NSC (National Service Center) number for` `chemotherapeutic agents listed in the Self` `Instructional Manual for Tumor Registrars, Book 8,` `Surveillance, Epidemiology and End Results Program,` `National Cancer Institute.`
1577	GAS CHEMOTHERAPEUTIC TOXICITY	GAS2;46	SET	'1' FOR Chemo discontinued due to toxicity; '2' FOR No chemo toxicity; '9' FOR Not documented; LAST EDITED: `MAY 02, 2001` DESCRIPTION: `This item describes whether the administration of chemotherapy was discontinued as a result of toxicity.`
1578	GAS CHEMOTHERAPY/SURG SEQUENCE	GAS2;47	SET	'1' FOR Chemo administered, no surgery; '2' FOR Chemo administered before surgery; '3' FOR Chemo administered after surgery; '4' FOR Chemo administered before and after surgery; '9' FOR Chemo and surgery administered, seq unk; LAST EDITED: `MAY 02, 2001` DESCRIPTION: `This data item describes the sequence in which chemotherapy and surgery of the primary site were administered.`
1579	GAS COMPLICATION #1	GAS2;48	POINTER TO ICD DIAGNOSIS FILE (#80)	ICD DIAGNOSIS(#80) INPUT TRANSFORM: `S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0" D ^DIC K DIC S DIC=$G(DIE),X=+Y K:Y<0 X` OUTPUT TRANSFORM: `I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(ONCICD,U,4)` LAST EDITED: `JUN 08, 2012` DESCRIPTION: `This item describes the first medical complication acquired by the patient during or resulting from the first course of therapy. Record valid ICD-CM codes.` `Allowable Codes: 001.00 - 999.90 (valid ICD-CM codes)` `E930.0 - E949.7 (valid ICD-CM adverse effect codes)` SCREEN: `S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0"` EXPLANATION: `If the COMPLICATIONS (YES/NO) field is set to "No", then no editing of this field is allowed.`
1579.1	GAS COMPLICATION #2	GAS2;49	POINTER TO ICD DIAGNOSIS FILE (#80)	ICD DIAGNOSIS(#80) INPUT TRANSFORM: `S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X` OUTPUT TRANSFORM: `I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(ONCICD,U,4)` LAST EDITED: `JUN 08, 2012` DESCRIPTION: `This item describes the first medical complication acquired by the patient during or resulting from the first course of therapy. Record valid ICD-CM codes.` `Allowable Codes: 001.00 - 999.90 (valid ICD-CM codes)` `E930.0 - E949.7 (valid ICD-CM adverse effect codes)` SCREEN: `S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0"` EXPLANATION: `If the COMPLICATIONS (YES/NO) field is set to "No", then no editing of this field is allowed.`
1579.2	GAS COMPLICATION #3	GAS2;50	POINTER TO ICD DIAGNOSIS FILE (#80)	ICD DIAGNOSIS(#80) INPUT TRANSFORM: `S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X` OUTPUT TRANSFORM: `I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(ONCICD,U,4)` LAST EDITED: `JUN 08, 2012` DESCRIPTION: `This item describes the first medical complication acquired by the patient during or resulting from the first course of therapy. Record valid ICD-CM codes.` `Allowable Codes: 001.00 - 999.90 (valid ICD-CM codes)` `E930.0 - E949.7 (valid ICD-CM adverse effect codes)` SCREEN: `S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0"` EXPLANATION: `If the COMPLICATIONS (YES/NO) field is set to "No", then no editing of this field is allowed.`
1579.3	GAS COMPLICATION #4	GAS2;51	POINTER TO ICD DIAGNOSIS FILE (#80)	ICD DIAGNOSIS(#80) INPUT TRANSFORM: `S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0" D ^DIC K DIC S DIC=$G(DIE),X=+Y K:Y<0 X` OUTPUT TRANSFORM: `I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(ONCICD,U,4)` LAST EDITED: `JUN 08, 2012` DESCRIPTION: `This item describes the first medical complication acquired by the patient during or resulting from the first course of therapy. Record valid ICD-CM codes.` `Allowable Codes: 001.00 - 999.90 (valid ICD-CM codes)` `E930.0 - E949.7 (valid ICD-CM adverse effect codes)` SCREEN: `S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0"` EXPLANATION: `If the COMPLICATIONS (YES/NO) field is set to "No", then no editing of this field is allowed.`
1579.4	GAS COMPLICATION #5	GAS2;52	POINTER TO ICD DIAGNOSIS FILE (#80)	ICD DIAGNOSIS(#80) INPUT TRANSFORM: `S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X` OUTPUT TRANSFORM: `I Y'="" N ONCICD S ONCICD=$$ICDDX^ICDCODE(Y) S:(ONCICD=-1) Y=-1 S:(Y'=-1) Y=$P(ONCICD,U,2)_" "_$P(ONCICD,U,4)` LAST EDITED: `JUN 08, 2012` DESCRIPTION: `This item describes the first medical complication acquired by the patient during or resulting from the first course of therapy. Record valid ICD-CM codes.` `Allowable Codes: 001.00 - 999.90 (valid ICD-CM codes)` `E930.0 - E949.7 (valid ICD-CM adverse effect codes)` SCREEN: `S DIC("S")="I $P($G(^ONCO(165.5,DA,""LUN2"")),U,40)'=0"` EXPLANATION: `If the COMPLICATIONS (YES/NO) field is set to "No", then no editing of this field is allowed.`
1764	SUMMARY STAGE 2018	EOD;4	SET	'0' FOR In situ; '1' FOR Localized only; '2' FOR Regional by direct extension only; '3' FOR Regional lymph nodes only; '4' FOR Regional BOTH direct ext and LN; '7' FOR Distant site(s)/node(s) involved; '8' FOR Benign/Borderline; '9' FOR Unknown; LAST EDITED: `NOV 12, 2019` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `This item stores the directly assigned Summary Stage 2018. Effective for cases diagnosed 1/1/2018+. Rationale: The SEER program has collected staging information on cases since its inception in 1973. Summary Stage groups` `cases into broad categories of in situ, local, regional, and distant. Summary Stage can be used to evaluate disease spread at diagnosis, treatment patterns and outcomes over time. Codes: 0 In situ 1 Localized only 2` `Regional by direct extension only 3 Regional lymph nodes only 4 Regional by BOTH direct extension AND lymph node involvement 7 Distant site(s)/node(s) involved 8 Benign/borderline* 9 Unknown if extension or metastasis` `(unstaged, unknown, or unspecified)` `Death certificate only case` SCREEN: `S DIC("S")="D SCRNSS^ONCSCHMM"` EXPLANATION: `Applicable codes depend on the Schema` CROSS-REFERENCE: `^^TRIGGER^165.5^7012` `1)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"NCR18")):^("NCR18"),1:"") S X=$P(Y(1),U,13),X=X S DIU=X K Y S X=DIV S X=9,X=X X ^DD(165.5,1764,1,1,1.4)` `1.4)= S DIH=$G(^ONCO(165.5,DIV(0),"NCR18")),DIV=X S $P(^("NCR18"),U,13)=DIV,DIH=165.5,DIG=7012 D ^DICR` `2)= K DIV S DIV=X,D0=DA,DIV(0)=D0 S Y(1)=$S($D(^ONCO(165.5,D0,"NCR18")):^("NCR18"),1:"") S X=$P(Y(1),U,13),X=X S DIU=X K Y S X="" S DIH=$G(^ONCO(165.5,DIV(0),"NCR18")),DIV=X S $P(^("NCR18"),U,13)=DIV,DIH=165.5,DIG=7012 D ^` `DICR` `CREATE VALUE)= INTERNAL(9)` `DELETE VALUE)= @` `FIELD)= DERIVED SUMM` `This field will set the DERIVED SUMMARY STAGE to be set to '9'.`
1772	EOD PRIMARY TUMOR	EOD;1	NUMBER	INPUT TRANSFORM: `K:X'?1.3N X I $D(X) D PTIT^ONCOEOD1` LAST EDITED: `MAR 13, 2019` HELP-PROMPT: `Type a number between 0 and 999, 0 decimal digits.` DESCRIPTION: `EOD Primary Tumor is part of the EOD 2018 data collection system and is used to classify continuous growth (extension) of primary tumor.` EXECUTABLE HELP: `D PTHLP^ONCOEOD1` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1774	EOD REGIONAL NODES	EOD;2	NUMBER	INPUT TRANSFORM: `K:X'?1.3N X I $D(X) D RNIT^ONCOEOD1` LAST EDITED: `MAR 13, 2019` HELP-PROMPT: `Type a number between 0 and 999, 0 decimal digits.` DESCRIPTION: `EOD Regional Nodes is part of the EOD 2018 data collection system and is used to classify the regional lymph nodes involved with cancer at the time of diagnosis.` EXECUTABLE HELP: `D RNHLP^ONCOEOD1` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
1776	EOD METS	EOD;3	NUMBER	INPUT TRANSFORM: `K:X'?1.3N X I $D(X) D MTIT^ONCOEOD1` LAST EDITED: `MAR 13, 2019` HELP-PROMPT: `Type a number between 0 and 99, 0 decimal digits.` DESCRIPTION: `EOD Mets is part of the EOD 2018 data collection system and is used to classify the distant site(s) of metastatic involvement at time of diagnosis.` EXECUTABLE HELP: `D MTHLP^ONCOEOD1` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
2000	DIVISION	DIV;1	POINTER TO INSTITUTION FILE (#4)	**********************REQUIRED FIELD********************** INSTITUTION(#4) LAST EDITED: `DEC 17, 1999` DESCRIPTION: `DIVISION is the division to which this primary belongs.`
3000	CLASS OF CASE CONVERSION FLAG	CONV;1	SET	'1' FOR Converted; LAST EDITED: `SEP 16, 2009` HELP-PROMPT: `Enter 1 (Converted) if CLASS OF CASE has been converted to NAACCR v12.` DESCRIPTION: `Indicates that the CLASS OF CASE value has been converted to NAACCR v12.`
3001	STATE AT DX CONVERSION FLAG	CONV;2	SET	'1' FOR Converted; LAST EDITED: `SEP 16, 2009` HELP-PROMPT: `Enter 1 (Converted) if STATE AT DX has been converted to NAACCR v12.` DESCRIPTION: `Indicates that the STATE AT DX value has been converted to NAACCR v12.`
3700	SEER SSF1-HPV STATUS	SSD4;33	SET	'0' FOR Neg vrl DNA (ISH); '1' FOR Pos vrl DNA (ISH); '2' FOR Neg vrl DNA (PCR); '3' FOR Pos vrl DNA (PCR); '4' FOR Neg ISH E6/E7 RNA; '5' FOR Pos ISH E6/E7 RNA; '6' FOR Neg RT-PCR; '7' FOR Pos RT-PCR; '8' FOR Reported, status unk; '9' FOR Unk if performed; LAST EDITED: `SEP 12, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `SEER Site-specific Factor 1 is new for 2018. This data item is reserved for human papilloma virus (HPV) status. This data item only applies to:` `Oropharynx (p16+): C019, C024, C051-C052, C090-C091,` `C098-C099, C100, C102-C103, C108-C109, C111` `Oropharynx (p16-) and Hypopharynx: C019, C024, C051-C052,` `C090-C091, C098-C099, C100, C102-C103, C108-C109, C111` `C129, C130-C132, C138-C139` `Lip and Oral Cavity: C000-C009, C020-C023, C028-C029, C030-C031,` `C039, C040-C041, C048-C049, C050, C058-C059, C060-C062, C068-C069 There is evidence that human papilloma virus (HPV) plays a role in the pathogenesis of some cancers. HPV testing may be performed for prognostic` `purposes; testing may also be performed on metastatic sites to aid in determination of the primary site.` `0 HPV negative for viral DNA by ISH test 1 HPV positive for viral DNA by ISH test 2 HPV negative for viral DNA by PCR test 3 HPV positive for viral DNA by PCR test 4 HPV negative by ISH E6/E7 RNA test 5` `HPV positive by ISH E6/E7 RNA test 6 HPV negative by RT-PCR E6/E7 RNA test 7 HPV positive by RT-PCR E6/E7 RNA test 8 HPV status reported in medical records as` `positive or negative but test type is unknown 9 Unknown if HPV test detecting viral DNA and or RNA was performed`
3800	SCHEMA ID	SSD1;1	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>5!($L(X)<5) X` `MAXIMUM LENGTH: 5` LAST EDITED: `SEP 07, 2018` HELP-PROMPT: `Answer must be 5 characters in length.` DESCRIPTION: `This field contains the SCHEMA ID for the Abstract which is calculated using the Site/GP, Histology and possibly Schema Discriminators.`
3800.1	SCHEMA ID DESCRIPTION	SSD5;6	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>70!($L(X)<5) X` `MAXIMUM LENGTH: 70` LAST EDITED: `DEC 20, 2021` HELP-PROMPT: `Answer must be 5-70 characters in length.` DESCRIPTION: `This field will contain the Schema ID and description which will be useful for the Cancer Cube.`
3801	CHROMOSOME 1P: (LOH)	SSD1;2	SET	'0' FOR LOH not identified/not present; '1' FOR LOH identified/present; '6' FOR Benign or borderline tumor; '7' FOR Test ordered, results not in chart; '8' FOR Not applicable; '9' FOR Not documented in patient record; LAST EDITED: `JUN 21, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Chromosome 1p: Loss of Heterozygosity (LOH) refers to the loss of genetic material normally found on the short arm of one of the patient's two copies of chromosome 1. Codeletion of Chromosome 1p and 19q is a diagnostic,` `prognostic and predictive marker for gliomas and is strongly associated with the oligodendroglioma phenotype. Codes: 0 Chromosome 1p deletion/LOH not identified/not present 1 Chromosome 1p deletion/LOH` `identified/present 6 Benign or borderline tumor 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case` `(If this item is required by your standard setter, use of` `code 8 will result in an edit error.) 9 Not documented in patient record` `Cannot be determined by the pathologist` `Chromosome 1p deletion/LOH not assessed or unknown if assessed`
3802	CHROMOSOME 19Q: (LOH)	SSD1;3	SET	'0' FOR LOH not identified/not present; '1' FOR LOH present; '6' FOR Benign or borderline tumor; '7' FOR Test ordered, results not in chart; '8' FOR Not applicable; '9' FOR Not documented in patient record; LAST EDITED: `JUN 21, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Chromosome 19q: Loss of Heterozygosity (LOH) refers to the loss of genetic material normally found on the long arm of one of the patient's two copies of chromosome 19. Codeletion of Chromosome 1p and 19q is a diagnostic,` `prognostic and predictive marker for gliomas and is strongly associated with the oligodendroglioma phenotype. Codes: 0 Chromosome 19q deletion/LOH not identified/not present 1 Chromosome 19q deletion/LOH present 6` `Benign or borderline tumor 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case` `If this item is required by your standard setter, use of code 8 will` `result in an edit error.) 9 Not documented in patient record` `Cannot be determined by the pathologist` `Chromosome 19q: LOH not assessed or unknown if assessed`
3803	ADENOID CYSTIC BASALOID PTTRN	SSD1;4	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>5!($L(X)<1)!'(X?0.3AN0.1"."1N) X I $D(X) D DEC3^ONCSCHMM` `MAXIMUM LENGTH: 5` LAST EDITED: `OCT 09, 2019` HELP-PROMPT: `Answer must be 1-5 characters in length.` DESCRIPTION: `Adenoid Cystic Basaloid Pattern, the presence of a basaloid pattern on pathological examination is a prognostic factor for adenoid cystic carcinoma of the lacrimal gland. Rationale: Adenoid Cystic Basaloid Pattern is a` `Registry Data Collection Variable in AJCC 8. This data item was previously collected as Lacrimal Gland, SSF#6. Codes: 0.0-100.0 0.0 to 100.0 percent basaloid pattern XXX.5 Basaloid pattern present, percentage not stated` `XXX.8 Not applicable: Information not collected for this case` `(If this item is required by your standard setter, use of code` `XXX.8 will result in an edit error.) XXX.9 Not documented in medical record` `Adenoid Cystic Basaloid Pattern not assessed or unknown if assessed` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3804	ADENOPATHY	SSD1;5	SET	'0' FOR Adenopathy not identified/not present; '1' FOR Adenopathy present; '5' FOR NA, site not C421; '9' FOR Not documented in medical record; LAST EDITED: `JUN 27, 2022` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Adenopathy is defined as the presence of lymph nodes greater than 1.5 cm on physical examination (PE) and is part of the staging criteria for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL). Rationale:` `Adenopathy is a prognostic factor required for staging of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) in AJCC 8th edition, Chapter 79 Hodgkin and Non-Hodgkin Lymphomas. It is a new data item for` `cases diagnosed 1/1/2018+. Codes: 0 Adenopathy not identified/not present` `No lymph nodes >1.5 cm 1 Adenopathy present` `Presence of lymph nodes >1.5 cm 5 Not applicable: Primary site is not C421 9 Not documented in medical record` `Adenopathy not assessed or unknown if assessed` SCREEN: `S DIC("S")="D SCRNFIV^ONCSCHMM"` EXPLANATION: `Codes depend on appropriate primary site`
3805	AFP POST-ORCHIECTOMY LAB VAL	SSD1;6	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>7!($L(X)<1)!'(X?0.5AN0.1"."1N) X I $D(X) D DEC5^ONCSCHMM` `MAXIMUM LENGTH: 7` LAST EDITED: `AUG 01, 2019` HELP-PROMPT: `Answer must be 1-7 characters in length.` DESCRIPTION: `AFP (Alpha Fetoprotein) Post-Orchiectomy Lab Value refers to the lowest AFP value measured post-orchiectomy. AFP is a serum tumor marker that is often elevated in patients with nonseminomatous germ cell tumors of the` `testis. The Post-Orchiectomy lab value is used to monitor response to therapy. Rationale: AFP (Alpha Fetoprotein) Post-Orchiectomy Lab Value is a Registry Data Collection Variable in AJCC. It was previously collected as` `Testis CS SSF#12. Codes: 0.0 0.0 nanograms/milliliter (ng/mL) 0.1-99999.9 0.1-99,999.9 ng/mL XXXXX.1 100,000 ng/mL or greater XXXXX.7 Test ordered, results not in chart XXXXX.8 Not applicable: Information` `not collected for this case` `(If this information is required by your standard setter,` `use of code XXXXX.8 may result in an edit error.) XXXXX.9 Not documented in medical record` `Noorchiectomy performed` `AFP (Alpha Fetoprotein) Post-Orchiectomy Lab Value` `not assessed or unknown if assessed` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3806	AFP POST-ORCHIECTOMY RANGE	SSD1;7	SET	'0' FOR Within normal limits; '1' FOR Above normal & <1000ng/mL; '2' FOR 1000-10000ng/mL; '3' FOR >10000ng/mL; '4' FOR AFP stated to be elevated; '7' FOR Test ordered, results not in chart; '8' FOR N/A; '9' FOR Not documented in medical record; LAST EDITED: `JUL 09, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `AFP (Alpha Fetoprotein) Post-Orchiectomy Range identifies the range category of the lowest AFP value measured post-orchiectomy. AFP is a serum tumor marker that is often elevated in patients with nonseminomatous germ cell` `tumors of the testis. The Post-Orchiectomy lab value is used to monitor response to therapy. Rationale: AFP (Alpha Fetoprotein) Post-Orchiectomy Range is a Registry Data Collection Variable in AJCC. AFP (Alpha` `Fetoprotein) Post-Orchiectomy Range is used to assign the S Category Pathological and was previously collected as Testis CS SSF#13. Codes: 0 Within normal limits 1 Above normal and less than 1,000 nanograms/milliliter` `(ng/mL) 2 1,000 -10,000 ng/mL 3 Greater than 10,000 ng/mL 4 Post-Orchiectomy alpha fetoprotein (AFP) stated to be elevated 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this` `case` `(If this information is required by your standard setter, use of` `code 8 may result in an edit error.) 9 Not documented in medical record` `No orchiectomy performed` `AFP (Alpha Fetoprotein) Post-Orchiectomy Range not assessed or` `unknown if assessed`
3807	AFP PRE-ORCHIECTOMY LAB VALUE	SSD1;8	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>7!($L(X)<1)!'(X?0.5AN0.1"."1N) X I $D(X) D DEC5^ONCSCHMM` `MAXIMUM LENGTH: 7` LAST EDITED: `AUG 01, 2019` HELP-PROMPT: `Answer must be 1-7 characters in length.` DESCRIPTION: `AFP (Alpha Fetoprotein) Pre-Orchiectomy Lab Value refers to the AFP value measured prior to treatment. AFP is a tumor marker that is often elevated in patients with nonseminomatous germ cell tumors of the testis.` `Rationale: AFP (Alpha Fetoprotein) Pre-Orchiectomy Lab Value is a Registry Data Collection Variable in AJCC. It was previously collected as Testis CS SSF#6 Codes: 0.0 0.0 nanograms/milliliter (ng/mL) 0.1-99999.9` `0.1-99,999.9 ng/mL XXXXX.1 100,000 ng/mL or greater XXXXX.7 Test ordered, results not in chart XXXXX.8 Not applicable: Information not collected for this case` `(If this information is required by your standard setter,` `use of code XXXXX.8 may result in an edit error.) XXXXX.9 Not documented in medical record` `AFP (Alpha Fetoprotein) Pre-Orchiectomy Lab Value` `not assessed or unknown if assessed` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3808	AFP PRE-ORCHIECTOMY RANGE	SSD1;9	SET	'0' FOR Within normal limits; '1' FOR Above normal & <1000ng/mL; '2' FOR 1000-10000ng/mL; '3' FOR >10000ng/mL; '4' FOR AFP stated to be elevated; '7' FOR Test ordered, results not in chart; '8' FOR N/A; '9' FOR Not documented in medical record; LAST EDITED: `JUL 09, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `AFP (Alpha Fetoprotein) Pre-Orchiectomy Range identifies the range category of the highest AFP value measured prior to treatment. AFP is a serum tumor marker that is often elevated in patients with nonseminomatous germ` `cell tumors of the testis. Rationale: AFP (Alpha Fetoprotein) Pre-Orchiectomy Range is a Registry Data Collection Variable in AJCC. AFP (Alpha Fetoprotein) Pre-Orchiectomy Range is used to assign the S Category Clinical` `and was previously collected as Testis CS SSF#7. Codes: 0 Within normal limits 1 Above normal and less than 1,000 nanograms/milliliter (ng/mL) 2 1,000 -10,000 ng/mL 3 Greater than 10,000 ng/mL 4 Pre-Orchiectomy` `alpha fetoprotein (AFP) stated to be elevated 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case` `(If this information is required by your standard setter,` `use of code 8 may result in an edit error.) 9 Not documented in medical record` `AFP (Alpha Fetoprotein) Pre-Orchiectomy Range not assessed` `or unknown if assessed`
3809	AFP PRETREATMENT INTERPRET	SSD1;10	SET	'0' FOR Within normal limits; '1' FOR Positive/elevated; '2' FOR Borderline; '7' FOR Test ordered, results not in chart; '8' FOR N/A; '9' FOR Not documented; LAST EDITED: `JUN 28, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `AFP (Alpha Fetoprotein) Pretreatment Interpretation, a nonspecific serum protein that generally is elevated in the setting of hepatocellular carcinoma (HCC), is a prognostic factor for liver cancer. Rationale: AFP (Alpha` `Fetoprotein) Pretreatment Interpretation is a Registry Data Collection Variable in AJCC. This data item was previously collected for Liver, CS SSF# 1. Codes: 0 Negative/normal; within normal limits 1 Positive/elevated` `2 Borderline; undetermined if positive or negative 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case` `(If this item is required by your standard setter, use of code 8 will` `result in an edit error.) 9 Not documented in medical record` `AFP pretreatment interpretation not assessed or unknown if assessed`
3810	AFP PRETREATMENT LAB VALUE	SSD1;11	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>6!($L(X)<1)!'(X?0.4AN0.1"."1N) X I $D(X) D DEC4^ONCSCHMM` `MAXIMUM LENGTH: 6` LAST EDITED: `AUG 01, 2019` HELP-PROMPT: `Answer must be 1-6 characters in length.` DESCRIPTION: `AFP (Alpha Fetoprotein) Pretreatment Lab Value is a nonspecific serum protein that generally is elevated in the setting of hepatocellular carcinoma (HCC). This data item pertains to the pre-treatment lab value. Rationale:` `AFP (Alpha Fetoprotein) Pretreatment Lab Value is a Registry Data Collection Variable in AJCC. This data item was previously collected for Liver, CS SSF# 3. Codes: 0.0 0.0 nanograms/milliliter (ng/ml); not detected` `0.1-9999.9 0.1-9999.9 ng/ml` `(Exact value to nearest tenth of ng/ml) XXXX.1 10,000.0 ng/ml or greater XXXX.7 Test ordered, results not in chart XXXX.8 Not applicable: Information not collected for this case` `(If this item is required by your standard setter, use of` `code XXXX.8 will result in an edit error.) XXXX.9 Not documented in medical record` `AFP (Alpha Fetoprotein) Pretreatment Lab Value not` `assessed or unknown if assessed` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3811	ANEMIA	SSD1;12	SET	'0' FOR Anemia not present, Hgb GT or equal 11.0 g/dL; '1' FOR Anemia present, Hgb<11.0 g/dL; '5' FOR NA, site not C421; '6' FOR Lab value unk, physician states pt is anemic; '7' FOR Test ordered, results not in chart; '9' FOR Not documented in medical record; LAST EDITED: `MAY 03, 2023` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Anemia is defined by a deficiency of red blood cells or of hemoglobin in the blood. In staging of Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia (CLL/SLL), anemia is defined as Hgb less than 11.0 g/dL. Rationale:` `Anemia is a prognostic factor required for staging of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) in AJCC 8th edition, Chapter 79 Hodgkin and Non-Hodgkin Lymphomas. It is a new data item for cases` `diagnosed 1/1/2018+. Codes: 0 Anemia not present` `Hgb >=11.0 g/dL` `Physician states RAI stage 0-II 1 Anemia present` `Hgb <11.0 g/dL 5 Not applicable: Primary site is not C421 6 Lab value unknown, physician states patient is anemic` `Physician states RAI stage III 7 Test ordered, results not in chart 9 Not documented in medical record` `Anemia not assessed or unknown if assessed` SCREEN: `S DIC("S")="D SCRNFIV^ONCSCHMM"` EXPLANATION: `Codes depend on appropriate primary site`
3812	B SYMPTOMS	SSD1;13	SET	'0' FOR No B symptoms (asymptomatic); '1' FOR Any B symptom(s); '8' FOR N/A; '9' FOR Not documented in medical record; LAST EDITED: `JUN 28, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `B symptoms refer to systemic symptoms of fever, night sweats, and weight loss which can be associated with both Hodgkin lymphoma and some non-Hodgkin lymphomas. The presence of B symptoms is a prognostic factor for some` `lymphomas. Rationale: B symptoms is a Registry Data Collection Variable in AJCC. This data item was previously collected for Lymphomas, SSF# 2. Codes: 0 No B symptoms (asymptomatic)` `Classified as "A" by physician when asymptomatic 1 Any B symptom(s)` `Night sweats (drenching)` `Unexplained fever (above 38 degrees C)` `Unexplained weight loss (generally greater than 10% of body` `weight in the six months before admission)` `B symptoms, NOS` `Classified as "B" by physician when symptomatic 8 Not applicable: Information not collected for this case` `(If this item is required by your standard setter, use of code 8 will` `result in an edit error.) 9 Not documented in medical record` `B symptoms not assessed or unknown if assessed`
3813	BILIRUBIN PRE TOTAL LAB VALUE	SSD1;14	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>5!($L(X)<1)!'(X?0.3AN0.1"."1N) X I $D(X) D DEC3^ONCSCHMM` `MAXIMUM LENGTH: 5` LAST EDITED: `AUG 01, 2019` HELP-PROMPT: `Answer must be 1-5 characters in length.` DESCRIPTION: `Bilirubin Pretreatment Total Lab Value records the bilirubin value prior to treatment. Bilirubin level is an indicator of how effectively the liver excretes bile and is required to calculate the Model for End-Stage Liver` `Disease (MELD) score used to assign priority for liver transplant. Rationale: Bilirubin Pretreatment Total Lab Value is a Registry Data Collection Variable in AJCC. This data item was previously collected as Liver, CS` `SSF# 6. Codes: 0.0 0.0 milligram/deciliter (mg/dL)` `0.0 micromole/liter (umol/L) 0.1-999.9 0.1-999.9 milligram/deciliter (mg/dL)` `0.1-999.9 micromole/liter (umol/L) XXX.1 1000 milligram/deciliter (mg/dL) or greater` `1000 micromole/liter (umol/L) or greater XXX.7 Test ordered, results not in chart XXX.8 Not applicable: Information not collected for this case` `(If this item is required by your standard setter, use of` `code XXX.8 will result in an edit error.) XXX.9 Not documented in medical record` `Bilirubin Pretreatment Total Lab Value not assessed or unknown` `if assessed` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3814	BILIRUBIN PRETREATMENT UNIT	SSD1;15	SET	'1' FOR Milligrams per deciliter (mg/dL); '2' FOR Micromoles/liter (umol/L); '7' FOR Test ordered, results not in chart; '8' FOR N/A; '9' FOR Not documented in medical record; LAST EDITED: `JUN 28, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Bilirubin Pretreatment Unit of Measure identifies the unit of measure for the bilirubin value measured prior to treatment. Bilirubin is commonly measured in units of Milligrams/deciliter (mg/dL) in the United States and` `Micromoles/liter (umol/L) in Canada and Europe. Rationale: Bilirubin Pretreatment is a Registry Data Collection Variable in AJCC. Bilirubin Pretreatment Unit of Measure is needed to identify the unit in which bilirubin` `is measured and was previously collected as Liver, CS SSF# 7. Codes: 1 Milligrams per deciliter (mg/dL) 2 Micromoles/liter (umol/L) 7 Test ordered, results not in chart 8 Not applicable: Information not collected` `for this case` `(If this item is required by your standard setter, use of` `code 8 will result in an edit error.) 9 Not documented in medical record` `Bilirubin unit of measure not assessed or unknown if assessed`
3815	BONE INVASION	SSD1;16	SET	'0' FOR Bone invasion not present/not identified on imaging; '1' FOR Bone invasion present/identified on imaging; '8' FOR N/A; '9' FOR Not documented in medical record; LAST EDITED: `JUL 09, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Bone invasion, the presence or absence of bone invasion based on imaging, is a prognostic factor for soft tissue sarcomas. Rationale: Bone Invasion is a Registry Data Collection Variable in AJCC. This data item was` `previously collected for Soft Tissue, SSF# 3. Codes: 0 Bone invasion not present/not identified on imaging 1 Bone invasion present/identified on imaging 8 Not applicable: Information not collected for this case` `(If this information is required by your standard setter, use of` `code 8 may result in an edit error.) 9 Not documented in medical record` `Bone invasion not assessed or unknown if assessed`
3816	BRAIN MOLECULAR MARKERS	SSD1;17	POINTER TO ONCO BRAIN MOLECULAR MARKERS FILE (#167.1)	ONCO BRAIN MOLECULAR MARKERS(#167.1) LAST EDITED: `JUL 09, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Multiple brain molecular markers have become standard pathology components necessary for diagnosis. This data item captures clinically important brain cancer subtypes identified by molecular markers that are not` `distinguishable by ICD-O-3 codes. Rationale: Collection of these clinically important brain cancer subtypes has been recommended by CBTRUS. Codes: 01 Diffuse astrocytoma, IDH-mutant (9400/3) 02 Diffuse astrocytoma,` `IDH-wildtype (9400/3) 03 Anaplastic astrocytoma, IDH-mutant (9401/3) 04 Anaplastic astrocytoma, IDH-wildtype (9401/3) 05 Glioblastoma, IDH-wildtype (9440/3) 06 Oligodendroglioma, IDH-mutant and 1 p/19q` `co-deleted (9450/3) 07 Anaplastic oligodendroglioma, IDH-mutant and 1 p/19q` `co-deleted (9451/3) 08 Medulloblastoma, SHH-activated and TP53-wildtype (9471/3) 09 Embryonal tumor with multilayered rosettes, C19MC-` `altered (9478/3) 85 Not applicable: Histology not 9400/3, 9401/3, 9440/3,` `9450/3, 9451/3, 9471/3, 9478/3 86 Benign or borderline tumor 87 Test ordered, results not in chart 88 Not applicable: Information not collected for this case` `(If this item is required by your standard setter,` `use of code 88 will result in an edit error.) 99 Not documented in patient record` `No microscopic confirmation` `Brain molecular markers not assessed or unknown if assessed`
3817	BRESLOW TUMOR THICKNESS	SSD1;18	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>4!($L(X)<1) X I $D(X) D BTTIT^ONCSCHMM` `MAXIMUM LENGTH: 4` LAST EDITED: `SEP 18, 2019` HELP-PROMPT: `Answer must be 1-4 characters in length.` DESCRIPTION: `Breslow Tumor Thickness, the measurement of the thickness of a Melanoma as defined by Dr. Alexander Breslow, is a prognostic factor for Melanoma of the Skin. Rationale: Breslow Tumor Thickness is a Registry Data` `Collection Variable in AJCC. It was previously collected as Melanoma Skin, CS SSF# 1. Codes:` `0.0 No mass/tumor found` `0.1 Greater than 0.0 and less than or equal to 0.1 0.2-99.9 0.2 - 99.9 millimeters XX.1 100 millimeters or larger A0.1-A9.9 Stated as "at least" some measured value of 0.1 to 9.9 AX.0 Stated as greater than 9.9` `mm XX.8 Not applicable: Information not collected for this schema` `(If this item is required by your standard setter, use of` `code XX.8 will result in an edit error) XX.9 Not documented in medical record` `Microinvasion; microscopic focus or foci only and no depth given` `Cannot be determined by pathologist` `In situ melanoma` `Breslow Tumor Thickness not assessed or unknown if assessed` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3818	CA-125 PRETREATMENT INTER	SSD1;19	SET	'0' FOR Negative/normal; '1' FOR Positive/elevated; '2' FOR Stated as borderline; '7' FOR Test ordered, results not in chart; '8' FOR N/A; '9' FOR Not documented; LAST EDITED: `JUL 09, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Carbohydrate Antigen 125 (CA-125) is a tumor marker that is useful for following the response to therapy in patients with ovarian cancer, who may have elevated levels of this marker. Rationale: Preoperative CA-125 is a` `Registry Data Collection Variable listed in AJCC. It was previously collected as Ovary, CS SSF# 1. Codes: 0 Negative/normal; within normal limits 1 Positive/elevated 2 Stated as borderline; undetermined whether` `positive or negative 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case` `(If this item is required by your standard setter, use of` `code 8 will result in an edit error) 9 Not documented in medical record` `CA-125 not assessed or unknown if assessed`
3819	CEA PRETREATMENT INTER	SSD1;20	SET	'0' FOR CEA negative/normal; '1' FOR CEA positive/elevated; '2' FOR Borderline; '3' FOR Undetermined if positive or negative; '7' FOR Test ordered, results not in chart; '8' FOR N/A; '9' FOR Not documented; LAST EDITED: `JUL 09, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `CEA (Carcinoembryonic Antigen) Pretreatment Interpretation refers to the interpretation of the CEA value prior to treatment. CEA is a glycoprotein that is produced by adenocarcinomas from all sites as well as many squamous` `cell carcinomas of the lung and other sites. CEA may be measured in blood, plasma or serum. CEA is a prognostic marker for adenocarcinomas of the appendix, colon and rectum and is used to monitor response to treatment` `Rationale: CEA (Carcinoembryonic Antigen) is a Registry Data Collection Variable for AJCC 8. CEA (Carcinoembryonic Antigen) Pretreatment Interpretation was previously collected as Colon and Rectum, CS SSF #1. Codes: 0` `CEA negative/normal; within normal limits 1 CEA positive/elevated 2 Borderline 3 Undetermined if positive or negative (normal values not available)` `AND no MD interpretation 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case` `(If this data item is required by your standard setter, use of` `code 8 will result in an edit error.) 9 Not documented in medical record` `CEA (Carcinoembryonic Antigen) Pretreatment Interpretation not` `assessed or unknown if assessed`
3820	CEA PRETREATMENT LAB VALUE	SSD1;21	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>6!($L(X)<1)!'(X?0.4AN0.1"."1N) X I $D(X) D DEC4^ONCSCHMM` `MAXIMUM LENGTH: 6` LAST EDITED: `JUL 31, 2019` HELP-PROMPT: `Answer must be 1-6 characters in length.` DESCRIPTION: `CEA (Carcinoembryonic Antigen) Pretreatment Lab Value records the CEA value prior to treatment. CEA is a nonspecific tumor marker that has prognostic significance for colon and rectum cancer. Rationale: CEA` `(Carcinoembryonic Antigen) Pretreatment Lab Value is a Registry Data Collection Variable in AJCC. It was previously collected as Colon and Rectum, CS SSF# 3. Codes: 0.0 0.0 nanograms/milliliter (ng/m) exactly 0.1-9999.9` `0.1-9999.9 ng/ml` `(Exact value to nearest tenth in ng/ml) XXXX.1 10,000 ng/ml or greater XXXX.7 Test ordered, results not in chart XXXX.8 Not applicable: Information not collected for this case` `(If this information is required by your standard setter, use` `of code XXXX.8 may result in an edit error.) XXXX.9 Not documented in medical record` `CEA (Carcinoembryonic Antigen) Pretreatment Lab Value not` `assessed or unknown if assessed` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3821	CHROMOSOME 3 STATUS	SSD1;22	SET	'0' FOR No loss of chromosome 3; '1' FOR Partial loss of chromosome 3; '2' FOR Complete loss of chromosome 3; '3' FOR Loss of chromosome 3, NOS; '7' FOR Test ordered, results not in chart; '8' FOR N/A; '9' FOR Not documented; LAST EDITED: `JUL 09, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Chromosome 3 Status refers to the partial or total loss of Chromosome 3, which is a prognostic factor for uveal melanoma. Rationale: Chromosome 3 Status is a Registry Data Collection Variable in AJCC. This data item was` `previously collected as Uveal Melanoma, CS SSF# 5. Codes: 0 No loss of chromosome 3 1 Partial loss of chromosome 3 2 Complete loss of chromosome 3 3 Loss of chromosome 3, NOS 7 Test ordered, results not in chart` `8 Not applicable: Information not collected for this case` `(If this information is required by your standard setter, use` `of code 8 may result in an edit error.) 9 Not documented in medical record` `Chromosome 3 status not assessed or unknown if assessed`
3822	CHROMOSOME 8Q STATUS	SSD1;23	SET	'0' FOR No gain in chromosome 8q; '1' FOR Gain in chromosome 8q; '7' FOR Test ordered, results not in chart; '8' FOR N/A; '9' FOR Not documented in medical record; LAST EDITED: `JUL 09, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Chromosome 8q Status refers to gain in Chromosome 8q, which is a prognostic factor for uveal melanoma. Rationale: Chromosome 8q Status is a Registry Data Collection Variable in AJCC. This data item was previously` `collected as Uveal Melanoma, CS SSF# 7. Codes: 0 No gain in chromosome 8q 1 Gain in chromosome 8q 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case` `(If this information is required by your standard setter,` `use of code 8 may result in an edit error.) 9 Not documented in medical record` `Chromosome 8q status not assessed or unknown if assessed`
3823	CIRCUMFERENTIAL RESECT MARGIN	SSD1;24	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>4!($L(X)<1)!'(X?0.2AN0.1"."1N) X I $D(X) D DEC2^ONCSCHMM` `MAXIMUM LENGTH: 4` LAST EDITED: `AUG 01, 2019` HELP-PROMPT: `Answer must be 1-4 characters in length.` DESCRIPTION: `Circumferential or Radial Resection Margin, the distance in millimeters between the leading edge of the tumor and the surgically dissected margin as recorded on the pathology report, is a prognostic indicator for colon and` `rectal cancer. This may also be referred to as the Radial Resection Margin or surgical clearance. Rationale: Circumferential or Radial Resection Margin is a Registry Data Collection Variable in AJCC. It was previously` `collected as Colon and Rectum CS SSF# 6. Codes:` `0.0 Circumferential resection margin (CRM) positive` `Margin IS involved with tumor` `Described as "less than 1 millimeter (mm)" 0.1-99.9 Distance of tumor from margin: 0.1- 99.9 millimeters (mm)` `(Exact size to nearest tenth of millimeter) XX.0 100 mm or greater XX.1 Margins clear, distance from tumor not stated` `Circumferential or radial resection margin negative, NOS` `No residual tumor identified on specimen XX.2 Margins cannot be assessed XX.3 Described as "at least" 1 mm XX.4 Described as "at least" 2 mm XX.5 Described as "at least" 3 mm XX.6 Described as "greater` `than" 3 mm XX.7 No resection of primary site` `Surgical procedure did not remove enough tissue to measure` `the circumferential or radial resection margin` `(Examples include: polypectomy only, endoscopic mucosal` `resection (EMR), excisional biopsy only, transanal disk excision) XX.8 Not applicable: Information not collected for this case` `(If this information is required by your standard setter, use of` `code XX.8 may result in an edit error.) XX.9 Not documented in medical record` `Circumferential or radial resection margin not assessed` `or unknown if assessed` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3824	CREATININE PRETREAT LAB VALUE	SSD1;25	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>4!($L(X)<1)!'(X?0.2AN0.1"."1N) X I $D(X) D DEC2^ONCSCHMM` `MAXIMUM LENGTH: 4` LAST EDITED: `AUG 01, 2019` HELP-PROMPT: `Answer must be 1-4 characters in length.` DESCRIPTION: `Creatinine Pretreatment Lab Value, an indicator of kidney function is required to calculate the Model for End-Stage Liver Disease (MELD) score, which is used to assign priority for liver transplant. Rationale: Creatinine` `Pretreatment Lab Value is a Registry Data Collection Variable in AJCC. This data item was previously collected for Liver, CS SSF# 4. Codes:` `0.0 0.0 milligram/deciliter (mg/dl)` `0.0 micromole/liter (umol/L) 0.1-99.9 0.1-99.9 milligram/deciliter (mg/dl)` `0.1-99.9 micromole/liter (umol/L)` `(Exact value to nearest tenth of mg/dl or umol/L) XX.1 100 mg/dl or greater` `100 umol/L or greater XX.7 Test ordered, results not in chart XX.8 Not applicable: Information not collected for this case` `(If this item is required by your standard setter, use of` `code XX.8 will result in an edit error.) XX.9 Not documented in medical record` `Creatinine Pretreatment Lab Value not assessed or` `unknown if assessed` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3825	CREATININE PRETREAT UNIT	SSD1;26	SET	'1' FOR Milligrams/deciliter; '2' FOR Micromoles/liter; '7' FOR Test ordered, results not in chart; '8' FOR N/A; '9' FOR Not documented; LAST EDITED: `JUL 10, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Creatinine Pretreatment Unit of Measure identifies the unit of measure for the creatinine value measured in blood or serum prior to treatment. Creatinine is commonly measured in units of Milligrams/deciliter (mg/dL) in` `the United States and Micromoles/liter (umol/L) in Canada and Europe. Rationale: Creatinine Pretreatment is a Registry Data Collection Variable in AJCC. Creatinine Pretreatment Unit of Measure is needed to identify the` `unit in which creatinine is measured and was previously collected as Liver, CS SSF# 5. Codes: 1 Milligrams/deciliter (mg/dL) 2 Micromoles/liter (umol/L) 7 Test ordered, results not in chart 8 Not applicable:` `Information not collected for this case` `(If this item is required by your standard setter, use of` `code 8 will result in an edit error.) 9 Not documented in medical record` `Creatinine unit of measure not assessed or` `unknown if assessed`
3826	ER PERCENT POSITIVE	SSD1;27	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>3!($L(X)<1)!'(X?1.3AN) X I $D(X) D ERR^ONCSCHMM` `MAXIMUM LENGTH: 3` LAST EDITED: `JUN 25, 2020` HELP-PROMPT: `Answer must be 1-3 characters in length.` DESCRIPTION: `Estrogen Receptor, Percent Positive Range is the percent of cells staining estrogen receptor positive by IHC. Rationale: Estrogen Receptor, Percent Positive Range is a Registry Data Collection Variable in AJCC. It is a` `new data item for cases diagnosed 1/1/2018+. Codes: 000 ER negative, or stated as less than 1% 001-100 1-100 percent R10 Stated as 1-10% R20 Stated as 11-20% R30 Stated as 21-30% R40 Stated as 31-40% R50` `Stated as 41-50% R60 Stated as 51-60% R70 Stated as 61-70% R80 Stated as 71-80% R90 Stated as 81-90% R99 Stated as 91-100% XX8 Not applicable: Information not collected for this case` `(If this item is required by your standard setter, use of` `code XX8 will result in an edit error.) XX9 Not documented in medical record` `Estrogen Receptor, Percent Positive Range not assessed` `or unknown if assessed` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3827	ER SUMMARY	SSD1;28	SET	'0' FOR ER negative; '1' FOR ER positive; '7' FOR Test ordered, results not in chart; '9' FOR Not documented in medical record; LAST EDITED: `OCT 21, 2019` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `ER (Estrogen Receptor) Summary is a summary of results of the estrogen receptor (ER) assay. Rationale: This data item is required for prognostic stage grouping in AJCC 8th ed- ition, Chapter 48, Breast. It was previously` `collected as Breast CS SSF # 1. Codes: 0 ER negative 1 ER positive 7 Test ordered, results not in chart 9 Not documented in medical record` `Cannot be determined (indeterminate)` `ER (Estrogen Receptor) Summary status not assessed` `or unknown if assessed`
3828	ER ALLRED SCORE	SSD1;29	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<1)!'(X?0.1AN1N) X I $D(X) D ERTA^ONCSCHMM` `MAXIMUM LENGTH: 2` LAST EDITED: `OCT 22, 2019` HELP-PROMPT: `Answer must be 1-2 characters in length.` DESCRIPTION: `Estrogen Receptor, Total Allred Score is based on the percentage of cells that stain positive by IHC for estrogen receptor (ER) and the intensity of that staining. Rationale: Estrogen Receptor, Total Allred Score is a` `Registry Data Collection Variable in AJCC. It is a new data item for cases diagnosed 1/1/2018+. Codes: 00 Total ER Allred score of 0 01 Total ER Allred score of 1 02 Total ER Allred score of 2 03 Total ER Allred` `score of 3 04 Total ER Allred score of 4 05 Total ER Allred score of 5 06 Total ER Allred score of 6 07 Total ER Allred score of 7 08 Total ER Allred score of 8 X8 Not applicable: Information not collected for` `this case` `(If this item is required by your standard setter, use of` `code X8 will result in an edit error.) X9 Not documented in medical record` `Estrogen Receptor, Total Allred Score not assessed,` `or unknown if assessed` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3829	ESOPHAGUS EGJ TUMOR EPICENTER	SSD1;30	SET	'0' FOR U - Upper; '1' FOR M - Middle; '2' FOR L - Lower; '9' FOR X - Esophagus, NOS; LAST EDITED: `JUL 11, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Esophagus and Esophagogastric Junction (EGJ), Squamous Cell (including adenosquamous), Tumor Location refers to the position of the epicenter of the tumor in the esophagus. Rationale: This data item is required for` `prognostic stage grouping for squamous and adenosquamous carcinoma in AJCC 8th edition, Chapter 16. It is a new data item for cases diagnosed 1/1/2018+. Codes: 0 U: Upper (Cervical/Proximal esophagus to lower border` `of azygos vein) 1 M: Middle (Lower border of azygos vein to lower border` `of inferior pulmonary vein) 2 L: Lower (Lower border of inferior pulmonary vein to stomach,` `including gastroesophageal junction) 9 X: Esophagus, NOS` `Specific location of epicenter not documented in medical record` `Specific location of epicenter not assessed or unknown if assessed`
3830	ENE CLIN (NON-HEAD AND NECK)	SSD1;31	SET	'0' FOR ENE not present/not identified; '1' FOR ENE present based on exam or imaging; '2' FOR ENE present based on microscopic confirmation; '7' FOR No LN involvement; '8' FOR N/A; '9' FOR Not documented; LAST EDITED: `SEP 09, 2019` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Extranodal Extension (ENE) Clinical is defined as "the extension of a nodal metastasis through the lymph node capsule into adjacent tissue" during the diagnostic workup. This data item defines clinical ENE for sites other` `than Head and Neck. Rationale: Extranodal Extension Clinical (non-Head and Neck) is a Registry Data Collection Variable for AJCC. This data item was previously collected for Penis, SSF# 17. Codes: 0 Regional lymph` `nodes involved, ENE not present/not identified` `during diagnostic workup 1 Regional lymph nodes involved, ENE present/identified during` `diagnostic workup, based on physical exam and/or imaging 2 Regional lymph nodes involved, ENE present/identified during` `diagnostic workup, based on microscopic confirmation 7 No lymph node involvement during diagnostic workup (cN0) 8 Not applicable: Information not collected for this case` `(If this information is required by your standard setter, use of` `code 8 may result in an edit error) 9 Not documented in medical record` `Clinical ENE not assessed or unknown if assessed during` `diagnostic workup` `Clinical assessment of lymph nodes not done, or unknown if done`
3831	ENE HEAD AND NECK CLINICAL	SSD1;32	SET	'0' FOR ENE not present/not identified; '1' FOR ENE present based on physical exam; '2' FOR ENE present based on microscopic confirmation; '7' FOR No LN involvement; '8' FOR N/A; '9' FOR Not documented; LAST EDITED: `SEP 09, 2019` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Extranodal extension (ENE) is defined as "the extension of a nodal metastasis through the lymph node capsule into adjacent tissue" and is a prognostic factor for most head and neck tumors. This data item pertains to` `clinical staging extension. Rationale Extranodal Extension Head and Neck Clinical is a Registry Data Collection Variable in AJCC. It was previously collected as Head and Neck SSF# 8 (Common SSF). Codes: 0 Regional` `lymph nodes involved, ENE not present/not identified` `during diagnostic workup 1 Regional lymph nodes involved, ENE present/identified during` `diagnostic workup, based on physical exam and/or imaging 2 Regional lymph nodes involved, ENE present/identified during` `diagnostic workup, based on microscopic confirmation 7 No lymph node involvement during diagnostic workup (cN0) 8 Not applicable: Information not collected for this case` `(If this information is required by your standard setter, use of` `code 8 may result in an edit error) 9 Not documented in medical record` `Clinical ENE not assessed or unknown if assessed during` `diagnostic workup` `Clinical assessment of lymph nodes not done, or unknown if done`
3832	ENE HEAD AND NECK PATHOLOGICAL	SSD1;33	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>3!($L(X)<1)!'(X?0.1AN0.1"."1N) X I $D(X) D DEC1^ONCSCHMM` `MAXIMUM LENGTH: 3` LAST EDITED: `AUG 01, 2019` HELP-PROMPT: `Answer must be 1-3 characters in length.` DESCRIPTION: `Extranodal extension (ENE) is defined as "the extension of a nodal metastasis through the lymph node capsule into adjacent tissue" and is a prognostic factor for most head and neck tumors. This data item pertains to` `pathological staging extension. Rationale: Extranodal Extension Head and Neck Pathological is a Registry Data Collection Variable in AJCC. It was previously collected as Head and Neck SSF# 9 (Common SSF). Codes: 0.0` `Lymph nodes positive for cancer but ENE not identified` `or negative 0.1-9.9 ENE 0.1 to 9.9 mm X.1 ENE 10 mm or greater X.2 ENE microscopic, size unknown` `Stated as ENE (mi) X.3 ENE major, size unknown` `Stated as ENE (ma) X.4 ENE present, microscopic or major unknown, size unknown X.7 Surgically resected regional lymph nodes negative for cancer (pN0) X.8 Not applicable: Information not collected for this` `case` `(If this information is required by your standard setter, use of` `code X.8 may result in an edit error) X.9 Not documented in medical record` `No surgical resection of regional lymph nodes` `ENE not assessed pathologically, or unknown if assessed` `Pathological assessment of lymph nodes not done,` `or unknown if done` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3833	ENE PATH (NON-HEAD AND NECK)	SSD1;34	SET	'0' FOR ENE not present/not identified; '1' FOR ENE present from surgical resection; '7' FOR No LN involvement from surgical resection; '8' FOR N/A; '9' FOR Not documented; LAST EDITED: `SEP 09, 2019` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Extranodal Extension Pathological is defined as "the extension of a nodal metastasis through the lymph node capsule into adjacent tissue" identified as part of the surgical resection. This data item defines pathological` `ENE for sites other than Head and Neck. Rationale: Extranodal Extension Pathological (non-Head and Neck) is a Registry Data Collection Variable for AJCC. This data item was previously collected for Penis, SSF# 17. Codes:` `0 Regional lymph nodes involved, ENE not present/not identified` `from surgical resection 1 Regional lymph nodes involved, ENE present/identified` `from surgical resection 7 No lymph node involvement from surgical resection (pN0) 8 Not applicable: Information not collected for this case` `(If this information is required by your standard setter, use of` `code 8 may result in an edit error) 9 Not documented in medical record` `No surgical resection of regional lymph nodes` `Cannot be determined` `Pathological assessment of lymph nodes not done,` `or unknown if done` `Extranodal Extension Pathological not assessed` `or unknown if assessed`
3834	EXTRAVASCULAR MATRIX PATTERNS	SSD1;35	SET	'0' FOR Extravascular matrix pattern not present/not identified; '1' FOR Extravascular matrix pattern present/identified; '8' FOR N/A; '9' FOR Not documented; LAST EDITED: `JUL 11, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Extravascular Matrix Patterns, the presence of loops and networks in extracellular matrix patterns, is a prognostic factor for uveal melanoma. Rationale: Extravascular Matrix Pattern is a Registry Data Collection Variable` `in AJCC 8. This data item was previously collected as Uveal Melanoma, CS SSF #11 and CS SSF# 12. These two data items were combined and simplified into one data for cases diagnosed 1/1/2018+. Codes: 0 Extravascular` `matrix pattern not present/not identified 1 Extravascular matrix pattern present/identified 8 Not applicable: Information not collected for this case` `(If this information is required by your standard setter, use of` `code 8 may result in an edit error.) 9 Not documented in medical record` `Extravascular Matrix Pattern not assessed` `or unknown if assessed`
3835	FIBROSIS SCORE	SSD2;1	SET	'0' FOR Ishak fibrosis score 0-4; '1' FOR Ishak fibrosis score 5-6; '7' FOR Clinical statement of advanced/severe fibrosis or cirrhosis; '8' FOR N/A; '9' FOR Not documented in medical record; LAST EDITED: `JUL 12, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Fibrosis Score, the degree of fibrosis of the liver based on pathological examination, is a prognostic factor for liver cancer. Rationale: Fibrosis Score is a Registry Data Collection Variable in AJCC. This data item was` `previously collected for Liver, CS SSF# 2. Codes: 0 Ishak fibrosis score 0-4` `No to moderate fibrosis` `METAVIR score F0-F3` `Batt-Ludwig score 0-3 1 Ishak fibrosis score 5-6` `Advanced/severe fibrosis` `METAVIR score F4` `Batt-Ludwig score 4` `Developing cirrhosis` `Incomplete cirrhosis` `Transition to cirrhosis` `Cirrhosis, probable or definite` `Cirrhosis, NOS 7 Clinical statement of advanced/severe fibrosis or cirrhosis, AND` `Not histologically confirmed or unknown if histologically confirmed 8 Not applicable: Information not collected for this case` `(If this item is required by your standard setter, use of` `code 8 will result in an edit error.) 9 Not documented in medical record` `Stated in medical record that patient does not have advanced` `cirrhosis/advanced fibrosis, not histologically confirmed or` `unknown if histologically confirmed` `Fibrosis score stated but cannot be assigned to codes 0 or 1` `Fibrosis score stated but scoring system not recorded` `Fibrosis Score not assessed or unknown if assessed`
3836	FIGO STAGE	SSD2;2	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>5!($L(X)<1) X I $D(X) D FIGO^ONCSCHMM` `MAXIMUM LENGTH: 5` OUTPUT TRANSFORM: `NOT EXECUTABLE!! -- SPECIFIER NEEDS AN "O"!` LAST EDITED: `AUG 23, 2021` HELP-PROMPT: `Answer must be 1-5 characters in length.` DESCRIPTION: `Federation Internationale de Gynecologie et d'Obstetrique (FIGO) is a staging system for female reproductive cancers. Rationale: FIGO stage is a Registry Data Collection Variable in AJCC for the female genital cancers.` `This data item was previously collected for the female genital cancers as: Vulva SSF #10, Vagina SSF #1, Cervix SSF #1, Corpus Carcinoma SSF #1, Corpus Sarcoma SSF #1, Ovary SSF #2, Fallopian Tube SSF #1, Peritoneum Female` `Genital SSF #1, and Placenta SSF #2.` EXECUTABLE HELP: `D FIGOHLP^ONCSCHMM` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3837	GESTATIONAL TROPHOBLASTIC	SSD2;3	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<1)!'(X?1AN1N) X` `MAXIMUM LENGTH: 2` LAST EDITED: `JUL 12, 2018` HELP-PROMPT: `Answer must be 1-2 characters in length.` DESCRIPTION: `Gestational Trophoblastic Prognostic Scoring Index, a score based on the FIGO-modified World Health Organization (WHO) Prognostic Scoring Index, is used to stratify women with gestational trophoblastic neoplasia in` `addition to the anatomical stage group. The risk score is appended to the anatomic stage. Rationale: This data item is required for prognostic stage grouping in AJCC 8th edition, Chapter 56 Gestational Trophoblastic` `Neoplasms. It was previously collected as Placenta, CS SSF # 1. Codes: 00-25 Risk factor score` `X9 Not documented in medical record` `Prognostic scoring index not assessed, or unknown if assessed`
3838	GLEASON PATTERNS CLINICAL	SSD2;4	POINTER TO GLEASON PATTERNS FILE (#167.2)	GLEASON PATTERNS(#167.2) INPUT TRANSFORM: `S DIC("S")="I 1 K ONCGPAT" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X` OUTPUT TRANSFORM: `S:Y'="" Y=$P(^ONCO(167.2,Y,0),U,1)_" "_$P(^ONCO(167.2,Y,0),U,2)` LAST EDITED: `JUN 22, 2020` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Prostate cancers are graded using Gleason score or pattern. This data item represents the Gleason primary and secondary patterns from needle core biopsy or TURP. Rationale Gleason Patterns Clinical is a Registry Data` `Collection Variable for Clinical Stage for AJCC. This data item was previously collected as Prostate, CS SSF# 7.` SCREEN: `S DIC("S")="I 1 K ONCGPAT"` EXPLANATION: `Use Description field for Code X7` EXECUTABLE HELP: `K ONCGPAT`
3839	GLEASON PATTERNS PATHOLOGICAL	SSD2;5	POINTER TO GLEASON PATTERNS FILE (#167.2)	GLEASON PATTERNS(#167.2) INPUT TRANSFORM: `S DIC("S")="I 1 S ONCGPAT=1" D ^DIC K DIC S DIC=DIE,X=+Y K:Y<0 X` OUTPUT TRANSFORM: `S:Y'="" Y=$P(^ONCO(167.2,Y,0),U,1)_" "_$S(Y=32:$P(^ONCO(167.2,Y,0),U,3),1:$P(^ONCO(167.2,Y,0),U,2))` LAST EDITED: `JUN 22, 2020` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Prostate cancers are graded using Gleason score or pattern. This data item represents the Gleason primary and secondary patterns from prostatectomy or autopsy. Rationale Gleason Patterns Pathological is a Registry Data` `Collection Variable for AJCC. This data item was previously collected as Prostate, CS SSF# 9.` SCREEN: `S DIC("S")="I 1 S ONCGPAT=1"` EXPLANATION: `Use Second Description field for Code X7` EXECUTABLE HELP: `S ONCGPAT=1`
3840	GLEASON SCORE CLINICAL	SSD2;6	SET	'02' FOR Gleason 2; '03' FOR Gleason 3; '04' FOR Gleason 4; '05' FOR Gleason 5; '06' FOR Gleason 6; '07' FOR Gleason 7; '08' FOR Gleason 8; '09' FOR Gleason 9; '10' FOR Gleason 10; 'X7' FOR No needle core biopsy/TURP performed; 'X8' FOR N/A; 'X9' FOR Not documented; LAST EDITED: `JUL 16, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `This data item records the Gleason score based on adding the values for primary and secondary patterns in Needle Core Biopsy or TURP. Rationale: Gleason Score Clinical is a Registry Data Collection Variable for AJCC.` `This data item was previously collected as Prostate, CS SSF# 8. Codes: 02 Gleason score 2 03 Gleason score 3 04 Gleason score 4 05 Gleason score 5 06 Gleason score 6 07 Gleason score 7 08 Gleason score 8 09` `Gleason score 9 10 Gleason score 10 X7 No needle core biopsy/TURP performed X8 Not applicable: Information not collected for this case` `(If this information is required by your standard setter, use of` `code X8 may result in an edit error.) X9 Not documented in medical record` `Gleason Score Clinical not assessed or unknown if assessed`
3841	GLEASON SCORE PATHOLOGICAL	SSD2;7	SET	'02' FOR Gleason 2; '03' FOR Gleason 3; '04' FOR Gleason 4; '05' FOR Gleason 5; '06' FOR Gleason 6; '07' FOR Gleason 7; '08' FOR Gleason 8; '09' FOR Gleason 9; '10' FOR Gleason 10; 'X7' FOR No prostatectomy done; 'X8' FOR N/A; 'X9' FOR Not documented; LAST EDITED: `JUL 16, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `This data item records the Gleason score based on adding the values for primary and secondary patterns from prostatectomy or autopsy. Rationale: Gleason Score Pathological is a Registry Data Collection Variable for AJCC.` `This data item was previously collected as Prostate, CS SSF# 10. Codes: 02 Gleason score 2 03 Gleason score 3 04 Gleason score 4 05 Gleason score 5 06 Gleason score 6 07 Gleason score 7 08 Gleason score 8 09` `Gleason score 9 10 Gleason score 10 X7 No prostatectomy done X8 Not applicable: Information not collected for this case` `(If this information is required by your standard setter, use of` `code X8 may result in an edit error.) X9 Not documented in medical record` `Gleason Score Pathological not assessed or unknown if assessed`
3842	GLEASON TERTIARY PATTERN	SSD2;8	SET	'10' FOR Tertiary pattern 1; '20' FOR Tertiary pattern 2; '30' FOR Tertiary pattern 3; '40' FOR Tertiary pattern 4; '50' FOR Tertiary pattern 5; 'X7' FOR No prostatectomy/autopsy performed; 'X8' FOR N/A; 'X9' FOR Not documented in medical record; LAST EDITED: `JUL 16, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Prostate cancers are graded using Gleason score or pattern. This data item represents the tertiary pattern value from prostatectomy or autopsy. Rationale: Tertiary Gleason pattern on prostatectomy is a Registry Data` `Collection Variable for AJCC. This data item was previously collected as Prostate, CS SSF# 11. Codes: 10 Tertiary pattern 1 20 Tertiary pattern 2 30 Tertiary pattern 3 40 Tertiary pattern 4 50 Tertiary pattern 5` `X7 No prostatectomy/autopsy performed X8 Not applicable: Information not collected for this case` `(If this information is required by your standard setter, use of` `code X8 may result in an edit error.) X9 Not documented in medical record` `Gleason Tertiary Pattern not assessed or unknown if assessed`
3846	HCG POST-ORCHIECTOMY LAB VALUE	SSD2;12	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>7!($L(X)<1)!'(X?0.5AN0.1"."1N) X I $D(X) D DEC5^ONCSCHMM` `MAXIMUM LENGTH: 7` LAST EDITED: `AUG 01, 2019` HELP-PROMPT: `Answer must be 1-7 characters in length.` DESCRIPTION: `hCG (Human Chorionic Gonadotropin) Post-orchiectomy Lab Value refers to the lowest hCG value measured post-orchiectomy. hCG is a serum tumor marker that is often elevated in patients with nonseminomatous germ cell tumors` `of the testis. The Post- Orchiectomy lab value is used to monitor response to therapy. Rationale: hCG (Human Chorionic Gonadotropin) Post-orchiectomy Lab Value is a Registry Data Collection Variable in AJCC. It was` `previously collected as Testis CS SSF# 14. Codes:` `0.0 0.0 milli-International Units/milliliter (mIU/mL) 0.1-99999.9 0.1-99,999.9 mIU/mL XXXXX.1 100,000 mIU/mL or greater XXXXX.7 Test ordered, results not in chart XXXXX.8 Not applicable: Information not` `collected for this case` `(If this information is required by your standard setter,` `use of code XXXXX.8 may result in an edit error.) XXXXX.9 Not documented in medical record` `No orchiectomy performed` `hCG (Human Chorionic Gonadotropin) Post-orchiectomy` `Lab Value not assessed or unknown if assessed` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3847	HCG POST-ORCHIECTOMY RANGE	SSD2;13	SET	'0' FOR Within normal limits; '1' FOR Above normal and <5000mlU; '2' FOR 5000-50000mlU; '3' FOR >50000mlU; '4' FOR Stated to be elevated; '7' FOR Test ordered, results not in chart; '8' FOR N/A; '9' FOR Not documented; LAST EDITED: `JUL 17, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Human Chorionic Gonadotropin (hCG) Post-orchiectomy Range identifies the range category of the lowest hCG value measured post-orchiectomy. hCG is a serum tumor marker that is often elevated in patients with` `nonseminomatous germ cell tumors of the testis. The Post-Orchiectomy lab value is used to monitor response to therapy. Rationale: hCG (Human Chorionic Gonadotropin) is a Registry Data Collection Variable in AJCC. hCG` `(Human Chorionic Gonadotropin) Post- orchiectomy Range is used to assign the S Category Pathological and was previously collected as Testis CS SSF# 15. Codes: 0 Within normal limits 1 Above normal and less than 5,000` `milli-International` `Units/milliliter (mIU/mL) 2 5,000-50,000 mIU/mL 3 Greater than 50,000 mIU/mL 4 Post-orchiectomy human chorionic gonadotropin (hCG) stated` `to be elevated 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case` `(If this information is required by your standard setter,` `use of code 8 may result in an edit error.) 9 Not documented in medical record` `No orchiectomy performed` `hCG (Human Chorionic Gonadotropin) Post-orchiectomy` `Range not assessed or unknown if assessed`
3848	HCG PRE-ORCHIECTOMY LAB VALUE	SSD2;14	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>7!($L(X)<1)!'(X?0.5AN0.1"."1N) X I $D(X) D DEC5^ONCSCHMM` `MAXIMUM LENGTH: 7` LAST EDITED: `AUG 01, 2019` HELP-PROMPT: `Answer must be 1-7 characters in length.` DESCRIPTION: `hCG (Human Chorionic Gonadotropin) Pre-orchiectomy Lab Value refers to the hCG value measured prior to treatment. hCG is a serum tumor marker that is often elevated in patients with nonseminomatous germ cell tumors of the` `testis. Rationale: hCG (Human Chorionic Gonadotropin) Pre-orchiectomy Lab Value is a Registry Data Collection Variable in AJCC. It was previously collected as Testis CS SSF# 8. Codes:` `0.0 0.0 milli-International Units/milliliter (mIU/mL) 0.1-99999.9 0.1-99,999.9 mIU/mL XXXXX.1 100,000 mIU/mL or greater XXXXX.7 Test ordered, results not in chart XXXXX.8 Not applicable: Information not` `collected for this case` `(If this information is required by your standard setter,` `use of code XXXXX.8 may result in an edit error.) XXXXX.9 Not documented in medical record` `hCG (Human Chorionic Gonadotropin) Pre-orchiectomy` `Lab Value not assessed or unknown if assessed` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3849	HCG PRE-ORCHIECTOMY RANGE	SSD2;15	SET	'0' FOR Within normal limits; '1' FOR Above normal and <5000mlU; '2' FOR 5000-50000mlU; '3' FOR >50000mlU; '4' FOR Stated to be elevated; '7' FOR Test ordered, results not in chart; '8' FOR N/A; '9' FOR Not documented; LAST EDITED: `JUL 17, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Human Chorionic Gonadotropin (hCG) Pre-orchiectomy Range identifies the range category of the highest hCG value measured prior to treatment. hCG is a serum tumor marker that is often elevated in patients with` `nonseminomatous germ cell tumors of the testis. Rationale: hCG (Human Chorionic Gonadotropin) is a Registry Data Collection Variable in AJCC. hCG (Human Chorionic Gonadotropin) Pre- orchiectomy Range is used to assign the` `S Category Clinical and was previously collected as Testis CS SSF# 9. Codes: 0 Within normal limits 1 Above normal and less than 5,000 milli-International` `Units/milliliter (mIU/mL) 2 5,000 - 50,000 mIU/mL 3 Greater than 50,000 mIU/mL 4 Pre-orchiectomy human chorionic gonadotropin (hCG)` `stated to be elevated 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case` `(If this information is required by your standard setter,` `use of code 8 may result in an edit error.) 9 Not documented in medical record` `hCG pre-orchiectomy range not assessed or unknown if assessed`
3850	HER2 IHC SUMMARY	SSD2;16	SET	'0' FOR Negative (Score 0); '1' FOR Negative (Score 1+); '2' FOR Equivocal (Score 2+); '3' FOR Positive (Score 3+); '4' FOR Stated as negative, but score not stated; '7' FOR Test ordered, results not in chart; '8' FOR N/A; '9' FOR Not documented in medical record; LAST EDITED: `JUL 17, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `HER2 IHC Summary is the summary score for HER2 testing by IHC. Rationale: HER2 IHC Summary is a Registry Data Collection Variable in AJCC. It is a new data item for cases diagnosed 1/1/2018+. Codes: 0 Negative (Score` `0) 1 Negative (Score 1+) 2 Equivocal (Score 2+)` `Stated as equivocal 3 Positive (Score 3+)` `Stated as positive 4 Stated as negative, but score not stated 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case` `(If this item is required by your standard setter, use of` `code 8 will result in an edit error.) 9 Not documented in medical record` `Cannot be determined (indeterminate)` `HER2 IHC Summary not assessed or unknown if assessed`
3851	HER2 ISH DUAL PROBE COPY NUM	SSD2;17	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>4!($L(X)<1)!'(X?0.2AN0.1"."1N) X I $D(X) D DEC2^ONCSCHMM` `MAXIMUM LENGTH: 4` LAST EDITED: `AUG 01, 2019` HELP-PROMPT: `Answer must be 1-4 characters in length.` DESCRIPTION: `HER2 in situ hybridization (ISH) Dual Probe Copy Number is the HER2 copy number based on a dual probe test. Rationale: HER2 ISH Dual Probe Copy Number is a Registry Data Collection Variable in AJCC. It is a new data item` `for cases diagnosed 1/1/2018+. Codes: 0.0-99.9 Reported HER2 copy number of 0.0-99.9` `XX.1 Reported HER2 copy number of 100 or greater` `XX.7 Test ordered, results not in chart` `XX.8 Not applicable: Information not collected for this case` `(If this item is required by your standard setter, use of` `code XX.8 will result in an edit error.)` `XX.9 Not documented in medical record` `Cannot be determined (indeterminate)` `HER2 ISH Dual Probe Copy Number not assessed or` `unknown if assessed` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3852	HER2 ISH DUAL PROBE RATIO	SSD2;18	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>4!($L(X)<1)!'(X?0.2AN0.1"."1N) X I $D(X) D DEC2^ONCSCHMM` `MAXIMUM LENGTH: 4` LAST EDITED: `AUG 26, 2019` HELP-PROMPT: `Answer must be 1-4 characters in length.` DESCRIPTION: `HER2 in situ hybridization (ISH) Dual Probe Ratio is the summary score for HER2 testing using a dual probe. The test will report results for both HER2 and CEP17, the latter used as a control. The HER2/CEP17 ratio is` `reported. Rationale: HER2 ISH Dual Probe Ratio is a Registry Data Collection Variable in AJCC. It is a new data item for cases diagnosed 1/1/2018+. Codes: 0.0-99.9 Ratio of 0.0 to 99.9 XX.2 Less than 2.0 XX.3` `Greater than or equal to 2.0 XX.7 Test ordered, results not in chart XX.8 Not applicable: Information not collected for this case` `(If this item is required by your standard setter, use of` `code XX.8 will result in an edit error.) XX.9 Not documented in medical record` `Results cannot be determined (indeterminate)` `HER2 ISH Dual Probe Ratio not assessed or` `unknown if assessed` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3853	HER2 ISH SINGLE PROBE COPY NUM	SSD2;19	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>4!($L(X)<1)!'(X?0.2AN0.1"."1N) X I $D(X) D DEC2^ONCSCHMM` `MAXIMUM LENGTH: 4` LAST EDITED: `AUG 26, 2019` HELP-PROMPT: `Answer must be 1-4 characters in length.` DESCRIPTION: `HER2 in situ hybridization (ISH) Single Probe Copy Number is the HER2 copy number based on a single probe test. Rationale: HER2 ISH Single Probe Copy Number is a Registry Data Collection Variable in AJCC. It is a new data` `item for cases diagnosed 1/1/2018+. Codes: 0.0-99.9 Reported HER2 copy number of 0.0-99.9 XX.1 Reported HER2 copy number of 100 or greater XX.7 Test ordered, results not in chart XX.8 Not applicable: Information` `not collected for this case` `(If this item is required by your standard setter, use of` `code XX.8 will result in an edit error.) XX.9 Not documented in medical record` `Cannot be determined (indeterminate)` `HER2 ISH Single Probe Copy Number not assessed` `or unknown if assessed` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3854	HER2 ISH SUMMARY	SSD2;20	SET	'0' FOR Negative [not amplified]; '2' FOR Equivocal; '3' FOR Positive [amplified]; '7' FOR Test ordered, results not in chart; '8' FOR N/A; '9' FOR Not documented in medical record; LAST EDITED: `JUL 17, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `HER2 in situ hybridization (ISH) Summary is the summary score for results of testing for ERBB2 gene copy number by any ISH method. An immunohistochemistry (IHC) test identifies the protein expressed by the gene (ERBB2),` `and an ISH test identifies the number of copies of the gene (ERBB2) itself. Rationale: HER2 ISH Summary is a Registry Data Collection Variable in AJCC. It is a new data item for cases diagnosed 1/1/2018+. Codes: 0` `Negative [not amplified] 2 Equivocal 3 Positive [amplified] 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case` `(If this item is required by your standard setter, use of` `code 8 will result in an edit error.) 9 Not documented in medical record` `Results cannot be determined (indeterminate)` `HER2 ISH Summary not assessed or unknown if assessed`
3855	HER2 OVERALL SUMMARY	SSD2;21	SET	'0' FOR HER2 negative, equivocal; '1' FOR HER2 positive; '7' FOR Test ordered, results not in chart; '8' FOR NA; '9' FOR Not documented in medical record; LAST EDITED: `JUN 27, 2022` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `HER2 Overall Summary is a summary of results from HER2 testing. Rationale: This data item is required for prognostic stage grouping in AJCC 8th edition Chapter 48, Breast. It was previously collected as Breast, CS SSF #` `15. Codes: 0 HER2 negative; equivocal 1 HER2 positive 7 Test ordered, results not in chart 8 Not applicable/Not collected 9 Not documented in medical record` `Cannot be determined (indeterminate)` `HER2 Overall Summary status not assessed or unknown if assessed`
3856	HERITABLE TRAIT	SSD2;22	SET	'0' FOR H0-Normal RB1 alleles; '1' FOR H1-RB1 gene mutation; '7' FOR Test ordered, results not in chart; '9' FOR HX-Not documented in medical record; LAST EDITED: `JUL 23, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Heritable trait pertains to evidence that a tumor is associated with a heritable mutation. In retinoblastoma, the heritable trait is a germline mutation in the RB1 gene, which is associated with bilateral disease, family` `history of retinoblastoma, presence of concomitant CNS midline embryonic tumor (commonly in pineal region), or retinoblastoma with an intracranial primitive neuroectodermal tumor (i.e., trilateral retinoblastoma).` `Children with any of these features may be assigned the H1 status without molecular testing. High quality molecular testing for RB1 mutation is required to determine the presence or absence of RB1 mutation for children` `without clinical features of a heritable mutation. Heritable trait is required for prognostic stage grouping in AJCC 8th edition, Chapter 68 Retinoblastoma. It is a new data item for cases diagnosed 1/1/2018+. Codes: 0` `H0: Normal RB1 alleles` `No clinical evidence of mutation 1 H1: RB1 gene mutation OR` `Clinical evidence of mutation 7 Test ordered, results not in chart 9 HX: Not documented in medical record` `Test not done, or unknown if done` `Insufficient evidence of a constitutional RB1 gene mutation`
3857	HIGH RISK CYTOGENETICS	SSD2;23	SET	'0' FOR High-risk cytogenetics not identified/not present; '1' FOR High-risk cytogenetics present; '5' FOR Schema Discriminator 1 coded to 1 or 9; '7' FOR Test ordered, results not in chart; '9' FOR Not documented in medical record; LAST EDITED: `JUN 28, 2022` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `High Risk Cytogenetics is defined as one or more of t(4;14), t(14;16), or del 17p identified from FISH test results and is part of the staging criteria for plasma cell myeloma. Rationale: High Risk Cytogenetics is a` `prognostic factor required in AJCC 8th edition, Chapter 82 Plasma Cell Myeloma and Plasma Cell Disorders, for staging of plasma cell myeloma. It is a new data item for cases diagnosed 1/1/2018+. Codes: 0 High-risk` `cytogenetics not identified/not present 1 High-risk cytogenetics present 5 Schema Discriminator 1: Plasma Cell Myeloma Terminology coded to 1 or 9 7 Test ordered, results not in chart 9 Not documented in medical` `record` `High Risk Cytogenetics not assessed or unknown if assessed` SCREEN: `S DIC("S")="D SCRN555^ONCSCHMM"` EXPLANATION: `Codes depend on appropriate schema discriminator`
3858	HIGH RISK HISTOLOGIC FEATURES	SSD2;24	SET	'0' FOR No high risk features; '1' FOR Desmoplasia; '2' FOR Poor differentiation (grade 3); '3' FOR Sarcomatoid differentiation; '4' FOR Undifferentiated (grade 4); '5' FOR Multiple features; '6' FOR Histologic features NOS; '8' FOR N/A; '9' FOR Not documented; LAST EDITED: `JUL 23, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `High Risk Histologic Features are defined in AJCC 8 Chapter 15 to include the terms "poor differentiation, desmoplasia, sarcomatoid differentiation, undifferentiated." High risk histologic features are a prognostic factor` `for cutaneous squamous cell carcinomas of the head and neck. Rationale: High Risk Histologic Features is a Registry Data Collection Variable in AJCC. It was previously collected as Skin, CS SSF # 12. Codes: 0 No high` `risk histologic features 1 Desmoplasia 2 Poor differentiation (grade 3) 3 Sarcomatoid differentiation 4 Undifferentiated (grade 4) 5 Multiple high risk histologic features 6 Histologic features, NOS (type of` `high risk histologic` `feature not specified) 8 Not applicable: Information not collected for this case` `(If this information is required by your standard setter,` `use of code 8 may result in an edit error) 9 Not documented in medical record` `High risk histologic features not assessed or unknown if assessed`
3859	HIV STATUS	SSD2;25	SET	'0' FOR Not associated with HIV/AIDS; '1' FOR Associated with HIV/AIDS; '7' FOR Test ordered, results not in chart; '8' FOR N/A; '9' FOR Not documented in medical record; LAST EDITED: `JUL 23, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `HIV status refers to infection with the Human Immunodeficiency Virus which causes Acquired Immune Deficiency Syndrome (AIDS). AIDS is associated with increased risk of developing some lymphomas. Rationale: HIV status may` `be collected by the surveillance community for neoplasms (e.g., Kaposi Sarcoma, Lymphomas) that are closely related to HIV/AIDS. Prior to 2018, Lymphoma SSF#1 and Kaposi Sarcoma SSF# 1, were used for HIV Status. Codes: 0` `Not associated with Human Immunodeficiency` `Virus (HIV)/Acquired Immune Deficiency Syndrome(AIDS)` `HIV negative 1 Associated with HIV/AIDS` `HIV positive 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case` `(If this item is required by your standard setter, use of` `code 8 will result in an edit error.) 9 Not documented in medical record` `HIV status not assessed or unknown if assessed`
3860	INR PROTHROMBIN TIME	SSD2;26	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>3!($L(X)<1)!'(X?0.1AN0.1"."1N) X I $D(X) D DEC1^ONCSCHMM` `MAXIMUM LENGTH: 3` LAST EDITED: `AUG 01, 2019` HELP-PROMPT: `Answer must be 1-3 characters in length.` DESCRIPTION: `International Normalized Ratio for Prothrombin Time (INR), an indicator of the liver's ability to make clotting factors, is required to calculate the Model for End-Stage Liver Disease (MELD) score, which is used to assign` `priority for liver transplant. Rationale: International Normalized Ratio for Prothrombin Time (INR) is a Registry Data Collection Variable in AJCC. This data item was previously collected for Liver, CS SSF# 8. Codes: 0.0` `0.0 0.1 0.1 or less 0.2-9.9 0.2 - 9.9 (Exact ratio to nearest tenth) X.1 10 or greater X.7 Test ordered, results not in chart X.8 Not applicable: Information not collected for this case` `(If this information is required by your standard setter,` `use of code X.8 may result in an edit error.) X.9 Not documented in medical record` `INR (International Normalized Ratio for Prothrombin Time)` `not assessed or unknown if assessed` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3861	IPSILATERANL ADRENAL GLAND INV	SSD2;27	SET	'0' FOR Not present/not identified; '1' FOR Direct involvement (contiguous involvement); '2' FOR Separate nodule (noncontiguous involvement); '3' FOR Combo of 1-2; '4' FOR Involvement, unk if direct or separate; '8' FOR N/A; '9' FOR Not documented; LAST EDITED: `JUL 23, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Ipsilateral adrenal gland involvement pertains to direct extension of the tumor into the ipsilateral adrenal gland (continuous) or ipsilateral adrenal gland involvement by a separate nodule (noncontiguous). Rationale:` `Ipsilateral adrenal gland involvement for Kidney is a Registry Data Collection Variable in AJCC. It was previously collected as Kidney, CS SSF #3. Codes: 0 Ipsilateral adrenal gland involvement not present/not` `identified 1 Adrenal gland involvement by direct involvement (contiguous` `involvement) 2 Adrenal gland involvement by separate nodule (noncontiguous` `involvement) 3 Combination of code 1-2 4 Ipsilateral adrenal gland involvement, unknown if direct` `involvement or separate nodule 8 Not applicable: Information not collected for this case` `(If this information is required by your standard setter, use of` `code 8 may result in an edit error.) 9 Not documented in medical record` `Ipsilateral adrenal gland not resected` `Ipsilateral adrenal gland involvement not assessed or` `unknown if assessed` `No surgical resection of primary site is performed`
3862	JAK2	SSD2;28	SET	'0' FOR Stated as negative; '1' FOR Positive for mutation V617F w or w/o other; '2' FOR Positive for exon 12; '3' FOR Positive for oth spec mutation; '4' FOR Positive for more than 1 other than V617F; '5' FOR Positive NOS; '7' FOR Results not in chart; '8' FOR N/A; '9' FOR Not documented; LAST EDITED: `JUL 24, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Janus Kinase 2 (JAK2, JAK 2) is a gene mutation that increases susceptibility to several myeloproliferative neoplasms (MPNs). Testing for the JAK2 mutation is done on whole blood. Nearly all people with polycythemia vera,` `and about half of those with primary myelofibrosis and essential thrombocythemia, have the mutation. JAK2 analysis continues to increase in use for hematopoietic neoplasms. Rationale: JAK2 can be collected by the` `surveillance community for myeloproliferative neoplasms. Prior to 2018, HemeRetic SSF#1 was used for JAK2. Codes: 0 JAK2 result stated as negative 1 JAK2 positive for mutation V617F WITH or WITHOUT other mutations 2` `JAK2 positive for exon 12 mutation 3 JAK2 positive for other specified mutation 4 JAK2 positive for more than one mutation other than V617F 5 JAK2 positive NOS` `Specific mutation(s) not stated 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case` `(If this item is required by your standard setter, use of` `code 8 will result in an edit error.) 9 Not documented in medical record` `JAK2 not assessed or unknown if assessed`
3863	KI-67	SSD2;29	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>5!($L(X)<1)!'(X?0.3AN0.1"."1N) X I $D(X) D DEC3^ONCSCHMM` `MAXIMUM LENGTH: 5` LAST EDITED: `AUG 01, 2019` HELP-PROMPT: `Answer must be 1-5 characters in length.` DESCRIPTION: `Ki-67 (MIB-1) is a marker of cell proliferation. A high value indicates a tumor that is proliferating more rapidly. Rationale: Ki-67 (MIB-1) is a Registry Data Collection Variable in AJCC. It is a new data item for cases` `diagnosed 1/1/2018+. Codes: 0.0-100.0 0.0 to 100.0 percent positive: enter percent positive XXX.7 Test done, actual percentage not stated XXX.8 Not applicable: Information not collected for this case` `(If this item is required by your standard setter, use of` `code XXX.8 will result in an edit error.) XXX.9 Not documented in medical record` `Ki-67 (MIB-1) not assessed or unknown if assessed` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3864	INVASION BEYOND CAPSULE	SSD2;30	SET	'0' FOR Invasion beyond capsule not identified; '1' FOR Perinephric (beyond renal capsule) fat or tissue; '2' FOR Renal sinus; '3' FOR Gerota's fascia; '4' FOR Any combo of codes 1-3; '5' FOR Invasion beyond capsule, NOS; '8' FOR N/A; '9' FOR Not documented; LAST EDITED: `JUL 24, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Invasion beyond capsule pertains to the pathologically confirmed invasion of the tumor beyond the fibrous capsule in which the kidney is enclosed. Rationale: Invasion beyond capsule into specific tissues for Kidney is a` `Registry Data Collection Variable in AJCC. It was previously collected as Kidney, CS SSF #1. Codes: 0 Invasion beyond capsule not identified 1 Perinephric (beyond renal capsule) fat or tissue 2 Renal sinus 3` `Gerota's fascia 4 Any combination of codes 1-3 5 Invasion beyond capsule, NOS 8 Not applicable: Information not collected for this case` `(If this information is required by your standard setter, use of` `code 8 may result in an edit error.) 9 Not documented in medical record` `Invasion beyond capsule not assessed or unknown if assessed` `No surgical resection of primary site is performed`
3865	KIT GENE IMMUNOHISTOCHEMISTRY	SSD2;31	SET	'0' FOR KIT negative,normal-within normal limits; '1' FOR KIT positive; '7' FOR Test ordered, results not in chart; '8' FOR N/A; '9' FOR Not documented in medical record; LAST EDITED: `JUL 25, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `KIT Gene Immunohistochemistry (IHC) is the expression of the KIT gene in tumor tissue specimens based on immunohistochemical (IHC) stains. A positive test is a diagnostic and predictive marker for GIST tumors. Rationale:` `KIT Gene Immunohistochemistry (IHC) is a Registry Data Collection Variable in AJCC. This data item was previously collected for GIST schemas in CS (different SSF's). Codes: 0 KIT negative/normal; within normal limits 1` `KIT positive 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case` `(If this information is required by your standard setter, use of` `code 8 may result in an edit error.) 9 Not documented in medical record` `Cannot be determined by pathologist` `KIT not assessed or unknown if assessed`
3866	KRAS	SSD2;32	SET	'0' FOR Normal (wild type); '1' FOR Abnormal in codons 12,13 and or 61; '2' FOR Abnormal in codon 146 only; '3' FOR Abnormal but not in codons 12,13,61 or 146; '4' FOR Abnormal NOS, codon not specified; '7' FOR Test ordered, results not in chart; '8' FOR N/A; '9' FOR Not documented; LAST EDITED: `JUL 25, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `KRAS is an important signaling intermediate in the growth receptor pathway which controls cell proliferation and survival. KRAS is a protein with production controlled by the K-ras gene. When the K-ras gene is activated` `through mutation during colorectal carcinogenesis, production of KRAS continuously stimulates cell proliferation and prevents cell deaths. Activating mutations in KRAS are an adverse prognostic factor for colorectal` `carcinoma and predict a poor response to monoclonal anti-EGFR antibody therapy in advanced colorectal carcinoma. Rationale: KRAS is a Registry Data Collection Variable in AJCC. It was previously collected as Colon and` `Rectum CS SSF# 9. Codes: 0 Normal (wild type)` `Negative for mutations 1 Abnormal (mutated) in codon(s) 12, 13 and/or 61 2 Abnormal (mutated) in codon 146 only 3 Abnormal (mutated), but not in codon(s) 12, 13, 61, or 146 4 Abnormal (mutated), NOS, codon(s)` `not specified 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case` `(If this information is required by your standard setter, use of` `code 8 may result in an edit error.) 9 Not documented in medical record` `KRAS not assessed or unknown if assessed`
3867	LDH POST-ORCHIECTOMY RANGE	SSD2;33	SET	'0' FOR Within normal limits; '1' FOR Less than 1.5xN; '2' FOR 1.5 to 10xN; '3' FOR Greater than 10xN; '4' FOR LDH range stated to be elevated; '7' FOR Test ordered, results not in chart; '8' FOR N/A; '9' FOR Not documented; LAST EDITED: `JUL 25, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `LDH (Lactate Dehydrogenase) Post-Orchiectomy Range identifies the range category of the lowest LDH value measured post-orchiectomy. LDH is a nonspecific marker for testicular cancer that is elevated in some germ cell` `tumors. The Post-Orchiectomy lab value is used to monitor response to therapy. Rationale: LDH (Lactate Dehydrogenase) is a Registry Data Collection Variable in AJCC. LDH (Lactate Dehydrogenase) Post-Orchiectomy Range is` `used to assign the S Category Pathological and was previously collected as Testis CS SSF# 16. Codes: 0 Within normal limits 1 Less than 1.5 x N` `(Less than 1.5 times the upper limit of normal for LDH) 2 1.5 to 10 x N` `(Between 1.5 and 10 times the upper limit of normal for LDH) 3 Greater than 10 x N` `(Greater than 10 times the upper limit of normal for LDH) 4 Post-Orchiectomy lactate dehydrogenase (LDH) range stated` `to be elevated 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case` `(If this information is required by your standard setter, use of` `code 8 may result in an edit error.) 9 Not documented in medical record` `No orchiectomy performed` `LDH (Lactate Dehydrogenase) Post-Orchiectomy Range` `not assessed or unknown if assessed`
3868	LDH PRE-ORCHIECTOMY RANGE	SSD2;34	SET	'0' FOR Within normal limits; '1' FOR Less than 1.5xN; '2' FOR 1.5 to 10xN; '3' FOR Greater than 10xN; '4' FOR LDH range stated to be elevated; '7' FOR Test ordered; '8' FOR N/A; '9' FOR Not documented; LAST EDITED: `JUL 25, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Lactate Dehydrogenase (LDH) Range identifies the range category of the highest LDH value measured prior to treatment. LDH is a nonspecific marker for testicular cancer that is elevated in some germ cell tumors. This data` `item refers to the Pre-Orchiectomy range. Rationale: LDH (Lactate Dehydrogenase) is a Registry Data Collection Variable in AJCC. LDH (Lactate Dehydrogenase) Pre-Orchiectomy Range is used to assign the S Category Clinical` `and was previously collected as Testis CS SSF# 10. Codes: 0 Within normal limits 1 Less than 1.5 x N` `(Less than 1.5 times the upper limit of normal for LDH) 2 1.5 to 10 x N` `(Between 1.5 and 10 times the upper limit of normal for LDH) 3 Greater than 10 x N` `(Greater than 10 times the upper limit of normal for LDH) 4 Pre-Orchiectomy lactate dehydrogenase (LDH) range stated` `to be elevated 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case` `(If this information is required by your standard setter, use of` `code 8 may result in an edit error.) 9 Not documented in medical record` `LDH (Lactate Dehydrogenase) Pre-Orchiectomy Range` `not assessed or unknown if assessed`
3869	LDH LEVEL	SSD2;35	SET	'0' FOR Normal LDH level; '1' FOR Above normal LDH level - High; '5' FOR Schema Discriminator 1 coded to 1 or 9; '7' FOR Test ordered, results not in chart; '9' FOR Not documented in medical record; LAST EDITED: `JUN 28, 2022` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `LDH (Lactate Dehydrogenase) is an enzyme involved in conversion of sugars to energy and present in most cells in the body. Elevated pretreatment LDH is an adverse prognostic factor for plasma cell myeloma and melanoma of` `the skin. Rationale: LDH (Lactate Dehydrogenase) Level is a prognostic factor required in AJCC 8th edition for Chapter 83 Plasma Cell Myeloma and Plasma Cell Disorders and Chapter 47 Melanoma Skin. For Plasma Cell` `Myeloma, LDH is part of the RISS Stage and is new for cases diagnosed 1/1/2018+. For Melanoma Skin, LDH is used to define the M subcategories and was previously collected as Melanoma Skin, SSF #4. Codes: 0 Normal LDH` `level` `Low, below normal 1 Above normal LDH level; High 5 Schema Discriminator 1: Plasma Cell Myeloma Terminology coded to 1 or 9 7 Test ordered, results not in chart 9 Not documented in medical record` `LDH (Lactate Dehydrogenase) Pretreatment Level not assessed` `or unknown if assessed` SCREEN: `S DIC("S")="D SCRN555^ONCSCHMM"` EXPLANATION: `Codes depend on appropriate schema discriminator`
3870	LDH UPPER LIMITS OF NORMAL	SSD2;36	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>3!($L(X)<1)!'(X?0.2AN1N) X I $D(X) D GEN3^ONCSCHMM` `MAXIMUM LENGTH: 3` LAST EDITED: `JUL 26, 2019` HELP-PROMPT: `Answer must be 1-3 characters in length.` DESCRIPTION: `LDH (Lactate Dehydrogenase), an enzyme involved in converting sugars to energy in the body, is elevated in some malignancies. LDH level is a prognostic factor for patients with Stage IV melanoma. This data Item refers to` `the Upper Limit of Normal in the laboratory test used to interpret the Serum LDH result. Rationale: LDH (Lactate Dehydrogenase) Upper Limits of Normal is a Registry Data Collection Variable in AJCC. It was previously` `collected as Melanoma Skin, CS SSF# 6. Codes: 001-999 001 - 999 upper limit of normal` `(Exact upper limit of normal) XX8 Not applicable: Information not collected for this case` `(If this information is required by your standard setter,` `use of code XX8 may result in an edit error.) XX9 Not documented in medical record` `LDH Upper Limit not assessed or unknown if assessed` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3871	LN ASSESS METH FEMORAL-INGUIN	SSD3;1	SET	'0' FOR Radiography, imaging; '1' FOR Incisional biopsy, fine needle aspiration (FNA); '2' FOR Lymphadenectomy; '7' FOR Regional LN(s) assessed, unknown assessment method; '8' FOR N/A; '9' FOR Not documented in medical record; LAST EDITED: `JUL 26, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `This data item describes the method used to assess involvement of femoral-inguinal lymph nodes associated with certain female genital cancers. Rationale: Method of assessment of regional nodal status is listed as a` `Registry Data Collection Variable in the AJCC GYN chapters. This data item was previously collected as Vulva, SSF# 15. Codes: 0 Radiography, imaging` `(Ultrasound (US), computed tomography scan (CT), magnetic` `resonance imaging (MRI), positron emission tomography scan (PET))` `Physical exam only 1 Incisional biopsy; fine needle aspiration (FNA) 2 Lymphadenectomy` `Excisional biopsy or resection with microscopic confirmation 7 Regional lymph node(s) assessed, unknown assessment method 8 Not applicable: Information not collected for this case` `(If this item is required by your standard setter, use of code 8` `will result in an edit error.) 9 Not documented in medical record` `Regional lymph nodes not assessed or unknown if assessed`
3872	LN ASSESS METHOD PARA-AORTIC	SSD3;2	SET	'0' FOR Radiography, imaging; '1' FOR Incisional biopsy, fine needle aspiration (FNA); '2' FOR Lymphadenectomy; '7' FOR Regional LN(s) assessed, unknown assessment method; '8' FOR N/A; '9' FOR Not documented in medical record; LAST EDITED: `JUL 26, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `This data item describes the method used to assess involvement of para-aortic lymph nodes associated with certain female genital cancers. Rationale: Method of assessment of regional nodal status is listed as a Registry` `Data Collection Variable in the AJCC GYN chapters. This data item was previously collected as Vagina, CS SSF# 5. Codes: 0 Radiography, imaging` `(Ultrasound (US), computed tomography scan (CT), magnetic` `resonance imaging (MRI), positron emission tomography scan (PET))` `Physical exam only 1 Incisional biopsy; fine needle aspiration (FNA) 2 Lymphadenectomy` `Excisional biopsy or resection with microscopic confirmation 7 Regional lymph node(s) assessed, unknown assessment method 8 Not applicable: Information not collected for this case` `(If this item is required by your standard setter, use of code 8` `will result in an edit error.) 9 Not documented in medical record` `Regional lymph nodes not assessed or unknown if assessed`
3873	LN ASSESSMENT METHOD PELVIC	SSD3;3	SET	'0' FOR Radiography, imaging; '1' FOR Incisional biopsy, fine needle aspiration (FNA); '2' FOR Lymphadenectomy; '7' FOR Regional LN(s) assessed, unknown assessment method; '8' FOR N/A; '9' FOR Not documented in medical record; LAST EDITED: `JUL 26, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `This data item describes the method used to assess involvement of pelvic lymph nodes associated with certain female genital cancers. Rationale: Method of assessment of regional nodal status is listed as a Registry Data` `Collection Variable in the AJCC GYN chapters. This data item was previously collected as Vagina, CS SSF# 3. Codes: 0 Ultrasound (US), computed tomography scan (CT), magnetic` `resonance imaging (MRI), positron emission tomography scan (PET))` `Physical exam only 1 Incisional biopsy; fine needle aspiration (FNA) 2 Lymphadenectomy` `Excisional biopsy or resection with microscopic confirmation 7 Regional lymph node(s) assessed, unknown assessment method 8 Not applicable: Information not collected for this case` `(If this item is required by your standard setter, use of code 8 will` `result in an edit error.) 9 Not documented in medical record` `Regional lymph nodes not assessed or unknown if assessed`
3874	LN DISTANT ASSESSMENT METHOD	SSD3;4	SET	'0' FOR Radiography, imaging; '1' FOR Incisional biopsy, fine needle aspiration (FNA); '2' FOR Lymphadenectomy; '7' FOR Distant LN(s) assessed, unknown assessment method; '8' FOR N/A; '9' FOR Not documented in medical record; LAST EDITED: `JUL 26, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `This data item describes the method used to assess involvement of Distant (mediastinal, scalene) nodes associated with certain female genital cancers. Rationale: Method of assessment of distant nodal status is listed as a` `Registry Data Collection Variable in the AJCC GYN chapters. This data item was previously collected as Vagina, CS SSF# 7. Codes: 0 Radiography, imaging` `(Ultrasound (US), computed tomography scan (CT), magnetic` `resonance imaging (MRI), positron emission tomography scan (PET))` `Physical exam only 1 Incisional biopsy; fine needle aspiration (FNA) 2 Lymphadenectomy` `Excisional biopsy or resection with microscopic confirmation 7 Distant lymph node(s) assessed, unknown assessment method 8 Not applicable: Information not collected for this case` `(If this item is required by your standard setter, use of code 8` `will result in an edit error.) 9 Not documented in medical record` `Distant lymph nodes not assessed or unknown if assessed`
3875	LN DISTANT MEDIASTINAL,SCALENE	SSD3;5	SET	'0' FOR Negative mediastinal and scalene lymph nodes; '1' FOR Positive mediastinal lymph nodes; '2' FOR Positive scalene lymph nodes; '3' FOR Positive mediastinal and scalene lymph nodes; '8' FOR N/A; '9' FOR Not documented; LAST EDITED: `JUL 26, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `This data item describes the status of Distant (mediastinal, scalene) nodes associated with certain female genital cancers. Rationale: Specific distant lymph node involvement is listed as a Registry Data Collection` `Variable in the AJCC. This data was previously collected as Vagina, CS SSF# 6. Codes: 0 Negative mediastinal and scalene lymph nodes 1 Positive mediastinal lymph nodes 2 Positive scalene lymph nodes 3 Positive` `mediastinal and scalene lymph nodes 8 Not applicable: Information not collected for this case` `(If this item is required by your standard setter, use of code 8` `will result in an edit error.) 9 Not documented in medical record` `Mediastinal and scalene lymph nodes not assessed or` `unknown if assessed`
3876	LN HEAD & NECK LEVELS I-III	SSD3;6	SET	'0' FOR No inv of Levels I,II or III; '1' FOR Level I; '2' FOR Level II; '3' FOR Level III; '4' FOR Level I & II; '5' FOR Level I & III; '6' FOR Level II & III; '7' FOR Levels I,II and III; '8' FOR N/A; '9' FOR Not documented; LAST EDITED: `JUL 26, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Lymph Nodes for Head and Neck, Levels I-III records the involvement of Levels I-III lymph nodes. Rationale: Level of nodal involvement is a Registry Data Collection Variable in AJCC for several head and neck chapters.` `This data item was previously collected as Head and Neck SSF# 3 (common SSF). Codes: 0 No involvement in Levels I, II, or III lymph nodes 1 Level I lymph node(s) involved 2 Level II lymph node(s) involved 3 Level` `III lymph node(s) involved 4 Levels I and II lymph nodes involved 5 Levels I and III lymph nodes involved 6 Levels II and III lymph nodes involved 7 Levels I, II and III lymph nodes involved 8 Not applicable:` `Information not collected for this case` `(If this item is required by your standard setter, use of code 8` `will result in an edit error) 9 Not documented in medical record` `Positive nodes, but level of positive node(s) unknown` `Lymph node levels I-III not assessed, or unknown if assessed`
3877	LN HEAD & NECK LEVELS IV-V	SSD3;7	SET	'0' FOR No inv of Levels IV or V; '1' FOR Level IV; '2' FOR Level V; '3' FOR Levels IV & V; '8' FOR N/A; '9' FOR Not documented in medical record; LAST EDITED: `JUL 26, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Lymph Nodes for Head and Neck, Levels IV-V records the involvement of Levels IV-V lymph nodes. Rationale: Level of nodal involvement is a Registry Data Collection Variable in AJCC. This data item was previously collected` `as Head and Neck SSF# 4 (common SSF). Codes: 0 No involvement in Levels IV or V lymph nodes 1 Level IV lymph node(s) involved 2 Level V lymph node(s) involved 3 Levels IV and V lymph node(s) involved 8 Not` `applicable: Information not collected for this case` `(If this item is required by your standard setter, use of code 8` `will result in an edit error) 9 Not documented in medical record` `Positive nodes, but level of positive node(s) unknown` `Lymph node levels IV-V not assessed, or unknown if assessed`
3878	LN HEAD & NECK LEVELS VI-VII	SSD3;8	SET	'0' FOR No inv in Levels VI or VII; '1' FOR Level VI; '2' FOR Level VII; '3' FOR Levels VI and VII; '8' FOR N/A; '9' FOR Not documented in medical record; LAST EDITED: `JUL 26, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Lymph Nodes for Head and Neck, Levels VI-VII records the involvement of Levels VI-VII lymph nodes. Rationale: Level of nodal involvement is a Registry Data Collection Variable in AJCC. This data item was previously` `collected as Head and Neck SSF# 5 (common SSF). Codes: 0 No involvement in Levels VI or VII lymph nodes 1 Level VI lymph node(s) involved 2 Level VII lymph node(s) involved 3 Levels VI and VII lymph node(s)` `involved 8 Not applicable: Information not collected for this case` `(If this item is required by your standard setter, use of` `code 8 will result in an edit error) 9 Not documented in medical record` `Positive nodes, but level of positive node(s) unknown` `Lymph nodes levels VI-VII not assessed, or unknown if assessed`
3879	LN HEAD AND NECK OTHER	SSD3;9	SET	'0' FOR No inv other head & neck LN regions; '1' FOR Buccinator LN(s); '2' FOR Parapharyngeal LN(s); '3' FOR Periparotid & intraparotid LN(s); '4' FOR Preauricular LN(s); '5' FOR Retropharyngeal LN(s); '6' FOR Suboccipital; '7' FOR Any combo 1-6; '8' FOR N/A; '9' FOR Not; LAST EDITED: `JUL 26, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Lymph Nodes for Head and Neck, Other records the involvement of lymph nodes other than Levels I-III, IV-V, and VI-VII. Rationale: Level of nodal involvement is a Registry Data Collection Variable in AJCC. This data item` `was previously collected as Head and Neck SSF# 6 (common SSF). Codes: 0 No involvement in other head and neck lymph node regions 1 Buccinator (facial) lymph node(s) involved 2 Parapharyngeal lymph node(s) involved 3` `Periparotid and intraparotid lymph node(s) involved 4 Preauricular lymph node(s) involved 5 Retropharyngeal lymph node(s) involved 6 Suboccipital/retroauricular lymph node(s) involved 7 Any combination of codes` `1-6 8 Not applicable: Information not collected for this case` `(If this item is required by your standard setter, use of code 8` `will result in an edit error.) 9 Not documented in medical record` `Positive nodes, but level of positive node(s) unknown` `Other Head and Neck lymph nodes not assessed,` `or unknown if assessed`
3880	LN ISOLATED TUMOR CELLS (ITC)	SSD3;10	SET	'0' FOR Regional lymph nodes negative for ITCs; '1' FOR Regional lymph nodes positive; '8' FOR N/A; '9' FOR Not documented in medical record; LAST EDITED: `JUL 26, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Lymph Nodes Isolated Tumor Cells (ITC), the presence of isolated tumor cells in regional lymph node(s) that may be detected by hematoxylin and eosin or by immunohistochemical staining, is a potential prognostic factor for` `Merkel Cell Carcinoma. Rationale: Regional lymph nodes positive for ITCs (Tumor cell clusters not greater than 0.2 millimeter (mm)) Codes: 0 Regional lymph nodes negative for ITCs 1 Regional lymph nodes positive for` `ITCs` `(Tumor cell clusters not greater than 0.2 millimeter (mm)) 8 Not applicable: Information not collected for this case` `(If this information is required by your standard setter, use of` `code 8 may result in an edit error.) 9 Not documented in medical record` `ITCs not assessed or unknown if assessed`
3881	LN LATERALITY	SSD3;11	SET	'0' FOR No regional lymph node involvement; '1' FOR Unilateral; '2' FOR Bilateral; '3' FOR Laterality unknown; '8' FOR N/A; '9' FOR Not documented in medical record; LAST EDITED: `AUG 07, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `This data item describes whether positive regional lymph nodes are unilateral or bilateral. Rationale: Laterality of regional node metastasis is a Registry Data Collection Variable in AJCC. This data item was previously` `collected as Vulva, CS SSF# 11. Codes: 0 No regional lymph node involvement 1 Unilateral - all positive regional nodes with same laterality OR` `only one regional node positive 2 Bilateral - positive bilateral regional lymph nodes 3 Laterality unknown - positive regional lymph nodes with` `unknown laterality 8 Not applicable: Information not collected for this case` `(If this information is required by your standard setter,` `use of code 8 may result in an edit error.) 9 Not documented in medical record` `Lymph node laterality not assessed or unknown if assessed`
3882	LN POSITIVE AXILLARY LVL I-II	SSD3;12	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<1)!'(X?0.1AN1N) X I $D(X) D GEN2^ONCSCHMM` `MAXIMUM LENGTH: 2` LAST EDITED: `JUL 26, 2019` HELP-PROMPT: `Answer must be 1-2 characters in length.` DESCRIPTION: `This data item pertains to the number of positive ipsilateral level I and II axillary lymph nodes and intramammary lymph nodes based on pathological information. Rationale: Lymph Nodes Positive Axillary Level I-II can be` `collected by the surveillance community for breast cancers. Prior to 2018, Breast SSF#3 was used for Lymph Nodes Positive Axillary Level I-II. Codes: 00 All ipsilateral axillary nodes examined negative 01-99 1 - 99` `nodes positive` `(Exact number of nodes positive) X1 100 or more nodes positive X5 Positive nodes, number unspecified X6 Positive aspiration or needle core biopsy of lymph node(s) X8 Not applicable: Information not` `collected for this case` `(If this item is required by your standard setter,` `use of code X8 will result in an edit error.) X9 Not documented in medical record` `Level I-II axillary nodes not assessed or unknown if assessed` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3883	LN SIZE	SSD3;13	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>4!($L(X)<1)!'(X?0.2AN0.1"."1N) X I $D(X) D DEC2^ONCSCHMM` `MAXIMUM LENGTH: 4` LAST EDITED: `AUG 01, 2019` HELP-PROMPT: `Answer must be 1-4 characters in length.` DESCRIPTION: `Lymph Nodes Size records diameter of the involved regional lymph node(s) with the largest diameter of any involved regional lymph node(s). Pathological measurement takes precedence over a clinical measurement for the same` `node. Rational: Lymph Nodes Size is a Registry Data Collection Variable in AJCC for several chapters. It was previously collected in the Head and Neck chapters as Size of Lymph Nodes, SSF# 1 Codes: 0.0 No involved` `regional nodes 0.1-99.9 0.1-99.9 millimeters (mm)` `(Exact size of lymph node to nearest tenth of a mm) XX.1 100 millimeters (mm) or greater XX.2 Microscopic focus or foci only and no size of focus given XX.3 Described as "less than 1 centimeter (cm)" XX.4` `Described as "at least" 2 cm XX.5 Described as "at least" 3 cm XX.6 Described as "at least" 4 cm XX.7 Described as greater than 5 cm XX.8 Not applicable: Information not collected for this case` `(If this item is required by your standard setter,` `use of code XX.8 will result in an edit error) XX.9 Not documented in medical record` `Regional lymph node(s) involved, size not stated` `Lymph Nodes Size not assessed, or unknown if assessed` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3884	LN STATUS FEM-ING,PAR-AOR,PLV	SSD3;14	POINTER TO ONCO LN STATUS FILE (#167.3)	ONCO LN STATUS(#167.3) OUTPUT TRANSFORM: `S:Y'="" Y=$P(^ONCO(167.3,Y,0),U,1)_" "_$P(^ONCO(167.3,Y,0),U,2)` LAST EDITED: `NOV 07, 2019` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `This data item describes the status of femoral-inguinal, para-aortic and pelvic lymph nodes associated with certain female genital cancers. Rationale: Specific regional lymph node involvement is listed as a Registry Data` `Collection Variable in AJCC. This information was previously collected as Vagina, CS SSF# 2 and CS SSF# 4 Codes: 0 Negative femoral-inguinal, para-aortic and pelvic lymph nodes 1 Positive femoral-inguinal lymph nodes 2` `Positive para-aortic lymph nodes 3 Positive pelvic lymph nodes 4 Positive femoral-inguinal and para-aortic lymph nodes 5 Positive femoral-inguinal and pelvic lymph nodes 6 Positive para-aortic and pelvic lymph` `nodes 7 Positive para-aortic, pelvic, and femoral-inguinal lymph nodes 8 Not applicable: Information not collected for this case` `(If this information is required by your standard setter,` `use of code 8 may result in an edit error.) 9 Not documented in medical record` `Femoral-Inguinal, Para-aortic and Pelvic lymph nodes` `not assessed or unknown if assessed`
3885	LYMPHOCYTOSIS	SSD3;15	SET	'0' FOR Not present, count LT or EQ 5000; '1' FOR Present, count > 5000; '5' FOR NA, not C421; '6' FOR Lab value unk, physician states lymphocytosis present; '7' FOR Test ordered, results not in chart; '9' FOR Not documented; LAST EDITED: `MAY 09, 2023` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Lymphocytosis is defined by an excess of lymphocytes in the blood. In staging of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), lymphocytosis is defined as an absolute lymphocyte count (ALC) greater` `than 5,000 cells/ÂµL. Rationale: Lymphocytosis is a prognostic factor required for staging of Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia (CLL/SLL) in AJCC 8th edition, Chapter 79 Hodgkin and Non-Hodgkin` `Lymphomas. It is a new data item for cases diagnosed 1/1/2018+. Codes: 0 Lymphocytosis not present` `Absolute lymphocyte count <= 5,000 cells/ ÂµL 1 Lymphocytosis present` `Absolute lymphocyte count > 5,000 cells/ÂµL 5 Not applicable: Primary site is not C421 6 Lab value unknown, physician states lymphocytosis is present` `Physician states RAI stage 0-IV 7 Test ordered, results not in chart 9 Not documented in medical record` `Lymphocytosis not assessed or unknown if assessed` SCREEN: `S DIC("S")="D SCRNFIV^ONCSCHMM"` EXPLANATION: `Codes depend on appropriate primary site`
3886	MAJOR VEIN INVOLVEMENT	SSD3;16	SET	'0' FOR Not present or not identified; '1' FOR Renal vein or its segmental branches; '2' FOR Inferior vena cava (IVC); '3' FOR Major vein invasion, NOS; '4' FOR Any combination of codes 1-3; '8' FOR N/A; '9' FOR Not documented in medical record; LAST EDITED: `AUG 14, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Major vein involvement pertains to the invasion of the kidney tumor into major veins. Rationale: Involvement of major veins for Kidney is a Registry Data Collection Variable in AJCC. It was previously collected as Kidney,` `CS SSF #2. Codes: 0 Major vein involvement not present/not identified 1 Renal vein or its segmental branches 2 Inferior vena cava (IVC) 3 Major vein invasion, NOS 4 Any combination of codes 1-3 8 Not` `applicable: Information not collected for this case` `(If this information is required by your standard setter, use of` `code 8 may result in an edit error.) 9 Not documented in medical record` `Vein involvement not assessed or unknown if assessed` `No surgical resection of primary site is performed`
3887	MEASURED BASAL DIAMETER	SSD3;17	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>4!($L(X)<1)!'(X?0.2AN0.1"."1N) X I $D(X) D DEC2^ONCSCHMM` `MAXIMUM LENGTH: 4` LAST EDITED: `AUG 01, 2019` HELP-PROMPT: `Answer must be 1-4 characters in length.` DESCRIPTION: `Measured Basal Diameter, the largest basal diameter of a uveal melanoma, is a prognostic indicator for this tumor. Rationale: Measured Basal Diameter is listed as a Registry Data Collection Variable in AJCC. It was` `previously collected as Uveal Melanoma, CS SSF# 2. Codes: 0.0 No mass/tumor found 0.1-99.9 0.1-99.9 millimeters (mm)` `(Exact measurement to nearest tenth of mm) XX.0 100 millimeters (mm) or larger XX.1 Described as "less than 3 mm" XX.2 Described as "at least" 3 mm XX.3 Described as "at least" 6 mm XX.4 Described as` `"at least" 9 mm XX.5 Described as "at least" 12 mm XX.6 Described as "at least" 15 mm XX.8 Not applicable: Information not collected for this case` `(If this information is required by your standard setter,` `use of code XX.8 may result in an edit error.) XX.9 Not documented in medical record` `Cannot be determined by pathologist` `Measured Basal Diameter not assessed or unknown if assessed` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3888	MEASURED THICKNESS	SSD3;18	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>4!($L(X)<1)!'(X?0.2AN0.1"."1N) X I $D(X) D DEC2^ONCSCHMM` `MAXIMUM LENGTH: 4` LAST EDITED: `AUG 01, 2019` HELP-PROMPT: `Answer must be 1-4 characters in length.` DESCRIPTION: `Measured Thickness, or height, of a uveal melanoma, is a prognostic indicator for this tumor. Rationale: Measured Thickness is listed as a Registry Data Collection Variable in AJCC. It was previously collected as Uveal` `Melanoma, CS SSF# 3. Codes: 0.0 No mass/tumor found 0.1-99.9 0.1-99.9 millimeters (mm)` `(Exact measurement to nearest tenth of mm) XX.0 100 millimeters (mm) or larger XX.1 Described as "less than 3 mm" XX.2 Described as "at least" 3 mm XX.3 Described as "at least" 6 mm XX.4 Described as` `"at least" 9 mm XX.5 Described as "at least" 12 mm XX.6 Described as "greater than" 15 mm XX.8 Not applicable: Information not collected for this case` `(If this information is required by your standard setter,` `use of code XX.8 may result in an edit error.) XX.9 Not documented in medical record` `Cannot be determined` `Measured Thickness not assessed or unknown if assessed` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3889	METHYLATION OF MGMT	SSD3;19	SET	'0' FOR Absent or not present, unmethylated MGMT; '1' FOR Present, low level; '2' FOR Present, high level; '3' FOR Present, level unspecified; '6' FOR Benign or borderline tumor; '7' FOR Test ordered, results not in chart; '8' FOR N/A; '9' FOR Not documented; LAST EDITED: `AUG 14, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `O6-Methylguanine-Methyltransferase (MGMT) is an enzyme in cells that repairs DNA. Methylation of the MGMT gene reduces production of MGMT enzyme and the ability of tumor cells to repair damage caused by chemotherapy.` `Methylation of MGMT is a prognostic and predictive factor for high grade gliomas. Rationale: Methylation of O6-Methylguanine-Methyltransferase (MGMT) is a Registry Data Collection Variable in AJCC. It was previously` `collected as Brain, CS SSF #4. Codes: 0 MGMT methylation absent/not present, unmethylated MGMT 1 MGMT methylation present, low level` `Hypomethylated` `Partial methylated 2 MGMT methylation present, high level` `Hypermethylated 3 MGMT Methylation present, level unspecified 6 Benign or borderline tumor 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case` `(If this item is required by your standard setter,` `use of code 8 will result in an edit error.) 9 Not documented in patient record` `Cannot be determined by the pathologist` `MGMT not assessed or unknown if assessed`
3890	MICROSATELLITE INSTABILITY	SSD3;20	SET	'0' FOR Microsatellite instability (MSI) stable, microsatellite stable (MSS), negative NOS; '1' FOR MSI unstable low (MSI-L); '2' FOR MSI unstable high (MSI-H); '8' FOR N/A; '9' FOR Not documented; LAST EDITED: `AUG 14, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Microsatellite Instability (MSI) is a form of genetic instability manifested by changes in the length of repeated single- to six-nucleotide sequences (known as DNA microsatellite sequences). High MSI, found in about 15% of` `colorectal carcinomas, is an adverse prognostic factor for colorectal carcinomas and predicts poor response to 5-FU chemotherapy (although the addition of oxaliplatin in FOLFOX regimens negates the adverse effects [page` `266 AJCC manual]). High MSI is a hallmark of hereditary nonpolyposis colorectal carcinoma, also known as Lynch syndrome. Rationale: Microsatellite Instability (MSI) is a Registry Data Collection Variable in AJCC. It was` `previously collected as Colon and Rectum, CS SSF# 7. Codes: 0 Microsatellite instability (MSI) stable;` `microsatellite stable (MSS); negative NOS` `AND/OR Mismatch repair (MMR) intact, no loss of nuclear expression of MMR proteins 1 MSI unstable low (MSI-L) 2 MSI unstable high (MSI-H)` `AND/OR` `MMR-D (loss of nuclear expression of one or more MMR proteins,` `MMR protein deficient) 8 Not applicable: Information not collected for this case` `(If this information is required by your standard setter,` `use of code 8 may result in an edit error.) 9 Not documented in medical record` `MSI-indeterminate` `Microsatellite instability not assessed or unknown if assessed`
3891	MICROVASCULAR DENSITY	SSD3;21	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<1)!'(X?0.1AN1N) X I $D(X) D GEN2^ONCSCHMM` `MAXIMUM LENGTH: 2` LAST EDITED: `JUL 26, 2019` HELP-PROMPT: `Answer must be 1-2 characters in length.` DESCRIPTION: `Microvascular Density (MVD), a quantitative measure of tumor vascularity, is a prognostic factor for uveal melanoma. Rationale: Microvascular Density (MVD), is a Registry Data Collection Variable in AJCC. This data item` `was previously collected as Uveal Melanoma, CS SSF# 13. Codes: 00 No vessels involved 01-99 01-99 vessels per 0.3 square millimeter (mm2) X1 Greater than or equal to 100 vessels per 0.3 square millimeter (mm2) X2` `Lowest quartile for laboratory X3 Second quartile for laboratory X4 Third quartile for laboratory X5 Highest quartile for laboratory X7 Test ordered, results not in chart X8 Not applicable: Information not` `collected for this case` `(If this information is required by your standard setter,` `use of code 8 may result in an edit error.) X9 Not documented in medical record` `Microvascular Density (MVD) not assessed or unknown if assessed` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3892	MITOTIC COUNT UVEAL MELANOMA	SSD3;22	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>4!($L(X)<1)!'(X?0.2AN0.1"."1N) X I $D(X) D DEC2^ONCSCHMM` `MAXIMUM LENGTH: 4` LAST EDITED: `AUG 01, 2019` HELP-PROMPT: `Answer must be 1-4 characters in length.` DESCRIPTION: `Mitotic Count Uveal Melanoma, the number of mitoses per 40 high-power fields (HPF) based on pathological evaluation, is a prognostic factor for uveal melanoma. Rationale: Mitotic Count Uveal Melanoma is listed as a` `Registry Data Collection Variable in AJCC. It was previously collected as Uveal Melanoma, CS SSF# 9. Codes: 0.0 0 mitoses per 40 high-power fields (HPF)` `Mitoses absent, no mitoses present, no mitotic activity 0.1-99.9 0.1-99.9 mitosis per 40 HPF XX.1 100 or more mitoses per 40 HPF XX.2 Stated as low mitotic count or rate with no specific number XX.3 Stated` `as high mitotic count or rate with no specific number XX.4 Mitotic count described with denominator other than 40 HPF XX.7 Test ordered, results not in chart XX.8 Not applicable: Information not collected for this` `case` `(If this information is required by your standard setter,` `use of code XX.8 may result in an edit error.) XX.9 Not documented in medical record` `Mitotic Count Uveal Melanoma not assessed or` `unknown if assessed` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3893	MITOTIC RATE MELANOMA	SSD3;23	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<1)!'(X?0.1AN1N) X I $D(X) D GEN2^ONCSCHMM` `MAXIMUM LENGTH: 2` LAST EDITED: `JUL 26, 2019` HELP-PROMPT: `Answer must be 1-2 characters in length.` DESCRIPTION: `Mitotic Rate Melanoma, the number of mitoses per square millimeter based on pathological evaluation, is a prognostic factor for melanoma of the skin. Rationale: Mitotic Rate Melanoma is a Registry Data Collection Variable` `in AJCC. It was previously collected as Melanoma Skin, CS SSF# 7. Codes: 00 0 mitoses per square millimeter (mm)` `Mitoses absent` `No mitoses present 01-99 1 - 99 mitoses/square mm` `(Exact measurement in mitoses/square mm) X1 100 mitoses/square mm or more X2 Stated as "less than 1 mitosis/square mm"` `Stated as "nonmitogenic" X3 Stated as "at least 1 mitosis/square mm"` `Stated as "mitogenic" X4 Mitotic rate described with denominator other` `than square millimeter (mm) X7 Test ordered, results not in chart X8 Not applicable: Information not collected for this case` `(If this information is required by your standard setter,` `use of code X8 may result in an edit error.) X9 Not documented in medical record` `Mitotic Rate Melanoma not assessed or unknown if assessed` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3894	MULTIGENE SIGNATURE METHOD	SSD3;24	SET	'1' FOR Mammaprint; '2' FOR PAM50 (Prosigna); '3' FOR Breast Cancer Index; '4' FOR EndoPredict; '5' FOR Test performed, type of test unknown; '6' FOR Multiple tests, any test in codes 1-4; '7' FOR Test ordered; '8' FOR N/A; '9' FOR Not documented; LAST EDITED: `AUG 14, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Multigene signatures or classifiers are assays of a panel of genes from a tumor specimen, intended to provide a quantitative assessment of the likelihood of response to chemotherapy and to evaluate prognosis or the` `likelihood of future metastasis. This data item identifies the multigene signature method used. Oncotype Dx is coded elsewhere. Rationale: Multigene Signature Method is a Registry Data Collection Variable in AJCC. It was` `previously collected as Breast, CS SSF #22. See also Multigene Signature Results. Codes: 1 Mammaprint 2 PAM50 (Prosigna) 3 Breast Cancer Index 4 EndoPredict 5 Test performed, type of test unknown 6 Multiple` `tests, any tests in codes 1-4 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case` `(If this item is required by your standard setter,` `use of code 8 will result in an edit error.) 9 Not documented in medical record` `Multigene Signature Method not assessed or unknown if assessed`
3895	MULTIGENE SIGNATURE RESULTS	SSD3;25	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<1)!'(X?0.1AN1N) X I $D(X) D GEN2^ONCSCHMM` `MAXIMUM LENGTH: 2` LAST EDITED: `JUL 26, 2019` HELP-PROMPT: `Answer must be 1-2 characters in length.` DESCRIPTION: `Multigene signatures or classifiers are assays of a panel of genes from a tumor specimen, intended to provide a quantitative assessment of the likelihood of response to chemotherapy and to evaluate prognosis or the` `likelihood of future metastasis. This data item identified the multigene signature result. Oncotype Dx is coded elsewhere. Rationale: Multigene Signature Results is a Registry Data Collection Variable in AJCC. It was` `previously collected as Breast, CS SSF #23. See also Multigene Signature Method. Codes: 00-99 Enter actual recurrence score` `Note: Depending on the test, the range of values` `may be different X1 Score 100 X2 Low risk X3 Moderate [intermediate] risk X4 High risk X7 Test ordered, results not in chart X8 Not applicable: Information not collected for this case` `(If this item is required by your standard setter,` `use of code X8 will result in an edit error.) X9 Not documented in medical record` `Multigene Signature Results not assessed or` `unknown if assessed` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3896	NCCN IPI	SSD3;26	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<1)!'(X?0.1AN1N) X I $D(X) D GEN2^ONCSCHMM` `MAXIMUM LENGTH: 2` LAST EDITED: `JUL 26, 2019` HELP-PROMPT: `Answer must be 1-2 characters in length.` DESCRIPTION: `The NCCN International Prognostic Index (IPI) (previously only "IPI") is used to define risk groups for specific lymphomas using a 0-5 score range, based on age, stage, number of extranodal sites of involvement, patient's` `performance status and pretreatment LDH level. Rationale: NCCN International Prognostic Index (IPI) is a Registry Data Collection Variable in AJCC. It was previously collected for Lymphomas, SSF# 3. Codes: 00-08 0-8` `points X1 Stated as low risk (0-1 point) X2 Stated as low intermediate risk (2-3 points) X3 Stated as intermediate risk (4-5 points) X4 Stated as high risk (6-8 points) X8 Not applicable: Information not` `collected for this case` `(If this item is required by your standard setter,` `use of code X8 will result in an edit error.) X9 Not documented in medical record` `NCCN International Prognostic Index (IPI) not assessed` `or unknown if assessed` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3897	NUMBER OF CORES EXAMINED	SSD3;27	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<1)!'(X?0.1AN1N) X I $D(X) D GEN2^ONCSCHMM` `MAXIMUM LENGTH: 2` LAST EDITED: `MAY 11, 2020` HELP-PROMPT: `Answer must be 1-2 characters in length.` DESCRIPTION: `This data item represents the number of cores examined as documented in the pathology report from needle biopsy of the prostate gland. Rationale: Number of Cores Examined is a Registry Data Collection Variable for AJCC.` `This data item was previously collected as Prostate, CS SSF# 13. Codes: 01-99 1 - 99 cores examined` `(Exact number of cores examined) X1 100 or more cores examined X6 Biopsy cores examined, number unknown X7 No needle core biopsy performed X8 Not applicable: Information not collected for this case` `(If this information is required by your standard setter,` `use of code X8 may result in an edit error.) X9 Not documented in medical record` `Number of cores examined not assessed` `or unknown if assessed` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3898	NUMBER OF CORES POSITIVE	SSD3;28	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<1)!'(X?0.1AN1N) X I $D(X) D GEN2^ONCSCHMM` `MAXIMUM LENGTH: 2` LAST EDITED: `MAY 11, 2020` HELP-PROMPT: `Answer must be 1-2 characters in length.` DESCRIPTION: `This data item represents the number of positive cores documented in the pathology report from needle biopsy of the prostate gland. Rationale: Number of Cores Positive is a Registry Data Collection Variable for AJCC. This` `data item was previously collected as Prostate, CS SSF# 12. Codes: 00 All examined cores negative 01-99 1 - 99 cores positive` `(Exact number of cores positive) X1 100 or more cores positive X6 Biopsy cores positive, number unknown X7 No needle core biopsy performed X8 Not applicable: Information not collected for this case` `(If this information is required by your standard setter,` `use of code X8 may result in an edit error.) X9 Not documented in medical record` `Number of Cores Positive not assessed` `or unknown if assessed` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3899	NUM OF EXAMINED PARA-AORTIC	SSD3;29	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<1)!'(X?0.1AN1N) X I $D(X) D GEN2^ONCSCHMM` `MAXIMUM LENGTH: 2` LAST EDITED: `JUL 26, 2019` HELP-PROMPT: `Answer must be 1-2 characters in length.` DESCRIPTION: `Number of examined para-aortic nodes is the number of nodes examined based on para-aortic nodal dissection. Rationale: Number of Examined Para-aortic Nodes is listed as a Registry Data Collection Variable in AJCC. This` `data item was previously collected as Corpus, CS SSF# 6. Codes: 00 No para-aortic nodes examined 01-99 1 - 99 para-aortic nodes examined` `(Exact number of para-aortic lymph nodes examined) X1 100 or more para-aortic nodes examined X2 Para-aortic nodes examined, number unknown X6 No para-aortic lymph nodes removed, but` `aspiration or core biopsy of para-aortic node(s) only X8 Not applicable: Information not collected for this case` `(If this item is required by your standard setter,` `use of code X8 will result in an edit error.) X9 Not documented in medical record` `Cannot be determined, indeterminate if positive` `para-aortic nodes present` `Para-aortic lymph nodes not assessed` `or unknown if assessed` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3900	NUM OF EXAMINED PELVIC NODES	SSD3;30	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<1)!'(X?0.1AN1N) X I $D(X) D GEN2^ONCSCHMM` `MAXIMUM LENGTH: 2` LAST EDITED: `JUL 26, 2019` HELP-PROMPT: `Answer must be 1-2 characters in length.` DESCRIPTION: `Number of examined pelvic nodes is the number of nodes examined based on pelvic nodal dissection. Rationale: Number of Examined Pelvic Nodes is listed as a Registry Data Collection Variable in AJCC. This data item was` `previously collected as Corpus, CS SSF# 4. Codes: 00 No pelvic lymph nodes examined 01-99 1 - 99 pelvic lymph nodes examined` `(Exact number of pelvic lymph nodes examined) X1 100 or more pelvic nodes examined X2 Pelvic nodes examined, number unknown X6 No pelvic lymph nodes removed, but aspiration or core` `biopsy of pelvic node(s) only X8 Not applicable: Information not collected for this case` `(If this item is required by your standard setter,` `use of code X8 will result in an edit error.) X9 Not documented in medical record` `Cannot be determined, indeterminate if positive pelvic` `nodes present` `Pelvic lymph nodes not assessed or unknown if assessed` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3901	NUM OF POS PARA-AORTIC NODES	SSD3;31	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<1)!'(X?0.1AN1N) X I $D(X) D GEN2^ONCSCHMM` `MAXIMUM LENGTH: 2` LAST EDITED: `JUL 26, 2019` HELP-PROMPT: `Answer must be 1-2 characters in length.` DESCRIPTION: `Number of Positive Para-Aortic Nodes is the number of positive nodes based on para-aortic nodal dissection Rationale: Number of Positive Para-aortic Nodes is listed as a Registry Data Collection Variable in AJCC. This data` `item was previously collected as Corpus, CS SSF# 5. Codes: 00 All para-aortic lymph nodes examined negative 01-99 1-99 para-aortic lymph nodes positive` `(Exact number of nodes positive) X1 100 or more para-aortic nodes positive X2 Positive para-aortic nodes identified, number unknown X6 Positive aspiration or core biopsy of para-aortic lymph node(s) X8 Not` `applicable: Information not collected for this case` `(If this item is required by your standard setter,` `use of code X8 will result in an edit error.) X9 Not documented in medical record` `Cannot be determined, indeterminate if positive` `para-aortic nodes present` `Para-aortic lymph nodes not assessed` `or unknown if assessed` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3902	NUM OF POSITIVE PELVIC NODES	SSD3;32	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<1)!'(X?0.1AN1N) X I $D(X) D GEN2^ONCSCHMM` `MAXIMUM LENGTH: 2` LAST EDITED: `JUL 26, 2019` HELP-PROMPT: `Answer must be 1-2 characters in length.` DESCRIPTION: `Number of Positive Pelvic Nodes is the number of positive nodes based on pelvic nodal dissection. Rationale: Number of Positive Pelvic Nodes is listed as a Registry Data Collection Variable in AJCC. This data item was` `previously collected as Corpus, CS SSF# 3. Codes: 00 All pelvic nodes examined negative 01-99 1 - 99 pelvic nodes positive` `(Exact number of nodes positive) X1 100 or more pelvic nodes positive X2 Positive pelvic nodes identified, number unknown X6 Positive aspiration or core biopsy of pelvic lymph node(s) X8 Not applicable:` `Information not collected for this case` `(If this item is required by your standard setter,` `use of code X8 will result in an edit error.) X9 Not documented in medical record` `Cannot be determined, indeterminate if positive` `pelvic nodes present` `Pelvic lymph nodes not assessed` `or unknown if assessed` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3903	ONCOTYPE DX RECUR SCORE-DCIS	SSD3;33	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>3!($L(X)<1)!'(X?0.2AN1N) X I $D(X) D GEN3^ONCSCHMM` `MAXIMUM LENGTH: 3` LAST EDITED: `JUL 26, 2019` HELP-PROMPT: `Answer must be 1-3 characters in length.` DESCRIPTION: `Oncotype Dx Recurrence Score-DCIS is a numeric score of a genomic test to predict the risk of local recurrence of breast cancer based on the assessment of 12 genes. Rationale: Oncotype Dx Recurrence Score-DCIS is a` `Registry Data Collection Variable in AJCC. It is a new data item for cases diagnosed 1/1/2018+. Codes: 0-100 Enter actual recurrence score between 0 and 100 XX6 Not applicable: invasive case XX7 Test ordered,` `results not in chart XX8 Not applicable: Information not collected for this case` `(If this item is required by your standard setter,` `use of code XX8 will result in an edit error.) XX9 Not documented in medical record` `Oncotype Dx Recurrence Score-DCIS not assessed` `or unknown if assessed` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3904	ONCOTYPE DX REC SCORE-INVASIVE	SSD3;34	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>3!($L(X)<1)!'(X?0.2AN1N) X I $D(X) D GEN3^ONCSCHMM` `MAXIMUM LENGTH: 3` LAST EDITED: `JUL 26, 2019` HELP-PROMPT: `Answer must be 1-3 characters in length.` DESCRIPTION: `Oncotype Dx Recurrence Score-Invasive is a numeric score of a genomic test to predict the likelihood of distant recurrence of invasive breast cancer based on the assessment of 21 genes. Rationale: Oncotype Dx Recurrence` `Score-Invasive is a Registry Data Collection Variable in AJCC. It is a new data item for cases diagnosed 1/1/2018+. Codes: 0-100 Enter actual recurrence score between 0 and 100 XX4 Stated as less than 11 XX5 Stated` `as equal to or greater than 11 XX6 Not applicable: in situ case XX7 Test ordered, results not in chart XX9 Not documented in medical record` `Oncotype Dx Recurrence Score-Invasive not assessed` `or unknown if assessed` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3905	ONCOTYPE DX RISK LEVEL-DCIS	SSD4;1	SET	'0' FOR Low risk; '1' FOR Intermediate risk; '2' FOR High risk; '6' FOR Not applicable, invasive case; '7' FOR Test ordered, results not in chart; '8' FOR N/A; '9' FOR Not documented in medical record; LAST EDITED: `AUG 15, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Oncotype Dx Risk Level-DCIS stratifies Oncotype Dx recurrence scores into low, intermediate, and high risk of local recurrence. Rationale: Oncotype Dx Risk Level-DCIS is a Registry Data Collection Variable in AJCC. It is` `a new data item for cases diagnosed 1/1/2018+. Codes: 0 Low risk (recurrence score 0-38) 1 Intermediate risk (recurrence score 39-54) 2 High risk (recurrence score greater than or equal to 55) 6 Not applicable:` `invasive case 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case` `(If this item is required by your standard setter,` `use of code 8 will result in an edit error.) 9 Not documented in medical record` `Oncotype Dx Risk Level-DCIS not assessed or unknown if assessed`
3906	ONCOTYPE DX RISK LEVEL-INVAS	SSD4;2	SET	'0' FOR Low risk; '1' FOR Intermediate risk; '2' FOR High risk; '6' FOR Not applicable, DCIS case; '7' FOR Test done, results not in chart; '8' FOR N/A; '9' FOR Not documented in medical record; LAST EDITED: `AUG 15, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Oncotype Dx Risk Level-Invasive stratifies Oncotype Dx recurrence scores into low, intermediate, and high risk of distant recurrence. Rationale: Oncotype Dx Risk Level-Invasive is a Registry Data Collection Variable in` `AJCC. It is a new data item for cases diagnosed 1/1/2018+. Codes: 0 Low risk (recurrence score 0-17) 1 Intermediate risk (recurrence score 18-30) 2 High risk (recurrence score greater than or equal to 31) 6 Not` `applicable: DCIS case 7 Test done, results not in chart 8 Not applicable: Information not collected for this case` `(If this item is required by your standard setter,` `use of code 8 will result in an edit error.) 9 Not documented in medical record` `Oncotype Dx Risk Level-Invasive not assessed or unknown if assessed`
3907	ORGANOMEGALY	SSD4;3	SET	'0' FOR Organomegaly of liver and/or spleen not present; '1' FOR Organomegaly of liver and/or spleen present; '5' FOR NA, site not C421; '9' FOR Not documented in medical record; LAST EDITED: `JUN 27, 2022` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Organomegaly is defined as presence of enlarged liver and/or spleen on physical examination and is part of the staging criteria for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL). Rationale:` `Organomegaly is a prognostic factor required for staging of CLL/SLL in AJCC 8th edition, Chapter 79 Hodgkin and Non-Hodgkin Lymphomas. It is a new data item for cases diagnosed 1/1/2018+. Codes: 0 Organomegaly of liver` `and/or spleen not present 1 Organomegaly of liver and/or spleen present 5 Not applicable: Primary site is not C421 9 Not documented in medical record` `Organomegaly not assessed or unknown if assessed` SCREEN: `S DIC("S")="D SCRNFIV^ONCSCHMM"` EXPLANATION: `Codes depend on appropriate site`
3908	PERCENT NECROSIS PST NEOADJVNT	SSD4;4	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>5!($L(X)<1)!'(X?0.3AN0.1"."1N) X I $D(X) D DEC3^ONCSCHMM` `MAXIMUM LENGTH: 5` LAST EDITED: `AUG 01, 2019` HELP-PROMPT: `Answer must be 1-5 characters in length.` DESCRIPTION: `Percent Necrosis Post Neoadjuvant is a prognostic factor for bone sarcomas. Rationale Percent Necrosis Post Neoadjuvant is a Registry Data Collection Variable for AJCC. It was previously collected as Bone, CS SSF# 3.` `Codes 0.0 Tumor necrosis not identified/not present 0.1-100.0 0.1-100.0 percent tumor necrosis` `(Percentage of tumor necrosis to nearest tenth of a percent) XXX.2 Tumor necrosis present, percent not stated XXX.8 Not applicable: Information not collected for this case` `(If this item is required by your standard setter,` `use of code XXX.8 will result in an edit error.) XXX.9 Not documented in medical record` `No histologic examined of primary site` `No neoadjuvant therapy` `No surgical resection of primary site is performed` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3909	PERINEURAL INVASION 2018	SSD4;5	SET	'0' FOR Perineural invasion not identified/not present; '1' FOR Perineural invasion identified/present; '8' FOR N/A; '9' FOR Not documented in medical record; LAST EDITED: `AUG 15, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Perineural Invasion, within or adjacent to the primary tumor, is a negative prognostic factor for cutaneous squamous cell carcinomas of the head and neck and carcinomas of the colon and rectum, eyelid and lacrimal gland.` `Rationale: Perineural Invasion is a Registry Data Collection Variable in AJCC. It was previously collected as Colon and Rectum CS SSF# 8 and Lacrimal Gland CS SSF# 4. Codes: 0 Perineural invasion not identified/not` `present 1 Perineural invasion identified/present 8 Not applicable: Information not collected for this case` `(If this information is required by your standard setter,` `use of code 8 may result in an edit error.) 9 Not documented in medical record` `Pathology report does not mention perineural invasion` `Cannot be determined by the pathologist` `Perineural invasion not assessed or unknown if assessed`
3910	PERIPHERAL BLOOD INVOLV 2018	SSD4;6	POINTER TO ONCO PERIPHERAL BLOOD INVOLVEMENT FILE (#167.4)	ONCO PERIPHERAL BLOOD INVOLVEMENT(#167.4) LAST EDITED: `AUG 15, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Peripheral blood involvement, summarized in "B category", refers to the percentage of peripheral blood lymphocytes that are atypical (Sezary) cells and whether they are "Clone negative" or "Clone positive". Rationale:` `Peripheral blood involvement is a prognostic factor required in AJCC 8th edition, Chapter 81 Primary Cutaneous Lymphomas, for staging of Mycosis Fungoides and Sezary Syndrome. It was previously collected as Mycosis` `Fungoides, CS SSF #1. Codes: 0 Absence of significant blood involvement` `5% or less of peripheral blood lymphocytes are atypical (Sezary) cells` `Clone unknown` `Stated as B0 1 Absence of significant blood involvement` `5% or less of peripheral blood lymphocytes are atypical (Sezary) cells` `Clone negative` `Stated as B0a 2 Absence of significant blood involvement:` `5% or less of peripheral blood lymphocytes are atypical (Sezary) cells` `Clone positive` `Stated as B0b 3 Low blood tumor burden` `More than 5% of peripheral blood lymphocytes are` `atypical (Sezary) cells but does not meet the criteria of B2` `Clone unknown` `Stated as B1 4 Low blood tumor burden` `More than 5% of peripheral blood lymphocytes are` `atypical (Sezary) cells but does not meet the criteria of B2` `Clone negative` `Stated as B1a 5 Low blood tumor burden` `More than 5% of peripheral blood lymphocytes are` `atypical (Sezary) cells but does not meet the criteria of B2` `Clone positive` `Stated as B1b 6 High blood tumor burden` `Greater than or equal to 1000 Sezary cells per microliter (uL)` `Clone positive` `Stated as B2 7 Test ordered, results not in chart 9Not documented in medical record` `Peripheral Blood Involvement not assessed or unknown if assessed`
3911	PERITONEAL CYTOLOGY	SSD4;7	SET	'0' FOR Negative for malignancy; '1' FOR Atypical and/or suspicious; '2' FOR Malignant (positive for malignancy); '3' FOR Unsatisfactory/nondiagnostic; '7' FOR Test order, results not in chart; '8' FOR N/A; '9' FOR Not documented in medical record; LAST EDITED: `AUG 16, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Peritoneal cytology pertains to the results of cytologic examination for malignant cells performed on fluid that is obtained from the peritoneal cavity. Rationale: Peritoneal Cytology is listed as a Registry Data` `Collection Variable in AJCC. This data item was previously collected as Corpus, CS SSF# 2. Codes: 0 Peritoneal cytology/washing negative for malignancy 1 Peritoneal cytology/washing atypical and/or suspicious 2` `Peritoneal cytology/washing malignant (positive for malignancy) 3 Unsatisfactory/nondiagnostic 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case` `(If this item is required by your standard setter,` `use of code 8 will result in an edit error.) 9 Not documented in medical record` `Peritoneal cytology not assessed or unknown if assessed`
3913	PLEURAL EFFUSION	SSD4;8	SET	'0' FOR Not identified/not present; '1' FOR Present, non-malignant (negative); '2' FOR Present, malignant (positive); '3' FOR Atypical mesothelial cells; '4' FOR Pleural effusion, NOS; '8' FOR N/A; '9' FOR Not documented in medical record; LAST EDITED: `AUG 16, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Pleural effusion is the accumulation of fluid between the parietal pleura (the pleura covering the chest wall and diaphragm) and the visceral pleura (the pleura covering the lungs). Rationale: Pleural Effusion is` `collected by the surveillance community for pleura cancers. Prior to 2018, Pleura SSF #1 was used for Pleural Effusion. Codes: 0 Pleural effusion not identified/not present 1 Pleural effusion present, non-malignant` `(negative) 2 Pleural effusion present, malignant (positive) 3 Pleural effusion, atypical/atypical mesothelial cells 4 Pleural effusion, NOS 8 Not applicable: Information not collected for this case` `(If this item is required by your standard setter,` `use of code 8 will result in an edit error.) 9 Not documented in medical record` `Pleural Effusion not assessed or unknown if assessed`
3914	PR PERCENT POSITIVE	SSD4;9	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>3!($L(X)<1)!'(X?1.3AN) X I $D(X) D ERR^ONCSCHMM` `MAXIMUM LENGTH: 3` LAST EDITED: `JUN 25, 2020` HELP-PROMPT: `Answer must be 1-3 characters in length.` DESCRIPTION: `Progesterone Receptor, Percent Positive or Range is the percent of cells staining progesterone receptor positive measured by IHC. Rationale: Progesterone Receptor, Percent Positive or Range is a Registry Data Collection` `Variable in AJCC. It is a new data item for cases diagnosed 1/1/2018+. Codes: 000 PR negative, or stated as less than 1% 001-100 1-100 percent R10 Stated as 1-10% R20 Stated as 11-20% R30 Stated as 21-30% R40` `Stated as 31-40% R50 Stated as 41-50% R60 Stated as 51-60% R70 Stated as 61-70% R80 Stated as 71-80% R90 Stated as 81-90% R99 Stated as 91-100% XX8 Not applicable: Information not collected for this case` `(If this item is required by your standard setter,` `use of code XX8 will result in an edit error.) XX9 Not documented in medical record` `PR (Progesterone Receptor) Percent Positive or` `Range not assessed or unknown if assessed Notes: -Physician statement of PR (Progesterone Receptor) Percent Positive or` `Range can be used to code this data item. -Code this data item using the same report used to record PR Summary. -If PR negative, or percentage less than 1%, code 000. -The actual PR (1-100%) percent takes priority` `over the range codes. -If PR positive but percentage unknown, code XX9.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3915	PR SUMMARY	SSD4;10	SET	'0' FOR PR negative; '1' FOR PR positive; '7' FOR Test ordered, results not in chart; '9' FOR Not documented in medical record; LAST EDITED: `OCT 21, 2019` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `PR (Progesterone Receptor) Summary is a summary of results from the progesterone receptor (PR) assay. Rationale: This data item is required for prognostic stage grouping in AJCC 8th edition, Chapter 48, Breast. It was` `previously collected as Breast CS SSF # 2. Codes: 0 PR negative 1 PR positive 7 Test ordered, results not in chart 9 Not documented in medical record` `Cannot be determined (indeterminate)` `PR (Progesterone Receptor) Summary status not assessed` `or unknown if assessed Note 1: Physician statement of PR (Progesterone Receptor) Summary status can be used to code this data item when no other information is available. Note 2: The result of the PR test` `performed on the primary breast tissue is to be recorded in this data item. Note 3: Results from nodal or metastatic tissue may be used ONLY when there is no evidence of primary tumor. Note 4: In cases where PR is` `reported on more than one breast tumor specimen, record the highest value. If any sample is positive, record as positive.` `Exception: If PR is positive on an in situ specimen and PR is negative on all tested invasive specimens, code PR as negative (code 0). Note 5: If neoadjuvant therapy is given, record the assay from tumor specimens` `prior to neoadjuvant therapy.` `If neoadjuvant therapy is given and there are no PR results from pre-treatment specimens, report the findings from post-treatment specimens. Note 6: If the patient is PR positive and node negative, a multigene test` `such as Oncotype Dx may be performed, in which case another PR test will be performed. Do not record the results of that test in this field.` `Record only the results of the test which made the patient eligible to be given the multigene test.`
3916	PR ALLRED SCORE	SSD4;11	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<1)!'(X?0.1AN1N) X I $D(X) D ERTA^ONCSCHMM` `MAXIMUM LENGTH: 2` LAST EDITED: `OCT 22, 2019` HELP-PROMPT: `Answer must be 1-2 characters in length.` DESCRIPTION: `Progesterone Receptor, Total Allred Score is based on the percentage of cells that stain by IHC for progesterone receptor (PR) and the intensity of that staining. Rationale: Progesterone Receptor, Total Allred Score is a` `Registry Data Collection Variable in AJCC. It is a new data item for cases diagnosed 1/1/2018+. Codes: 00 Total PR Allred score of 0 01 Total PR Allred score of 1 02 Total PR Allred score of 2 03 Total PR Allred` `score of 3 04 Total PR Allred score of 4 05 Total PR Allred score of 5 06 Total PR Allred score of 6 07 Total PR Allred score of 7 08 Total PR Allred score of 8 X8 Not applicable: Information not collected for` `this case` `(If this item is required by your standard setter,` `use of code X8 will result in an edit error.) X9 Not documented in medical record` `PR (Progesterone Receptor) Total Allred Score not assessed,` `or unknown if assessed` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3917	PRIMARY SCLEROSING CHOLANGITIS	SSD4;12	SET	'0' FOR PSC not identified/not present; '1' FOR PSC present; '8' FOR N/A; '9' FOR Not documented in medical record; LAST EDITED: `AUG 16, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Primary sclerosing cholangitis denotes a chronic autoimmune inflammation of the bile ducts that leads to scar formation and narrowing of the ducts over time. It is a prognostic factor for intrahepatic bile duct cancer.` `Rationale: Primary Sclerosing Cholangitis is a Registry Data Collection Variable in AJCC. This data item was previously collected for Intrahepatic Bile Duct, SSF# 11. Codes: 0 PSC not identified/not present 1 PSC` `present 8 Not applicable: Information not collected for this case` `(If this information is required by your standard setter,` `use of code 8 may result in an edit error.) 9 Not documented in medical record` `PSC not assessed or unknown if assessed`
3918	PROFOUND IMMUNE SUPPRESSION	SSD4;13	SET	'0' FOR No immune suppression identified; '1' FOR HIV/AIDS; '2' FOR Solid organ transplant recipient; '3' FOR Chronic lymphocytic leukemia; '4' FOR Non-Hodgkin lymphoma; '5' FOR Multiple; '6' FOR Profound; '8' FOR N/A; '9' FOR Not documented; LAST EDITED: `AUG 16, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Profound Immune Suppression, suppressed immune status that may be associated with HIV/AIDs, solid organ transplant, chronic lymphocytic leukemia, non-Hodgkin lymphoma, multiple conditions or other conditions, increases the` `risk of developing Merkel Cell Carcinoma and is an adverse prognostic factor. Rationale: Profound Immune Suppression is a Registry Data Collection Variable in AJCC. It was previously collected as Merkel Cell Penis, SSF` `#22, Merkel Cell Scrotum SSF #22, Merkel Cell Skin, SSF# 22, and Merkel Cell Vulva, SSF# 22. Codes: 0 No immune suppression condition(s) identified/not present 1 Human Immunodeficiency Virus (HIV)/Acquired` `Immunodeficiency Syndrome (AIDS) 2 Solid organ transplant recipient 3 Chronic lymphocytic leukemia 4 Non-Hodgkin lymphoma 5 Multiple immune suppression conditions 6 Profound immune suppression present 8` `Not applicable: Information not collected for this case` `(If this information is required by your standard setter,` `use of code 8 may result in an edit error.) 9 Not documented in medical record` `Profound immune suppression not assessed` `or unknown if assessed`
3919	PROSTATE PATHOLOGICAL EXT	SSD4;14	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>3!($L(X)<1) X I $D(X) D PROPE^ONCSCHMM` `MAXIMUM LENGTH: 3` LAST EDITED: `JUN 10, 2020` HELP-PROMPT: `Answer must be 1-3 characters in length.` DESCRIPTION: `Pathological extension is used to assign pT category for prostate cancer based on radical prostatectomy specimens. Rationale: Pathological extension is used in EOD. It was previously collected as Prostate, CS SSF# 3.` `Codes: (See the most current version of EOD (Prostate) (https://staging.seer.cancer.gov/) for rules and site-specific codes and coding structures.)` `000 In situ: noninvasive; intraepithelial 300 Invasion into (but not beyond) prostatic capsule` `Intracapsular involvement only` `No extracapsular extension` `Confined to prostate, NOS` `Localized, NOS 350 Bladder neck, microscopic invasion` `Extraprostatic extension (beyond prostatic capsule), unilateral,` `bilateral, or NOS WITHOUT invasion of the seminal vesicles` `Extension to periprostatic tissue WITHOUT invasion of seminal vesicles 400 Tumor invades seminal vesicle(s) 500 Extraprostatic tumor that is not fixed` `WITHOUT invasion of adjacent structures` `Periprostatic extension, NOS (unknown if seminal vesicle(s) involved)` `Extraprostatic extension, NOS (unknown if seminal vesicle(s) involved)` `Through capsule, NOS 600 Bladder neck, except microscopic bladder neck involvement` `Bladder, NOS` `External sphincter` `Extraprostatic urethra (membranous urethra)` `Fixation, NOS` `Levator muscles` `Rectovesical (Denonvillier's) fascia` `Rectum` `Skeletal muscle` `Ureter(s) 700 Extension to or fixation to pelvic wall or pelvic bone` `"Frozen pelvis", NOS` `Further contiguous extension including` `Other organs` `Penis` `Sigmoid colon` `Soft tissue other than periprostatic 800 No evidence of primary tumor 900 No prostatectomy or autopsy performed 950 Prostatectomy performed, but not first course of treatment` `for example performed after disease progression 999 Unknown; extension not stated` `Unknown if prostatectomy done` `Primary tumor cannot be assessed` `Not documented in patient record` `Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3920	PSA LAB VALUE	SSD4;15	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>5!($L(X)<1)!'(X?0.3AN0.1"."1N) X I $D(X) D DEC3^ONCSCHMM` `MAXIMUM LENGTH: 5` LAST EDITED: `AUG 01, 2019` HELP-PROMPT: `Answer must be 1-5 characters in length.` DESCRIPTION: `PSA (Prostatic Specific Antigen) is a protein produced by cells of the prostate gland and is elevated in patients with prostate cancer. This data item pertains to PSA lab value. Rationale: This data item is required for` `prognostic stage grouping in AJCC 8th edition, Chapter 58, Prostate. It was previously collected as Prostate, CS SSF# 1. Codes: 0.1 0.1 or less nanograms/milliliter (ng/ml)` `(Exact value to nearest tenth of ng/ml) 0.2-999.9 0.2-999.9 ng/ml` `(Exact value to nearest tenth of ng/ml) XXX.1 1,000 ng/ml or greater XXX.2 Lab value not available, physician states PSA is` `negative/normal XXX.3 Lab value not available, physician states PSA is` `positive/elevated/high XXX.7 Test ordered, results not in chart XXX.9 Not documented in medical record` `PSA lab value not assessed or unknown if assessed` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3921	RESIDUAL TUM VOL PST CYTO	SSD4;16	POINTER TO ONCO RESIDUAL TUMOR VOLUME FILE (#167.5)	ONCO RESIDUAL TUMOR VOLUME(#167.5) LAST EDITED: `AUG 16, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Gross residual tumor after primary cytoreductive surgery is a prognostic factor for ovarian cancer and residual tumor volume after cytoreductive surgery is a prognostic factor for late stage ovarian cancers. Rationale:` `Residual Tumor Volume Post Cytoreduction is a Registry Data Collection Variable listed in AJCC. It was previously collected as Ovary, CS SSF # 3. Codes: 00 No gross residual tumor nodules 10 Residual tumor nodule(s) 1` `centimeter (cm) or less` `AND neoadjuvant chemotherapy not given or unknown if given 20 Residual tumor nodule(s) 1 cm or less` `AND neoadjuvant chemotherapy given (before surgery) 30 Residual tumor nodule(s) greater than 1 cm` `AND neoadjuvant chemotherapy not given or unknown if given 40 Residual tumor nodule(s) greater than 1 cm` `AND neoadjuvant chemotherapy given (before surgery) 90 Macroscopic residual tumor, size not stated` `AND neoadjuvant chemotherapy not given or unknown if given 91 Macroscopic residual tumor nodule(s), size not stated` `AND neoadjuvant chemotherapy given (before surgery) 92 Procedure described as optimal debulking and size of residual tumor` `nodule(s) not given AND neoadjuvant chemotherapy not given` `or unknown if given 93 Procedure described as optimal debulking and size of residual tumor` `nodue(s) not given AND neoadjuvant chemotherapy given (before` `surgery) 97 No cytoreductive surgery performed 98 Not applicable: Information not collected for this case` `(If this item is required by your standard setter, use of` `code 98 will result in an edit error.) 99 Not documented in medical record` `Residual tumor status after cytoreductive surgery not` `assessed or unknown if assessed`
3922	RESPONSE TO NEOADJUVANT THERA	SSD4;17	SET	'0' FOR Neoadjuvant therapy not given; '1' FOR Complete response (CR); '2' FOR Partial response (PR); '3' FOR Response to treatment, but not noted if complete or partial; '4' FOR No response (NR); '8' FOR N/A; '9' FOR Not documented; LAST EDITED: `AUG 20, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `This data item records the physician's statement of response to neoadjuvant chemotherapy. Rationale: Response to Neoadjuvant Therapy is a Registry Data Collection Variable in AJCC. It was previously collected as Breast,` `CS SSF #21. Codes: 0 Neoadjuvant therapy not given 1 Stated as complete response (CR) 2 Stated as partial response (PR) 3 Stated as response to treatment, but not noted if complete or partial 4 Stated as no` `response (NR) 8 Not applicable: Information not collected for this case` `(If this item is required by your standard setter,` `use of code 8 will result in an edit error.) 9 Not documented in medical record` `Response to neoadjuvant therapy not assessed or unknown if assessed`
3923	S CATEGORY CLINICAL	SSD4;18	SET	'0' FOR S0; '1' FOR S1; '2' FOR S2; '3' FOR S3; '9' FOR SX; LAST EDITED: `AUG 20, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `S Category Clinical combines the results of pre-orchiectomy Alpha Fetoprotein (AFP), Human Chorionic Gonadotropin (hCG) and Lactate Dehydrogenase (LDH) into a summary S value. Rationale: S Category Clinical is required` `for prognostic stage grouping in AJCC 8th edition, Chapter 59 Testis. It is a new data item for cases diagnosed 1/1/2018+. Codes: 0 S0: Marker study levels within normal levels 1 S1: At least one of these values is` `elevated AND` `LDH less than 1.5 x N* AND` `hCG (mIU/L) less than 5,000 AND` `AFP (ng/mL) less than 1,000 2 S2:` `LDH 1.5 x N* to 10 x N* OR` `hCG (mIU/L) 5,000 to 50,000 OR` `AFP (ng/mL) 1,000 to 10,000 3 S3: Only one elevated test is needed` `LDH greater than 10 x N* OR` `hcG (mIU/mL) greater than 50,000 OR` `AFP (ng/mL) greater than 10,000 9 SX: Not documented in medical record` `S Category Clinical not assessed or unknown if assessed` `*N indicates the upper limit of normal for the LDH assay.`
3924	S CATEGORY PATHOLOGICAL	SSD4;19	SET	'0' FOR S0; '1' FOR S1; '2' FOR S2; '3' FOR S3; '9' FOR SX; LAST EDITED: `AUG 20, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `S Category Pathological combines the results of post-orchiectomy Alpha Fetoprotein (AFP), Human Chorionic Gonadotropin (hCG) and Lactate Dehydrogenase (LDH) into a summary S value. Rationale: S Category Pathological is` `required for prognostic stage grouping in AJCC 8th edition, Chapter 59 Testis. It is a new data item for cases diagnosed 1/1/2018+. Codes: 0 S0: Marker study levels within normal levels 1 S1: At least one of these` `values is elevated AND` `LDH less than 1.5 x N* AND` `hCG (mIU/L) less than 5,000 AND` `AFP (ng/mL) less than 1,000 2 S2:` `LDH 1.5 x N* to 10 x N* OR` `hCG (mIU/L) 5,000 to 50,000 OR` `AFP (ng/mL) 1,000 to 10,000 3 S3: Only one elevated test is needed` `LDH greater than 10 x N* OR` `hcG (mIU/mL) greater than 50,000 OR` `AFP (ng/mL) greater than 10,000 9 SX: Not documented in medical record` `S Category Pathological not assessed or unknown if assessed` `*N indicates the upper limit of normal for the LDH assay.`
3925	SARCOMATOID FEATURES	SSD4;20	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>3!($L(X)<1)!'(X?1.3AN) X I $D(X) D SAR^ONCSCHMM` `MAXIMUM LENGTH: 3` LAST EDITED: `JUN 25, 2020` HELP-PROMPT: `Answer must be 1-3 characters in length.` DESCRIPTION: `Sarcomatoid features: present or absent and percentage refers to the observation of sheets and fascicles of malignant spindle cells in a kidney tumor which can occur across all histologic subtypes. The percentage of` `sarcomatoid component has been shown to correlate with cancer-specific mortality. Rationale: Sarcomatoid features for Kidney is a Registry Data Collection Variable in AJCC. It was previously collected as Kidney, CS SSF` `#4. Codes: 000 Sarcomatoid features not present/not identified 000-100 Sarcomatoid features 1-100% R01 Sarcomatoid features stated as less than 10% R02 Sarcomatoid features stated as range 10%-30% present R03` `Sarcomatoid features stated as a range 31% to 50% present R04 Sarcomatoid features stated as a range 51% to 80% present R05 Sarcomatoid features stated as greater than 80% XX5 Sarcomatoid features present from` `metastatic site only AND` `Sarcomatoid features not present in primary site,` `or unknown if present XX6 Sarcomatoid features present, percentage unknown XX7 Not applicable: Not a renal cell carcinoma morphology XX8 Not applicable: Information not collected for this case` `(If this information is required by your standard setter,` `use of code XX8 may result in an edit error.) XX9 Not documented in medical record` `Sarcomatoid features not assessed or unknown if assessed` `No surgical resection of primary site is performed` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3926	SCHEMA DISCRIMINATOR 1	SSD4;21	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>9)!(X<0)!(X?.E1"."1N.N) X I $D(X) S ONCSDND=1 D SDIT^ONCSCHMG` LAST EDITED: `SEP 07, 2018` HELP-PROMPT: `Type a number between 0 and 9, 0 decimal digits.` DESCRIPTION: `Captures additional information needed to generate AJCC ID [995] and Schema ID [3800] for some anatomic sites. Discriminators can be based on sub site, histology or other features which affect prognosis. Rationale: A` `schema discriminator is used to assign AJCC ID [995] when site and histology alone are insufficient to identify the applicable AJCC staging method and to assign Schema ID [3800], which links each case to the appropriate` `SSDIs, Summary Stage and EOD data collection system.` EXECUTABLE HELP: `S ONCSDND=1 D SDHLP^ONCSCHMG` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3927	SCHEMA DISCRIMINATOR 2	SSD4;22	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>9)!(X<0)!(X?.E1"."1N.N) X I $D(X) S ONCSDND=2 D SDIT^ONCSCHMG` LAST EDITED: `SEP 07, 2018` HELP-PROMPT: `Type a number between 0 and 9, 0 decimal digits.` DESCRIPTION: `Captures additional information needed to generate AJCC ID [995] and Schema ID [3800] for some anatomic sites. Discriminators can be based on sub site, histology or other features which affect prognosis. Rationale: A` `schema discriminator is used to assign AJCC ID [995] when site and histology alone are insufficient to identify the applicable AJCC staging method and to assign Schema ID [3800], which links each case to the appropriate` `SSDIs, Summary Stage and EOD data collection system.` EXECUTABLE HELP: `S ONCSDND=2 D SDHLP^ONCSCHMG` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3928	SCHEMA DISCRIMINATOR 3	SSD4;23	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>9)!(X<0)!(X?.E1"."1N.N) X` LAST EDITED: `SEP 07, 2018` HELP-PROMPT: `Type a number between 0 and 9, 0 decimal digits.` DESCRIPTION: `Captures additional information needed to generate AJCC ID [995] and Schema ID [3800] for some anatomic sites. Discriminators can be based on sub site, histology or other features which affect prognosis. Rationale: A` `schema discriminator is used to assign AJCC ID [995] when site and histology alone are insufficient to identify the applicable AJCC staging method and to assign Schema ID [3800], which links each case to the appropriate` `SSDIs, Summary Stage and EOD data collection system.`
3929	SEPARATE TUMOR NODULES	SSD4;24	SET	'0' FOR Single tumor only; '1' FOR Ipsilateral lung same lobe; '2' FOR Ipsilateral lung different lobe; '3' FOR Ipsilateral lung same AND diff lobes; '4' FOR Ipsilateral lung unk if same or diff; '7' FOR Multiple nodules; '8' FOR N/A; '9' FOR Not documented; LAST EDITED: `AUG 21, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `"Separate tumor nodules" refers to what is conceptually a single tumor with intrapulmonary metastasis in the ipsilateral (same) lung. Their presence in the same or different lobes of lung from the primary tumor affects the` `T and M categories. Rationale: This data item was previously collected for Lung, SSF# 1 and at least one standard setter is continuing to collect it. Codes: 0 No separate tumor nodules; single tumor only` `Separate tumor nodules of same histologic` `not identified/not present` `Intrapulmonary metastasis not identified/not present` `Multiple nodules described as multiple foci of adenocarcinoma in situ` `or minimally invasive adenocarcinoma 1 Separate tumor nodules of same histologic type` `in ipsilateral lung, same lobe 2 Separate tumor nodules of same histologic type` `in ipsilateral lung, different lobe 3 Separate tumor nodules of same histologic type` `in ipsilateral lung, same AND different lobes 4 Separate tumor nodules of same histologic type` `in ipsilateral lung, unknown if same or different lobe(s) 7 Multiple nodules or foci of tumor present, not classifiable` `based on notes 3 and 4 8 Not applicable: Information not collected for this case` `(If this item is required by your standard setter,` `use of code 8 will result in an edit error.) 9 Not documented in medical record` `Primary tumor is in situ` `Separate Tumor Nodules not assessed or unknown if assessed`
3930	SERUM ALBUMIN PRETREAT VALUE	SSD4;25	SET	'0' FOR Serum albumin <3.5g/dL; '1' FOR Serum albumin greater or equal 3.5g/dL; '5' FOR Schema Discriminator 1 coded to 1 or 9; '7' FOR Test ordered, results not in chart; '9' FOR Not documented in medical record; LAST EDITED: `JUN 28, 2022` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Albumin is the most abundant protein in human blood plasma. Serum albumin pretreatment level is a prognostic factor for plasma cell myeloma. Rationale: Serum albumin pretreatment level is a prognostic factor required in` `AJCC 8th edition, Chapter 82 Plasma Cell Myeloma and Plasma Cell Disorders, for the Revised International Staging System (RISS). It is a new data item for cases diagnosed 1/1/2018+. Codes: 0 Serum albumin <3.5 g/dL 1` `Serum albumin > or =3.5 g/dL 5 Schema Discriminator 1: Plasma Cell Myeloma Terminology coded to 1 or 9 7 Test ordered, results not in chart 9 Not documented in medical record` `Serum Albumin Pretreatment Level not assessed or unknown if assessed` SCREEN: `S DIC("S")="D SCRN555^ONCSCHMM"` EXPLANATION: `Codes depend on appropriate schema discriminator`
3931	SERUM BETA-2 MICROGLOBULIN	SSD4;26	SET	'0' FOR Less than 3.5mg/L; '1' FOR Greater than or equal 3.5mg/L AND Less than 5.5mg/L; '2' FOR Greater than or equal 5.5mg/L; '5' FOR Schema Discriminator 1 coded to 1 or 9; '7' FOR Test ordered, results not in chart; '9' FOR Not documented; LAST EDITED: `JUN 28, 2022` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Serum Beta-2 Microglobulin is a protein that is found on the surface of many cells and plentiful on the surface of white blood cells. Increased production or destruction of these cells causes Serum ß2 (beta-2)` `Microglobulin level to increase. Elevated Serum ß2 (beta-2) Microglobulin level is a prognostic factor for plasma cell myeloma. Rationale: Serum Beta-2 Microglobulin Pretreatment Level is a prognostic factor required in` `AJCC 8th edition, Chapter 82 Plasma Cell Myeloma and Plasma Cell Disorders, for staging of plasma cell myeloma. It is a new data item for cases diagnosed 1/1/2018+. Codes: 0 ß2-microglobulin <3.5 mg/L 1` `ß2-microglobulin > or =3.5 mg/L <5.5 mg/L 2 ß2-microglobulin > or =5.5 mg/L 5 Schema Discriminator 1: Plasma Cell Myeloma Terminology coded to 1 or 9 7 Test ordered, results not in chart 9 Not documented in medical` `record` `Serum Beta-2 Microglobulin Pretreatment Level not assessed or` `unknown if assessed` SCREEN: `S DIC("S")="D SCRN555^ONCSCHMM"` EXPLANATION: `Codes depend on appropriate schema discriminator`
3932	LDH LAB VALUE	SSD4;27	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>7!($L(X)<1)!'(X?0.5AN0.1"."1N) X I $D(X) D DEC5^ONCSCHMM` `MAXIMUM LENGTH: 7` LAST EDITED: `JAN 26, 2021` HELP-PROMPT: `Answer must be 1-7 characters in length.` DESCRIPTION: `LDH (Lactate Dehydrogenase) Lab Value, measured in serum, is a predictor of treatment response, progression-free survival and overall survival for patients with Stage IV melanoma of the skin. Rationale: LDH (Lactate` `Dehydrogenase) Lab Value is a Registry Data Collection Variable in AJCC. It was previously collected as Melanoma Skin, CS SSF# 5. Codes:` `0.0 0.0 (U/L) 0.1-99999.9 0.1-99,999.9 U/L XXXXX.1 100,000 U/L or greater XXXXX.7 Test ordered, results not in chart XXXXX.8 Not applicable: Information not collected for this case` `(If this item is required by your standard setter,` `use of code XXXXX.8 will result in an edit error.) XXXXX.9 Not documented in medical record` `LDH (Lactate Dehydrogenase) Pretreatment Lab` `Value not assessed or unknown if assessed` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3933	THROMBOCYTOPENIA	SSD4;28	SET	'0' FOR Thromb not present, Plt GT or equal 100000; '1' FOR Thromb present, Plt < 100000; '5' FOR NA, not C421; '6' FOR Lab value unk, physician states Thromb present or RAI stage IV; '7' FOR Test ordered, results not in chart; '9' FOR Not documented; LAST EDITED: `SEP 26, 2023` HELP-PROMPT: `Enter a code from the list that corresponds to the Thrombocytopenia for this patient's primary.` DESCRIPTION: `Thrombocytopenia is defined by a deficiency of platelets in the blood. In staging of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), thrombocytopenia is defined as Platelets (Plt) less than 100,000/ÂµL.` `Rationale: Thrombocytopenia is a prognostic factor required for staging of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) in AJCC 8th edition, Chapter 79 Hodgkin and Non-Hodgkin Lymphomas. It is a new` `data item for cases diagnosed 1/1/2018+. Codes: 0 Thrombocytopenia not present` `Platelets (Plt) >= 100,000/ÂµL` `Physician states RAI stage 0-III 1 Thrombocytopenia present` `Platelets (Plt) < 100,000/ÂµL 5 Not applicable: Primary site is not C421 6 Lab value unknown, physician states thrombocytopenia is present` `Physician states RAI stage IV 7 Test ordered, results not in chart 9 Not documented in medical record` `Thrombocytopenia not assessed or unknown if assessed` SCREEN: `S DIC("S")="D SCRNFIV^ONCSCHMM"` EXPLANATION: `Codes depend on appropriate primary site`
3934	TUMOR DEPOSITS	SSD4;29	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<1)!'(X?0.1AN1N) X I $D(X) D GEN2^ONCSCHMM` `MAXIMUM LENGTH: 2` LAST EDITED: `JUL 26, 2019` HELP-PROMPT: `Answer must be 1-2 characters in length.` DESCRIPTION: `A tumor deposit is defined as a discrete nodule of cancer in pericolic/perirectal fat or in adjacent mesentery (mesocolic or rectal fat) within the lymph drainage area of the primary carcinoma, without identifiable lymph` `node tissue or identifiable vascular structure. Rationale: The presence of tumor deposits is a Registry Data Collection Variable in AJCC. It was previously collected as Colon and Rectum CS SSF# 4. Codes: 00 No tumor` `deposits 01-99 01-99 Tumor deposits (Exact number of Tumor Deposits) X1 100 or more Tumor Deposits X2 Tumor Deposits identified, number unknown X8 Not applicable: Information not collected for this case` `(If this information is required by your standard setter,` `use of code X8 may result in an edit error.) X9 Not documented in medical record` `Cannot be determined by the pathologist` `Pathology report does not mention tumor deposits` `No surgical resection done` `Tumor Deposits not assessed or unknown if assessed` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3935	TUMOR GROWTH PATTERNS	SSD4;30	SET	'1' FOR Mass-forming; '2' FOR Periductal infiltrating; '3' FOR Mixed mass-forming and periductal infiltrating; '8' FOR N/A; '9' FOR Not documented in medical record; LAST EDITED: `AUG 22, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Tumor Growth Pattern refers to the growth pattern of intrahepatic cholangiocarcinoma. Rationale: Tumor Growth Pattern is a Registry Data Collection Variable in AJCC. This data item was previously collected for` `Intrahepatic Bile Duct, SSF# 10. Codes: 1 Mass-forming 2 Periductal infiltrating 3 Mixed mass-forming and periductal infiltrating 8 Not applicable: Information not collected for this case` `(If this information is required by your standard setter,` `use of code 8 may result in an edit error.) 9 Not documented in medical record` `Pathology report does not mention tumor growth pattern` `Cannot be determined by the pathologist` `Tumor growth pattern not assessed or unknown if assessed`
3936	ULCERATION 2018	SSD4;31	SET	'0' FOR Ulceration not identified/not present; '1' FOR Ulceration present; '8' FOR N/A; '9' FOR Not documented in medical record; LAST EDITED: `AUG 22, 2018` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Ulceration, the absence of an intact epidermis overlying the primary melanoma based upon histopathological examination, is a prognostic factor for melanoma of the skin. Rationale Ulceration is a Registry Data Collection` `Variable in AJCC. It was previously collected as Melanoma Skin, CS SSF# 2. Codes 0 Ulceration not identified/not present 1 Ulceration present 8 Not applicable: Information not collected for this case` `(If this item is required by your standard setter,` `use of code 8 will result in an edit error.) 9 Not documented in medical record` `Cannot be determined by the pathologist` `Pathology report does not mention ulceration` `Ulceration not assessed or unknown if assessed`
3937	VISCERAL PARIETAL PLEURAL INV	SSD4;32	SET	'0' FOR No evidence/PL0; '4' FOR Inv of visceral pleura, NOS/PL1 or PL2; '5' FOR Invades into or through parietal pleura OR chest wall/PL3; '6' FOR Extends to pleura, NOS; '8' FOR N/A; '9' FOR Not documented; LAST EDITED: `JUN 01, 2021` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Visceral and Parietal Pleural Invasion is defined as invasion beyond the elastic layer or to the surface of the visceral pleura. Rationale: Visceral and Parietal Pleural Invasion (previously called "pleural/elastic layer` `invasion (PL)") is a Registry Data Collection Variable for AJCC. This data item was previously collected for Lung, SSF# 2. Codes: 0 No evidence of visceral pleural invasion identified` `Tumor does not completely traverse the elastic layer of the pleura` `Stated as PL0 4 Invasion of visceral pleura present, NOS` `Stated as PL1 or PL2 5 Tumor invades into or through the parietal pleural OR chest wall` `Stated as PL3 6 Tumor extends to pleura, NOS; not stated if visceral or parietal 8 Not applicable: Information not collected for this case` `(If this item is required by your standard setter,` `use of code 8 will result in an edit error.) 9 Not documented in medical record` `No surgical resection of primary site is performed` `Visceral Pleural Invasion not assessed or unknown if assessed` `or cannot be determined`
3938	ALK REARRANGEMENT	SSD5;1	SET	'0' FOR Normal/ALK negative; '1' FOR EML4-ALK,KIF5B-ALK,TFG-ALK,KLC1-ALK; '2' FOR Other ALK not listed in code 1; '4' FOR Rearrangement, NOS; '7' FOR Test ordered, results not in chart; '8' FOR N/A; '9' FOR Not documented; LAST EDITED: `JUN 01, 2021` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Testing for ALK rearrangement is performed for patients with advanced non-small cell lung cancer (NSCLC) to identify tumors which are sensitive to small-molecule ALK kinase inhibitors. Rationale: ALK rearrangement is` `recommended by treatment guidelines for patients with advanced lung cancer as a prognostic marker and factor in determining appropriate therapy. It is a new data item for cases diagnosed 01/01/2021+. Codes: 0 Normal` `ALK negative` `Negative for rearrangement, no rearrangement identified,` `no mutations (somatic) identified, not present, not detected 1 Abnormal Rearrangement identified/detected: EML4-ALK,` `KIF5B-ALK, TFG-ALK, and/or KLC1-ALK 2 Rearrangement identified/detected: Other ALK` `Rearrangement not listed in code 1 4 Rearrangement, NOS 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case` `If this information is required by your standard setter,` `use of code 8 may result in an edit error. 9 Not documented in medical record` `ALK Rearrangement not assessed or unknown if assessed`
3939	EGFR MUTATIONAL ANALYSIS	SSD5;2	SET	'0' FOR Normal, EGFR negative,EGFR wild type; '1' FOR Abnormal-detected in exon(s) 18,19,20,21; '2' FOR Abnormal-detected BUT NOT in exon(s) 18,19,20,21; '4' FOR Detected, NOS; '7' FOR Test ordered, results not in chart; '8' FOR N/A; '9' FOR Not documented; LAST EDITED: `JUN 01, 2021` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Epidermal growth factor receptor (EGFR) mutational analysis is performed for patients with advanced non-small cell lung cancer (NSCLC) to identify patients with certain activating mutations in the EGFR gene which are` `sensitive to tyrosine kinase inhibitors. Rationale: EGFR mutational analysis is recommended by treatment guidelines for patients with advanced lung cancer as a prognostic marker and factor in determining appropriate` `therapy. It is a new data item for cases diagnosed 01/01/2021+. Codes: 0 Normal` `EGFR negative, EGFR wild type` `Negative for mutations, no alterations,` `no mutations (somatic) identified, not present, not detected 1 Abnormal (mutated)/detected in exon(s) 18, 19, 20, and/or 21 2 Abnormal (mutated)/detected but not in exon(s) 18, 19, 20, and/or 21 4 Abnormal` `(mutated)/detected, NOS, exon(s) not specified 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case` `If this information is required by your standard setter,` `use of code 8 may result in an edit error. 9 Not documented in medical record` `EGFR not assessed or unknown if assessed`
3940	BRAF MUTATIONAL ANALYSIS	SSD5;3	SET	'0' FOR Normal; '1' FOR Detected, BRAF V600E (c.1799T>A) mutation; '2' FOR Detected, but not BRAF V600E (c.1799T>A) mutation; '4' FOR Abnormal, NOS; '7' FOR Test ordered, results not in chart; '8' FOR N/A; '9' FOR Not documented; LAST EDITED: `JAN 14, 2021` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `The BRAF oncoprotein is involved in transmitting cell growth and proliferation signals from KRAS and NRAS. The BRAF V600E mutation is associated with poorer prognosis and predicts lack of response to anti-EGFR therapies.` `Rationale: BRAF mutational analysis is recommended in clinical guidelines for patients with advanced colorectal cancer as a prognostic marker and factor in determining appropriate therapy. It is a new data item for cases` `diagnosed 1/1/2021+. Codes: 0 Normal` `BRAF negative, BRAF wild type` `Negative for (somatic) mutations, no alterations,` `no (somatic) mutations identified, not present, not detected 1 Abnormal (mutated)/detected: BRAF V600E (c.1799T>A) mutation 2 Abnormal (mutated)/detected, but not BRAF V600E (c.1799T>A) mutation 4 Abnormal` `(mutated), NOS 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case` `If this information is required by your standard setter,` `use of code 8 may result in an edit error.) 9 Not documented in medical record` `BRAF not assessed or unknown if assessed`
3941	NRAS MUTATIONAL ANALYSIS	SSD5;4	SET	'0' FOR Normal; '1' FOR Detected in codon(s) 12,13, and/or 61; '2' FOR Detected, codon(s) specified but not in codon(s) 12,13, or 61; '4' FOR Abnormal, NOS; '7' FOR Test ordered, results not in chart; '8' FOR N/A; '9' FOR Not documented; LAST EDITED: `JAN 14, 2021` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `NRAS is a signaling intermediate in the growth receptor pathway. Certain NRAS mutations predict poor response to anti-EGFR therapy in patients with metastatic colorectal cancer. Rationale: NRAS mutational analysis is` `recommended in clinical guidelines for patients with metastatic colon cancer who are being considered for anti-EGFR therapy. It is a new data item for cases diagnosed 01/01/2021+. Codes: 0 Normal` `NRAS negative; NRAS wild type` `Negative for (somatic) mutations, no alterations,` `no (somatic) mutations identified, not present, not detected 1 Abnormal (mutated)/detected in codon(s) 12, 13, and/or 61 2 Abnormal (mutated)/detected, codon(s) specified but not` `in codon(s) 12, 13, or 61 4 Abnormal (mutated), NOS, codon(s) not specified 7 Test ordered, results not in chart 8 Not applicable: Information not collected for this case` `If this information is required by your standard setter,` `use of code 8 may result in an edit error. 9 Not documented in medical record` `NRAS not assessed or unknown if assessed`
3942	CA 19-9 PRETX LAB VALUE	SSD5;5	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>6!($L(X)<1)!'(X?0.4AN0.1"."1N) X I $D(X) D DEC4^ONCSCHMM` `MAXIMUM LENGTH: 6` LAST EDITED: `JAN 14, 2021` HELP-PROMPT: `Answer must be 1-6 characters in length.` DESCRIPTION: `Carbohydrate Antigen (CA) 19-9 Pretreatment Lab Value records the CA 19-9 value prior to treatment. CA 19-9 is a tumor marker that has prognostic significance for pancreatic cancer. Rationale: CA 19-9 Pretreatment Lab` `Value is a strong predictor of resectability in the absence of metastatic disease. It is a new data item for cases diagnosed 01/01/2021+. Codes: 0.0 0.0 Units/milliliter (U/ml) exactly 0.1-9999.9 0.1-9999.9 U/ml` `Exact value to nearest tenth in U/ml) XXXX.1 10,000 U/ml or greater XXXX.2 Lab value not available, physician states CA 19-9 is` `negative/normal XXXX.3 Lab value not available, physician states CA 19-9 is` `positive/elevated/high XXXX.7 Test ordered, results not in chart XXXX.8 Not applicable: Information not collected for this case` `If this information is required by your standard setter,` `use of code XXXX.8 may result in an edit error. XXXX.9 Not documented in medical record` `CA (Carbohydrate Antigen) 19-9 Pretreatment Lab Value` `not assessed or unknown if assessed` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3943	NCDB-SARSCOV2-TEST	NCR21;1	SET	'0' FOR Patient not tested for SARS-CoV2; '1' FOR Patient tested for Active SARS-CoV2; '9' FOR Unknown if patient tested for SARS-CoV2; LAST EDITED: `FEB 02, 2021` HELP-PROMPT: `Enter the value corresponding to the correct SARS-CoV2 test` DESCRIPTION: `This data item is designed to track whether patient received a SARS-CoV-2 test or not. Collection based on diagnosis years 2020 and 2021.` `Rationale: To evaluate the impact of COVID-19 diagnosis on cancer patients.` `Codes: 0 Patient not tested for SARS-CoV-2: facility records support` `that patient did not undergo pre-admit or in-hospital testing 1 Patient tested for Active SARS-CoV2 9 Unknown if patient tested for SARS-CoV-2/No facility record of` `preadmit hospital testing of SARS-CoV-2 Note: This item may be left blank.`
3944	NCDB-SARSCOV2-POSITIVE	NCR21;2	SET	'0' FOR Patient did not test positive for active SARS-CoV-2; '1' FOR Patient tested positive for active SARS-CoV-2; '9' FOR Unknown if tested or test done, results unknown; LAST EDITED: `FEB 02, 2021` HELP-PROMPT: `Enter the value corresponding to the correct SARS-CoV2 test` DESCRIPTION: `Data item is designed to track whether patient received a POSITIVE SARS-CoV-2 test or not. Collection based on diagnosis years 2020 and 2021.` `Rationale: To evaluate the impact of COVID-19 diagnosis on cancer patients.` `Codes: 0 Patient did not test positive for active SARS-CoV-2:` `No positive test 1 Patient tested positive for active SARS-CoV-2: test` `positive on at least one test 9 Unknown if tested; test done, results unknown Note: This item may be left blank.`
3945	NCDB-SARSCOV2-POSITIVE DATE	NCR21;3	DATE	INPUT TRANSFORM: `S %DT="E",%DT(0)="-NOW" D ^%DT S X=Y K:Y<1 X` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `JUL 06, 2021` HELP-PROMPT: `Enter the date the patient had a positive COVID-19 test` DESCRIPTION: `This field stores the date of the first positive COVID-19 test for the patient. Collection based on diagnosis years 2020 and 2021.` `Rationale: To evaluate the impact of COVID-19 diagnosis on cancer patients.` `This field will store the date the patient had a positive test for SARS-CoV-2, the virus that causes the 2019 novel coronavirus disease (COVID-19) as documented by a medical provider. May be blank if date of the test is` `unknown or the date of a positive (diagnostic or serologic) test is unknown for SARS-CoV-2.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
3946	NCDB-COVID19-TX IMPACT	NCR21;4	SET	'1' FOR Treatment not affected; '2' FOR First course timeline delayed; '3' FOR First course plan altered; '4' FOR Cancelled first course; '5' FOR Patient refused treatment due to COVID-19; '9' FOR Unknown; LAST EDITED: `FEB 02, 2021` HELP-PROMPT: `Enter the code evaluating treatment impact` DESCRIPTION: `This field stores whether or not the first course of treatment (diagnosis, staging, treatment or other cancer management events) was impacted by hospital avail- ability (limited access to facilities or postponement of` `non-essential procedures) due to COVID-19 pandemic. Collection based on diagnosis years 2020 and 2021.` `Rationale: To evaluate the impact of COVID-19 pandemic on cancer patients.` `Codes: 1 Treatment not affected; active surveillance, no change 2 First Course of Treatment timeline delayed 3 First Course of Treatment plan altered 4 Cancelled First Course of Treatment 5 Patient refused treatment` `due to COVID-19 9 Not known if treatment affected Note: This item may be left blank.`
3950	MACROSCOPIC EVAL OF MESORECTUM	SSD5;7	SET	'00' FOR Did not receive TME; '10' FOR Incomplete; '20' FOR Nearly complete; '30' FOR Complete; '40' FOR TME performed, not specified; '99' FOR Unknown; LAST EDITED: `JUN 06, 2022` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Description: This data item records the results of a macroscopic evaluation of the mesorectum from a total mesorectal excision (TME).` `Rationale: Numerous studies have demonstrated the total mesorectal excision (TME) improves local recurrence rates and the corresponding survival by as much as 20%. Macroscopic pathologic assessment of the completeness of` `the mesorectum, scored as complete, partially complete, or incomplete, accurately predicts both local recurrence and distant metastasis.` `Codes: 00 Patient did not receive TME 10 Incomplete 20 Nearly complete 30 Complete 40 TME performed not specified on pathology report as incomplete,` `nearly complete, or complete TME performed, but pathology report` `not available Physician statement that TME performed, no mention` `of incomplete, nearly complete, or complete status 99 Unknown if TME performed Blank Site not rectum (C20.9)`
3955	DERIVED RAI STAGE	SSD5;8	SET	'0' FOR Lymphocytosis; '1' FOR Lymphocytosis & Adenopathy; '2' FOR Lymphocytosis & Organomegaly; '3' FOR Lymphocytosis & Anemia; '4' FOR Lymphocytosis & Thrombocytopenia; '8' FOR N/A; '9' FOR Unk; LAST EDITED: `JUN 06, 2022` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Description: This data item stores the Derived Rai stage value derived from the values coded in the following SSDIs for the Lymphoma-CLL/SLL schema (9823/3):` `Lymphocytosis [3885]` `Adenopathy [3804]` `Organomegaly [3907]` `Anemia [3811]` `Thrombocytopenia [3933] The Rai stage is only applicable for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (9823/3) cases where the primary site is bone marrow (C421). For cases with a primary site` `other than bone marrow (C421), the derived Rai stage will be 8 and all the SSDIs will be coded to 5. Derivation will be run on all cases diagnosed 1/1/2018 and forward.` `Rationale: The Derived Rai stage can be used to evaluate disease spread at diagnosis, treatment patterns and outcomes over time.` `Codes: 0 Lymphocytosis 1 Lymphocytosis and Adenopathy 2 Lymphocytosis and Organomegaly` `(Adenopathy is any value other than 5) 3 Lymphocytosis and Anemia` `(Adenopathy and Organomegaly are any value other than 5) 4 Lymphocytosis and Thrombocytopenia` `(Adenopathy, Organomegaly and Anemia are any value other than 5) 8 Does not apply, primary site not bone marrow (C421)` `(All 5 SSDIs should be set to 5) 9 Unknown` `(All 5 SSDIs are 9 or blank; at least one is set to 9 OR` `Lymphocytosis is 0,7,9 OR` `Lymphocytosis is blank and one of the other SSDIs` `is a value other than 5 0r 9)`
3956	P16	SSD5;9	SET	'0' FOR p16 Negative, Nonreactive; '1' FOR p16 Positive - Diffuse, Strong reactivity; '8' FOR N/A; '9' FOR Not tested for p16 - Unknown; LAST EDITED: `JUN 06, 2022` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Description: The p16 biomarker is over-expressed (produced) in response to HPV. It is therefore a surrogate marker for HPV disease.` `Rationale: Patients with HPV have a different survival or outcome so it is important to be able to distinguish this by documenting the p16 results. Testing is performed by immunohistochemistry (IHC) which is inexpensive` `and has near universal availability. It has an easily standardized interpretation. HPV testing is usually performed through DNA testing which is more expensive and less widely available. HPV testing also has technically` `more variability with the interpretation. p16 is a tumor suppressor protein also known as cyclin- dependent kinase inhibitor 2A. The p16 biomarker is over- expressed (produced) in response to HPV. It is therefore a` `surrogate marker for HPV disease.` `Codes: 0 p16 Negative; Nonreactive 1 p16 Positive; Diffuse, Strong reactivity 8 Not applicable: Information not collected for this case` `(If this time is required by your standard setter, use of` `code 8 will result in an edit error). 9 Not tested for p16; Unknown Blank Diagnosis year prior to 2021` `Note 1: This SSDI is effective for diagnosis years 2022+` `For cases diagnosed 2018-2021, leave this SSDI blank Note 2: Code 0 for p16 expression of weak intensity or limited distribution. Note 3: This data item must be based on testing results for p16` `overexpression.` `A statement of a patient being HPV positive or negative` `is not enough to code this data item` `Testing for HPV by DNA, mRNA, antibody, or other` `methods should not be coded in this data item Do not confuse p16 with HPV 16, which is a specific strain of virus`
3957	LN STATUS PELVIC	SSD5;10	SET	'0' FOR Negative pelvic lymph nodes; '1' FOR Positive pelvic lymph nodes; '8' FOR N/A; '9' FOR Not documented on medical record; LAST EDITED: `JUN 06, 2022` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Description: This data item describes the status of pelvic lymph nodes associated with certain female genital cancers.` `Rationale: Specific regional lymph node involvement is listed as a Registry Data Collection Variable in AJCC. This information was previously collected as Cervix SSF #2. Variable in AJCC. This information was previously` `collected as Cervix SSF #2.` `Codes: 0 Negative pelvic lymph nodes 1 Positive pelvic lymph nodes 8 Not applicable: Information not collected for this case (If this` `information is required by your standard setter, use of code 8` `may result in edit error.) 9 Not documented in medical record` `Pelvic lymph node(s) not assessed or unknown if assessed`
3958	LN STATUS PARA-AORTIC	SSD5;11	SET	'0' FOR Negative para-aortic lymph nodes; '1' FOR Positive para-aortic lymph nodes; '8' FOR N/A; '9' FOR Not documented in medical record; LAST EDITED: `JUN 06, 2022` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Description: This data item describes the status of para-aortic lymph nodes associated with certain female genital cancers.` `Rationale: Specific regional lymph node involvement is listed as a Registry Data Collection Variable in AJCC. This information was previously collected as Vagina SSF #4.` `See Lymph Node Assessment Methods and Status for Regional and Distant Lymph Nodes in GYN sites for additional information.` `Codes: 0 Negative para-aortic lymph nodes 1 Positive para-aortic lymph nodes 8 Not applicable: Information not collected for this case (If` `this information is required by your standard setter, use` `of code 8 may result in an edit error.) 9 Not documented in medical record` `Para-aortic lymph node(s) not assessed or unknown if assessed`
3959	LN STATUS FEMORAL-INGUINAL	SSD5;12	SET	'0' FOR Negative femoral-inguinal lymph nodes; '1' FOR Positive femoral-inguinal lymph nodes; '8' FOR N/A; '9' FOR Not documented in medical record; LAST EDITED: `JUN 06, 2022` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Description: This data item describes the status of femoral-inguinal lymph nodes associated with certain female genital cancers.` `Rationale: Specific regional lymph node involvement is listed as a Registry Data Collection Variable in AJCC.` `See Lymph Node Assessment Methods and Status for Regional and Distant Lymph Nodes in GYN sites for additional information.` `Codes: 0 Negative femoral-inguinal lymph nodes 1 Positive femoral-inguinal lymph nodes 8 Not applicable: Information not collected for this case` `(If this information is required by your standard setter,` `use of code 8 may result in an edit error.) 9 Not documented in medical record Femoral-Inguinal lymph nodes not assessed or unknown if assessed`
3960	HISTOLOGIC SUBTYPE	SSD5;13	SET	'0' FOR Histology is not 8480; '1' FOR Low-grade appendiceal mucinous neoplasm (LAMN); '2' FOR High-grade appendiceal mucinous neoplasm (HAMN); '3' FOR Mucinous/Mucus/Mucoid/Colloid adenocarcinoma/carcinoma; '4' FOR Other terminology coded to 8480; LAST EDITED: `SEP 26, 2023` HELP-PROMPT: `Enter a code from the list that corresponds to the histologic subtype of this patient's primary.` DESCRIPTION: `Histology code for appendiceal tumors (8480) is defined as "Mucinous Adenocarcinoma (in situ or invasive)." In the AJCC 8th chapter for Appendix-Carcinoma, there are also low-grade appendiceal mucinous neoplasm (LAMN) and` `high- grade appendiceal mucinous neoplasm (HAMN) diagnoses that are assigned the same histology.`
3961	CLINICAL MARGIN WIDTH	SSD5;14	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>4!($L(X)<1)!'(X?0.2AN0.1"."1N) X I $D(X) D DEC2^ONCSCHMM` `MAXIMUM LENGTH: 4` LAST EDITED: `SEP 26, 2023` HELP-PROMPT: `Answer must be 1-4 characters in length. Enter the clinical margin width in centimeters as measured by the surgeon.` DESCRIPTION: `Clinical Margin Width describes the margins from a wide excision for a melanoma primary. The margin width is measured by the surgeon prior to the procedure. The measurement is taken, in centimeters, from the edge of the` `lesion or the prior excision scar to the peripheral margin of the specimen. 0.1 Documented as 0.1cm or less (1mm or less) 0.2-9.9 0.2 cm - 9.9 cm XX.1 10 centimeters or greater XX.8 Not Applicable.` `Information not collected for` `this schema (If this information is required` `by your standard setter, use of code XX.8 may` `result in an edit error) XX.9 Not documented in medical record` `No Wide Excision performed` `Mohs or similar procedure` `Wide Excision performed, but clinical margin` `width not documented.` `No surgical resection performed (B000)` `Unknown if procedure performed.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
5000	AJCC ID	AJCC8;1	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>4!($L(X)<1)!'(X?0.2"X"0.2N0.1"."0.1N) X` `MAXIMUM LENGTH: 4` LAST EDITED: `OCT 25, 2018` HELP-PROMPT: `Answer must be 1-4 characters in length.` DESCRIPTION: `This field is the AJCC ID for the case. The values for this field are based on the chapters of the AJCC 8th Edition Staging Manual. The value will be derived primarily by the Site/Histology fields. For cases where` `staging is not available this field will be "XX".`
5001	AJCC TNM CLIN T	AJCC8;2	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>15!($L(X)<1) X I $D(X) S ONCNODE=1 D AJCCIT^ONCSCHMG` `MAXIMUM LENGTH: 15` LAST EDITED: `FEB 13, 2019` HELP-PROMPT: `Answer must be 1-15 characters in length.` DESCRIPTION: `Detailed site-specific codes for the clinical tumor (T) as defined by the current AJCC edition.` EXECUTABLE HELP: `S ONCNODE=1 D AJCCHP^ONCSCHMG` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
5002	AJCC TNM CLIN N	AJCC8;3	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>15!($L(X)<1) X I $D(X) S ONCNODE=2 D AJCCIT^ONCSCHMG` `MAXIMUM LENGTH: 15` LAST EDITED: `AUG 28, 2019` HELP-PROMPT: `Answer must be 1-15 characters in length.` DESCRIPTION: `Detailed site-specific codes for the clinical nodes (N) as defined by the current AJCC edition.` EXECUTABLE HELP: `S ONCNODE=2 D AJCCHP^ONCSCHMG` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
5003	AJCC TNM CLIN M	AJCC8;4	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>15!($L(X)<1) X I $D(X) S ONCNODE=3 D AJCCIT^ONCSCHMG` `MAXIMUM LENGTH: 15` LAST EDITED: `JAN 30, 2019` HELP-PROMPT: `Answer must be 1-15 characters in length.` DESCRIPTION: `Detailed site-specific codes for the clinical metastases (M) as defined by the current AJCC edition.` EXECUTABLE HELP: `S ONCNODE=3 D AJCCHP^ONCSCHMG` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
5004	AJCC TNM CLIN STAGE GROUP	AJCC8;5	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>15!($L(X)<1) X I $D(X) S STGIND="C",ONCSHLST="NO" D INP^ONCSGA8H` `MAXIMUM LENGTH: 15` LAST EDITED: `AUG 20, 2021` HELP-PROMPT: `Answer must be 1-15 characters in length.` DESCRIPTION: `Detailed site-specific codes for the clinical stage group as defined by the current AJCC edition.` EXECUTABLE HELP: `S STGIND="C" D HELP^ONCSGA8H` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^G^MUMPS` `1)= D CSSG^ONCOCRC` `2)= D KSG^ONCOCRC` `Maintains STAGE GROUPING-AJCC Field (#38.5). See fields #38 and #88. This is an update for new AJCC TNM staging fields 8th Edition and beyond.`
5011	AJCC TNM PATH T	AJCC8;6	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>15!($L(X)<1) X I $D(X) S ONCNODE=1,ONCTNMTP="P" D AJCCIT^ONCSCHMG` `MAXIMUM LENGTH: 15` LAST EDITED: `FEB 14, 2019` HELP-PROMPT: `Answer must be 1-15 characters in length.` DESCRIPTION: `Detailed site-specific codes for the pathological tumor (T) as defined by the current AJCC edition.` EXECUTABLE HELP: `S ONCNODE=1,ONCTNMTP="P" D AJCCHP^ONCSCHMG` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
5012	AJCC TNM PATH N	AJCC8;7	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>15!($L(X)<1) X I $D(X) S ONCNODE=2,ONCTNMTP="P" D AJCCIT^ONCSCHMG` `MAXIMUM LENGTH: 15` LAST EDITED: `FEB 14, 2019` HELP-PROMPT: `Answer must be 1-15 characters in length.` DESCRIPTION: `Detailed site-specific codes for the pathological nodes (T) as defined by the current AJCC edition.` EXECUTABLE HELP: `S ONCNODE=2,ONCTNMTP="P" D AJCCHP^ONCSCHMG` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
5013	AJCC TNM PATH M	AJCC8;8	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>15!($L(X)<1) X I $D(X) S ONCNODE=3 D AJCCIT^ONCSCHMG` `MAXIMUM LENGTH: 15` LAST EDITED: `OCT 30, 2018` HELP-PROMPT: `Answer must be 1-15 characters in length.` DESCRIPTION: `Detailed site-specific codes for the pathological metastases (T) as defined by the currect AJCC edition.` EXECUTABLE HELP: `S ONCNODE=3 D AJCCHP^ONCSCHMG` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
5014	AJCC TNM PATH STAGE GROUP	AJCC8;9	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>15!($L(X)<1) X I $D(X) S STGIND="P",ONCSHLST="NO" D INP^ONCSGA8H` `MAXIMUM LENGTH: 15` LAST EDITED: `APR 06, 2021` HELP-PROMPT: `Answer must be 1-15 characters in length.` DESCRIPTION: `Detailed site-specific codes for the pathological stage group as defined by the current AJCC edition.` EXECUTABLE HELP: `S STGIND="P" D HELP^ONCSGA8H` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER` CROSS-REFERENCE: `165.5^H^MUMPS` `1)= D PSSG^ONCOCRC` `2)= D KSG^ONCOCRC` `Maintains STAGE GROUPING-AJCC Field (#38.5). See fields #38 and #88. This is an update for new AJCC TNM staging fields 8th Edition and beyond.`
5021	AJCC TNM POST THER (yp) T	AJCC8;10	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>15!($L(X)<1) X I $D(X) S ONCNODE=1,ONCTNMTP="Y" D AJCCIT^ONCSCHMG` `MAXIMUM LENGTH: 15` LAST EDITED: `AUG 16, 2021` HELP-PROMPT: `Answer must be 1-15 characters in length.` DESCRIPTION: `Detailed site-specific codes for the post-therapy path (yp) tumor (T) as defined by the current AJCC edition.` EXECUTABLE HELP: `S ONCNODE=1,ONCTNMTP="Y" D AJCCHP^ONCSCHMG` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
5022	AJCC TNM POST THER (yp) N	AJCC8;11	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>15!($L(X)<1) X I $D(X) S ONCNODE=2,ONCTNMTP="Y" D AJCCIT^ONCSCHMG` `MAXIMUM LENGTH: 15` LAST EDITED: `JUN 28, 2021` HELP-PROMPT: `Answer must be 1-15 characters in length.` DESCRIPTION: `Detailed site-specific codes for the postneoadjuvant therapy Path nodes (N) as defined by the current AJCC edition.` EXECUTABLE HELP: `S ONCNODE=2,ONCTNMTP="Y" D AJCCHP^ONCSCHMG` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
5023	AJCC TNM POST THER (yp) M	AJCC8;12	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>15!($L(X)<1) X I $D(X) S ONCNODE=3 D AJCCIT^ONCSCHMG` `MAXIMUM LENGTH: 15` LAST EDITED: `JUN 28, 2021` HELP-PROMPT: `Answer must be 1-15 characters in length.` DESCRIPTION: `Detailed site-specific codes for the postneoadjuvant therapy category matestases (M) as defined by the current AJCC edition.` EXECUTABLE HELP: `S ONCNODE=3 D AJCCHP^ONCSCHMG` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
5024	AJCC TNM POST THER (yp) SG	AJCC8;13	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>15!($L(X)<1) X I $D(X) S STGIND="PT",ONCSHLST="NO" D INP^ONCSGA8H` `MAXIMUM LENGTH: 15` LAST EDITED: `JUN 28, 2021` HELP-PROMPT: `Answer must be 1-15 characters in length.` DESCRIPTION: `Detailed site-specific codes for the postneoadjuvant therapy Path stage group as defined by the current AJCC edition.` EXECUTABLE HELP: `S STGIND="PT" D HELP^ONCSGA8H` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
5025	AJCC TNM POST THER (yc) T	AJCC8;20	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>15!($L(X)<1) X I $D(X) S ONCNODE=1,ONCTNMTP="Y",ONCYC="yc" D AJCCIT^ONCSCHMG` `MAXIMUM LENGTH: 15` LAST EDITED: `AUG 16, 2021` HELP-PROMPT: `Answer must be 1-15 characters in length.` DESCRIPTION: `Detailed site-specific codes for the post-therapy clinical (yc) tumor (T) as defined by the current AJCC edition.` EXECUTABLE HELP: `S ONCNODE=1,ONCTNMTP="Y",ONCYC="yc" D AJCCHP^ONCSCHMG` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
5026	AJCC TNM POST THER (yc) N	AJCC8;21	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>15!($L(X)<1) X I $D(X) S ONCNODE=2,ONCTNMTP="Y",ONCYC="yc" D AJCCIT^ONCSCHMG` `MAXIMUM LENGTH: 15` LAST EDITED: `AUG 16, 2021` HELP-PROMPT: `Answer must be 1-15 characters in length.` DESCRIPTION: `Detailed site-specific codes for the post-therapy clinical (yc) nodes (N) as defined by the current AJCC edition.` EXECUTABLE HELP: `S ONCNODE=2,ONCTNMTP="Y",ONCYC="yc" D AJCCHP^ONCSCHMG` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
5027	AJCC TNM POST THER (yc) M	AJCC8;22	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>15!($L(X)<1) X I $D(X) S ONCNODE=3 D AJCCIT^ONCSCHMG` `MAXIMUM LENGTH: 15` LAST EDITED: `JUN 28, 2021` HELP-PROMPT: `Answer must be 1-15 characters in length.` DESCRIPTION: `Detailed site-specific codes for the post-therapy clinical (yc) metastases (M) as defined by the current AJCC edition.` EXECUTABLE HELP: `S ONCNODE=3 D AJCCHP^ONCSCHMG` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
5028	AJCC TNM POST THER (yc) SG	AJCC8;23	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>15!($L(X)<1) X I $D(X) S STGIND="PT",ONCSHLST="NO" D INP^ONCSGA8H` `MAXIMUM LENGTH: 15` LAST EDITED: `JUN 28, 2021` HELP-PROMPT: `Answer must be 1-15 characters in length.` DESCRIPTION: `Detailed site-specific codes for the post therapy clinical (yc) stage group as defined by AJCC.` EXECUTABLE HELP: `S STGIND="PT" D HELP^ONCSGA8H` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
5031	AJCC TNM CLIN T SUFFIX	AJCC8;14	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>4!($L(X)<1) X I $D(X) S ONCSFFX="T" D SUFFIT^ONCSCHMG` `MAXIMUM LENGTH: 4` LAST EDITED: `AUG 28, 2019` HELP-PROMPT: `Answer must be 1-4 characters in length.` DESCRIPTION: `This field is the Clinical Suffix that may be added to the Clinical T-Code for AJCC 8th Edition staging.` EXECUTABLE HELP: `S ONCSFFX="T" D SUFFHLP^ONCSCHMG` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
5032	AJCC TNM PATH T SUFFIX	AJCC8;16	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>4!($L(X)<1) X I $D(X) S ONCSFFX="T" D SUFFIT^ONCSCHMG` `MAXIMUM LENGTH: 4` LAST EDITED: `AUG 28, 2019` HELP-PROMPT: `Answer must be 1-4 characters in length.` DESCRIPTION: `This field is the Pathologic Suffix that may be added to the Pathologic T-Code for AJCC 8th Edition staging.` EXECUTABLE HELP: `S ONCSFFX="T" D SUFFHLP^ONCSCHMG` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
5033	AJCC TNM POST THER (yp) T SFX	AJCC8;18	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>4!($L(X)<1) X I $D(X) S ONCSFFX="T" D SUFFIT^ONCSCHMG` `MAXIMUM LENGTH: 4` LAST EDITED: `JUN 28, 2021` HELP-PROMPT: `Answer must be 1-4 characters in length.` DESCRIPTION: `This field is the detailed site-specific codes for the postneoadjuvant therapy Path T category suffix as defined by AJCC.` EXECUTABLE HELP: `S ONCSFFX="T" D SUFFHLP^ONCSCHMG` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
5033.5	AJCC TNM POST THER (yc) T SFX	AJCC8;24	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>4!($L(X)<1) X I $D(X) S ONCSFFX="T" D SUFFIT^ONCSCHMG` `MAXIMUM LENGTH: 4` LAST EDITED: `JUN 28, 2021` HELP-PROMPT: `Answer must be 1-4 characters in length.` DESCRIPTION: `Detailed site-specific codes for the post therapy clinical (yc) tumor T category suffix as defined by AJCC.` EXECUTABLE HELP: `S ONCSFFX="T" D SUFFHLP^ONCSCHMG` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
5034	AJCC TNM CLIN N SUFFIX	AJCC8;15	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>4!($L(X)<1) X I $D(X) S ONCSFFX="N" D SUFFIT^ONCSCHMG` `MAXIMUM LENGTH: 4` LAST EDITED: `AUG 28, 2019` HELP-PROMPT: `Answer must be 1-4 characters in length.` DESCRIPTION: `This field is the Clinical Suffix that may be added to the Clinical N-Code for AJCC 8th Edition staging.` EXECUTABLE HELP: `S ONCSFFX="N" D SUFFHLP^ONCSCHMG` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
5035	AJCC TNM PATH N SUFFIX	AJCC8;17	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>4!($L(X)<1) X I $D(X) S ONCSFFX="N" D SUFFIT^ONCSCHMG` `MAXIMUM LENGTH: 4` LAST EDITED: `AUG 28, 2019` HELP-PROMPT: `Answer must be 1-4 characters in length.` DESCRIPTION: `This field is the Pathologic Suffix that may be added to the Pathologic N-Code for AJCC 8th Edition staging.` EXECUTABLE HELP: `S ONCSFFX="N" D SUFFHLP^ONCSCHMG` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
5036	AJCC TNM POST THER (yp) N SFX	AJCC8;19	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>4!($L(X)<1) X I $D(X) S ONCSFFX="N" D SUFFIT^ONCSCHMG` `MAXIMUM LENGTH: 4` LAST EDITED: `JUN 28, 2021` HELP-PROMPT: `Answer must be 1-4 characters in length.` DESCRIPTION: `This field is the detailed site-specific codes for the postneoadjuvant therapy Path N category suffix as defined by AJCC.` EXECUTABLE HELP: `S ONCSFFX="N" D SUFFHLP^ONCSCHMG` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
5036.5	AJCC TNM POST THER (yc) N SFX	AJCC8;25	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>4!($L(X)<1) X I $D(X) S ONCSFFX="N" D SUFFIT^ONCSCHMG` `MAXIMUM LENGTH: 4` LAST EDITED: `JUN 28, 2021` HELP-PROMPT: `Answer must be 1-4 characters in length.` DESCRIPTION: `Detailed site-specific codes for the post therapy clinical (yc) N category suffix as defined by AJCC.` EXECUTABLE HELP: `S ONCSFFX="N" D SUFFHLP^ONCSCHMG` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
5501	PHASE 1 DOSE PER FRACTION	RAD18;1	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>5!($L(X)<1)!'(X?1.5N) X I $D(X) D RADPH5^ONCSCHMM` `MAXIMUM LENGTH: 5` LAST EDITED: `MAR 26, 2020` HELP-PROMPT: `Answer must be 1-5 characters in length.` DESCRIPTION: `Records the dose per fraction (treatment session) delivered to the patient in the first phase of radiation during the first course of treatment. The unit of measure is centiGray (cGy). This data item is required for` `CoC-accredited facilities as of 01/01/2018. Rationale: Radiation therapy is delivered in one or more phases with identified dose per fraction. It is necessary to capture information describing the dose per fraction to` `evaluate patterns of radiation oncology care. Outcomes are strongly related to the dose delivered. Codes: 00000 Radiation therapy was not administered 00001-99997 Record the actual Phase I dose delivered in cGy 99998` `Not applicable, brachytherapy or` `radioisotopes administered to the patient 99999 Regional radiation therapy was administered` `but dose is unknown, it is unknown whether` `radiation therapy was administered.` `Death Certificate only.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
5502	PHASE 1 RAD EXT BEAM PLAN TECH	RAD18;2	POINTER TO ONCO RADIATION EXTERNAL BEAM FILE (#164.81)	ONCO RADIATION EXTERNAL BEAM(#164.81) OUTPUT TRANSFORM: `S Y=$P($G(^ONCO(164.81,+Y,0)),U,2)` LAST EDITED: `JUL 11, 2019` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Identifies the external beam radiation planning technique used to administer the first phase of radiation treatment during the first course of treatment. This data item is required for CoC-accredited facilities as of` `01/01/2018. Rationale: External beam radiation is the most commonly-used radiation modality in North America. In this data item we specified the planning technique for external beam treatment. Identifying the radiation` `technique is of interest for patterns of care and comparative effectiveness studies.`
5503	PHASE 1 NUMBER OF FRACTIONS	RAD18;3	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) D RADPH3^ONCSCHMM` `MAXIMUM LENGTH: 3` LAST EDITED: `OCT 09, 2019` HELP-PROMPT: `Answer must be 1-3 characters in length.` DESCRIPTION: `Records the total number of fractions (treatment sessions) delivered to the patient in the first phase of radiation during the first course of treatment. This data item is required for CoC-accredited facilities as of` `01/01/2018. Rationale: Radiation therapy is delivered in one or more phases with each phase spread out over a number of fractions (treatment sessions). It is necessary to capture information describing the number of` `fraction(s) to evaluate patterns of radiation oncology care. Codes: 000 Radiation therapy was not administered to the patient. 001-998 Number of fractions administered to the patient during` `the first phase of radiation therapy. 999 Phase I Radiation therapy was administered, but the` `number of fractions is unknown; It is unknown` `whether radiation therapy was administered.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
5504	PHASE 1 RAD TREATMENT VOLUME	RAD18;4	POINTER TO ONCO RADIATION TREATMENT VOLUME FILE (#164.82)	ONCO RADIATION TREATMENT VOLUME(#164.82) OUTPUT TRANSFORM: `S Y=$P($G(^ONCO(164.82,+Y,0)),U,2)` LAST EDITED: `JUL 11, 2019` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Identifies the primary treatment volume or primary anatomic target treated during the first phase of radiation therapy during the first course of treatment. This data item is required for CoC-accredited facilities as of` `01/01/2018. Rationale: Radiation treatment is commonly delivered in one or more phases. Typically, in each phase, the primary tumor or tumor bed is treated. This data item should be used to indicate the primary target` `volume, which might include the primary tumor or tumor bed. If the primary tumor was not targeted, record the other regional or distant site that was targeted. Draining lymph nodes may also be targeted during the first` `phase. These will be identified in a separate data item Phase I Radiation to Draining Lymph Nodes [1505].` `This data item provides information describing the anatomical structure targeted by radiation therapy during the first phase of radiation treatment and can be used to determine whether the site of the primary diseases was` `treated with radiation or if other regional or distant sites were targeted. This information is useful in evaluating the patterns of care within a facility and on a regional or national basis. The breakdown and` `reorganization of the sites will allow for concise reporting.`
5505	PHASE 1 RAD TO DRAINING LN	RAD18;5	POINTER TO ONCO RADIATION TO DRAINING LN FILE (#164.83)	ONCO RADIATION TO DRAINING LN(#164.83) OUTPUT TRANSFORM: `S Y=$P($G(^ONCO(164.83,+Y,0)),U,2)` LAST EDITED: `JUL 11, 2019` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Identifies the draining lymph nodes treated (if any) during the first phase of radiation therapy delivered to the patient during the first course of treatment. This data item is required for CoC-accredited facilities as of` `01/01/2018. Rationale: The first phase of radiation treatment commonly targets both the primary tumor (or tumor bed) and draining lymph nodes as a secondary site. This data item should be used to indicate the draining` `regional lymph nodes, if any, that were irradiated during the first phase of radiation.`
5506	PHASE 1 RAD TREATMENT MODALITY	RAD18;6	POINTER TO ONCO RADIATION TREATMENT MODALITY FILE (#164.84)	ONCO RADIATION TREATMENT MODALITY(#164.84) OUTPUT TRANSFORM: `S Y=$P($G(^ONCO(164.84,+Y,0)),U,2)` LAST EDITED: `JUL 11, 2019` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Identifies the radiation modality administered during the first phase of radiation treatment delivered during the first course of treatment. This data item is required for CoC-accredited facilities as of 01/01/2018.` `Rationale: Radiation modality reflects whether a treatment was external beam, brachytherapy, a radioisotope as well as their major subtypes, or a combination of modalities. This data item should be used to indicate the` `radiation modality administered during the first phase of radiation.`
5507	PHASE 1 TOTAL DOSE	RAD18;7	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>6!($L(X)<1)!'(X?1.6N) X I $D(X) D RADPH6^ONCSCHMM` `MAXIMUM LENGTH: 6` LAST EDITED: `OCT 09, 2019` HELP-PROMPT: `Answer must be 1-6 characters in length.` DESCRIPTION: `Identifies the total radiation dose delivered to the patient in the first phase of radiation treatment during the first course of treatment. The unit of measure is centiGray (cGy). This data item is required for` `CoC-accredited facilities as of 01/01/2018. Rationale: To evaluate the patterns of radiation care, it is necessary to capture information describing the prescribed dose of Phase I radiation to the patient during the first` `course of treatment. Outcomes are strongly related to the total dose delivered. Codes: 000000 No therapy administered 000001-999997 Record the actual total dose delivered in cGy 999998 Not applicable, radioisotopes` `administered` `to the patient 999999 Radiation therapy was administered, but the` `dose is unknown; it is unknown whether` `radiation therapy was administered` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
5511	PHASE 2 DOSE PER FRACTION	RAD18;8	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>5!($L(X)<1)!'(X?1.5N) X I $D(X) D RADPH5^ONCSCHMM` `MAXIMUM LENGTH: 5` LAST EDITED: `OCT 09, 2019` HELP-PROMPT: `Answer must be 1-5 characters in length.` DESCRIPTION: `Records the dose per fraction (treatment session) delivered to the patient in the second phase of radiation during the first course of treatment. The unit of measure is centiGray (cGy). This data item is required for` `CoC-accredited facilities as of 01/01/2018. Rationale: Radiation therapy is delivered in one or more phases with identified dose per fraction. It is necessary to capture information describing the dose per fraction to` `evaluate patterns of radiation oncology care. Outcomes are strongly related to the dose delivered. Codes: 00000 Radiation therapy was not administered 00001-99997 Record the actual Phase II dose delivered in cGy 99998` `Not applicable, brachytherapy or` `radioisotopes administered to the patient 99999 Regional radiation therapy was administered` `but dose is unknown, it is unknown whether` `radiation therapy was administered.` `Death Certificate only.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
5512	PHASE 2 RAD EXT BEAM PLAN TECH	RAD18;9	POINTER TO ONCO RADIATION EXTERNAL BEAM FILE (#164.81)	ONCO RADIATION EXTERNAL BEAM(#164.81) OUTPUT TRANSFORM: `S Y=$P($G(^ONCO(164.81,+Y,0)),U,2)` LAST EDITED: `JUL 11, 2019` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Identifies the external beam radiation planning technique used to administer the second phase of radiation treatment during the first course of treatment. This data item is required for CoC-accredited facilities for cases` `diagnosed as of 01/01/2018. Rationale: External beam radiation is the most commonly-used radiation modality in North America. In this data item we specified the planning technique for external beam treatment. Identifying` `the radiation technique is of interest for patterns of care and comparative effectiveness studies.`
5513	PHASE 2 NUMBER OF FRACTIONS	RAD18;10	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) D RADPH3^ONCSCHMM` `MAXIMUM LENGTH: 3` LAST EDITED: `OCT 09, 2019` HELP-PROMPT: `Answer must be 1-3 characters in length.` DESCRIPTION: `Records the total number of fractions (treatment sessions) administered to the patient in the second phase of radiation during the first course of treatment. This data item is required for CoC-accredited facilities for` `cases diagnosed as of 01/01/2018. Rationale: Radiation therapy is delivered in one or more phases with each phase spread out over a number of fractions (treatment sessions). It is necessary to capture information` `describing the number of fraction(s) to evaluate patterns of radiation oncology care. Codes: 000 Radiation therapy was not administered to the patient 001-998 Number of fractions administered to the patient during` `the second phase of radiation therapy 999 Phase II Radiation therapy was administered, but the` `number of fractions is unknown; It is unknown whether` `radiation therapy was administered` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
5514	PHASE 2 RAD TREATMENT VOLUME	RAD18;11	POINTER TO ONCO RADIATION TREATMENT VOLUME FILE (#164.82)	ONCO RADIATION TREATMENT VOLUME(#164.82) OUTPUT TRANSFORM: `S Y=$P($G(^ONCO(164.82,+Y,0)),U,2)` LAST EDITED: `JUL 11, 2019` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Identifies the primary treatment volume or primary anatomic target treated during the second phase of radiation therapy during the first course of treatment. This data item is required for CoC-accredited facilities as of` `cases diagnosed 01/01/2018. Rationale: Radiation treatment is commonly delivered in one or more phases. Typically, in each phase, the primary tumor or tumor bed is treated. This data item should be used to indicate the` `primary target volume, which might include the primary tumor or tumor bed. If the primary tumor was not targeted, record the other regional or distant site that was targeted. Draining lymph nodes may also be targeted` `during the second phase. These will be identified in a separate data item Phase II Radiation to Draining Lymph Nodes [1515].`
5515	PHASE 2 RAD TO DRAINING LN	RAD18;12	POINTER TO ONCO RADIATION TO DRAINING LN FILE (#164.83)	ONCO RADIATION TO DRAINING LN(#164.83) OUTPUT TRANSFORM: `S Y=$P($G(^ONCO(164.83,+Y,0)),U,2)` LAST EDITED: `JUL 11, 2019` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Identifies the draining lymph nodes treated (if any) during the second phase of radiation therapy delivered to the patient during the first course of treatment. This data item is required for CoC-accredited facilities as` `of cases diagnosed 01/01/2018. Rationale: The second phase of radiation treatment commonly targets both the primary tumor (or tumor bed) and draining lymph nodes as a secondary site. This data item should be used to` `indicate the draining regional lymph nodes, if any, that were irradiated during the second phase of radiation.`
5516	PHASE 2 RAD TREATMENT MODALITY	RAD18;13	POINTER TO ONCO RADIATION TREATMENT MODALITY FILE (#164.84)	ONCO RADIATION TREATMENT MODALITY(#164.84) OUTPUT TRANSFORM: `S Y=$P($G(^ONCO(164.84,+Y,0)),U,2)` LAST EDITED: `JUL 11, 2019` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Identifies the radiation modality administered during the second phase of radiation treatment delivered during the first course of treatment. This data item is required for CoC-accredited facilities as of 01/01/2018.` `Rationale: Radiation modality reflects whether a treatment was external beam, brachytherapy, a radioisotope as well as their major subtypes, or a combination of modalities. This data item should be used to indicate the` `radiation modality administered during the second phase of radiation.`
5517	PHASE 2 TOTAL DOSE	RAD18;14	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>6!($L(X)<1)!'(X?1.6N) X I $D(X) D RADPH6^ONCSCHMM` `MAXIMUM LENGTH: 6` LAST EDITED: `OCT 09, 2019` HELP-PROMPT: `Answer must be 1-6 characters in length.` DESCRIPTION: `Identifies the total radiation dose administered in the second phase of radiation treatment delivered to the patient during the first course of treatment. The unit of measure is centiGray (cGy). This data item is required` `for CoC-accredited facilities for cases diagnosed as of 01/01/2018. Rationale: To evaluate the patterns of radiation care, it is necessary to capture information describing the prescribed dose of Phase II radiation to the` `patient during the first course of treatment. Outcomes are strongly related to the total dose delivered. Codes 000000 No radiation treatment 000001-999997 Record the actual total dose delivered in cGy 999998 Not` `applicable, brachytherapy or radioisotopes` `administered to the patient 999999 Radiation therapy was administered, but the` `dose is unknown; it is unknown whether` `radiation therapy was administered` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
5521	PHASE 3 DOSE PER FRACTION	RAD18;15	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>5!($L(X)<1)!'(X?1.5N) X I $D(X) D RADPH5^ONCSCHMM` `MAXIMUM LENGTH: 5` LAST EDITED: `OCT 09, 2019` HELP-PROMPT: `Answer must be 1-5 characters in length.` DESCRIPTION: `Records the dose per fraction (treatment session) delivered to the patient in the third phase of radiation during the first course of treatment. The unit of measure is centiGray (cGy). This data item is required for` `CoC-accredited facilities as of 01/01/2018. Rationale: Radiation therapy is delivered in one or more phases with identified dose per fraction. It is necessary to capture information describing the dose per fraction to` `evaluate patterns of radiation oncology care. Outcomes are strongly related to the dose delivered. Codes: 00000 Radiation therapy was not administered 00001-99997 Record the actual Phase II dose delivered in cGy 99998` `Not applicable, brachytherapy or` `radioisotopes administered to the patient 99999 Regional radiation therapy was administered` `but dose is unknown, it is unknown whether` `radiation therapy was administered.` `Death Certificate only.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
5522	PHASE 3 RAD EXT BEAM PLAN TECH	RAD18;16	POINTER TO ONCO RADIATION EXTERNAL BEAM FILE (#164.81)	ONCO RADIATION EXTERNAL BEAM(#164.81) OUTPUT TRANSFORM: `S Y=$P($G(^ONCO(164.81,+Y,0)),U,2)` LAST EDITED: `JUL 11, 2019` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Identifies the external beam radiation planning technique used to administer the third phase of radiation treatment during the first course of treatment. This data item is required for CoC-accredited facilities for cases` `diagnosed as of 01/01/2018. Rationale: External beam radiation is the most commonly-used radiation modality in North America. In this data item we specified the planning technique for external beam treatment. Identifying` `the radiation technique is of interest for patterns of care and comparative effectiveness studies.`
5523	PHASE 3 NUMBER OF FRACTIONS	RAD18;17	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>3!($L(X)<1)!'(X?1.3N) X I $D(X) D RADPH3^ONCSCHMM` `MAXIMUM LENGTH: 3` LAST EDITED: `OCT 09, 2019` HELP-PROMPT: `Answer must be 1-3 characters in length.` DESCRIPTION: `Records the total number of fractions (treatment sessions) administered to the patient in the third phase of radiation during the first course of treatment. This data item is required for CoC-accredited facilities for` `cases diagnosed as of 01/01/2018. Rationale: Radiation therapy is delivered in one or more phases with each phase spread out over a number of fractions (treatment sessions). It is necessary to capture information` `describing the number of fraction(s) to evaluate patterns of radiation oncology care. Codes: 000 Radiation therapy was not administered to the patient 001-998 Number of fractions administered to the patient during` `the third phase of radiation therapy 999 Phase II Radiation therapy was administered, but the` `number of fractions is unknown; It is unknown whether` `radiation therapy was administered` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
5524	PHASE 3 RAD TREATMENT VOLUME	RAD18;18	POINTER TO ONCO RADIATION TREATMENT VOLUME FILE (#164.82)	ONCO RADIATION TREATMENT VOLUME(#164.82) OUTPUT TRANSFORM: `S Y=$P($G(^ONCO(164.82,+Y,0)),U,2)` LAST EDITED: `JUL 11, 2019` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Identifies the primary treatment volume or primary anatomic target treated during the third phase of radiation therapy during the first course of treatment. This data item is required for CoC-accredited facilities as of` `cases diagnosed 01/01/2018. Rationale: Radiation treatment is commonly delivered in one or more phases. Typically, in each phase, the primary tumor or tumor bed is treated. This data item should be used to indicate the` `primary target volume, which might include the primary tumor or tumor bed. If the primary tumor was not targeted, record the other regional or distant site that was targeted. Draining lymph nodes may also be targeted` `during the second phase. These will be identified in a separate data item Phase II Radiation to Draining Lymph Nodes [1515].`
5525	PHASE 3 RAD TO DRAINING LN	RAD18;19	POINTER TO ONCO RADIATION TO DRAINING LN FILE (#164.83)	ONCO RADIATION TO DRAINING LN(#164.83) OUTPUT TRANSFORM: `S Y=$P($G(^ONCO(164.83,+Y,0)),U,2)` LAST EDITED: `JUL 11, 2019` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Identifies the draining lymph nodes treated (if any) during the third phase of radiation therapy delivered to the patient during the first course of treatment. This data item is required for CoC-accredited facilities as of` `cases diagnosed 01/01/2018. Rationale: The third phase of radiation treatment commonly targets both the primary tumor (or tumor bed) and draining lymph nodes as a secondary site. This data item should be used to indicate` `the draining regional lymph nodes, if any, that were irradiated during the second phase of radiation.`
5526	PHASE 3 RAD TREATMENT MODALITY	RAD18;20	POINTER TO ONCO RADIATION TREATMENT MODALITY FILE (#164.84)	ONCO RADIATION TREATMENT MODALITY(#164.84) OUTPUT TRANSFORM: `S Y=$P($G(^ONCO(164.84,+Y,0)),U,2)` LAST EDITED: `JUL 11, 2019` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Identifies the radiation modality administered during the third phase of radiation treatment delivered during the first course of treatment. This data item is required for CoC-accredited facilities as of 01/01/2018.` `Rationale: Radiation modality reflects whether a treatment was external beam, brachytherapy, a radioisotope as well as their major subtypes, or a combination of modalities. This data item should be used to indicate the` `radiation modality administered during the second phase of radiation.`
5527	PHASE 3 TOTAL DOSE	RAD18;21	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>6!($L(X)<1)!'(X?1.6N) X I $D(X) D RADPH6^ONCSCHMM` `MAXIMUM LENGTH: 6` LAST EDITED: `OCT 09, 2019` HELP-PROMPT: `Answer must be 1-6 characters in length.` DESCRIPTION: `Identifies the total radiation dose administered in the second phase of radiation treatment delivered to the patient during the first course of treatment. The unit of measure is centiGray (cGy). This data item is required` `for CoC-accredited facilities for cases diagnosed as of 01/01/2018. Rationale: To evaluate the patterns of radiation care, it is necessary to capture information describing the prescribed dose of Phase II radiation to the` `patient during the first course of treatment. Outcomes are strongly related to the total dose delivered. Codes 000000 No radiation treatment 000001-999997 Record the actual total dose delivered in cGy 999998 Not` `applicable, brachytherapy or radioisotopes` `administered to the patient 999999 Radiation therapy was administered, but the` `dose is unknown; it is unknown whether` `radiation therapy was administered` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
7000	STATE AT DX GEOCODE 1970/80/90	NCR18;1	POINTER TO STATE FILE (#5)	STATE(#5) LAST EDITED: `FEB 06, 2019` HELP-PROMPT: `Enter a valid state.` DESCRIPTION: `Code for the state of the patient's residence at the time the tumor was diagnosed is a derived (geocoded) variable based on Census Boundary files from 1970, 1980, or 1990 Decennial Census. Rationale: Populating the` `GeoLocationID 70/80/90 [351] correctly requires FIPS code for state and not the USPS abbreviations. Also, on rare occasions, the boundaries of states do change (North Carolina and South Carolina border, for example).`
7001	STATE AT DX GEOCODE 2010	NCR18;2	POINTER TO STATE FILE (#5)	STATE(#5) LAST EDITED: `FEB 06, 2019` HELP-PROMPT: `Enter a valid state.` DESCRIPTION: `Code for the state of the patient's residence at the time the tumor was diagnosed is a derived (geocoded) variable based on Census Boundary files from 2010 Decennial Census. Rationale: Populating the GeoLocationID 2010` `[353] correctly requires FIPS code for state and not the USPS abbreviations. Also, on rare occasions, the boundaries of states do change (North Carolina and South Carolina border, for example).`
7002	BEHAVIOR (73-91) ICD-O-1	NCR18;3	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>9)!(X<0)!(X?.E1"."1N.N) X` LAST EDITED: `FEB 06, 2019` HELP-PROMPT: `Type a number between 0 and 9, 0 decimal digits.` DESCRIPTION: `Area for retaining behavior portion (1 digit) of the ICD-O-1 or field trial morphology codes entered before a conversion to ICD-O-2. See grouped data item Morph (73-91) ICD-O-1 [1970] in Appendix E. The item name includes` `years 73-91. However, some states may have used the codes for cases before 1973. It is a subfield of the morphology code. Codes: For tumors diagnosed before 1992, contains the ICD-O-1 or field trial 1-digit behavior code` `as originally coded, if available. Blank for tumors coded directly into a later version of ICD-O.`
7003	GRADE (73-91) ICD-O-1	NCR18;4	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>9)!(X<0)!(X?.E1"."1N.N) X` LAST EDITED: `FEB 06, 2019` HELP-PROMPT: `Type a number between 0 and 9, 0 decimal digits.` DESCRIPTION: `Area for retaining the grade portion (1 digit) of the ICD-O-1 or field trial grade code entered before a conversion to ICD-O-2. See grouped data item Morph (73-91) ICD-O-1 [1970] in Appendix E. The item name includes years` `1973-91. However, some states may have used the codes for cases before 1973. Codes: For cases diagnosed before 1992, contains the ICD-O-1 or field trial 1-digit grade code as originally coded, if available.`
7004	RUCA 2000	NCR18;5	SET	'1' FOR Urban commuting area RUCA 1.0,1.1,2.0,2.1,3.0,4.1,5.1,7.1,8.1,10.1; '2' FOR Not an urban commuting area; '9' FOR Unknown or census tract N/A RUCA 99; LAST EDITED: `FEB 06, 2019` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `A measure of how accessible to an urban center a cancer patient's census tract at diagnosis is based on the USDA identification of urban and rural commuting areas. The variable is a binomial-either in an urban commuting` `area or not. The measure indicates proximity to large urban centers and can be an indicator of access to oncology specialists and cancer treatment facilities. Collecting the variable with each decennial census allows for` `retrospective and cross- sectional epidemiologic analysis.`
7005	RUCA 2010	NCR18;6	SET	'1' FOR Urban commuting area RUCA 1.0,1.1,2.0,2.1,3.0,4.1,5.1,7.1,8.1,10.1; '2' FOR Not an urban commuting area; '9' FOR Unknown or census tract N/A RUCA 99; LAST EDITED: `FEB 06, 2019` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `A measure of how accessible to an urban center a cancer patient's census tract at diagnosis is based on the USDA identification of urban and rural commuting areas. The variable is a binomial-either in an urban commuting` `area or not. The measure indicates proximity to large urban centers and can be an indicator of access to oncology specialists and cancer treatment facilities. Collecting the variable with each decennial census allows for` `retrospective and cross- sectional epidemiologic analysis.`
7006	URIC 2000	NCR18;7	SET	'1' FOR All Urban; '2' FOR Mostly Urban; '3' FOR Mostly Rural; '4' FOR All Rural; '9' FOR Unknown or N/A; LAST EDITED: `FEB 06, 2019` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `A measure of how urban a cancer patient's census tract at diagnosis is based on the Census Bureau's identification of urban and rural areas (already collect at county-level). The variable is a 4 code continuum. The` `measure indicates of the rural nature of the place of residence and can be an indicator of access to recreation, access to food stores, exposures to pollutants, crime levels, social cohesion, etc. Collecting the variable` `with each decennial census allows for retrospective and cross-sectional epidemiologic analysis. Codes:` `1 All urban-the percent of the population in an urban area = 100%` `2 Mostly urban-the percent of the population in an urban area < 100% and = 50%` `3 Mostly rural-the percent of the population in an urban area > 0% and < 50%` `4 All rural-the percent of the population in an urban area = 0%` `9 Unknown or not applicable-census tract not available or tract population was zero at the last decadal census`
7007	URIC 2010	NCR18;8	SET	'1' FOR All Urban; '2' FOR Mostly Urban; '3' FOR Mostly Rural; '4' FOR All Rural; '9' FOR Unknown or N/A; LAST EDITED: `FEB 06, 2019` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `A measure of how urban a cancer patient's census tract at diagnosis is based on the Census Bureau's identification of urban and rural areas (already collect at county-level). The variable is a 4 code continuum. The` `measure indicates of the rural nature of the place of residence and can be an indicator of access to recreation, access to food stores, exposures to pollutants, crime levels, social cohesion, etc. Collecting the variable` `with each decennial census allows for retrospective and cross-sectional epidemiologic analysis. Codes:` `1 All urban-the percent of the population in an urban area = 100%` `2 Mostly urban-the percent of the population in an urban area < 100% and = 50%` `3 Mostly rural-the percent of the population in an urban area > 0% and < 50%` `4 All rural-the percent of the population in an urban area = 0%` `9 Unknown or not applicable-census tract not available or tract population was zero at the last decadal census`
7008	DERIVED EOD 2018 T	NCR18;9	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>15!($L(X)<1) X` `MAXIMUM LENGTH: 15` LAST EDITED: `FEB 06, 2019` HELP-PROMPT: `Answer must be 1-15 characters in length.` DESCRIPTION: `This item stores the derived EOD 2018 T value derived from coded fields using the EOD algorithm. Effective for cases diagnosed 1/1/2018+. Rationale: Derived EOD 2018 T can be used to evaluate disease spread at diagnosis,` `treatment patterns and outcomes over time.` `Derived EOD 2018 T is only available at the central registry level. Codes: See the most current version of EOD (https://staging.seer.cancer.gov/) for rules and site-specific codes and coding structures.`
7009	DERIVED EOD 2018 N	NCR18;10	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>15!($L(X)<1) X` `MAXIMUM LENGTH: 15` LAST EDITED: `FEB 06, 2019` HELP-PROMPT: `Answer must be 1-15 characters in length.` DESCRIPTION: `This item stores the derived EOD 2018 N value derived from coded fields using the EOD algorithm. Effective for cases diagnosed 1/1/2018+. Rationale: Derived EOD 2018 N can be used to evaluate disease spread at diagnosis,` `treatment patterns and outcomes over time.` `Derived EOD 2018 N is only available at the central registry level. Codes: See the most current version of EOD (https://staging.seer.cancer.gov/) for rules and site-specific codes and coding structures.`
7010	DERIVED EOD 2018 M	NCR18;11	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>15!($L(X)<1) X` `MAXIMUM LENGTH: 15` LAST EDITED: `FEB 06, 2019` HELP-PROMPT: `Answer must be 1-15 characters in length.` DESCRIPTION: `This item stores the derived EOD 2018 M value derived from coded fields using the EOD algorithm. Effective for cases diagnosed 1/1/2018+. Rationale: Derived EOD 2018 M can be used to evaluate disease spread at diagnosis,` `treatment patterns and outcomes over time.` `Derived EOD 2018 M is only available at the central registry level. Codes: See the most current version of EOD (https://staging.seer.cancer.gov/) for rules and site-specific codes and coding structures.`
7011	DERIVED EOD 2018 STAGE GROUP	NCR18;12	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>15!($L(X)<1) X` `MAXIMUM LENGTH: 15` LAST EDITED: `FEB 06, 2019` HELP-PROMPT: `Answer must be 1-15 characters in length.` DESCRIPTION: `This item stores the derived EOD 2018 SG value derived from coded fields using the EOD algorithm. Effective for cases diagnosed 1/1/2018+. Rationale: Derived EOD 2018 SG can be used to evaluate disease spread at` `diagnosis, treatment patterns and outcomes over time.` `Derived EOD 2018 SG is only available at the central registry level. Codes: See the most current version of EOD (https://staging.seer.cancer.gov/) for rules and site-specific codes and coding structures.`
7012	DERIVED SUMMARY STAGE 2018	NCR18;13	SET	'0' FOR In situ; '1' FOR Localized; '2' FOR Regional, direct ext only; '3' FOR Regional, reg LN only; '4' FOR Regional, direct ext and reg LN; '7' FOR Distant; '8' FOR Benign, borderline; '9' FOR Unknown; LAST EDITED: `FEB 06, 2019` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Derived Summary Stage 2018 is derived using the EOD data collection system (EOD Primary Tumor [772], EOD Regional Nodes [774] and EOD Mets [776]) algorithm. Other data items may be included in the derivation process.` `Effective for cases diagnosed 1/1/2018+. Rationale: The SEER program has collected staging information on cases since its inception in 1973. Summary Stage groups cases into broad categories of in situ, local, regional,` `and distant. Summary Stage can be used to evaluate disease spread at diagnosis, treatment patterns and outcomes over time.` NOTES: `TRIGGERED by the SUMMARY STAGE 2018 field of the ONCOLOGY PRIMARY File`
7013	DATE REGIONAL LN DISSECTION	NCR18;14	DATE	INPUT TRANSFORM: `D DFIT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `OCT 17, 2019` HELP-PROMPT: `Enter the date NON-SENTINEL regional node dissection was performed.` DESCRIPTION: `Records the date NON-SENTINEL regional node dissection was performed. This data item is required for CoC-accredited facilities as of cases diagnosed 01/01/2018 and later. Rationale: It is a known fact that sentinel lymph` `node biopsies have been under-reported. Additionally, the timing and results of sentinel lymph node biopsy procedures are used in quality of care measures. This data item can be used to more accurately assess the date of` `regional node dissection separate from the date of sentinel lymph node biopsy if performed.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
7014	DATE REG LN DISSECTION FLAG	NCR18;15	SET	'10' FOR No information whatsoever can be inferred from this exceptional value; '11' FOR No proper value is applicable in this context; '12' FOR A proper value is applicable but not known; LAST EDITED: `FEB 06, 2019` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `This flag explains why there is no appropriate value in the corresponding date data item, Date of Regional Lymph Node Dissection [682]. This data item is required for CoC-accredited facilities as of cases diagnosed` `01/01/2018 and later.` `Coding Instructions: -Leave this item blank if Date of Regional Lymph Node Dissection has a` `full or partial date recorded -Code 10 if it is unknown whether Regional Lymph Nodes were dissected. -Code 11 if no Regional Lymph Nodes were dissected. -Code 12 if the Date of the Regional Lymph Node Dissection` `cannot be` `determined, but regional lymph nodes were dissected.`
7015	SENTINEL LYMPH NODES POSITIVE	NCR18;16	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) D GEN2^ONCSCHMM` `MAXIMUM LENGTH: 2` LAST EDITED: `SEP 18, 2019` HELP-PROMPT: `Answer must be 1-2 characters in length.` DESCRIPTION: `Records the exact number of sentinel lymph nodes biopsied by the pathologist and found to contain metastases. This data item is required for CoC-accredited facilities as of cases diagnosed 01/01/2018 and later. This data` `item is required for breast and melanoma cases only. Rationale: It is a known fact that sentinel lymph node biopsies have been under- reported. Additionally, the timing and results of sentinel lymph node biopsy procedures` `are used in quality of care measures. This data item can be used to more accurately assess the number of positive sentinel lymph nodes biopsied separate from the number of positive lymph nodes identified during additional` `subsequent regional node dissection procedures, if performed. Codes: 00 All sentinel nodes examined are negative 01-90 Sentinel nodes are positive (code exact number of nodes positive) 95 Positive aspiration of` `sentinel lymph node(s) was performed 97 Positive sentinel nodes are documented, but the number is unspecified; For breast ONLY: SLN and RLND occurred during the same procedure 98 No sentinel nodes were biopsied 99 It is` `unknown whether sentinel nodes are positive; not applicable; not stated in patient record` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
7016	SENTINEL LYMPH NODES EXAMINED	NCR18;17	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>2!($L(X)<1)!'(X?1.2N) X I $D(X) D GEN2^ONCSCHMM` `MAXIMUM LENGTH: 2` LAST EDITED: `SEP 18, 2019` HELP-PROMPT: `Answer must be 1-2 characters in length.` DESCRIPTION: `Records the exact number of sentinel lymph nodes biopsied by the pathologist and found to contain metastases. This data item is required for CoC-accredited facilities as of cases diagnosed 01/01/2018 and later. This data` `item is required for breast and melanoma cases only. Rationale: It is a known fact that sentinel lymph node biopsies have been under- reported. Additionally, the timing and results of sentinel lymph node biopsy procedures` `are used in quality of care measures. This data item can be used to more accurately assess the number of positive sentinel lymph nodes biopsied separate from the number of positive lymph nodes identified during additional` `subsequent regional node dissection procedures, if performed. Codes: 00 No sentinel nodes were examined 01-90 Sentinel nodes were examined (code the exact number of sentinel lymph nodes examined) 95 No sentinel nodes` `were removed, but aspiration of sentinel node(s) was perf ormed 98 Sentinel lymph nodes were biopsied, but the number is unknown 99 It is unknown whether sentinel nodes were examined; not stated in patient record` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
7017	DATE OF SENTINEL LN BIOPSY	NCR18;18	DATE	INPUT TRANSFORM: `D DFIT^ONCODSR` OUTPUT TRANSFORM: `S X=Y D DATEOT^ONCOES` LAST EDITED: `OCT 07, 2019` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Records the date of the sentinel lymph node(s) biopsy procedure. This data item is required for CoC-accredited facilities as of cases diagnosed 01/01/2018 and later. This data item is required for breast and melanoma` `cases only.` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
7018	DATE OF SENTINEL LN BIOPSY FLG	NCR18;19	SET	'10' FOR No information whatsoever can be inferred from this exceptional value; '11' FOR No proper value is applicable in this context; '12' FOR A proper value is applicable but unknown; LAST EDITED: `FEB 06, 2019` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `This flag explains why there is no appropriate value in the corresponding date data item, Date of Sentinel Lymph Node Biopsy [832]. This data item is required for CoC-accredited facilities as of cases diagnosed 01/01/2018` `and later. This data item is required for breast and melanoma cases only.` `Coding Instructions: -Leave this item blank if Date of Sentinel Lymph Node Biopsy has a full` `or partial date recorded. -Code 10 if it is unknown whether sentinel lymph nodes were biopsied. -Code 11 if no sentinel lymph node biopsy was performed. -Code 12 if the Date of Sentinel Lymph Node Biopsy cannot be` `determined,` `but a sentinel lymph node biopsy was performed.`
7019	NPCR DERIVED AJCC8 CLN STG GRP	NCR18;20	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>15!($L(X)<1) X` `MAXIMUM LENGTH: 15` LAST EDITED: `FEB 06, 2019` HELP-PROMPT: `Answer must be 1-15 characters in length.` DESCRIPTION: `This item stores the results of NPCR's derived algorithmic calculation of clinical stage group based on AJCC T, N, and M and relevant biomarkers and prognostic factors. The algorithm derives AJCC 8th ed. stage group for` `2018, however, updates to future AJCC editions are anticipated. The derived values for 7th ed. were stored in NPCR Derived Clin Stg Grp [3650]. Rationale: The purpose of the derived stage fields is to segregate data` `values for AJCC stage groups derived from the NPCR algorithm from values directly entered from the medical record or by the registrar. NPCR's primary interest is in the directly-entered values, but derived values will have` `a purpose primarily at the central registry. It is important to not mix data values from the two sources in the same data items. This item was added in 2018 because the required length to hold AJCC stage group values` `increased from 4 columns to 15. Codes (in addition to those published in the AJCC Cancer Staging Manual)` `88 Not applicable` `99 Unknown` `BlankNot staged`
7020	NPCR DERIVED AJCC8 PTH STG GRP	NCR18;21	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>15!($L(X)<1) X` `MAXIMUM LENGTH: 15` LAST EDITED: `FEB 06, 2019` HELP-PROMPT: `Answer must be 1-15 characters in length.` DESCRIPTION: `This item stores the results of NPCR's derived algorithmic calculation of pathologic stage group based on AJCC T, N, and M and relevant biomarkers and prognostic factors. The algorithm derives AJCC 8th ed. stage group for` `2018, however, updates to future AJCC editions are anticipated. The derived values for 7th ed. were stored in NPCR Derived Path Stg Grp [3650]. Rationale: The purpose of the derived stage fields is to segregate data` `values for AJCC stage groups derived from the NPCR algorithm from values directly entered from the medical record or by the registrar. NPCR's primary interest is in the directly-entered values, but derived values will have` `a purpose primarily at the central registry. It is important to not mix data values from the two sources in the same data items. This item was added in 2018 because the required length to hold AJCC stage group values` `increased from 4 columns to 15. Codes (in addition to those published in the AJCC Cancer Staging Manual)` `88 Not applicable` `99 Unknown` `BlankNot staged`
7021	NPCR DERIVED AJCC8 PT STG GRP	NCR18;22	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>15!($L(X)<1) X` `MAXIMUM LENGTH: 15` LAST EDITED: `FEB 06, 2019` HELP-PROMPT: `Answer must be 1-15 characters in length.` DESCRIPTION: `This item stores the results of NPCR's derived algorithmic calculation of post-therapy stage group based on AJCC T, N, and M and relevant biomarkers and prognostic factors. The algorithm derives AJCC 8th ed. stage group` `for 2018, however, updates to future AJCC editions are anticipated. The derived values for 7th ed. were stored in NPCR Derived Post-Therapy Stg Grp [3650]. Rationale: The purpose of the derived stage fields is to` `segregate data values for AJCC stage groups derived from the NPCR algorithm from values directly entered from the medical record or by the registrar. NPCR's primary interest is in the directly-entered values, but derived` `values will have a purpose primarily at the central registry. It is important to not mix data values from the two sources in the same data items. This item was added in 2018 because the required length to hold AJCC stage` `group values increased from 4 columns to 15. Codes (in addition to those published in the AJCC Cancer Staging Manual)` `88 Not applicable` `99 Unknown` `BlankNot staged`
7022	NPCR SPECIFIC FIELD	NCR18;23	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>75!($L(X)<1) X` `MAXIMUM LENGTH: 75` LAST EDITED: `FEB 06, 2019` HELP-PROMPT: `Answer must be 1-75 characters in length.` DESCRIPTION: `A 75 character field to be used when information for a particular primary site needs to be collected by NPCR. This field allows NPCR to retain data collected through the CER project and is a place holder when additional` `site-specific information is needed.`
7023	STATE AT DX GEOCODE 2000	NCR18;24	POINTER TO STATE FILE (#5)	STATE(#5) LAST EDITED: `FEB 06, 2019` HELP-PROMPT: `Enter a valid state.` DESCRIPTION: `Code for the state of the patient's residence at the time the tumor was diagnosed is a derived (geocoded) variable based on Census Boundary files from 2000 Decennial Census. Rationale: Populating the GeoLocationID 2000` `[353] correctly requires FIPS code for state and not the USPS abbreviations. Also, on rare occasions, the boundaries of states do change (North Carolina and South Carolina border, for example).`
7024	NUMBER OF PHASES RAD TX	NCR18B;1	SET	'00' FOR No Radiation Treatment; '01' FOR 1 phase; '02' FOR 2 phases; '03' FOR 3 phases; '04' FOR 4 or more phases; '99' FOR Unknown number of phases; LAST EDITED: `FEB 06, 2019` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Identifies the total number of phases administered to the patient during the first course of treatment. A "phase" consists of one or more consecutive treatments delivered to the same anatomic volume with no change in the` `treatment technique. Although the majority of courses of radiation therapy are completed in one or two phases (historically, the "regional" and "boost" treatments) there are occasions in which three or more phases are` `used, most typically with head and neck malignancies. This data item is required for CoC-accredited facilities as of cases diagnosed 01/01/2018 and later.`
7025	RADIATION TREATMENT DISC EARLY	NCR18B;2	SET	'00' FOR No rad TX; '01' FOR Completed as prescribed; '02' FOR Toxicity; '03' FOR Contraindicated; '04' FOR Patient decision; '05' FOR Family decision; '06' FOR Patient expired; '07' FOR Not documented; '99' FOR Unknown; LAST EDITED: `FEB 10, 2020` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `This field is used to identify patients/tumors whose radiation treatment course was discontinued earlier than initially planned. That is the patients/tumors received fewer treatment fractions (sessions) than originally` `intended by the treating physician. This data item is required for CoC-accredited facilities as of cases diagnosed 01/01/2018 and later. Codes: 00 No radiation treatment 01 Radiation treatment completed as prescribed` `02 Radiation treatment discontinued early - toxicity 03 Radiation treatment discontinued early - contraindicated due` `to other patient risk factors (comorbid conditions, advanced age,` `progression of tumor prior to planned radiation etc.) 04 Radiation treatment discontinued early - patient decision 05 Radiation discontinued early - family decision 06 Radiation discontinued early - patient` `expired 07 Radiation discontinued early - reason not documented 99 Unknown if radiation treatment discontinued; Unknown whether radiation therapy administered`
7026	TOTAL DOSE	NCR18B;3	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>6!($L(X)<1)!'(X?1.6N) X I $D(X) D RADPH6^ONCSCHMM` `MAXIMUM LENGTH: 6` LAST EDITED: `MAR 30, 2020` HELP-PROMPT: `Answer must be 1-6 characters in length.` DESCRIPTION: `Identifies the total radiation dose administered to the patient across all phases during the first course of treatment. The unit of measure is centiGray (cGy). This data item is required for CoC-accredited facilities as of` `cases diagnosed 01/01/2018 and later. To evaluate the patterns of radiation care, it is necessary to capture information describing the prescribed total dose of radiation during the first course of treatment. Outcomes are` `strongly related to the dose delivered. Codes: 000000 No radiation treatment 000001-999997 Record the actual dose delivered in cGy 999998 Not applicable, radioisotopes administered` `to the patient 999999 Radiation therapy was administered, but the` `dose is unknown; it is unknown whether` `radiation therapy was administered` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
7027	OVER-RIDE TNM STAGE	NCR18B;4	SET	'1' FOR Reviewed and confirmed as reported; LAST EDITED: `FEB 06, 2019` HELP-PROMPT: `Enter 1 or leave blank.` DESCRIPTION: `Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate` `that data in a record (or records) have been reviewed and, while unusual, are correct. This over-ride is used with the following edits in the NAACCR Metafile of the EDITS software: Primary Site, TNM Clin Stage Valid A- Ed` `7 (CoC) Primary Site, TNM Clin Stage Valid B- Ed 7 (CoC) Primary Site, TNM Path Stage Valid A- Ed 7 (CoC) Primary Site, TNM Path Stage Valid B- Ed 7 (CoC) These edits check T, N, and M combinations against stage group.` `Adding this over-ride allows the edit to pass when combinations of T, N, and M are entered that are not included in the stage tables used with the edits. Rationale This over-ride will allow registrars to enter combination` `of T, N, and M with a stage group that differs from the combinations documented in the AJCC Staging Manual. Codes:` `1 Reviewed and confirmed as reported` `BlankNot reviewed or reviewed and corrected`
7028	OVER-RIDE TNM TIS	NCR18B;5	SET	'1' FOR Reviewed and confirmed as reported; LAST EDITED: `FEB 06, 2019` HELP-PROMPT: `Enter 1 or leave blank.` DESCRIPTION: `Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate` `that data in a record (or records) have been reviewed and, while unusual, are correct. This over-ride is used with the following edits in the NAACCR Metafile of the EDITS software: TNM Clin T, N, M, In Situ (CoC) TNM Path` `T, N, M, In Situ (CoC) If the patient has a T value indicating in situ/ noninvasive, this edit verifies that the N, M, and stage group reflect in situ/noninvasive disease. However, there are certain circumstances where` `AJCC does allow a T value indicating in situ/noninvasive and N, M, and/or stage group that indicates invasive disease. An over-ride is required to accommodate these situations. Rationale This over-ride will allow` `registrars to enter combination of T, N, and M with a stage group that differs from the combinations documented in the AJCC Staging Manual. Codes:` `1 Reviewed and confirmed as reported` `BlankNot reviewed or reviewed and corrected`
7029	OVER-RIDE TNM 3	NCR18B;6	SET	'1' FOR Reviewed and confirmed as reported; LAST EDITED: `FEB 06, 2019` HELP-PROMPT: `Enter 1 or leave blank.` DESCRIPTION: `Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate` `that data in a record (or records) have been reviewed and, while unusual, are correct. Rationale This over-ride will allow registrars to enter combination of T, N, and M with a stage group that differs from the` `combinations documented in the AJCC Staging Manual. Codes:` `1 Reviewed and confirmed as reported` `BlankNot reviewed or reviewed and corrected`
7030	OVER-RIDE NAME/SEX	NCR18B;7	SET	'1' FOR Reviewed and confirmed as reported; LAST EDITED: `FEB 06, 2019` HELP-PROMPT: `Enter 1 or leave blank.` DESCRIPTION: `This over-ride is used with the following edit in the NAACCR Metafile of the EDITS software: Sex, Name-First, Date of Birth (NAACCR) Rationale: Some edits check for code combinations that are possible, but quite rare. If` `the code combination generates an error message and review of the case indicates that the codes are correct for the case, then the over-ride flag is used to skip the edit in the future. See Chapter IV, Recommended Data` `Edits and Software Coordination of Standards. Over-ride flag as used in the EDITS Software Package Edits of the type Sex, Name does not allow extremely rare or nonexistent combinations of first name and sex, such as` `John/female. Codes:` `1 Reviewed and confirmed as reported` `BlankNot reviewed or reviewed and corrected`
7031	HISTOLOGY (73-91) ICD-O-1	NCR18B;8	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>9999)!(X<0)!(X?.E1"."1N.N) X` LAST EDITED: `FEB 06, 2019` HELP-PROMPT: `Type a number between 0 and 9999, 0 decimal digits.` DESCRIPTION: `Area for retaining the histology portion (4 digits) of the ICD-O-1 or field trial morphology codes entered before a conversion to ICD-O-2. See grouped data item Morph (73-91) ICD-O-1 [1970], in Appendix E. The item name` `includes years 1973-91. However, some states may have used the codes for cases before 1973. Codes: For cases diagnosed before 1992, contains the ICD-O-1 or field trial 4-digit histology code as originally coded, if` `available. Blank for tumors coded directly into ICD-O-2 or ICD-O-3 (i.e., 1992 and later cases).`
7032	RQRS NCDB SUBMISSION FLAG	NCR18B;9	SET	'1' FOR Data Submission for RQRS; '2' FOR Data Submission for NCDB Annual Call for Data; LAST EDITED: `FEB 06, 2019` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `This flag identifies the type of data submission from reporting facilities to the CoC National Cancer Database (NCDB). This data item is required for CoC-accredited facilities with submission starting 01/01/2018.` `Rationale: CoC-accredited hospitals make multiple data submissions for various reasons: Rapid Quality Reporting System (current, generally incomplete cases) NCDB Call for Data (older, complete cases) The NCDB is moving to` `submission of data via a single data portal rather than the current separate data portals for RQRS and NCDB. This data item will facilitate identification of the purpose of the data submission at the receiving end. Codes` `1 Data Submission for RQRS` `2 Data Submission for NCDB Annual Call for Data`
7033	COC ACCREDITED FLAG	NCR18B;10	SET	'0' FOR Abstract prepared at a facility WITHOUT CoC; '1' FOR ANALYTIC abstract prepared at facility WITH CoC; '2' FOR NON-ANALYTIC abstract prepared at facility WITH CoC; LAST EDITED: `FEB 06, 2019` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `CoC Accredited Flag is assigned at the point and time of data abstraction to label an abstract being prepared for an analytic cancer case at a facility accredited by the Commission on Cancer (CoC). The flag may be assigned` `manually or can be defaulted by the registry's software. Codes` `0 Abstract prepared at a facility WITHOUT CoC` `accreditation of its cancer program` `1 ANALYTIC abstract prepared at facility WITH` `CoC accreditation of its cancer program (Includes Class of Case codes 10-22)` `2 NON-ANALYTIC abstract prepared at facility` `WITH CoC accreditation of its cancer program (Includes Class of Case codes 30-43 and 99, plus code 00 which CoC considers analytic but does not require to be staged)` `BlankNot applicable; DCO`
7034	VITAL STATUS RECODE	NCR18B;11	SET	'0' FOR Dead as of study cutoff date; '1' FOR Alive as of study cutoff date; LAST EDITED: `FEB 06, 2019` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `This variable is akin to Vital Status [1760], with the exception that any patient that dies after the follow-up cut-off date is recoded to alive as of the cut-off date. This variable is used as part of the algorithm for` `calculating the survival time recode variables (NAACCR items 1782- 1788) and is used for survival, prevalence, and multiple primary - standardized incidence ratio analyses in SEERStat. This recode is necessary to conduct` `survival and prevalence analyses outside of SEERStat using other statistical software.`
7037	RECORD NUMBER RECODE	NCR18B;14	NUMBER	INPUT TRANSFORM: `K:+X'=X!(X>99)!(X<1)!(X?.E1"."1N.N) X` LAST EDITED: `FEB 06, 2019` HELP-PROMPT: `Type a number between 1 and 99, 0 decimal digits.` DESCRIPTION: `This variable sequentially numbers a person's tumors within each dataset. The ordered values are based on date of diagnosis and then sequence number central. This variable is used as part of the algorithm for calculating` `the survival time recode variables (NAACCR items 1782-1788) and is used for survival, prevalence, and multiple primary - standardized incidence ratio analyses in SEER*Stat. Codes:` `01 Record number 01 for patient in database` `02 Record number 02 for patient in database` `...` `99 Record number 99 for patient in database`
7038	SEER CAUSE SPECIFIC COD	NCR18B;15	SET	'0' FOR Alive or dead of other cause; '1' FOR Dead (attributable to this cancer dx); '8' FOR Missing/Unknown cause of death; '9' FOR Not applicable/Not first tumor; LAST EDITED: `FEB 06, 2019` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `This variable was created for use in cause-specific survival and designates that the person died of their cancer. Adapted from http://seer.cancer.gov/causespecific/: Cause-specific survival is a net survival measure` `representing survival of a specified cause of death in the absence of other causes of death. Estimates are calculated by specifying the cause of death. Individuals who die of causes other than the specified cause are` `considered to be censored. This requires a cause of death variable that accurately captures all causes related to the specific cause. Vital records offices use algorithms to process causes of death from death certificates` `in order to identify a single, disease-specific, underlying cause of death. In some cases, attribution of a single cause of death may be difficult and misattribution may occur. For example a death may be attributed to the` `site of metastasis instead of the primary site.`
7039	SEER OTHER COD	NCR18B;16	SET	'0' FOR Alive or dead due to cancer; '1' FOR Dead (attributable to causes other than this cancer diagnosis); '8' FOR Missing/Unknown cause of death; '9' FOR Not applicable/not first tumor; LAST EDITED: `FEB 06, 2019` HELP-PROMPT: `Enter a code from the list.` DESCRIPTION: `Using the same recoding logic as the 'SEER cause-specific death classification' variable, the 'SEER other cause of death classification' variable designates that the person died of causes other than their cancer. Adapted` `from http://seer.cancer.gov/causespecific/: The 'SEER other cause of death classification' variable is used to obtain the other-cause survival probability for a cohort of patients. It is used when deaths attributed to` `causes other than cancer are treated as events and deaths from cancer are treated as censored observation. This variable is used in the SEER*Stat left-truncated life table session. -specific survival and crude probability` `of death using cause of death information.`
7040	MEDICARE BENEFICIARY ID	NCR18B;17	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>11!($L(X)<1)!'(X?1.11AN) X` `MAXIMUM LENGTH: 11` LAST EDITED: `FEB 06, 2019` HELP-PROMPT: `Answer must be 1-11 characters in length.` DESCRIPTION: `Congress passed the Medicare Access and CHIP Reauthorization ACT to remove Social Security Number (SSN) from Medicare ID card and replace the existing Medicare Health Insurance Claim Numbers with a Medicare Beneficiary` `Identifier (MBI). The MBI will be a randomly generated identifier that will not include a SSN or any personal identifiable information.`
10104	RX HOSP--SURG BREAST	3.2;4	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>4!($L(X)<4) X I $D(X) D RXSBIT^ONCOSUR1` `MAXIMUM LENGTH: 4` LAST EDITED: `AUG 29, 2022` HELP-PROMPT: `Enter the surgical procedure code performed at this facility for 2022 breast cases, 4 characters in length.` DESCRIPTION: `This field records the surgical procedure performed of the primary site at this facility. This data item is required for date of diagnosis 2022 breast cases only.` EXECUTABLE HELP: `D RXSBHP^ONCOSUR1` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
10105	RX SUMM--SURG BREAST	3.2;5	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>4!($L(X)<4) X I $D(X) D RXSBIT^ONCOSUR1` `MAXIMUM LENGTH: 4` LAST EDITED: `AUG 29, 2022` HELP-PROMPT: `Enter the surgical procedure code performed at any facility, 4 characters in length.` DESCRIPTION: `This field records the surgical procedure performed of the primary site performed at any facility. This data item is required for 2022 breast cases only.` EXECUTABLE HELP: `D RXSBHP^ONCOSUR1` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
10106	RX HOSP--RECON BREAST	3.2;6	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>4!($L(X)<4) X I $D(X) D RXRECIT^ONCOSUR1` `MAXIMUM LENGTH: 4` LAST EDITED: `AUG 29, 2022` HELP-PROMPT: `Enter the reconstruction procedure performed at this facility, 4 characters in length.` DESCRIPTION: `This field records the reconstruction procedure immediately following resection performed at this facility. This data item is required for 2022 breast cases only.` EXECUTABLE HELP: `D RXRECHP^ONCOSUR1` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`
10107	RX SUMM--RECON BREAST	3.2;7	FREE TEXT	INPUT TRANSFORM: `K:$L(X)>4!($L(X)<4) X I $D(X) D RXRECIT^ONCOSUR1` `MAXIMUM LENGTH: 4` LAST EDITED: `AUG 29, 2022` HELP-PROMPT: `Enter the reconstruction procedure performed at any facility, 4 characters in length.` DESCRIPTION: `This field records the reconstruction procedure immediately following resection performed at any facility. This data item is required for 2022 breast cases only.` EXECUTABLE HELP: `D RXRECHP^ONCOSUR1` NOTES: `XXXX--CAN'T BE ALTERED EXCEPT BY PROGRAMMER`

Customize PDF page

Package: Oncology

Global: ^ONCO(165.5

Information

Description

Accessed By FileMan Db Calls, Total: 201

Pointed To By FileMan Files, Total: 1

Pointer To FileMan Files, Total: 42

Fields, Total: 1896

ICR, Total: 1